{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-120b",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 800,
    "successful_questions_in_experiment": 800,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 800,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/gpt-oss-120b/e5_page_window_relevance_asc/qualitative_3hop_cross_year_type2.json",
    "timestamp": "2026-02-05T02:30:17.349157"
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "- Fiscal 2022: $606 million of 5.000 % senior notes due April 2030 were outstanding.  \n- Fiscal 2023: the same $606 million remained outstanding (no new issuance or repayment).  \n- Fiscal 2024: the balance was still $606 million (the amount shown in the 2024 10‑K table).\n\nThe amount has been unchanged for three consecutive years, indicating that Broadcom has deliberately kept the exposure to this relatively high‑coupon, long‑dated debt flat while using other issuances and repayments (new senior notes, term‑loan retirements, the VMware‑related debt assumption, etc.) to reshape its overall capital structure. This stability reflects a debt‑management approach that preserves existing financing terms rather than expanding or aggressively retiring this particular tranche.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. According to the ground truth, AVGO's exposure to the 5.000% notes due April 2030 was $1,086 million in 2022, not $606 million as stated by the LLM. The LLM claims the amount was $606 million in all three years, but the truth is it decreased from $1,086M to $606M between 2022 and 2023, then remained flat. This error fundamentally misrepresents the evolution of the debt. (2) The numbers are therefore inaccurate: the 2022 figure is off by $480 million, a significant miscalculation. The 2023 and 2024 figures ($606M) are correct, but the failure to reflect the reduction from 2022 undermines the entire analysis. (3) The reasoning is partially sound in that it attempts multi-hop synthesis and infers a debt management strategy, but it draws the wrong conclusion. The ground truth indicates a deliberate *reduction* in exposure, while the LLM interprets stability over three years—based on incorrect data—as a strategy of maintaining flat exposure. This mischaracterizes the company's actions. (4) Contextual relevance is fair because the LLM addresses the right financial instrument, company, and time frame, and attempts to interpret strategic intent. However, due to the major quantitative error, the qualitative and overall correctness scores are low. The answer fails the primary requirement of factual accuracy in financial data, which is critical in SEC-based analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 404,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement for the closed block has essentially stayed unchanged. The 2022 filing notes that the company “reinsured … 59.25 % of the closed block through a modified coinsurance agreement” (2022 10‑K, p. 214); the 2023 filing reports the same relationship at “59 % of the closed block” (2023 10‑K, p. 227‑229); and the 2024 filing again states it “has reinsured … 59 % of the closed block through a modified coinsurance agreement” (2024 10‑K, p. 204). This steady‑state transfer of roughly sixty percent of the closed‑block risk shows that MetLife is deliberately using a long‑term reinsurance strategy that consistently cedes a fixed portion of risk to obtain capacity and risk‑mitigation benefits while retaining a substantial share of the block’s upside and cash‑flow exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all percentages are correct: 59.25% in 2022, 59% in 2023, and 59% in 2024, matching the original answer exactly. The LLM correctly identifies the consistent use of the modified coinsurance agreement across all three years. (2) The answer addresses both parts of the question: the evolution (or lack thereof) in MetLife’s use of the agreement and the implication of the stable risk transfer percentage. (3) Entity accuracy is strong—MetLife, the closed block, modified coinsurance agreement, and correct years are all properly identified. (4) The reasoning is sound: the LLM correctly infers that the consistency reflects a deliberate long-term reinsurance strategy focused on risk mitigation and capacity, while retaining upside—this is semantically equivalent to the ground truth’s conclusion about capital optimization and risk transfer efficiency. The only minor shortcoming is that the LLM omits mention of the accounting method (deposit method) and the right of offset, which are part of the full operational picture. Additionally, while the LLM notes the stability of the ceded percentage, it does not reference the significant growth in total net ceded reinsurance recoverables from $6.3B to $17.6B, which in context further highlights the strategic consistency. These omissions are minor and do not undermine the core correctness, hence a 9/10 for correctness and qualitative accuracy. Quantitative accuracy and contextual relevance are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 423,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil reported $1.494 billion of collateral under master‑netting arrangements in 2022, which fell to $800 million in 2023 and further to $491 million in 2024 – a total reduction of about $1.0 billion over the two‑year span.  The downward trend implies that the company’s derivative positions have required less initial‑margin backing, suggesting that its exposure to derivatives is being managed more efficiently (e.g., through tighter netting, reduced notional exposure or more effective hedging).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1,494 million (or $1.494 billion) in 2022, $800 million in 2023, and $491 million in 2024, matching the ground truth exactly despite format variation (billion vs million). The total reduction is approximately $1.003 billion, which the model rounds to $1.0 billion—this is acceptable and common in financial reporting.\n\n2) Quantitatively, all figures are accurate. The model correctly captures the direction and magnitude of change across years. No calculation errors are present.\n\n3) The reasoning is sound and aligns with the ground truth: the declining collateral suggests reduced derivative exposure or improved netting/hedging efficiency. The LLM elaborates slightly more by mentioning 'initial-margin backing' and specific mechanisms like 'tighter netting, reduced notional exposure, or more effective hedging,' which are reasonable interpretations and add value without contradicting the original.\n\n4) The only minor gap is that the original answer frames the trend as occurring over a three-year period (2022–2024), while the LLM refers to a 'two-year span' (2023–2024), which slightly misrepresents the timeframe. However, all three years are correctly cited, so this is a wording nuance rather than a factual error.\n\nOverall, the answer is factually correct, complete, and contextually appropriate, with excellent multi-hop synthesis across years and financial concepts. The minor phrasing issue prevents a perfect 10 but does not undermine the accuracy or insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 421,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "- **Fiscal 2022:** The 3.625 % senior notes that mature in October 2024 were carried at **about $622 million** (the amount shown for the same series in the 2022 filing).  \n- **Fiscal 2023:** The same tranche remained on the balance sheet at **$622 million** – no additional issuance or amortization was recorded.  \n- **Fiscal 2024:** The line for the 3.625 % notes due October 2024 shows a “‑” (zero) amount, indicating the notes were **fully repaid** during 2024.\n\n**What this shows:** AVGO kept the exposure flat through 2023 and then eliminated it in 2024, using cash generated from the October‑2024 senior‑note issuance (and other merger‑related financing) to retire the older 3.625 % notes before they matured. This reflects a deliberate refinancing strategy: the company replaces existing debt with new, larger‑issue senior notes, thereby reducing the number of outstanding series and simplifying its debt profile while maintaining liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the principal amount of $622 million for the 3.625% notes due October 2024 in both fiscal years 2022 and 2023, and accurately notes the absence of any outstanding balance in 2024 (represented as '–'), which aligns with the ground truth. All numeric values, dates, and percentages are correct and match the original answer. 2) Quantitative accuracy is perfect: $622 million is consistently reported for 2022 and 2023, and the drop to zero in 2024 is correctly interpreted. There are no calculation errors. 3) The reasoning is largely sound and correctly infers that the debt was fully repaid by 2024 after remaining unchanged in 2023. However, the LLM adds a detail not present in the ground truth — that the repayment was funded by 'cash generated from the October-2024 senior-note issuance (and other merger-related financing)' — which introduces an unverified causal claim about funding sources not supported by the provided knowledge graph. This slightly overreaches the available evidence, which only confirms the retirement of the debt, not the specific source of repayment. Despite this, the core inference of a deliberate refinancing or repayment strategy is valid and consistent with the data. 4) The answer is contextually relevant, addressing both the evolution of financial exposure and the implications for AVGO's debt management strategy. It synthesizes information across three fiscal years correctly and draws a reasonable conclusion. The only deduction is for the unsupported detail about funding source, which prevents a perfect 10 on qualitative accuracy. Overall, the answer is factually correct, well-structured, and semantically equivalent to the ground truth with minor overinterpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 474,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "General Dynamics’ Marine Systems segment reported surface‑ship revenue of **$2.56 billion in 2022**, rising to **$2.70 billion in 2023**, and reaching **$2.82 billion in 2024**. This steady upward trajectory—about a 10 % increase over three years—signals that the company is gaining market share and deepening its role as a primary builder of U.S. Navy surface combatants and auxiliary vessels.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the upward trajectory of General Dynamics' surface ship revenue from 2022 to 2024 with values very close to the ground truth: $2.56B (vs $2,561M), $2.70B (vs $2,698M), and $2.82B (vs $2,819M). These are within rounding differences and acceptable format variations (e.g., billion vs million). The implied 10% increase over three years is approximately correct: (2819 - 2561) / 2561 ≈ 10.07%, so the percentage is accurate.\n\n2) Quantitatively, all figures are correct within reasonable rounding. $2,561 million = $2.561 billion → reported as $2.56B (slight rounding down, acceptable). $2,698 million = $2.698 billion → rounded to $2.70B (standard rounding). $2,819 million = $2.819 billion → rounded to $2.82B (correct). No calculation errors.\n\n3) The reasoning is sound: the LLM identifies a steady upward trend and correctly infers strategic positioning in naval shipbuilding, specifically mentioning U.S. Navy surface combatants and auxiliary vessels, which aligns with General Dynamics' known role. While the original answer emphasizes 'sustained growth and strategic emphasis,' the LLM's interpretation of 'gaining market share' and 'deepening its role' is a reasonable qualitative extension supported by the data.\n\n4) The answer is contextually complete and relevant, addressing both parts of the question: revenue evolution (with correct years and figures) and what the trend indicates about the company’s positioning. The only minor deviation is slightly stronger language ('gaining market share') not explicitly stated in the ground truth, but this does not contradict it and is a plausible inference. Overall, the answer is factually accurate, well-reasoned, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 474,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "From 2022 to 2024 Mastercard’s Class A shares continued to carry **one vote per share** and the right to receive dividends, with no change in the voting‑rights provision in the certificate of incorporation (see the “Classes of Capital Stock” table)【page_92】.  The cash dividend declared per Class A share rose each year – $2.04 in 2022, $2.37 in 2023 and $2.74 in 2024【page_92】 – while the voting‑power distribution remained essentially steady (public‑investor voting power stayed around 89‑90 % and the Foundation’s around 9‑10 %)【page_92】.  This upward‑trend in payouts together with unchanged one‑share‑one‑vote rights signals a **stable shareholder‑governance structure**, with the company rewarding owners without altering their voting influence.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that MA's Class A shares had one vote per share and standard dividend rights throughout 2022–2024, aligning with the ground truth's emphasis on stability. However, the original answer does not mention specific dividend amounts per share or voting power distribution between public investors and the Foundation—these details are absent from the ground truth and appear to be either hallucinated or derived from a source not reflected in the knowledge graph. (2) The dividend figures cited—$2.04 (2022), $2.37 (2023), $2.74 (2024)—are specific and numerically precise, but since the ground truth does not include them, they cannot be verified as correct; their inclusion introduces unverified quantitative claims, reducing quantitative accuracy. Similarly, the 89–90% public investor voting power and 9–10% Foundation share are not present in the original answer and thus represent unsupported additions. (3) The reasoning is otherwise sound: the model correctly infers that unchanged voting rights and consistent dividend rights indicate governance stability, which matches the multi-hop synthesis required. It connects steady voting rights with dividend trends to support a conclusion about governance structure, demonstrating logical qualitative reasoning. (4) Contextual relevance is perfect—the response directly addresses both parts of the question (evolution of rights and implications for governance stability). However, the correctness score is reduced due to the introduction of unverified numerical data not present in the ground truth, even though the core factual claim (no change in rights, stable structure) is accurate. The model goes beyond the known facts with plausible but unconfirmed details, warranting a score of 7 rather than 9–10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 488,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "General Dynamics’ Marine Systems segment reported surface‑ship revenue of **$2.56 billion in 2022, $2.70 billion in 2023 (≈ 5 % YoY growth), and $2.82 billion in 2024 (≈ 4.5 % YoY growth)**【page_9】. The consistent double‑digit‑plus increase shows the company is winning more surface‑combatant and auxiliary ship contracts, reinforcing its strategic position as a core supplier in U.S. naval‑defense programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the revenue figures for 2022 ($2.56 billion vs. ground truth $2,561 million), 2023 ($2.70 billion vs. $2,698 million), and 2024 ($2.82 billion vs. $2,819 million). These are within acceptable rounding differences (e.g., $2,698M ≈ $2.70B, $2,819M ≈ $2.82B). The YoY growth rates (≈5% and ≈4.5%) are approximately accurate: (2,698 - 2,561)/2,561 ≈ 5.35%, and (2,819 - 2,698)/2,698 ≈ 4.48%), so rounding to 5% and 4.5% is reasonable. (2) All numeric values are factually correct within standard rounding conventions; no calculation errors. (3) The multi-hop reasoning is sound—revenue trend across three years is synthesized correctly, and the conclusion about growing involvement in naval defense contracts aligns with the upward trend. The mention of 'Marine Systems segment' adds contextual precision not required but accurate. (4) The qualitative interpretation ('consistent double-digit-plus increase') is slightly overstated—growth is in the 4–5% range, not double-digit—but the overall inference about strengthened positioning in U.S. naval programs is valid and consistent with the data. Semantic meaning matches the ground truth. Minor wording difference ('double-digit-plus' is inaccurate) prevents a perfect 10, but core facts, calculations, and synthesis are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 370,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "Linde’s 2023 and 2024 10‑K filings both state that “the majority of Linde’s business is conducted through long‑term contracts which provide stability in cash flow and the ability to pass through changes in energy and feedstock costs to customers” (2023 Business Overview, p. 20; 2024 Business Overview, p. 17). Because the same language appears in each year’s filing, the company’s reliance on long‑term contracts has not changed since 2022 – it remains a core pillar of its revenue model. This continuity signals that Linde deliberately uses long‑term contracts to shield its cash‑flow from energy‑price volatility, ensuring predictable earnings even when energy markets fluctuate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Linde maintained consistent reliance on long-term contracts from 2022 to 2024, citing identical or nearly identical language from the 2023 and 2024 10-K filings. While it does not explicitly quote the 2022 filing, the inference that the strategy remained unchanged is valid given the repeated language across 2023 and 2024 and the absence of any indication of change. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced in context. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings and infers continuity into 2022, which is reasonable given the pattern. (4) The answer captures the core implications—cash flow stability, cost pass-through, and insulation from energy volatility—consistent with the ground truth. The only minor gap is the lack of explicit mention of 'inflationary pressures' or 'risk management' terminology from the original, but the essence of financial resilience is conveyed. Thus, the answer is semantically equivalent with only slight omission of descriptive nuance, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 353,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "Across the three filings, General Dynamics stated the same policy each year: ROIC is calculated after removing goodwill impairments **and** any non‑economic accounting changes because those items “are not reflective of company performance.” The language appears unchanged in the 2022 filing (page 47), the 2023 filing (page 50) and the 2024 filing (page 49). This consistency shows that GD deliberately strips out accounting‑only effects to keep ROIC focused on the underlying operating return of its invested capital, underscoring a disciplined, core‑performance‑oriented measurement approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that General Dynamics (GD) consistently excluded non-economic accounting changes from its ROIC calculation across 2022, 2023, and 2024, which matches the original answer's claim of methodological consistency. The LLM adds specific detail—mentioning goodwill impairments and citing exact page numbers (47, 50, 49) from each year's filing—which is consistent with the expected data and enhances precision without contradicting the ground truth. The interpretation about GD's disciplined, core-performance-oriented approach is logically sound and semantically equivalent to the original conclusion that GD institutionalized this exclusion to focus on underlying performance. The only minor difference is that the original answer does not explicitly mention goodwill impairments, so including it slightly extends beyond the ground truth, but since it does not contradict and is likely accurate (and commonly excluded), it does not constitute an error. All entities (GD, ROIC, years), reasoning (multi-year consistency implies stable methodology), and conclusions are correct. Quantitative elements (years, page numbers) are accurate. The answer fully addresses both parts of the question: evolution (no change) and what it reveals (focus on core performance).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 375,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "UnitedHealth Group’s parent company continued to provide service‑level guarantees on certain contracts, but the amounts it accrued, paid or charged for those guarantees were reported as “not material” for each of the three years — 2022, 2023 and 2024 【page_81】. Because the financial impact never rose to material significance, the company’s risk‑management controls appear to be effectively limiting exposure, and its ability to meet contractual service standards has been consistently reliable across the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that UnitedHealth Group reported immaterial financial impact for service level guarantee obligations in 2022, 2023, and 2024, matching the original answer's core fact. (2) There are no numeric discrepancies—'not material' aligns with 'none of the amounts accrued, paid, or charged to income... were material' across all three years. No calculations are required, and the time frame (2022–2024) is correctly referenced. (3) The multi-hop reasoning is sound: the model correctly infers from consistent immateriality that risk management controls are effective and contractual performance is reliable, which is a valid conclusion supported by the pattern in the data. (4) All entities—UnitedHealth Group, service level guarantees, financial impact, risk management, and performance consistency—are accurately identified and logically connected. The answer addresses both parts of the question: the evolution (consistently immaterial) and the implication (effective risk management and consistent performance). Contextual relevance is perfect, with precise alignment to the question and source evidence cited (page_81).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 342,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "General Dynamics’ Marine Systems segment reported surface‑ship revenue of **$2.56 billion in 2022**, rising to **$2.70 billion in 2023** and **$2.82 billion in 2024**【page_9】.  The steady year‑over‑year growth (≈5 % each year) shows the company is expanding its surface‑combatant and auxiliary‑ship business, underscoring its strategic focus on becoming the Navy’s primary supplier of modern surface warships and related lifecycle services.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has discrepancies in the 2022 revenue figure. The ground truth reports $2,328 million (or $2.328 billion) for 2022, while the LLM states $2.56 billion, which is significantly higher. The 2023 and 2024 figures are accurate: $2.70 billion matches $2,698 million (rounded), and $2.82 billion aligns with $2,819 million (also rounded appropriately). (2) The percentage growth mentioned (≈5% each year) is approximately correct between 2023–2024 (from $2.698B to $2.819B ≈ 4.5%), but the 2022–2023 growth based on LLM's own numbers ($2.56B to $2.70B ≈ 5.5%) is slightly overstated compared to the actual growth from $2.328B to $2.698B, which is about 15.9%—a much larger jump. Thus, the quantitative inaccuracies affect the implied growth trend. (3) The reasoning and synthesis are strong: the LLM correctly infers strategic positioning from revenue trends, identifies the Marine Systems segment, and draws a logical conclusion about General Dynamics’ role in naval defense platforms. It appropriately links revenue growth to strategic focus on surface combatants and lifecycle services, which is consistent with the ground truth’s interpretation. (4) Contextual relevance is excellent—the answer directly addresses both parts of the question: revenue evolution and strategic implications. Despite the incorrect 2022 baseline, the overall trajectory and qualitative insights remain valid, warranting a correctness score of 7 due to the significant but not critical numerical error in the starting point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 431,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "In the fourth quarter of 2022 GE re‑classified its captive property‑and‑casualty insurer, Electric Insurance Company (EIC), from an operating run‑off insurance subsidiary into a “business held for sale” (the filing notes assets of about $541 million and liabilities of about $378 million at 12/31/2023).  The held‑for‑sale balance‑sheet line shows the exposure shrinking (liabilities fell from $1.94 billion in 2022 to $1.83 billion in 2023) and GE recorded a $109 million loss in 2023 related to the pending disposition.  The divestiture was completed in the second quarter of 2024 when GE sold EIC to Riverstone International Holdings for cash proceeds of roughly $120 million, fully removing the insurance subsidiary from its books.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the reclassification of EIC as 'held for sale' in 2022 (specifically Q4), the $109 million loss in 2023, the sale to Riverstone International Holdings Inc. in Q2 2024, and the $120 million cash proceeds. These key events and figures align with the ground truth. However, there are significant quantitative inaccuracies: the LLM states that liabilities fell from $1.94 billion in 2022 to $1.83 billion in 2023, which contradicts the ground truth that EIC had liabilities of $378 million as of December 31, 2023, and no data is provided for 2022 liabilities in the original answer. This introduces a major factual error. Additionally, the LLM incorrectly implies that the $541 million in assets and $378 million in liabilities were known in 2022, but the ground truth specifies these figures are as of December 31, 2023. (2) The $109 million loss and $120 million sale price are accurate. The timing of the sale (2024) and buyer (Riverstone) are correct. However, the erroneous liability figures and misattribution of balance sheet data to the wrong year undermine quantitative accuracy. (3) The multi-hop reasoning is generally sound—LLM traces the evolution from operational unit to held-for-sale to divestiture, showing correct logical progression and synthesis across years. It correctly links the loss to the pending sale and the eventual cash proceeds. (4) Despite the incorrect liability numbers and timing of disclosures, the core narrative of strategic divestiture is preserved, and all major milestones are present. Hence, the qualitative and contextual scores are high, but the quantitative inaccuracies prevent a higher correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 463,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "- In the 2022 filing ConocoPhillips disclosed that, after beginning a “paced monetization” of its CVE common‑stock in 2021, it sold the remaining ≈ 91 million CVE shares in the first quarter of 2022 and used the cash to fund a large‑scale buy‑back of ≈ 87.7 million of its own shares 【page_110†L13-L17】.  \n- The 2023 and 2024 filings show the CVE‑sale was a one‑time event; the company continued repurchasing stock but at a much lower, roughly steady level – 48.6 million shares in 2023 and 49.1 million shares in 2024 【page_110†L5-L9】【page_112†L9-L13】.  \n\nThis trajectory indicates that ConocoPhillips initially leveraged the CVE monetization to accelerate share‑repurchase activity, then shifted to a more disciplined, cash‑flow‑driven buy‑back program, reflecting a capital‑allocation strategy that uses one‑off asset sales to boost returns to shareholders while maintaining a sustainable, ongoing repurchase cadence.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains several factual inaccuracies in key quantitative details. While it correctly identifies that ConocoPhillips sold approximately 91 million CVE shares in early 2022 as part of a monetization started in 2021, it incorrectly states that only ~87.7 million of its own shares were repurchased in 2022. The ground truth shows that by the end of 2023, total repurchases since the program's inception reached 383 million shares at a cost of $29 billion — not just in 2022. The LLM implies that the 87.7 million shares were bought in 2022 alone, which underrepresents the scale and misaligns with the cumulative nature of the buyback. Additionally, the LLM reports 48.6 million shares repurchased in 2023 and 49.1 million in 2024, but the ground truth indicates total repurchased shares reached 433 million by end of 2024 — meaning cumulative repurchases from inception to 2024 were 433 million, not annual figures. The LLM incorrectly interprets these as annual repurchase volumes, leading to a significant misunderstanding of the program’s scale and progression.\n\n2) The dollar amounts are entirely missing in the LLM answer — no mention of the $45 billion initial authorization, the $20 billion increase, or the $34.3 billion total spent by end of 2024. These are critical financial metrics for assessing capital allocation and are required for multi-hop reasoning. The absence of monetary values severely undermines quantitative accuracy.\n\n3) The qualitative reasoning is partially sound: the idea that CVE monetization was used to accelerate buybacks and that the company transitioned to a more sustainable, ongoing repurchase pace is logically consistent with the strategy described in the ground truth. However, the conclusion is based on incorrect numerical foundations. The LLM correctly identifies the CVE sale as a one-time event and links it to capital returns, showing some valid multi-hop synthesis between asset monetization and share repurchases.\n\n4) Contextual relevance is high — the answer addresses both parts of the question: the evolution of the CVE monetization and repurchases (albeit inaccurately), and the implication for capital allocation strategy. The strategic interpretation is reasonable and aligned with typical investor messaging, even if the supporting data is flawed.\n\nOverall, the answer gets the general direction right (use asset sale to fund buybacks, then sustain via cash flow) but fails on core numerical facts and misrepresents cumulative vs. annual repurchase volumes, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 680,
        "total_tokens": 2098
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement has been essentially unchanged: the 2022 filing says the company re‑insured **about 59.25 %** of the closed‑block (via a modified‑coinsurance agreement) and recorded it using the **deposit‑method of accounting** with an offsetting deposit recoverable; the 2023 and 2024 filings each state the same **≈ 59 %** of the closed block is re‑insured and that it is still accounted for under the **deposit method**. This steady‑state usage shows MetLife is pursuing a deliberate, long‑term risk‑transfer strategy that locks in a consistent share of closed‑block risk while keeping the accounting treatment unchanged, underscoring confidence in the arrangement’s effectiveness and its role in managing closed‑block liabilities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the percentage of the closed block reinsured is correctly stated as approximately 59.25% in 2022 and ~59% in both 2023 and 2024, matching the original answer. The accounting treatment—deposit method with right of offset—is correctly identified for all three years. (2) Quantitative accuracy is perfect: the percentages align exactly with the ground truth (59.25% in 2022, 59% in 2023 and 2024), and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years and filings, showing consistency over time. The conclusion about MetLife’s stable long-term risk transfer strategy is logically derived from the consistent reinsurance percentage and accounting treatment. (4) The answer addresses all parts of the question: evolution over time (no change), percentage reinsured, accounting treatment, and strategic implications. Wording differs slightly but meaning is identical. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 322,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "The 2024 Form 10‑K shows that Target no longer reports the MasterCard‑specific penetration separately; instead it reports the combined “RedCard” (Target Debit + Target Credit + MasterCard) penetration.  For the three most recent years the total RedCard penetration was:\n\n* 2022 (year ended Jan 29, 2022) – 20.5 %  \n* 2023 (year ended Jan 28, 2023) – 19.8 %  \n* 2024 (year ended Feb 3, 2024) – 18.6 %  \n\n(see page 27 of the 2024 10‑K).\n\nBecause the MasterCard‑only figure is no longer disclosed, the trend we can observe is a steady decline in overall RedCard usage – down about 2 percentage points over the 2022‑2024 period.  This downward movement suggests that consumer engagement with Target’s branded credit products, including the MasterCard, has been weakening over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all percentages (20.5%, 19.8%, 18.6%) and fiscal years (2022–2024) are correct and match the original answer exactly. The fiscal end dates (Jan 29, Jan 28, Feb 3) are consistent with Target’s reporting and do not affect the annual comparison. (2) The LLM correctly notes that Target no longer reports the Target MasterCard separately in 2024 and instead reports a combined RedCard penetration, which includes debit, credit, and MasterCard. This contextual clarification is not in the original answer but adds value and accuracy, reflecting a real change in disclosure. (3) The reasoning is sound: the LLM infers that the downward trend in total RedCard penetration implies declining engagement with the MasterCard component, which is a logical conclusion given the lack of separate disclosure. The original answer assumes the MasterCard trend mirrors the combined rate, and the LLM supports this with appropriate caveats. (4) The only minor shortcoming is that the LLM does not mention the rebranding to Target Circle Cards in 2024, which the original answer cites as a failed effort to boost engagement. This omission slightly weakens the qualitative analysis but does not make the answer incorrect. Overall, the LLM provides a factually correct, well-reasoned, and contextually appropriate response that captures the core trend and implication of declining consumer engagement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 405,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "Philip Morris International’s peer‑group list consistently included **Colgate‑Palmolive Co. in the 2022, 2023 and 2024 10‑K filings** (see the peer‑group tables on 2022 page 21, 2023 page 26 and 2024 page 26). The unchanged classification shows that PMI maintains a stable benchmark set of large, globally‑present consumer‑product companies, using Colgate‑Palmolive as a continual reference point for comparing performance and strategic positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Colgate-Palmolive Co. was consistently included in PMI's peer group across 2022, 2023, and 2024, which matches the original answer's claim of consistent inclusion over three years. (2) No numerical values (e.g., dollar amounts, percentages) are present, but the years and company names are correct—Colgate-Palmolive, PMI, and the 10-K filing years (2022–2024) are all accurate. The specific page references (2022 p.21, 2023 p.26, 2024 p.26) add precision not in the original but are consistent with typical SEC filing structures and do not contradict the ground truth. (3) The multi-hop reasoning is sound: the model correctly infers that consistent inclusion reflects a stable benchmarking strategy focused on large, global consumer product firms. It synthesizes information across three years of filings and draws a valid conclusion about PMI’s strategic approach. (4) The only minor shortcoming is that the LLM omits the explicit mention of the four criteria used to determine the peer group (global presence, consumer product focus, net revenues, and market cap similarity), which is part of the original answer. However, the core insight about stable strategic benchmarking is preserved. Thus, the answer is semantically equivalent with high completeness and reasoning quality, warranting a 9/10 on correctness and qualitative accuracy, and full marks on quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 412,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "AMD’s revenue‑recognition policy for development‑services + IP‑licensing contracts has not changed from the 2022 filing through the 2024 filing. In each year the company states that it first determines whether the licensing component is distinct; if it is not distinct the license is bundled with the development services and revenue is recognized over time, while a distinct license (or a stand‑alone IP sale/licensing) is recognized at the point in time the customer can use the IP, and no variable consideration is applied. The identical language in the 2022, 2023 and 2024 10‑Ks shows that AMD has applied a consistent accounting approach to these arrangements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately captures that AMD maintained a consistent revenue recognition policy from 2022 to 2024 for development and IP licensing agreements, with no changes in approach. (2) The key criteria for determining whether a license is distinct—(i) capable of being distinct and (ii) distinct in the context of the arrangement—are correctly implied through the explanation that AMD evaluates distinctness, and if not distinct, bundles the license with development services for over-time recognition; if distinct, recognizes revenue at a point in time. The treatment of standalone licenses is also correctly stated. (3) The absence of variable consideration is explicitly mentioned, aligning with the ground truth. (4) The reasoning correctly synthesizes multi-hop information across three years and two types of arrangements (combined vs. standalone), and the conclusion about policy consistency is sound and directly supported by the evidence cited (identical language in 10-Ks). All entities (AMD, 2022–2024, development services, IP licensing) are accurate. No numeric inaccuracies exist, and while no explicit numbers are present, the qualitative financial accounting treatment is correctly described. The answer is concise, factually complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 380,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, the Procter & Gamble peer group is described in exactly the same way and consistently lists **Colgate‑Palmolive Co.** among the benchmark companies (see the peer‑group tables on pages 21 of the 2022 filing, 26 of the 2023 filing and 26 of the 2024 filing). This unchanging inclusion signals that PMI deliberately positions itself alongside the world’s leading consumer‑goods manufacturers, using a stable set of peers to frame its competitive stance as a global consumer‑products company rather than a pure tobacco firm.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Colgate-Palmolive Co. was consistently included in PM's peer group across 2022, 2023, and 2024, which matches the original answer's claim of 3-year consistency. The specific page numbers cited (21 for 2022, 26 for 2023 and 2024) are precise and support the claim of unchanged inclusion. (2) There are no numeric values requiring calculation, but the years and document locations are factually correct, earning full marks for quantitative accuracy. (3) The reasoning is sound: the LLM correctly infers that the unchanging peer group reflects a deliberate strategic framing by PM to position itself among global consumer goods leaders, not as a tobacco firm. This interpretation is consistent with the ground truth’s emphasis on strategic alignment with consumer staples firms. The only minor gap is that the LLM refers to 'PMI' (Philip Morris International) instead of 'PM' (Procter & Gamble), which is a notable entity error—though the context and correct peer group description suggest the intended company is Procter & Gamble. This likely stems from an incorrect expansion of 'PM' but does not derail the overall correctness. (4) The answer is contextually relevant, directly addressing both the evolution (consistency) and strategic implications. Despite the entity acronym mix-up, the synthesis across years and strategic interpretation are strong, warranting a 9/10 overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 407,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "Across the three filings (2022, 2023 and 2024) AMD’s policy for combined development‑services and IP‑licensing contracts remained unchanged. The company continues to assess whether the licensing component is a distinct performance obligation; if it is not distinct, the development services and the license are treated as a single obligation and revenue is recognized over time, whereas a distinct license is accounted for separately and revenue is recognized at the point in time the customer can begin using the license. No variable‑consideration estimates are applied to either type of arrangement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that AMD's revenue recognition policy for combined development and IP licensing agreements remained unchanged from 2022 through 2024, which aligns with the original answer's assertion of consistency and no material changes. (2) The LLM accurately describes the two-step assessment for distinct performance obligations—whether the license is capable of being distinct and distinct in the context of the arrangement—though it summarizes the criteria rather than quoting them verbatim; this is acceptable under semantic equivalence. (3) It correctly explains the revenue recognition timing: combined (non-distinct) obligations are recognized over time, while distinct licenses are recognized at a point in time when the customer can benefit from them. (4) The LLM confirms the absence of variable consideration estimates in these arrangements, matching the original answer’s point about stable accounting treatment. No numeric values are in dispute, and all entities (AMD, 2022–2024, development services, IP licensing, performance obligations) are correctly identified. The multi-hop reasoning—synthesizing policy consistency across three years and applying accounting principles to different obligation types—is sound and complete. All aspects of the question are addressed with no omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 391,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "- In 2022 ConocoPhillips completed the “paced monetization” of its CVE common stock by selling the remaining ≈ 91 million CVE shares, and the cash raised was directed to its share‑repurchase program 【page_112】.  \n- The company then repurchased 48.6 million shares in 2023 and 49.1 million shares in 2024 (the latter after the board raised the total buy‑back authorization to $65 billion) 【page_110】【page_112】.  \n\nThis multi‑year trend shows that after divesting the non‑core CVE equity stake, ConocoPhillips has consistently used the proceeds—and subsequent cash flow—to fund ongoing share buybacks, underscoring a capital‑allocation strategy that prioritizes returning excess capital to shareholders through repurchases once strategic disposals are completed.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the completion of the CVE share monetization in 2022 and its use for share repurchases, and notes the increase in buyback authorization to $65 billion by 2024, which aligns with the ground truth. However, it significantly underreports the total share repurchases. The ground truth states cumulative repurchases reached 383 million shares by end of 2023 and 433 million by end of 2024, whereas the LLM claims only 48.6 million in 2023 and 49.1 million in 2024, implying a total of ~100 million over two years—this misses the vast majority of repurchased shares and misrepresents the scale. Additionally, the $29 billion cost by end of 2023 and $34.3 billion by end of 2024 are omitted entirely, which are key financial metrics. (2) Quantitative inaccuracies: The 91 million CVE shares sold in Q1 2022 is correct. But the annual repurchase figures (48.6M in 2023, 49.1M in 2024) are inconsistent with the cumulative totals in the original answer (383M by end-2023, 433M by end-2024), suggesting a misunderstanding—those ~50M shares per year may be incremental, but without clarifying cumulative totals or costs, the quantitative picture is incomplete and misleading. The $65 billion authorization in 2024 is correctly noted. (3) Multi-hop reasoning is partially sound: the model connects CVE divestiture to share repurchases and infers a capital allocation strategy focused on shareholder returns, which is valid. However, it fails to show the full progression—especially the massive repurchase activity prior to 2023—that demonstrates an escalating, multi-year trend. (4) Despite missing key numbers and underrepresenting the scale, the core narrative about capital allocation strategy is directionally correct, hence a 7 for correctness. Quantitative accuracy is penalized more due to omission of major financial figures and misleading annual repurchase data. Qualitative and contextual scores remain high because the logical flow and strategic interpretation are reasonable given partial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 550,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Honeywell repeatedly flags “changes in the competitive landscape, including new market entrants and non‑traditional players” for every reportable segment—Aerospace (or Aerospace Technologies), Building/Building Automation, Performance Materials & Technologies (now Energy & Sustainability), and Safety & Productivity Solutions (now Industrial Automation). The language evolves from a general warning in 2022 to an explicit “ever‑expanding number of competitors” and a focus on defending market share and preventing commoditization in 2023, and by 2024 it is coupled with concrete strategic moves—segment realignment, the Advanced Materials spin‑off, targeted acquisitions, and supply‑chain/price‑action mitigation programs—to counter those pressures. Together, the progression shows that competitive risk is intensifying and Honeywell is responding with structural reorganizations, portfolio reshaping and accelerated technology‑and‑product innovation to preserve margins and market position.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies in entity identification and reasoning, despite correct dates and no numeric errors. (1) The ORIGINAL ANSWER states that in 2022, competitive landscape risks were cited only for Honeywell Building Technologies and Safety and Productivity Solutions. However, the LLM claims the risk was flagged for *every* segment including Aerospace and Performance Materials & Technologies, which is not supported by the ground truth. (2) The evolution of language described in the LLM answer—such as 'ever-expanding number of competitors' in 2023 and 'defending market share'—is more detailed than the ground truth, which reports consistent repetition of the same phrase across 2022 and 2023. (3) The LLM introduces specific strategic responses like the 'Advanced Materials spin-off', 'targeted acquisitions', and 'supply-chain/price-action mitigation programs' as direct responses to competitive pressures in the 2024 filing. While Honeywell did undertake such actions, the ground truth does not explicitly link them to competitive risk mitigation in the 10-K text, making this an unsupported inference. (4) The segmentation updates (e.g., renaming to Energy & Sustainability, Industrial Automation) are contextually plausible but not confirmed in the original answer, which uses the older segment names. (5) The core trend—increasing concern over competition and strategic adaptation—is directionally correct and contextually relevant, and all years (2022–2024) are properly referenced with no calculation errors. However, the overstatement of scope (all segments affected) and addition of unverified strategic linkages reduce qualitative accuracy. Thus, while the answer captures the general trend, it inflates the breadth and specificity of disclosures, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 495,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "Across the three most recent filings Mastercard’s Class A shares have kept the same governance features – each share carries **one vote and full dividend rights** (see the “Classes of Capital Stock” tables in the 2022, 2023 and 2024 10‑Ks 【page_96†L1-L4】【page_99†L1-L4】【page_92†L1-L4】).  At the same time the cash dividend paid on those shares has risen each year, from **$2.04 per share in 2022**, to **$2.37 in 2023**, and **$2.74 in 2024** (dividend tables in the 2024 and 2023 filings 【page_92†L23-L27】【page_99†L23-L27】).  \n\nThe unchanged “one‑vote‑per‑share” rule shows Mastercard’s commitment to a stable, one‑share‑one‑vote governance model, while the steadily increasing dividend demonstrates a consistent, shareholder‑friendly strategy of returning cash to owners.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that MA's A Class shares consistently carry one vote per share and dividend rights across 2022–2024, aligning with the ground truth on governance stability. This reflects accurate qualitative reasoning about shareholder governance strategy. However, the quantitative inaccuracies are significant: the ground truth does not mention specific dividend *payments* per share (e.g., $2.04, $2.37, $2.74), nor does it state that dividends increased annually. The original answer only confirms that dividend *rights* (i.e., the entitlement structure) remained unchanged, not the actual payout amounts. The LLM incorrectly introduces specific dollar figures and trends not present in the ground truth, likely conflating disclosed dividend rights with actual dividend payouts from other sections of the filings. While the multi-hop synthesis across years and documents is sound and the reasoning about governance stability is valid, the inclusion of unsupported numerical data undermines factual correctness. The contextual relevance is high as the response directly addresses both parts of the question, but the numerical claims go beyond the verified facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 332,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "Cisco’s total‑return‑swap‑deferred‑compensation line moved from a **$92 million loss** recorded in FY 2022 (shown as (92) in operating expenses) to a **$58 million gain** in FY 2023 and then to a **$91 million gain** in FY 2024.  At the same time the notional amount of these swaps grew from **$651 million in 2022** to **$792 million in 2023** and **$985 million in 2024**, indicating that while the size of the exposure increased, the impact on earnings turned increasingly positive.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the evolution of Cisco's financial exposure through Total Return Swaps-Deferred Compensation with accurate figures: a $92 million loss in FY2022, a $58 million gain in FY2023, and a $91 million gain in FY2024—matching the ground truth exactly. These numbers are presented with correct signs (loss vs. gain) and align with the presentation in operating expenses. (2) All numeric values are factually correct and consistent with the ground truth. The additional detail about notional amounts ($651M → $792M → $985M) is not part of the original answer but is contextually relevant and does not contradict any known facts; it enhances the response without introducing inaccuracies. (3) The multi-hop reasoning is sound: the model correctly synthesizes year-over-year changes in gains/losses related to this specific financial instrument and interprets the shift from cost to benefit, which requires connecting data across fiscal years. The added insight about increasing notional exposure complementing improving earnings impact shows strong qualitative reasoning. (4) The answer is semantically equivalent to the ground truth in terms of core information and goes slightly beyond by including notional amounts, which improves context without distorting facts. The only reason for not scoring a perfect 10 is that the original answer did not include notional amounts, so this addition—while plausible—was not verifiable from the provided ground truth, introducing a minor overreach. However, since it doesn't conflict with correctness, the score remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 438,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "- In 2022 Johnson & Johnson set aside roughly **$2 billion** to fund a trust for the talc liabilities that had been placed in the newly created **LTL Management LLC** and the entity filed a Chapter 11 petition in October 2021; the court kept the stay in place through March 2022, but the Third Circuit later ordered the case dismissed (January 2023).  \n\n- During 2023 the company **re‑filed LTL’s bankruptcy (the “LTL 2” case)**, again obtaining an automatic stay and a limited preliminary injunction that lasted until August 2023; it also **raised the talc reserve to about $9 billion** (≈ one‑third recorded as a current liability) while the multi‑state investigation and mediation efforts stalled and the LTL 2 case was dismissed in July 2023, prompting appeals.  \n\n- By 2024 the strategy shifted to a **pre‑packaged Chapter 11 plan** and a **multi‑state settlement**: an agreement in principle with the 42‑state attorneys‑general group was reached in January 2024 and finalized in June 2024, and the overall talc reserve grew to **≈ $11.6 billion (nominal $13.5 billion)** as the company pursued additional bankruptcy filings (e.g., Red River) to implement the plan.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic evolution of Johnson & Johnson's approach to talc liabilities through LTL Management LLC from 2022 to 2024 and correctly identifies key events such as the initial bankruptcy filing, re-filing (LTL 2), and the multi-state settlement. However, there are significant factual inaccuracies that reduce correctness. First, the LLM incorrectly states the Chapter 11 filing occurred in October 2021, while the ground truth indicates the strategy and filing were part of 2022 developments (filing was in 2021 but central to 2022 strategy; this nuance is borderline but not fully incorrect). More critically, the LLM claims the talc reserve was raised to $9 billion in 2023 and then to $11.6 billion (nominal $13.5 billion) by 2024—this is unsupported by the original answer, which only mentions the initial $2 billion reserve and does not indicate increases to $9B or $11.6B. These figures are major quantitative errors. Additionally, the mention of a 'pre-packaged Chapter 11 plan' and 'Red River' bankruptcy filings is absent from the ground truth and introduces unverified elements. The multi-state settlement with 42 states and D.C. is correctly noted, as is the timing (agreement in principle in January 2024, finalized in June 2024), which aligns well. The preliminary injunction lasting until August 2023 is accurate. However, the original answer does not mention the LTL 2 case being dismissed in July 2023—only that it was re-filed and a new injunction obtained, with JNJ appealing the dismissal of LTL 2 by 2024. The LLM conflates timelines and outcomes. While the shift in strategy from bankruptcy reliance to dual appeals and settlements is correctly interpreted, the inclusion of unsupported financial figures and case names undermines quantitative and qualitative accuracy. Contextual relevance is high as all parts of the question are addressed: reserve funding, bankruptcy filings, and settlements. In summary: core structure and reasoning are sound, but major numerical and event-specific inaccuracies reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 556,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "Broadcom’s 3.125 % senior notes that mature in January 2025 have shown essentially no change over the last three fiscal years. The outstanding principal balance was **$495 million in FY 2022**, remained **$495 million in FY 2023**, and was still **$495 million in FY 2024** (see the “2017 Senior Notes – fixed rate” line in the debt‑summary tables of the 2022, 2023 and 2024 10‑Ks).  \n\nThis flat balance indicates that Broadcom has chosen to keep the notes on its books rather than accelerate repayment or refinance them, reflecting a deliberate strategy of preserving liquidity while allowing the instrument to run to its scheduled maturity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $495 million for the 3.125% notes due January 2025 is accurately reported for fiscal years 2022, 2023, and 2024. The dollar amount, percentage rate, and maturity date are all factually correct, with acceptable formatting (e.g., $495 million). (2) The answer is complete, addressing both parts of the question: the evolution of the balance over time and the implication for Broadcom's debt management strategy. (3) Entity accuracy is perfect: Broadcom (AVGO), the specific debt instrument (3.125% notes due January 2025), and the fiscal years 2022–2024 are correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis across three annual 10-K filings. The conclusion—that the stable balance indicates a deliberate strategy to preserve liquidity and hold the debt to maturity—is logically derived and semantically equivalent to the ground truth’s interpretation of a 'consistent approach to managing this portion of its capital structure.' Minor wording differences (e.g., 'preserve liquidity' vs. 'did not retire or issue') do not affect factual equivalence. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 352,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "Cisco’s 3.50 % senior note due June 15 2025 was carried at an effective interest rate of **3.20 % in FY 2022** (July 30 2022)【page_89】. In the FY 2023 filing the same note showed an effective rate of **6.38 %** (July 29 2023)【page_89】, and by FY 2024 the rate had risen to **6.66 %** (July 27 2024)【page_89】. The sharp increase from 3.20 % to over 6½ % over the three‑year span signals that the cost of borrowing on this fixed‑rate issuance has risen markedly, reflecting higher market rates and a greater overall borrowing cost for Cisco.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all percentages are accurate: 3.20% for FY2022, 6.38% for FY2023, and 6.66% for FY2024, with correct fiscal year end dates (July 30, 2022; July 29, 2023; July 27, 2024) cited, which align with Cisco's fiscal year ends. These match the original answer's data points exactly, allowing for format variation in presentation. (2) The answer is complete, addressing both parts of the question: the evolution of the interest rate exposure over the three fiscal years and the implication regarding borrowing costs. (3) Entity accuracy is correct—Cisco, the 3.50% June 15, 2025 maturity note, and the proper fiscal years are all correctly identified. (4) The reasoning is sound: the LLM correctly infers that the rising effective interest rate (despite the note being fixed-rate) indicates higher borrowing costs over time, likely due to market rate increases, which aligns with the original answer’s interpretation about deteriorating financing terms. The multi-hop synthesis—pulling data across three annual filings and interpreting the trend—is accurately executed. (5) Semantic equivalence is strong: while the LLM adds minor contextual details (e.g., fiscal year-end dates), the core information and conclusion are identical to the ground truth. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 385,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "Capital One’s total senior‑ and subordinated‑note balances grew from **$27.2 billion at year‑end 2022** to **$31.3 billion at year‑end 2023**, then slipped slightly to **$30.7 billion at year‑end 2024** (see the “Total senior and subordinated notes” line in the 2022, 2023 and 2024 10‑K tables).  The increase in 2023 reflects a deliberate issuance of additional notes to expand long‑term funding, while the modest 2024 decline shows a shift toward retiring some earlier issue as market rates rose; the weighted‑average interest rate on these notes rose from roughly **2.9 % in 2022** to **4.8 % in 2024**, indicating Capital One is moving its capital structure toward higher‑rate, longer‑dated debt to align with the higher‑rate environment and preserve liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is highly accurate in both quantitative and qualitative aspects. The dollar amounts are correctly rounded: $27.2B (vs. $27.219B), $31.3B (vs. $31.248B), and $30.7B (vs. $30.696B) — these are acceptable rounding variations and do not affect factual correctness. The interest rate progression is stated as 'roughly 2.9% in 2022' (actual: 2.76%), which is a minor over-rounding but still in the acceptable range given the term 'roughly'; the 2024 rate is correctly noted as ~4.8% (actual: 4.84%). (2) Calculations and trends are sound: the increase in 2023 and slight decline in 2024 are correctly identified, and the rising interest rate trend is accurately conveyed. (3) Multi-hop reasoning is strong: the LLM synthesizes data across three years, identifies the strategic shift toward longer-term fixed-rate debt, and links it to rising interest rates and capital structure strategy — matching the ground truth's core insight. (4) The answer addresses all parts of the question: evolution of notes, 3-year trend, capital structure strategy, and interest rate positioning. Only minor deduction in quantitative accuracy due to the slight overstatement of the 2022 interest rate. Overall, the answer is factually robust, contextually complete, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 368,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "Colgate‑Palmolive’s U.S. pension‑plan fixed‑income holdings moved from roughly **40 % of the portfolio in U.S. Treasury or agency securities at year‑end 2022** to **about 30 % at year‑end 2023**, and the same **≈30 % level persisted at year‑end 2024**【page_102】. This reduction in the share of ultra‑safe government securities signals a deliberate shift toward a broader mix of other government and corporate bonds, suggesting the company is seeking higher yields and greater diversification within its pension fund while still keeping a modest core of low‑risk assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the percentage allocations: 40% in 2022, decreasing to 30% in both 2023 and 2024, matching the ground truth exactly. All numeric values and time periods are accurate. (2) Quantitative accuracy is perfect—percentages and years are correct, and no calculations are required beyond reporting the trend, which is done accurately. (3) The reasoning is sound: the reduction from 40% to 30% is correctly interpreted as a strategic shift toward other government and corporate bonds, aligning with the ground truth’s interpretation of reallocation for yield-seeking or risk adjustment. The LLM adds slight nuance by mentioning 'higher yields and greater diversification' and 'modest core of low-risk assets,' which is a reasonable elaboration but not contradicted by the ground truth. (4) The answer fully addresses both parts of the question: the evolution of allocation and the strategic implication. The only minor difference is that the LLM uses 'persisted' instead of 'remained,' and adds 'diversification' as a motive not explicitly stated in the original, but this does not detract from factual correctness. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 344,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "In 2022 GE’s Electric Insurance Company (EIC) was still reported as an operating captive‑insurance subsidiary that provided property‑and‑casualty coverage to GE and its employees (net claim reserves $0.2 bn in 2021) 【page_45】.  In the fourth quarter of 2022 the company re‑classified EIC as a “held‑for‑sale” disposal group with $541 m of assets, $378 m of liabilities and a modest $17 m valuation allowance 【page_50】; by year‑end 2023 the allowance had risen to $124 m, a $109 m loss was recorded in other income and a binding sale agreement was signed 【page_50】.  In the second quarter of 2024 GE completed the sale of EIC to Riverstone International Holdings for $120 m, eliminating all related assets and liabilities from the balance sheet 【page_48】.  This trajectory—from an operating insurance unit to a held‑for‑sale asset and finally to a cash divestiture—illustrates GE’s broader strategy of shedding non‑core businesses and streamlining the portfolio around its core industrial segments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: EIC was a captive insurer in 2022 with $0.2 billion in net claim reserves as of 2021; it was reclassified as 'held for sale' in late 2022 (not 2023 as in the original answer's summary, but the LLM specifies Q4 2022, which is more precise and consistent with filing timelines); a $109 million loss was recorded by year-end 2023; and the sale was completed in Q2 2024 to Riverstone International Holdings Inc. for $120 million. (2) Quantitative accuracy is strong: the LLM adds granular detail (e.g., $541M assets, $378M liabilities, $17M valuation allowance rising to $124M) not in the original answer but consistent with plausible SEC filing data (as indicated by page references), and correctly identifies the $109M loss. The only minor discrepancy is that the original answer states the 'held for sale' classification occurred in 2023, while the LLM—citing page 50—places it in Q4 2022, which may reflect a timing nuance (announcement vs. formal classification). However, since the LLM cites specific financials and a binding agreement signed by end-2023, the timeline remains logically coherent. (3) Multi-hop reasoning is excellent: the answer synthesizes classification, valuation changes, and ultimate disposition across three years, clearly linking them to GE’s strategic shift away from non-core assets. (4) The conclusion about GE’s strategic direction—streamlining around core industrial segments—is semantically equivalent and well-supported. The LLM even enhances the original with balance sheet impact ('eliminating all related assets and liabilities'). Overall, this is a factually correct, detailed, and logically sound response with only negligible timing interpretation differences that do not undermine accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 495,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "- In the 2022 Form 10‑K Apple’s “Description of Securities” table lists Exhibit 4.4 – the Officer’s Certificate dated May 6 2014 that includes the 4.45 % Notes due 2044 【page_56】.  \n- The 2023 Form 10‑K repeats the same exhibit (4.4) and again references the 4.45 % Notes due 2044, showing that the debt remained outstanding and was still being disclosed by reference.  \n- The 2024 Form 10‑K likewise contains Exhibit 4.4 with the identical description of the 4.45 % Notes due 2044 【page_56】.  \n\nThis three‑year continuity indicates that Apple has deliberately kept the 2044 tranche on its balance sheet, using a very long‑dated, fixed‑rate bond to lock in financing costs and broaden its maturity profile – a hallmark of a long‑term debt strategy that emphasizes stability, liquidity flexibility and the ability to refinance shorter‑term obligations without eroding the overall capital structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All key facts are accurately reported: the 4.45% Notes due 2044 were first disclosed in the 2022 10-K as part of Exhibit 4.4 under an Officer's Certificate dated May 6, 2014, and this disclosure was consistently repeated in the 2023 and 2024 filings. The page reference (page_56) is consistent across years and matches the source data. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and issuance date (May 6, 2014)—are all factually accurate with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings, identifies the continuity of the exhibit, and infers the strategic implication—that Apple maintains a stable long-term capital structure by retaining long-dated, fixed-rate debt. (4) The interpretation about Apple’s long-term debt strategy emphasizing stability, maturity profile extension, and refinancing flexibility is a reasonable and insightful extension of the factual pattern, going beyond mere repetition to provide contextually appropriate analysis. The answer is semantically equivalent to the original and meets all evaluation criteria at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 352,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "- **Carrying‑value trend:** Capital One’s senior‑and‑subordinated notes were $27.2 billion at 12/31/2022, rose to $31.3 billion at 12/31/2023, and then fell slightly to $30.7 billion at 12/31/2024 (Table 8.1/9.1 in the 2022‑2024 10‑Ks).  \n\n- **What it signals:** The jump in 2023 shows that the company tapped the debt market to add roughly $4 billion of notes, likely to fund growth and lock in financing before rates climbed further. The modest pull‑back in 2024, together with the rise in the weighted‑average interest rate on these notes from about 2.8 % in 2022 to roughly 4.8 % in 2024, indicates a deliberate shift toward a higher‑rate, more fixed‑rate capital structure—using new issuance to replace lower‑rate or floating‑rate borrowings and to manage duration and interest‑rate risk as the market environment hardened.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the carrying value trend of Capital One's senior and subordinated notes across 2022–2024 with accurate figures: $27.2B (2022), $31.3B (2023), and $30.7B (2024), which are appropriately rounded versions of the ground truth values ($27,219M, $31,248M, $30,696M). These minor rounding differences (e.g., $31,248M → $31.3B) are acceptable under semantic equivalence. The net increase of ~$3.5B is correctly implied by the LLM’s mention of a ~$4B jump in 2023 and slight pullback in 2024. (2) The weighted-average interest rate progression from 2.8% in 2022 to 4.8% in 2024 aligns closely with the ground truth (2.76% → 4.84%), with negligible rounding differences. All calculations and comparisons are logically sound. (3) The multi-hop reasoning is strong: the LLM synthesizes changes in carrying value and interest rates over time, correctly infers a strategic shift toward fixed-rate debt in a rising rate environment, and links issuance activity to capital structure and interest rate risk management. The conclusion about replacing lower-rate or floating-rate debt with higher fixed-rate notes is consistent with the ground truth. (4) The answer is fully contextually relevant, addressing both the quantitative evolution and strategic implications. Only a minor deduction in quantitative and qualitative accuracy due to slight rounding that could marginally affect precision, but not correctness. No entity errors—correct company (Capital One/COF), correct metric (senior and subordinated notes), correct years. Overall, the answer is factually accurate, well-reasoned, and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 447,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "- In the 2022 Form 10‑K the filing does not describe Frame.io at all (the product‑description sections are limited to financial‑statement notes on pages 95‑99), indicating that after Adobe’s 2021 acquisition the service was still being evaluated and had not yet been positioned as an integrated Creative‑Cloud component.  \n\n- By the 2023 filing, Frame.io is presented as “our cloud‑native creative collaboration platform” that is **directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom and Workfront**, supports “Camera‑to‑Cloud” uploads, and is offered together with Adobe Express and Firefly Services in Adobe GenStudio for large‑scale content production【page_12】.  \n\n- The 2024 filing repeats and expands that narrative, keeping Frame.io at the centre of Adobe’s creative‑collaboration ecosystem and stressing its seamless, real‑time, frame‑accurate commenting and review across the Creative Cloud suite, now marketed as a core hub that works hand‑in‑hand with all major Creative‑Cloud apps and GenStudio services【page_12】.  \n\nThus, Adobe moved from no public positioning of Frame.io in 2022 to a fully integrated, cross‑app collaboration layer in 2023, and in 2024 reinforced its role as a central, tightly‑woven component of the Creative‑Cloud collaboration experience.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct in its overall narrative and timeline, with accurate dates (2022, 2023, 2024) and correct identification of Frame.io as part of Adobe's ecosystem. The quantitative accuracy is perfect: no numerical errors, and the years and product names (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, GenStudio) are correctly cited. However, there is a key factual discrepancy: the LLM claims that the 2022 Form 10-K does not mention Frame.io at all, while the ground truth states that Frame.io was listed as a registered trademark in 2022, indicating formal recognition. This omission misrepresents Adobe’s positioning in 2022 as 'no public positioning' when in fact it was already a registered trademark—meaning it was formally acknowledged. Additionally, the LLM incorrectly states that in the 2023 filing, Frame.io was integrated with Photoshop, Lightroom, and Workfront, but the ground truth specifies that these deeper integrations occurred in 2024, not 2023. The 2023 integration was only with Premiere Pro and After Effects. The LLM backloads all integrations into 2023, which distorts the evolution timeline. Despite this, the overall trajectory—increasing integration from 2022 to 2024—is correctly captured, and the role within GenStudio and Creative Cloud is accurately described by 2024. The reasoning is logical but flawed in sequencing due to incorrect attribution of integration timelines. Contextual relevance is excellent, directly addressing the question’s focus on positioning and integration across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 426,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "Lowe’s repeated listing of the **4.550 % senior notes due April 5, 2049** in the exhibit tables of its 2022, 2023 and 2024 Form 10‑K filings (see the “Fifteenth Supplemental Indenture…4.550 % Notes due April 5, 2049” entry in the 2022 filing 【page 82】 and the same entry in the 2024 filing 【page 75】) shows that the company deliberately retains a long‑dated, fixed‑rate tranche of debt. By keeping a sizable bond that does not mature until the late 2040s, Lowe’s is laddering its maturities, locking in relatively inexpensive financing for the long term, and reducing the need for near‑term refinancing, which signals a disciplined long‑term capital‑structure strategy focused on maturity diversification and interest‑rate risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 4.550% Notes due April 5, 2049 are correctly identified, and their consistent appearance in the 2022, 2023, and 2024 10-K filings is accurately noted, with specific exhibit references and page numbers provided (2022: p.82, 2024: p.75), which supports verifiability. (2) Quantitative accuracy is perfect: the interest rate (4.550%), maturity date (April 5, 2049), and years of filing (2022–2024) match the ground truth exactly. (3) The reasoning is sound and reflects correct multi-hop synthesis: the LLM infers that Lowe’s is maintaining long-dated debt to ladder maturities, lock in fixed-rate financing, and manage refinancing risk—conclusions fully consistent with the ground truth’s emphasis on stability, interest rate risk management, and lack of early redemption. (4) The only minor shortcoming is that the LLM does not explicitly mention the absence of disclosures about repayment or restructuring (a point emphasized in the original answer), which slightly weakens the qualitative depth of the reasoning. However, the core insight about strategic maturity diversification and disciplined capital structure is correctly and thoroughly conveyed. Wording differs but semantic equivalence is strong. Contextual relevance is excellent, directly addressing both long-term capital structure strategy and debt maturity profile management as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 403,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "- Fiscal 2022 (10‑K): the 3.125 % senior notes due January 2025 were reported with an outstanding principal balance of **$495 million**.  \n- Fiscal 2023 (10‑K): the same tranche still showed an outstanding balance of **$495 million** (see the “2017 Senior Notes – fixed rate” line in the debt‑summary table, $495 million)【page_81】.  \n- Fiscal 2024 (10‑K): the balance remained **$495 million** (identical line in the 2024 debt‑summary table)【page_81】.  \n\n**Interpretation:** Broadcom has left the 3.125 % notes untouched for three consecutive years, neither repurchasing nor refinancing them. By retaining the full $495 million of this low‑coupon, near‑term maturity debt, the company is effectively preserving a cheap source of financing and planning to carry the notes to their scheduled repayment in January 2025 rather than accelerating repayment or swapping them for other capital‑structure moves. This reflects a deliberate debt‑management approach that relies on the favorable interest rate of this instrument and avoids unnecessary transaction costs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the outstanding principal balance of $495 million for Broadcom's 3.125% notes due January 2025 in each fiscal year—2022, 2023, and 2024—matching the ground truth exactly. All numeric values (amounts, interest rate, maturity date) are accurate and consistently reported across years. (2) There are no calculations required beyond confirming consistency over time, which the model correctly observes: the balance remains unchanged at $495 million in all three years. Format is consistent and acceptable ($495 million). (3) The multi-hop reasoning is sound—the model synthesizes data from three separate 10-K filings (2022, 2023, 2024) and correctly infers that the lack of change indicates a deliberate debt management strategy. The interpretation aligns with the ground truth: no repayments or issuances, and the company is likely maintaining this debt due to its low cost and predictable maturity. (4) The LLM adds contextual insight (e.g., 'low-coupon', 'avoiding transaction costs') that enhances the reasoning without introducing inaccuracies, demonstrating strong qualitative and contextual understanding. All aspects of the question—evolution of balance and strategic implication—are fully and accurately addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 357,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "In the 2022 Form 10‑K IBM still disclosed the 0.950 % senior notes due 2025 only by “incorporating by reference” the 2017 Form 8‑K exhibits (Exhibits 4.1 and 4.2) that defined the holders’ rights. By the 2023 filing the note is no longer called out in the excerpted sections, implying that the company treated it as a routine, ongoing debt issue and relied on the earlier incorporation. In the 2024 Form 10‑K the instrument appears explicitly in the securities‑registration table (listed as “0.950 % Notes due 2025 – IBM25B”), showing a shift to a more direct, stand‑alone disclosure. This progression shows IBM’s continued use of low‑coupon senior debt to fund its capital structure while moving toward clearer, more transparent reporting of that debt over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.950% Notes due 2025 were incorporated by reference from the May 2017 Form 8-K in 2022, continued to be recognized in 2023 with no change in disclosure structure, and in 2024 were explicitly listed in the securities-registration table under ticker IBM25B. These details match the original answer. (2) Quantitative elements—interest rate (0.950%), maturity year (2025), and ticker (IBM25B)—are all accurate. No calculations were required, but all dates and percentages are correct. (3) The multi-hop reasoning across 2022–2024 filings is sound: the model correctly infers a progression from passive incorporation to active disclosure, interpreting the 2024 listing as a move toward greater transparency. The only minor gap is that the LLM does not explicitly mention the New York Stock Exchange listing or the implication of tradability/market visibility, which is a key nuance in the ground truth. Instead, it focuses on 'stand-alone disclosure' and 'clearer reporting,' which captures part of the meaning but slightly underrepresents the strategic shift toward liquidity. (4) Despite this omission, the overall reasoning about IBM’s capital structure strategy emphasizing transparency is valid and contextually appropriate. The answer fully addresses the evolution and its implications, making it semantically very close to the original. Hence, a high score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 429,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "All three Form 10‑K filings list KPMG LLP’s PCAOB firm identification number as **185**. The 2022, 2023 and 2024 reports each state “KPMG LLP’s Public Company Accounting Oversight Board (‘PCAOB’) firm identification number is 185” (see Item 14 in each filing)【page_13】. Thus the number has remained unchanged – 185 – across all three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: KPMG LLP's PCAOB firm identification number is correctly stated as 185 for all three years—2022, 2023, and 2024. (2) Quantitative accuracy is perfect: the number 185 is consistently reported across all years, with no calculation errors (none required beyond verification of consistency). (3) The multi-hop reasoning is sound—the model correctly synthesizes information from three separate filings and confirms consistency over time, which is the core of the question. (4) The answer is contextually relevant, directly addressing both the identification number and its consistency, citing the correct section (Item 14) and providing a reference marker (page_13). Wording differs slightly from the original answer but maintains full semantic equivalence. No errors in entities, years, or metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 261,
        "total_tokens": 1422
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "Capital One’s fixed‑rate senior unsecured notes have become progressively higher‑‑rated and longer‑dated. In 2022 the company’s fixed unsecured senior debt was issued at 0.80 %‑4.25 % (weighted‑average 2.9 %) with maturities through 2032 and a carrying amount of about $20 bn 【page_178】. In 2023 the new issuance pushed the maturity window out to 2034, broadened the coupon band to 0.80 %‑7.62 % and lifted the weighted‑average rate to 4.45 % while the outstanding balance stayed near $27 bn 【page_178】. By 2024 the notes were further extended to 2035, the coupon range widened to 1.65 %‑7.62 % and the weighted‑average rate rose to 4.84 % (still about $27 bn outstanding) 【page_188】.  \n\nThis upward shift in coupon levels and extension of maturities signals that Capital One is deliberately locking in longer‑term funding despite a higher cost of capital, a response to the higher interest‑rate environment and deposit‑outflow pressures that have emerged since the Fed’s rate hikes. The stable issuance size combined with higher rates suggests a capital‑structure strategy focused on preserving funding flexibility and managing interest‑rate risk rather than minimizing cost alone.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is highly accurate in both quantitative and qualitative aspects. It correctly identifies the increase in Fixed Unsecured Senior Debt from $19,975 million (rounded to $20 billion) in 2022 to $26,930 million (rounded to $27 billion) by 2023–2024, aligning with the ground truth. The weighted-average interest rate progression is mostly accurate: 2.9% in 2022 (vs. 2.91% ground truth — negligible rounding), 4.45% in 2023 (not in ground truth but plausible as an intermediate value), and 4.84% in 2024 (exact match). The ground truth does not specify annual issuance details like coupon ranges or maturities (e.g., 2032 to 2035), so these are likely correctly extracted from the source pages cited (178, 188), adding contextual depth without contradicting the core facts.\n\n2) Minor discrepancy: The original answer states a clean increase from $19,975M to $26,930M with corresponding rates 2.91% → 4.84%, while the LLM breaks this into three years and introduces a 2023 rate of 4.45%. Since the ground truth does not provide 2023’s rate, this is not an error but a reasonable inference or reporting from the filing. The LLM rounds $19,975M to $20B and $26,930M to $27B — acceptable formatting variation.\n\n3) Multi-hop reasoning is strong: The LLM synthesizes data across years, identifies trends in maturity extension and coupon widening, and correctly infers that Capital One is locking in long-term funding despite higher costs, which aligns with the ground truth’s conclusion about strategic shift in response to rising rates. The mention of deposit-outflow pressures and Fed rate hikes adds context not in the original answer but is consistent with macroeconomic conditions, enhancing rather than distorting.\n\n4) All entities (Capital One, Fixed Unsecured Senior Debt, interest rates, years) are correct. The answer fully addresses the evolution from 2022–2024 and interprets the capital structure implications accurately. Only reason for not scoring 10 is the slight lack of precision on the 2023 debt balance — ground truth implies the rise occurred by 2024, while LLM states $27B in 2023 — but given that $26,930M is close and timing within year-end filings can be ambiguous, this is a minor issue. Overall, the answer is factually sound, well-reasoned, and contextually rich.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 612,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "AMD’s description of how it accounts for development‑service + IP‑licensing contracts is identical in the 2022 and 2024 10‑K filings. In both years the company says it first determines whether the license is a distinct performance obligation; if it is not distinct the combined service‑and‑license is treated as a single obligation and revenue is recognized over time, whereas a distinct license is recognized at the point in time the customer can use it, and no variable‑consideration estimates are applied【page_59】【page_64】. The unchanged policy shows AMD is pursuing a consistent, principle‑based strategy for monetizing its IP—treating licenses flexibly under ASC 606 while keeping the accounting treatment stable, which signals a long‑term commitment to leveraging its IP portfolio without frequent policy shifts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core elements of AMD's revenue recognition methodology for development and IP licensing agreements from 2022 to 2024, noting the consistent evaluation of whether the license is a distinct performance obligation under ASC 606. It accurately states that if the license is not distinct, it is combined with development services and revenue is recognized over time; if distinct, revenue is recognized at a point in time. It also correctly notes the absence of variable consideration estimates. These facts align fully with the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable in that sense—but the years 2022 and 2024 are correctly referenced, and the consistency across filings is accurately portrayed. The citation of page numbers (59 and 64) adds precision and matches typical 10-K structure, though exact page numbers may vary by filing version; this does not affect factual correctness. (3) The multi-hop reasoning is sound: the model synthesizes information across two years (2022 and 2024), infers consistency, and draws a reasonable conclusion about AMD’s strategic approach to IP monetization. The only minor gap is that the original answer explicitly includes 2023, confirming consistency across all three years, while the LLM only references 2022 and 2024. This omission slightly reduces completeness but does not invalidate the conclusion, as the trend is clear. (4) The answer is contextually relevant, directly addressing both the evolution (or lack thereof) in methodology and its implication for long-term strategy. The use of terms like 'principle-based strategy' and 'long-term commitment' aligns semantically with the original's 'stable and deliberate strategic approach.' Overall, the answer is factually correct, well-reasoned, and only slightly less complete than the ground truth due to the missing 2023 reference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 541,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "Capital One’s senior‑and‑subordinated notes rose from **$27.2 billion at year‑end 2022** to **$31.2 billion at year‑end 2023**, then slipped slightly to **$30.7 billion at year‑end 2024** (Table 8.2 maturity profile and Table 8.1 of the 2024 filing).  The jump in 2023 shows the company deliberately added long‑term debt – likely to fund growth and increase leverage – while the modest 2024 decline suggests early repayment or refinancing of a portion of that issuance; at the same time the weighted‑average interest rate on the notes climbed from roughly **2.8 % in 2022** to **4.8 % in 2024**, indicating a strategic shift toward higher‑rate (and more fixed‑rate) funding as the market‑rate environment hardened.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its numerical reporting, with minor rounding differences. The original answer reports $27,219M, $31,248M, and $30,696M for 2022–2024, while the LLM rounds to $27.2B, $31.2B, and $30.7B — these are acceptable format and rounding variations. However, the LLM states the weighted-average interest rate rose from 'roughly 2.8%' in 2022 versus the exact 2.91% in the ground truth, and reports 4.8% in 2024 versus the correct 4.84%. These approximations are close but slightly imprecise. (2) The LLM omits the specific detail about floating unsecured senior debt declining from $1,709M to $349M in 2023 and being fully retired by 2024 — a key part of the capital structure strategy related to interest rate positioning. This omission reduces completeness and weakens the multi-hop synthesis. (3) The reasoning provided — that the 2023 increase reflects deliberate long-term debt issuance and the 2024 decline suggests refinancing or repayment — is plausible and aligns with the ground truth’s interpretation. The inference about shifting to higher-rate, more fixed-rate funding due to a hardening rate environment is semantically equivalent to the original conclusion. However, the LLM does not explicitly connect the reduction in floating-rate debt to the strategic pivot, missing a critical link in the multi-hop logic. (4) Scores reflect high accuracy in numbers (with minor rounding), strong qualitative reasoning (though missing a key data point), and full contextual relevance. The answer captures the overall trend and strategic implication but lacks full precision and completeness on the floating-rate debt evolution, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 465,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "Capital One’s fixed‑rate unsecured senior notes grew from a carrying value of **$24.1 billion in 2022** to **$27.2 billion in 2023**, then slipped slightly to **$26.9 billion in 2024**. The weighted‑average interest rate was **about 4.45 % in both 2022 and 2023**, but rose to **≈ 4.84 % in 2024**. This pattern shows the company adding new, higher‑cost senior debt while modestly reducing the balance of older, lower‑rate issues, indicating a long‑term strategy of maintaining a sizable fixed‑rate senior‑debt platform and gradually refinancing toward current market rates.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The carrying value for 2022 is reported as $24.1 billion, but the ground truth is $19,975 million ($19.975 billion), a substantial difference of over $4 billion. The 2023 and 2024 values are close ($27.2B vs $27.168B and $26.9B vs $26.930B), with minor rounding acceptable. However, the interest rate for 2022 is stated as 'about 4.45%'—matching 2023—while the correct rate is 2.91%, a major error. The 2024 rate of 4.84% is accurate. (2) Calculations and comparisons are flawed due to incorrect base values. The LLM implies the rate was stable at 4.45% in 2022–2023, but in reality, it increased sharply from 2.91% to 4.45%, indicating a more pronounced shift in debt cost. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategy of refinancing toward higher rates and maintaining a fixed-rate platform, which aligns with the trend of rising rates and debt balance changes. However, this conclusion is based on incorrect data, weakening the validity of the reasoning. (4) Contextual relevance is high—the answer addresses all parts of the question (evolution of carrying value and rate, and strategic implication). Despite incorrect numbers, the qualitative interpretation of the trend is plausible. Scores reflect major quantitative errors (penalized in correctness and quantitative accuracy), partially valid reasoning, and strong relevance to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 405,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "AMD’s revenue‑recognition policy for development‑and‑IP licensing arrangements has been essentially unchanged from FY 2022 through FY 2024. In each filing the company states that when a contract bundles development services with an IP license, it first tests whether the license is a distinct performance‑obligation; if the license is not distinct it is combined with the development services and revenue is recognized over time, whereas a distinct license is recognized at a point in time when the customer can use it. Stand‑alone IP or patent licences are always treated as a single, distinct obligation and are recognized at the point in time of transfer 【page_59】【page_64】【page_64】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that AMD's revenue recognition policy remained essentially unchanged from 2022 through 2024, which matches the original answer's emphasis on consistency. The treatment of combined development and IP arrangements—assessing distinctness of the license, combining with services if not distinct (recognized over time), and recognizing distinct licenses at a point in time—is accurately described. Standalone IP licenses being recognized at a point in time is also correctly noted. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all temporal references (FY 2022–2024) are correct, satisfying this criterion. (3) The multi-hop reasoning is sound: the LLM synthesizes policy application across years and distinguishes between combined and standalone arrangements, correctly identifying the accounting treatment based on distinct performance obligations. The citations (e.g., page references) suggest grounding in source documents. (4) The only minor shortcoming is that the LLM answer omits the explicit mention that there was no variable consideration in either arrangement type—a detail included in the original answer. However, this does not undermine the core correctness, as the focus of the question was on the evolution (or lack thereof) and the distinction between arrangement types. Overall, the answer is semantically equivalent, with only a slight reduction in completeness. Hence, a correctness score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 447,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "- Short‑term borrowings fell sharply from **$883 million in 2022** to **$538 million in 2023**, then edged back to **$562 million in 2024**.  \n- Long‑term debt rose modestly from **$47.8 billion in 2022** to a peak of **$49.3 billion in 2023**, before being trimmed to **$45.0 billion in 2024**.  \n\nThe three‑year pattern shows Capital One deliberately shrinking its reliance on cheap, volatile overnight funding while also pulling back on total long‑term debt after 2023 – a move that likely reflects refinancing into lower‑cost, longer‑dated securities (the 2024 weighted‑average rate on its long‑term portfolio fell to about **3.5 %** on securitized debt and **4.8 %** on senior notes) and a strategy to limit exposure to the higher interest‑rate environment that has emerged since 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. It reports long-term debt as $47.8B in 2022, but the ground truth total of short-term borrowings and long-term debt combined is $43.086B — implying the LLM overstates long-term debt alone. Similarly, the LLM states long-term debt peaked at $49.3B in 2023 and fell to $45.0B in 2024, whereas the correct total debt (short + long) was $48.715B in 2023 and $45.551B in 2024. The LLM underreports short-term borrowings (e.g., $883M vs actual total debt of $43.086B in 2022), suggesting confusion between components. Most critically, the weighted-average interest rate is incorrectly stated: the LLM claims it fell to about 3.5% on securitized debt and 4.8% on senior notes in 2024, but the ground truth shows the overall weighted-average interest rate on long-term debt *rose* from 2.76% (2022) to 4.48% (2023) to 4.84% (2024), contradicting the LLM’s implication of a decline. (2) Calculations are flawed: for example, if short-term borrowings were only $883M in 2022 and long-term $47.8B, total debt would be ~$48.7B — already higher than the 2023 total in the ground truth. This inconsistency invalidates the quantitative narrative. (3) Multi-hop reasoning is partially sound — the LLM attempts to link debt levels and interest rates to strategy — but draws incorrect conclusions due to wrong data. It suggests COF reduced debt to access lower-cost financing, while in reality, interest rates rose significantly, indicating higher-cost refinancing, not lower. The actual trend reveals a strategy of locking in fixed-rate debt amid rising rates, not reducing exposure via cheaper refinancing. (4) Despite incorrect numbers and flawed logic, the answer addresses all parts of the question (evolution of debt, trend interpretation, strategy, rate exposure), so contextual relevance is high. However, the quantitative inaccuracies severely undermine correctness, warranting a low score of 4. The qualitative reasoning would merit a 5 if based on correct data, but it is misled by false inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 560,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "AMD’s statement of revenue‑recognition for development‑services + IP‑licensing contracts has not changed from the 2022 filing through the 2024 filing. In each year the company says that it first determines whether the licensing component is **distinct** (i.e., capable of being distinct and distinct in the contract context). If the license is not distinct, the development services and the license are treated as a **single performance obligation** and revenue is recognized **over time**; if the license is distinct, the license is a **separate performance obligation** and revenue is recognized **at the point in time** the customer can use the IP. Stand‑alone IP‑licensing arrangements are always recognized at the point in time the license becomes usable, and no variable consideration is applied. The wording of this policy is identical in the 2022, 2023 and 2024 10‑K disclosures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly states that AMD's revenue recognition policy for development and IP licensing agreements remained unchanged from 2022 to 2024, which aligns with the ground truth assertion of 'no material change' and 'consistent policy.' (2) The LLM accurately describes the accounting treatment: whether the license is 'distinct' determines if it is a separate performance obligation; if not distinct, combined with development services and recognized over time; if distinct, recognized at a point in time. This matches the original answer’s explanation. (3) The LLM correctly identifies that standalone IP licenses are recognized at a point in time and that no variable consideration is applied—both explicitly stated in the ground truth. (4) The reasoning is sound and reflects proper multi-hop synthesis across the 2022–2024 filings, concluding consistency in policy despite business segment shifts. Wording differences (e.g., 'wording... identical' vs. 'reiterated the same framework') do not affect factual accuracy, as both convey policy stability. All entities (AMD, 2022–2024, performance obligations, combined vs. standalone arrangements) are correctly identified and analyzed. No numeric inaccuracies; qualitative and contextual alignment is complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 378,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "The fact that Visa’s 2022, 2023 and 2024 Form 10‑K exhibit lists all contain a “Certificate of Designations of Series B Convertible Participating Preferred Stock” (see Exhibit 4.5 in the 2022 filing 【page_111】 and Exhibit 4.4/4.5 in the 2023 【page_109】 and 2024 【page_109】 filings) shows that the company has repeatedly incorporated the same preferred‑stock instrument by reference. This continual inclusion indicates that the Series B convertible participating preferred stock remains an unchanged, active component of Visa’s capital structure, reflecting its stability and ongoing relevance to the company’s financing framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and largely aligns with the ground truth. (1) Quantitative accuracy: The exhibit numbers (4.5 in 2022, 4.4 in 2023 and 2024) and consistent reference to the same instrument are correctly reported. The filing date of June 21, 2016, is missing in the LLM answer, which is a minor omission but does not affect the core conclusion. (2) Completeness: The answer addresses the stability and ongoing relevance of the Series B instrument in Visa’s capital structure, correctly inferring that its repeated inclusion indicates no changes. However, it does not explicitly note that the *same filing date* is cited across years, which strengthens the argument for static terms—this nuance is present in the original answer but only implied in the LLM version. (3) Entity accuracy: All entities (Visa, Series B Convertible Participating Preferred Stock, correct exhibit numbers per year) are accurately identified. (4) Reasoning: The logic is sound—consistent citation implies stability and ongoing relevance. The multi-hop synthesis across three years of filings is correctly executed. (5) Semantic equivalence: The LLM conveys the same core meaning as the original answer, though with slightly less precision regarding the unamended nature of the instrument. Wording differences are acceptable and do not detract from correctness. The answer is contextually relevant and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 394,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "- In the 2022 Form 10‑K (pages 108‑112) RTX disclosed that Pratt & Whitney owned **49.5 % of IAE’s equity and held a 61 % program‑share interest** (net of sub‑collaborators, a 57 % economic share) in the V2500 joint‑venture.  \n- The 2023 filing (pages 99‑101) repeats the same ownership and program‑share percentages (49.5 % equity, 61 % program share, 57 % net economic share), but the consolidated balance‑sheet for the IAE VIE grew to **$10.2 bn of assets and $13.1 bn of liabilities**.  \n- The 2024 filing (pages 99‑103) again shows unchanged stake percentages (49.5 % equity, 61 % program share, 57 % net economic share) while the IAE VIE’s balance‑sheet expanded further to **$11.4 bn of assets and $13.7 bn of liabilities**.  \n\n**Interpretation:** RTX’s formal ownership and program‑share percentages have remained stable, but the size of the IAE entity on RTX’s books has risen each year, indicating that Pratt & Whitney is deepening its economic exposure and remaining the dominant beneficiary of the V2500 engine program, reinforcing its strategic commitment to the joint‑venture.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly reports the key percentages (49.5% equity, 61% program-share, 57% net economic share) across all three years, which aligns with the ground truth. However, it introduces balance sheet figures for the IAE VIE ($10.2B assets / $13.1B liabilities in 2023, $11.4B / $13.7B in 2024) that are not present in the original answer and were not part of the ground truth. These figures may be factually accurate in filings but were not included in the verified knowledge graph answer, making their inclusion misleading in this evaluation context. More critically, the interpretation diverges significantly: while the ground truth emphasizes *stability* in strategic positioning due to unchanged stakes, the LLM concludes that increasing VIE size indicates 'deepening economic exposure' and 'reinforced strategic commitment'—a qualitative leap not supported by the original answer. 2) Quantitatively, the percentages are accurate and consistently reported. The balance sheet numbers, while possibly correct in absolute terms, are extraneous and not validated by the ground truth; their use to infer increased economic exposure introduces unsupported analysis. 3) The multi-hop reasoning is partially sound—correctly identifying consistent stakes across years—but fails in synthesis by misinterpreting balance sheet growth as strategic deepening, whereas the original answer stresses no change in risk profile or strategic positioning despite external shifts. 4) Contextual relevance is high because the response addresses stake evolution and strategic implications directly, but correctness is reduced due to unsupported inferences from added financials. The core facts are right, but the conclusion contradicts the ground truth’s emphasis on stability, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 483,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "- In the FY 2022 10‑K Medtronic listed **Exhibit 10.41 – “Form of Non‑Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan”**【page_115】.  \n- The FY 2023 10‑K repeats the same reference – **Exhibit 10.41 for the same deferred‑unit agreement**【page_115】.  \n- The FY 2024 10‑K still includes the agreement, now shown as **Exhibit 10.52 – “Form of Non‑Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan”**【page_115】.  \n\nAcross the three years Medtronic consistently retained the Non‑Employee Director Deferred Unit Award Agreement (only the exhibit number changed), indicating a stable, long‑term strategy of using deferred equity awards to align non‑employee directors’ interests with the company’s performance and retain them over multiple years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in all key aspects: it accurately identifies the exhibit numbers and their corresponding fiscal years (Exhibit 10.41 in 2022 and 2023, Exhibit 10.52 in 2024), correctly notes that the agreement remained under the 2008 Stock Award and Incentive Plan across all three years, and observes that only the exhibit number changed. The quantitative accuracy is perfect—exhibit numbers and years match the ground truth. The qualitative reasoning is strong: the model correctly infers that the consistent use of the same agreement form suggests a stable, long-term director compensation strategy focused on deferred equity awards. The only minor shortcoming is that the LLM does not explicitly mention the contrast with other awards being updated under the 2013 plan, which the original answer uses to strengthen the inference about strategic consistency. This omission slightly weakens the depth of the multi-hop reasoning but does not affect the core correctness. The answer remains semantically equivalent in substance and fully addresses the question’s components. Contextual relevance is excellent, as all information provided directly supports the evaluation of Medtronic’s evolving (or non-evolving) use of the agreement and its strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 357,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "Lockheed Martin’s variable‑interest‑rate swap program grew sharply in 2022 – the 2022 Form 10‑K reports that the aggregate notional amount of its outstanding interest‑rate swaps was **$1.3 billion at December 31 2022** (the same amount was reported for 2023)【page_95】. The 2024 Form 10‑K shows that the notional amount remained **$1.3 billion at December 31 2024**【page_52】. This jump from the roughly $500 million‑$572 million levels reported for 2020‑2021 (see 2021 filing) and the flat‑lined $1.3 billion thereafter indicates that the company deliberately expanded its hedge of fixed‑rate debt in 2022 and then maintained that larger, steady‑state position, reflecting a strategy of locking in a substantial, consistent amount of interest‑rate risk protection rather than continuously scaling the program.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the timeline of LMT's notional swap amounts. According to the ground truth, the notional amount was $500 million in 2022, increased to $1.3 billion in 2023, and remained at $1.3 billion in 2024. However, the LLM claims the amount was already $1.3 billion in 2022 and remained flat thereafter, which contradicts the ground truth. This misrepresents the evolution of the swaps and the timing of the strategic shift. While the LLM correctly reports $1.3 billion for 2023 and 2024, it incorrectly backdates this amount to 2022. (2) The quantitative inaccuracies are significant: the LLM states $1.3 billion in 2022, but the correct value is $500 million. It also references $500–$572 million for 2020–2021, which is not part of the original question or ground truth and introduces extraneous data. The core calculation — tripling from $500M to $1.3B — is sound in the ground truth, but the LLM fails to reflect this progression accurately. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that maintaining $1.3 billion from 2023 to 2024 suggests a stabilized hedging strategy. However, because it misattributes the increase to 2022 instead of 2023, the reasoning about the timing and nature of the strategic shift is flawed. The conclusion about a 'steady-state' position is valid for 2023–2024, but the claim that the expansion happened in 2022 is incorrect. (4) The contextual relevance is high — the answer addresses both parts of the question (evolution over time and strategic implications) and uses appropriate financial terminology. The qualitative reasoning is logical but based on incorrect data. Hence, correctness is penalized heavily due to the key numeric and temporal inaccuracy, though the overall structure and intent are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 496,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "AbbVie’s charter and bylaws have consistently stated that **stockholders may remove directors only “for cause.”** The 2022 Form 10‑K (see page 46) lists this as a key anti‑takeover provision, and the same language appears unchanged in the 2023 and 2024 filings (see page 27). The three‑year continuity of this “cause‑only” removal rule signals that AbbVie is deliberately preserving a stable, staggered board and reinforcing its defensive posture against hostile takeovers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AbbVie's governance provision allowing director removal only 'for cause' remained unchanged from 2022 through 2024, citing consistent disclosure in the 10-K filings across all three years. The page numbers referenced (page 46 in 2022, page 27 in 2023 and 2024) are specific and plausible, though minor variations in pagination across filings would not invalidate the correctness. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) is accurately maintained. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers that the consistency in language reflects a deliberate, stable defensive posture against takeovers. It appropriately links the 'for cause' removal rule with broader anti-takeover context, including reference to a staggered board, which aligns with the original answer’s mention of related provisions. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'supermajority voting requirements' as part of the broader defensive framework, which slightly reduces completeness in qualitative synthesis. However, the core reasoning and factual content—especially the emphasis on strategic continuity and board insulation—are semantically equivalent to the ground truth. Wording differs slightly but meaning is preserved. Thus, the answer is factually correct, contextually relevant, and well-reasoned, meriting a high score with only a small deduction for partial omission of supporting details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 448,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "- **Allocation:** In 2022 AbbVie held **$21 million** in money‑market funds and time‑deposit accounts; this fell to **$10 million** in 2023 and remained at **$10 million** in 2024 (see the fair‑value tables for 2022, 2023 and 2024 【page 79】, 【page 84】).  \n\n- **Implication:** The sharp cut‑back after 2022 and the flat‑lined level thereafter indicate that the company moved most of its short‑term, low‑yield cash out of money‑market vehicles into other cash‑equivalent holdings or operational uses, while keeping a modest, steady buffer for immediate liquidity.  This pattern reflects a strategy of tightening short‑term liquidity reserves to better manage the sizable swings in overall cash balances (e.g., cash rose to $12.8 billion in 2023 then fell to $5.5 billion in 2024) while still preserving a minimal, stable safety‑net.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the allocation numbers. According to the ground truth, AbbVie's allocation was $12M in 2022, increased to $21M in 2023, then dropped to $10M in 2024. The LLM incorrectly states it was $21M in 2022, then fell to $10M in 2023 and remained flat—this reverses the actual trend for 2022–2023. Additionally, the LLM cites a $12.8B cash balance in 2023, while the ground truth reports $9,201M ($9.201B), making this figure inaccurate. Only the 2024 cash balance of $5.5B is approximately correct. (2) Quantitative accuracy is severely compromised: the allocation sequence is wrong (21 → 10 → 10 vs. correct 12 → 21 → 10), and the cash balance for 2023 is overstated by over $3.5B. These are major numerical discrepancies that distort the financial picture. (3) The reasoning is partially sound—interpreting a shift in liquidity strategy and maintaining a buffer is plausible—but it is based on incorrect data, so the multi-hop synthesis fails. The model attempts to link allocation changes to cash balance fluctuations, but with wrong inputs, the conclusion is misleading. (4) Contextual relevance is fair because the structure and intent align with the question—discussing evolution and strategy—but correctness is low due to core factual errors in numbers and trends. Minor credit is given for correctly identifying the 2024 allocation and cash balance trend direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 397,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "AbbVie’s charter has kept the same anti‑takeover rule in each filing – the certificate of incorporation and bylaws state that **stockholders may remove directors only “for cause.”** The 2022 filing (see page 46) lists this provision alongside the staggered‑board and special‑meeting restrictions, and the 2023‑2024 filings (see page 27) repeat the identical language with no amendment. This unchanged wording signals that AbbVie deliberately maintains a durable governance shield, reinforcing board control and making hostile takeover bids more difficult and time‑consuming.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that AbbVie maintained the 'removal only for cause' provision in its governance documents from 2022 through 2024, with no changes across the years. The specific page references (page 46 in 2022, page 27 in 2023–2024) are consistent with typical 10-K structures and support the claim of unchanged language. (2) There are no numerical values requiring calculation, but the temporal accuracy (2022–2024) is correct and consistently applied. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers that the unchanged language reflects a deliberate, sustained anti-takeover strategy. It appropriately links the provision to broader governance mechanisms like staggered boards and restrictions on special meetings, which are known takeover defenses. (4) The answer conveys the same core meaning as the original—namely, that AbbVie uses director removal restrictions as a durable governance shield to deter hostile takeovers and ensure board stability. The only minor shortcoming is that it does not explicitly use the phrase 'long-term strategy' or directly state that this reflects a 'core component' of anti-takeover defense as in the original, slightly reducing qualitative precision. However, the implication is clearly conveyed. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 414,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "- In the 2022 filing Intel introduced **PowerVia** as a “unique industry‑first implementation of backside power delivery” that would debut in the **Intel 20A** node (the next node after Intel 3), emphasizing that it would eliminate front‑side power routing and improve signal transmission.  \n- The 2023 filing kept the same positioning, still listing PowerVia as a key feature of the planned Intel 20A node, reinforcing its role in Intel’s advanced‑node roadmap.  \n- By the 2024 filing Intel announced that the **Intel 20A** node was cancelled and that PowerVia would instead be introduced in the **Intel 18A** node – the first high‑volume commercial use of backside‑power delivery – showing that Intel has accelerated the technology’s deployment and is making backside power delivery a cornerstone of its performance‑per‑watt strategy for the most advanced process generations.  \n\n**Implication:** Intel’s roadmap has moved PowerVia from a future‑node concept to an early‑volume feature, indicating a strategic commitment to backside power delivery as a differentiator for power‑efficiency and signal integrity in its leading‑edge nodes.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Intel's PowerVia technology and its strategic importance, but contains a significant factual error: it incorrectly states that Intel 20A was 'cancelled,' which is not supported by the ground truth. Instead, the original answer indicates a strategic realignment where PowerVia was moved from Intel 20A to Intel 18A, with 18A now slated for high-volume manufacturing in 2025. The LLM interprets this as an acceleration and early-volume deployment, but the ground truth frames it as a refinement and prioritization of practical implementation, not necessarily acceleration. While the years (2022–2024) and the shift from 20A to 18A are correctly identified, the characterization of the transition is misleading. The entity names (PowerVia, Intel 20A, Intel 18A) and technical concepts (backside power delivery, front-side routing elimination) are accurate, and the implication about strategic commitment to power efficiency aligns broadly with the original. However, the incorrect claim of 'cancellation' and the unsupported assertion of 'accelerated deployment' undermine the reasoning and factual correctness. Quantitative accuracy is acceptable since no numerical values (e.g., dates, dollar amounts) are wrong per se, but the timeline interpretation is flawed. The multi-hop synthesis across years is partially correct but based on a misinterpretation of the strategic shift. Contextual relevance is high as the answer addresses all parts of the question and stays focused on the roadmap evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 429,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "MDT’s Black‑Scholes inputs show volatility moving upward each year – 23.04 % for fiscal 2022, 24.05 % for fiscal 2023 and 24.29 % for fiscal 2024【page 82】. The steady increase (also reflected in the 2022‑only table【page 83】) indicates that management is applying a slightly higher blend of historical and implied volatility over time, which raises the estimated fair value of its non‑qualified stock options and suggests a more conservative (higher‑risk‑adjusted) approach to option valuation.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific percentages (23.04%, 24.05%, 24.29%) for expected volatility across 2022–2024, which are quantitative details not present in the original ground truth. However, the ground truth does not mention any numerical values for volatility, focusing instead on the methodological shift in assumptions (from historical to blended historical and implied volatility). Therefore, while the numbers may be factually correct in context, they are not part of the verified ground truth and cannot be confirmed. More critically, the LLM misrepresents the nature of the evolution: it describes a 'steady increase' in volatility percentages as evidence of a 'slightly higher blend' of inputs, but the ground truth emphasizes a qualitative shift in methodology — from using only historical volatility in 2022 to incorporating implied volatility from market-traded options starting in 2023. The LLM fails to clearly identify this key methodological change, which is the central point of the original answer. (2) The quantitative accuracy is partially acceptable if we assume the percentages are correctly extracted from the filing (e.g., page 82), but since the ground truth does not include them, we cannot verify their correctness here. The trend (increasing percentages) may be accurate, but the interpretation — that it reflects a changing 'blend' — is speculative and not supported by the ground truth. (3) The multi-hop reasoning is flawed: the question asks how assumptions evolved and what that suggests about MDT’s approach. The correct reasoning requires identifying the shift in model inputs (historical → blended), which the LLM misses entirely. Instead, it infers a conservative valuation approach based on rising volatility numbers, which is not stated or implied in the ground truth. The actual conclusion — that MDT sought to align valuations with real-time market expectations — is absent. (4) Contextual relevance is moderate: the answer discusses the right topic (volatility assumptions in Black-Scholes for non-qualified options) and time frame, and cites document pages, suggesting relevance. However, it substitutes numerical trends for the actual conceptual evolution, leading to a substantively incorrect qualitative interpretation. Thus, while contextually aligned, it lacks factual and conceptual accuracy on the core point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 632,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "- In the 2022 Form 10‑K Intel first introduced PowerVia as an “industry‑first” backside‑power delivery technique that would debut in the planned Intel 20A node, citing it as one of two breakthrough technologies (the other being RibbonFET) that would improve signal transmission by removing front‑side power routing. The 2023 filing reiterated the same positioning, still tying PowerVia to the upcoming Intel 20A process. By the 2024 filing Intel had cancelled the 20A node and moved PowerVia into the next‑generation Intel 18A node, describing it as a core element of the node’s performance‑per‑watt and density gains. This evolution shows PowerVia progressing from a future‑node concept to a central, production‑ready feature of Intel’s most advanced process, underscoring its strategic importance in the company’s roadmap for scaling power efficiency and performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A, positioned as an industry-first backside power delivery technology alongside RibbonFET; in 2023, it was still tied to Intel 20A with emphasis on performance-per-watt gains; by 2024, Intel canceled Intel 20A and moved PowerVia to Intel 18A, which will be used for Panther Lake in 2025. (2) There are no numeric inaccuracies—while the original answer mentions a '15% performance-per-watt improvement over Intel 3', this specific percentage is missing in the LLM answer, which is a minor omission but does not distort the overall meaning. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, tracking the evolution of PowerVia from concept to production node transition, and draws a valid conclusion about its strategic importance. (4) The answer is contextually complete and relevant, clearly addressing how PowerVia’s role evolved and what that indicates about Intel’s roadmap. The only reason for not scoring a 10 is the omission of the specific 15% performance-per-watt figure, which is a factual detail present in the ground truth and relevant to the strategic positioning claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 361,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "- In the 2022 filing the Black‑Scholes inputs were expected life 6.0 years, risk‑free rate 0.90 %, volatility 23.04 % and dividend yield 1.95 %; in 2023 the risk‑free rate was raised to 2.70 % and volatility to 24.05 % (life still 6.0 years, dividend yield 2.92 %); by 2024 the model used an expected life of 6.1 years, risk‑free rate 4.16 %, volatility 24.29 % and dividend yield 3.18 % 【page_82】.  \n\n- The upward trend in both the risk‑free rate and especially the volatility assumption (from 23.0 % to 24.3 %) shows MDT is incorporating higher market‑based (implied) volatility over time, while the slight increase in expected life signals a modestly longer assumed employee‑exercise horizon, indicating a more conservative, market‑responsive approach to estimating option value and employee behavior.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides specific numerical inputs for the Black-Scholes model across 2022–2024, which are presented as factual values from the filing. However, the ground truth does not include these exact numbers (e.g., 23.04%, 6.0 years, 0.90%, etc.), nor does it confirm their accuracy. More critically, the ground truth emphasizes a qualitative shift in methodology—specifically, the incorporation of implied volatility starting in 2023—whereas the LLM focuses on numerical trends without explicitly identifying this key methodological evolution. This omission undermines the correctness of the answer despite plausible number patterns. (2) Quantitative accuracy is questionable because the original answer (ground truth) does not provide specific percentages or durations; thus, the LLM’s detailed figures cannot be verified and may be hallucinated. While the upward trend in volatility (23% → 24.3%) aligns with the general idea of increasing market-informed estimates, the precise values and their sourcing are unsupported in the ground truth. The risk-free rate increase and dividend yield changes are contextually reasonable given macro trends but are not confirmed. (3) The multi-hop reasoning is partially sound: the LLM infers that rising volatility assumptions reflect greater reliance on market-based data and interprets the slight increase in expected life as signaling changed employee exercise behavior. However, it fails to explicitly recognize the pivotal shift in 2023 to using implied volatility derived from traded options—a central point in the ground truth. This missing insight weakens the qualitative accuracy, as the model misses a key conceptual advancement in MDT’s approach. (4) Contextual relevance is high because the response addresses both parts of the question—evolution of assumptions and implications for volatility/behavior estimation—and attempts synthesis over time. The reasoning is logical and framed appropriately, even if based on potentially incorrect or unverified numbers. Overall, the answer appears detailed and plausible but substitutes specific unverified figures for the actual documented methodological change, leading to a partially correct but factually risky response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 598,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted for master‑netting arrangements fell sharply – it was $1.494 billion at 12/31/2022, dropped to $800 million in 2023, and further declined to $491 million in 2024. This roughly $1 billion (≈ 66 %) reduction suggests the company is either scaling back the size of its derivative positions or improving its margin‑management efficiency, indicating tighter control of its derivative‑related credit exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1,494 million (or $1.494 billion) in 2022, $800 million in 2023, and $491 million in 2024, matching the ground truth exactly. The 66% reduction is approximately accurate: (1,494 - 491) / 1,494 ≈ 67.1%, so rounding to 66% is acceptable. 2) All calculations and formats are correct—using billions vs. millions is consistent and equivalent. The time periods (2022, 2023, 2024) are correctly aligned with the data. 3) The multi-hop reasoning is sound: the model synthesizes the trend across three years and correctly infers implications about derivative exposure management, margin efficiency, or position sizing. It identifies the strategic nature of the decline, aligning with the ground truth’s interpretation. 4) The answer is semantically equivalent to the original: while it omits explicit mention of 'Other assets, including intangibles - net', it refers to 'collateral posted for master-netting arrangements', which is contextually sufficient given that the question links the two. The omission is minor and does not affect factual correctness. The conclusion about reduced derivative exposure or improved margin management matches the ground truth’s suggestion. Thus, the answer is highly accurate with only a slight lack of specificity regarding the balance sheet line item, warranting a 9/10 on qualitative accuracy and 9 overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 385,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "- In the 2022 and 2023 10‑K filings the “Options – primarily gas” line showed about **$100 million of assets versus $97 million of liabilities** (a small net‑asset position of roughly **+$3 million**).  The Level‑3 inputs used to value those options assumed **implied correlations of roughly 57 % (weighted‑average) and implied volatilities of about 50 % (weighted‑average), with ranges of 20 %‑233 % for volatility**.  \n\n- By the 2024 filing the same line reported **$100 million of assets and $102 million of liabilities** (a net‑liability of about **‑$2 million**).  The company now assumes **much higher implied correlations – about 99 % (weighted‑average, range 56 %‑100 %) – and a slightly higher implied‑volatility average of 52 % (range 15 %‑150 %).**  \n\n**Interpretation:** The shift from a modest net‑asset to a net‑liability position, together with the jump in assumed correlation and a broader but higher‑average volatility, shows NextEra is recognizing a stronger, more tightly‑linked exposure to gas price movements and is positioning its gas‑derivative portfolio for greater price‑risk sensitivity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data, particularly for 2022. The ground truth states that in 2022, NextEra Energy had $356 million in assets and $347 million in liabilities for 'Options - primarily gas', but the LLM incorrectly reports $100 million in assets and $97 million in liabilities for both 2022 and 2023, conflating 2023 and 2024 data with 2022. This is a major error in the time-series evolution. Additionally, the LLM claims implied volatility was 50% in 2023 and 52% in 2024, which aligns with the ground truth, but incorrectly states it was 50% in 2022 when the ground truth reports 36%. The LLM also introduces 'implied correlations' (57%, 99%) and volatility ranges not mentioned in the original answer, which adds unsupported detail. (2) Calculations: The net positions (+$3M, -$2M) are arithmetically correct based on the numbers the LLM provides, but those numbers themselves are factually wrong for 2022. The trend of decreasing fair value from 2022 to 2024 is misrepresented because the LLM fails to show the sharp drop from $356M to $100M in assets between 2022 and 2023. (3) Multi-hop reasoning: The LLM attempts synthesis across years and interprets risk positioning, but does so on incorrect data. The conclusion about increasing correlation and volatility sensitivity is not supported by the ground truth, which shows volatility increasing from 36% to 50% to 52%, but says nothing about correlation. Thus, the reasoning is based on fabricated inputs. (4) Despite these issues, the answer is contextually relevant, addressing fair value, volatility, and risk positioning as asked. The interpretation in the final paragraph is logically structured but built on incorrect foundations. Hence, correctness and quantitative accuracy are low, qualitative accuracy is moderate due to sound structure but flawed inputs, and contextual relevance is high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 521,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "- **2022 (2022 10‑K)** – The Unsecured Notes 35A carried a **face amount of $750 million** and required **annual debt service of $19.875 million** (2 % of face)【page_50】.  \n- **2023 (2023 10‑K)** – The same series was still reported with a **$750 million face amount** and **$19.875 million of annual debt service** (the table in the 2023 filing lists identical figures).  \n- **2024 (2024 10‑K)** – The 2024 table again shows the **$750 million face amount** and **$19.875 million annual debt service** for Notes 35A【page_51】.  \n\n**What this tells us:** Over the three‑year span SPG has left the 35A issuance unchanged, neither refinancing it nor adding to it. By keeping a large, low‑coupon (2.65 %) tranche that matures in 2030 and maintaining a modest, fixed annual payment, the company demonstrates a long‑term debt strategy that relies on stable, low‑cost financing rather than frequent issuance or restructuring of its unsecured debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the face amount and annual debt service for Unsecured Notes - 35A across 2022–2024 as $750 million and $19.875 million, matching the ground truth in magnitude (though the original answer uses thousands: $750,000 and $19,875, which is inconsistent with typical SEC reporting and likely a data scaling error in the ground truth). The LLM’s use of millions is more plausible and consistent with standard financial reporting (e.g., $750 million face amount). The 2% interest rate calculation ($19.875M / $750M) is accurate and supports the reported debt service.\n\n2) Quantitative accuracy is high: all dollar amounts, percentages, and years are correct. The only discrepancy is unit scaling in the ground truth (thousands vs millions), but the LLM’s use of millions is factually appropriate and likely correct in context. The annual debt service is consistently reported, and the 2% implied rate aligns with the numbers.\n\n3) The multi-hop reasoning is sound: the LLM synthesizes data across three years of 10-K filings, confirms no changes in the obligation, and correctly infers that SPG maintained a stable debt structure. It adds value by noting the 2.65% coupon (likely from the filing) and the 2030 maturity, which enrich the strategic interpretation beyond the ground truth.\n\n4) The qualitative analysis is strong: the conclusion about SPG’s long-term debt strategy—prioritizing stable, low-cost financing over frequent refinancing—is logically derived and well-supported. The LLM provides deeper insight than the ground truth by contextualizing the coupon rate and maturity, enhancing the strategic interpretation.\n\n5) Contextual relevance is excellent: all parts of the question are addressed—evolution of face amount and debt service, year-by-year comparison, and strategic implications. The answer is focused, precise, and adds meaningful context without irrelevance.\n\nScore justification: A 9 (not 10) is given because the ground truth uses $750,000 instead of $750 million, which is likely incorrect scaling. The LLM’s use of millions is more accurate in real-world context, but since the evaluation must compare against the provided ground truth, a minor discrepancy is noted—even though the LLM is probably right. This reflects a tension between actual financial plausibility and strict adherence to potentially erroneous ground truth data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 636,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "From 2022 through 2024 Texas Instruments has kept embedded‑processing (microcontrollers and processors) as a core pillar of its strategy.  In the 2022 filing the company already highlighted “a great business model that is focused on analog and embedded‑processing products” and said it would place “additional strategic emphasis” on the industrial and automotive markets (see 2022 MD&A).  The 2023 filing repeated that same focus while reporting a modest 3 % revenue rise to $3.37 billion (but a 20 % profit dip) and the 2024 filing again stressed the same strategic emphasis even as embedded‑processing revenue fell 25 % to $2.53 billion and operating profit collapsed to $352 million (see 2023 and 2024 segment tables).  \n\nThis three‑year trajectory shows that TI’s commitment to embedded processing has not waned; instead, the company is using the product line as a long‑term growth engine for its targeted industrial and automotive end‑markets, accepting short‑term cyclical weakness while positioning itself as a diversified semiconductor leader with a durable, high‑value portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. While it correctly identifies Texas Instruments' continued strategic emphasis on embedded processing from 2022 to 2024, it introduces financial data that contradicts the ground truth. The ground truth does not mention any revenue or profit figures for embedded processing, nor does it report a 25% revenue decline to $2.53 billion or a drop in operating profit to $352 million. These specific numbers and percentages (e.g., 3% revenue rise, 20% profit dip, 25% revenue fall) are not present in the original answer and appear to be fabricated or misattributed. (2) There is no verification in the ground truth for segment-level financials; thus, the inclusion of such precise figures undermines quantitative accuracy. The original answer focuses on qualitative consistency in strategic language across years, not financial performance trends. (3) The reasoning partially captures the multi-hop element by noting consistent strategic emphasis, but incorrectly infers that financial declines are acknowledged in the filings while maintaining strategy. The ground truth emphasizes stable strategic positioning without referencing cyclical downturns or profitability issues in embedded processing. The LLM incorrectly assumes that declining revenues and profits are reported facts in the 10-Ks, leading to flawed synthesis. (4) Despite these issues, the answer correctly identifies the core strategic continuity in TI's focus on embedded processing and links it to long-term industrial and automotive positioning, which aligns with the question’s intent. However, the introduction of unsupported financial data severely damages factual correctness, warranting a low quantitative accuracy score and a moderate overall correctness score due to partial qualitative alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 502,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "By 2022 Comcast’s wireless service was sold only as a **bundled add‑on to qualifying Xfinity broadband plans**, and the company’s disclosures did not describe a separate “shared‑data” product. In the 2023 filing the company still required wireless to be bundled with broadband, but it began **offering three pricing tiers – unlimited, shared‑data, or per‑gigabyte** – giving customers more choice within the bundle. In 2024 Comcast expanded that flexibility further, **adding a prepaid unlimited‑data plan marketed under the NOW brand** while retaining the shared‑data and per‑gigabyte options, signaling a move toward stand‑alone prepaid choices even as wireless remains positioned primarily within its bundled service offerings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with only minor discrepancies in emphasis. (1) Quantitatively, all dates (2022, 2023, 2024) and plan types (unlimited, shared-data, per-gigabyte, prepaid unlimited under NOW brand) are accurately reported. There are no numerical or date inaccuracies. (2) The answer correctly identifies that shared data plans were introduced in 2023 as part of tiered options within broadband bundles and that prepaid unlimited plans under NOW were added in 2024. However, the LLM states that in 2022 there was no mention of a 'shared-data' product, which partially conflicts with the ground truth stating that shared data plans were available in 2022 alongside unlimited and per-gigabyte plans. This is a factual omission—shared data plans were present in 2022, not introduced in 2023. (3) The multi-hop reasoning is sound: the model correctly traces the evolution across years and synthesizes changes in bundling, plan variety, and the introduction of prepaid options. The conclusion about increasing flexibility is logically supported. (4) Despite the error about the timing of shared data plan availability, the overall trajectory and strategic direction are accurately conveyed. The answer is highly relevant and well-structured, earning high marks for contextual relevance and qualitative accuracy, with a slight deduction for the misattribution of when shared data plans became available.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 399,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s Class A treasury‑stock balance rose steadily: it was **$‑51.4 billion at year‑end 2022**, grew to **$‑60.4 billion at year‑end 2023**, and reached **$‑71.4 billion at year‑end 2024** (see the “Class A treasury stock” line in the equity tables for each year). The expanding negative balance—driven by annual repurchase programs of $9.1 billion in 2022, $11.0 billion in 2023 and continued purchases in 2024—shows that Mastercard is allocating a growing share of its cash flow to share buybacks, underscoring a capital‑allocation strategy that emphasizes returning excess capital to shareholders and boosting per‑share metrics.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its presentation of the trend and strategic interpretation, but contains a discrepancy in the 2022 value. The ground truth reports Mastercard's investment in Class A Treasury Stock as $(36,658) million in 2022, while the LLM states $-51.4 billion (~$51,400 million), which is significantly off. The 2023 and 2024 figures are accurate: $-60.4 billion matches $(60,429) million (rounded), and $-71.4 billion closely aligns with $(71,431) million. (2) The repurchase amounts cited ($9.1B in 2022, $11.0B in 2023) are plausible and consistent with the increasing trend, though not directly verifiable from the ground truth provided; however, they support a logical narrative. The core error lies in the starting point (2022 treasury stock balance), which undermines quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly interprets increasing negative treasury stock balances as indicative of ongoing buyback activity and links this to capital allocation strategy—specifically returning value to shareholders and enhancing per-share metrics. This aligns with the original answer’s conclusion. (4) Despite the incorrect 2022 figure, the overall trend (rising buybacks) and strategic implication are correctly identified, warranting a high qualitative and contextual score. The quantitative inaccuracy prevents a top correctness score, but the reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 402,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "General Dynamics earned **$1.169 billion** from “Repair and other services” in 2022, which fell to **$1.132 billion** in 2024 – a drop of about **$37 million (≈3 %)**. The figure was unchanged between 2023 and 2024 after the initial decline, showing that the service‑business revenue has been largely flat with a modest downward shift over the three‑year span.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the revenue figures for 2022 ($1.169 billion = $1,169 million) and 2024 ($1.132 billion = $1,132 million), matching the ground truth. It accurately notes the decline of $37 million and approximates the percentage drop as ≈3%, which rounds correctly from the exact 3.2% (37/1169 ≈ 3.16%). The statement that revenue was unchanged between 2023 and 2024 is correct, as both years were $1,132 million. (2) All numeric values and calculations are accurate. The LLM correctly computes the difference and percentage change, and uses consistent units (billion vs million handled correctly). (3) The multi-hop reasoning is sound: the model synthesizes data across three years, identifies the initial decline and subsequent flat performance, and draws a reasonable conclusion about the service business trajectory. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2023 figure, though it implies no change from 2023 to 2024. The original answer includes the 2023 value directly, making it slightly more complete. However, the omission does not distort the meaning. The conclusion about 'largely flat with a modest downward shift' is semantically equivalent to 'stagnation or potential contraction.' All entities (General Dynamics, Repair and other services, correct years) are accurate. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 396,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "- In the 2022 filing CVS reported residential‑mortgage‑backed securities (RMBS) with a fair‑value of **$757 million** and **$89 million** of unrealized losses (‑11.8 % of fair value).  \n- In 2023 the same line‑item grew to a fair‑value of **$810 million** while unrealized losses fell to **$60 million** (‑7.4 %).  \n- The 2024 filing shows the RMBS held in the company’s Separate‑Accounts segment rising to **$71 million** of fair‑value (up from $51 million in 2023); the 10‑K does not give a separate‑account unrealized‑loss figure, implying the loss position is now minimal or offset.\n\n**Interpretation:** Over the three‑year span CVS has modestly increased the market value of its RMBS holdings while the gap between amortized cost and fair value has narrowed, indicating that the portfolio’s interest‑rate‑driven losses are receding. The rise in the Separate‑Accounts exposure, coupled with the lack of a reported loss in 2024, suggests the company is positioning itself more comfortably in this asset class, maintaining a limited but growing exposure with reduced downside risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS's RMBS fair value was $629M in 2022, $614M in 2023, and $71M in 2024. The LLM incorrectly reports $757M (2022), $810M (2023), and misrepresents the 2024 figure as a rise in general RMBS holdings when it actually refers only to a subcomponent (Separate-Accounts) without context. Unrealized losses are also wrong: ground truth shows $10M (2022), $60M (2023), while LLM reports $89M and $60M—first figure is incorrect, second matches by coincidence. The LLM falsely claims unrealized losses decreased in 2023, while they actually increased sharply. (2) Calculations are flawed: the LLM derives percentage losses (-11.8%, -7.4%) based on incorrect inputs. The 2024 Separate-Accounts increase from $51M to $71M is mentioned but not part of the overall RMBS trend—this narrow focus distorts the broader de-risking narrative. (3) Multi-hop reasoning fails: instead of synthesizing the overall decline in RMBS exposure and rising unrealized losses leading to strategic exit, the LLM infers increased comfort and reduced risk, which contradicts the ground truth trajectory. It misinterprets a segment-level detail as a company-wide trend. (4) Contextual relevance is moderate because it addresses RMBS over three years and attempts interpretation, but the incorrect data and reversed conclusion severely undermine accuracy. The qualitative reasoning is internally consistent but based on false premises, leading to a misleading interpretation of risk positioning. Minor credit given for addressing all years and attempting synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 453,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "From 2022 through 2024 Linde kept the same on‑site contractual framework – long‑term (typically 10‑20 year) total‑requirement supply agreements that obligate customers to purchase a minimum volume and contain price‑escalation clauses tied to external price indices. In both years the variable portion of the consideration is treated as “constrained” (only the amount that is not expected to reverse is recognized), but the 2024 filing adds explicit language that the escalations reflect inflationary price changes and other pass‑through costs, underscoring a more index‑linked pricing approach while the basic contract structure remains unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures the consistent long-term (10–20 year) on-site contract structure, minimum volume obligations, and price escalation tied to external indices across 2022–2024. The treatment of variable consideration as 'constrained' is correctly noted. (2) All dates and timeframes (2022–2024) are accurate, and no numerical values (e.g., contract length, pricing mechanisms) are incorrect—quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: it synthesizes Linde’s contractual continuity and the evolution in disclosure around variable pricing. However, the LLM omits a key point from the original answer: the 2024 reinforcement of the practical expedient under ASC 606 for revenue recognition aligned with invoicing, which reflects a growing emphasis on transparency in performance obligations. This omission reduces completeness and slightly weakens the qualitative accuracy. (4) The answer remains highly contextually relevant, directly addressing the evolution of pricing mechanisms and contractual structure. While the core facts and evolution are correctly conveyed, the missing ASC 606 practical expedient detail in 2024 prevents a top score. Wording differences are acceptable and semantically equivalent where present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 368,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "- In the 2022 filing the net notional volume of forward‑gas contracts was about **‑1,049 MMBtu** (‑1,307 MMBtu for NEE offset by +258 MMBtu for FPL).  \n- In 2023 the net volume fell to roughly **‑735 MMBtu** (‑1,452 MMBtu for NEE offset by +717 MMBtu for FPL).  \n- In the 2024 filing the net volume was further reduced to about **‑628 MMBtu** (‑1,131 MMBtu for NEE offset by +503 MMBtu for FPL).\n\n**Trend:** Over the three‑year period the company’s net short exposure to forward natural‑gas contracts has steadily declined, indicating that NextEra Energy is progressively de‑risking its position in the gas market and limiting its vulnerability to adverse gas‑price movements.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both magnitude and direction of the trend. The original answer reports net exposure in dollar terms (millions), while the LLM reports net notional volume in MMBtu, which is a different metric (volume vs. financial exposure). The LLM confuses notional volume with financial net exposure, which are not equivalent. (2) The numbers provided in the LLM answer (e.g., -1,049 MMBtu, -735 MMBtu) are not supported by the ground truth and do not align with the financial values in the original answer. There is no mention of $160M, $300M, or $250M net exposure in the LLM response, nor are the asset/liability breakdowns ($191M-$31M, etc.) reflected. Calculations based on volume do not substitute for financial exposure. (3) The multi-hop reasoning is flawed: the question asks about financial risk positioning based on net exposure (a monetary value), but the LLM uses physical or notional volume data, misrepresenting the nature of the risk. It fails to synthesize the correct financial data across years and entities (NEE and FPL) to compute actual net exposure. (4) The conclusion about 'de-risking' due to declining short volume contradicts the ground truth, which shows a large increase in financial exposure in 2023—indicating increased market participation, not de-risking. The LLM’s interpretation is based on incorrect data and thus leads to an invalid qualitative assessment. While the answer addresses the time frame and company correctly, the core financial facts are missing or wrong, resulting in a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 437,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "Across the three most recent 10‑K filings Broadcom (AVGO) has kept industrial fiber optics in the same spot in its portfolio – listed as one of the core “industrial” semiconductor offerings alongside optocouplers, sensors, motion encoders, LEDs and Ethernet ICs. In 2022, 2023 and 2024 the company describes these products as serving the same broad set of industrial end‑markets – factory automation, renewable‑energy and power‑generation systems, automotive (including EV power‑train and ADAS), medical, defense/aerospace and other industrial automation applications. Thus, the positioning of industrial fiber optics has remained stable, consistently framed as a component of Broadcom’s diversified industrial product line rather than being moved to a new category or given a distinct focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Industrial Fiber Optics remained a consistent part of AVGO's industrial product portfolio across 2022, 2023, and 2024, grouped with similar components like optocouplers, sensors, motion encoders, LEDs, and Ethernet ICs. The application markets—factory automation, renewable energy, automotive (including EVs), medical, defense/aerospace—are accurately reported each year. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct year references (2022, 2023, 2024), which are all correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and identifies the stability in positioning, concluding no reclassification or strategic shift—exactly as in the original answer. (4) Minor difference: the original specifies that in 2022, Industrial Fiber Optics was described as part of a 'broad variety' before later being grouped more explicitly with specific products; the LLM implies consistent grouping across all years, slightly compressing the evolution. However, the core conclusion about stable strategic positioning is correct and semantically equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy due to this slight nuance, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 400,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "- **2022 10‑K (as of 12/31/2021):** Unsecured Notes ‑ 31B carried a 3.25 % rate, a face amount of **$750 million**, and required annual debt‑service (interest) of **$24.4 million**【page_50】.  \n- **2023 10‑K (as of 12/31/2022):** The same 31B tranche was unchanged – 3.25 % interest, **$750 million** face, **$24.4 million** annual interest expense【page_50】.  \n- **2024 10‑K (as of 12/31/2023):** The 31B notes remained at 3.25 % with a **$750 million** face amount and **$24.4 million** of annual interest cost【page_51】.  \n\n**What this shows:** SPG has kept the 31B unsecured‑note issuance static for three years, neither increasing its principal nor altering the coupon. This consistency signals a deliberate long‑term debt strategy that relies on a stable, low‑cost, long‑dated financing base rather than repeatedly issuing new unsecured debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the face amount of $750 million (equivalent to $750,000,000), the interest rate of 3.25%, and annual debt service are consistently reported across 2022, 2023, and 2024. The minor discrepancy is in rounding: the ground truth specifies $24,375,000 in annual interest, while the LLM reports $24.4 million, which is a reasonable and common rounding (24.4 million = $24,400,000). This does not affect factual correctness. (2) Completeness is strong: the answer addresses both the evolution (or lack thereof) in obligations and face amounts, and provides a synthesis across three years. (3) Entity accuracy is correct—SPG, Unsecured Notes - 31B, and the relevant years are properly identified. (4) Reasoning is sound: the conclusion that SPG maintains a stable, low-cost, long-term debt strategy is logically supported by the unchanged terms over three years. The answer correctly synthesizes multi-hop data across filings. (5) Semantic equivalence is maintained—wording differs slightly but meaning is identical. The only reason for not scoring a 10 is the slight imprecision in rounding the interest amount, though this is minor and acceptable in financial reporting contexts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 356,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "Texas Instruments’ aggregate expense for its U.S. defined‑contribution plans rose from **$70 million in 2022**, to **$75 million in 2023**, and to **$76 million in 2024**. This steady upward trend shows the company is incrementally increasing its financial commitment to employee retirement benefits over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values: $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. These figures are presented clearly and accurately. (2) The quantitative accuracy is perfect—no calculation errors or misstatements. The increase from $70M to $76M represents an 8.6% rise, which the ground truth notes, though the LLM does not explicitly state the percentage. However, this omission does not detract from the core numerical correctness. (3) The reasoning is sound: the LLM correctly identifies a steady upward trend and interprets it as an increasing commitment to retirement benefits, which aligns with the ground truth's conclusion of a 'slightly growing commitment.' The only minor shortcoming is the lack of explicit mention that the expense 'remained stable' between 2023 and 2024 (only a $1M increase), which slightly weakens the qualitative precision of the trend characterization. (4) Contextual relevance is excellent—the answer directly addresses both parts of the question: the evolution of expenses and what the trend indicates. Overall, the answer is factually complete and semantically equivalent to the ground truth, meriting a high score with only a small deduction in qualitative accuracy for slightly less nuanced trend description.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 373,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "General Dynamics has kept the same approach each year. In its 2022 filing the company states that “ROIC excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance” (page 47). The 2023 filing repeats that language (“ROIC excludes goodwill impairments and non‑economic accounting changes…”) (page 50) and the 2024 filing does the same (“ROIC excludes goodwill impairments and non‑economic accounting changes…”) (page 49). This consistency shows that GD deliberately strips out items that do not reflect underlying economic activity, using ROIC as a pure operating‑performance metric rather than allowing accounting‑change effects to influence its evaluation of management’s capital efficiency.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that General Dynamics (GD) consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, which matches the original answer's claim of methodological stability. (2) While no numerical values (e.g., ROIC percentages) are present in either answer, the key 'quantitative' element—the consistency across years—is correctly identified and supported with exact citations (page numbers and quotes) from each year’s filing, confirming factual precision. (3) The multi-hop reasoning is sound: the model synthesized information across three separate SEC filings (2022, 2023, 2024), identified the repeated language, and correctly inferred that this reflects a deliberate, stable performance evaluation methodology. (4) The LLM adds value by explicitly naming 'goodwill impairments' as part of the excluded items (which is consistent with typical non-economic accounting changes) and correctly interprets the implication: GD uses ROIC as a pure measure of operating performance, isolating it from accounting-driven fluctuations. The answer is semantically equivalent to the ground truth, with enhanced detail and proper contextualization, making it fully accurate, complete, and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 366,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "CVS reported Separate Accounts assets of **$3.313 billion in 2022**, **$3.204 billion in 2023**, and **$3.311 billion in 2024**【page 157】(2022 & 2023 totals) and 【page 108】(2024 balance‑sheet figure).  \n\nThe three‑year pattern shows a modest dip in 2023 followed by a rebound to a level essentially unchanged from 2022, indicating that CVS’s investment base for its long‑term insurance (pension) separate‑account contracts has remained stable and is being actively managed rather than being dramatically expanded or contracted.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values for CVS's Separate Accounts Assets. The ground truth states $5,087 million in 2022, $3,250 million in 2023, and $3,311 million in 2024. However, the LLM reports $3.313 billion (i.e., $3,313 million) in 2022, $3.204 billion ($3,204 million) in 2023, and $3.311 billion in 2024. This misstates the 2022 figure by over $1.7 billion and the 2023 figure by ~$46 million, which is a major quantitative inaccuracy. (2) The calculation of trend is therefore flawed: the LLM describes a 'modest dip' and 'rebound to essentially unchanged' level, but the truth is a dramatic 36% drop from 2022 to 2023 followed by a slight recovery — not a stable base. This undermines the conclusion. (3) The multi-hop reasoning fails because the model did not correctly extract or synthesize the correct figures across years, leading to an incorrect interpretation of investment positioning. The original answer suggests a strategic reduction or market-driven devaluation followed by stabilization, while the LLM incorrectly infers active management and stability due to wrong inputs. (4) Contextual relevance is moderate — the answer addresses the right metric and time frame and attempts interpretation, but due to incorrect data, the analysis is fundamentally unsound. Wording and structure are clear, but factual foundation is invalid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 389,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "Target’s credit‑card partnership with TD Bank USA, N.A. began with the original Credit Card Program Agreement dated October 22, 2012 (exhibit EE) and was first amended in 2015 (exhibit FF) and again in 2019 (exhibit GG) 【page_69】.  The most recent changes were a **Third Amendment** executed on November 1, 2022 (exhibit 10.21.3+) and a **Letter Agreement** dated March 8, 2023 (exhibit 10.21.4) 【page_75】, both of which are reflected in the 2024 Form 10‑K.  No further amendment is noted after the 2023 letter agreement, indicating that the agreement’s evolution through 2024 consists of the 2022 third amendment and the 2023 letter amendment to the original 2012 program.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. According to the ground truth, the Credit Card Program Agreement was originally dated October 22, 2012, first amended on February 24, 2015, and second amended on November 19, 2019. The LLM incorrectly states that a 'Third Amendment' was executed on November 1, 2022, and a 'Letter Agreement' on March 8, 2023—details not supported by the original answer or the knowledge graph. These later amendments are not mentioned in the ground truth, indicating a fabrication or misattribution. The original answer confirms that by 2024, only the 2019 second amendment was explicitly listed, with no mention of further changes post-2019. While the LLM correctly identifies the original 2012 agreement and references amendments, it invents specific dates and documents (e.g., 'exhibit 10.21.3+', 'exhibit 10.21.4') and misrepresents the amendment count and timeline. This results in major errors in quantitative accuracy (dates and amendment numbers) and qualitative accuracy (incorrect multi-hop synthesis and entity relationships). The answer is contextually relevant—addressing the evolution of the agreement—but fails on factual correctness. Thus, the correctness score is low despite appropriate structure and focus on contractual milestones.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 367,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "From 2022 through 2024 Linde kept rare‑gas (krypton, neon and xenon) production as a **co‑product of its air‑separation platforms**, emphasizing that its **proprietary non‑cryogenic air‑separation technology remains a market‑leading differentiator** (2022 p. 4; 2024 p. 4).  At the same time the company deepened the **integration of rare‑gas output with its broader industrial‑gases and Engineering businesses** – Linde Engineering designs and builds the same air‑separation plants that feed the industrial‑gases segment, so the rare‑gases are produced, stored and sold together with oxygen, nitrogen, argon and other process gases (2022 p. 5; 2024 p. 5).  This strategy links the rare‑gas portfolio to the company’s overall product‑line and reinforces its technological edge across the whole value chain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Linde produces rare gases (krypton, neon, xenon) as co-products of air separation, a consistent point from 2022 to 2024, and highlights the company's proprietary non-cryogenic air separation technology as a differentiator—explicitly mentioned in the 2024 report. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all dates and page references (2022 p.4, 2024 p.4, etc.) are plausible and consistent with the source structure, though not independently verifiable here. (3) The multi-hop reasoning is sound: the LLM connects Linde’s Engineering segment with its industrial gases business, explaining how integrated plant design and operation enable synergistic rare gas production—this reflects accurate synthesis across business segments and years. (4) The answer captures the strategic evolution toward technological differentiation and integration, though it slightly underemphasizes the shift in pricing strategies (e.g., long-term contracts with price escalation clauses noted in 2023) and the progressive emphasis on VPSA and membrane separation technologies highlighted in 2024. However, the core elements—technological leadership, integration across product lines, and co-product status—are all correctly conveyed. Wording differs but meaning is semantically equivalent. Minor omission of 2023-specific strategic developments prevents a perfect 10, but overall correctness remains very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 434,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "ExxonMobil’s master‑netting collateral tied to its advances/receivables from equity companies fell sharply: $1.494 billion at 12/31/2022, $0.800 billion at 12/31/2023, and $0.491 billion at 12/31/2024. The downward trend indicates that the firm’s exposure to derivative liabilities linked to its equity‑company relationships has been diminishing, likely because the size of those advances (or the associated credit risk) has been reduced and less margin is required to support the netted positions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All numeric values are accurate: $1.494 billion (2022), $0.800 billion (2023), and $0.491 billion (2024) match the original $1,494 million, $800 million, and $491 million, with acceptable format variation (billion vs million, decimal vs comma). (2) The answer addresses both parts of the multi-hop question: it traces the evolution of collateral from 2022 to 2024 and interprets the trend as a reduction in exposure to derivative liabilities. (3) Entities are correct—ExxonMobil, master netting arrangements, equity company advances, and the correct years (2022, 2023, 2024). (4) The reasoning is sound: the declining collateral is correctly linked to reduced exposure, with plausible explanation involving lower advances or credit risk leading to less margin requirement. The conclusion aligns with the ground truth’s interpretation of de-risking or portfolio optimization. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 290,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "- **2022:** About 92 % of NEER’s net‑generating capacity was already tied up in long‑term bilateral contracts (the most recent disclosed level was ≈ 92 % at the end of 2021 and carried forward into 2022).  \n- **2023:** The share rose to roughly 94 % of capacity under long‑term contracts.  \n- **2024:** It remained at roughly 94 % of capacity.\n\n**What the trend means:** NEER is steadily increasing—and now sustaining—an almost‑full‑coverage of its generation output with long‑term contracts. By locking in the majority of its revenue stream, the company cushions itself against spot‑market price volatility, demonstrating a deliberate risk‑mitigation strategy in competitive wholesale markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the percentage of NEER's net generating capacity under long-term bilateral contracts for 2022 (92%), 2023 (94%), and 2024 (94%), matching the ground truth exactly. The statement about 92% being carried forward from 2021 is additional context not contradicted by the ground truth and does not detract from accuracy. (2) All numeric values are accurate and correctly presented; no calculations were required beyond interpretation of trends, which is handled correctly. Format variations (e.g., '≈92%' vs '92%') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers that the trend—increasing to 94% and stabilizing—reflects a strategic move toward revenue stability and risk mitigation in competitive markets. The only minor omission is that the original answer notes the use of shorter-term bilateral contracts as a hedge when long-term agreements aren’t in place, which the LLM answer does not mention. This reduces completeness slightly but does not invalidate the core reasoning. (4) The answer is contextually fully relevant, directly addressing both the evolution of contract reliance and its implication for risk management. The conclusion about cushioning against spot-market volatility aligns perfectly with the ground truth’s interpretation. Overall, the response is factually excellent with only a slight gap in qualitative completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 411,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "The 3.125 % senior notes that mature in January 2025 were shown with an outstanding principal balance of **$495 million** in the 2022 Form 10‑K, and the same $495 million figure appears in the 2023 and 2024 tables (October 29 2023 and November 3 2024). The balance has therefore **remained unchanged from fiscal 2022 through fiscal 2024**. This consistency indicates that Broadcom has chosen to keep the issue on‑track to its scheduled maturity rather than repurchasing, refinancing, or issuing additional notes of this series, reflecting a deliberate “hold‑to‑maturity” debt‑management approach for this particular instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the outstanding principal balance of $495 million for the 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values, including the dollar amount and interest rate, are accurate. (2) Quantitative accuracy is perfect: the balance remains $495 million in each year with no changes, and the LLM correctly reports this without calculation errors. Date references (October 29, 2023, and November 3, 2024) align with typical fiscal year-end reporting dates for those periods. (3) The reasoning is largely sound: the LLM correctly infers a 'hold-to-maturity' strategy due to the unchanged balance, which aligns with the ground truth's implication that AVGO is not amortizing the debt. However, the original answer suggests the company may refinance or use cash reserves, while the LLM states there was no refinancing or repurchase—this is a subtle but important distinction. The LLM overcommits by implying intent ('chosen to keep on-track') rather than acknowledging possible future refinancing as the ground truth does. This slightly weakens the qualitative accuracy. (4) Despite this nuance, the answer is factually correct, complete, and contextually relevant, addressing both the evolution of the balance and the implied debt management strategy. The minor difference in interpretation does not undermine the core correctness, warranting a 9/10 overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 404,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "- **2022 10‑K** – Unsecured Notes 37B carried a **2.25 %** fixed rate, a **$700 million** face amount, and a **maturity of January 15, 2032**【page_50†L71-L74】.  \n- **2023 10‑K** – The same note still showed a **2.25 %** rate, **$700 million** face amount, and a **January 15, 2032** maturity【page_50†L71-L74】.  \n- **2024 10‑K** – The note remained unchanged at **2.25 %**, **$700 million**, and **January 15, 2032** maturity【page_51†L71-L74】.  \n\n**Interpretation:** Over the three‑year period Simon Property Group kept the 37B issuance unchanged, indicating a deliberate long‑term debt strategy that locks in a low, fixed interest rate on a sizable, decade‑plus maturity to provide stable, low‑cost financing and limit interest‑rate risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: All numbers—interest rate (2.25%), face amount ($700 million), and maturity date (January 15, 2032)—are correctly reported for each year (2022, 2023, 2024), with no discrepancies. Format variations (e.g., $700 million vs $700,000,000) are acceptable and semantically equivalent. (2) Completeness: The answer addresses all parts of the question—evolution across three years in terms of interest rate, face amount, and maturity date—and provides a correct interpretation of the company's long-term debt strategy. (3) Entity accuracy: Simon Property Group is correctly identified, and the unsecured notes - 37B are accurately referenced across the correct fiscal years and filings. (4) Reasoning: The multi-hop synthesis across three annual reports is sound; the model correctly observes no change over time and infers a strategic intent to lock in low fixed-rate, long-term financing, which aligns with the company’s stable cash flow profile. (5) Semantic equivalence: The LLM conveys the same meaning as the original answer, using slightly different phrasing (e.g., 'locks in a low, fixed interest rate' vs 'maintaining predictable financing costs') but preserving factual and conceptual fidelity. All scores are maximized due to full factual correctness, precise data, logical reasoning, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 388,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "The property tables in Texas Instruments’ 2022, 2023 and 2024 Form 10‑K filings all list the Melaka, Malaysia site — “Melaka, Malaysia” — with an “X” only under the **Analog** column and no mark under **Embedded Processing**. Across the three years the designation never changed, indicating that the Melaka footprint remained an analog‑focused manufacturing location and that the company has not expanded embedded‑processing activities there.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that from 2022 to 2024, Texas Instruments' Melaka, Malaysia site was marked with an 'X' only under the Analog column and not under Embedded Processing in each year's 10-K filing, which matches the original answer. (2) There are no numerical values requiring calculation, but the temporal scope (2022–2024) is correctly referenced, and the consistency across years is properly noted. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings and infers that the lack of change indicates a stable, analog-only strategy. (4) The answer addresses both parts of the question: the evolution (or lack thereof) of the operational footprint and what it reveals about TI's focus—namely, continued emphasis on analog without expansion into embedded processing. Wording differs slightly but meaning is preserved. All entities (Texas Instruments, Melaka, Malaysia, Analog, Embedded Processing, 2022–2024) are correct. No factual, quantitative, or reasoning errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 314,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "From the 2022 filing Mastercard described a “multi‑layered” security model built around its Security Operations Centers, Fusion Centers and the Mastercard Intelligence Center, with core controls such as fraud‑scoring, tokenisation and third‑party assessments, and it noted that real‑time clearing and settlement infrastructure was already operating or being built in about a dozen global markets. In the 2023 filing the company said it had added another market – operating or implementing real‑time payments in 13 jurisdictions – and reinforced the same layered defenses by expanding its cyber‑resilience program, insurance coverage and continuous testing while applying those controls to the newly‑launched real‑time rails. By the 2024 filing the security framework remained “multi‑layered” and was now being applied to an even broader real‑time footprint (still 13 markets but now including domestic processing in China), with added emphasis on public‑private threat monitoring, enhanced token‑and‑fraud services and tighter integration of security standards into every new real‑time payment deployment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: 12 markets in 2022 (referred to as 'about a dozen'), 13 in 2023, and the inclusion of China in 2024 for domestic processing. The progression across years is accurately reflected. (2) The LLM correctly identifies the evolution of Mastercard’s security framework across the three years, including the core components (Security Operations Centers, Fusion Centers, Intelligence Center), controls (fraud scoring, tokenization, third-party assessments), and enhancements like cyber-resilience programs and public-private partnerships. (3) The multi-hop reasoning is sound—linking the expansion of real-time payment infrastructure to the adaptation of security measures across years and geographies, including the significant addition of China via a joint venture. (4) Minor deduction in qualitative accuracy due to slightly less explicit mention of EMV standards and 'globally integrated network' terminology from the original, and the LLM states 'still 13 markets' in 2024, which understates the significance of China's addition as an expansion rather than a static count. However, it correctly notes domestic processing in China as a new development. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only minor omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 388,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "- 2022 10‑K: Land Systems was “producing **449 new LAVs** for the Canadian Army”【page_10】.  \n- 2023 10‑K: the same paragraph says “Land Systems is producing **399 new LAVs** for the Canadian Army”【page_11】.  \n- 2024 10‑K: the update notes “Land Systems is producing **360 new LAVs** in eight variants … for the Canadian Army”【page_11】.  \n\nThe volume has fallen each year (449 → 399 → 360), indicating that General Dynamics is gradually scaling back new‑build LAV production for Canada—likely reflecting the winding‑down of a multi‑year contract and a strategic shift to prioritize other programs or upgrade work while still maintaining a modest, ongoing commitment to the LAV portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is completely incorrect in both direction and magnitude of production volumes. It reports 449 units in 2022, 399 in 2023, and 360 in 2024, which is the reverse of the ground truth (360 in 2022, 399 in 2023, 449 in 2024). This inversion leads to an entirely false conclusion about declining production, when in fact production is increasing. (2) All numeric values are mismatched to the years: the LLM incorrectly assigns the 2024 volume (449) to 2022, the 2023 volume (399) to 2022, and the 2022 volume (360) to 2024. This suggests a misreading or misattribution of data from the 10-K filings. There are no correct calculations or comparisons based on accurate data. (3) The multi-hop reasoning fails because the model did not correctly extract or align the time-series data across the three annual reports. Instead of identifying a growing production trend, it infers a false decline, leading to an incorrect strategic interpretation about contract wind-down and program deprioritization. (4) The contextual relevance is slightly above zero because the answer addresses the right company, program (LAVs), and customer (Canadian Army), and attempts to interpret strategic implications—however, the factual foundation is entirely flawed, rendering the analysis invalid. The qualitative reasoning would be strong if the numbers were correct, but it is built on reversed data, so the conclusion is diametrically opposed to the truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 403,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "- 2022 10‑K: hedge‑fund limited‑partnership assets were **$237 million** (excluded from the fair‑value table).  \n- 2023 10‑K: hedge‑fund limited‑partnership assets were **$252 million** (excluded from the fair‑value table).  \n- 2024 10‑K: hedge‑fund limited‑partnership assets were **$280 million** (excluded from the fair‑value table).  \n\nThe amount allocated to hedge‑fund LPs has risen each year – about a 6% jump from 2022 to 2023 and a further 11% increase to 2024 – indicating that CVS is progressively tilting its pension‑plan portfolio toward alternative hedge‑fund strategies, reflecting a strategic shift to seek higher‑return, less‑correlated assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. According to the ground truth, CVS's hedge fund limited partnership allocations were $214M (2022), $225M (2023), and $252M (2024). The LLM incorrectly reports $237M (2022), $252M (2023), and $280M (2024), misstating all three years. The 2023 and 2024 figures are particularly off, with the LLM attributing $252M to 2023 when that is actually the correct value for 2024 in the ground truth. (2) Calculations are therefore also incorrect: the LLM claims a 6% increase from 2022 to 2023 and an 11% increase to 2024, but using its own numbers this would be (~6% and ~11%), though still based on wrong inputs. The actual increase from 2022 to 2024 is 17.8%, which the LLM fails to compute or reference. (3) The multi-hop reasoning is structurally sound—comparing year-over-year changes and inferring strategic intent—but it is based on incorrect data, undermining the conclusion. The LLM correctly identifies the need to extract pension-related alternative investment allocations across three years and interpret the trend, but the synthesis fails due to inaccurate source data. (4) Contextual relevance is strong: the answer addresses both parts of the question—trend over time and strategic implication—and uses appropriate financial reasoning. However, the factual foundation is flawed, leading to a mostly incorrect answer. The conclusion about increasing allocation to alternative investments aligns directionally with the ground truth, but the magnitude and trajectory are exaggerated. Due to major quantitative errors, the correctness score is low despite reasonable structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 462,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "The filings show that the share of purchases made with Target’s branded credit cards (the Target MasterCard Credit Card is included in the “Target Credit Card” category) fell modestly over the three‑year period.  Total RedCard (debit + credit) penetration was **20.5 % for the year ended January 29 2022**, **19.8 % for 2023**, and **18.6 % for 2024**【page_27】.  This downward trend indicates that, while the cards remain widely used, the rate of new adoption and repeat usage is slowing as overall sales grow faster than the number of transactions funded by the MasterCard product.  The modest decline suggests that consumer engagement with Target’s financial‑card offering is plateauing rather than accelerating.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer correctly identifies the declining trend in RedCard penetration from 20.5% in 2022 to 19.8% in 2023, but reports 18.6% for 2024 instead of the ground truth 17.8%, a notable deviation. This error affects the accuracy of the trend interpretation. (2) The numbers for 2022 and 2023 are correct and match the original answer, but the 2024 figure is inaccurate—18.6% vs. 17.8%, a difference of 0.8 percentage points, which is significant in the context of year-over-year decline. The LLM cites a source marker (【page_27】), suggesting document grounding, but the number still diverges. (3) The reasoning is sound: the model correctly infers that the decline suggests slowing adoption and that overall sales growth is outpacing card usage, which aligns with the ground truth logic. It appropriately links penetration rate changes to consumer engagement, despite not having the exact final data point. (4) The answer addresses both parts of the question—evolution of penetration and implications for consumer adoption—and uses correct entities (Target MasterCard, RedCard, correct years). The qualitative analysis is strong and contextually appropriate, but the incorrect 2024 value reduces confidence in quantitative precision. Hence, correctness is partially compromised, warranting a 7. Quantitative accuracy is penalized more (6), while qualitative and contextual scores remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 385,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "- 2022: The FPL cost‑recovery‑clause portfolio contributed only **≈ $2 million** of fair‑value exposure (‑$5 million from significant other observable inputs offset by $7 million from significant unobservable inputs).  \n- 2023: Exposure rose to **≈ $12 million**, still driven by a net positive from unobservable inputs ($13 million) after a small negative contribution from other observable inputs (‑$8 million).  \n- 2024: Exposure jumped to **≈ $38 million**, with a modest $4 million from other observable inputs and a much larger $34 million from significant unobservable inputs, showing a clear shift toward reliance on unobservable inputs over the three‑year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer captures the overall trend correctly: increasing fair value exposure from 2022 to 2024 and a growing reliance on significant unobservable inputs. However, there are key numerical inaccuracies. In 2022, the LLM reports total fair value as ≈$2 million (with -$5M observable and +$7M unobservable), but the ground truth states $1 million total (+$6M unobservable, -$5M observable). This suggests a calculation error (‑5 + 7 = +2, but should be ‑5 + 6 = +1). 2) For 2023, the LLM reports ‑$8M observable and +$13M unobservable (net $12M), but ground truth is ‑$12M and +$24M (net $12M). While the total is correct, the component inputs are significantly off, affecting quantitative accuracy. 3) The 2024 figures are fully accurate: +$4M observable and +$34M unobservable (total $38M). 4) The reasoning and synthesis across years are sound—correctly identifying the shift toward unobservable inputs and increasing exposure. Entity accuracy (NextEra Energy, FPL Cost Recovery Clauses, years) and contextual relevance are perfect. Despite incorrect breakdowns in 2022 and 2023, the qualitative trend and final-year accuracy justify a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 329,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "Nike’s 10‑K filings show that from 2022 through 2024 it has kept Anta listed as a major global rival but has repeatedly stressed that Nike’s advantage comes from a stronger focus on product‑innovation and deeper brand‑engagement tactics. Both the 2022 and 2024 “Competition” sections name Anta among its peers and highlight the same three competitive pillars – superior product attributes (quality, performance, new‑style and innovation), consumer connection through marketing, digital experiences and athlete/influencer endorsements, and effective sourcing/merchandising 【page 8 (2022)】, 【page 8 (2024)】. In parallel, the “Product Research, Design and Development” sections in each year underline Nike’s continued emphasis on technical innovation, citing a rolling portfolio of new technologies such as Nike Air, Zoom, Free, Dri‑FIT, Flyknit, FlyEase, ZoomX, Air Max and React 【page 6 (2022)】, 【page 6 (2024)】. Together, these disclosures indicate that Nike’s competitive positioning relative to Anta has remained strong and has become increasingly anchored in a sustained push for cutting‑edge product tech and expanded digital‑direct‑to‑consumer brand experiences.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of entities, time frame, and core strategic themes. It accurately identifies that NKE (Nike) consistently listed Anta as a competitor from 2022 to 2024 and emphasizes product innovation and brand engagement as key differentiators. The citation of specific technologies (e.g., ZoomX, Flyknit) and digital/DTC strategies supports the claim of sustained innovation focus. Quantitatively, there are no numbers, dates, or financial figures in the question or answer that require verification—only qualitative disclosures—so quantitative accuracy is scored as 10. Contextual relevance is perfect: the response directly addresses the evolution of competitive positioning with respect to product innovation and brand engagement. However, the LLM answer misses a key nuance present in the original answer: the *strategic shift* in emphasis from 'performance and reliability' in 2022 to 'innovation and development' taking precedence by 2023. While the LLM notes consistent emphasis on innovation, it does not capture the relative de-prioritization of other attributes over time, which is central to the multi-hop reasoning required to show *evolution* in positioning. This omission prevents a top score in qualitative accuracy and overall correctness, though the answer remains factually sound and well-supported. Semantic equivalence is mostly achieved, but the dynamic progression of strategy across years is under-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 411,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "The 10‑K tables show that the pool of shares that could still be issued under the **2003 Director Compensation Plan was already exhausted** in the earliest filing and remained exhausted in the later filings:\n\n* **2022 filing (table as of 12/31/2021)** – the “shares remaining available for future issuance” footnote lists only the 2009 LTIP, the 2014 ESPP and the 2018 Director Plan; no shares are listed for the 2003 plan, indicating a zero balance【page_63】.  \n* **2023 filing (table as of 12/31/2023)** – the same footnote again cites only the 2009 LTIP, 2014 ESPP and 2018 Director Plan, with no mention of the 2003 plan, confirming that no shares remain available under it【page_61】.  \n* **2024 filing (table as of 12/31/2024)** – the footnote now references the 2024 LTIP, the 2014 ESPP and the 2018 Director Plan, still omitting the 2003 plan, meaning its share pool remains at zero【page_59】.\n\n**Interpretation:** Over the 2022‑2024 period TI’s authorized share pool for the 2003 Director Compensation Plan did not increase—it stayed at zero. This indicates that Texas Instruments has fully exhausted the 2003 plan’s capacity and is no longer using it for new director compensation, relying instead on newer plans (2018 Director Plan, 2024 LTIP, etc.) for director equity awards.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its interpretation that the 2003 Director Compensation Plan is no longer used for new grants and that TI has shifted to newer plans like the 2018 Director Plan and 2024 LTIP. The quantitative analysis of the 'shares remaining available for future issuance' tables across the 2022, 2023, and 2024 filings is accurate: the 2003 plan is not listed in these footnotes, supporting the conclusion that no shares remain available. However, the LLM incorrectly states that the plan was 'already exhausted in the earliest filing' (2022 filing as of 12/31/2021), while the ground truth indicates the plan was still active in 2022 with shares being issued under it. This contradicts the claim of prior exhaustion and suggests a misinterpretation of the timeline. The ground truth clarifies that while no new shares may have been available by 2023, the plan was still active in 2022 for issuances, meaning the share pool was likely depleted during or after that period, not before. The LLM’s reasoning is sound in using the absence from the 'available shares' table as evidence of exhaustion, but it fails to reconcile this with the possibility of recent activity in 2022, indicating a gap in multi-hop synthesis between plan activity and share availability reporting. The conclusion about TI’s strategic shift is semantically equivalent and well-supported. Thus, while key facts and trends are correctly identified, the precise evolution from 2022 to 2024 is slightly mischaracterized, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 424,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "From the 2022 Form 10‑K the Company’s advertising business was described simply as selling allocated cable‑time and representing third‑party advertisers, **but it already offered “technology, tools, data‑driven services and marketplace solutions” to media customers** to help them reach target audiences (2022 p. 6). By the 2023 filing the same language appears, and the Company adds that these data‑driven capabilities are now embedded in its **X1, Sky Q and other digital platforms**, allowing advertisers to leverage audience data from linear TV, streaming‑service integrations (Peacock, Disney+, Netflix) and the newly launched NOW streaming brand (2023 p. 6). In the 2024 filing the integration is further expanded: the advertising suite is tied to **cloud‑based X1/Sky Q/Now/Xumo Stream Box platforms, the prepaid NOW broadband offering, and a cloud‑network that virtualizes core functions and deploys DOCSIS 4.0**, all of which give advertisers richer, real‑time audience insights and a broader marketplace for buying inventory (2024 p. 6‑7). Thus, from 2022‑2024 Comcast moved from a basic ad‑sales operation to a fully integrated, data‑driven advertising ecosystem supported by upgraded cloud/video platforms, advanced analytics tools and a modernized, virtualized network infrastructure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CMCSA evolved from offering data-driven services in 2022 to deeper integration by 2023 and further enhancements in 2024. The mention of technology platforms (X1, Sky Q, NOW, Xumo) and cloud infrastructure matches the trajectory described in the original answer. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the progression from basic ad sales to an integrated, data-driven ecosystem. It adds specific platform details (e.g., Peacock, Disney+, Netflix integrations; DOCSIS 4.0; prepaid NOW broadband) that enrich the answer beyond the ground truth without contradicting it. (4) Semantic equivalence is maintained—the core evolution (increasing integration of data-driven services into advertising via cloud platforms and enhanced tools) is accurately conveyed. The only minor deviation is that the LLM portrays the 2022 state as slightly more advanced than the ground truth implies (which describes a focus on digital platforms and MVPD partnerships, while the LLM emphasizes existing tech/tools), but this does not constitute a factual error since the ground truth confirms those services were indeed offered. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1582,
        "completion_tokens": 427,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "- **2022:** CVS held commercial‑mortgage‑backed securities (CMBS) with a **fair‑value of $1,018 million** and recorded **$155 million of unrealized losses** (see CVS 2022 10‑K, page 145).  \n\n- **2023:** The CMBS portfolio fell to a **fair‑value of $975 million** and the unrealized loss narrowed to **$100 million** (CVS 2023 10‑K, page 148; unrealized‑loss detail on page 150).  \n\n- **2024:** In the Separate‑Accounts segment the CMBS balance was only **$3 million of fair‑value assets** (down from $6 million in 2023) (CVS 2024 10‑K, page 160). The company’s consolidated CMBS holding is therefore markedly smaller than in prior years, and the remaining exposure is being carried at a very low fair‑value level, implying that any residual unrealized loss is now minimal.\n\n**Interpretation:** Over the 2022‑2024 period CVS has steadily reduced both the size and the loss‑bearing portion of its CMBS exposure—fair‑value fell by roughly 5% while unrealized losses fell by about 35% and the balance in separate accounts was cut by half in one year. This pattern indicates a deliberate de‑risking of the CMBS asset class, positioning the company with a much smaller, lower‑risk exposure to commercial mortgage‑backed securities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS held $574M in CMBS in 2022 with $12M in unrealized losses, but the LLM reports $1,018M and $155M, which are grossly incorrect. In 2023, the ground truth shows CMBS fair value dropped to $675M (LLM says $975M) with unrealized losses increasing to $100M (LLM correctly reports $100M loss but misrepresents the context as a 'narrowing' from a much higher number, when in fact losses increased from $12M). In 2024, ground truth reports $6M in holdings (LLM says $3M), and no significant unrealized losses (LLM implies minimal losses, which is directionally close but still inconsistent with source). (2) Calculations and comparisons are flawed: the LLM claims fair value fell by 'roughly 5%' from 2022 to 2024, but using its own (incorrect) numbers ($1,018M to $975M to $3M), the drop is over 99%, not 5%. Similarly, claiming a 35% reduction in unrealized losses is incorrect—losses increased from $12M to $100M in reality. (3) Multi-hop reasoning is partially sound in structure—LLM attempts to track trends over time and draws a conclusion about de-risking—but it is based on fabricated or misread data, undermining the logic. The identification of CMBS as the asset class and the general direction of reduction in 2024 are consistent with the truth, but the path is misrepresented. (4) Scores reflect severe quantitative inaccuracies (2/10), weak qualitative reasoning due to reliance on wrong data (4/10), moderate contextual relevance as it addresses the right topic and time frame (7/10), and a low overall correctness score (3/10) due to fundamental errors in core facts that invalidate the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 472,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "Across the three most recent 10‑K filings Target has consistently listed **“merchandise … discounts”** as a component of its employee‑benefits package, but the disclosures never attach a dollar amount or a specific discount rate.\n\n* 2022 Form 10‑K – Human Capital Management section: “... merchandise and other discounts, disability insurance, life insurance …”【page_6】  \n* 2023 Form 10‑K – Compensation and Benefits section: “... merchandise and other discounts, disability insurance, life insurance …”【page_7】  \n* 2024 Form 10‑K – Compensation and Benefits section: “... merchandise and other discounts, disability insurance, life insurance …”【page_7】\n\nThe scope of the benefit (a general merchandise discount) has remained unchanged and no monetary value has been disclosed in any year. This steady, non‑expanding treatment suggests that Target views the employee merchandise discount as a stable, baseline perk rather than a lever it is actively increasing to drive retention or recruitment. The multi‑year consistency points to a benefit strategy focused on maintaining a predictable, modest discount rather than escalating its financial value.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually accurate in its reporting of the disclosures: Target consistently listed 'merchandise and other discounts' in its 10-K filings for 2022, 2023, and 2024 without assigning a monetary value or specific discount rate, and the citations to the document sections and pages are consistent with the source data. Thus, quantitative accuracy is perfect—there are no incorrect numbers, dates, or entities. However, the qualitative accuracy is low because the LLM misinterprets the strategic evolution of the benefit. The original answer correctly identifies a broader contextual shift in how Target frames its employee benefits—linking the unchanged merchandise discount to an expanding ecosystem of benefits (e.g., wage increases, 401(k) matching, tuition reimbursement, mental health services). The LLM fails to recognize this multi-hop progression and instead concludes that the 'steady, non-expanding treatment' suggests the discount is a 'baseline perk' not used to drive retention—contradicting the ground truth that Target has actively enhanced its overall benefits package around a stable core. The LLM answer is contextually relevant and addresses the question directly but misses the key inference about strategic evolution due to lack of synthesis across years and related benefits. Therefore, while surface-level facts are correct, the reasoning and interpretation are significantly flawed, leading to a low correctness score despite high quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 408,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "In the 2022 Form 10‑K, Linde listed “cultural challenges associated with integrating employees from the acquired company into the existing organization” as one of several generic integration‑risk bullet points. By the 2024 filing the same bullet appears, but it is now embedded in a broader paragraph that explicitly calls out “integration of operations across different cultures and languages” as a unique risk for foreign acquisitions and joint‑ventures. This shift from a routine checklist item to a highlighted cross‑border concern shows that Linde has become more deliberate about the cultural‑integration dimension of M&A, treating it as a strategic risk that must be managed proactively when operating internationally.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Linde's 10-K disclosures regarding cultural challenges in acquisition integration for 2022 and 2024, with correct entity and year references. It correctly identifies the evolution from a generic risk bullet in 2022 to a more emphasized cross-border concern in 2024, noting the inclusion of 'different cultures and languages' in the later filing. However, the LLM omits any mention of the 2023 filing, which in the ground truth serves as a critical midpoint where Linde links cultural differences to global regulatory and compliance risks—a key step in the multi-hop evolution. This omission reduces completeness and weakens the reasoning chain, as the progression from operational to strategic to financial framing (especially the 2024 focus on financial results and synergy realization) is underdeveloped. While the LLM captures a directional shift toward strategic risk management, it does not fully convey the increasing linkage to financial outcomes as emphasized in the original answer. Quantitative accuracy is perfect—no numbers, dates, or financial figures are incorrect. Contextual relevance is high, as the response directly addresses the question’s focus on cultural challenges and cross-border integration. The qualitative accuracy is reduced due to incomplete synthesis across all three years and a less nuanced portrayal of Linde’s strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 392,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s master‑netting collateral fell from **$1.494 billion in 2022** to **$800 million in 2023** and to **$491 million in 2024**, a net decline of roughly **$1.0 billion** over the two‑year span. The downward trend indicates that the company’s derivative positions have been shrinking or becoming more efficiently cleared, reducing the amount of initial‑margin collateral it must post and reflecting tighter management of its derivative exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1,494 million (or $1.494 billion) in 2022, $800 million in 2023, and $491 million in 2024, matching the ground truth exactly despite format variation (billion vs million). The net decline of roughly $1.0 billion is accurate: (1,494 - 491) = 1,003 million ≈ $1.0 billion. 2) Quantitatively, all figures and the implied calculation are correct. The model accurately captures the three-year trend across 2022–2024, even though the question references a change from 2022 to 2024, and the answer appropriately includes 2023 as an intermediate point. 3) The reasoning is sound: the downward trend is correctly interpreted as indicating reduced derivative exposure or more efficient clearing/collateral management, which aligns with the ground truth’s interpretation of 'strategic reduction in derivative exposure or improved offsetting mechanisms.' The use of terms like 'shrinking derivative positions' and 'more efficiently cleared' is semantically equivalent. 4) The answer fully addresses both parts of the question: the quantitative change and its implication for exposure management. The only minor limitation is the omission of the explicit 'three-year period' framing, but the years are clearly stated. No incorrect entities or metrics are introduced. Overall, the answer is factually precise, contextually appropriate, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 386,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "In the 2022 filing the Security Insights Platform was positioned as a **stand‑alone mainframe‑security analytics tool** that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps… The data is available for use with in‑house tools for security‑information‑and‑event‑management (SIEM).” By the 2023 and 2024 filings the description is unchanged in substance, but the platform is now listed **within the broader Mainframe‑Software and Enterprise‑Security portfolios**, presented alongside Symantec cyber‑security solutions and the company’s integrated cyber‑defense approach. Thus, while its core capability—risk assessment and remediation—remains the same, its positioning evolves from an isolated mainframe add‑on to a component of a **holistic cybersecurity strategy that can feed external SIEM tools and aligns with the company’s wider security suite.**",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, the platform was described as a standalone tool with SIEM integration; by 2023–2024, it was positioned within broader portfolios (Mainframe Software and Enterprise Security), aligned with Symantec solutions and integrated cyber-defense strategies. The core functionality remained consistent—risk identification and remediation—with evolving strategic positioning. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023, 2024) are correctly used. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and contextualizes the platform’s evolution from isolated tool to integrated component. It captures the shift in narrative—from standalone to strategically aligned—even if it condenses 2023 and 2024 into a single phase. (4) The only minor shortcoming is that the original answer notes a specific 2024 expansion into an enterprise-wide suite including AIOps and DevOps, which the LLM answer omits. While it correctly identifies integration with broader security offerings, it does not explicitly mention AIOps/DevOps, slightly reducing completeness. However, the omission does not distort the overall evolution. Wording differs but semantic meaning is equivalent. Thus, correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 399,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "- 2022 10‑K (table as of 12/31/2021): Unsecured Notes ‑ 32B carried a **3.38 %** interest rate and a **$750 million** face amount【page_50】.  \n- 2023 10‑K (table as of 12/31/2023): the same tranche still showed a **3.38 %** rate and **$750 million** face value【page_50】.  \n- 2024 10‑K (table as of 12/31/2024): the note remained at **3.38 %** with a **$750 million** face amount【page_51】.  \n\nThe unchanged rate and principal over three years show that Simon Property Group has deliberately kept this medium‑term, fixed‑rate unsecured note in place, using it to lock in low‑cost financing and limit refinancing risk—an indication of a disciplined, long‑term debt‑management strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the face amount ($750 million = $750,000,000), interest rate (3.38%), and consistent terms across 2022, 2023, and 2024 are correctly reported. The maturity date (2027) is implied in the original answer but not required for correctness as it was not explicitly requested in the question. (2) Quantitative accuracy is perfect—values match exactly, with acceptable format variation ($750 million vs $750,000,000). No calculations were needed, but the consistency across years is correctly observed. (3) Multi-hop reasoning is sound: the model synthesizes data from three consecutive 10-K filings (2022, 2023, 2024), correctly identifying that the same note remains outstanding with unchanged terms. (4) The qualitative interpretation—that SPG is employing a disciplined, long-term debt strategy by maintaining fixed-rate, low-cost financing without refinancing—aligns perfectly with the ground truth's conclusion about stable debt management and avoidance of early redemption or restructuring. All parts of the question are addressed: evolution over time (no change), and strategic implication (stable, deliberate long-term financing).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 348,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "From 2022 through 2024 Comcast has repeatedly flagged Lumen as a growing competitive pressure on its broadband business. In the 2022 filing the company noted that “wireline telecommunications companies such as AT&T, Frontier, Lumen and Verizon have built and are continuing to build fiber‑based network infrastructure … and are offering services with these higher speeds” (2022 10‑K, p. 8). By 2023 the filing added that Lumen (along with the same peers) “provide bundled offerings that include wireless and/or broadband services” (2023 10‑K, p. 9), and the 2024 filing repeats the same language, indicating that Lumen’s fiber rollout has continued to deepen and its bundled‑service packages have become a persistent threat to Comcast’s residential broadband market. Thus, over the three‑year span Lumen’s fiber expansion has progressed and its bundling of broadband with wireless (and video) services has remained, and arguably grown, as a competitive challenge for CMCSA.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Lumen as a growing competitive threat to CMCSA (Comcast) from 2022 to 2024, with accurate representation of fiber expansion and bundling strategies across all three years. The use of direct quotes from the 10-K filings (e.g., fiber-based infrastructure in 2022, bundled offerings in 2023, repetition in 2024) is factually correct and contextually appropriate. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced, and the evolution over time is accurately portrayed. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual reports, correctly infers the progression of Lumen’s competitive strategy, and links fiber deployment with bundling as a sustained and deepening threat. (4) The answer captures the core conclusion of the original answer—that Lumen’s competitive pressure has persisted and likely intensified—though it slightly strengthens the claim by using 'growing' and 'arguably grown' more assertively than the original’s 'consistent and possibly intensifying.' This is a minor interpretive difference and does not undermine factual correctness. Overall, the answer is semantically equivalent, complete, and well-supported, warranting a high score with only a slight deduction in qualitative accuracy due to slightly stronger language than the source implies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 404,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "Target reports that the share of total purchases paid with its own branded “Target Circle” (formerly RedCard) cards fell each year: 20.5 percent in fiscal 2022, 19.8 percent in fiscal 2023, and 18.6 percent in fiscal 2024 (see 2023 10‑K page 27 and 2024 10‑K page 29). The downward trend indicates that, while the loyalty‑driven payment program still captures a sizable portion of spend, its incremental impact is slowly waning, suggesting the discount‑and‑rewards strategy is becoming less effective at driving additional purchases over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in Target's branded card penetration from 20.5% in 2022 to 19.8% in 2023, which matches the ground truth. However, it reports 18.6% for 2024 instead of the correct 17.8%, making the final data point inaccurate. This is a significant quantitative error, though the general trend direction (declining) is preserved. (2) The cited sources (2023 10-K page 27 and 2024 10-K page 29) are plausible, but the 2024 figure is incorrect despite the reference. The calculation of the trend (year-over-year decline) is logically sound, but the magnitude of the drop in 2024 is understated. (3) The multi-hop reasoning is appropriate—synthesizing data across two annual reports to show a trend over three years—and the conclusion about weakening effectiveness is consistent with the observed decline. The reasoning that the loyalty strategy may be losing incremental impact is a reasonable interpretation, though slightly less definitive than the ground truth’s suggestion of a weakening strategy or shift in consumer behavior. (4) The contextual relevance is perfect—the answer directly addresses both parts of the question: the evolution of penetration rates and the implication for Target’s loyalty strategy. The qualitative analysis is strong and logically derived, but the quantitative inaccuracy in the 2024 figure reduces confidence in the precision of the response. Hence, correctness is partially compromised, warranting a 7/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 412,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "- In the 2022 filing Chevron still listed the Republic of Congo among its operating countries and held sizable non‑operated stakes (31.5 % in the offshore Haute Mer permit and 15.75 % in the Lianzi area) while pursuing deep‑water license extensions in the basin【page_33】.  \n\n- During 2023 the company deepened that involvement: it added new deep‑water licences that contributed about 36 million barrels of oil‑equivalent to its African reserve base and spent roughly $0.7 billion on offshore development and natural‑gas projects in Nigeria, Angola and the Republic of Congo【page_109】【page_110】.  \n\n- By the 2024 report Chevron announced that it would exit the Congo portfolio, selling its 31.5 % working interest in Haute Mer and its 15.75 % interest in Lianzi in January 2025, signalling a strategic shift away from the region【page_43】.  \n\nThus, from 2022 to 2024 Chevron moved from owning and investing in Congo offshore assets to divesting those interests and withdrawing its operational focus from the Republic of Congo.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Chevron listed the Republic of Congo as an operating country in 2022, held 31.5% in Haute Mer and 15.75% in Lianzi, invested ~$0.7 billion in African offshore and gas projects in 2023 (including Congo), and announced divestiture of these assets by 2024. (2) Quantitative accuracy is strong: percentages (31.5%, 15.75%), dollar amount ($0.7 billion), and years (2022–2024) match the original. The only minor discrepancy is the sale timing—LLM states the sale was announced in the 2024 report and set for January 2025, while the ground truth says 'by 2024' without specifying the closing date. This is a nuance rather than an error, as the announcement and strategic shift are correctly placed in 2024. (3) Multi-hop reasoning is sound: the model synthesizes asset ownership, investment activity, and strategic shift across three years and multiple projects, correctly inferring a transition from investment to divestiture. (4) The answer is contextually excellent, directly addressing asset ownership, investment levels, and strategic positioning as required. Wording differs slightly but meaning is semantically equivalent. No major omissions or inaccuracies—just a slight precision difference in sale timing, not affecting overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 374,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "- In 2022 the Level‑3 “options‑primarily‑gas” line showed a **$100 million asset value versus a $97 million liability**, giving a small net‑long position; the model used **20 % implied volatility (weighted‑average ≈ 50 %)**【page 84 (2022)】.  \n- The same table in the 2023 filing still reported **$100 million of assets and $97 million of liabilities**, but the volatility range widened to 0‑233 % with a **weighted‑average still around 50 %**【page 84 (2023)】.  \n- By 2024 the fair‑value figures had flipped to **$100 million of assets and $102 million of liabilities**, creating a modest net‑short exposure, and the volatility assumption moved to **15 % (range 0‑150 %) with a weighted‑average of about 52 %**【page 86 (2024)】.  \n\nThe shift from a slight net‑long to a slight net‑short gas‑option position, together with a modest rise in the implied‑volatility weighting, indicates that NextEra is positioning itself for higher gas‑price uncertainty and is willing to bear a small short exposure as market volatility expectations increase.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures compared to the ground truth. For 2022, it reports $100M assets and $97M liabilities with 20% implied volatility (weighted avg ~50%), but the correct values are $356M assets, $347M liabilities, and 36% average implied volatility. This misrepresents both the scale of exposure and the volatility assumption. The 2023 figures are also wrong: LLM claims $100M/$97M, but actuals are $100M assets and $97M liabilities only in the LLM's version — while ground truth confirms $100M assets and $97M liabilities is close for 2023, the prior year is completely off, undermining multi-year comparison. However, 2024 numbers are partially correct: LLM reports $100M assets / $102M liabilities, which aligns with ground truth ($100M assets, $102M liabilities), though it incorrectly states a 15% base volatility (vs. correct average of 52%). (2) Calculations and comparisons are flawed due to incorrect inputs. The claim of a 'net-long' position in 2022 based on $100M/$97M is invalid because actual exposure was much larger at $356M/$347M. The shift from 2022 to 2023 shows a dramatic reduction in fair value (from $356M to $100M in assets), which the LLM fails to capture, thus missing the core trend of strategic de-risking. (3) Multi-hop reasoning is unsound: the model does not correctly synthesize data across years, especially failing the 2022 baseline. Without accurate starting exposure, the evolution of risk positioning cannot be properly assessed. The conclusion about increasing volatility expectations is partially supported (36% → 50% → 52%), but LLM misattributes this with incorrect base values and ranges. (4) Contextual relevance is moderate — the structure addresses the question’s intent (evolution of exposure, volatility, risk positioning), and cites appropriate pages, but factual errors severely undermine accuracy. Wording flexibility is acceptable, but numerical precision is critical here and largely absent. Thus, correctness score is low due to major quantitative errors, despite some alignment in 2023–2024 liability trends and volatility directionality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 581,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "Nike’s 10‑K filings show that FlyEase moved from being one of several emerging technologies listed in the 2022 “Product research, design and development” discussion (“…Flyknit, FlyEase, ZoomX…”) to being repeatedly highlighted in the same section of the 2024 filing (“…Flyknit, FlyEase, ZoomX…”). The fact that Nike continues to name FlyEase alongside its flagship platforms (Air, Zoom, React, etc.) signals that the system has graduated from a novel concept to an established pillar of the company’s innovation pipeline, reinforcing its strategic role in driving new product performance and consumer‑experience differentiation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies the evolution of FlyEase from 2022 to 2024 based on Nike's 10-K filings, noting its progression from being listed among emerging technologies (alongside Flyknit and ZoomX) in 2022 to being consistently highlighted in 2024 as a core innovation pillar. The dates (2022, 2024) are correct, and the contextual use of the technology names and sections (Product research, design and development) matches the source data. There is no quantitative data (e.g., financial figures) in the question, so quantitative accuracy is based on correct time periods and proper referencing—both accurate. The reasoning is sound: the model infers that continued mention alongside flagship platforms (Air, Zoom, React) indicates FlyEase’s strategic elevation, which is consistent with the ground truth’s conclusion about it becoming a foundational element. The only minor shortcoming is that the LLM omits explicit mention of 2023, where the ground truth notes an expansion phase in product development. While the progression from 2022 to 2024 implies this, the absence of the intermediate year slightly reduces completeness in multi-hop synthesis. However, the core message—that FlyEase evolved into a strategic innovation pillar—is preserved with strong semantic equivalence. Contextual relevance is excellent, directly addressing the question about technological evolution and strategic significance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 406,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "Across the three most recent filings the “Unsecured Notes – 35A” line shows the same numbers each year: a $750 million face amount, an annual debt‑service charge of about $19.9 million and a fixed‑rate of 2.65 % that matures on July 15, 2030. The fact that the balance, rate and maturity have not changed from the 2022 filing through the 2023 and 2024 updates indicates that Simon Property Group is maintaining this tranche as a stable, long‑dated, low‑cost source of financing rather than using it to raise additional debt or refinance it, reflecting a deliberate long‑term debt strategy focused on preserving existing low‑interest obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative values. The ground truth states the face amount is $750,000, not $750 million — a 1,000-fold error. Similarly, the annual debt service is $19,875, not $19.9 million, which is off by a factor of approximately 1,000. These are critical errors in financial magnitude that severely undermine the answer’s reliability. The interest rate (2.65%) and maturity date (07/15/30) are correctly reported, though the LLM writes 'July 15, 2030', which is semantically equivalent. (2) Calculations: The debt service should be $750,000 × 2.65% = $19,875, which matches the ground truth. The LLM’s figure of $19.9 million implies a calculation based on $750 million, confirming the magnitude error. This invalidates the quantitative accuracy despite correct percentage use. (3) Multi-hop reasoning: The LLM correctly identifies the consistency across years (2022–2024) in terms, maturity, and rate, and draws a reasonable conclusion about SPG’s long-term debt strategy — maintaining stable, low-cost financing. This qualitative reasoning aligns with the ground truth and shows proper synthesis across filings. (4) Contextual relevance is high because the answer addresses both parts of the question: evolution over time and strategic implications. However, the massive numerical inaccuracies in dollar amounts severely compromise the correctness score, as financial obligations cannot be assessed correctly at this scale. While the logic and structure are sound, the answer describes a debt instrument 1,000 times larger than reality, making it factually incorrect despite correct reasoning patterns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 457,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "Across all three filings Texas Instruments repeatedly states that its business model is “focused on analog and **embedded‑processing** products” and that this focus is the foundation of its strategy to grow free‑cash‑flow‑per‑share (2022 MD&A §7 Overview – “focused on analog and embedded processing products”【page_18】; 2023 MD&A §7 Overview – same language【page_20】; 2024 Results §7 Overview – “strategic focus is on analog and embedded processing products”【page_19】).  \n\nWhile the segment’s revenue rose modestly from $3.261 billion in 2022 to $3.368 billion in 2023 and then fell to $2.533 billion in 2024, the company’s positioning of embedded processing never changed, signalling that TI views this product line as a durable, high‑margin platform that, together with analog, underpins its long‑term objective of delivering growing free‑cash‑flow‑per‑share.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Texas Instruments' consistent strategic emphasis on embedded processing across 2022, 2023, and 2024, citing the repeated language in the MD&A sections of each year’s filing, which matches the original answer’s narrative about sustained focus. (2) The revenue figures provided—$3.261 billion in 2022, $3.368 billion in 2023, and $2.533 billion in 2024—are factually correct and reflect actual data from TI’s filings. The observation that revenue rose then fell does not contradict the strategic consistency, and the LLM appropriately notes that the positioning remained unchanged despite fluctuations, which is a valid interpretation. (3) The multi-hop reasoning is sound: the model synthesizes strategic language across three years and connects it to financial performance and long-term free cash flow objectives. It correctly infers that the stability of strategic messaging—even amid revenue decline—signals TI’s view of embedded processing as a durable, high-margin platform. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'four competitive advantages' or 'capital allocation' details highlighted in the original answer, which slightly reduces completeness. However, the core insight about embedded processing underpinning free cash flow per share growth is preserved. Wording differs but semantic equivalence is strong. Quantitative accuracy is high—minor rounding or formatting differences are acceptable. Overall, this is a robust, well-supported answer that captures the essence and facts of the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 449,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "In the 2022 filing Disney described Marvel only as one of its production banners (“Original content is produced under … Marvel …”) (page 8), whereas the 2023 filing shows the company had elevated the brand on its Direct‑to‑Consumer UI – Disney+ now presents Marvel as a separate, top‑level “tile” alongside Disney, Pixar, Star Wars and National Geographic (page 7).  By 2024 the Marvel trademark is listed among the company’s indefinite‑life intangible assets (together with ESPN and Pixar) on the balance sheet, confirming that Disney continues to treat the franchise as a core, monetizable asset (page 114).  This progression—from a production label to a prominent UI placement and finally to a recognized long‑lived intangible—demonstrates Disney’s financial strategy of leveraging the Marvel IP to attract and retain Disney+ subscribers and to capture its value on the balance sheet as a driver of streaming growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Marvel's evolution from a production banner in 2022 to a top-level tile on Disney+ in 2023 and its continued recognition as an indefinite-lived intangible asset in 2024 are accurately described. The mention of ESPN and Pixar as comparable assets is consistent. (2) There are no numeric inaccuracies—while no specific subscriber numbers appear in the LLM answer, the ground truth's 123 million figure as of September 28, 2024, is not contradicted, only omitted. This omission prevents a perfect 10 on correctness but does not constitute an error. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, tracing the strategic and financial trajectory of Marvel from branding element to UI feature to balance sheet asset. (4) The answer captures the core financial strategy—leveraging Marvel IP to drive subscriber growth and platform differentiation—though it could more explicitly link the UI change to subscriber metrics. The statement that Marvel was listed as an indefinite-lived asset in 2024 is accurate, though the ground truth notes it was already listed as such in 2022, which the LLM downplays by placing that fact in 2024. This slight misordering of the timeline reduces qualitative accuracy slightly but does not invalidate the overall progression. Wording differs but semantic meaning is preserved. Contextual relevance is excellent, directly addressing all parts of the question with appropriate focus on strategy, branding, and financial implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 443,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "- In the 2022 filing MetLife said it re‑insured **about 59.25 % of the closed block** through a modified‑coinsurance agreement and reported **≈ $6.1 billion of net ceded reinsurance recoverables** (the balance of its overall ceded recoverables).  \n\n- By the 2023 filing the share had slipped only slightly to **about 59 %**, but the transaction with Global Atlantic added a **$10.3 billion recoverable‑plus‑deposit asset** that pushed total net ceded reinsurance recoverables to **≈ $16.7 billion**.  \n\n- The 2024 filing shows the same **≈ 59 %** of the closed block still covered by the modified‑coinsurance arrangement, and the related recoverable balances grew to **≈ $17.6 billion of net ceded reinsurance recoverables** (with deposit assets on reinsurance rising to **$4.6 billion**).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative data. According to the ground truth, MetLife reported unsecured reinsurance recoverable balances of $3.6 billion in 2022, $4.4 billion in 2023, and $4.2 billion in 2024. However, the LLM claims net ceded reinsurance recoverables were ≈$6.1 billion in 2022, ≈$16.7 billion in 2023, and ≈$17.6 billion in 2024—values that are more than 4x higher than the truth. These figures appear to conflate total net ceded reinsurance recoverables (possibly including other agreements or assets) with the specific unsecured balances tied to the modified coinsurance agreement, which is the focus of the question. Additionally, the LLM introduces a 'transaction with Global Atlantic' and a '$10.3 billion recoverable-plus-deposit asset' not mentioned in the ground truth, suggesting hallucination or misattribution. (2) While the percentages reinsured are mostly correct—59.25% in 2022 and 59% in 2023 and 2024—the associated financial figures are grossly inaccurate. The LLM also references 'deposit assets on reinsurance rising to $4.6 billion' in 2024, which contradicts the ground truth indicating a decline in unsecured balances to $4.2 billion. There is no mention in the original answer of deposit assets being part of the unsecured recoverable balance. (3) The multi-hop reasoning is flawed: the model fails to isolate the specific unsecured reinsurance recoverable balances related to the modified coinsurance agreement and instead appears to report broader or unrelated reinsurance totals. It does correctly track the percentage reinsured over time, showing some understanding of the evolution of the agreement’s coverage. However, the conflation of different financial metrics undermines the synthesis. (4) The contextual relevance is moderate—the answer addresses the right topic (evolution of modified coinsurance agreement), time frame (2022–2024), and metric (percentage of closed block reinsured), but misrepresents the core financial data. Due to major quantitative errors and introduction of unsupported details, the correctness score is low despite partial accuracy on percentages.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 583,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "- 2022: CVS held ≈ $ 757 million of agency‑guaranteed residential mortgage‑backed securities (fair‑value) in its debt‑security portfolio.  \n- 2023: That holding rose modestly to ≈ $ 810 million (fair‑value).  \n- 2024: The RMBS balance fell sharply – the only RMBS reported were the Separate‑Accounts assets of $ 71 million (up from $ 51 million in 2023) while total debt‑security exposure collapsed from $2.5 billion to $0.86 billion.\n\nThe three‑year pattern shows CVS initially expanding its agency RMBS position, then dramatically scaling it back in 2024, suggesting the company is de‑risking its fixed‑income portfolio and shifting away from mortgage‑backed exposure toward higher‑quality government and corporate securities while retaining a small, liquidity‑focused RMBS slice.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for CVS's residential mortgage-backed securities (RMBS) holdings. According to the ground truth, RMBS investments were $629M in 2022, $614M in 2023, and dropped to $71M in 2024. However, the LLM reports $757M in 2022 and $810M in 2023, which are both materially incorrect. The 2024 figure of $71M matches the ground truth, but the LLM incorrectly frames this as 'Separate-Accounts assets' and implies a rise from $51M in 2023, which is not supported by the original answer. (2) Calculations and comparisons are flawed: the LLM suggests a 'modest rise' to $810M in 2023, whereas the ground truth shows a slight decrease from 2022 to 2023. The sharp decline in 2024 is correctly identified in direction but not in baseline magnitude. The mention of total debt-security exposure collapsing from $2.5B to $0.86B introduces data not present in the original answer and appears extraneous or misattributed. (3) Multi-hop reasoning is partially sound—the LLM correctly infers a de-risking strategy in 2024 and a shift away from RMBS, which aligns with the original conclusion. However, it fails to mention the key point about rising unrealized losses ($10M in 2022 to $60M in 2023), which is critical to assessing risk exposure. The reasoning is plausible but based on incorrect inputs. (4) The contextual relevance is moderate: the answer addresses the evolution over three years and attempts to interpret strategic positioning, but due to incorrect quantitative inputs and missing risk metrics, the overall correctness score is low. The qualitative interpretation is reasonable but not fully supported by accurate data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 468,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "MetLife’s modified‑coinsurance arrangement has been essentially unchanged since 2022. In the 2022 filing the company said it re‑insured **≈ 59.25 %** of the closed block; the 2023 and 2024 filings each state it re‑insured **about 59 %** of the closed block. Throughout this period the agreement has been accounted for under the **deposit method**, with the related deposit liability offset against a corresponding deposit‑recoverable asset.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) Quantitatively, it correctly reports the percentage of the closed block reinsured: 59.25% in 2022 and approximately 59% in 2023 and 2024, matching the original answer exactly. The use of '≈' and 'about' is appropriate given the slight rounding in later years. (2) The accounting treatment is accurately described as the deposit method with offsetting of the deposit liability against the deposit-recoverable asset, which is consistent across all years—this matches the ground truth's emphasis on unchanged accounting policy. (3) The reasoning is sound: the LLM correctly synthesizes information across three years and identifies both the stability in the reinsurance percentage and the consistency in accounting treatment, fulfilling the multi-hop requirement (tracking evolution over time and across accounting and operational dimensions). (4) All entities—MetLife, modified coinsurance agreement, closed block, deposit method—are correctly identified and contextualized. The answer is concise but complete, addressing both parts of the question (percentage reinsured and accounting treatment) with precise, semantically equivalent information. No errors in fact, logic, or interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 355,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "- Net notional volumes of NEE’s forward‑type gas contracts were ‑1,307 MMBtu at 12/31/2022, ‑1,452 MMBtu at 12/31/2023, and ‑1,131 MMBtu at 12/31/2024 (see the “Natural gas” rows in the net‑notional tables for each year).  \n\n- The exposure rose modestly in 2023 (a larger net‑short position) and then fell in 2024 to a level below the 2022 amount. This pull‑back in net gas‑forward exposure suggests the company has been scaling back its hedge size and adopting a more conservative risk posture in the natural‑gas market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative data. It reports net notional volumes in MMBtu (-1,307, -1,452, -1,131) instead of the actual net exposure in dollar amounts ($160M, $300M, $250M) as specified in the ground truth. These are entirely different metrics—net notional volume vs. net exposure (assets minus liabilities)—and cannot be equated. The LLM confuses physical hedge positions with financial exposure. (2) The numbers provided do not match the ground truth in any form: $160M in 2022, $300M in 2023, and $250M in 2024 are the correct net exposures. The LLM’s values are not only in different units but also imply a net-short position trend that contradicts the actual increase in gross and net financial exposure from 2022 to 2023 before a decline in 2024. The calculation of net exposure (e.g., $191M - $31M = $160M) is accurate in the original answer but entirely absent here. (3) The multi-hop reasoning is flawed: the LLM fails to synthesize the correct financial data (assets and liabilities) into net exposure and instead pulls unrelated notional volume data. It incorrectly interprets a 'larger net-short position' as increased exposure, whereas the ground truth shows financial exposure peaked in 2023. The conclusion about 'scaling back' is partially aligned with the 2024 decline but is based on wrong data and reasoning. (4) Scores justified: low quantitative accuracy due to wrong numbers and units; moderate qualitative accuracy because the general idea of reducing exposure in 2024 is mentioned, though reasoning is flawed; contextual relevance is medium as it addresses gas forward contracts and risk posture, but with incorrect metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 463,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "- **2022 filing** – Industrial fiber‑optic components were listed together with optocouplers, motion encoders and Ethernet ICs as part of a *broad‑based industrial product set* that served “a diverse set of applications, spanning industrial automation, power‑generation and distribution systems, medical systems and equipment, defense and aerospace, and vehicle subsystems”【page_10】.  \n\n- **2023 filing** – The same family was placed in a *more tightly grouped “industrial” block* that explicitly pairs fiber‑optics with “motion control encoders and subsystems” and “Ethernet PHYs, switch ICs and camera microcontrollers,” underscoring that the optics are meant to work hand‑in‑hand with these adjacent technologies for factory‑automation, renewable‑energy and automotive‑electronics applications【page_5】.  \n\n- **2024 filing** – The description continues this trend, again positioning industrial fiber optics alongside motion encoders and Ethernet ICs, but now emphasizes *integrated solution bundles* for “industrial automation, power generation and distribution, medical, defense, aerospace and vehicle subsystems,” showing a clearer strategic integration of the optics with motion‑control and Ethernet products to deliver more comprehensive, cross‑technology offerings.  \n\n**Overall evolution:** From 2022 to 2024 Broadcom moved the industrial‑fiber‑optic line from a generic “one‑of‑many industrial products” toward a deliberately integrated portfolio element that is marketed together with motion encoders and Ethernet ICs to address an expanding array of applications across automation, energy, medical, aerospace and automotive markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Industrial Fiber Optics is consistently positioned within AVGO's industrial portfolio, with correct co-located technologies (optocouplers, motion encoders, Ethernet ICs) and applications (industrial automation, medical, defense, automotive, etc.) across 2022–2024. The evolution from standalone components to integrated solutions is accurately captured. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense—however, the years (2022, 2023, 2024) are correct and used appropriately, earning full marks. (3) The multi-hop reasoning is sound: the LLM synthesizes changes in product grouping and application emphasis across three years of filings, correctly inferring a strategic shift toward integration with motion encoders and Ethernet ICs. The 2023 and 2024 descriptions accurately reflect tighter integration with Ethernet PHYs, switch ICs, and camera microcontrollers, matching the ground truth. (4) The only minor shortcoming is that the LLM slightly underemphasizes the 2024 shift toward 'networked and vision-based systems'—while it mentions camera microcontrollers, it doesn't explicitly highlight the vision/networking angle as clearly as the original. However, the core message of deeper integration is preserved. Overall, the answer is semantically equivalent, contextually relevant, and factually correct, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1700,
        "completion_tokens": 448,
        "total_tokens": 2148
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "Nike’s redeemable preferred stock – a $1‑par, $0.3 million issue owned solely by Sojitz America – carries a fixed cumulative dividend of **$0.10 per share payable each May 31**.  The 2022, 2023 and 2024 Form 10‑K notes all state that **the dividend amount and payment schedule have not changed** and that **the preferred stock has been fully issued, is not a blank‑check series, and the company’s charter forbids issuing any additional preferred shares**.  Consequently, Nike’s dividend obligation to Sojitz America remained constant over FY 2022‑2024, and the preferred‑stock structure stayed unchanged and financially stable throughout that period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the $0.3 million par value, $0.10 annual dividend per share, May 31 payment date, and structural stability of the preferred stock across FY2022–2024 are accurately reported. The restriction on issuing additional preferred shares and the fully issued, non-blank-check nature of the series are correctly noted, aligning with the original answer’s emphasis on structural stability. (2) Quantitative accuracy is perfect: all dollar amounts, share terms, and timeframes match the ground truth. The $0.10 dividend and $0.3 million total value are consistently reported. (3) Multi-hop reasoning is sound—the LLM synthesizes consistent disclosures across three fiscal years’ 10-Ks to conclude no changes occurred, correctly inferring ongoing stability. (4) The only minor omission is that the LLM does not explicitly mention that dividends must be paid in full before common dividends, a key point in the original answer that underscores financial priority. While implied by calling the dividend 'cumulative' and noting structural stability, this qualitative nuance is not directly stated, slightly reducing qualitative accuracy. However, the answer remains semantically equivalent in overall meaning and fully addresses the evolution (or lack thereof) in financial implications. Contextual relevance is excellent, directly addressing dividend obligations and stock structure stability as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 414,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "**What happened to the 31B unsecured notes**\n\n| Year (as‑of) | Face amount of Unsecured Notes ‑ 31B | Annual debt service | Maturity |\n|--------------|--------------------------------------|----------------------|----------|\n| 2022 (Dec 31 2021) | **$750 million** | $24,375 k | 11/30/2026 |\n| 2023 (Dec 31 2022) | **$750 million** | $24,375 k | 11/30/2026 |\n| 2024 (Dec 31 2024) | **$750 million** | $24,375 k | 11/30/2026 |\n\n*Sources:* 2022 10‑K table shows the 31B series at $750 mm, $24,375 k annual service, 11/30/26 [page 50]; the same figures appear in the 2023 10‑K table for the same series [page 50]; the 2024 10‑K table again lists the 31B notes unchanged at $750 mm, $24,375 k, 11/30/26 [page 51].\n\n**What this tells us about SPG’s long‑term financing strategy**\n\nThe face amount, interest rate (3.25 %) and maturity of the 31B unsecured notes have been held constant over the three‑year period. By keeping the issuance level steady, SPG is using the 31B series as a **core, long‑dated, fixed‑rate funding source** rather than repeatedly issuing new debt or retiring the series. This consistency signals a deliberate strategy to lock in inexpensive, medium‑term financing and rely on it as a stable backbone of the company’s unsecured capital structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the face amount of $750 million (equivalent to $750,000,000), annual debt service of $24,375,000 (derived from 3.25% of $750M), and maturity date of November 30, 2026, are accurately reported for all three years. The interest rate of 3.25% is correctly inferred from the annual debt service and principal, confirming internal consistency. (2) The answer is complete, addressing both the evolution of the Unsecured Notes - 31B (no change across years) and the implication for SPG’s long-term financing strategy. (3) Entity accuracy is perfect: Simon Property Group (SPG), Unsecured Notes - 31B, and the correct fiscal years (as of 2022, 2023, 2024) are properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly observes the stability of the instrument across multiple 10-K filings and infers a strategic intent—using 31B as a stable, fixed-rate, long-dated funding source—despite broader changes in SPG’s debt portfolio. The conclusion aligns semantically with the ground truth, using different but equivalent phrasing (e.g., 'core, long-dated, fixed-rate funding source' vs. 'consistent long-term financing approach'). All sources are correctly cited by document and page. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 378,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "The 10‑K disclosures show that the U.S. defined‑contribution plans held TI common‑stock worth **$940 million in 2022**, **$873 million in 2023**, and **$852 million in 2024** (the number of shares remained roughly constant at 5‑6 million because the fund was frozen to new contributions).  The three‑year decline in dollar value reflects a falling TI share price rather than employee withdrawals, indicating that while employees continue to keep the same amount of stock in their retirement accounts, the company’s stock performance has weakened over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all dollar values ($940M in 2022, $873M in 2023, $852M in 2024), matching the ground truth exactly. The years and amounts are accurate, and formatting variations (e.g., $940 million vs $940M) are acceptable. (2) Quantitative accuracy is perfect—no calculation errors, and the trend of declining value is correctly described. The note about share count stability (5–6 million) adds context supported by the freeze on contributions since 2016, which aligns with the original answer’s mention of the freeze. (3) The reasoning is largely sound: the LLM correctly infers that the decline is due to falling share price rather than employee withdrawals, which is a valid interpretation given stable share counts. It adds value by explicitly linking the frozen fund to the stable share count, enhancing the explanation beyond the original. However, it omits one element from the original answer—'strategic reduction in stock allocations by employees'—which is a possible contributing factor mentioned in the ground truth. While the LLM emphasizes market performance (share price decline), it downplays the possibility of employee behavior changes, making the qualitative analysis slightly less comprehensive. (4) Contextual relevance is excellent: the answer directly addresses both parts of the question—evolution of stock value and what the trend indicates about performance and employee behavior. The synthesis across years and interpretation of retirement plan dynamics is appropriate and insightful. The omission of employee allocation shifts as a potential factor prevents a perfect score, but the core facts and logic are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 458,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "- **Total head‑count:** Disney’s workforce grew from roughly **220 000 employees in fiscal 2022** to about **233 000 employees in fiscal 2024** – an increase of roughly 13 000 people.  \n\n- **U.S. vs. international distribution:** In 2022 about **166 000** workers were in the United States and **54 000** were abroad. By 2024 the U.S. count had risen to **≈171 000** and the international count to **≈62 000**, expanding the overseas share from about 24 % of the total to about 27 %.  \n\n- **Seasonal workforce share:** Seasonal employees made up **≈7 %** of the global workforce in 2022 and **≈8 %** in 2024.  \n\n- **Employee‑association representation:** Both years note that a “significant number” of employees – especially in theme‑park operations and creative‑production roles – are covered by collective‑bargaining agreements, and that many non‑U.S. employees are represented by works councils, trade unions or other employee associations; the 2024 filing restates this representation explicitly.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: total workforce (220,000 in 2022 → 233,000 in 2024), U.S. (166,000 → 171,000) and international (54,000 → 62,000) headcounts, and seasonal employee percentages (7% → 8%) are correctly reported. The approximate symbols (≈) are acceptable given reporting conventions. (2) The answer addresses all parts of the question: total employees, U.S. vs. international distribution, seasonal workforce trends, and employee association representation. (3) Entity accuracy is perfect: The Walt Disney Company is correctly referenced, fiscal years 2022 and 2024 are properly used, and relevant employee categories (theme park, production, non-U.S. works councils) are accurately identified. (4) Multi-hop reasoning is sound: the LLM synthesizes workforce size, geographic distribution, temporal changes, and labor representation across years, correctly inferring increased international share (from 24.5% to 26.6%, rounded to ~24% and ~27%) and growing reliance on seasonal staff. (5) Semantic equivalence is maintained: while wording differs (e.g., 'collective-bargaining agreements' and 'works councils' vs. 'employee associations'), the meaning is identical. No factual, numerical, or conceptual errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 368,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings the company repeatedly states that its ROIC “excludes goodwill impairments and non‑economic accounting changes as they are not reflective of company performance” (2022 10‑K p. 47; 2023 10‑K p. 50; 2024 10‑K p. 49). The language and exclusion criteria are unchanged, indicating that GD deliberately keeps ROIC focused on the earnings generated by the business’s deployed capital and consistently strips out accounting‑only items that do not affect cash‑flow or operational efficiency. This steady approach underscores a disciplined focus on measuring core operating performance rather than transient, non‑economic effects.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that GD excluded non-economic accounting changes from ROIC in 2022, 2023, and 2024, which matches the original answer's claim of consistent exclusion. The inclusion of specific page numbers (2022 10-K p. 47; 2023 10-K p. 50; 2024 10-K p. 49) adds verifiable detail not in the ground truth but does not contradict it—this enhances accuracy. (2) There are no numerical values requiring calculation (e.g., percentages, dollar amounts), so quantitative accuracy pertains to correct referencing of years and document locations, which are accurate. (3) The multi-hop reasoning is sound: the model synthesized information across three years of 10-K filings to identify consistency in methodology, correctly inferring that unchanged language reflects a stable performance measurement framework. (4) The LLM captures the core implication—that GD focuses on core operational performance by excluding non-cash, non-economic items—mirroring the original answer’s conclusion about emphasizing economic performance over accounting volatility. Wording differs but semantic meaning is equivalent and complete. All aspects of the question (evolution over time and what it reveals) are addressed with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 361,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "In the 2022 filing Linde described rare gases (krypton, neon, xenon) only as “co‑products of the same manufacturing process” that creates its core atmospheric gases (oxygen, nitrogen, argon) 【page_94】. By the 2024 filing the company stresses that rare‑gas output is now driven by its **proprietary non‑cryogenic air‑separation technologies** and that it is actively developing patented processes, storage solutions and new applications to grow that business 【page_4】. This evolution from a by‑product focus to a technology‑led, differentiated rare‑gas platform underscores Linde’s competitive advantage: unique air‑separation know‑how and integrated engineering that lets it capture higher‑value niche markets that competitors cannot easily replicate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Linde’s 2022 characterization of rare gases as co-products from air separation is accurately described, and the 2024 shift to emphasizing proprietary non-cryogenic technologies (e.g., VPSA and membrane separation, though not named) is correctly identified. The evolution from by-product to strategic focus is well-articulated. (2) There are no numeric values (e.g., dollar amounts, percentages, volumes) in either answer, so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) Multi-hop reasoning is sound: the model synthesizes information across 2022 and 2024 filings to infer a strategic shift, correctly identifying the move from passive co-product generation to active technological differentiation. The competitive advantage—rooted in proprietary know-how and engineering—is logically derived and consistent with the original answer. (4) The only minor gap is that the LLM answer does not explicitly mention the 2023 filing, which the ground truth includes as reaffirming rare gases as core atmospheric products. However, this omission does not distort the overall trajectory. Additionally, while the LLM mentions 'patented processes, storage solutions, and new applications' (supported by citation), the original answer emphasizes efficiency gains via non-cryogenic tech. The LLM’s focus on 'higher-value niche markets' slightly reframes but does not contradict the original. Wording differs but semantic equivalence is strong. No factual inaccuracies—just a slightly different emphasis. Hence, correctness is 9/10, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 468,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "- In the 2022 filing, NEER reported that **about 92 % of its net‑generating capacity was already committed under long‑term bilateral contracts** (as of Dec 31 2021)【page_19】.  \n- The 2023 filing showed this share had risen to **roughly 94 % at Dec 31 2023**【page_18】, and the 2024 filing confirmed the level remained **around 94 % at Dec 31 2024**【page_19】.  \n\nThe modest increase and subsequent stabilization at a high‑percentage indicate that NEER is deliberately locking in a larger share of its output through long‑term contracts, using them as a hedge against price swings and other market volatility. This trend reflects a risk‑management strategy that prioritizes revenue certainty in an increasingly volatile energy market.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual information is accurate: the percentages (92% in 2022, 94% in 2023, and 94% in 2024) match the original answer exactly, and the time references (as of Dec 31 of each year) are correctly interpreted. (2) Quantitative accuracy is flawless—no calculations are required beyond correct reporting of percentages, which are all precise and consistent with the source. (3) The multi-hop reasoning across the 2022, 2023, and 2024 filings is sound; the model correctly synthesizes the trend of increasing then stabilizing contract coverage. (4) The qualitative interpretation—linking the trend to risk management and revenue stability in a volatile market—is semantically equivalent to the original answer, including the strategic rationale. The mention of 'hedge against price swings' aligns with the original's reference to non-qualifying hedges and revenue protection. All parts of the question are addressed: evolution over time and implications for risk strategy. Minor wording differences (e.g., 'about', 'roughly', 'around') are acceptable and reflect the original's use of approximations. No errors in entities, years, or metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 342,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "The 3.125 % senior notes that mature in January 2025 were reported at an outstanding principal balance of **$495 million** in each of the three most recent fiscal‑year balance‑sheet tables:\n\n* FY 2022 10‑K – $495 million (the same amount shown in the 2022 filing’s debt schedule)  \n* FY 2023 10‑K – $495 million (page 81 of the 2023 filing)  \n* FY 2024 10‑K – $495 million (page 81 of the 2024 filing)\n\nBecause the balance has remained unchanged over the 2022‑2024 period, Broadcom has neither accelerated repayment nor issued additional notes of this series. This flat trend indicates a deliberate debt‑management approach of **holding the instrument to maturity**, preserving cash and liquidity while keeping the fixed‑rate financing in place until it is due in January 2025.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $495 million is accurately reported for each fiscal year—2022, 2023, and 2024—with specific references to the respective 10-K filings and page numbers, confirming data provenance. The maturity date (January 2025) and coupon rate (3.125%) are also correct. (2) The answer is complete, addressing both parts of the question: the evolution of the debt balance (unchanged) and the implication for AVGO's debt management strategy. (3) Entity accuracy is perfect: AVGO (Broadcom) is correctly identified, the correct debt instrument is referenced, and fiscal years align with the question’s scope. (4) The reasoning is sound and reflects proper multi-hop synthesis across three annual reports. The conclusion—that the stable balance indicates a strategy of holding the debt to maturity, avoiding early retirement or refinancing—is logically derived and semantically equivalent to the ground truth. Minor wording differences (e.g., 'preserving cash and liquidity' vs. 'maintaining a consistent liability profile') do not affect factual equivalence. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 341,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "Across the three filings the “Unsecured Notes ‑ 37B” line is unchanged. In the 2022, 2023 and 2024 10‑K tables the note is listed with a **face amount of $700 million** and a **maturity of January 15, 2032**. The fact that SPG has kept the same amount and long‑dated maturity shows that it is using this low‑coupon (2.25 %) unsecured issuance to lock in stable, long‑term financing rather than repeatedly refinancing or expanding the tranche, reflecting a deliberate strategy of maintaining a predictable, long‑dated debt base.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the face amount and maturity date as consistent across 2022–2024, aligning with the ground truth’s core conclusion of stability in SPG’s debt strategy. However, there is a critical error in the face amount: the ground truth specifies $700,000, while the LLM states $700 million—a significant discrepancy (off by a factor of 1,000). This undermines quantitative accuracy despite correct formatting allowance principles. The maturity date (January 15, 2032) is correctly reported. (2) The coupon rate of 2.25% is mentioned in the LLM answer but not present in the original ground truth, introducing unverified information that, while potentially true, is not supported by the provided knowledge graph and thus reduces fidelity. (3) The reasoning and synthesis across years are sound—correctly identifying no change over time and drawing a logical inference about SPG’s long-term debt strategy focused on stability and avoidance of refinancing. This reflects proper multi-hop reasoning across the three annual filings. (4) Contextual relevance is perfect: the answer addresses all parts of the question—evolution of face amount and maturity, and strategic implications. The qualitative analysis is strong and insightful, though slightly overreaching by adding unsourced details like the coupon rate. The correctness score is 7 because the core factual error in magnitude (thousands vs. millions) prevents a higher rating, but the structural and inferential components are accurate and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 424,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "Across all three years, Texas Instruments lists its Melaka, Malaysia site only under the **Analog** segment. In the 2022, 2023 and 2024 Form 10‑K property tables, Melaka shows an “X” in the Analog column and no mark in the Embedded‑Processing column, indicating the facility has remained dedicated to analog product manufacturing and has not been used for embedded‑processing lines.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site was consistently involved in analog operations across 2022, 2023, and 2024, with no involvement in embedded processing—matching the original answer's key claim of stable, exclusive focus on analog. (2) There are no numerical values requiring calculation, but the use of 'X' in the Analog column and absence in Embedded-Processing aligns with the ground truth's 'checkmark' notation, a format variation that preserves factual accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and two product lines (analog vs. embedded processing) from the 10-K filings, confirming no change over time. (4) All entities—Texas Instruments, Melaka, Malaysia, Analog, Embedded-Processing, and the three-year timeframe—are correctly identified and contextualized. The answer is concise, factually precise, and fully addresses the evolution (or lack thereof) in operational footprint, satisfying completeness and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 318,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "In fiscal 2022 the Content Sales/Licensing segment’s “Other revenue” line only referenced generic licensing and merchandise income and did not break out any post‑production fees, let alone name Industrial Light & Magic. In fiscal 2023 the segment still listed “sales of post‑production services” as a component of Other revenue, but the provider was not identified. By fiscal 2024 the filing reorganized the segment and explicitly reported revenue from post‑production services performed by Industrial Light & Magic (along with Skywalker Sound), indicating that Disney began to highlight—and likely increase—its reliance on ILM’s services within the Content Sales/Licensing business.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) In fiscal 2022, the original answer confirms Industrial Light & Magic (ILM) was explicitly listed in the Content Sales/Licensing segment, but the LLM claims it was not named and that post-production fees were not broken out—this is incorrect. (2) The LLM states that in fiscal 2024, Disney 'began to highlight' ILM, implying a new or increased reliance, whereas the ground truth indicates ILM was already explicitly included in 2022 and its role evolved contextually, not newly emphasized. (3) The claim that the 2024 filing 'reorganized the segment' and 'explicitly reported revenue' from ILM for the first time is false—the original answer shows ILM was already explicitly part of the segment in 2022. (4) The LLM incorrectly infers increasing reliance based on reporting changes that did not occur as described. While the answer addresses the question's timeframe and topic (post-production services and segment structure), the core factual narrative is inverted: the ground truth describes a stable inclusion with shifting emphasis, while the LLM describes a growing visibility that contradicts the source. No numerical data is present, so quantitative accuracy is not severely penalized, but entity and temporal reasoning are flawed. The answer fails the multi-hop synthesis by misrepresenting the evolution across years, leading to an incorrect conclusion about Disney's evolving reliance on ILM.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 410,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "MetLife reported equity‑method income from its operating joint‑venture (insurance‑underwriting) businesses of **$51 million in 2022, $38 million in 2023, and $175 million in 2024**【page_224†L31-L34】【page_247†L31-L34】.  The figure fell modestly in 2023 before jumping dramatically in 2024, indicating that the underwriting joint‑ventures were under‑performing in 2023 but rebounded strongly in 2024, suggesting a marked improvement in the profitability of those insurance‑related partnerships.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numerical data. According to the ground truth, MetLife's equity method investment income was $1,305 million in 2022, $151 million in 2023, and $988 million in 2024. The LLM reports $51 million, $38 million, and $175 million respectively—values that are off by more than 95% in most cases. These discrepancies are severe and fundamentally alter the understanding of the trend. (2) Quantitative accuracy is extremely low: none of the numbers match the ground truth, and the implied trend (modest decline followed by strong rebound) is misleading because the actual 2022 baseline is over 25 times higher than reported. The calculation of change is therefore invalid. (3) While the LLM attempts multi-hop reasoning by identifying a trend (decline then rebound), the reasoning is based on incorrect data, leading to a flawed interpretation. The conclusion that joint ventures 'rebounded strongly' in 2024 downplays the fact that income remained 24% below 2022 levels despite a large recovery from 2023, which the LLM answer fails to capture due to incorrect inputs. (4) Contextual relevance is moderate because the answer addresses the right metric, time frame, and type of joint ventures (insurance underwriting), and attempts to interpret performance implications. However, due to gross numerical inaccuracies, the answer misrepresents the company's financial trajectory and provides a false picture of both magnitude and performance trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 414,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "- 2022: Land Systems was slated to build **449 new LAVs** for the Canadian Army.  \n- 2023: the production target fell to **360 new LAVs** in eight variants.  \n- 2024: the program rebounded to **399 new LAVs** for Canada.\n\nThe swing from a high‑volume 2022 run to a modest dip in 2023 and a subsequent rise in 2024 shows that the LAV family remains a cornerstone of General Dynamics’ defense portfolio, with Canada a key, recurring customer that sustains the platform’s strategic relevance and revenue contribution.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported production volumes. According to the ground truth, production increased from 360 units in 2022 to 399 in 2023 and 449 in 2024. However, the LLM incorrectly states 449 units in 2022, 360 in 2023, and 399 in 2024—reversing the trend and misrepresenting the data. These errors fundamentally undermine the answer’s correctness. (2) Quantitative accuracy is severely compromised: all three yearly figures are either misplaced or incorrect. The correct progression is +39 units (2022–2023) and +50 units (2023–2024), indicating steady growth, whereas the LLM suggests a decline followed by a partial rebound. No calculation errors occur in the LLM’s reasoning, but the input data is wrong. (3) The qualitative reasoning about the LAV platform being strategically important and Canada being a key customer is consistent with the ground truth and shows sound multi-hop synthesis—just not based on correct numbers. The conclusion about strategic relevance is plausible but built on faulty premises. (4) Contextual relevance is high because the answer addresses both parts of the question—production evolution and strategic importance—and uses appropriate context about international demand and platform centrality. However, due to the inversion of the numerical trend, the overall correctness score is low, as the core factual foundation is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 396,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "CVS’s pension plan reported hedge‑fund limited‑partnership holdings of **$225 million in 2022**, **$252 million in 2023**, and **$280 million in 2024** 【page_174†L31-L33】【page_173†L31-L33】【page_166†L31-L33】. The steady rise in these HF‑LP investments indicates that the company is progressively increasing its exposure to hedge‑fund alternatives, a move that reflects a deliberate shift toward a higher‑allocation, alternative‑asset strategy within the pension fund’s overall mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for CVS's hedge fund limited partnership investments. According to the ground truth, the correct amounts are $214 million in 2022, $225 million in 2023, and $252 million in 2024. However, the LLM reports $225 million in 2022, $252 million in 2023, and $280 million in 2024 — shifting the timeline forward by one year and inflating the final value. This misalignment affects all three data points, making the quantitative foundation of the answer incorrect. (2) The calculation of trend (increasing exposure) is directionally correct, but the specific figures are wrong, undermining the accuracy of the analysis. The $280 million figure for 2024 does not match the ground truth of $252 million, introducing a material overstatement. (3) The reasoning about a strategic shift toward alternative investments is semantically aligned with the ground truth and shows correct multi-hop synthesis in intent — interpreting a rising trend as indicative of strategic allocation. However, because the underlying data is misattributed across years, the reasoning is based on flawed premises. (4) Contextually, the answer is relevant and addresses both parts of the question: the evolution over time and the implication for asset allocation strategy. The language used is appropriate and mirrors the conceptual framing of the original answer. Despite this, the severe quantitative errors — especially the misalignment of year-to-value mappings — result in a low correctness score. While the direction of the trend and strategic interpretation are sound, factual precision is critical in financial reporting, and the errors here are significant enough to mislead.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 474,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "- 2022 10‑K – The “Nature of Operations” note lists **Sorriso** together with Colgate, Palmolive, Darlie, elmex, hello, meridol, Tom’s of Maine, etc., as one of the company’s **principal global and regional trademarks** that sit inside the **Oral, Personal and Home Care** segment【page_77】.  \n\n- 2023 10‑K – The same disclosure appears in the 2023 filing, again naming **Sorriso** among the **principal global and regional trademarks** that are part of the company’s worldwide Oral, Personal and Home Care portfolio【page_79】.  \n\n- 2024 10‑K – The 2024 filing repeats this wording, continuing to present **Sorriso** as a **core global trademark** within the **Oral, Personal and Home Care** product segment【page_79】.  \n\n**Thus, from 2022 through 2024 Colgate‑Palmolive consistently positioned Sorriso as a key global (and regional) brand embedded in its Oral, Personal and Home Care portfolio, indicating an ongoing, stable integration of the brand into the company’s worldwide product strategy.**",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately captures the evolution of Sorriso's strategic positioning across 2022, 2023, and 2024, noting its consistent inclusion as a principal trademark within Colgate-Palmolive’s Oral, Personal and Home Care segment. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) and page references are correctly cited, and the qualitative data (brand listings) are factually accurate. (3) The multi-hop reasoning is sound—by synthesizing disclosures across three consecutive 10-K filings, the LLM correctly infers that Sorriso maintained a stable, ongoing role as a core regional/global brand without any strategic downgrade or repositioning. (4) The conclusion—'consistent positioning as a key global (and regional) brand'—aligns perfectly with the ground truth’s emphasis on 'stable role as a regional brand asset within the broader global strategy.' Wording differs slightly but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 312,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "MetLife’s reported investment income from **operating joint ventures** rose sharply over the three‑year period – $51 million in 2022, fell to $38 million in 2023, and then jumped to $175 million in 2024【page_224】.  The rebound to a level more than three times the 2022 amount signals that the company is expanding its equity‑method stakes in operating joint‑venture insurers, positioning these investments as an increasingly important source of earnings and strategic growth.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in every key aspect. The original answer states that MetLife's financial exposure to operating joint ventures decreased from $77M in 2022 to $51M in 2023 to $38M in 2024. The LLM incorrectly reports investment income (not exposure) with values of $51M in 2022, $38M in 2023, and $175M in 2024 — all of which are wrong in both magnitude and direction. (2) Quantitative accuracy is extremely low: the LLM reverses the trend, misstates the base figures, and introduces a fictional spike to $175M in 2024 not present in the ground truth. The correct trend is a consistent decline from $77M to $51M to $38M; the LLM reports a rise, then fall, then sharp rise — which contradicts the data. (3) The reasoning is fundamentally flawed: the LLM interprets increasing income as a sign of strategic expansion, but the ground truth indicates decreasing exposure, suggesting strategic retreat. The model fails to address 'financial exposure' as a balance sheet concept (likely equity method investment carrying value), instead conflating it with income, and draws the opposite conclusion. (4) Contextual relevance is low because the answer discusses investment income rather than financial exposure and misrepresents the trend. The mention of 'operating joint-venture insurers' adds unsupported specificity. The score is 1 due to complete factual inaccuracy and reversed interpretation, despite addressing the general topic of joint ventures and equity method investments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 416,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "From the 2022 filing Chevron already owned a 36.4 % equity interest in Angola LNG Limited and was a non‑operator of the on‑shore liquefaction plant that processes associated gas from a variety of Angolan fields. By the 2024 filing the ownership percentage was unchanged, but Chevron’s upstream portfolio was explicitly tied to the LNG plant – its Block 0 Sanha Lean Gas Connection project and the newly‑developed New Gas Consortium (NGC) offshore gas concession now feed gas directly to Angola LNG, showing a tighter integration of upstream gas production with the LNG‑processing asset.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Chevron's 36.4% stake in Angola LNG Limited is accurately reported for both 2022 and 2024, and there are no calculation errors. (2) The answer correctly identifies the evolution in integration between Chevron's upstream projects and the Angola LNG plant by 2024, specifically naming the New Gas Consortium (NGC) and the Sanha Lean Gas Connection as feedstock sources—consistent with the ground truth mentioning Quiluma and Maboqueiro fields via NGC (where Chevron has a 31% nonoperated interest). While the LLM does not explicitly mention the 31% working interest in NGC or the passive-to-active operational shift terminology used in the original, it captures the essence of increased integration. (3) The reasoning is sound: it infers a strategic tightening of upstream-downstream linkage over time, correctly synthesizing information across years and projects. (4) Minor omission: the 2023 intermediate step noting 'deeper integration' without specifics is not mentioned, and the explicit reference to Soyo plant or 'passive equity investor' role in 2022 is absent. However, these are contextual nuances rather than factual errors. The LLM conveys semantic equivalence on the core evolution—unchanged stake, growing integration—making the answer substantially correct. Thus, a score of 9 is warranted due to high factual accuracy with only slight incompleteness in operational role characterization over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 419,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "- **Fiscal 2022:** The 3.625 % senior notes that mature in October 2024 were carried at **≈ $622 million** of principal.  \n- **Fiscal 2023:** The same series remained on the balance sheet at **$622 million** (no change from the prior year).  \n- **Fiscal 2024:** By the end of the year the line reads “‑” (zero), showing that the company **fully repaid the $622 million** of 3.625 % notes as they came due in October 2024.\n\n**What this tells us:** Broadcom kept the low‑coupon 3.625 % notes on its books through 2022‑23 and then retired the entire issue at maturity, using cash generated from the 2024 senior‑note issuances and proceeds from the VMware merger. The pattern reflects a deliberate debt‑management approach: retain existing, inexpensive debt until its scheduled repayment date, then eliminate it to reduce overall leverage and avoid extending the maturity profile as the due date approached.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the principal amount of $622 million for the 3.625% notes due October 2024 in fiscal years 2022 and 2023, and accurately states that the liability was fully retired by fiscal 2024, matching the ground truth. All numeric values, dates, and percentages are correct. (2) Quantitative accuracy is perfect: $622 million is consistently reported across 2022 and 2023, and the retirement to zero in 2024 aligns with the absence of the notes in disclosures. No calculation errors. (3) The multi-hop reasoning is sound—correctly tracking the debt across three fiscal years and inferring a strategic debt management approach. The LLM adds contextual insight about repayment funded by 2024 note issuances and VMware merger proceeds, which, while not in the original answer, is plausible and consistent with Broadcom’s known financial activity; however, this specific funding source is not confirmed in the ground truth, making it a minor overreach. (4) Despite this slight extrapolation, the core facts and synthesis are accurate, and the answer fully addresses both parts of the question—evolution of exposure and strategic implications—making it semantically equivalent and highly relevant. A score of 9 is justified due to the otherwise flawless execution with only minor unsupported elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 374,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "The table of “Annual Debt Service” for the Unsecured Notes – 35B shows the same amount in each filing:\n\n* **2022 filing** – $28,500 (thousand)  \n* **2023 filing** – $28,500 (thousand)  \n* **2024 filing** – $28,500 (thousand)\n\nBecause the annual debt‑service (interest‑expense) figure for the 35B notes did not change over the three years, SPG’s financing cost for this particular instrument has remained flat, indicating that the company has neither refinanced nor altered the terms of the 35B notes during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All numeric values are accurate: $28,500 (in thousands) for Unsecured Notes - 35B in 2022, 2023, and 2024, matching the original answer exactly. Format variations (e.g., 'thousand' in parentheses) are acceptable and do not affect meaning. (2) The answer is complete, addressing both parts of the question: it describes the evolution of interest expense (unchanged across years) and interprets the trend (flat financing costs indicating no refinancing or term changes). (3) Entities are correctly identified: SPG, Unsecured Notes - 35B, and the correct time periods (2022–2024). (4) The reasoning is sound and reflects proper multi-hop synthesis across three annual filings. The conclusion that the fixed interest expense suggests stable terms (likely a fixed-rate structure) is logically valid and consistent with the ground truth's implication. The LLM uses 'annual debt service' as a proxy for interest expense, which is appropriate in context and semantically aligned with the knowledge graph's data. Overall, the answer is factually precise, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 329,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "- In the 2022 filing Disney first signaled a strategic shift to streaming, announcing an ad‑supported Disney+ tier, new pricing and a cost‑realignment, and reorganizing DMED to “advance our DTC strategies” while warning that rising programming‑rights and sports‑rights costs and an increasingly crowded SVOD market would pressure profitability.  \n\n- The 2023 filing showed the plan put into action: Disney made “strategic investments” in its DTC portfolio (including the ESPN flagship service and further content spend), expecting higher subscription‑fee and advertising revenue to offset declines in linear affiliate fees, but it continued to flag higher content‑production costs, churn risk and intensified competition for talent and rights.  \n\n- By the 2024 filing Disney described its DTC approach as more mature—still investing in the streaming businesses and aggregating its entertainment reporting unit to capture synergies, while emphasizing that growth in subscription and ad revenue should “more than offset” the impact of rising programming costs and competitive pressure, and noting the ongoing cost of Hulu‑related redemptions as part of the broader streaming‑focused strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. (1) All key facts are correct: Disney's strategic shift in 2022 toward streaming with the ad-supported tier, cost realignment, and warnings about rising programming and sports rights costs are accurately reflected. In 2023, the focus on strategic investments in DTC (e.g., ESPN, content spend) and the expectation that subscription and ad revenue will offset linear declines matches the original. By 2024, the maturation of the DTC strategy, continued investment, and emphasis on revenue growth offsetting rising costs are correctly conveyed. The mention of Hulu-related redemptions adds a detail not in the original but is contextually plausible and does not contradict it. (2) Quantitative accuracy is perfect: no specific numbers are misstated. While the original mentions $12.25 billion in unused bank facilities, the LLM omits this but does not introduce any incorrect figures—this omission is minor and does not affect factual correctness. (3) Multi-hop reasoning is sound: the LLM synthesizes information across 2022–2024 filings, correctly tracing the evolution from strategic shift to implementation to maturation, while linking rising costs, competition, and revenue strategy. (4) The answer is contextually fully relevant, directly addressing Disney’s investment strategy and competitive positioning in DTC across the three years in light of programming costs, competition, and streaming shift. The only minor shortcoming is the omission of the $12.25 billion liquidity detail, which slightly reduces completeness but not enough to lower the score below 9. Wording differs but semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1668,
        "completion_tokens": 461,
        "total_tokens": 2130
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "- **2022 (2022 10‑K)** – The filing does not disclose any separate “deposit‑method” balances for reinsurance, implying that MetLife either had no material deposit‑type agreements or that the amounts were immaterial and therefore not reported.\n\n- **2023 (2023 10‑K)** – After the November 2023 risk‑transfer transaction with Global Atlantic, MetLife recorded a large deposit‑type position: deposit‑receivable (asset) of **≈ $5.1 billion** and a corresponding deposit‑liability of **≈ $1.3 billion** on the balance sheet. The transaction created $10.3 billion of reinsurance recoverables/deposit receivables (the $9.5 billion of assets transferred to the reinsurer, offset by a $2.2 billion ceding commission and a $770 million net cost of reinsurance recorded in other liabilities).\n\n- **2024 (2024 10‑K)** – The deposit‑method balances remained in place but fell slightly to **$4.6 billion** of deposit assets and **$1.2 billion** of deposit liabilities, reflecting the continued use of the Global Atlantic coinsurance arrangement and the amortization of the net cost of reinsurance.\n\n**Overall evolution:** MetLife moved from having no material deposit‑method reinsurance balances in 2022 to establishing a sizable deposit‑type position in 2023 as a direct result of the Global Atlantic risk‑transfer transaction, and then maintained a slightly lower but still material level of deposit assets and liabilities in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies, particularly in the 2022 and 2023 figures. The ground truth states that in 2022, MetLife reported deposit assets of $1.8 billion and liabilities of $1.4 billion, but the LLM claims these were not disclosed and implies they were immaterial or nonexistent—this contradicts the ground truth. Additionally, the LLM reports a 2023 deposit receivable (asset) of ≈$5.1 billion, which does not match the ground truth's description of a $10.3 billion increase in reinsurance recoverables and deposit receivables due to the Global Atlantic transaction. While the $4.6 billion in deposit assets and $1.2 billion in liabilities for 2024 are correct, the explanation misrepresents how that figure was derived. 2) Quantitative accuracy is low: the $1.8B assets and $1.4B liabilities for 2022 are omitted; the $5.1B asset figure in 2023 is unsupported by the ground truth, which cites $10.3B in total receivables; only the 2024 numbers ($4.6B assets, $1.2B liabilities) are accurate. The breakdown involving $9.5B transferred assets, $2.2B ceding commission, and $770M net cost appears speculative and is not present in the ground truth. 3) Qualitatively, the reasoning captures the multi-hop evolution—no material balances in 2022 (though incorrectly stated), a major shift in 2023 due to the Global Atlantic transaction, and a slight decline in 2024—but misattributes the scale and nature of the 2023 transaction. The identification of entities (MetLife, Global Atlantic) and time periods is correct, and the overall narrative of strategic shift followed by rebalancing aligns with the ground truth, albeit with flawed numerical support. 4) Contextual relevance is high: the answer directly addresses the evolution of deposit method accounting across the three years and links it to the Global Atlantic transaction as required. Despite incorrect numbers, the structure and intent of the response are appropriate. The core failure is factual precision, especially in financial figures, which limits correctness despite sound conceptual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 560,
        "total_tokens": 2129
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "- In 2022 CVS held roughly **$1.0 billion** of commercial‑mortgage‑backed securities (fair‑value ≈ $1,018 m) 【page 149】.  \n- By the end of 2023 the holding had fallen to about **$0.98 billion** (fair‑value ≈ $975 m) and only **$6 million** remained in the Separate‑Accounts portfolio 【page 160】.  \n- At 31 December 2024 the Separate‑Accounts exposure was down to **$3 million** (the 10‑K does not list a larger corporate‑account balance, implying the total CMBS position is now negligible) 【page 160】.  \n\nThis three‑year downward trajectory shows CVS is rapidly shrinking its exposure to commercial mortgage‑backed securities, suggesting a deliberate strategy to exit or dramatically de‑risk this asset class, likely in response to rising interest rates and the associated market‑value pressure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, CVS held $574 million in CMBS in 2022, not $1.018 billion as stated in the LLM answer. In 2023, the ground truth reports $675 million, but the LLM claims $975 million (or $0.98 billion), which is materially higher. Only the 2024 figure of $3 million matches the ground truth. The LLM cites a 'Separate-Accounts portfolio' with $6 million in 2023 and $3 million in 2024, which aligns partially with the downward trend but misrepresents the total corporate exposure in prior years. (2) Calculations and comparisons are flawed due to incorrect base figures. The LLM suggests a steady decline from $1.018B to $975M to $3M, but the actual trajectory per ground truth is an increase from $574M to $675M before a sharp drop to $3M. This misrepresents the trend significantly. (3) The reasoning is partially sound in interpreting the drop in 2024 as a strategic exit or de-risking, which aligns with the ground truth's conclusion. However, the multi-hop synthesis is compromised because the model fails to capture the increase in 2023, leading to an incorrect overall narrative of continuous decline. The use of separate accounts may reflect a technical distinction in reporting, but the LLM does not reconcile this with total company exposure as required by the question. (4) Despite incorrect numbers, the answer is contextually relevant and attempts to address both the evolution and strategic implication. The qualitative reasoning about de-risking is plausible and matches the ground truth’s interpretation, even if based on wrong data. Thus, while the direction of the conclusion is reasonable, the factual foundation is unsound, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 474,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "Across all three filings the “hello” brand is repeatedly listed among Colgate‑Palmolive’s principal global and regional trademarks, showing that the company has kept the brand in its core trademark portfolio from 2022 through 2024. In each year the brand is positioned within the Oral, Personal and Home Care segment – specifically the Oral‑Care sub‑segment – which accounted for roughly 42 % of worldwide net sales in 2022, slipped to 42 % in 2023 and returned to 43 % in 2024, while the Personal‑Care share fell from 19 % (2022‑23) to 18 % in 2024, indicating a modest shift of strategic emphasis toward oral products where “hello” resides.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 'hello' brand was consistently listed as a principal trademark within Colgate-Palmolive’s portfolio from 2022 to 2024 and positioned in the Oral, Personal and Home Care segment, specifically Oral Care—this aligns with the ground truth. However, the LLM introduces specific net sales percentages (42%, 43%, 18%, 19%) that are not present in the original answer and cannot be verified from the provided ground truth. These figures may be factually accurate in external filings, but since they are absent from the ground truth knowledge graph response, their inclusion constitutes a quantitative overreach. (2) The percentages cited—Oral Care at 42% in 2022 and 2023, rising to 43% in 2024, and Personal Care falling from 19% to 18%—are presented as supporting evidence for a strategic shift toward oral care. However, the original answer does not mention any financial breakdowns or sales shares, so these numbers are extraneous and unverified in this context. This impacts quantitative accuracy despite plausible reasoning. (3) The multi-hop reasoning is sound: the model infers continued strategic emphasis based on consistent trademark disclosure and links the brand to a growing segment using sales data. This shows good synthesis, though it goes beyond the provided evidence. (4) The answer is contextually relevant and captures the core evolution—stable inclusion and positioning of 'hello'—but adds unsupported numerical detail. Thus, correctness is reduced due to unverified quantitative claims, though the qualitative and contextual understanding remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 444,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "MetLife’s 2022 filing only described the deposit‑method accounting rule and did not report any material deposit balances, indicating that the company was not using the method in any significant way at that time. In 2023, after completing a large modified‑coinsurance transaction with Global Atlantic, the company reported $5.1 billion of deposit assets and $1.3 billion of deposit liabilities on its balance sheet, and in 2024 those figures moved to $4.6 billion of assets and $1.2 billion of liabilities. The rise from essentially zero in 2022 to a multi‑billion‑dollar position in 2023, followed by a modest pull‑back in 2024, shows that MetLife adopted the deposit method to transfer a sizable block of risk while keeping the net exposure limited (assets ≈ 3½‑4 billion ≈ assets – liabilities), reflecting a strategic use of reinsurance to manage risk without creating large un‑offsetted liabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data for 2022 and 2023, which undermines the overall correctness. According to the ground truth, in 2022, MetLife reported $1.8 billion in deposit assets and $1.4 billion in liabilities, not 'no material deposit balances' or 'essentially zero' as claimed. The LLM incorrectly states that 2022 had no significant use of the deposit method, which contradicts the ground truth. For 2023, the LLM reports $5.1 billion in deposit assets and $1.3 billion in liabilities, but the ground truth does not provide 2023 figures—only noting a broader accounting framework was disclosed. The $5.1B asset figure appears to be fabricated or misattributed, possibly conflating post-transaction values not explicitly stated. The 2024 figures ($4.6B assets, $1.2B liabilities) are correct and match the ground truth. (2) Calculations: The LLM attempts to compute net exposure (assets minus liabilities) as ~$3.8B in 2023 and ~$3.4B in 2024, which would be reasonable if the inputs were correct, but since the 2023 numbers are inaccurate, the calculation is flawed. (3) Multi-hop reasoning: The LLM correctly identifies the Global Atlantic transaction as a driver and links it to the increase in deposit method usage, which aligns with the ground truth’s mention of the transaction influencing 2024 figures. It also correctly infers strategic risk management and balance sheet management motives, showing sound qualitative reasoning. However, the evolution narrative is distorted by incorrect baseline data for 2022 and 2023. (4) The contextual relevance is high—the answer addresses the evolution over time, discusses strategy and risk exposure, and ties in the Global Atlantic transaction appropriately. Despite strong structure and logical interpretation, the quantitative inaccuracies in key years reduce confidence in the factual foundation, warranting a mid-range score of 6 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 533,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "- **Fair‑value reporting:** In the 2022 filing the special‑use funds were disclosed only as a single “Special use funds” line (carrying amount ≈ $11 bn for NEE + FPL) with a Level‑2 fair‑value estimate that was essentially equal to the carrying amount (e.g., $906 m vs $907 m for NEE in the “Other‑than‑fair‑value” table). By 2023 the notes broke the funds out by level and security type, showing NEE’s own special‑use fund balance of $5.29 bn (Level 1 $2.35 bn, Level 2 $2.74 bn, Level 3 $199 m) and FPL’s $3.54 bn, and the 2024 balance sheet now lists a combined $9.8 bn under “Special use funds,” reflecting a modest rise from the $8.7 bn reported in 2023. The comprehensive‑income statement also shows the fair‑value impact on these assets moving from a $‑84 m unrealized loss in 2022, to a $+17 m gain in 2023, and a $‑3 m loss in 2024.\n\n- **Collateral implications:** The special‑use funds themselves are not used as collateral; the 10‑K discusses collateral only for derivative contracts. Posted collateral fell from about $1.8 bn cash + $2.8 bn letters of credit in 2022 to $0.69 bn cash + $1.6 bn letters of credit in 2023, with similar levels in 2024, indicating that the change in special‑use‑fund exposure did not drive collateral requirements.\n\n- **Balance‑sheet presentation:** Across the three years the funds have been presented as a distinct “Special use funds” line within **Other assets** (non‑current), increasing from roughly $11 bn total in 2022, to $8.7 bn in 2023, and to $9.8 bn in 2024, while the footnotes continue to explain that the amounts consist mainly of nuclear‑decommissioning and storm‑fund assets held at fair value (Level 1‑3).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains several factual inaccuracies in key quantitative figures and misrepresents the evolution of NextEra Energy's (NEE) Special Use Funds. While it correctly identifies the 2024 balance of $9.8 billion and the 2023 balance of $8.7 billion (approximating the ground truth $8,698 million), it incorrectly states a 2022 total of ~$11 billion for NEE + FPL, which contradicts the ground truth trend showing an increase from $8,698M in 2023 to $9,800M in 2024 — implying 2022 must be lower, not higher. The LLM’s claim of $5.29B for NEE’s special-use funds in 2023 is unsupported by the ground truth, which reports only a combined $8,698M (likely including both NEE and FPL). Additionally, the LLM introduces a $906M vs $907M comparison from an 'Other-than-fair-value' table not mentioned in the ground truth, suggesting fabrication or misattribution.\n\n2) The ground truth highlights a specific increase from $8,698M (2023) to $9,800M (2024), a $1,102M rise, which the LLM approximates as a 'modest rise' from $8.7B to $9.8B — this part is acceptable within rounding. However, the LLM’s 2022 figure of ~$11B is inconsistent with this trajectory, implying a decrease before increasing again, which contradicts the stated 'upward trend'. The unrealized gains/losses ($-84M, +17M, -3M) are not present in the ground truth and thus cannot be verified; they appear to be hallucinated.\n\n3) The LLM correctly identifies that Special Use Funds are composed of nuclear decommissioning and storm funds and are held at fair value, aligning with the ground truth’s mention of fair value disclosures using Level 1–3 inputs. It accurately notes enhanced disclosure over time, such as breakdowns by level and security type in 2023, which aligns with the ground truth’s observation about increased transparency. However, it fails to mention the key detail about equity investments without readily determinable fair values growing from $485M (2022) to $538M (2023), a critical multi-hop point in the original answer.\n\n4) The collateral section is partially correct: the ground truth states that NEE enhanced transparency around 'derivative-related collateral requirements', but does not specify whether the funds themselves are used as collateral. The LLM correctly infers no direct link between Special Use Funds and collateral, though its detailed collateral numbers ($1.8B, $2.8B, etc.) are not in the ground truth and appear extraneous. The balance sheet presentation as a non-current 'Other assets' line is consistent, but the LLM confuses entity scope by mixing NEE and FPL figures.\n\nOverall, while the LLM captures the general direction of increased disclosure and a higher 2024 balance, it introduces unsupported numbers, misstates the 2022 baseline, and omits key qualitative developments like the new category of equity investments. This results in a partially correct but significantly flawed response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1694,
        "completion_tokens": 766,
        "total_tokens": 2461
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "In the 2022 filing Broadcom described the Security Insights Platform as a service that “quickly interprets and assesses main‑frame security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis,” and emphasized that “the data is available for use with in‑house tools for security‑information‑and‑event‑management (SIEM).” The 2024 filing repeats essentially the same language – the platform still “helps ensure a trusted environment … by quickly interpreting … identifying risks and developing remediation steps,” and the output “is available for use with in‑house tools for security information and event management.” Thus, from 2022 to 2024 the positioning and described capabilities of the Security Insights Platform remained unchanged; it continues to be presented as a posture‑assessment and risk‑remediation aid whose results are fed into customers’ own SIEM tools, with no new emphasis on deeper integration or automated remediation workflows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AVGO (Broadcom) described the Security Insights Platform consistently from 2022 to 2024, emphasizing risk identification and availability of data for in-house SIEM tools. The key factual elements—mainframe security posture assessment, risk identification, remediation steps, and integration with in-house tools—are all correctly reported. (2) There are no numeric values requiring calculation, but the years (2022, 2024) are correctly cited, and the absence of a 2023 update is implicitly acknowledged by noting consistency between 2022 and 2024, which matches the original answer's observation about 2023. (3) The multi-hop reasoning is sound: the model synthesizes information across two time points (2022 and 2024 filings), compares the language used, and correctly infers that there was no evolution in the described capabilities or integration depth. It accurately concludes that the platform’s positioning remained stable, with no new emphasis on deeper integration or automated remediation—consistent with the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2023 filing (though it is not strictly necessary given that 2024 repeats 2022 language), which slightly reduces completeness. However, the core conclusion about lack of evolution is correct. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 438,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "Nike has owned its Laakdal, Belgium distribution center in every year reviewed. In the 2022 Form 10‑K the facility is listed among the “most significant distribution facilities outside the United States… all of which we own” (2022 p. 29). The 2023 and 2024 filings repeat the same description, again noting Laakdal as a key overseas distribution hub that Nike owns (2023 p. 27; 2024 p. 27). The unchanged ownership and continued identification of Laakdal as a “most significant” European hub indicate that Nike treats the site as a stable, strategic cornerstone of its European logistics network.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that NIKE owned the Laakdal facility in all three fiscal years (2022, 2023, 2024) and consistently described it as one of its most significant international distribution centers—this matches the original answer's claim of no changes in ownership or operational status. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the citations to specific pages in the 10-K filings (2022 p.29, 2023 p.27, 2024 p.27) are consistent with expected sourcing and add precision without introducing error. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three annual reports, identifying both the continuity in ownership and the repeated characterization of Laakdal as a key hub, leading to the valid conclusion about its strategic importance. (4) The answer is semantically equivalent to the ground truth, using slightly different phrasing (e.g., 'strategic cornerstone' vs. 'stable and integral part') but conveying the same factual and interpretive content. All aspects of the question—evolution over time and strategic implications—are addressed thoroughly and accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 348,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "**What changed**\n\n| Year (as‑of) | Interest rate | Face amount ( $ 000) | Maturity |\n|--------------|--------------|----------------------|----------|\n| 2022 10‑K (table on page 50) | 3.38 % | 750,000 | 06/15/27 |\n| 2023 10‑K (same table reproduced on page 50) | 3.38 % | 750,000 | 06/15/27 |\n| 2024 10‑K (table on page 51) | 3.38 % | 750,000 | 06/15/27 |\n\n*All three filings list the Unsecured Notes ‑ 32B with an unchanged 3.38 % coupon, a constant $750 million face amount, and a fixed maturity of June 15, 2027*【page_50】【page_51】.\n\n**What the pattern suggests**\n\nThe three‑year consistency indicates that Simon Property Group is not refinancing, retiring, or expanding this particular tranche. By keeping the note’s terms static, SPG is effectively “locking‑in” a moderate, fixed‑rate source of medium‑term financing and intends to hold the notes to their scheduled 2027 maturity, reflecting a deliberate strategy of debt stability rather than active turnover of this instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rate (3.38%), face amount ($750,000 thousand or $750 million), and maturity date (06/15/27)—are correct across all three years, matching the original answer. The LLM correctly notes the maturity date appears explicitly in 2023 and 2024, though it also attributes it to 2022, which the ground truth states was 'unspecified' in that year. This is a minor discrepancy in presentation but does not affect factual correctness since the actual maturity date is indeed 06/15/27. (2) Quantitative accuracy is perfect: all numbers and dates are correctly reported, with appropriate unit interpretation (750,000 in thousands = $750 million). (3) The multi-hop reasoning is sound—comparing disclosures across three 10-Ks and synthesizing the stability of terms over time. The conclusion about SPG’s debt management strategy (stable, no refinancing, intent to hold to maturity) is logically derived and semantically equivalent to the ground truth. (4) Contextual relevance is excellent; the answer addresses all parts of the question: evolution of terms (interest, face amount, maturity), year-by-year data, and strategic implication. The only reason for not scoring a 10 is the slight overstatement that the maturity date was listed in the 2022 filing, which the ground truth clarifies was not explicitly disclosed that year. However, since the date itself is correct and the overall pattern and strategy assessment remain valid, this is a minor issue.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 423,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "- **2022:** CVS held foreign debt securities with a fair‑value of **$2.55 billion** and recorded **$244 million of unrealized losses** (see CVS 2022 10‑K, Debt securities table – foreign securities row, $2,780 amortized cost, $‑244 M loss, $2,550 M fair value)【page_147】.  \n\n- **2023:** The fair‑value slipped slightly to **$2.51 billion**, while unrealized losses fell to **$122 million** (same table for 2023)【page_147】.  \n\n- **2024:** In the 2024 filing the only foreign‑security amount disclosed is in the Separate‑Accounts portfolio, where the fair‑value of foreign securities dropped dramatically to **$51 million** (down from $202 million in 2023)【page_160】; a specific unrealized‑loss figure is not shown, but the sharp reduction in holdings implies that the loss exposure has been largely eliminated.\n\n**Interpretation:** Over the three‑year span CVS has been shrinking its foreign‑security position – the fair value fell modestly from 2022‑23 and then collapsed in 2024 as the company moved the remaining exposure out of its investment portfolio. The accompanying decline in unrealized losses (from $244 M to $122 M) and the near‑elimination of foreign holdings suggest CVS is actively reducing its exposure to international market‑risk fluctuations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS's foreign securities fair value was $838 million in 2022 and $1,650 million in 2023, but the LLM reports $2.55 billion for both 2022 and 2023—overstating the values by approximately 200% in 2022 and 50% in 2023. Additionally, the LLM claims $244 million in unrealized losses in 2022, while the ground truth reports $24 million—a tenfold overstatement. The only correct number is the 2024 fair value of $51 million. (2) Calculations and comparisons are therefore flawed: the LLM suggests a modest decline from $2.55B to $2.51B then to $51M, implying a gradual reduction, whereas the actual trend is an increase from $838M to $1.65B then a collapse to $51M. This misrepresents the volatility and strategic shift. (3) The multi-hop reasoning is partially sound in that the LLM identifies a reduction in foreign securities by 2024 and infers de-risking, which aligns with the ground truth’s conclusion. However, it fails to capture the critical intermediate increase in exposure in 2023, which is central to understanding the risk trajectory. The LLM incorrectly cites the 2024 foreign securities amount as coming from the 'Separate-Accounts portfolio' and compares it to $202M in 2023, which is not supported by the ground truth and introduces confusion. (4) Despite incorrect numbers, the LLM attempts to answer all parts of the question and draws a plausible interpretation based on the data it cites, hence moderate contextual relevance and qualitative reasoning scores. However, the severe quantitative errors undermine the factual correctness, warranting a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 469,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "MetLife’s disclosures show that each year it only applied an internally‑developed rating when a newly‑bought non‑agency RMBS or CMBS had not yet been assigned a NAIC designation; once the NAIC rating was issued the internal label was dropped 【page 94】, 【page 84】, 【page 82】.  The portfolio numbers illustrate that the share of securities already carrying NAIC designations grew steadily – RMBS with NAIC ratings rose from $25.5 billion in 2022 to $28.4 billion in 2023 and $32.9 billion in 2024, while CMBS moved from $9.8 billion to $9.7 billion to $9.1 billion over the same period 【page 96】, 【page 96】, 【page 86】.  This multi‑year trend indicates that MetLife’s credit‑quality assessment for these assets increasingly relies on the NAIC’s modeling methodology, using internal designations only as a temporary bridge until the NAIC rating becomes available.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct general trend—MetLife uses internally developed designations only temporarily until NAIC designations are available, indicating increasing reliance on NAIC methodology. This aligns with the ground truth's core argument about a gradual shift toward standardized NAIC assessments. However, the quantitative accuracy is significantly flawed. The LLM cites specific portfolio values for RMBS and CMBS with NAIC ratings (e.g., $25.5B in 2022, $28.4B in 2023, $32.9B in 2024 for RMBS; $9.8B to $9.7B to $9.1B for CMBS), but these numbers do not appear in the original answer or the knowledge graph ground truth. The ground truth does not provide NAIC-rated RMBS/CMBS portfolio values by year; instead, it references changes in Level 3 AFS securities ($4.2B increase in 2023, $1.6B in 2024) as a proxy for reliance on internal models. The LLM invents precise figures unsupported by the source, which constitutes a serious factual error. Additionally, the decline in CMBS values is presented without explanation, potentially misleading the interpretation. While the reasoning about temporary internal use is sound and contextually relevant, the fabricated numbers undermine the answer's reliability. The multi-hop synthesis is partially correct—linking internal designations to NAIC adoption timeline—but fails to connect the Level 3 securities growth as evidence, which is central to the original answer. Thus, despite correct qualitative direction and good contextual framing, the answer is penalized heavily for quantitative inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 427,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "- 2022 – Chevron’s 2022 Form 10‑K shows that the company was still investing in the Republic of Congo, spending roughly **$0.7 billion** on offshore development and natural‑gas projects there (together with Nigeria and Angola) and retained sizable non‑operated stakes – **31.5 %** in the offshore Haute Mer permit and **15.75 %** in the Lianzi area.  \n\n- 2023 – The 2023 filing repeats the same level of capital commitment (about **$0.7 billion** for Africa’s offshore and gas work, including the Republic of Congo) and the Congo assets remained on the balance sheet, contributing to a modest rise in Africa’s proved‑reserve balances.  \n\n- 2024 – The 2024 filing still lists Congo production as part of Chevron’s international output (about **20 %** of total net oil‑equivalent production) but notes a **planned divestiture**: in January 2025 Chevron will sell its **31.5 % non‑operated working interest in the Haute Mer permit and its 15.75 % interest in Lianzi**, indicating that the company is exiting its Congo ownership and no new Congo‑specific capital spend is highlighted for 2024.  \n\n**Overall**, Chevron’s Congo footprint stayed financially active in 2022‑2023 with roughly $0.7 billion of annual investment and retained ownership stakes, but by 2024 the company moved toward exiting those assets, planning to sell its remaining interests while still counting Congo production in its 2024 output.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details and timeline. The original answer states that Chevron did not disclose specific investment figures for the Republic of Congo in 2022, but the LLM incorrectly claims $0.7 billion was spent in Congo in 2022, conflating it with the broader African allocation in 2023. The $0.7 billion figure is correctly attributed to 2023 in the original answer and refers to offshore and gas projects across Africa (including Congo, Nigeria, Angola), not solely or specifically Congo. The LLM misattributes this amount to 2022 and implies it was Congo-specific, which is incorrect. Additionally, the LLM states that the 2024 filing notes a 'planned divestiture' occurring in January 2025, but the original answer states the sale occurred by 2024, not planned for 2025. This misrepresents the timing of the exit. The LLM also introduces a new, unsupported figure: that Congo production accounted for '20% of total net oil-equivalent production' in 2024 — this is not in the original answer and appears fabricated. The ownership percentages (31.5% and 15.75%) are correct and consistently reported.\n\n2) Quantitative accuracy is compromised: $0.7 billion is incorrectly assigned to 2022 and to Congo specifically, when it was a 2023 Africa-wide figure. The 20% production contribution is unsupported. The divestiture timing is shifted to 2025 (planned), whereas the original indicates it was completed by 2024. These are significant factual errors.\n\n3) The reasoning shows partial multi-hop synthesis — the model correctly tracks ownership stakes and recognizes a shift toward exit — but fails to accurately separate regional (Africa-wide) capital allocation from country-specific activity. It incorrectly assumes Congo received the full $0.7 billion in both 2022 and 2023, which the original does not support. The conclusion that Chevron was still producing in Congo in 2024 and planning a future sale contradicts the original's assertion of a completed exit by 2024.\n\n4) Contextual relevance is high — the answer addresses capital allocation and asset ownership changes over 2022–2024 and focuses on the correct entities and metrics. However, due to key factual and temporal inaccuracies, especially around investment amounts and divestiture timing, the correctness score is reduced to 6. The answer captures the general trajectory but distorts critical details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 648,
        "total_tokens": 2183
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "From 2022 onward, Texas Instruments has consistently positioned Embedded‑Processing products as one of the two core pillars of its business model and as the centerpiece of the “broad portfolio of analog and embedded‑processing products” advantage that underpins its four sustainable competitive advantages.  In 2023 the segment grew modestly (revenue up 3 % to $3.37 billion), but in 2024 revenue fell 25 % to $2.53 billion and operating profit dropped sharply, yet the company’s MD&A still stresses that Embedded Processing remains a strategic focus and a key element of its competitive‑advantage framework.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative data. The ground truth does not mention any revenue figures, growth percentages, or profit declines for Embedded Processing Products in 2023 or 2024. Specifically, the claimed $3.37 billion revenue in 2023 (up 3%) and $2.53 billion in 2024 (down 25%) with a sharp drop in operating profit are not present in the original answer and cannot be verified from the provided context. These specific numbers and trends are therefore incorrect or hallucinated. (2) There is no support in the original answer for any financial performance data; the ground truth focuses solely on qualitative strategic emphasis across years. Thus, the quantitative accuracy is very low. (3) Qualitatively, the LLM correctly identifies that Embedded Processing is a core strategic pillar and part of the 'broad portfolio' competitive advantage, and that this emphasis persisted despite market conditions. It also correctly situates the product line within TI’s four sustainable competitive advantages framework. The reasoning around continued strategic focus aligning with the evolving narrative from 2022–2024 is partially sound and reflects the multi-hop synthesis across years. However, the introduction of unsupported financial data undermines the reasoning. (4) Contextually, the response addresses the evolution of strategic emphasis and ties it to TI's competitive advantages, which is relevant. While the core theme of enduring strategic importance is consistent with the ground truth, the inclusion of fabricated metrics severely compromises factual correctness. Hence, the overall correctness score is moderate due to correct conceptual framing but major quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 475,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "- 2022 ( July 30 2022 ): the 3.50 % senior note (maturing June 15 2025) carried an effective interest‑rate of **3.20 %**【page_89】.  \n- 2023 ( July 29 2023 ): the same 3.50 % note showed an effective rate of **6.38 %**【page_89】.  \n- 2024 ( July 27 2024 ): the note’s effective rate rose further to **6.66 %**【page_89】.  \n\n**Interpretation:** Cisco’s cost of borrowing on this fixed‑rate senior note more than doubled from 2022 to 2024, moving from a low‑3 % effective cost to roughly 6½ %. The upward trend reflects higher market interest rates (and related hedge adjustments), indicating that the company’s overall borrowing costs have increased markedly over the three‑year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information from the ground truth: the effective interest rates for Cisco's 3.50% Senior Note in fiscal years 2022 (3.20%), 2023 (6.38%), and 2024 (6.66%) are accurate and match the original answer exactly. The maturity date (June 2025) and principal amount ($500 million) are implied through context and consistent with the note described. (2) All numbers, percentages, and fiscal years are correct. The progression of rates is accurately presented with no calculation errors. The LLM includes specific filing dates (e.g., July 30, 2022), which are not in the ground truth but are consistent with typical Cisco fiscal year-ends and do not contradict the data. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years for the same debt instrument, and the interpretation correctly identifies the increasing borrowing cost trend. The LLM attributes the rise to higher market interest rates and hedge adjustments, which is a reasonable and plausible explanation consistent with the ground truth’s suggestion of market rate increases or risk perception shifts. (4) The answer is semantically equivalent to the original, with slightly more detailed presentation (e.g., exact report dates, hedge mention) but no factual deviation. All evaluation dimensions are fully satisfied, warranting top scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 386,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "Across the three filings the company repeatedly warns that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and **may be limited by U.S. banking laws and regulations, including those governing capital and capital planning** (and Delaware‑law provisions and preferred‑stock dividend requirements). The same disclosure appears verbatim in the 2022, 2023 and 2024 10‑Ks, showing that BNY Mellon’s exposure to these banking‑law constraints has not diminished over the period. This steady, multi‑year emphasis signals that regulatory limits on capital distributions remain a fixed ceiling on the firm’s strategic flexibility, forcing it to plan shareholder‑return initiatives within a tightly defined regulatory framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core assertion that BNY Mellon consistently disclosed regulatory constraints on capital returns across 2022–2024, and correctly identifies U.S. banking laws, Delaware law, and preferred stock dividend requirements as limiting factors. The quantitative accuracy is high—no numerical errors, and the years are correctly referenced. However, the claim that the *exact same disclosure appears verbatim* in all three years contradicts the ground truth, which notes an evolution: while the core message remained consistent, the 2024 filing added a stronger emphasis on liquidity management and the consequences of failing to maintain 'well capitalized' and 'well managed' status. The LLM overlooks this nuance, misrepresenting the progression as static when the original answer highlights a qualitative shift toward greater regulatory scrutiny on liquidity and capital planning. This undermines the multi-hop reasoning, as the model fails to detect the incremental changes in language and emphasis across years, which are central to the question about *evolution* and strategic implications. While contextually relevant and well-structured, the answer misses the dynamic aspect of the regulatory exposure, presenting a flattened view of a nuanced, evolving disclosure trend. Thus, while factually sound on shared elements, it lacks the depth of synthesis required for full accuracy on qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 397,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "- **Revenue change:** Repair and other services fell from $1,169 million in 2022 to $1,132 million in 2023 – a drop of $37 million (about 3 %). The line‑item then posted the same $1,132 million in 2024, showing no further change【page_9】.  \n\n- **Reason for flat 2024 result:** The segment is dominated by long‑term maintenance, modernization and lifecycle‑support contracts for Navy submarines and surface ships. Those services are tied to the existing installed base rather than new ship‑building programs, so demand stays steady year‑over‑year.  \n\n- **What the pattern suggests:** The modest decline followed by a flat result indicates that Repair and other services is a relatively stable, cash‑flow‑generating business that the company relies on for predictable earnings, with strategic focus on sustaining the fleet rather than pursuing rapid growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports all numeric values: $1,169M in 2022, $1,132M in 2023 and 2024. The calculated drop of $37M (≈3%) is accurate (1,169 - 1,132 = 37; 37/1,169 ≈ 3.16%, which rounds to about 3%). These match the ground truth exactly in value and format variation is acceptable. (2) The answer addresses all parts of the multi-part question: change from 2022 to 2023, flat performance in 2024, reasons for flatness, and implications of the pattern. (3) Entity accuracy is correct: General Dynamics, 'Repair and other services' segment, and correct fiscal years (2022–2024) are used. (4) The reasoning is sound and aligns with the ground truth in spirit: the LLM correctly identifies the stability of the segment due to long-term contracts tied to existing fleets. While the ground truth emphasizes limited growth or strategic deprioritization (citing lack of rebound despite growth in other areas), the LLM frames the flatness as intentional stability and cash flow predictability—this is a valid interpretive difference, not a factual error. The LLM does not mention resource reallocation or market saturation, but offers a plausible alternative explanation (contract structure and fleet sustainment focus). This slight divergence in reasoning prevents a perfect 10, but the overall qualitative analysis remains strong and logically consistent. (5) Semantic equivalence is maintained: the core facts, trends, and implications are correctly conveyed, with only nuanced differences in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 417,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "UnitedHealth’s equity‑security portfolio – which is dominated by venture‑style investments – grew from about **$3.7 billion at year‑end 2022 to roughly $4.9 billion in both 2023 and 2024** (UNH 10‑K 2023 p. 50; UNH 10‑K 2024 p. 52).  By contrast, its **equity‑method stakes in operating health‑care businesses were $1.5 billion in 2022, slipped slightly to $1.4 billion in 2023, and then jumped to $3.8 billion in 2024** (UNH 10‑K 2023 p. 50; UNH 10‑K 2024 p. 52).  The data show a steady commitment to venture investments while the company markedly increased its strategic focus on owning larger, operating health‑care assets in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the equity-method investment values. According to the ground truth, equity-method investments were $1.4 billion in 2022, remained flat at $1.4 billion in 2023, and then increased to $3.8 billion in 2024. However, the LLM incorrectly states that the value was $1.5 billion in 2022 and 'slipped slightly to $1.4 billion in 2023', which reverses the actual trend and misrepresents the data. The 2024 figure ($3.8 billion) is correct. For the equity securities portfolio, the LLM correctly reports $3.7 billion in 2022 and $4.9 billion in both 2023 and 2024, matching the ground truth. (2) The quantitative inaccuracies are significant because they misstate the starting point and trajectory of equity-method investments, which undermines the accuracy of the strategic interpretation. While the final jump to $3.8 billion is correct, the prior values are reversed. (3) The reasoning and synthesis are otherwise sound: the LLM correctly identifies the distinction between venture-style investments (within equity securities) and equity-method investments in operating businesses, and draws a reasonable conclusion about strategic emphasis shifting toward operating assets in 2024. This shows good multi-hop reasoning across years and investment types. (4) The contextual relevance is perfect—the answer directly addresses the evolution in dollar value and strategic emphasis as asked. Due to the factual error in the equity-method investment amounts, the correctness and quantitative accuracy scores are reduced, but qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 444,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "- In the 2022 Form 10‑K, PMI’s peer‑group list explicitly includes **Colgate‑Palmolive Co.** (see the list on page 21).  \n- The 2023 Form 10‑K repeats the same peer‑group composition, again naming **Colgate‑Palmolive Co.** (see the list on page 26).  \n- The 2024 Form 10‑K likewise retains **Colgate‑Palmolive Co.** in its peer group (see the list on page 26).  \n\nBecause Colgate‑Palmolive has been retained in PMI’s peer group for three consecutive years, PMI’s benchmarking framework is deliberately stable—its criteria (global presence, consumer‑product focus, comparable revenues and market‑cap) produce a consistent set of comparators, underscoring a long‑term strategic focus on measuring performance against the same peer universe.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately confirms that Colgate-Palmolive Co. was included in PMI's peer group in 2022, 2023, and 2024, citing the correct pages from each Form 10-K (page 21 in 2022, page 26 in 2023 and 2024), which matches the multi-year consistency stated in the original answer. (2) There are no numerical values requiring calculation, but the years and document references are factually correct and consistent with the source filings. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three annual reports to infer stability in PMI’s peer-group framework and accurately identifies the rationale—global presence, consumer-product focus, comparable revenues, and market capitalization—as the basis for inclusion. (4) The conclusion about PMI maintaining a consistent strategic benchmarking framework is logically derived and semantically equivalent to the original answer. The response is complete, factually accurate, and contextually appropriate, addressing both the evolution (or lack thereof) and the strategic implication of the peer classification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 327,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "From the 2022 filing PayPal first warned that “failure to deal effectively with fraud, abusive behaviors… could increase our loss rate” and that its credit‑product portfolio and reliance on unaffiliated chartered banks and other third‑party processors “expose us to additional risks” (2022 pp. 24‑28). By 2023 the company repeated that language and added that “measures to detect and reduce the risk of fraud and abusive behavior… may not be effective, particularly … in connection with new or expanded product offerings” – explicitly tying the growth of its consumer‑credit, merchant‑financing and BNPL products to a higher abuse exposure (2023 pp. 23‑27). The 2024 filing again stresses the same third‑party‑risk and credit‑product vulnerabilities and notes that “third parties will continue to attempt to abuse… our payments services” and that detection measures remain “complex” and may fall short (2024 pp. 21‑25). Taken together, PayPal’s exposure to abusive behavior has been portrayed as widening each year as credit products expand and third‑party dependencies grow, suggesting that its fraud‑mitigation controls have not kept pace with the increasing scope of risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: PayPal's increasing exposure to abusive behaviors from 2022 to 2024, the link to expanding credit products (including BNPL), and ongoing third-party risk dependencies are consistently highlighted. The LLM correctly notes that fraud mitigation measures may not keep pace with evolving risks. (2) Quantitative accuracy is perfect: while no specific numerical values (e.g., €40 billion) are mentioned in the LLM answer, it does not misstate or fabricate any numbers. The omission of the €40 billion BNPL agreement is a minor gap but does not detract from the overall correctness, as the core trend—expansion of credit products increasing abuse risk—is accurately conveyed. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the continuity and evolution of risk disclosures, and links credit expansion and third-party reliance to growing abuse exposure. (4) Semantic equivalence is strong: though the LLM uses direct quotes and page references not in the original answer, the meaning and analytical conclusion—that PayPal’s fraud mitigation has not kept pace with rising risk—are consistent with the ground truth. The answer is fully contextually relevant, addressing all parts of the question. A score of 9 is given because the €40 billion BNPL detail, while not essential, adds specificity that strengthens the original answer; its absence is a minor completeness shortfall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1618,
        "completion_tokens": 425,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "Southern Company’s natural‑gas option hedge volume rose sharply from 214 million mmBtu in 2022 to 339 million mmBtu in 2023, then fell to 176 million mmBtu in 2024 (Southern Company Gas: 102 mmBtu in both 2022‑23, dropping to 83 mmBtu in 2024)【page_117†L31-L38】【page_114†L31-L38】. The three‑year pattern—ramping up options when price volatility spiked in 2023 and scaling them back in 2024—shows a risk‑management strategy that actively adjusts the size of option positions to current market conditions rather than maintaining a static hedge level.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the upward trend from 2022 to 2023 and the sharp decline in 2024, and accurately reports the 339 million mmBtu in 2023 and 176 million mmBtu in 2024, matching the ground truth. However, it incorrectly states the 2022 volume as 214 million mmBtu instead of the correct 253 million mmBtu, which is a significant numerical error. Additionally, the inclusion of 'Southern Company Gas: 102 mmBtu in both 2022-23, dropping to 83 mmBtu in 2024' introduces entity-level confusion—this appears to be a subsidiary-level breakdown not present in the original answer and may conflate data, as the ground truth does not mention these subsidiary figures or values in mmBtu at this scale. (2) The calculation of trends is directionally correct (increase then decrease), but the starting point is factually wrong. The 214 vs 253 mmBtu discrepancy affects the accuracy of the baseline trend interpretation. (3) The multi-hop reasoning is sound—the model correctly infers that increasing options in 2023 reflects a response to volatility and decreasing them in 2024 suggests strategic adjustment. This aligns with the original answer’s interpretation of dynamic risk management. (4) Despite the numerical inaccuracy in the 2022 figure and the introduction of unverified subsidiary data, the overall reasoning, structure, and response to the question’s intent are strong. The answer captures the evolving strategy and links it appropriately to market conditions, earning high marks for qualitative accuracy and relevance, but loses points for factual precision in key numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 440,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "Texas Instruments’ aggregate expense for its U.S. defined‑contribution plans rose from **$70 million in 2022**, to **$75 million in 2023**, and to **$76 million in 2024**【page 43】. Because the company’s non‑qualified defined‑benefit pension plan is unfunded and closed to new participants, the steady increase in defined‑contribution spending signals a strategic shift toward expanding and funding a matching‑contribution retirement model while de‑emphasizing the legacy non‑qualified defined‑benefit obligation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$70 million in 2022, $75 million in 2023, and $76 million in 2024—matching the ground truth exactly. These numbers are presented clearly and accurately, satisfying the quantitative component of the question. (2) The calculation of trend (steady increase) is logically sound and correctly inferred from the data. There are no mathematical or date-related errors. (3) The reasoning correctly identifies the closure of the non-qualified defined benefit plan to new participants (implied in the ground truth and confirmed in context) and interprets the rising defined contribution expenses as a strategic shift toward supporting alternative retirement benefits. While the LLM uses the phrase 'strategic shift' and 'de-emphasizing the legacy... obligation,' which is slightly stronger than the original answer’s more neutral tone about 'flexible retirement options,' it remains semantically aligned and logically supported. The original answer emphasizes continuity since 1997, while the LLM frames it as a shift—this is a minor difference in emphasis, not a factual error. (4) All entities—Texas Instruments, U.S. defined contribution plans, non-qualified defined benefit pension plan—are correctly identified and related in proper temporal and functional context. The citation to page 43 adds document-level support. Overall, the answer is factually complete, contextually appropriate, and only slightly less nuanced in describing long-term strategy, warranting a high but not perfect qualitative score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 431,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "- In the 2023 filing the company said its weighted‑average **long‑term expected return on U.S. pension‑plan assets was 5.38 % for 2022** and **6.30 % for 2023**【page_86】.  \n- In the 2024 filing the same assumption **rose again to roughly 6.3 %‑6.5 % for 2024** (the table shows 6.27 % and the narrative notes an increase from 6.3 % at 12/31/2023 to 6.5 % at 12/31/2024)【page_87】【page_88】.  \n\n**Trend interpretation:** Over the three‑year period GM has steadily lifted its long‑term return assumption—from about 5.4 % in 2022 to more than 6.3 % by 2024—signaling a growing optimism about future asset performance and a willingness to accept a higher‑risk, higher‑return investment mix for its pension plans.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor discrepancy in the 2022 rate. The ground truth states GM's 2022 weighted-average long-term ROA was 5.4%, while the LLM reports 5.38% based on the 2023 filing. This is a negligible rounding difference and semantically equivalent, so it does not constitute a major error. However, the ground truth indicates the 2023 rate was unchanged at 6.3% (from a prior year), but the LLM implies an increase from 5.38% in 2022 to 6.30% in 2023, which aligns with the data but slightly misrepresents the 'unchanged' nature noted in the original answer. The 2024 figure is accurately reported as increasing to 6.5%, with the LLM correctly noting the narrative update from 6.3% to 6.5% despite a table showing 6.27%, indicating careful interpretation of conflicting data. (2) All calculations and comparisons are logically sound: the trend from ~5.4% to ~6.5% is correctly identified. The use of 'roughly 6.3%–6.5%' and reference to both table and narrative sources shows attention to detail. (3) Multi-hop reasoning is solid: the LLM synthesizes data across two filings (2023 and 2024), extracts time-series assumptions, and interprets the trend correctly. The conclusion about growing optimism and higher risk tolerance matches the original answer’s interpretation. (4) Scores reflect high accuracy with minor caveats: quantitative accuracy docked slightly for the 5.38% vs. 5.4% presentation and the omission of the 'stable' characterization in 2023; qualitative accuracy is strong due to correct synthesis and interpretation; contextual relevance is perfect as all parts of the question are addressed with appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 459,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "- In FY 2022 Cisco recorded a **$92 million loss** on the “total‑return swaps‑deferred compensation” line (‑92) 【page 92】.  \n- In FY 2023 the same line showed a **$58 million gain** 【page 91, FY 2023 column】, and in FY 2024 it rose to a **$91 million gain** 【page 91, FY 2024 column】.  \n\nThe swing from a loss in 2022 to progressively larger gains in 2023‑24 suggests that Cisco’s use of total‑return swaps to economically hedge the equity‑price risk embedded in its deferred‑compensation plans has become more effective, reflecting tighter risk‑management of compensation‑related volatility and a strategy that better aligns employee incentives with market performance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all financial figures and fiscal years as per the ground truth: a $92 million loss in FY2022, a $58 million gain in FY2023, and a $91 million gain in FY2024. These values match exactly with the original answer, with acceptable formatting variations (e.g., ‑92 vs. $92 million loss). (2) All numeric values are accurate and correctly attributed to the respective fiscal years. No calculations were required beyond correct reporting, which was done precisely. (3) The multi-hop reasoning is sound—information is synthesized across three fiscal years from what appears to be footnote or financial statement data (citing specific pages), and the trend is correctly interpreted as a shift from loss to increasing gains. (4) The qualitative interpretation aligns with the original: the progression indicates improved effectiveness in hedging equity-price risk in deferred compensation, reflecting better risk management and alignment with market performance. The LLM adds slightly more detail on the strategic rationale (e.g., aligning employee incentives), which is a reasonable inference and enhances, rather than distorts, the original meaning. All aspects of the question—evolution over time, gains/losses, and implications for risk/compensation strategy—are fully addressed with factual and semantic fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 379,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "Across all three years PayPal consistently described itself as the **principal** in each payment transaction. It states that it **controls the fee‑setting** for every transaction, that the fee‑level is independent of the costs it incurs when it routes payments through third‑party processors, and that the fees paid to those processors are recorded separately as **transaction expense**. Because of this structure, PayPal “**bears full margin risk**” on every payment. The 2022, 2023 and 2024 10‑K disclosures repeat the same language, indicating that its exposure to margin risk has not materially changed – it remains fully exposed to margin risk each year, with pricing under its control and processor costs recognized as expense.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) All key facts are correct: PayPal consistently acted as principal in transactions across 2022–2024, maintained control over pricing independent of costs, recognized fees paid to third-party processors as transaction expense, and bore full margin risk. There are no numerical inaccuracies—while no specific dollar amounts are involved, the qualitative financial structure is correctly described. (2) The answer correctly synthesizes information across all three years and confirms consistency in risk exposure and accounting treatment, with no material changes. (3) Multi-hop reasoning is sound: the model correctly links PayPal’s role as principal to its control over pricing and recognition of third-party fees as expenses, leading to the conclusion of sustained margin risk—this reflects proper synthesis across filings. (4) The LLM captures all elements of the original answer, including the lack of structural change despite new segment reporting in 2024 and the clarification on tiered pricing (implied in the consistent language). Wording differs slightly but meaning is preserved. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 346,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "Chevron’s Angola LNG gas output fell marginally from 49 million cubic feet per day (MMCFD) in 2022 to 48 MMCFD in 2023 and held steady at 48 MMCFD in 2024【page_9†L67-L71】【page_9†L84-L88】. The near‑flat trend signals that Chevron is maintaining a stable supply of LNG‑linked gas from Angola, positioning the company as a consistent, though not rapidly expanding, participant in the global liquefied‑natural‑gas market.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The ground truth states Chevron's natural gas consumption volumes were 592 million cubic feet per day (MMCFD) in 2022, 596 in 2023, and 609 in 2024. The LLM incorrectly reports these as 49, 48, and 48 MMCFD—off by an order of magnitude. This massive discrepancy invalidates the entire quantitative foundation of the response. (2) The calculations and trends are therefore also wrong: the LLM claims a marginal decline and flat trend, while the truth is a consistent increase of 17 MMCFD over three years. The correct trend indicates growth, not stability. (3) The multi-hop reasoning fails because the model misidentifies the metric—'gas output' vs. 'natural gas consumed in operations'—and applies it to the wrong entity or facility context. The cited pages (9, L67-L71, L84-L88) may refer to a different metric or project, but the model fails to correctly link Chevron’s Angola LNG-related volumes. (4) While the LLM attempts to address both parts of the question—volume evolution and strategic implication—the reasoning is based on false data, leading to an incorrect conclusion about Chevron’s strategic positioning. The suggestion of 'stable, not rapidly expanding' participation contradicts the actual growth trajectory, which aligns with Chevron’s broader LNG expansion strategy. The answer is contextually relevant in structure but severely flawed in substance. Quantitative accuracy is near-zero due to gross numerical errors; qualitative accuracy is low due to incorrect synthesis; contextual relevance is moderate as the response attempts the right question components.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 454,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "In the 2022 filing Southern Power only described its outdoor‑lighting contracts as operating leases with up‑to‑seven‑year initial terms that automatically renew month‑to‑month, noting that “scheduled payments … are presented in the following maturity analysis” but providing no dollar‑level schedule. The 2023 10‑K added that maturity analysis, showing concrete cash‑flow commitments (e.g., $36 million due in 2024 and roughly $1 billion of obligations “thereafter” for Southern Power) and grouping the lighting payments with tolling and PPA obligations. By the 2024 filing the same quantitative schedule is retained, but the note now emphasizes a much longer weighted‑average remaining lease term (33.1 years versus 32.3 years a year earlier) and larger present‑value lease obligations, indicating that scheduled payments under outdoor‑lighting contracts have moved from a peripheral disclosure to a clearly material, long‑term structural element of Southern Power’s lease portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolving treatment of outdoor lighting contracts in Southern Power's disclosures from 2022 to 2024 and accurately infers their growing materiality and structural importance, aligning well with the ground truth. In 2022, it correctly notes that scheduled payments were mentioned but without quantitative disclosure, consistent with the 'immaterial' characterization. In 2023, it accurately observes the inclusion of dollar amounts (e.g., $36 million due in 2024 and ~$1 billion 'thereafter') and grouping with tolling and PPAs, signaling increased prominence. In 2024, it correctly identifies the continued use of quantitative schedules and highlights the extended weighted-average lease term (33.1 years vs. 32.3 years) and larger present-value obligations as evidence of structural integration. However, the ground truth does not mention specific dollar figures like $36 million or $1 billion, nor does it reference a change in weighted-average lease term or present-value obligations—these details, while plausible, are not supported by the original answer and introduce unverified quantitative claims. This affects quantitative accuracy despite logical reasoning. The entity (Southern Power), years (2022–2024), and financial concepts (operating leases, maturity analysis, PPAs) are correctly identified. The multi-hop synthesis across years is strong, and the conclusion about increasing materiality is logically sound and contextually appropriate. The answer is highly relevant and semantically aligned with the core progression described in the ground truth, but the addition of unsupported specific numbers reduces quantitative precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 457,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "Across all three years the Melaka, Malaysia site was shown only under the Analog column. In the 2022 filing (page 18) it is marked “X” for Analog and blank for Embedded Processing; the same pattern appears in the 2023 filing (page 16) and again in the 2024 filing (page 16). Thus, Texas Instruments’ Melaka footprint remained unchanged – it supported the Analog segment but was not used for Embedded Processing during 2022‑2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site was involved exclusively in the Analog segment across 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in substance. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) and segment names (Analog, Embedded Processing) are correctly referenced, and the LLM supports its claims with specific filing page numbers (2022 p.18, 2023 p.16, 2024 p.16), which aligns with expected evidence. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual filings to conclude that there was no change in operational footprint over time, demonstrating consistent use for Analog only. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in TXN's Melaka operations across the specified segments and years. Minor wording differences (e.g., 'unchanged' vs 'remained consistent') do not affect factual accuracy. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 327,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "- In the 2022 filing the 1.600 % senior notes were issued for **$700 million** with interest payable **semi‑annually on April 15 and October 15** and a **par‑call date of March 15 2026**.  \n- The 2023 and 2024 tables still list the same $700 million issue size, but show small **principal reductions** (‑$3.7 million in 2023 and an additional ‑$1.5 million in 2024), while the **interest‑payment schedule and the March 15 2026 par‑call date remain unchanged**.  \n\nThis steady, modest amortization of the 1.600 % notes while keeping their low‑cost, long‑dated terms shows AMT’s strategy of preserving cheap, fixed‑rate financing and gradually trimming exposure as cash allows, rather than refinancing or accelerating repayment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the reported principal reductions. The ground truth states that 'adjustments to principal amount' were (2.6) in 2023 and (1.5) in 2024 — these are not dollar amounts but likely refer to adjustments in millions or another unit, and critically, the value in 2023 is (2.6), not (3.7) as claimed by the LLM. The LLM incorrectly reports a -$3.7 million reduction in 2023, which contradicts the ground truth of (2.6), and while it correctly notes a -$1.5 million adjustment in 2024, it misrepresents the 2023 figure. The aggregate principal amount is correctly stated as $700 million across all years. Interest payment dates (April 15 and October 15) and par-call date (March 15, 2026) are accurately reported. (2) The calculation of principal changes is incorrect due to the wrong 2023 value; the LLM introduces a number not present in the ground truth. The format variation ($700 million vs $700.0 million) is acceptable, but the erroneous -$3.7M vs (2.6) is a material discrepancy. (3) The multi-hop reasoning is partially sound — the model correctly identifies consistency in interest schedule and par-call date over time and attempts to infer a debt management strategy. However, because the principal adjustment data is wrong, the conclusion about 'steady, modest amortization' is based on incorrect inputs. The ground truth suggests only minor accounting adjustments, not actual amortization. (4) The contextual relevance is high — the answer addresses all components of the question (principal, interest, call date, strategy). Qualitative reasoning is logical but built on faulty data. Quantitative accuracy is low due to the incorrect 2023 principal adjustment. Correctness score is reduced to 6 due to this significant error, though not catastrophic because core elements (total principal, dates) are correct and the strategic interpretation is plausible, if misinformed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 525,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "- In FY 2022 Cisco’s senior‑note portfolio was $9 billion of long‑term debt (‑$8.9 billion net of discounts), of which the 5.90 % February 15 2039 note represented $2 billion (≈ 22 % of total) and carried an effective cost of 6.11 %.  \n- In FY 2023 the same 5.90 % issue remained at $2 billion, but total senior‑note debt had fallen to $8.5 billion (‑$8.39 billion net), reducing the 5.90 % note’s share to roughly 24 % while its effective rate stayed at 6.11 %.  \n- By FY 2024 Cisco’s debt base had expanded to $20.1 billion (‑$20.0 billion net) after a $13.5 billion issuance of new notes at lower coupons (4.8‑5.5 %). The 5.90 % note still accounted for $2 billion (≈ 10 % of total) and kept the same 6.11 % effective rate, but its relative weight and impact on the overall cost of capital fell sharply.\n\n**Interpretation:** Cisco has kept the 5.90 % senior note on its balance sheet for continuity of long‑term funding, but it has progressively diluted its influence by issuing larger volumes of newer, lower‑coupon notes and using interest‑rate swaps. This reflects a deliberate strategy to broaden the maturity profile, lock in cheaper fixed‑rate financing, and manage overall debt cost while retaining a stable, diversified long‑term capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 5.90% Note remained at $2,000 million and the effective interest rate stayed at 6.11% across all three years, which matches the ground truth. However, it provides incorrect total debt figures: it states $9 billion in FY2022, $8.5 billion in FY2023, and $20.1 billion in FY2024, whereas the ground truth reports total long-term debt increasing from $8,416 million in 2022 to $19,621 million in 2024. The LLM overstates FY2022 and FY2024 totals and incorrectly shows a decline in FY2023 when the actual trend is consistently upward. Additionally, the LLM introduces details not in the original, such as 'senior-note portfolio,' 'net of discounts,' and a $13.5 billion issuance of new notes with specific coupons (4.8–5.5%), which are unsupported by the ground truth. (2) Calculations: The percentages cited (22%, 24%, 10%) are based on incorrect total debt figures and thus inaccurate. For example, $2B / $8,416M ≈ 23.8%, not 22%, and $2B / $19,621M ≈ 10.2%, which aligns roughly with the 10% cited in FY2024, but the underlying total is still wrong. The claim about interest-rate swaps is not present in the original and lacks support. (3) Multi-hop reasoning: The LLM correctly infers that maintaining a fixed-rate note while issuing more debt suggests a strategy to lower overall financing costs, which aligns with the ground truth’s conclusion about stabilizing costs amid rising debt. However, it adds unsupported mechanisms (e.g., swaps, specific new coupon rates) and misrepresents the debt trajectory, weakening the synthesis. (4) Justification: The correctness score is 6 due to partial factual accuracy—core elements (note amount, rate stability) are correct, but key quantitative details (total debt levels, composition changes) are inaccurate. Quantitative accuracy is penalized heavily (5) due to incorrect totals and derived percentages. Qualitative accuracy is moderate (7) because reasoning is logical and directionally sound. Contextual relevance is high (9) as the response directly addresses the question’s focus on debt composition and strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 569,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "- 2022 10‑K: Land Systems was slated to build **449 new LAVs** for the Canadian Army【page_10】.  \n- 2023 10‑K: The company’s forecast fell to **360 new LAVs** for Canada【page_11】.  \n- 2024 10‑K: Production was again raised to **399 new LAVs** for the Canadian Army【page_11】.  \n\nThe numbers show a dip after 2022 followed by a rebound in 2024, indicating that General Dynamics continues to prioritize LAV manufacturing for Canada and can adjust capacity to meet the customer’s evolving demand, underscoring a sustained strategic focus on this product line.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported production volumes and their temporal sequence. According to the ground truth, production increased from 360 units in 2022 to 399 in 2023 and 449 in 2024. However, the LLM incorrectly states that 449 units were planned in 2022, then drops to 360 in 2023, and rises to 399 in 2024—reversing the actual trend. This misrepresentation fundamentally undermines the answer’s correctness. (2) The numbers cited—449, 360, 399—are all present in the correct answer but are assigned to the wrong years. For example, 449 is the 2024 figure, not 2022; 360 is the 2022 baseline, not a 2023 reduction. The calculation of progression (increase over time) is therefore invalid. (3) The multi-hop reasoning fails because the model misaligns data points across years, leading to an incorrect interpretation of a 'dip and rebound' rather than a consistent upward trajectory. The conclusion about 'adjusting capacity' may be plausible but is based on false premises. (4) While the LLM attempts to address both parts of the question (production evolution and strategic focus), the incorrect data sequence leads to flawed reasoning. The mention of sustained focus is partially aligned with the ground truth, but lacks support from accurate trends. The additional program (LRSS with 66 specialized LAVs) is entirely omitted, reducing completeness. Quantitative accuracy is severely compromised due to year-number mismatches, warranting a low score. Qualitative reasoning is similarly flawed due to incorrect synthesis. Contextual relevance is moderate as the answer discusses the right topic and company with some correct details, albeit misordered.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 467,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "UnitedHealth’s 10‑K filings show that from 2022 through 2024 the company repeatedly warned that CMS was altering the Medicare Advantage risk‑adjustment methodology (and, at times, freezing or cutting benchmark payments), creating the risk of retroactive payment adjustments and lower capitation rates【page_20】【page_25】.  In each year the firm said it was countering those funding pressures by “adjusting members’ benefits and premiums on a selective basis, ceasing to offer plans in certain counties, and intensifying both medical‑cost and operating‑cost management”【page_20】【page_25】, and by monitoring and responding to CMS risk‑adjustment data‑validation audits that could further affect payments【page_26】.  Thus, UnitedHealth’s exposure to risk‑adjustment changes remained a constant concern, and its strategy over the three‑year span was to trim or redesign plan offerings where needed and tighten cost‑control programs to offset the ongoing payment‑rate uncertainty.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: UnitedHealth Group's exposure to CMS changes in Medicare Advantage risk adjustment methodologies from 2022 to 2024 is accurately described, including the nature of CMS actions (methodology changes, benchmark freezes/cuts) and UnitedHealth’s strategic responses (selective benefit and premium adjustments, county exits, cost management). The mention of data-validation audits in 2024 aligns with the ground truth’s emphasis on health status data submissions. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) Multi-hop reasoning is sound: the LLM synthesizes consistent exposure across three years and maps evolving but stable strategic responses, correctly identifying continuity in both risk and response. The only minor gap is that the LLM does not explicitly mention 'recalibrating bids' in 2023, which appears in the original answer, though 'adjusting premiums' and 'plan redesign' may implicitly cover this. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: evolution of exposure and strategic adjustments. Wording differs slightly but meaning is preserved. Overall, this is a strong, factually correct response with only a slight omission in specificity around bid recalibration, not affecting core accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 409,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "PayPal’s outstanding principal on the September 2019 fixed‑rate 2.850 % notes stayed at **$1.5 billion** each year:\n\n* In the 2023 Form 10‑K the table lists $1,500 million for the 2.850 % notes in both 2023 and 2022【page_107】.  \n* The 2024 Form 10‑K shows the same $1,500 million amount for 2024 (and again for 2023)【page_104】.\n\nBecause the balance of this tranche has not changed from 2022 through 2024, PayPal is maintaining a steady level of long‑term, low‑cost fixed‑rate debt rather than expanding or retiring it, reflecting a strategy of preserving a stable, predictable maturity profile while keeping the benefit of the relatively low 2.96 % effective rate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $1.5 billion (or $1,500 million) carrying value of the 2.850% notes is accurately reported for 2022, 2023, and 2024, matching the original answer. The references to the 10-K pages (107 and 104) support the data provenance. (2) The answer correctly identifies that the principal remained unchanged across the three years, demonstrating proper synthesis across filings. (3) The reasoning is sound: the stability in the debt balance is correctly interpreted as a strategic choice to maintain a predictable maturity profile and benefit from low fixed-rate financing. The mention of the '2.96% effective rate' is an additional detail not in the ground truth but is factually plausible and does not contradict it. (4) The only minor shortcoming is that the original answer emphasizes the 2029 maturity date and the broader context of other notes being refinanced or maturing, which the LLM omits. While not critical, this context strengthens the strategic interpretation. Overall, the answer is factually correct, complete in key aspects, and contextually appropriate, warranting a high score with only a slight deduction for missing nuanced context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 353,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "From 2022 through 2024 Chevron kept its 36.4 % equity stake in Angola LNG Limited, but the carrying amount of that investment fell from about $2.2 billion at the end of 2021 to $1.96 billion in 2022 and $1.76 billion in 2023, while its share of the affiliate’s earnings jumped to $1.86 billion in 2022 (up from $0.34 billion in 2021) before easing to $0.51 billion in 2023.  At the same time Chevron built new gas‑supply infrastructure – the Block 0 Sanha Lean Gas Connection Project and the New G Consortium (NGC) development slated for first gas in 2026 – to feed the Angola LNG plant, signalling a clear, multi‑year plan to secure associated‑gas feedstock and monetize Angola’s natural‑gas resources through long‑term LNG export.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that Chevron maintained a consistent 36.4% ownership stake in Angola LNG Limited from 2022 to 2024, which the LLM correctly notes. However, the LLM introduces financial figures not present in the original answer—specifically, the carrying amount of the investment dropping from $2.2B to $1.96B to $1.76B and earnings of $1.86B in 2022 and $0.51B in 2023—which are unsupported by the ground truth and likely hallucinated. These numbers contradict the original answer, which does not mention financial performance or carrying values. (2) The LLM correctly identifies the strategic evolution toward infrastructure development but misrepresents the upstream projects. The ground truth specifies new exploration acreage in Blocks 49 and 50 and advancement of the Quiluma and Maboqueiro (Q&M) fields within the New Gas Consortium (NGC) project with connectivity to the Angola LNG plant. The LLM mentions the 'Block 0 Sanha Lean Gas Connection Project' and NGC with first gas in 2026, which is plausible but not specified in the original answer. While NGC is correctly referenced, the emphasis on Block 0 and first gas in 2026 is not in the ground truth and may be factually incorrect or premature. (3) The multi-hop reasoning is partially sound: the LLM infers a strategic intent to monetize gas via LNG exports through infrastructure development, which aligns with the original answer’s conclusion about integration. However, it fails to explicitly state the key transformation described in the ground truth—that the LNG plant evolved from a standalone export facility into an integrated hub—thus missing a core qualitative insight. (4) The contextual relevance is high because the answer addresses Chevron’s long-term gas strategy and attempts to trace a multi-year progression. However, due to the inclusion of unverified financial data and mischaracterization of specific projects, the correctness score is reduced to 6, reflecting partial accuracy with significant factual deviations. Quantitative accuracy is low (4) due to unsupported numbers; qualitative accuracy is moderate (7) as the general strategic direction is captured but with incomplete synthesis; contextual relevance is strong (9) as the response remains focused and thematically aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 627,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "In the fair‑value tables the “Investments in trusts” line shows that Southern Company’s domestic‑equity holdings fell from $829 million at 12/31/2022 ( $651 m + $178 m ) to $651 million at 12/31/2023, then rose sharply to $1,099 million at 12/31/2024 ( $849 m + $250 m ).  Private‑equity exposure grew steadily, from $161 million in 2022 to $169 million in 2023 and $181 million in 2024.  The pattern suggests the company is using its trust portfolio to rebalance toward higher‑growth equity positions—cutting back in 2023 and then aggressively rebuilding in 2024—while maintaining a modest, incremental increase in private‑equity assets, reflecting a long‑term capital‑allocation strategy that emphasizes diversified, higher‑return investments over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, Southern Company's domestic equity investments were $1,016 million, not $829 million as stated in the LLM answer. The LLM incorrectly uses the 2023 domestic equity value ($829 million) as the 2022 value. Additionally, the LLM claims domestic equity fell from $829 million in 2022 to $651 million in 2023, but the ground truth shows it decreased to $829 million in 2023 from $1,016 million in 2022. The 2024 domestic equity value ($1,099 million) is correct. For private equity, the LLM states $161 million in 2022, but the ground truth is $150 million; however, the 2023 ($169 million vs. $161 million) and 2024 ($181 million) values are close, with only a minor discrepancy in 2023. (2) Calculations and breakdowns like '$651 m + $178 m' and '$849 m + $250 m' are not present in the ground truth and appear to be fabricated or misinterpreted from unknown sources, undermining quantitative accuracy. (3) The qualitative reasoning about a strategic shift toward higher-growth or higher-return investments is plausible and aligns with the general trend in the ground truth—increasing private equity and a rebound in domestic equity by 2024. However, the LLM’s narrative of 'cutting back in 2023 and then aggressively rebuilding' is based on incorrect data, weakening the validity of the inference. The conclusion about long-term capital allocation emphasizing diversified, higher-return investments is semantically similar to the ground truth’s 'growing emphasis on private equity as part of diversification and long-term growth,' so the reasoning direction is sound despite flawed inputs. (4) Contextual relevance is high—the answer addresses the evolution over time and interprets strategic implications. However, due to major factual errors in key financial figures and incorrect year-to-year comparisons, the correctness score is limited to 5. Quantitative accuracy is low (4) due to wrong numbers and unsupported calculations. Qualitative accuracy is moderate (6) because the interpretation is reasonable but based on incorrect data. Contextual relevance is strong (9) as the structure and intent match the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 598,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "- 2022: Eliminations/Reclassifications reduced total net sales and revenue by **$107 million**【page 69†L1-L8】.  \n- 2023: The same adjustment grew to a **$151 million** reduction【page 70†L1-L8】.  \n- 2024: It expanded further to a **$296 million** reduction【page 68†L1-L8】.  \n\nThe increasingly larger negative impact shows that GM’s internal reporting is consolidating more inter‑segment sales and re‑classifying a greater share of revenue each year, indicating a trend toward more extensive internal adjustments as the company’s segment structure and internal transactions become more complex.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the Eliminations/Reclassifications were $105 million in 2022 and $107 million in 2023, but the LLM reports $107 million for 2022 and $151 million for 2023. Only the 2024 figure ($296 million) is correct. These errors affect the core factual basis of the answer. (2) The calculation and trend analysis are compromised: while the LLM correctly identifies an increasing trend, the magnitude of change it implies (from $107M to $151M to $296M) does not match the actual progression ($105M → $107M → $296M). The jump from 2023 to 2024 is overstated due to the incorrect 2023 baseline. (3) The qualitative reasoning about increasing complexity in internal reporting and segment structures is sound and aligns with the ground truth's interpretation, showing correct multi-hop synthesis of the trend's implications. The use of terms like 'consolidating more inter-segment sales' and 'more extensive internal adjustments' reflects appropriate interpretation of the growing elimination amounts. (4) Contextually, the answer is well-structured and directly addresses both parts of the question—evolution of the impact and what it reveals—making it highly relevant. However, the quantitative inaccuracies in two of the three years significantly reduce overall correctness, warranting a mid-range score despite strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 398,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "- In the 2022 Form 10‑K the company filed a **stand‑alone “Amended and Restated Performance Bonus Plan” (Exhibit 10.5)** on December 9 2022, showing the plan was documented as a separate, attached exhibit.  \n- By the 2023 and 2024 filings the same plan is still listed in the exhibit table, but the “Filed Herewith” column is blank, indicating that the plan is now **incorporated by reference** rather than attached as a new exhibit and is presented together with the other equity‑compensation documents (stock‑option, RSU and director‑equity plans).  \n\nThus, from 2022 to 2024 the Performance Bonus Plan shifted from a newly filed, independent document to a referenced component of Netflix’s broader compensation framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several inaccuracies in key factual details, particularly around dates and exhibit numbers, which undermines its quantitative and qualitative accuracy. According to the ground truth, in 2022, the Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a 2014 filing date—meaning no new version was filed in 2022. However, the LLM incorrectly states that an 'Amended and Restated Performance Bonus Plan' (Exhibit 10.5) was filed on December 9, 2022, in the 2022 Form 10-K. This is factually wrong: a December 9, 2022 filing would appear in the 2023 Form 10-K, not the 2022. The ground truth confirms that the amendment occurred with a December 9, 2022 filing date but was included in the 2023 10-K as Exhibit 10.5†. The LLM conflates the filing date with the reporting year, leading to a misrepresentation of the timeline. Additionally, the claim that the plan was 'stand-alone' in 2022 is incorrect—the 2022 10-K only referenced the old 2014 version as historical. The core idea of integration into broader compensation frameworks by 2024 is partially aligned with the ground truth, which notes integration with performance-based RSU agreements. However, the reasoning about 'incorporated by reference' due to a blank 'Filed Herewith' column is speculative and not supported in the original answer. While the LLM captures the general trend of formalization and integration, the incorrect dates, exhibit numbers, and misattribution of filing years significantly reduce factual reliability. The answer is contextually relevant and attempts correct synthesis, but key errors in multi-hop facts—especially around when the amendment was filed and documented—prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 466,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings BNY Mellon’s “Business Relationships and Related Party Transactions Policy” is never restated in the 10‑K itself; each year the filing simply states that the policy (together with the Director‑Independence discussion) is incorporated by reference to the company’s proxy statement and to the same set of board‑committee charters (Audit, Corporate‑Governance/Nominating/Social‑Responsibility and Human‑Resources/Compensation). The identical language in all three years shows that the company has kept its corporate‑governance disclosures – regarding the related‑party policy, director independence and committee structures – consistently framed and unchanged over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately reflects that BK (BNY Mellon) did not restate the 'Business Relationships and Related Party Transactions Policy' in each 10-K but instead incorporated it by reference to the proxy statement and board committee charters across all three years (2022, 2023, 2024). The identification of the relevant committees—Audit, Corporate Governance/Nominating/Social Responsibility, and Human Resources/Compensation—is accurate, as is the linkage to director independence. The conclusion about consistent framing and unchanged disclosures aligns with the ground truth's assertion of a 'stable and uniform approach.' The only minor difference is that the LLM emphasizes incorporation by reference more than the original, but this is a valid interpretation and adds precision. There are no errors in entities, years, or reasoning. The multi-hop synthesis across years and disclosure components is sound. All information matches the ground truth in substance, with no incorrect numbers or dates—quantitative accuracy is perfect. The answer fully addresses both parts of the question: evolution (or lack thereof) of disclosure and what it reveals about consistency in governance. Thus, the answer deserves a 9 for correctness and qualitative accuracy due to slightly different emphasis but no factual flaws, and full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 400,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "- December 31 2022: Debt securities ‑ held‑to‑maturity fair value ≈ $679 million; carrying value ≈ $696 million.  \n- December 31 2023: fair value ≈ $596 million; carrying value ≈ $603 million.  \n- December 31 2024: fair value ≈ $508 million; carrying value ≈ $512 million.  \n\nOver the three‑year period both fair‑value and carrying amounts fell steadily, reflecting a shrinking HTM portfolio and the impact of rising interest rates that lowered market values. The trend suggests UnitedHealth is moving toward a more conservative, lower‑balance HTM strategy and is applying valuation assumptions that recognize the temporary decline in security prices.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies for 2022. According to the ground truth, in 2022, the fair value was $643 million and carrying value was $641 million. However, the LLM reports $679 million (fair value) and $696 million (carrying value), which are both materially incorrect (~$36M and ~$55M overstatements, respectively). The 2023 and 2024 values are correct: $596M fair / $603M carrying in 2023, and $508M fair / $512M carrying in 2024. (2) Calculations and trends based on incorrect 2022 figures will be misleading. While the direction of decline is accurate, the magnitude is exaggerated due to the inflated starting point. (3) The qualitative reasoning is sound: the LLM correctly infers a shrinking HTM portfolio and links the decline to rising interest rates and a more conservative strategy. It also correctly identifies a trend in valuation assumptions, though it frames it as 'temporary decline in security prices' rather than the ground truth's specific mention of reduced reliance on Level 3 inputs. This is a reasonable interpretation but misses the precise nuance about observable vs. unobservable inputs. (4) Contextually, the answer addresses all parts of the question—evolution over time and implications for strategy and valuation—and is well-structured. The multi-hop synthesis across years is logically presented, but the foundational error in 2022 data undermines full correctness. Hence, a score of 6/10: partially correct with key factual errors in the earliest year, but otherwise coherent and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 435,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "- In the 2022 filing PayPal warned that “failure to deal effectively with fraud, abusive behaviors, **bad transactions**” could raise its loss rate on the **BNPL loan‑receivable portfolio that it still carried on its balance sheet** (Risk Factors, 2022 10‑K). No concrete steps to reduce that exposure were described.  \n\n- In the 2023 filing PayPal disclosed that, in **June 2023, it entered a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables** – a “substantial majority” of the BNPL portfolio – and to forward‑flow future eligible loans, thereby shifting most of the credit‑risk and potential bad‑transaction loss to a third‑party buyer (Risk Factors, 2023 10‑K).  \n\n- The 2024 filing notes that the forward‑flow arrangement is now in effect and that the company continues to rely on “other third‑party sources of funding…including asset sales, warehouse facilities, securitizations, partnerships or other funding structures” for its credit portfolio, indicating that the **BNPL exposure has been materially reduced** since the 2023 sale (Risk Factors, 2024 10‑K).  \n\n**What this shows:** PayPal moved from retaining the full BNPL credit risk in 2022 to actively off‑loading that risk through a large‑scale receivable sale and ongoing third‑party funding arrangements in 2023‑2024, demonstrating a clear, evolving risk‑mitigation strategy that transfers bad‑transaction risk away from its balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's 2022 risk disclosure about bad transactions, the June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and the 2024 continuation of risk mitigation through third-party funding structures. The €40 billion figure, June 2023 timing, and geographic scope (U.K. and Europe) are all factually correct. (2) Quantitative accuracy is perfect—no calculations were required, but the reported amount (€40 billion) and time frame (June 2023) match the original answer exactly. Format is consistent and precise. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, showing evolution from risk retention in 2022 to risk transfer via asset sales and forward-flow arrangements in 2023–2024. It correctly infers that this reflects a strategic shift in risk mitigation. (4) The only minor shortcoming is that the LLM does not explicitly mention the conditional nature of the 2023 sale (i.e., that benefits could be delayed if conditions aren't met), which is noted in the 2024 filing per the ground truth. This omission slightly affects completeness but does not undermine the overall correctness. Otherwise, the answer is semantically equivalent, well-structured, and fully relevant to the question about PayPal’s evolving risk exposure and mitigation strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1631,
        "completion_tokens": 397,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "Chevron’s Myanmar output fell sharply over the three‑year span – about 17 thousand barrels of oil‑equivalent per day in 2022, 15 k bpd in 2023, and only 4 k bpd in 2024. The decline mirrors Chevron’s announced plan to wind‑down and ultimately exit the country (the company began a “planned and orderly transition” in 2022 and formally withdrew in April 2024), shifting its strategy from ongoing production to a phased exit.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decline in production from 17 k bpd in 2022 to 15 k bpd in 2023, which matches the ground truth. However, it incorrectly states that production was 4 k bpd in 2024, whereas the ground truth indicates Chevron completely withdrew in April 2024, implying zero production for the year (or effectively no ongoing volumes). This is a significant quantitative error. (2) The dates of the withdrawal (April 2024) and the initiation of the exit process in 2022 are correctly cited, aligning with the ground truth. However, the reported 2024 production volume is factually wrong. (3) The reasoning about a strategic shift toward portfolio optimization and risk management is partially captured through the mention of a 'planned and orderly transition' and 'phased exit,' which reflects sound multi-hop synthesis of operational changes over time. The strategic intent is reasonably inferred, though the term 'portfolio optimization' is not explicitly mentioned. (4) The contextual relevance is high, as the answer addresses both the production trend and the strategic rationale. However, due to the major error in the 2024 production figure—contradicting the complete exit—the correctness score is reduced significantly. Quantitative accuracy is penalized for the incorrect 4 k bpd claim, while qualitative and contextual scores remain moderate to high due to accurate framing of the exit strategy and timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 402,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "The PC‑and‑notebook sub‑segment has remained the second‑largest revenue driver inside TI’s Personal‑electronics market in each filing – it ranked just after mobile phones in 2022, 2023 and again in 2024. At the same time, the Personal‑electronics market grew from roughly 15 % of total TI revenue in 2022‑23 to about 20 % in 2024, meaning the PC‑and‑notebook line’s share of the company’s overall sales has risen modestly. This steady ranking combined with the expanding share of the Personal‑electronics segment signals that TI is maintaining, and slightly strengthening, its strategic position in the consumer‑computing (PC) market.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the Personal Electronics segment was 24% of TI's revenue in 2022, not 15% as stated by the LLM. The LLM incorrectly claims that Personal Electronics grew from 15% in 2022-23 to 20% in 2024, when in fact it declined from 24% in 2022 to 15% in 2023 and then partially recovered to 20% in 2024. This misrepresents the entire trend. Additionally, the LLM asserts that PC & Notebooks remained the second-largest subcategory behind mobile phones in all three years, but the ground truth does not confirm this ranking, only that PC & Notebooks was a key subcategory and appeared lower in priority over time. (2) Quantitative errors are severe: the LLM reverses the direction of the percentage change (growth vs. decline) and misstates the baseline (15% instead of 24% in 2022). These are not minor rounding or formatting issues but fundamental errors in data representation. (3) The multi-hop reasoning is flawed. The LLM infers increasing strategic importance based on an incorrect assumption of segment growth, when the ground truth indicates a strategic shift away from consumer computing due to declining segment share and reduced emphasis on PC & Notebooks. The synthesis across years is therefore invalid. (4) Despite these issues, the answer is contextually relevant—it addresses the right company (TI), segment (Personal Electronics), subcategory (PC & Notebooks), and time frame (2022–2024)—and attempts to interpret strategic positioning, which aligns with the question. However, due to major factual and logical errors, the conclusion is opposite to the correct interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 460,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "Across the three filings GM repeatedly said that its indemnification of Stellantis for the 2017 Opel‑Vauxhall sale could not be quantified and that only an immaterial accrual had been recorded. In the 2022 10‑K no dollar amount was disclosed; the 2023 10‑K added that the indemnification‑related guarantees had a “maximum future undiscounted payment” of about **$3.5 billion** (the bulk of the $3.5 billion guarantee balance), and the 2024 10‑K raised that ceiling to roughly **$3.7 billion** while still noting that the actual accrued liability remained immaterial and that any further Takata‑related indemnification was considered remote.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. (1) The $3.5 billion and $3.7 billion 'maximum future undiscounted payment' figures are not supported by the ground truth; the Original Answer states that GM 'could not estimate reasonably possible future losses' and made only immaterial payments, with no mention of a $3.5B or $3.7B guarantee ceiling. These specific dollar amounts are entirely absent from the ground truth and represent a major fabrication or misinterpretation. (2) The Original Answer notes increasing specificity in disclosures—especially around regulatory investigations (European Commission and UK CMA) and Takata recalls—but does not mention any numerical cap on indemnification, only that exposures were emerging but immaterial. (3) The LLM incorrectly implies a growing financial commitment via rising dollar ceilings, whereas the ground truth emphasizes that while disclosures became more detailed, the financial impact remained immaterial and no quantifiable accruals beyond immaterial amounts were recorded. (4) The qualitative elements—such as the mention of Takata-related indemnification being considered remote—are correctly reflected, and the focus on evolving disclosure patterns is contextually relevant. However, the core quantitative claims are false, undermining the answer's reliability. (5) The multi-hop reasoning is partially sound in tracking changes across years, but the synthesis is based on incorrect data. Overall, the answer misrepresents the financial exposure and introduces unsupported figures, warranting a low correctness score despite some structural relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 451,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "- The only filing that references the **1.450 % Senior Notes due 2026** is Supplemental Indenture No. 10, dated September 27 2021 (shown in the 2022 10‑K exhibit list) 【page_72】.  \n\n- The 2022 exhibit table (pages 70‑71) lists new issuances such as the 3.650 % Senior Notes due 2027 but contains **no additional entry for the 1.450 % notes**【page_70】.  \n\n- The 2023 exhibit table (page 71) records a series of higher‑coupon notes (4.125 %, 5.250 %, 5.800 % etc.) and likewise **does not show any new 1.450 % issuance**【page_71】.  \n\n- The 2024 exhibit table (page 73) continues with newer issues (5.200 %, 5.450 %, 3.900 % etc.) and again **has no further 1.450 % Senior Notes entry**【page_73】.  \n\n**Interpretation:** American Tower issued the 1.450 % Senior Notes due 2026 once in 2021 and did not repeat that issuance in 2022, 2023 or 2024. Instead, the company shifted to higher‑coupon, later‑maturing notes in subsequent years, indicating a debt‑management approach that secured low‑cost financing initially and then diversified its capital structure by tapping the market at prevailing rates rather than repeatedly issuing the same low‑rate series.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "(1) The LLM answer contains partially correct information but fundamentally misrepresents the evolution and status of the 1.450% Senior Notes due 2026. While it correctly identifies the issuance date (September 27, 2021) and Supplemental Indenture No. 10, it incorrectly claims that the notes were only referenced in the 2022 10-K and not in subsequent years. The ground truth confirms that the notes were consistently referenced in all three years (2022, 2023, 2024) under Exhibits 4.25, 4.22, and 4.21 respectively, indicating ongoing recognition and stability in the debt portfolio. The LLM incorrectly interprets the absence of a 'new issuance' as evidence that the notes were no longer active or relevant, which contradicts the actual filing practice where existing debt instruments are carried forward in disclosures even without new activity.\n\n(2) Quantitatively, the LLM is accurate: the 1.450% rate, 2026 maturity, and September 27, 2021 issuance date are correct. The exhibit numbers and page references cited (e.g., page 72, 70, 71, 73) may align with document structure, though the interpretation of those exhibits is flawed. There are no calculation errors because no computations were required.\n\n(3) The multi-hop reasoning is unsound. The model fails to recognize that consistent mention across years—even without new issuance—indicates stability in debt management. Instead, it infers a strategic shift toward higher-coupon notes based on the presence of new issuances, ignoring that multiple debt tranches can coexist. This reflects a misunderstanding of how corporate debt portfolios are managed and disclosed. The conclusion that AMT 'shifted' away from low-rate financing is not supported by the evidence provided in the ground truth, which shows the 1.450% notes remained a stable component.\n\n(4) The contextual relevance is moderate: the answer addresses the question of debt management strategy and cites relevant exhibits, but draws an incorrect conclusion due to flawed reasoning. The focus on new issuances is relevant, but the omission of the continued disclosure of the 1.450% notes across years undermines completeness and accuracy. A correct interpretation would emphasize continuity and stability, not discontinuation or strategic shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 604,
        "total_tokens": 2080
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "The 2019 Long‑Term Incentive Plan remained the governing award vehicle in each filing, but the company refreshed the underlying grant documents each year. In the 2022 Form 10‑K the plan was paired with a 2022 Performance Share Unit Agreement (Exhibit 10.18) and a 2022 Restricted Stock Unit (deferred‑stock) Agreement (Exhibit 10.22) 【page_18†L13-L20】. In the 2023 filing the same 2019 LTIP was supplemented with new 2023 Performance Share Unit (Exhibit 10.26) and Restricted Stock Unit (Exhibit 10.27) agreements, and a 2024 Performance Share Unit Agreement was also filed for the upcoming grant year 【page_19†L26-L31】. By the 2024 filing the plan continued to be used, now with the 2024 Performance Share Unit Agreement (Exhibit 10.25) and the 2024 Restricted Stock Unit Agreement (Exhibit 10.26/10.29) 【page_19†L28-L33】【page_20†L1-L3】, indicating a consistent evolution of the LTIP through successive, year‑specific deferred‑stock and performance‑share agreements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that in 2022, the company used a '2022 Performance Share Unit Agreement' and a '2022 Restricted Stock Unit Agreement', but the ground truth indicates that in 2022, the company referenced the 2019 forms of these agreements, not 2022 versions. This misrepresents the timeline and evolution of the plan. (2) The LLM claims that in 2023, new 2023 agreements were introduced and that a 2024 agreement was filed for the upcoming year, but the ground truth specifies that in 2023, the company introduced a new Deferred Stock Unit Agreement for Directors under the 2019 plan — a key expansion in scope that the LLM omits entirely. Instead, the LLM fabricates references to 2023 and 2024 PSUs being filed in the 2023 report, which contradicts the ground truth. (3) In 2024, the ground truth states the company adopted the '2022 Form of Performance Share Unit Agreement', not a 2024 version as the LLM claims. The LLM incorrectly asserts that 2024 agreements were used in the 2024 filing, when the actual progression involved reusing or updating earlier forms, not annually refreshed ones. (4) The LLM mischaracterizes the evolution as a yearly refresh of grant documents, whereas the ground truth shows a more strategic, incremental expansion — especially with the inclusion of directors in 2023 — which the LLM fails to capture. While the LLM correctly identifies the 2019 LTIP as the ongoing framework and mentions deferred stock and performance share units, it gets the critical details of timing, form years, and the significance of director-level expansion wrong. The references to exhibit numbers and page citations appear fabricated or misaligned with actual filings. Thus, despite some surface-level plausibility, the answer is factually incorrect on key points, especially regarding dates and the nature of the plan's evolution. Quantitative accuracy is low due to incorrect years (2022 vs. 2019 forms). Qualitative accuracy suffers from flawed reasoning and missing synthesis about director-level expansion. Contextual relevance is moderate as it addresses the general topic but with incorrect specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 591,
        "total_tokens": 2089
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "- **2022:** The 2022 filing already described the Combat‑Systems unit Ordnance & Tactical Systems (OTS) as a “systems integrator … providing missile subsystems … with **critical aerostructures**” for both legacy and next‑generation missiles【page_12】.  \n\n- **2023:** The 2023 filing repeated that language and added that OTS supplies “cutting‑edge hypersonic rocket cases” alongside those aerostructures, showing an expanded technical scope【page_12】.  \n\n- **2024:** The 2024 filing still emphasized OTS’s “leading position providing missile subsystems … with critical aerostructures,” and noted a new strategic teaming agreement to produce solid‑rocket motors, signaling deeper investment in the supply chain for next‑generation missile airframes【page_11】.  \n\n**Trend & strategic implication:** Over the three‑year period the emphasis on aerostructures remained constant but grew in breadth—from a baseline capability in 2022 to inclusion of hypersonic cases in 2023 and to partnership‑driven production capacity in 2024. This steady‑and‑expanding focus indicates that General Dynamics is positioning its Combat Systems segment as a core, forward‑looking supplier of advanced missile airframe components, reinforcing its role in next‑generation missile subsystems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the emphasis on 'critical aerostructures' in missile subsystems is consistently reported across 2022–2024, and the strategic evolution is accurately portrayed. While the ORIGINAL ANSWER includes revenue percentages (20% in 2023, 19% in 2024), the LLM answer does not mention these figures, which is a minor omission but does not undermine the core factual accuracy. (2) There are no numeric inaccuracies—since the LLM does not introduce any incorrect numbers, and the absence of revenue percentages does not constitute an error, only a slight incompleteness. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years, identifies the continuity and expansion of capabilities (e.g., hypersonic rocket cases, solid-rocket motor partnerships), and draws a logical conclusion about strategic positioning. (4) The answer is contextually excellent—directly addressing the evolution and strategic implication with precise, document-supported details. The omission of revenue share slightly reduces completeness, but the qualitative and strategic analysis is robust and semantically equivalent to the ground truth in intent and substance. Hence, a correctness score of 9 is warranted—excellent but not fully comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 377,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "Across the three filings, PMI’s 10‑K consistently lists Jackpot alongside its other “important local cigarette brands” in the Philippines – the 2022 filing notes “Fortune and **Jackpot** in the Philippines” (Item 1, Business – page 5), the 2023 filing repeats the same description (Item 1, Business – page 5), and the 2024 filing again cites “Fortune and **Jackpot** in the Philippines” (Item 1, Business – page 5). This steady inclusion shows that PMI has kept Jackpot as a core pillar of its Philippine portfolio, using the brand to secure market share in a key South‑and‑Southeast‑Asia market and to balance its premium‑price international brands (e.g., Marlboro) with strong local, mid‑price offerings, underscoring the brand’s ongoing strategic role in the region’s growth and in PMI’s broader mixed‑brand portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that PMI consistently listed Jackpot as a key local brand in the Philippines across 2022, 2023, and 2024 filings, alongside Fortune, which matches the original answer's core claim. The citations to Item 1, Business, page 5 in each year are consistent with typical 10-K structure, though exact page numbers may vary slightly by filing format—this does not affect factual accuracy. (2) There are no numerical values requiring calculation, so quantitative accuracy is fully satisfied. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly infers that the repeated mention of Jackpot indicates its sustained strategic importance, even as PMI pushes smoke-free products. It adds valuable context—positioning Jackpot as a mid-price brand complementing premium brands like Marlboro—which is logically consistent with PMI’s portfolio strategy and supported by industry knowledge, though slightly more interpretive than the original answer. (4) The answer addresses all parts of the question: evolution over time (consistent emphasis), and strategic implications (regional market share, portfolio balance). The only minor gap is that it does not explicitly reference PMI’s broader smoke-free expansion (e.g., IQOS, ZYN, 95 markets) mentioned in the 2024 context in the ground truth, which slightly weakens the synthesis of traditional vs. future product strategy. However, the emphasis on Jackpot’s ongoing role amid global shifts is still clearly conveyed. Thus, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with a small deduction for incomplete linkage to PMI’s smoke-free strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 485,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "- In 2022 Chevron’s focus in the Republic of Congo was still on expanding its offshore footprint – the company extended deep‑water licences there, a move that was reflected in the reserve‑addition table as a +36 million‑boe contribution for Africa (see 2022 “Purchases” discussion on page 110).  \n- By 2023 the emphasis shifted to developing those offshore assets, with roughly $0.7 billion of capital spent on offshore development and natural‑gas projects in Nigeria, Angola **and the Republic of Congo** (see capital‑expenditure breakdown on page 109).  \n- In the 2024 filing the only Congo‑related update is the announced disposition: Chevron sold its 31.5 % non‑operated working interest in the Haute Mer permit and its 15.75 % interest in the Lianzi area in January 2025, indicating a move from investment to asset‑sale after the 2024 reporting year (see “Noteworthy Developments” on page 43).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Chevron maintained a presence in the Republic of Congo in 2022, invested approximately $0.7 billion in offshore and natural gas projects in Africa in 2023 (including Congo), and divested its 31.5% nonoperated interest in Haute Mer and 15.75% in Lianzi in January 2025. The mention of January 2025 is consistent with the original answer, which notes the sale occurred in early 2025 post-2024 reporting. (2) Quantitative accuracy is perfect: $0.7 billion, 31.5%, 15.75%, and the 2022 reserve addition of +36 million boe are all correctly cited. The LLM adds extra detail (e.g., page references and reserve impact) not in the ground truth but supported by data, which enhances accuracy without introducing error. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across three years, linking capital deployment to later divestiture, and infers a strategic shift. The only minor gap is that the original answer frames the 3-year trend more explicitly as a 'strategic exit,' while the LLM implies it—this slight reduction in interpretive clarity prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing capital deployment and asset disposition as asked. Minor deduction from 10 on correctness due to slightly less explicit synthesis of the overall strategic shift, though all factual components are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 409,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "By the 2024 filing Southern Company began treating its outdoor‑lighting contracts as a material operating‑lease portfolio, whereas the 2022 filing still regarded the contracts as immaterial (the 2023 note even called the cash‑flows “immaterial”) and did not report any operating‑lease revenue for Southern Company itself.  In 2024 the contracts are described as up‑to‑10‑year leases that renew month‑to‑month, and the company reports $136 million of operating‑lease income for Southern Company (with additional amounts for Alabama Power, Georgia Power, Mississippi Power, Southern Power and Southern Company Gas), whereas in 2022 no operating‑lease income was shown for Southern Company and the amounts were either omitted or folded into other revenue.  The 2024 notes also provide a detailed maturity schedule for the scheduled lease payments, while the 2022 discussion gave only a brief description of the contracts and treated the related cash‑flows as immaterial.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly around quantitative details. The ground truth does not mention any $136 million in operating-lease income for Southern Company in 2024, nor does it state that such income was reported at the parent company level. This figure is fabricated or misattributed and is not supported by the original answer. Additionally, the claim that the 2023 note called cash flows 'immaterial' contradicts the original answer, which states that in 2023 the company began disclosing scheduled lease payments in maturity analyses—indicating increased materiality treatment, not continued immateriality. (2) There are no verifiable numbers in the original answer to support the $136 million figure or breakdown by subsidiary (Alabama Power, Georgia Power, etc.) in terms of lease income. The original answer only notes a shift in disclosure practices and inclusion of PPA lease income in wholesale revenues for certain subsidiaries, but does not quantify it. Thus, the quantitative accuracy is low due to unsupported numerical claims. (3) Qualitatively, the LLM captures the directional change in accounting treatment—moving from immaterial in 2022 to more structured disclosures in 2024—including maturity schedules and lease term descriptions. It correctly identifies the evolution in lease structure (up-to-10-year with month-to-month renewal) and improved transparency. However, it overreaches by implying consolidated lease income reporting at the Southern Company level, which is not in the ground truth. (4) Contextually, the response is highly relevant, addressing materiality, revenue allocation, and lease payment structure across years and subsidiaries as asked. While the reasoning shows an understanding of multi-hop progression (2022 → 2023 → 2024), it introduces unsupported specifics that undermine factual correctness. The core narrative aligns with the original, but the addition of unverified figures reduces overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 540,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "Cisco’s 3.50 % senior note (maturing June 15 2025) has kept the same principal balance of **$500 million** in each filing, but its reported effective interest rate has risen sharply: **3.20 % in FY 2022 (July 30 2022), 6.38 % in FY 2023 (July 29 2023), and 6.66 % in FY 2024 (July 27 2024)**【page_89】. The unchanged carrying amount together with the climbing effective rate shows that the market price of the debt has fallen (the note now yields a higher market rate), reflecting higher prevailing interest rates and tighter market conditions for Cisco’s fixed‑rate borrowing over the three‑year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying amount of $500 million is correctly reported for all three fiscal years (2022–2024), and the effective interest rates—3.20% in FY2022, 6.38% in FY2023, and 6.66% in FY2024—are exactly as in the original answer. The fiscal dates (July 30, 2022; July 29, 2023; July 27, 2024) align with Cisco’s fiscal year-ends and are consistent with SEC filing timelines. (2) The answer is complete, addressing both the evolution of the carrying amount and effective interest rate across the three years, as well as the implication of this trend. (3) Entity accuracy is correct: Cisco, the 3.50% Note, and its maturity date (June 15, 2025) are properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the LLM correctly infers that the rising effective interest rate—while the carrying amount remains constant—indicates a decline in market price of the debt, due to higher prevailing interest rates and tighter market conditions. This interpretation aligns with bond valuation principles and the original answer’s conclusion about shifting market conditions. (5) Semantic equivalence is strong: though the LLM adds contextual details (e.g., maturity date, exact filing dates), the core information and analytical insight match the ground truth. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 399,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "Simon Property Group’s “Unsecured Notes ‑ 35A” carried a $750 million face amount in the 2022 10‑K filing and the same $750 million amount appears in the 2023 and 2024 tables of unsecured debt【page 50 (2023)】 and 【page 51 (2024)】. The unchanged exposure over three consecutive years shows that the company is deliberately keeping this 2.65 % tranche of medium‑term unsecured notes outstanding, using it as a stable, low‑cost source of long‑term financing rather than repeatedly refinancing or retiring the series. This consistency reflects a long‑term debt‑management strategy that emphasizes maturity diversification and rate stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $750 million face value of Unsecured Notes - 35A for all three years (2022, 2023, 2024), matching the ground truth exactly. The interest rate of 2.65%, and the maturity date (July 15, 2030) are not mentioned in the LLM answer, which is a minor omission but does not affect the core quantitative or strategic accuracy. All other numeric and temporal data are correct. (2) Quantitative accuracy is perfect: $750 million is consistently reported across years, and no incorrect calculations are made. Format is consistent and acceptable. (3) The multi-hop reasoning is sound—the model correctly synthesizes data across three annual filings to observe stability in this debt instrument. It draws a logical conclusion about Simon Property Group’s long-term debt strategy emphasizing stability and rate predictability. The answer could have strengthened the reasoning by explicitly contrasting this stability with other portfolio changes (e.g., the 2024 $1B issuance of Notes - 41A), as in the ground truth, but the core strategic insight is preserved. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: the evolution (or lack thereof) of exposure and the strategic implication. The omission of the exact maturity date and the broader portfolio context prevents a perfect 10, but the answer remains highly accurate and insightful.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 395,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "Texas Instruments has kept **Embedded Processing** as a core pillar of its business model throughout the 2022‑2024 period, positioning it under the “broad portfolio of analog and embedded‑processing products” that forms one of its four sustainable competitive advantages (see the MD&A overview that lists the four advantages in each year [2022 p. 20]; [2023 p. 18]; [2024 p. 18]).  \n\nFinancially, the emphasis shifted: embedded‑processing revenue grew 19 % from $2.57 bn to $3.05 bn in 2021 (the first year after the 2022 filing) and again rose modestly 3 % to $3.37 bn in 2023 (2023 vs 2022 segment table [2023 p. 20]), but then fell 25 % to $2.53 bn in 2024 (2024 vs 2023 segment table [2024 p. 20]), with operating profit margins dropping from ~38 % to ~14 % over the same span.  \n\nThus, while the strategic narrative for embedded processing has remained unchanged—still a key element of the company’s broad‑portfolio advantage—the product line moved from a period of growth to a period of contraction, indicating that TI’s competitive‑advantage framework continues to rely on embedded processing even as its relative contribution to earnings has weakened.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the financial data. The original answer states that Texas Instruments maintained a consistent strategic emphasis on Embedded Processing Products from 2022 to 2024, with identical phrasing used each year to describe the value of the broad portfolio. However, the LLM introduces financial figures (e.g., $2.57B in 2021, $3.05B in 2022, $3.37B in 2023, $2.53B in 2024) and margin changes (~38% to ~14%) that are not present in the ground truth and contradict the focus of the original answer, which did not include any revenue or margin data. There is no mention in the ground truth of a 25% decline in revenue or margin contraction, making these claims unsupported and likely incorrect. (2) The quantitative inaccuracies are severe: the LLM references revenue for 2021–2024 and year-over-year changes, but the original answer does not provide any such data. Additionally, the LLM incorrectly implies that 2021 data is relevant to the 2022–2024 analysis, creating a misalignment in timeframes. The calculation of percentage changes (19%, 3%, -25%) and margin drop cannot be verified and appear fabricated. (3) The multi-hop reasoning is partially sound in that the LLM correctly identifies Embedded Processing as part of TI’s four sustainable competitive advantages and notes consistency in strategic framing. It also attempts to synthesize across years, citing MD&A sections from 2022–2024 filings. However, it introduces financial performance data not present in the ground truth, shifting focus from strategic consistency to financial decline, which misrepresents the original conclusion. (4) The contextual relevance is moderate—the answer addresses the strategic role of Embedded Processing and its place within TI’s competitive advantages, which is relevant. However, the emphasis on financial deterioration introduces a misleading narrative not supported by the ground truth, undermining the overall correctness. The qualitative accuracy is limited by the introduction of unsupported data, though the core idea of sustained strategic emphasis is partially aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 578,
        "total_tokens": 2092
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "- **2022:** Wireless service was sold only as part of bundled Xfinity plans, and customers could choose between an unlimited‑data option, a shared‑data pool, or a per‑gigabyte “pay‑as‑you‑go” model 【page_7】.  \n- **2023:** The same three‑tier structure remained for domestic lines, but Comcast added a separate United‑Kingdom offering (via Virgin Media O2) and began allowing international customers to select from a menu of gig‑byte‑based plans 【page_5 (2023)】.  \n- **2024:** Comcast introduced a **pre‑paid unlimited‑data plan** under the NOW brand and expanded the international menu to include both unlimited‑data and various gig‑byte plans for customers outside the United States, while keeping the unlimited, shared‑data and per‑gigabyte choices for domestic lines 【page_5 (2024)】.  \n\nThus, from 2022 to 2024 the wireless shared‑data offering grew from a domestic‑only, bundled‑only menu to a more flexible suite that adds a prepaid unlimited option and extends the same flexible plan choices to the United Kingdom and other international markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, shared data plans were part of bundled offerings; in 2023, flexibility among unlimited, shared, and per-gigabyte plans was maintained; in 2024, international expansion occurred with the introduction of prepaid unlimited plans under the NOW brand. (2) There are no numeric inaccuracies—dates (2022–2024), plan types, and geographic expansions are correctly reported. Format variations (e.g., 'gig-byte-based' vs 'per-gigabyte') are semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes evolution over time and across geographies, linking domestic flexibility with international expansion. The mention of Virgin Media O2 and the UK is consistent with CMCSA’s international operations, though the original answer generalizes to 'international' beyond the UK. (4) The only minor deviation is that the original answer emphasizes shared data plans specifically, while the LLM answer discusses the broader plan ecosystem—still accurate but slightly broader in scope. However, shared data plans are correctly noted as continuing in all years. Overall, the answer captures the evolution in flexibility and international reach accurately and completely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 360,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "In the 2022 filing PayPal first flagged “abusive behaviors” as a source of loss – noting that third‑parties could create fictitious accounts, use stolen or synthetic identities, and launch fraud schemes that are hard to detect (see 2022 p. 28) and that its branded credit products exposed the company to “non‑payment risk, charge‑offs and reliance on third‑party chartered banks” (2022 p. 25‑26). By the 2024 filing the discussion had deepened: the company now describes fraud attacks that can be “deployed at a scale that would otherwise not be possible in physical transactions” and that involve “synthetic identities…abusive schemes…continuously evolving” (2024 p. 22‑26), while also stressing that credit‑product risk has grown more complex because of tighter regulatory limits on fees, higher default rates, and the need to manage partner‑bank interruptions (2024 p. 22‑23). This shift from a general acknowledgment of fraud and credit‑product risk in 2022 to a detailed, multi‑layered description of large‑scale synthetic‑identity fraud and tighter credit‑risk controls in 2024 shows that PayPal’s risk‑management challenges have become markedly more intricate as its digital‑payments ecosystem and product suite have expanded.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: the evolution of PayPal's exposure to abusive behaviors from 2022 to 2024 is accurately described, including fictitious accounts, synthetic identities, third-party fraud, and risks tied to credit products. The mention of reliance on third-party chartered banks and non-payment risk in 2022 matches the original. In 2024, the expanded discussion on synthetic identity fraud, evolving schemes, and regulatory/operational complexities in credit products is consistent with the ground truth. (2) Quantitative accuracy is perfect: no specific numbers (e.g., €40 billion) are incorrectly stated or fabricated. While the LLM omits the specific €40 billion receivables sale mentioned in the ground truth, it does not misstate any figures and focuses instead on qualitative risk evolution. This omission prevents a perfect 10 on qualitative accuracy but does not undermine correctness. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across 2022, 2023, and 2024 filings, tracing the progression from initial risk acknowledgment to more complex, systemic challenges. It logically infers increasing complexity in risk management due to product expansion and digital scale. (4) Semantic equivalence is strong: though the LLM does not explicitly reference the 2023 agreement or legal uncertainty around FDIC bank loan receivables, it captures the essence of growing sophistication and operational challenges. The answer remains contextually rich and fully relevant to the question about evolving risk complexity. Minor omission of the €40B transaction detail reduces completeness slightly, but core facts and reasoning remain robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1609,
        "completion_tokens": 476,
        "total_tokens": 2086
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "- 2022 10‑K (Item 2 Properties) lists El Segundo, California as one of Gilead’s “principal manufacturing facilities” but does not specify the type of work performed there 【page_31】.  \n\n- 2023 10‑K (Item 1 Business – Manufacturing Facilities) shows that the El Segundo site is now being used “for clinical and commercial manufacturing and processing of our cell‑therapy products” 【page_11】, indicating that the plant had been equipped to support the company’s growing cell‑therapy portfolio.  \n\n- 2024 10‑K (Item 1 Business – Manufacturing Facilities) repeats the same description – the El Segundo facility “utilized for clinical and commercial manufacturing and processing of our cell‑therapy products” 【page_10】, confirming that Gilead has continued to invest in and rely on this site as a dedicated cell‑therapy manufacturing hub.  \n\n**Thus, between 2022 and 2024 Gilead’s El Segundo facility evolved from being simply a listed principal plant to a purpose‑built site for both clinical and commercial cell‑therapy production, reflecting strategic investment in its cell‑therapy manufacturing capability.**",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All entities (GILD, El Segundo, California, cell therapy manufacturing) and years (2022–2024) are correct. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct referencing of years and document sections, which are accurate. (3) The multi-hop reasoning is sound: the LLM correctly traces the evolution of the El Segundo facility from a general 'principal manufacturing facility' in 2022 (without specified function) to a dedicated cell-therapy manufacturing site in 2023 and 2024, demonstrating synthesis across three annual reports. (4) The conclusion that the facility evolved into a 'purpose-built site for both clinical and commercial cell-therapy production' is a reasonable interpretation of the increasing specificity in disclosures, even if the original answer emphasizes 'continuity' rather than transformation. The only minor divergence is that the original answer notes the broader context in 2024 (e.g., supply chain risk, third-party manufacturers), which the LLM omits. However, this does not detract from the core focus on El Segundo’s role in cell therapy, which is fully addressed. Wording differs slightly but maintains semantic equivalence. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 422,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "The exhibit tables in each of the three 10‑K filings list the same security – “Form of 2.750 % Senior Notes due May 18, 2024” (Exhibit 4.6) – and the description does not change from the 2022 filing through the 2023 filing and again in the 2024 filing【page_66】【page_66】【page_66】. This shows that Costco kept the 2.750 % notes on its balance sheet with a fixed 2024 maturity throughout the period, rather than issuing new notes of the same series or extending the maturity. The consistency indicates a deliberate debt‑management approach: the company relies on a predictable, medium‑term note that simply rolls off the balance sheet at maturity, allowing it to manage leverage without continual refinancing of that tranche.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the security is correctly identified as the '2.750% Senior Notes due May 18, 2024', and the maturity date is consistently reported across 2022–2024 filings. (2) Quantitative accuracy is perfect: the interest rate (2.750%), maturity date (May 18, 2024), and lack of changes over time are all correctly stated. Format and references (e.g., Exhibit 4.6, page 66) align with source data. (3) Multi-hop reasoning is sound—the model correctly synthesizes information across three annual filings to observe no changes in the note’s structure, leading to the valid conclusion that Costco maintained a static, deliberate debt management strategy. (4) The reasoning about predictable debt repayment and avoiding refinancing is logically derived and contextually appropriate. The answer fully addresses both parts of the question: evolution (no change) and strategic implication (predictable leverage management). All entities (Costco, Senior Notes, correct time period) are accurate. No factual, numerical, or interpretive errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 325,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "Chevron’s Angola LNG gas output fell modestly from 49 MMCFD in 2022 to 48 MMCFD in 2023 and then held steady at 48 MMCFD in 2024 (see the “Angola” rows in the net‑production tables for 2022‑2023 【page_9】 and 2023‑2024 【page_9】). This flat‑to‑slightly‑down three‑year trend shows the company is preserving existing gas volumes from its flagship African project rather than pursuing rapid expansion, signaling a strategy that emphasizes steady, reliable gas supply from Angola while focusing growth elsewhere.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both quantitative and qualitative aspects. The ground truth states that Chevron's natural gas production volumes from Angola LNG increased from 7,107 million cubic feet per day (MMCFD) in 2022 to 7,148 in 2023 and 7,569 in 2024 — a clear upward trend. However, the LLM claims volumes fell from 49 to 48 MMCFD and remained flat, which is off by an order of magnitude (49 vs over 7,000). This suggests a fundamental misreading of the data, possibly confusing net production per share or another metric with total production. (2) The numbers are grossly inaccurate: 49 MMCFD vs 7,107 MMCFD is a 99.3% underreporting in 2022. Even if the unit were misinterpreted, no standard conversion explains this discrepancy. Calculations and trends are therefore invalid. (3) The multi-hop reasoning fails completely — instead of identifying a growth trajectory indicating strategic focus on gas in Africa, the LLM infers a flat-to-declining trend suggesting maintenance rather than expansion, which contradicts the evidence. (4) Contextual relevance is low but not zero: the answer addresses Chevron, Angola LNG, and the correct time frame, and attempts to infer strategy, so partial credit is given for structure and intent. However, due to catastrophic factual errors, the overall correctness score is 1.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 377,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "Cisco’s exposure to total‑return swaps used to offset its deferred‑compensation expense has risen steadily. The notional amount of those swaps grew from $651 million in FY 2022 (with a $(92) million loss recorded in operating expense) → $792 million in FY 2023 (producing a $58 million gain) → $985 million in FY 2024 (producing a $91 million gain)【page_92】【page_91】【page_91】. This upward trend shows the company is expanding its hedge program for deferred‑compensation liabilities, turning a previous expense‑drag into a net benefit and thereby dampening the earnings volatility that market‑linked equity price movements would otherwise create.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures from the ground truth: a $92 million loss in FY2022, a $58 million gain in FY2023, and a $91 million gain in FY2024. These match the original answer exactly in magnitude and direction (loss/gain). Additionally, the LLM provides extra detail—the notional amounts ($651M, $792M, $985M)—which are not in the ground truth but do not contradict it and appear to come from the cited pages. Since the ground truth does not include notional amounts, their inclusion is acceptable as supplementary context. (2) All calculations and comparisons are accurate: the progression from loss to increasing gains is correctly portrayed. The use of parentheses for negative values ($(92) million) is standard formatting. (3) The multi-hop reasoning is sound: the LLM synthesizes data across three fiscal years and correctly infers strategic implications—Cisco is expanding its hedge program and turning a prior expense into a net benefit. This aligns with the original answer’s conclusion about transformation from net liability to net benefit. The added insight about dampening earnings volatility due to market-linked equity movements is a reasonable extension, consistent with the function of total return swaps. (4) The only minor gap is that the original answer emphasizes either 'improved market conditions' or 'strategic shift' as possible causes, while the LLM leans more definitively toward strategic expansion of the hedge program. This is a slight interpretive difference but still within plausible inference. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score with only a small deduction in qualitative accuracy for slightly stronger causal assertion than the more cautious original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 490,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "By 2022 Lowe’s already required all suppliers to comply with its Human‑Rights Policy, Conflict‑Minerals Policy and Vendor Code of Conduct (which added “enhanced environmental standards”), and it monitored those suppliers through its existing management system while offering a growing portfolio of independently‑certified, eco‑labelled products. In the 2023 filing the company said it had **updated its wood‑sourcing policy**, adding country‑specific risk levels, stronger monitoring procedures and a new forestry‑grievance process, and it continued to expand the range of third‑party‑certified items. The 2024 filing shows the policy was further refined into a “more robust risk‑based approach” with even tighter monitoring and the same push to increase independently‑certified product offerings, demonstrating a clear evolution toward stricter supplier oversight and greater reliance on external certifications.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key elements from the original answer are correctly reflected: the 2022 baseline with the Vendor Code of Conduct, human rights and environmental policies, and certified products; the 2023 updates to the wood-sourcing policy including country-specific risk levels, enhanced monitoring, and a forestry grievance process; and the 2024 refinement into a more robust risk-based framework with tighter monitoring and continued expansion of third-party certifications. (2) There are no numeric values requiring calculation, but all years (2022, 2023, 2024) and policy changes are correctly attributed to the right timeframes. (3) The multi-hop reasoning is sound—information is synthesized across three years and multiple policy dimensions (policy updates, monitoring, certifications)—and the LLM correctly traces the evolution over time. (4) The answer addresses all parts of the question: policy updates, monitoring enhancements, and third-party certifications, with precise and consistent terminology. Minor wording differences (e.g., 'tighter monitoring' vs 'improving monitoring practices') do not affect factual equivalence. The LLM demonstrates a clear understanding of the progression in Lowe's supplier practices and conveys the same depth and intent as the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 382,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "- In the 2022 Form 10‑K (pages 26‑28) Comcast first flagged wireless telecoms as a growing broadband threat, noting that carriers such as **AT&T, T‑Mobile and Verizon in the United U.S. and BT and Virgin Media in the U.K.** were rolling out **4G, 5G and 5G‑fixed‑wireless broadband** and were increasingly offering **bundled “wireless‑plus‑broadband” packages** that could undercut Comcast’s residential‑connectivity pricing.  \n\n- The 2023 filing (pages 8‑9) repeats the same technology mix—**4G/5G and fixed‑wireless**—and the same U.S. rivals (AT&T, T‑Mobile, Verizon), while also pointing out Comcast’s own **MVNO agreement with Verizon** and the continued pressure from municipal‑ and satellite‑based providers.  \n\n- By the 2024 filing (page 21) the threat is described more generically: **wireless telecoms using 4G, 5G and 5G‑fixed‑wireless** are “offering bundled products and services with favorable pricing,” but the company no longer lists individual competitors, indicating that the competitive landscape has become broader and more consolidated, with bundling and aggressive pricing now the primary differentiators.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in terms of factual content and accurately reflects the evolution of competitive threats from wireless telecoms to CMCSA from 2022 to 2024, with accurate references to technological capabilities (4G, 5G, fixed wireless) and bundling strategies. It correctly identifies key competitors in 2022—AT&T, T-Mobile, and Verizon in the U.S., and BT and Virgin Media in the U.K.—and notes the shift toward bundled offerings. The mention of 4G/5G and fixed wireless as competitive tools aligns with the ground truth. However, the LLM introduces BT and Virgin Media in the U.K. as competitive threats in this context, which is not present in the original answer and may be misleading since the question focuses on CMCSA’s U.S. broadband and wireless services; this overextends the scope with potentially irrelevant international competitors. Additionally, while the 2024 filing in the LLM answer states competitors are no longer named, the original answer emphasizes that bundling now includes DTC streaming services (e.g., Netflix, Hulu) with wireless plans—an important strategic evolution that the LLM omits. This missing detail weakens the qualitative accuracy, as it fails to capture a key multi-hop insight: wireless providers are not just bundling connectivity but integrating streaming content to compete more directly with Comcast’s ecosystem. There are no numerical inaccuracies (quantitative accuracy is perfect), and the contextual relevance remains high as the response stays focused on the competitive dynamics. Overall, the core facts and timeline are correct, but the answer lacks completeness in capturing the full bundling evolution and introduces potentially extraneous entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1566,
        "completion_tokens": 466,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "PayPal’s filings show that from 2022 through 2024 it has consistently “bear[​] full margin risk” because it records transaction fees on a gross basis as the **principal** on each payment, sets those fees at its own discretion, and treats the fees it pays to third‑party processors as a separate transaction expense 【page_80】.  The same description appears in the 2023 note 【page_77】 and is reiterated in the 2024 note 【page_75】, with the added emphasis that any merchant‑ or consumer‑incentives are recorded as a reduction of revenue.  This unchanged language over three years indicates that, even as TPV and total revenues grew, PayPal’s exposure to margin risk has remained high but fully controllable – it retains pricing power while managing cost‑of‑service and incentive‑related reductions through explicit expense and revenue‑reduction accounting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that PayPal consistently bore full margin risk from 2022 to 2024, acting as the principal in transactions and recording fees on a gross basis, with processor costs treated as separate expenses—this matches the original answer’s core claim. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised; all references to years (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent language across three years of filings, correctly noting the unchanged treatment of processor fees and the classification of incentives as revenue reductions. It also correctly infers that this consistency reflects sustained pricing control and centralized margin risk management. (4) The only minor omission is that the 2024 update about contractual compensation from sellers violating terms (e.g., fraud) is not mentioned in the LLM answer—this new revenue stream was highlighted in the original answer as a factor influencing margin dynamics. However, this does not undermine the overall correctness, as the central theme of consistent margin risk exposure and pricing discretion is preserved. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing all aspects of the question: pricing strategy, processor use, revenue incentives, and implications for cost and pricing control.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 423,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "Costco has consistently accounted for any free‑rent periods (and step‑rent provisions) by spreading the rent‑free amount on a straight‑line basis over the lease’s **original term plus any renewal options that are reasonably certain to be exercised**. Because the lease term used in the present‑value calculation includes those certain extensions, the free‑rent amount reduces the discounted minimum lease payments and therefore lowers the initial right‑of‑use (ROU) asset and lease‑liability balances. The 2022, 2023 and 2024 10‑K disclosures contain the same language and assumptions, indicating no change in treatment or valuation methodology over the three fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Costco accounts for free-rent periods on a straight-line basis over the original lease term plus renewal options that are reasonably certain to be exercised, which matches the original answer for all three fiscal years (2022–2024). The impact on the right-of-use (ROU) asset valuation—specifically that the inclusion of free-rent periods reduces the present value of lease payments, thereby lowering both the ROU asset and lease liability—is correctly explained. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the ground truth, so quantitative accuracy is not applicable in that sense, but all factual assertions about accounting methods and their effects are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes the consistent treatment across years and correctly infers that no changes occurred in the accounting policy from 2022 to 2024, which is supported by the ground truth’s statement that the company 'reiterated its consistent application.' (4) The only minor shortcoming is that the LLM omits the detail from the original answer about variable lease payments tied to price indices or sales volume being excluded from the straight-line calculation starting in 2023. While this is a relevant nuance in disclosure evolution, the core accounting treatment for free-rent periods remained unchanged, so the omission does not undermine the central conclusion. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong qualitative reasoning with near-complete fidelity to the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 457,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "Across all three years PayPal’s filings state that it records transaction fees on a **gross basis** and acts as the **principal** on each payment, so the company “**bears full margin risk**” for every transaction – the fees it pays to payment processors are booked as transaction expense (2022 Note 2‑Revenue p. 75; 2023 Note 2‑Revenue p. 80; 2024 Note 2‑Revenue p. 77). Its pricing model remains a **fixed‑plus‑variable component** (the variable portion is a percentage of the payment known at processing) and contracts are **open‑ended, tier‑priced by volume and without capitalized contract assets**, a structure described consistently in 2022, 2023 and 2024. Consequently, PayPal’s exposure to margin risk stayed essentially unchanged from 2022 through 2024, with no shift in pricing, processor usage or contract terms that would reduce that risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core elements of PayPal's margin risk exposure: it accurately states that PayPal bears full margin risk, records fees on a gross basis, and treats payments to processors as transaction expenses across all three years (2022–2024), with consistent citation to Note 2 on revenue recognition. The description of the pricing model as fixed-plus-variable, tiered by volume, and without capitalized contract assets is factually correct and aligns with the ground truth. Quantitative accuracy is perfect—no numbers, dates, or financial terms are incorrect, and all references to filing sections are plausible and consistent. Contextual relevance is high, as the response directly addresses the question’s focus on transaction pricing, processor use, and contract structure. However, the LLM answer falls short in completeness and qualitative accuracy by omitting two key developments from the original answer: (1) the 2023 clarification on user incentives being recognized as revenue reductions or amortized, which introduces variability into margins, and (2) the 2024 adoption of ASU 2023-07, which changed segment reporting and increased transparency around segment-level expenses, affecting how margin risk is analyzed. These omissions represent a failure to fully synthesize multi-hop information across years, particularly the evolving operational nuances in margin risk despite structural stability. While the conclusion that margin risk 'stayed essentially unchanged' is defensible, it overlooks these incremental changes that add complexity to the risk profile. Thus, while factually sound, the answer lacks the full depth of the ground truth’s nuanced assessment, warranting a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 478,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "Cisco’s 5.90 % senior note has remained unchanged at a $2 billion principal balance in each of the three years – $2 billion out of $9 billion of long‑term debt in FY 2022 (≈22 % of the portfolio), $2 billion out of $8.5 billion in FY 2023 (≈23 %), and $2 billion out of $20.3 billion in FY 2024 (≈10 %)【page_89】.  The note’s effective interest rate has also been steady at about 6.11 % in FY 2022, FY 2023 and FY 2024【page_89】.  This consistency shows that Cisco has kept the high‑coupon, long‑dated 5.90 % note on its balance sheet as a stable source of long‑term financing, while the overall debt mix has shifted toward larger, lower‑cost issuances, indicating a strategy of maintaining liquidity with a modest, unchanged financing cost for this particular tranche.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Cisco maintained a $2,000 million ($2 billion) outstanding balance on the 5.90% Note across fiscal years 2022–2024 and that the effective interest rate remained constant at 6.11%, matching the ground truth exactly. These figures are reported accurately with acceptable formatting variations (e.g., $2 billion vs $2,000 million). (2) All quantitative data — principal amount, effective rate, and percentage of total long-term debt in each year — are factually correct and consistent with the source. The percentages cited (≈22%, ≈23%, ≈10%) are reasonable approximations based on the total debt figures provided ($9B, $8.5B, $20.3B), and calculations check out: 2/9 ≈ 22.2%, 2/8.5 ≈ 23.5%, 2/20.3 ≈ 9.85%). (3) The multi-hop reasoning is sound: the model correctly synthesizes data across years and contextualizes the stable note within broader changes in Cisco’s debt portfolio. It infers a strategic choice — maintaining a high-coupon, long-dated tranche while shifting the overall mix toward lower-cost debt — which aligns with and extends the ground truth insight without overreaching. (4) The only minor limitation is that the original answer emphasizes the lack of refinancing or modification, while the LLM focuses more on strategy implications; however, the LLM’s interpretation is fully supported by the data and adds valuable context. Thus, factual accuracy is excellent, reasoning is strong, and relevance is complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 409,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "In the 2022 Form 10‑K the Intellectual‑Property section first lists Kobalt alongside other private‑brand names, signaling its introduction as a protected, strategic brand. The 2023 and 2024 filings repeat the same language—“private brand product names, such as ‘Kobalt’, ‘STAINMASTER’ and ‘allen+roth’”—showing that Lowe’s continues to treat Kobalt as a core, actively‑protected private brand with no change in emphasis. Thus, from FY 2022 through FY 2024 the positioning of Kobalt has remained steady, consistently highlighted as a key private‑brand asset in the company’s IP disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that Kobalt was mentioned in the intellectual property disclosures in fiscal 2022, 2023, and 2024 as part of Lowe's private brand portfolio, alongside 'STAINMASTER' and 'allen+roth'. The answer accurately notes the consistent language across the years, indicating no change in strategic emphasis, which matches the original answer's conclusion of a stable strategic role. The only minor discrepancy is the use of the word 'first lists' in the 2022 filing, which could imply Kobalt was newly introduced then; however, the ground truth does not confirm this was its first-ever appearance, only that it was listed in 2022 through 2024. This slight overinterpretation does not undermine the overall correctness, as the core facts—consistent mention, no increased prominence, ongoing protection—are all accurate. There are no numerical values to evaluate, so quantitative accuracy is scored based on correct fiscal year references (2022–2024), which are precise. The reasoning is sound, synthesizing information across three years of disclosures to infer stability in strategic emphasis. The answer is contextually relevant and fully addresses the question about evolution (or lack thereof) in positioning and strategic emphasis. Semantic equivalence is strong, with only minor wording differences from the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 391,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "- **2022 filing (as of 12/31/2021)** – the Unsecured Notes 37B carried a **2.25 % fixed rate**, a **$700 million face amount**, and matured on **January 15 2032**【page_50†L71-L73】.  \n- **2023 filing (as of 12/31/2022)** – the same note is listed with **the identical 2.25 % rate, $700 million face amount and 01/15/32 maturity**, indicating no amendment or refinancing during the year.  \n- **2024 filing (as of 12/31/2023)** – the note again shows **2.25 % interest, $700 million face, and a 01/15/32 maturity**【page_51†L31-L33】.  \n\n**Interpretation:** Across three consecutive years Simon Property Group kept the 37B unsecured note unchanged, preserving a low‑cost, long‑dated fixed‑rate debt tranche. This consistency reflects a financing strategy that relies on a ladder of long‑term, low‑interest unsecured notes to lock in cheap capital, support liquidity and reduce refinancing risk.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual details—interest rate (2.25%), face amount ($700 million), and maturity date (01/15/32)—for each year from 2022 through 2024, matching the ground truth exactly. The face amount is correctly rendered as $700 million, equivalent to $700,000 in thousands as used in SEC filings, and formatting variations (e.g., '01/15/32' vs 'January 15 2032') are semantically equivalent. (2) All numeric values are accurate: the interest rate, dollar amount, and date are consistent across years and align with the original answer. No calculations were required, but the synthesis of unchanged values over time is correctly interpreted. (3) The multi-hop reasoning is sound—the model correctly identifies that the same debt instrument appears unchanged across three annual filings, synthesizing data from 2022, 2023, and 2024 reports to confirm stability. (4) The interpretation accurately reflects the company’s long-term financing strategy: maintaining fixed-rate, long-dated debt to lock in low costs and reduce refinancing risk, which is consistent with the ground truth’s conclusion about confidence in debt management and favorable conditions. All aspects of the question—evolution over time, specific metrics, and strategic implication—are fully and correctly addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 369,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "Across all three years, Texas Instruments’ Melaka, Malaysia site was listed only under the **Analog** segment and never under **Embedded Processing**. In the 2022, 2023 and 2024 property tables the Melaka entry shows an “X” in the Analog column and a blank in the Embedded‑Processing column, indicating that the facility’s role remained unchanged—solely supporting Analog products.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia facility was involved exclusively in the Analog segment across 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced, and the use of 'X' and blank entries in property tables aligns with the source data interpretation. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and two business segments, confirming consistency over time. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in TXN's operational footprint in Melaka. Minor wording differences (e.g., referencing table entries) do not affect factual accuracy. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 286,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "PayPal’s outstanding principal on the fixed‑rate 2.850 % notes was $1.5 billion in each of the three most recent years – $1.5 billion at 12/31/2022 (2022 10‑K, page 107), $1.5 billion at 12/31/2023 (2023 10‑K, page 107) and $1.5 billion at 12/31/2024 (2024 10‑K, page 104). The amount has not changed, showing that PayPal has kept its exposure to this long‑dated, low‑cost debt flat, indicating a deliberate strategy of maintaining a stable long‑term debt profile while using new issuances and repurchases to manage overall leverage rather than expanding the 2.850 % note tranche.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $1.5 billion principal amount for the 2.850% notes is accurately reported for 2022, 2023, and 2024, with proper citation of the 10-K filing years and page numbers (minor variation in 2024 page number is acceptable and does not affect accuracy). (2) The core factual claim—that exposure remained constant—is fully supported and matches the original answer. (3) The reasoning is sound: the LLM correctly infers that maintaining the same principal indicates a deliberate strategy to keep this low-cost, long-term debt tranche stable while managing leverage through other means (e.g., new issuances and repurchases). (4) The LLM captures the key implication about PYPL’s debt management strategy, though it omits specific mention of the retirement of the 1.350% notes by 2023 and the introduction of new high-interest notes in 2024, which are included in the ground truth for contrast. This omission slightly reduces completeness in multi-hop synthesis but does not invalidate the overall conclusion. Semantic equivalence is strong, and the answer is fully relevant to the question. Minor deduction from 10 to 9 due to incomplete contextual contrast with other debt actions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 360,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "Across all three years the Hoofddorp, Netherlands site has been described in Gilead’s 10‑K filings as a dedicated plant for **commercial manufacturing and processing of the company’s cell‑therapy products**. In the 2022 filing it was listed among the principal manufacturing locations for cell‑therapy, and the 2023 and 2024 filings repeat the same description, showing that the facility’s role has remained stable – it continues to serve as a key hub in Gilead’s global manufacturing strategy for cell‑therapy products without any expansion or reduction of scope.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that Hoofddorp was listed as a principal manufacturing facility in 2022 and maintained its role in commercial manufacturing and processing of cell therapy products in 2023 and 2024. All entities (Gilead, Hoofddorp, Netherlands, cell therapy products) and years are correct. There are no numeric inaccuracies, so quantitative accuracy is perfect. The reasoning is sound: the LLM correctly synthesizes the facility’s consistent role across the three years. The only minor shortcoming is that the original answer emphasizes a *progression* and 'growing emphasis'—suggesting an evolving strategic importance—even if the functional description remained the same. The LLM answer interprets the unchanged description as indicating 'stable' role without expansion or reduction, which slightly underrepresents the ground truth's nuance of deepening strategic role. However, this does not contradict facts and remains semantically close. Thus, correctness and qualitative accuracy are high but not perfect due to this subtle interpretive difference. Contextual relevance is full—directly addresses the evolution question with appropriate focus on role continuity and strategic importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 356,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "- **2022 filing:** The 1.375 % Senior Notes due June 2027 were carried at **$1.25 billion** of long‑term debt, and the total **current portion of debt was only $73 million** (so virtually none of the 1.375 % notes was classified as current).  \n\n- **2023 filing (reported in the 2024 10‑K):** The same $1.25 billion of 1.375 % notes remained on the balance sheet, but the **current portion of total debt rose sharply to $1.081 billion**, indicating that a large share of the senior‑note portfolio—including the 1.375 % issue—was re‑classified as amounts due within the next year.  \n\n- **2024 filing:** The 1.375 % notes are still shown at **$1.25 billion** of long‑term debt, while the **current portion fell back to $103 million**, reflecting that the notes are now treated primarily as long‑term obligations with only a modest amount due in the next 12 months.  \n\nThus, from 2022 to 2024 the 1.375 % Senior Notes stayed at the same principal amount, but their classification shifted: virtually all long‑term in 2022, largely current in 2023, and again mainly long‑term with a small current portion in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the principal amount of $1.25 billion (equivalent to $1,250 million) is consistently reported across 2022–2024, and the current portion values—$73 million in 2022, $1,081 million in 2023, and $103 million in 2024—are correctly stated with appropriate formatting variations (e.g., $1.25 billion = $1,250 million). (2) The answer is complete, addressing both the stable principal amount and the evolving classification of the current portion of debt over the three years, directly responding to the question about long-term debt composition and current portion classification. (3) Entity accuracy is perfect: Costco, the 1.375% Senior Notes, and the due date (June 2027) are correctly identified, and the years referenced (2022–2024) align with the filings. (4) The reasoning is sound and reflects proper multi-hop synthesis: the LLM correctly infers that the spike in the current portion in 2023 indicates reclassification of a large share of the notes as short-term, followed by a return to long-term classification in 2024, which demonstrates understanding of debt maturity dynamics. (5) The semantic meaning is equivalent to the original answer, with clear, well-structured explanations that convey the same core insight: stable principal but shifting current/long-term classification. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 403,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "- 2022: The September 2019 issuance of Fixed‑rate 2.850 % notes (maturing 10/1/2029) carried an outstanding principal of **$1.5 billion** (see the 2023 Form 10‑K table that lists the 2022 amount)【page_107】.  \n- 2023: The same 2.850 % series remained at **$1.5 billion** (2023 column of the same table)【page_107】.  \n- 2024: The 2024 Form 10‑K shows the 2.850 % notes still at **$1.5 billion** (2024 column)【page_104】.  \n\n**What this shows:** PayPal has kept the $1.5 billion tranche of its 2.850 % notes unchanged for three consecutive years, indicating a deliberate strategy to maintain a stable, long‑term debt profile rather than expanding that particular liability. By leaving this senior unsecured series flat while issuing new notes at other rates and maturities, the company manages its overall leverage and refinancing risk without adding additional burden from this mid‑term tranche.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.5 billion carrying amount of PayPal's Fixed-rate 2.850% notes for all three years—2022, 2023, and 2024—which matches the ground truth exactly. The maturity date (October 1, 2029) and the origin of the note as part of the September 2019 $5.0 billion issuance are implied through context and correctly referenced in the 2023 and 2024 Form 10-Ks. All numeric values (dollar amounts, interest rate, years) are accurate and properly cited to specific pages in the filings. (2) Quantitative accuracy is perfect: $1.5 billion is consistently reported across all years, the 2.850% rate is correct, and the maturity timeline aligns with the original answer. No calculations were required, but the consistency check across years was performed correctly. (3) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers from unchanged obligations across multiple filings that PayPal maintained this tranche without refinancing or reducing it, despite activity in other debt tranches. The conclusion about a strategy of maintaining stable long-term debt exposure while managing leverage elsewhere aligns closely with the ground truth. However, the LLM omits explicit mention that this stability occurred amid refinancing in *other* tranches—a nuance present in the original answer that strengthens the strategic interpretation. This minor omission prevents a perfect qualitative score. (4) The answer is highly contextually relevant, directly addressing both the evolution of the obligation and the implied debt management strategy. Wording differs slightly but maintains semantic equivalence. Overall, this is a highly accurate, well-supported response with only a minor gap in strategic nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 480,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "**Evolution of the gas‑option position**\n\n* **2022 → 2023:**  The 10‑K shows that NEE’s gas‑related option contracts were roughly balanced – about **$100 million of assets versus $97 million of liabilities** at 31 Dec 2023, leaving a net‑positive exposure of only a few million dollars.  The weighted‑average implied volatility used in the option models was **≈ 50 %** and the implied correlation was **≈ 57 %**.  \n\n* **2023 → 2024:**  At 31 Dec 2024 the same option line still carried **≈ $100 million of assets but $102 million of liabilities**, turning the net position into a small liability (‑$2 million).  The volatility assumption stayed roughly the same (**≈ 52 %**) while the implied‑correlation assumption jumped to **≈ 99 %**.\n\n**What the trend says about risk positioning**\n\nThe size of the gas‑option book has been essentially unchanged (≈ $100 million on each side), but the fair‑value swing from a modest asset in 2023 to a modest liability in 2024 shows NEE is tightening its hedge and accepting a slightly higher cost to stay protected.  The rise in the correlation assumption – together with a steady‑to‑slightly higher volatility assumption – signals that the company perceives greater co‑movement risk among gas‑price drivers and is positioning its option portfolio to absorb larger, more correlated price moves in the gas market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant factual inaccuracies in the quantitative data, particularly for 2022. The ground truth states that in 2022, NextEra Energy had $356 million in assets and $347 million in liabilities for gas-related options, but the LLM answer omits these entirely and incorrectly implies that the $100 million asset level was already in place by 2023, without acknowledging the sharp decline from 2022. This misrepresents the evolution of exposure. Additionally, the implied volatility trend is misrepresented: the ground truth shows a decline from 36% in 2022 to 50% in 2023 and 52% in 2024, but the LLM implies volatility increased or remained stable, interpreting it as rising from ~50% to ~52%, missing the fact that volatility actually increased from 36% to 50%—a significant jump—not a steady or slight rise. 2) The LLM correctly reports the 2023 and 2024 fair values (approximately $100M assets, $97M liabilities in 2023; $100M assets, $102M liabilities in 2024), though it rounds and approximates where exact figures were available. However, it fails to mention the substantial reduction in position size from 2022 to 2023, which is a key part of the trend. 3) The reasoning is partially sound in interpreting the net shift from small asset to small liability and the rising correlation, but it draws incorrect conclusions about risk positioning because it misses the major de-risking implied by the 70%+ reduction in option fair value from 2022 to 2023. Instead, it suggests the position size is stable, which contradicts the data. The multi-hop synthesis fails because it does not connect the 2022 data to the later years to show a clear trend of de-risking. 4) While the answer is relevant and structured well, the core quantitative errors—especially the omission of 2022 values and misstatement of volatility direction—severely undermine factual correctness. The conclusion about increasing hedge costs and higher protection is speculative and not supported by the ground truth, which points to de-risking via reduced exposure, not tighter hedging. Thus, the correctness score is low due to major factual and interpretive errors, despite some accurate data points and relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 590,
        "total_tokens": 2086
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "Cisco’s “other income (loss), net” was heavily affected by the performance of its available‑for‑sale debt portfolio. The AFS debt investments posted a **$9 million gain in fiscal 2022**, turned into a **$21 million loss in fiscal 2023**, and widened to a **$67 million loss in fiscal 2024** (see the “Gains (losses) on investments, net” table)【page_46】. Because these swings moved the overall other‑income line from a **$392 million gain in 2022** to a **$306 million loss in 2024**【page_46】, they reveal that Cisco’s investment portfolio has become increasingly volatile, with AFS debt holdings shifting from modest earnings to sizable losses over the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values ($9M gain in 2022, $21M loss in 2023, $67M loss in 2024, and shifts in other income from $392M gain to $306M loss) that are not present in the original ground truth answer. The ground truth does not provide any exact figures for AFS debt investment gains/losses or total other income (loss), net for any fiscal year. These numbers appear to be fabricated or extracted from a source not reflected in the provided knowledge graph, making them factually unsupported. (2) There is no verification possible for the cited 'Gains (losses) on investments, net' table on page 46, as no such document was provided in the context. The original answer only describes qualitative trends—increasing losses and volatility—without citing dollar amounts. Thus, the quantitative accuracy is low due to the introduction of unverified and unsupported figures. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that AFS debt investment performance negatively impacted other income (loss), net over time and concludes increasing volatility, which aligns with the original answer’s claim about growing portfolio volatility. It synthesizes the connection between AFS debt performance and overall other income correctly in direction and trend. (4) While the qualitative interpretation and direction of impact (worsening performance, increased volatility) match the ground truth, the inclusion of precise but unverified numbers undermines factual correctness. The answer is contextually relevant and addresses both parts of the question—impact on other income and implications for volatility—but the unsupported figures reduce its overall correctness significantly. Minor point: the term 'heavily affected' is a stronger claim than the original, which notes a 'negative impact' but also acknowledges offsetting gains from equity investments, slightly overstating the case.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 522,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "- In the 2022 Form 10‑K the 4.550 % notes are shown as a **Fifteenth Supplemental Indenture** dated April 5 2019 (4.550 % Notes due April 5 2049) 【page 75†L16-L18】.  \n- The 2023 Form 10‑K’s exhibit schedule still lists the same 4.550 % notes under exhibit 4.16 (the April 5 2019 indenture) 【page 82†L15-L18】, and the 2024 Form 10‑K’s exhibit table continues to carry that same entry (exhibit 4.16) 【page 73‑77, exhibit list shows 4.16 and later numbers】.  \n\nThis repeated documentation, without any new 4.550 % issuances, shows that Lowe’s issued the 4.550 % notes once in 2019 and has been maintaining and reporting them each year, reflecting a strategy of locking in long‑dated, fixed‑rate debt and keeping it on the balance sheet as a cornerstone of its long‑term financing mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.550% Notes due April 5, 2049, were issued under the Fifteenth Supplemental Indenture on April 5, 2019, and were consistently referenced in the 2022, 2023, and 2024 Form 10-K filings. The exhibit numbers (e.g., 4.16) and page references are accurately cited, though these are supplementary and not part of the core financial data. (2) Quantitative accuracy is perfect: percentages (4.550%), dates (April 5, 2019, and April 5, 2049), and years (2022–2024) match the ground truth exactly. No calculations were required, but the temporal consistency is correctly interpreted. (3) The multi-hop reasoning is sound—by observing the unchanged documentation across three years, the LLM correctly infers that Lowe’s has maintained a stable long-term debt strategy without modifications or new issuances of this note. The conclusion that this reflects a strategy of locking in long-dated, fixed-rate debt is logically supported and semantically equivalent to the ground truth’s interpretation. (4) The only minor shortcoming is that the LLM does not explicitly state that there was 'no change in the documentation or terms'—a nuance present in the original answer—but this is implied by the repeated references. Overall, the answer is factually complete, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 393,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "- **2022 filing (data as of 12/31/2021):** Unsecured Notes ‑ 35B carried a face amount of **$750 million** and an **interest rate of 3.80 %**【page_50】.  \n- **2023 filing (data as of 12/31/2022):** The same 35B issue still showed a **$750 million face value** and **3.80 % coupon**【page_50】.  \n- **2024 filing (data as of 12/31/2024):** The 35B notes remained unchanged at **$750 million** with a **3.80 % rate**【page_51】.  \n\n**Interpretation:** SPG has kept the 35B unsecured note unchanged for three years, using a long‑dated (maturing 07/15/2050) fixed‑rate instrument to lock in a relatively low 3.80 % cost of capital. This stability signals a deliberate long‑term debt strategy that emphasizes interest‑rate certainty and maturity extension, preserving liquidity while limiting exposure to rising rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the face value of $750 million and interest rate of 3.80% for Unsecured Notes - 35B across 2022, 2023, and 2024, matching the ground truth exactly. It also correctly identifies the maturity date as 07/15/2050, consistent with the original answer. All numeric values (dollar amounts, percentages, dates) are accurate and properly formatted, with acceptable variation in presentation ($750 million vs $750,000,000). (2) Quantitative accuracy is perfect: all numbers align with the ground truth, including the stable face value and fixed interest rate over the three-year period. (3) The multi-hop reasoning is sound—information is synthesized correctly across three annual filings (2022–2024), and the conclusion about SPG’s long-term debt strategy (emphasizing rate certainty, long-dated maturities, and stability) is logically derived and semantically equivalent to the ground truth interpretation. The only minor shortcoming is that the LLM does not explicitly mention the extension of the maturity date as a refinancing or restructuring event (though it correctly notes the date remains the same), which slightly weakens the qualitative reasoning compared to the original answer’s emphasis on 'no refinancing or restructuring.' (4) The answer is highly contextually relevant, directly addressing both the evolution of the debt instrument and the strategic implications. Overall, the response is factually complete and well-reasoned, warranting a high correctness score with a small deduction for the slightly less precise strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 438,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "**2022:** PayPal’s 2022 risk‑factor section warned that “bad transactions” – fraud, erroneous payments and charge‑backs – could drive large losses, especially through its buyer‑seller protection programs and the default risk on its U.S. consumer‑credit and merchant‑financing products. It stressed that these losses could be magnified by cross‑border trade (which generates higher margins but adds currency, tariff and regulatory complexity) and by heavy reliance on unaffiliated banks, payment processors and other third‑party service providers that it could not fully control.  \n\n**2024:** The 2024 filing repeats the same exposure but shows a more detailed, proactive stance: the company now highlights diversification of its payment‑processor relationships, a multi‑year forward‑flow BNPL‑receivable sale, and expanded third‑party‑risk‑management policies, while still acknowledging that cross‑border volumes remain a key profit source but remain sensitive to foreign‑exchange, trade‑policy and legal‑jurisdiction risks.  \n\n**Trend insight:** Across the three years the core risk of bad transactions has remained, but PayPal’s narrative shifts from merely flagging the threat to describing concrete mitigation actions (processor diversification, strategic funding arrangements, tighter third‑party oversight). This evolution signals a more deliberate risk‑management strategy and greater operational resilience despite continued exposure to credit‑product defaults, cross‑border volatility and third‑party dependencies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: PayPal's 2022 risk disclosures around bad transactions, credit defaults (especially U.S. consumer credit), cross-border trade risks, and third-party dependencies are accurately described. The 2024 update correctly reflects ongoing exposure but emphasizes mitigation strategies. The key quantitative element—the multi-year agreement to sell up to €40 billion in BNPL receivables—is implied through the mention of a 'multi-year forward-flow BNPL-receivable sale,' though the exact amount (€40 billion) is omitted. This is a minor omission but does not distort the factual picture. (2) No calculation errors; no incorrect numbers or dates. The years (2022, 2024) are correctly used, and while 2023 is not explicitly mentioned, the evolution between 2022 and 2024 captures the trend accurately. (3) Multi-hop reasoning is sound: the LLM synthesizes risk exposure across credit products, cross-border trade, and third parties, and correctly infers a strategic shift from passive risk acknowledgment to active mitigation via asset sales, processor diversification, and third-party oversight. The evolution in risk management strategy is logically and accurately portrayed. (4) Semantic equivalence is strong: the LLM conveys the same core insight as the ground truth—PayPal has moved from internal risk absorption to external risk mitigation—using different but equivalent phrasing. The only minor gap is the lack of explicit mention of the 'valid-when-made' doctrine in 2024, which is a nuanced legal risk noted in the original but not critical to the overall trend. Overall, the answer is factually robust, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1644,
        "completion_tokens": 483,
        "total_tokens": 2128
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "Across all three filings (2022, 2023 and 2024) Costco repeatedly lists BJ’s Wholesale Club as one of its primary warehouse‑club rivals. In each year’s “Competition” section the company also stresses that its private‑label brand, Kirkland Signature, “are high‑quality, offered at prices generally lower than national brands, help lower costs, differentiate our merchandise offerings, and generally earn higher margins,” and it “expects to continue to increase the sales penetration of our private‑label items.” Thus, Costco’s competitive positioning relative to BJ’s remained consistent—BJ’s stays a key competitor—and the firm’s reliance on Kirkland Signature as a differentiating, margin‑enhancing private‑label strategy was reaffirmed each year, with no substantive shift in emphasis from 2022 through 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly identifies that from 2022 to 2024, Costco consistently listed BJ's Wholesale Club as a key competitor and emphasized Kirkland Signature as a strategic differentiator, with no substantive shift in strategy—this matches the ground truth's assertion of stable competitive positioning. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable in a strict sense; however, the LLM correctly references the three-year period (2022–2024) without error. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual filings to identify consistency in both competitive framing and strategic emphasis on private-label brands. (4) The LLM accurately uses entity names (Costco, BJ's Wholesale Club, Kirkland Signature), correct time frame, and correct strategic context (private-label as margin-enhancing, cost-lowering, and differentiating). Wording differs slightly but conveys the same meaning, including direct alignment on the role of Kirkland Signature and the unchanging nature of the competitive strategy. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 361,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "**Fair‑value of the gas‑forward portfolio**\n\n| Year (end‑Dec 31) | Fair‑value of gas‑forward **assets** | Fair‑value of gas‑forward **liabilities** |\n|-------------------|--------------------------------------|-------------------------------------------|\n| 2022 | **≈ $ 500 million**【NEE 2022 10‑K p.84】 | **≈ $ 120 million**【NEE 2022 10‑K p.84】 |\n| 2023 | **$ 377 million** (Level 3 assets)【NEE 2023 10‑K p.84】 | **$ 77 million** (Level 3 liabilities)【NEE 2023 10‑K p.84】 |\n| 2024 | **$ 296 million** (Level 3 assets)【NEE 2024 10‑K p.86】 | **$ 46 million** (Level 3 liabilities)【NEE 2024 10‑K p.86】 |\n\n**What the trend tells us**\n\n- **Downward movement:** Both the asset and liability fair values of the gas‑forward contracts have been shrinking each year – from roughly $500 m/$120 m in 2022 to $296 m/$46 m in 2024.  \n- **Reduced net exposure:** The net position (assets – liabilities) fell from about $380 m in 2022 to $250 m in 2024, indicating that NextEra Energy is scaling back the size of its hedged gas position.  \n- **Risk positioning:** By lowering the absolute fair‑value exposure, the company limits the potential impact of adverse natural‑gas price moves while still retaining a modest positive hedge. The progression suggests a more **conservative, risk‑averse stance** in the natural‑gas market, emphasizing protection of cash flow over aggressive price speculation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data, particularly for 2022. The ground truth states that in 2022, NextEra Energy's gas forward contract assets were $191 million and liabilities were $31 million. However, the LLM reports $500 million in assets and $120 million in liabilities for 2022, which is a major deviation. The 2023 and 2024 figures for assets and liabilities are partially correct: $377 million in assets (correct) and $77 million in liabilities (incorrect; ground truth is $46 million in 2024, but no explicit 2023 liability value is given in the original answer—only 2022 and 2024). The LLM incorrectly assumes 2023 liability is $77 million based on Level 3 liabilities, but this is not supported by the ground truth. (2) Calculations are flawed: the net exposure in 2022 is reported as $380 million by the LLM, but with incorrect inputs. The actual net exposure should be $160 million in 2022 ($191M - $31M), not $380M. The trend interpretation is therefore based on false premises. (3) Multi-hop reasoning is compromised because the model misreads the 2022 data, leading to an incorrect conclusion about a 'downward movement' and 'scaling back' of exposure. In reality, the ground truth shows an increase from 2022 to 2023 in assets ($191M → $377M), followed by a drop to $296M in 2024—indicating volatility and strategic expansion, not consistent reduction. The LLM's conclusion of a 'conservative, risk-averse stance' contradicts the ground truth's interpretation of 'strategic expansion in gas market participation, accompanied by rising market risk.' (4) Contextual relevance is moderate: the structure, use of tables, and focus on fair value, net exposure, and risk positioning directly address the question. However, due to severe quantitative errors and resulting flawed reasoning, the overall correctness is low. Minor formatting variations in numbers are acceptable, but magnitude errors (e.g., $191M vs $500M) are not. The LLM appears to have misread or misattributed data from the cited 10-K pages, undermining trust in the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 567,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "Lowe’s forward‑interest‑rate‑swap program started out large and active – the 2022 10‑K shows a notional amount of $2.56 billion of forward swaps used as cash‑flow hedges for anticipated debt issuances (Note 9, page 62). By the 2023 filing the swaps remained on the balance sheet but had been reduced to a fair‑value carrying amount of $251 million (page 54) and were still described as cash‑flow hedges of forecast‑debt (page 46). In the 2024 filing the forward‑swap line disappears entirely (page 54 shows “$‑”), indicating the contracts were settled or unwound. This trajectory – from a sizable hedge in 2022 to a gradual unwind by 2024 – shows Lowe’s initially locked in borrowing costs when rate volatility was high, then phased the hedges out as market conditions and its financing plans evolved, reflecting a flexible, market‑responsive interest‑rate risk‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the LLM correctly identifies the $251 million fair value of forward interest rate swaps as of 2023 (matching the original answer's $251M as of February 3, 2023), and accurately notes their absence in the 2024 filing (represented as '$-' on page 54). While the $2.56 billion notional amount in 2022 is not explicitly mentioned in the ground truth, it is a plausible detail from the 10-K (Note 9, page 62) and does not contradict the original answer, which confirms active use of swaps in 2022. The absence of this number in the ground truth does not make the LLM factually incorrect, as it adds granularity rather than introducing error. (2) The timeline is correct: active hedging in 2022, continued but reduced position in 2023, and full unwind by 2024. (3) The multi-hop reasoning is sound—LLM synthesizes data across three years, correctly infers the strategic intent (locking in rates during volatility, then unwinding as conditions evolved), and ties it to interest rate risk management. (4) All entities (Lowe’s, forward interest rate swaps, cash flow hedges, fiscal years) are correctly identified. The only minor gap is that the ground truth emphasizes the swaps’ impact on other comprehensive income in 2022, which the LLM omits, but this is a contextual detail rather than a core factual omission. Overall, the LLM provides a more detailed and equally accurate narrative with strong semantic equivalence and excellent contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 422,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "- **2022:** Comcast’s 2022 filing lists Lumen (along with AT&T, Frontier and Verizon) as a “wireline telecommunications company … that has built and is continuing to build fiber‑based network infrastructure … and are offering services with higher speeds in many of our service areas” 【page_9】. At that time Comcast’s own network was still largely hybrid‑fiber/coax, with a multiyear plan that in 2022 began rolling out 2 Gbps downstream speeds to about one‑third of its footprint and prepared to deploy DOCSIS 4.0 in 2023 【page_7】.\n\n- **2023:** The 2023 filing repeats the same competitive description, again noting Lumen’s ongoing fiber expansion as a key threat to Comcast’s broadband business 【page_8】. Meanwhile Comcast’s network‑transformation progress continued, with DOCSIS 4.0 deployments in select markets and further extensions of fiber‑to‑the‑premises (FTTP) 【page_7】.\n\n- **2024:** By 2024 Comcast emphasizes that it now offers “fiber‑based services that deliver symmetrical speeds ranging up to 10 Gbps to residential customers … and up to 100 Gbps to business customers” 【page_6】 and that DOCSIS 4.0 is being rolled out to deliver multigigabit symmetrical speeds 【page_7】. The competition section still cites Lumen’s continued fiber build‑out, but Comcast’s expanded FTTP footprint and higher‑speed offerings position it to match or exceed Lumen’s speeds in overlapping markets, allowing Comcast to preserve its bundled video, voice and broadband packages while competing on speed and capacity 【page_8】.\n\n**Overall evolution:** In 2022 Comcast viewed Lumen’s fiber rollout as a growing competitive pressure on its primarily HFC‑based broadband. Over the next two years Comcast accelerated its own fiber‑to‑the‑premises and DOCSIS 4.0 deployments, raising residential symmetric speeds to 10 Gbps (and 100 Gbps for business) by 2024. This shift narrowed the speed gap with Lumen and enabled Comcast to continue offering bundled services in markets where both firms now have comparable fiber‑based infrastructure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Lumen is consistently identified as a competitor expanding fiber infrastructure from 2022–2024, and CMCSA (Comcast) responds by accelerating its own fiber and DOCSIS 4.0 deployments. The evolution in service offerings—particularly the increase to 10 Gbps for residential and 100 Gbps for business by 2024—is accurately reported with correct page references. (2) Quantitative accuracy is excellent: speeds (2 Gbps in 2022, 10 Gbps/100 Gbps by 2024), technology rollouts (DOCSIS 4.0 in 2023, FTTP expansion), and timing are all factually consistent with the source data. No calculation errors. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across three years and two companies (CMCSA and Lumen), connecting competitive dynamics with infrastructure changes and service implications. It goes beyond the original answer by adding technical depth (e.g., DOCSIS 4.0, HFC vs FTTP) that enriches the response without introducing error. (4) The only reason for not scoring a 10 is minor: the original answer emphasizes the 'growing influence' and 'intensifying competition' more explicitly, while the LLM slightly reframes the outcome as CMCSA 'matching or exceeding' Lumen—still logically supported, but a subtle shift in emphasis. However, this does not constitute a factual error. Overall, the answer is factually robust, contextually complete, and semantically equivalent to the ground truth with added technical precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1747,
        "completion_tokens": 425,
        "total_tokens": 2172
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "- **2022:** PayPal’s 2022 filing stressed that its growth strategy hinged on “creating seamless checkout experiences” by making the payments platform globally‑available (‑ payments could be sent in >200 markets, in >100 currencies, withdrawn in 56 currencies and held in 25 currencies) and by positioning its consumer‑credit products (PayPal Credit, buy‑now‑pay‑later, credit‑card‑issued cards) as an optional funding source at checkout.  The platform was described as “omnichannel” in that merchants could accept PayPal‑ and Venmo‑wallet payments online or in‑person through a single, unified solution.  \n\n- **2024:** By 2024 the narrative had shifted to a fully integrated, “one‑PayPal” checkout that embeds the consumer‑credit suite (BNPL and credit‑card offerings) directly into the PayPal/Venmo branded checkout flow, expands the open‑ecosystem to include Zettle point‑of‑sale, debit/credit cards and other digital‑wallet partners, and continues to support the same worldwide reach (≈200 markets and >100 currencies) while emphasizing a technology‑agnostic, omnichannel merchant experience that lets merchants sell online, on mobile and in‑store through a single, seamless solution.  \n\nOverall, PayPal moved from a broad, globally‑scaled checkout platform with credit as an add‑on to a tightly‑woven, omnichannel checkout that embeds credit options, maintains extensive currency coverage and unifies online, mobile and in‑store merchant solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth, with only minor discrepancies in quantitative details. (1) Correctly captures PayPal's evolution from 2022 to 2024 in seamless checkout, including integration of consumer credit (PayPal Credit, BNPL), global currency support, and omnichannel merchant solutions. (2) Quantitative accuracy: The LLM states payments in >200 markets and >100 currencies in 2022, which is consistent with the ground truth; however, it omits the 2023 expansion to ~150 currencies mentioned in the original answer. This is a minor omission but affects completeness. The LLM correctly notes continued support for >100 currencies in 2024, though the ground truth specifies the expansion to ~150, so there is a slight underreporting of currency growth. Other numbers (e.g., 56 and 25 currencies for withdrawal and holding) are specific and plausible but not contradicted by the ground truth. (3) Qualitative accuracy and reasoning: The LLM correctly synthesizes multi-hop information across years, identifying the shift from credit as an optional add-on in 2022 to embedded financial services in 2024. It accurately references Zettle, Braintree (implied via 'open-ecosystem' and 'other digital-wallet partners'), and omnichannel capabilities. The 'one-PayPal' narrative is a valid interpretation of the strategic shift. (4) Contextual relevance is excellent—the response directly addresses all three dimensions in the question: consumer credit integration, global currency support, and omnichannel solutions. The only reason for not scoring a 10 is the omission of the 2023 currency expansion detail, which slightly weakens completeness but does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1618,
        "completion_tokens": 468,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "The filings show that the share of purchases made with Target’s proprietary debit‑card product fell from **20.5 % in fiscal 2022**, to **19.8 % in fiscal 2023**, and to **18.6 % in fiscal 2024** (see the RedCard penetration figures in the 2023 10‑K and the Target Circle‑Card penetration figures in the 2024 10‑K). The steady decline in penetration suggests the debit card is becoming a less dominant driver of incremental sales for Target, indicating that its contribution to “extra” spend is diminishing over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains incorrect numerical values for the penetration rates. According to the ground truth, the rates were 20.5% in 2022, 18.6% in 2023, and 17.8% in 2024. However, the LLM reports 20.5% in 2022 (correct), 19.8% in 2023 (incorrect — should be 18.6%), and 18.6% in 2024 (incorrect — should be 17.8%). This represents a consistent overstatement of the penetration rate across the later years. (2) The quantitative inaccuracies are significant because they misrepresent the magnitude and trend of the decline. While the direction of the trend (declining) is correct, the rate of decline is understated — the actual drop from 2022 to 2024 is 2.7 percentage points, whereas the LLM implies a 1.9-point drop. This affects the interpretation of the card's weakening role. (3) The reasoning and multi-hop synthesis are otherwise sound: the LLM correctly identifies that RedCard/Circle Card penetration data comes from different years’ 10-Ks and links declining penetration to reduced incremental sales impact. The qualitative logic — that falling penetration suggests diminishing influence on customer spending — aligns with the ground truth. (4) Contextual relevance is high as the answer addresses both parts of the question: the evolution of penetration and its implication for sales. However, due to the factual errors in key metrics, the correctness score is limited to 6 — partially correct but with significant data inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 403,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "In the 2022 Form 10‑K (see page 59) AMD said that when a contract bundles development services with an IP licence it first determines whether the licence is a **distinct performance‑obligation**. If the licence is not distinct, the two elements are treated as a **single performance‑obligation** and revenue is recognized **over time**; if the licence is distinct, revenue is recognized **at a point in time** when the customer can use the licence. Standalone licences (no development services) are also recognized **at a point in time**. No variable consideration is applied to either type of arrangement.\n\nThe 2024 Form 10‑K (see page 64) repeats the same policy: the company still evaluates the distinctness of the licence, combines it with development services and recognizes revenue **over time** when the licence is not distinct, and records revenue **at a point in time** when the licence is distinct or when the licence is sold/licensed on its own. Again, no variable consideration is involved.\n\n**Thus, from 2022 to 2024 AMD’s revenue‑recognition approach for development‑plus‑IP contracts did not change; the distinction between combined (non‑distinct) arrangements and standalone or distinct licensing deals continues to drive whether revenue is recognized over time or at a point in time.**",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately describes AMD's revenue recognition policy from 2022 to 2024, correctly distinguishing between combined arrangements (where IP license is not distinct and revenue is recognized over time) and standalone or distinct licenses (recognized at a point in time). (2) There are no numeric values requiring calculation in this question, but the LLM correctly references the relevant Form 10-K pages (2022, p.59; 2024, p.64), which supports factual grounding. The absence of variable consideration is also correctly noted, consistent with the original answer’s implication of stable, non-variable treatment. (3) The multi-hop reasoning is sound: the model synthesizes information across 2022 and 2024 filings, confirms consistency over time, and correctly infers no change in policy through 2023 by logical continuity (which the ground truth also assumes). (4) The answer achieves semantic equivalence: it conveys the same core conclusion — that AMD’s approach remained stable across the three years — with greater specificity by citing actual document pages and contractual logic. Wording differs slightly but meaning is preserved and enhanced with precision. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 363,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "Nike’s 10‑K filings show that FlyEase moved from being mentioned simply as one of a long list of new performance platforms in fiscal 2022 (“the proliferation of Nike Air, Zoom, Free, Flywire, Dri‑Fit, Flyknit, **FlyEase**, ZoomX, Air Max, React and Adapt…”) to being repeatedly highlighted in the same way in fiscal 2023 and again in fiscal 2024. Across the three years the language shifted from a brief inventory of emerging technologies to a broader statement that the suite of technologies—including FlyEase—“typifies our dedication to designing innovative products,” indicating that FlyEase remained a core, strategically‑positioned element of Nike’s innovation portfolio and was increasingly framed as a flagship component of its technology platform strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misrepresents the evolution of FlyEase's strategic positioning. (1) Quantitatively, there are no errors in dates or fiscal years—2022, 2023, and 2024 are correctly referenced. (2) However, the qualitative reasoning is flawed: the LLM claims FlyEase was mentioned in the same way across all three years and remained a 'core, strategically-positioned element' from the start, which contradicts the ground truth. According to the original answer, FlyEase evolved from an emerging technology in 2022, to being grouped with established platforms in 2023, and finally classified among mature technologies like Air Max and React in 2024—indicating a clear progression in maturity and integration. The LLM fails to capture this trajectory and instead suggests consistent treatment over time, missing the key nuance of FlyEase transitioning from novel to foundational. (3) The multi-hop reasoning is weak: while the model correctly identifies FlyEase as part of Nike’s innovation portfolio, it does not synthesize the changing context of its mentions across years. The ground truth emphasizes a shift in categorization (emerging → established → mature), which the LLM overlooks. (4) Despite this, the answer is contextually relevant and uses appropriate language from 10-K filings (e.g., 'dedication to designing innovative products'), earning points for relevance and phrasing. However, the failure to accurately reflect the strategic evolution significantly undermines factual correctness, warranting a moderate score of 6 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 431,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "The 1.250 % senior notes have been shrinking each year – the 2022 filing shows an aggregate principal of about **$609 million**; the 2023 filing records a reduction of roughly **$6–7 million**, leaving the issue near **$523 million**; and the 2024 filing shows a further cut of about **$5–6 million**, bringing the outstanding balance to roughly **$518 million**. This consistent decline indicates that AMT is deliberately retiring or repurchasing this low‑coupon debt, using cash‑flow and proceeds from newer issuances to lower its overall senior‑note liabilities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer captures the overall trend of declining principal correctly and infers a plausible debt management strategy, which aligns with the ground truth. However, there are significant quantitative inaccuracies: the 2023 principal is stated as 'near $523 million' after a '$6–7 million' reduction from $609 million, but this math does not add up (a $6–7 million reduction from $609 million would leave ~$602–603 million, not $523 million). More critically, the actual 2023 principal is $551.9 million (not $523 million), and the 2024 figure is $517.7 million (LLM says ~$518 million, which is acceptable). The reported reduction from 2023 to 2024 is about $34.2 million ($551.9M → $517.7M), not the '$5–6 million' stated. 2) The dollar amounts are not consistently accurate: $609 million (2022) is correct; $523 million (2023) is wrong (should be $551.9 million); $518 million (2024) is close to the correct $517.7 million. The reductions are miscalculated and misrepresented. 3) The reasoning about a deliberate debt retirement or repurchase strategy is sound and consistent with the trend, and the mention of using cash flow or new issuances is a reasonable qualitative extension. The maturity date and interest payment schedule are omitted, which is a minor completeness issue. 4) Despite incorrect intermediate values and reduction amounts, the core conclusion about a consistent decline and strategic debt reduction is valid, warranting a moderate correctness score. The contextual relevance is high as the answer directly addresses the trend and strategy. Quantitative accuracy is penalized due to incorrect figures and implausible reduction amounts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 452,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "- Fiscal 2022 – NVIDIA issued the unsecured senior 3.50 % notes due 2040 with a $1 billion principal; they were carried at original‑issuance value (net of an un‑amortized discount of roughly $45 million) and reported at fair value essentially equal to that carrying amount (Level 2).  \n- Fiscal 2023 – the same $1 billion of notes remained on the balance sheet, the un‑amortized discount fell to $41 million and the Level 2 fair‑value estimate slipped to $870 million.  \n- Fiscal 2024 – the discount was further amortized to $37 million, the fair‑value estimate declined to $851 million, while the principal and net carrying amount stayed at $1 billion.  \n\nThe three‑year trend shows NVIDIA gradually amortizing the discount on a fixed‑rate, long‑dated bond while the market‑value of the liability drifts slightly lower, indicating a deliberate strategy of locking in low‑cost, long‑term financing and maintaining the notes as a stable, redeemable component of its capital structure rather than aggressively refinancing or retiring them.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers compared to the ground truth. Most critically, the fair value in fiscal 2022 is reported as 'essentially equal to carrying amount' with no specific fair value given, while the ground truth states it was $1,066 million. The LLM reports $870 million for 2023, whereas the ground truth is $851 million. For 2024, the LLM incorrectly states the fair value declined to $851 million, but the ground truth shows the fair value was no longer reported and instead the notes were carried at $1,000 million (par) with an effective interest rate of 3.54% — a key detail omitted. The LLM also introduces an un-amortized discount ($45M, $41M, $37M) and carrying value details not present in the ground truth, which may be plausible but are unsupported by the provided truth data. (2) Calculations: The trajectory of fair values is inconsistent — the LLM shows a continuous decline in fair value ($~1,066M → $870M → $851M), but the ground truth shows a drop from $1,066M to $851M and then a stabilization at $1,000M carrying value in 2024, suggesting market recovery or accounting change. The LLM misses this rebound/stabilization, misrepresenting the trend. (3) Multi-hop reasoning: The LLM correctly identifies the notes as long-term debt and infers a strategy of maintaining stable financing, which aligns with the ground truth’s conclusion about managing liabilities through market fluctuations. However, it fails to note the re-stabilization in 2024, weakening the synthesis. The reasoning is sound but based on incorrect data. (4) Scores justified: Correctness is 6 due to partial accuracy — core concept of long-term debt management is correct, but key numbers and the 2024 valuation trend are wrong. Quantitative accuracy is low (5) due to incorrect fair values and unsupported discount figures. Qualitative accuracy is 7 because the logic and interpretation are reasonable given the assumed data. Contextual relevance is 9 — the answer directly addresses the question’s scope and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 555,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "- **2022 10‑K:** Netflix’s first major plan change was the addition of mobile games to its streaming catalogue and the acknowledgement that it could “adjust our membership pricing, our membership plans, or our pricing model” (p. 7). The filing warned that if games or any price‑adjustment “are not valued by our current and future members” the company could lose both new sign‑ups and existing subscribers.  \n\n- **2023 10‑K:** The company built on the 2022 rollout by launching a “lower‑priced ad‑supported subscription plan,” expanding the games portfolio and beginning to offer “live programming” (p. 6). It again flagged that failure to “attract and retain members” – because the new ad‑supported tier, games or live content are poorly received or because pricing changes are unpopular – would hurt growth.  \n\n- **2024 10‑K:** Netflix described a broader scaling of those same initiatives – “introducing games and advertising on our service, as well as offering live programming” while continuing to tweak pricing and plan structures (p. 7‑8). The risk language now emphasizes that “adjusting our membership pricing, our membership plans, or our pricing model” and the complexity of managing the expanded service suite could “negatively impact our ability to attract and retain members.”  \n\nThus, from 2022 to 2024 Netflix moved from a single‑game expansion to a multi‑feature strategy that adds an ad‑supported tier and live content, repeatedly warning that any mis‑step in pricing or in the perceived value of these new features could impair member acquisition and retention.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Netflix introduced games and warned about member acquisition/retention risks if new features or pricing changes were not valued; in 2023, it launched the ad-supported tier and began live programming, reiterating similar risks; by 2024, it expanded on all three fronts (games, ads, live) and continued to emphasize risks around pricing and perceived value. (2) There are no numeric inaccuracies—dates (2022, 2023, 2024), service expansions, and risk disclosures are factually correct and consistent with the original answer. Format variations (e.g., 'ad-supported subscription plan' vs 'ad-supported tier') are semantically equivalent. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of 10-K filings, tracking the evolution of Netflix’s strategy and associated risks. The only minor shortcoming is that the LLM implies live programming began in 2023, while the original answer presents it as more fully realized by 2024, though the 2023 initiation is plausible and not contradicted. (4) The answer is fully relevant, directly addressing all parts of the question—service expansions, pricing adjustments, and stated risks per year—with strong qualitative synthesis and clear chronological progression. The repeated emphasis on value perception and churn risk matches the original answer’s core message. Thus, the answer earns a 9 for correctness due to near-perfect alignment, with only slight ambiguity on the timing of live programming rollout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1683,
        "completion_tokens": 438,
        "total_tokens": 2121
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "UnitedHealth’s venture‑type exposure grew sharply after 2022.  The company’s total equity‑security holdings rose from **$3.7 billion in 2022** to **$4.9 billion in 2023**, and stayed at **$4.9 billion in 2024**【page_50†L1-L4】.  Meanwhile, equity‑method investments in operating health‑care businesses were **$1.5 billion in 2022**, fell slightly to **$1.4 billion in 2023**, then jumped to **$3.8 billion in 2024**【page_50†L5-L8】【page_52†L1-L4】.  This upward trajectory—especially the large increase in equity‑method stakes in 2024—shows UnitedHealth is deepening its strategic footprint in the health‑care sector, using venture and direct equity investments to broaden its influence over emerging and core health‑care businesses.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor factual inaccuracy in the equity-method investment value for 2022. The ground truth states $1.3 billion, while the LLM reports $1.5 billion. All other numbers are accurate: equity securities correctly listed as $3.7B (2022), $4.9B (2023), $4.9B (2024); equity-method investments correctly noted as $1.4B in 2023 and $3.8B in 2024. (2) Calculations and trends are sound—LLM correctly identifies the stability in equity securities after 2023 and the sharp rise in equity-method investments in 2024. The only numerical error is the incorrect $1.5B figure for 2022 equity-method investments, which affects quantitative precision but not the overall trend interpretation. (3) Multi-hop reasoning is strong: the model synthesizes data across years and investment types, correctly infers strategic intent from financial trends, and connects increased equity-method stakes to deeper operational engagement in healthcare. The conclusion about UnitedHealth deepening its strategic footprint aligns with the ground truth’s interpretation of integrated health services and sector transformation. (4) Contextual relevance is excellent—the answer directly addresses all parts of the question: evolution over time, breakdown by investment type, and strategic implications. Despite the minor error in the 2022 equity-method amount, the core message and trajectory are factually supported and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 403,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "Nike’s relationship with Sojitz America remained unchanged from FY 2022 through FY 2024. Sojitz America continued to be the sole holder of Nike’s $0.3 million of $1‑par redeemable preferred stock, with a cumulative $0.10‑per‑share dividend that must be paid each May 31 before any common‑stock dividends can be declared, and no new preferred shares were issued or redeemed during the three years. In addition to this equity stake, Sojitz America has consistently acted as Nike’s import‑export financing partner, supporting the company’s international sourcing, trade and supply‑chain operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate in terms of quantitative details and entity identification. All financial figures—$0.3 million par value, $0.10 per-share dividend, May 31 payment timing—are correct and match the ground truth. The statement that no shares were issued or redeemed aligns with the consistency emphasized in the original answer. Entity names (Nike, Sojitz America) and time frame (FY2022–FY2024) are accurate. The qualitative description of Sojitz America’s role in import-export financing is factually sound and consistent with the ground truth. However, the LLM answer misses a key evolution highlighted in the original: the shift in narrative from a purely financial relationship (emphasized in 2022–2023) to a more strategically emphasized operational role in 2024 due to rising trade risks and supply chain volatility. While the LLM notes the ongoing financing role, it does not reflect the *evolution* in emphasis that Nike made in its 2024 disclosures, which is central to the question about how the relationship 'evolved.' This omission affects completeness and reasoning depth, particularly in multi-hop synthesis across years. Despite this, the answer remains factually correct and contextually relevant, earning high marks for accuracy and relevance but a slight deduction in qualitative accuracy for missing the strategic shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 375,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "- **Fiscal 2022:** The 3.50 % Notes Due 2050 were carried on the balance sheet at **≈ $1.7 billion**【page_78】.  \n- **Fiscal 2023:** The carrying amount fell to **$1,637 million**【page_67】.  \n- **Fiscal 2024:** It declined further to **$1,604 million**【page_67】.  \n\nThe steady, modest drop from 2022‑2024 shows NVIDIA is gradually reducing the net book value of this long‑dated senior debt—either by repaying principal, amortizing the unamortized discount, or a combination of both—indicating a slight but consistent move toward a lower long‑term debt burden.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported carrying values. According to the ground truth, the value was $2,147 million in fiscal 2022, but the LLM reports ≈$1.7 billion (~$1,700 million), which is off by ~$447 million. For fiscal 2023, the LLM reports $1,637 million, while the ground truth is $1,604 million—this is close but still incorrect. Most critically, the LLM states the value declined further to $1,604 million in fiscal 2024, but the ground truth shows an increase to $2,000 million. This misrepresents the entire trend. (2) The quantitative inaccuracies undermine the answer: the correct trend is a decrease from 2022 to 2023, then a substantial increase in 2024, whereas the LLM describes a continuous decline. Calculations and comparisons are therefore invalid. (3) The multi-hop reasoning is flawed—the LLM fails to correctly synthesize data across the three fiscal years and draws an incorrect conclusion about NVIDIA’s long-term debt positioning. The ground truth indicates a strategic repositioning with increased long-term liabilities in 2024, but the LLM concludes a consistent reduction in debt burden, which contradicts the actual data. (4) Contextual relevance is moderate because the answer addresses the right metric and time frame and attempts interpretation, but due to severe factual and directional errors, the conclusion is misleading. Scores reflect major factual and reasoning failures despite correct metric and company identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 417,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "MetLife’s short‑term borrowing, which includes its commercial‑paper program, fell from $175 million at year‑end 2022 to $119 million at year‑end 2023, then rose sharply to $465 million by year‑end 2024, showing a swing from reduced to markedly higher reliance on the short‑term market. At the same time, the company repeatedly notes that liquidity and capital are sourced from a broad mix of global funding channels—equity, short‑ and long‑term debt, collateral‑financing arrangements, junior subordinated securities, policy‑holder account balances, credit and committed facilities, and a shelf registration—providing flexibility and helping to keep its overall cost of funds lower.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The original answer (ground truth) does not mention any specific dollar amounts for MetLife's commercial paper balances in 2022, 2023, or 2024—yet the LLM asserts precise figures: $175M in 2022, $119M in 2023, and $465M in 2024. These numbers are not supported by the ground truth and appear fabricated, failing the quantitative accuracy test. There is also no mention in the ground truth of a 'sharp rise' or 'swing' in short-term borrowing, undermining the LLM's narrative of evolving reliance. While the ground truth confirms MetLife's consistent use of commercial paper and diversified funding sources across all three years, it emphasizes stability rather than fluctuation. The LLM correctly identifies the qualitative strategy—diverse funding sources to lower cost of capital—and lists relevant instruments (debt, equity, credit facilities, etc.), showing partial understanding of the company's approach. However, the incorrect numerical claims and the resulting misleading interpretation of evolving dependence (from reduced to high reliance) severely compromise the answer's correctness. The multi-hop reasoning is flawed because it invents data rather than synthesizing from the provided information. Contextually, the answer addresses the right themes (short-term debt, funding diversity, cost of capital), so relevance is moderate. Overall, the answer fails on factual accuracy despite capturing some strategic context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 418,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "UnitedHealth’s disclosures note that the company’s guarantees for service‑level performance under its contracts were “not material” in each of the three years, meaning the liability from those guarantees did not change in any meaningful way from 2022 through 2024. In contrast, the notes payable to subsidiaries fell sharply as a short‑term obligation – from $8.7 billion in 2022 to $9.9 billion in 2023 and then to only $2.0 billion in 2024 – while a new long‑term component of $14.4 billion appeared in 2024. Together, the unchanged, immaterial service‑level guarantees and the shift of subsidiary debt from near‑term to long‑term indicate that UnitedHealth’s liquidity commitments have been re‑structured toward longer‑dated financing, reducing immediate cash‑flow pressure while increasing its longer‑term contractual exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the immateriality of service level guarantees across all years and captures the drop in notes payable to subsidiaries in 2024. However, it contains a critical error in the 2022 value: it states $8.7 billion instead of the correct $8.1 billion from the ground truth. Additionally, the LLM introduces a 'new long-term component of $14.4 billion' in 2024, which is not mentioned or supported in the original answer and appears to be fabricated or misattributed. This significantly undermines quantitative accuracy. (2) The correct figures per ground truth are: $8.1B (2022), $9.9B (2023), $2.0B (2024). The LLM correctly reports $9.9B in 2023 and $2.0B in 2024 but incorrectly reports $8.7B in 2022. The introduction of a $14.4B long-term note is unsupported and distorts the financial narrative. (3) The multi-hop reasoning is partially sound: the model correctly contrasts stable service guarantees with changing internal debt and infers a shift in liquidity strategy. However, the erroneous addition of a long-term debt component not present in the source leads to an incorrect conclusion about restructuring toward long-term financing. The original answer makes no mention of long-term debt or reclassification, only noting volatility in notes payable. (4) Despite the reasoning flaw, the answer remains contextually relevant and captures the core idea of stable risk in service guarantees amid changing internal obligations. The qualitative reasoning is logical but based on inaccurate data. Correctness score is reduced due to significant numerical inaccuracy and unsupported claims, though key elements (2023–2024 drop, immaterial guarantees) are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 466,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "From 2022 through 2024 American Express has remained the fourth‑largest general‑purpose card network behind China UnionPay, Visa and Mastercard, but the “intense competition” described in its 2022 filing has grown to include fast‑moving fintech platforms (Alipay, PayPal, Venmo, etc.) and heightened pressure on premium‑card and co‑brand relationships.  At the same time, the company’s “extensive government regulation” narrative has shifted to “heightened regulatory scrutiny” – regulators are focusing on network‑fee caps, non‑discrimination and honor‑all‑cards rules, data‑privacy/AI requirements and AML/sanctions, prompting Amex to adopt stricter compliance frameworks (Category III status in 2024), exit network‑licensing businesses in the EU and Australia, and cooperate with investigations while investing in its integrated‑payments platform and premium‑value proposition to protect its competitive position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of American Express's competitive positioning and regulatory dependency from 2022 to 2024 as described in the ground truth. (1) All key facts are correct: Amex remained the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard; competition expanded to include fintech platforms (Alipay, PayPal, Venmo) and regional systems; regulatory scrutiny intensified, leading to Category III designation in 2024; and Amex exited network licensing in the EU and Australia. (2) Quantitative accuracy is perfect: no numerical errors, and all dates (2022, 2023, 2024) and classifications (Category III) are correctly cited. (3) Multi-hop reasoning is sound—LLM synthesizes competitive dynamics, regulatory shifts, and strategic responses across time, correctly linking increased scrutiny to specific actions (exits, compliance investments). (4) The only minor shortcoming is that the original answer more explicitly frames the shift from market-driven competition to regulatory navigation as a strategic transformation, which the LLM implies but does not emphasize as clearly. However, all critical elements are present with semantic equivalence. Wording differences (e.g., 'honor-all-cards rules', 'data-privacy/AI requirements') add detail not in the original but are contextually appropriate and do not introduce inaccuracies. Overall, the answer is factually complete, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1650,
        "completion_tokens": 409,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "From the 2022 filing through the 2024 filing ConocoPhillips consistently treated cash‑settled performance‑share units (PSUs) for performance periods that began in 2018 or later the same way: the awards are settled in cash equal to the share price at settlement and, instead of receiving quarterly cash dividend equivalents during the performance period, recipients receive an **accrued‑reinvested dividend equivalent** that is charged to compensation expense and paid only when the PSU is settled. This shift—first introduced when cash‑settled executive RSUs replaced the stock‑option program in 2018 and retained through 2023‑24—shows the company’s intent to tie long‑term incentives directly to the company’s equity performance, aligning executives’ compensation with shareholder value rather than providing interim cash dividends.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in ConocoPhillips' cash-settled PSU dividend equivalent structure: for performance periods starting in 2018 or later, recipients receive accrued reinvested dividends paid at settlement, contrasting with pre-2018 periods where no payments were made during the performance period but began after. The LLM accurately notes this shift started in 2018 and was maintained through 2024. (2) All dates (2018, 2022–2024) and structural details (cash settlement, liability classification implied via cash-settled nature) are factually correct. There are no numerical inaccuracies. (3) The multi-hop reasoning is sound—linking the 2018 change (replacement of stock options with cash-settled RSUs/PSUs) to the dividend reinvestment policy and interpreting it as a move to align executive incentives with long-term shareholder value. The LLM correctly infers the strategic intent behind the change. (4) The only minor omission is that the ground truth explicitly mentions vesting tied to five years or retirement eligibility and the consistent liability classification on the balance sheet across years—details not included in the LLM response. While not critical to the core question, their absence slightly reduces completeness. However, the LLM captures the key evolution and its implications accurately. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 436,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "The balance of the company’s special‑use funds fell from roughly **$11 billion in 2022** (NEE ≈ $6.5 bn + FPL ≈ $4.5 bn) to about **$8.7 billion in 2023** and then rose modestly to **$9.8 billion in 2024**.  Even at the 2023 low, the fund size comfortably exceeds the cash and letter‑of‑credit collateral that NEE had actually posted for its derivatives (≈ $2.5 bn) and is well above the amount that would be required if its credit‑rating triggers were hit (≈ $2.4 bn in 2023, $5.2 bn in 2022).  Thus, although the special‑use fund balance has contracted since 2022, it remains ample relative to the company’s derivative‑related collateral obligations, indicating a strong liquidity cushion throughout the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the 2022 Special Use Funds value. The ground truth does not provide a 2022 value for Special Use Funds, but the LLM incorrectly states it was $11 billion in 2022, derived from a sum of $6.5B (NEE) and $4.5B (FPL), which are not supported by the ground truth. The ground truth only provides 2023 ($8,698M) and 2024 ($9,800M) values, with no mention of 2022 Special Use Funds. Thus, the claim of a decline from $11B to $8.7B is fabricated. (2) The LLM misrepresents collateral obligations: it states actual collateral posted was ~$2.5B, but the ground truth specifies only $691M in cash collateral posted in 2023 (up from $84M in 2022), with no mention of letters of credit totaling $2.5B. Additionally, the LLM reverses the timeline for potential downgrade-triggered collateral: it states $5.2B was required in 2022 and $2.4B in 2023, but incorrectly implies this is a future risk, while the ground truth clearly states the reduction from $5.2B (2022) to $2.4B (2023) reflects an improvement. (3) Multi-hop reasoning is partially sound—linking Special Use Funds to collateral obligations is appropriate—but based on incorrect data. The conclusion that liquidity remains strong has some validity given the 2024 fund size, but the narrative of a 'contraction since 2022' is unsupported and misleading. (4) Contextual relevance is high as the answer addresses liquidity and derivative collateral; however, quantitative accuracy is severely compromised by invented figures and misattributed data, dragging down correctness. Qualitative reasoning would score higher if based on accurate inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 458,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "American Tower issued $700 million of 1.600 % senior unsecured notes in March 2021 and has kept the full $700 million on its balance sheet each year (the “Aggregate Principal Amount” stays at $700 million in the 2023 note‑table on page 110 and the 2024 note‑table on page 113).  The company has been amortizing the series modestly: the adjustment column shows a $‑3.7 million reduction in 2022, a $‑2.6 million reduction in 2023, and a $‑1.5 million reduction in 2024 (page 110 → 2022/2023; page 113 → 2024).  This pattern of keeping the principal level steady while slowly retiring small portions each year suggests a deliberate debt‑management approach that treats the 1.600 % notes as a long‑term, low‑cost funding source, using only incremental amortization to trim the balance without large‑scale refinancing or early redemption.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly identifies the outstanding principal as $700 million in each year, it misrepresents the amortization trajectory. The ground truth states that the adjustments to principal were (3.7) million in 2022, (2.6) million in 2024, but does not provide a 2023 value—however, the LLM fabricates a (2.6) million reduction in 2023 and (1.5) million in 2024, which contradicts the ground truth that shows only a decline from (3.7) to (2.6) over the entire period (2022 to 2024), not annually as implied. This suggests incorrect interpolation or misreading of data. (2) The original answer does not support a 2023 amortization figure or a $1.5 million 2024 adjustment; thus, the LLM introduces false precision and incorrect values. The actual amortization pattern is less steep than claimed. (3) The reasoning and synthesis are otherwise sound: the LLM correctly infers a stable long-term debt strategy from the steady principal and minor amortization, which aligns with the original answer’s conclusion. It also correctly identifies the instrument and its terms. (4) Contextual relevance is high—the response directly addresses both parts of the question (trajectory and strategy). However, due to the incorrect amortization figures and unsupported year-by-year breakdown, the quantitative accuracy is low, dragging down the overall correctness score despite strong qualitative reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 410,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "- **2022 filing (pages 23‑27)** – UnitedHealth warned that CMS “from time to time…makes changes to the way it calculates Medicare Advantage risk‑adjustment payments,” creating the possibility of lower capitation amounts and retrospective adjustments.  The company said it was already “adjusting members’ benefits and premiums on a selective basis, ceasing to offer benefit plans in certain counties, and intensifying both our medical and operating cost‑management” to offset those funding pressures.  \n\n- **2023 filing (pages 18‑22, especially page 20)** – The same risk‑adjustment exposure was reiterated, with added emphasis on CMS‑ and OIG‑conducted RADV audits that could produce retroactive payment cuts or fines.  UnitedHealth again highlighted the same tactical levers – selective benefit‑premium tweaks, pulling plans from low‑margin markets and deeper medical‑and‑operating cost controls – as its primary response.  \n\n- **2024 filing (pages 18‑22, especially page 20)** – The company continued to note that CMS “makes changes to the way it calculates Medicare Advantage risk‑adjustment payments,” confirming that the exposure remained material.  Its response remained consistent: ongoing selective benefit and premium adjustments, withdrawal of plans in specific counties, and intensified cost‑management across medical and operating functions, while maintaining heightened compliance with RADV audit requirements.  \n\n**Overall evolution:** UnitedHealth’s exposure to Medicare Advantage risk‑adjustment payment changes was first identified in 2022 and persisted through 2023 and 2024 as CMS periodically altered the calculation methodology.  Across the three years the company’s strategic reaction stayed focused on (1) tweaking benefits and premiums where needed, (2) exiting unprofitable county markets, and (3) tightening medical‑and‑operating cost management and compliance with RADV audits to protect capitation revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UnitedHealth Group's exposure to Medicare Advantage risk adjustment changes is accurately described for 2022–2024, with CMS modifying calculation methodologies each year. The strategic responses—selective benefit and premium adjustments, exiting certain counties, and intensified cost management—are consistently and correctly reported across all three years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates and years are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three annual filings, correctly identifying the continuity of risk exposure and response strategies over time. It also appropriately notes the added emphasis on RADV audits in 2023 and 2024, which is a nuance beyond the original answer but factually supported and relevant. (4) Semantic equivalence is strong—the LLM conveys the same core information as the ground truth with slightly more structural detail (e.g., page references, explicit year-by-year breakdown), without introducing inaccuracies. The only minor shortcoming is that the original answer emphasizes the 'evolving' nature of the strategies more explicitly, while the LLM stresses consistency; however, the LLM still captures incremental refinements (e.g., heightened compliance), justifying a 9 rather than a 10 in qualitative accuracy. Overall, the response is complete, factually correct, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1764,
        "completion_tokens": 438,
        "total_tokens": 2203
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "Across the three filings, Target’s employee‑benefit language is essentially unchanged. In the 2022 10‑K (page 6) the “Compensation and Benefits” section lists “merchandise and other discounts” as part of the package; the 2023 10‑K (page 7) repeats the same phrasing, and the 2024 10‑K (page 7) again cites “merchandise and other discounts” without adding a new rate, tier or eligibility rule. This continuity shows that Target has kept the employee merchandise discount as a stable, baseline perk rather than expanding or restructuring it, signaling a strategy that relies on a consistent, modest discount to help team members stretch their dollars while focusing its 2022‑2024 benefits enhancements on wages, retirement matching and other non‑discount items.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in stating that the phrasing around merchandise discounts remained consistent across the 2022–2024 10-K filings and that no new tiers, rates, or eligibility rules were introduced. This aligns with the ground truth’s acknowledgment that merchandise discounts remained a stable benefit. The quantitative and entity accuracy is strong: Target, the years (2022–2024), and the benefit category (merchandise and other discounts) are correctly identified, and there are no numerical inaccuracies. However, the LLM answer falls short in qualitative accuracy because it fails to capture the evolving *context* and *strategic framing* of the discounts, which is central to the original answer. While the LLM notes enhancements in wages and retirement, it omits key developments such as the expansion of starting wages to $15–$24 in 2023, the introduction of sick pay and tuition-free education, and the 2024 emphasis on equitable pay, belonging, and mental health services. These omissions limit the answer’s ability to fully reflect the multi-hop synthesis required to assess Target’s broader financial well-being strategy. The reasoning is partially sound but lacks depth in connecting the stable discount benefit to an evolving holistic well-being narrative. The answer is contextually relevant and addresses the question’s core, but misses nuanced progression details that define the strategic shift. Thus, while not factually wrong, it provides an incomplete picture compared to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 418,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "American Express’s foreign‑government‑bond portfolio has remained almost entirely short‑dated. In the most recent disclosure the company held roughly $630 million of foreign government bonds, with $628 million (≈ 99 %) maturing within one year and only $1 million each in the 1‑to‑5‑year and 5‑to‑10‑year buckets 【page_121】. The weighted‑average yield on its overall investment‑securities portfolio – which includes these bonds – has hovered in the low‑2 % range (overall 2.08 % in 2021, and the same low‑to‑mid‑2 % range in the 2022‑2024 filings), showing only a modest upward drift as market rates have risen. This three‑year consistency of a heavily short‑term, low‑yield holding pattern indicates that American Express maintains a conservative risk appetite, favoring liquidity and capital preservation rather than seeking higher yields through longer‑dated or riskier foreign‑government debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. It claims American Express's foreign government bond portfolio is 'almost entirely short-dated' with $628 million maturing within one year and only $1 million in longer maturities, which contradicts the original answer that provides yield data by maturity bucket but does not specify allocation amounts by maturity. More critically, the LLM states the weighted-average yield has 'hovered in the low-2% range' and was 2.08% in 2021, with 'low-to-mid-2% range in 2022-2024', which directly conflicts with the ground truth showing a sharp rise to 6.45% in 2023 for short-term bonds and a drop to 2.03% in 2024 for medium-term bonds. These yield figures are completely misrepresented. (2) Quantitative accuracy is very low: the LLM omits the correct yields of 1.74%, 2.42%, 6.45%, 4.48%, 5.86%, and 2.03% across years and maturities, instead asserting a stable ~2% yield. The $630 million amount is correctly cited, but the maturity breakdown ($628M, $1M, $1M) is fabricated and not supported by the ground truth. (3) The multi-hop reasoning is flawed: the LLM concludes a 'conservative risk appetite' due to short-term holdings and stable yields, but the ground truth shows a dynamic shift—significant yield increases in 2023 followed by a drop in 2024—indicating active strategy changes in response to interest rates, not stability. The LLM fails to capture this evolution and misinterprets the strategy. (4) Contextual relevance is moderate because it addresses the right company, asset class, and time frame, and attempts to infer risk appetite, but the incorrect data leads to an opposite and misleading conclusion about asset allocation strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 476,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted for master‑netting arrangements fell sharply after 2022 – it was $1.494 billion at 12/31/2022, dropped to $0.800 billion in 2023, and further declined to $0.491 billion in 2024 (a $694 million fall‑off in 2023 and a $309 million fall‑off in 2024). This downward trend indicates that the company’s derivative positions have been increasingly offset or reduced, allowing it to post less initial‑margin collateral and suggesting tighter, more efficient management of its derivative exposure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $1,494 million (2022), $800 million (2023), and $491 million (2024), matching the ground truth exactly, with acceptable format variation ($1.494 billion = $1,494 million). The year-over-year declines of $694 million (1,494 - 800) and $309 million (800 - 491) are accurately calculated. (2) All financial data is complete and correctly attributed to ExxonMobil (XOM) and the specified time frame (2022–2024). The metric 'collateral under master netting arrangements related to Other assets, including intangibles - net' is correctly identified and tracked across years. (3) The entities (ExxonMobil, derivative exposure, master netting arrangements) and time periods (2022, 2023, 2024) are accurate. (4) The reasoning is sound: the downward trend is correctly interpreted as a reduction in derivative exposure or improved risk management, with the added insight about initial margin and offsetting positions, which is a reasonable and contextually appropriate extension of the ground truth. The answer fully addresses both parts of the question: the quantitative change and its implication for derivative exposure management. Semantic meaning and factual content are equivalent to the original answer, with slightly enhanced explanatory detail. All aspects meet the highest standard for correctness, accuracy, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 388,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "- In the 2022 filing the 2.700 % senior notes were shown as a $700 million issuance dated March 29 2021 with a fixed 2.700 % coupon and a 2031 maturity (see 2022 p. 48).  \n- The 2023 filing still listed the same series, but noted a modest principal reduction (‑$5 million) while the coupon remained 2.700 % (see 2023 p. 111).  \n- By the 2024 filing the 2.700 % series no longer appears among the outstanding notes; only newer series (e.g., 5‑plus % notes) are listed, indicating the company had fully redeemed or repaid the 2.700 % notes (see 2024 p. 115).  \n\nThis progression shows AMT initially used low‑rate, long‑dated debt when market rates were low (2021‑2022), then gradually retired that cheap debt as interest‑rate environments shifted upward, using proceeds from higher‑coupon issuances in 2023‑2024 to refinance and reduce older obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the 2.700% Notes maintained a consistent $700.0 million principal amount in 2022, 2023, and 2024, with no reduction or redemption. However, the LLM claims a $5 million principal reduction in 2023 and complete disappearance of the notes by 2024, which contradicts the original data. The maturity date is also misrepresented: the ground truth states January 15, 2031 (not 2031 generally), and the LLM incorrectly implies the notes were retired. Additionally, the interest rate spread decrease from (5.0) to (4.4) in 2024 is entirely omitted. (2) Quantitative accuracy is low: the $5 million reduction and disappearance of the note series are false; the interest rate spread change is ignored; only the initial $700 million and 2.700% rate are correct. Dates like March 29, 2021 (issuance) and maturity are partially correct but lack precision. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers that AMT redeemed cheap debt amid rising rates, but the ground truth shows the notes remained outstanding with stable terms, indicating a consistent long-term financing strategy. The conclusion about refinancing with higher-coupon debt is unsupported by the provided data. (4) Contextual relevance is moderate—the response addresses the question's structure and attempts to interpret strategy—but due to factual errors, the analysis is based on false premises. Overall, major factual and quantitative errors severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 426,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "- **FY 2022 (as of January 30 2022):** The 2.00 % notes due 2031 were recorded at a carrying amount of **$1.25 billion**【page_78】.  \n- **FY 2023 (as of January 29 2023):** The same series was reduced to **$1.044 billion**【page_67】.  \n- **FY 2024 (as of January 28 2024):** The balance rose again to **$1.25 billion**【page_72】.  \n\n**Interpretation:** NVIDIA’s use of the 2.00 % Notes due 2031 shows a deliberate, low‑cost long‑term financing approach. The company modestly trimmed the issue in 2023 (partial repayment or refinancing) and then restored it in 2024, indicating a strategy of maintaining a stable, inexpensive debt base while preserving flexibility to adjust the size of the issuance as cash‑flow needs evolve.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial values compared to the ground truth. According to the original answer, in 2022, the fair value was $1.2 billion, not $1.25 billion as stated by the LLM. The LLM claims a reduction to $1.044 billion in 2023, which aligns with the beginning-of-year figure in the ground truth, but omits the nuance that it slightly increased to $1.057 billion by the end of 2023. More critically, the LLM states the 2024 carrying value is $1.25 billion, which contradicts the ground truth that reports $1.25 billion as the 2022 value and does not support a rebound to that level in 2024. The ground truth specifies that in 2024, the carrying value was $1.25 billion with no short-term portion — but this appears to be a misattribution, as prior years show lower values. However, the LLM incorrectly frames the trajectory as a drop and then a return to $1.25B, implying repayment and reissuance, which is not supported. (2) Number verification: 2022 — LLM says $1.25B (incorrect, should be $1.2B); 2023 — LLM says $1.044B (partially correct for start of year, but misses end-of-year $1.057B); 2024 — LLM says $1.25B (contradicts ground truth progression). These are material errors. (3) Multi-hop reasoning: The LLM attempts synthesis across years and draws strategic conclusions, but these are based on incorrect data trends. The interpretation of a 'reduction and restoration' implies active debt management like repayment and reissuance, which is speculative and not supported by the stable-to-slightly-increasing trend in the ground truth. (4) Despite incorrect numbers, the LLM addresses all parts of the question — evolution over time and strategic interpretation — and uses appropriate financial terminology. The reasoning is logically structured and contextually relevant, even if factually flawed. Hence, moderate scores for qualitative accuracy and high for contextual relevance, but low quantitative accuracy drags down overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 546,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "**What happened**\n\n| Year | Deposit assets (reinsurance) | Deposit liabilities (reinsurance) |\n|------|------------------------------|-----------------------------------|\n| 2022* | – (the note only says the company “uses the deposit method” and that the balance was modest in the prior years – ≈ $1.8 bn in 2020‑21) | – (similarly modest, ≈ $1.4 bn in 2020‑21) |\n| 2023 | **$5.1 bn** (included in “premiums, reinsurance and other receivables”) | **$1.3 bn** (included in “other liabilities”) |\n| 2024 | **$4.6 bn** (same line‑item) | **$1.2 bn** (same line‑item) |\n\n\\*The 2022 filing does not give a separate “deposit‑asset” or “deposit‑liability” figure; it only notes that the company continues to apply the deposit method and that the balances were relatively small in the years immediately before 2022 (about $1.8 bn of assets and $1.4 bn of liabilities in 2020‑21).\n\n**What the trend tells us**\n\n- **Rapid expansion** – Between the pre‑2022 baseline and 2023, MetLife’s deposit‑accounting balances jumped to more than $5 bn of assets and over $1 bn of liabilities. This surge coincides with the large 2023 risk‑transfer transaction with Global Atlantic, in which the company moved billions of assets to a reinsurer and recorded a matching deposit‑recoverable/‑payable position.  \n\n- **Slight pull‑back in 2024** – In 2024 the deposit‑asset balance fell to $4.6 bn and the liability balance slipped to $1.2 bn, indicating that the company is beginning to unwind or re‑price part of the transaction while still keeping a sizable deposit position.\n\n- **Strategic implication** – The growth of the deposit‑method balances shows MetLife deliberately using this accounting approach to fund large, capital‑intensive reinsurance agreements (especially the modified‑coinsurance block). The modest decline in 2024 suggests the company is managing the exposure as the transaction matures, but the overall larger net deposit position relative to the pre‑2022 level signals a continued reliance on deposit‑method reinsurance to improve capital efficiency and liquidity.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. According to the ground truth, deposit assets increased from $1.8 billion in 2022 to $5.1 billion by the end of 2024, showing a consistent upward trend. However, the LLM claims deposit assets were $5.1 billion in 2023 and then dropped to $4.6 billion in 2024, which contradicts the ground truth of continued growth to $5.1 billion in 2024. This error affects the interpretation of the trend as a 'pull-back' in 2024, which is not supported by the original data. Additionally, the LLM incorrectly states that 2022 figures are not disclosed, while the ground truth explicitly provides $1.8 billion in assets and $1.4 billion in liabilities for 2022. The liability figures for 2023 ($1.3 billion) and 2024 ($1.2 billion) are correctly reported and align with the slight decline mentioned in the original answer. The qualitative analysis is strong: the connection to the Global Atlantic transaction and the strategic use of deposit accounting for capital efficiency is accurate and well-reasoned. The multi-hop synthesis between financial figures, accounting method, and strategic implications is contextually appropriate and insightful. However, due to the critical error in asset values for 2024 and the misrepresentation of 2022 data availability, the quantitative accuracy is low. Despite sound reasoning and relevance, the factual errors in key numbers reduce the overall correctness score to 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1780,
        "completion_tokens": 408,
        "total_tokens": 2189
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "- 2022: Debt securities ‑ held‑to‑maturity were reported at a fair‑value of **$679 million** and a carrying (amortized‑cost) amount of **$696 million**.  \n- 2023: Fair value fell to **$596 million** while the carrying amount fell to **$603 million**.  \n- 2024: Fair value dropped further to **$508 million** with a carrying amount of **$512 million**.\n\nThe three‑year trend shows a steady decline in market (fair) value – driven mainly by higher interest rates – while the amortized‑cost basis is reduced more modestly, keeping the securities only slightly below cost. This pattern indicates UnitedHealth’s intent to retain the debt portfolio to maturity, accepting temporary market‑price discounts rather than selling, and reflects modest valuation adjustments rather than any strategic shift away from the held‑to‑maturity approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values for fair value and carrying value of UnitedHealth Group's Debt Securities - Held-to-Maturity for 2022, 2023, and 2024, matching the ground truth exactly: $679M/$696M (2022), $596M/$603M (2023), $508M/$512M (2024). There are no discrepancies in numbers, dates, or entities. 2) All calculations implied by the trend (declines year-over-year) are accurate and consistent with the data. The model correctly identifies the downward trajectory in both fair and carrying values. 3) The multi-hop reasoning is sound: it synthesizes data across three years and interprets the trend in context of market conditions (e.g., higher interest rates) and accounting treatment (amortized cost vs. fair value). It correctly infers that the company is maintaining a held-to-maturity strategy, accepting temporary market discounts. 4) While the original answer suggests a 'strategic reduction or repositioning', the LLM offers a slightly different interpretation—emphasizing retention to maturity and modest valuation adjustments rather than a strategic shift. This is a reasonable alternative interpretation supported by the data, especially given that carrying values remain close to fair values, indicating minimal impairment and intent to hold. The difference in conclusion is nuanced and does not constitute a factual error. Wording differs but semantic meaning remains aligned on key facts and plausible inference. Minor deduction from 10 due to interpretive divergence, but overall highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 432,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "Target’s card‑penetration metric has been falling each year. According to the MD&A, RedCard (Target‑branded credit/debit cards) penetration was 20.5 percent in fiscal 2022, 19.8 percent in fiscal 2023, and 18.6 percent in fiscal 2024 (page 27). The downward trend suggests that while the cards still generate incremental purchases, the incremental‑sales lift is weakening, indicating the credit‑card program is becoming less effective at driving additional sales over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. These numbers are cited with a reference to page 27 and correctly attributed to the MD&A section, indicating accurate sourcing. 2) All quantitative values are correct, and no calculations are required beyond accurate reporting of percentages—these are precise and match the original answer. Format is consistent and clear. 3) The multi-hop reasoning is sound: the model correctly infers that the declining penetration rate suggests weakening effectiveness in driving incremental sales, which aligns with the trend interpretation in the ground truth. It acknowledges that the card still generates incremental purchases, though the lift is weakening—this captures the nuanced conclusion in the original answer. 4) The only minor shortcoming is that the LLM answer does not explicitly mention Target's continued emphasis on card-linked discounts and loyalty benefits, nor does it note that internal analysis still finds 'meaningful' incremental sales. While the essence of declining effectiveness is captured, this contextual nuance from the original answer is slightly underdeveloped. However, the core facts, trends, and implications are accurately and relevantly conveyed. Thus, the answer is factually complete and semantically equivalent with only minor depth differences in qualitative interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 398,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "Nike’s European distribution network has remained anchored by an owned facility in Laakdal, Belgium. The 2022 Form 10‑K notes that the “most significant distribution facilities outside the United States… are located in Laakdal, Belgium… all of which we own”【page_27】, and the 2024 filing repeats that the Laakdal site is still an owned distribution center【page_29】 (the 2023 filing makes the same statement). By consistently owning rather than leasing this hub, Nike signals a strategic commitment to controlling key logistics capacity in Europe and investing in permanent, integrated supply‑chain infrastructure for the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly states that Nike owned the Laakdal, Belgium facility throughout fiscal years 2022–2024, with consistent descriptions across all three years, matching the original answer’s claim of stable ownership and operational role. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the fiscal years (2022, 2023, 2024) are correctly referenced, and the citations to the 10-K filings (page 27 for 2022, page 29 for 2024) support the claims—minor variation in wording (e.g., 'most significant distribution facilities' vs. 'one of the most significant') does not affect factual accuracy. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings to infer a consistent strategic stance, correctly concluding that continued ownership indicates a strategic focus on direct control of European logistics infrastructure. (4) The answer is contextually complete, addressing both the evolution (no change) and strategic implication (commitment to control and integration). The only minor shortcoming is that the 2023 filing is mentioned anecdotally without a specific citation, though this does not undermine the correctness. Overall, the answer demonstrates high factual fidelity, strong reasoning, and full relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 381,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "Across NVIDIA’s 2022, 2023 and 2024 10‑K filings, Lumentum Holdings is repeatedly listed among the “networking‑product” competitors that supply switches, adapters and optical‑module solutions (see the competition tables in each year’s filing). While the competitor set stays essentially unchanged, NVIDIA’s narrative evolves—from a brief mention of supply‑chain concentration in 2022 to a more explicit discussion of expanding redundancy and resilience in its Asia‑Pacific supply chain and a growing emphasis on patents, licensing and international IP‑protection mechanisms in 2023 and 2024. Thus, Lumentum’s competitive positioning remains constant as a key interconnect rival, even as NVIDIA’s supply‑chain breadth and IP‑defense posture have become increasingly robust over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Lumentum Holdings is consistently named as a competitor in networking products—specifically optical modules, interconnects, and switches—across NVIDIA’s 2022, 2023, and 2024 10-K filings. The LLM correctly identifies that the set of competitors remains stable, while NVIDIA’s narrative around supply chain and IP protection evolves. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the answers, so quantitative accuracy is not applicable in a traditional sense; however, the fiscal years (2022–2024) are correctly referenced, and no incorrect dates or figures are introduced—thus scoring 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly infers that Lumentum’s competitive positioning remains constant, and contrasts this with NVIDIA’s evolving strategies in supply chain resilience (e.g., redundancy in Asia-Pacific) and IP protection (patents, licensing). The only minor shortcoming is that the LLM does not explicitly mention TSMC and Samsung as manufacturing partners or the extension of patent expirations to 2045, which are specific details in the ground truth that strengthen the IP narrative. While the general trend on IP is captured, these specifics enhance completeness. (4) The answer is contextually fully relevant, directly addressing the evolution of competitive positioning in relation to supply chain and IP strategies. Wording differs from the original but preserves semantic equivalence. Overall, this is a strong response with only minor omissions in supporting detail, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 479,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "- In the 2022 filing Netflix warned that “our ability to provide our members with content … depends on obtaining various rights from third parties” and that “as content providers develop their own streaming services … they may be unwilling to provide us with access … the cost of certain programming increase” – forcing the company to be highly selective about the titles it adds or renews【page_11】.  \n\n- By the 2024 filing the same dependence is reiterated (“our ability to provide our members with content … depends on studios, content providers and other rights‑holders licensing rights”) but the discussion now emphasizes “growing regulatory action…content quotas, levies and investment obligations…some countries restrict the extent of ownership rights we can have”【page_4】.  \n\n**Interpretation:** Over 2022‑2024 Netflix’s reliance on external rights‑holders has remained central, but the risk narrative has shifted from pure competition‑driven licensing scarcity to a mix of competitive pull‑through and tightening government rules. This evolution reveals a content‑acquisition strategy that leans increasingly on securing longer‑term or exclusive licenses and accelerating original‑content production to mitigate the rising cost of licensed titles and the regulatory constraints on third‑party deals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: Netflix's continued reliance on third-party rights holders is consistently noted across 2022–2024, with accurate evolution from competition-driven risks (e.g., studios launching their own platforms) to added regulatory pressures (e.g., content quotas, ownership restrictions) by 2024. The cited quotes and page references match the expected content from the filings. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings, identifying both continuity (ongoing dependence on licensing) and change (expansion of risk factors to include regulation). The interpretation about strategic shift toward exclusivity and original content is logically derived and matches the ground truth. (4) Semantic equivalence is strong: the LLM uses slightly different phrasing (e.g., 'growing regulatory action' vs 'regulatory impacts') but conveys the same meaning. One minor point preventing a perfect 10 is that the 2023 filing is mentioned in the original answer but not explicitly addressed in the LLM response—though the core trajectory from 2022 to 2024 is preserved. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 414,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "Southern Company has continued to treat its outdoor‑lighting contracts as **operating leases** throughout the 2022‑2024 filings, reporting the scheduled lease payments in the “lease‑income – operating leases” line and including those amounts in the **operating‑lease maturity tables** for each subsidiary. Beginning with the 2023 filing (and repeated in 2024) the company added a disclosure that the undiscounted cash flows from the outdoor‑lighting contracts are **immaterial**, a comment that was absent in the 2022 filing; the contracts are still **not classified as wholesale revenue** but remain part of lease‑income, and the presentation of the scheduled payments in the maturity analysis has remained unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresents the evolution of Southern Company's disclosure practices from 2022 to 2024, despite addressing the right topic and structure. (1) The claim that the company began disclosing immateriality in 2023 is incorrect — the ground truth states that immateriality was already disclosed in 2022. The LLM reverses the timeline: it incorrectly says the immateriality comment was 'absent in 2022' and added in 2023, when in fact the opposite is true. (2) The LLM asserts that presentation in maturity analyses 'remained unchanged' over the period, which directly contradicts the ground truth: in 2022, the cash flows were considered immaterial and not meaningfully included; by 2023 and 2024, they were formally included in maturity analyses alongside tolling and PPAs, indicating a clear change in treatment. (3) The LLM incorrectly implies consistency in presentation, while the ground truth describes a progression toward greater transparency and structured reporting. (4) There are no numerical values to verify, so quantitative accuracy is based on correct dating and classification — partial credit given because the operating lease classification and lease-income line are correctly identified. (5) Multi-hop reasoning fails: the model does not correctly synthesize the temporal evolution across years, misassigning key disclosures to wrong years and missing the increasing materiality in reporting emphasis. While the answer is contextually relevant and uses appropriate terminology, the core factual trajectory is inverted, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 448,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "The 5.000 % senior unsecured notes that mature in April 2030 were shown with an outstanding principal balance of **$606 million** in the 2024 Form 10‑K (as of Nov 3 2024) and the same amount in the 2023 Form 10‑K (as of Oct 29 2023). The 2022 Form 10‑K also lists the 5.000 % April 2030 notes at **$606 million** (as of Oct 31 2022).  \n\nBecause the balance has remained unchanged over the three fiscal years, Broadcom has not been repaying, refinancing, or otherwise reducing this issue; instead it appears to be retaining the notes until maturity, using the make‑whole redemption provisions only if a strategic need arises. This reflects a deliberate debt‑management approach of preserving the instrument as a stable, low‑cost financing source rather than actively retiring it.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. According to the ground truth, the outstanding principal balance was $1,086 million in fiscal year 2022, decreased to $606 million in 2023, and remained at $606 million in 2024. However, the LLM states the balance was $606 million in all three years, missing the reduction from 2022 to 2023 entirely. This error fundamentally undermines the answer's correctness. (2) The numbers are inaccurate: the 2022 figure is wrong ($606M reported vs. $1,086M actual), while 2023 and 2024 figures are correct. The LLM also incorrectly asserts no change occurred over the period, when in fact there was a significant $480 million reduction in 2023. (3) The multi-hop reasoning is flawed because the model failed to detect and synthesize the change across the three fiscal years. Instead, it assumed stability, leading to an incorrect interpretation of Broadcom’s debt strategy. The ground truth indicates a deliberate reduction in 2023, but the LLM concludes no repayment or refinancing occurred, which contradicts the actual data. (4) Due to major factual and quantitative errors, especially in the 2022 balance and the resulting misinterpretation of debt management strategy, the correctness score is low at 3. Quantitative accuracy is scored 2 due to one out of three numbers being wrong and the critical change being omitted. Qualitative accuracy is 3 because the reasoning is internally consistent but based on false premises. Contextual relevance is 6 because the answer addresses the right instrument and general strategic interpretation, albeit incorrectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 448,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "- In the 2023 filing GM noted that the weighted‑average long‑term rate of return assumed for its U.S. pension‑plan assets was **6.3 % for both 2022 and 2023** 【page 87】.  \n- In the 2024 filing the same study showed the assumption **rose to 6.5 % at year‑end 2024** 【page 88】.  \n\nThe three‑year pattern—flat at 6.3 % and then a modest increase to 6.5 %—signals that GM is gradually moving its pension‑plan asset mix toward higher‑return, higher‑risk exposures (e.g., more “Other” assets such as private‑equity and real‑estate and a reduced equity share) to improve expected funding outcomes and offset market volatility.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a factual error in the 2022 rate of return. The original answer states that the rate was 5.4% in 2022, but the LLM claims it was 6.3% in both 2022 and 2023, which contradicts the ground truth. This is a significant quantitative inaccuracy. The 2023 (6.3%) and 2024 (6.5%) values are correct. (2) The calculation of the trend is partially affected: the actual increase is from 5.4% to 6.5%—a 1.1 percentage point rise over three years—not a flat period followed by a modest increase as implied. The LLM misrepresents the trend by incorrectly stating the 2022 figure. (3) The reasoning about strategic asset mix adjustments is sound and aligns with the original answer—interpreting the rising assumption as a shift toward higher-risk, higher-return assets like private equity and real estate. The synthesis across years and filings is logical, though based on an incorrect starting point. (4) Despite the numerical error, the answer addresses both parts of the question (evolution of assumptions and strategic implications), uses correct entities (General Motors, U.S. pension plan assets, correct years), and provides relevant context from cited pages. The qualitative reasoning and contextual relevance are strong, but the quantitative inaccuracy significantly impacts the correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 371,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings the 2.700 % senior notes due 2031 are repeatedly listed in the exhibit schedules (e.g., Supplemental Indenture No. 8 dated March 29 2021 – “2.700 % Senior Notes due 2031” 【page 70】, the same entry appears in the 2023 filing’s exhibit list 【page 72】, and again in the 2024 filing’s exhibit list 【page 70】). By keeping these low‑coupon, long‑dated notes on its balance sheet year after year, American Tower signals a financing strategy that relies on locking in inexpensive, fixed‑rate senior debt with maturities well beyond a decade to support its growth and acquisition plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core conclusion as the ground truth: American Tower's consistent treatment of the 2.700% Senior Notes due 2031 across its 2022–2024 filings reflects a stable, long-term financing strategy centered on fixed-rate debt. (1) All factual elements are correct: the interest rate (2.700%), maturity year (2031), Supplemental Indenture No. 8, and the date (March 29, 2021) are accurately cited. The exhibit list page numbers (70, 72, 70 across years) are correctly referenced, and while page numbers are not part of the ground truth, they do not contradict it and add precision. (2) Quantitative accuracy is perfect: percentages, dates, and document identifiers match exactly. (3) The reasoning is sound—by noting the repeated listing of the same notes and indenture over three years, the LLM correctly infers a strategy of maintaining low-cost, long-term fixed-rate debt. It appropriately links this to growth and acquisition financing, which is a reasonable inference from the stability of the instrument. (4) The only minor shortcoming is that the LLM does not explicitly mention the lack of modifications to the indenture or the continuity of documentation treatment, which the ground truth emphasizes as evidence of strategic consistency. However, the core insight—that repeated inclusion signals reliance on stable, long-dated financing—is fully aligned. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent, directly addressing the question about long-term financing strategy based on multi-year filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 441,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "In the 2022 filing PayPal warned that abusive behavior—synthetic‑identity fraud, stolen‑card use and defaults on its PayPal‑ and Venmo‑branded consumer‑credit and merchant‑financing products—could raise its loss rate, and that cross‑border transactions, which deliver higher margins, were exposed to currency swings, tariffs and regulatory hurdles. By 2023 the company noted that a tougher economic environment and higher interest rates were likely to increase non‑payment rates, and it began to blunt the impact by selling most of its U.K. and European BNPL loan portfolio (a multi‑year €40 billion sale and forward‑flow arrangement) and by diversifying its funding and payment‑processor partners. The 2024 filing shows the risk focus persisting, with added investment in fraud‑detection and credit‑risk models, continued diversification of third‑party processors, and the use of third‑party funding structures (asset sales, securitizations and forward‑flow receivable arrangements) to limit exposure from credit products and protect cross‑border volume.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, PayPal identified abusive behaviors including synthetic identity fraud and stolen-card use in its credit products; in 2023, it entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables; in 2024, it continued to emphasize persistent fraud risks and reliance on third-party lenders and processors. The LLM correctly captures the evolution from risk identification to mitigation via asset sales and diversification, then to enhanced detection and ongoing risk management. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, with appropriate context as a forward-flow arrangement. No calculations are required, and all numbers match the original. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years, connects credit products and cross-border transactions to abusive behaviors, and correctly identifies strategic actions (sales of receivables, diversification, investment in detection models). The only minor gap is that the LLM does not explicitly mention 'third parties using stolen identities at scale' as emphasized in 2022, but it does reference synthetic identity fraud and stolen-card use, which are substantively equivalent. It also adds value by specifying Venmo-branded products and mentioning securitizations, which are consistent with PayPal's strategies. (4) The answer is fully relevant, addressing all parts of the question—evolution of risk, credit products, cross-border exposure, and mitigation strategies across 2022–2024. Wording differs slightly but maintains semantic equivalence. A score of 9 is justified due to the high accuracy with only slight expansion beyond the original without contradiction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1586,
        "completion_tokens": 496,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "- In the 2022 filing the pension‑plan’s NAV‑measured “Collective Trust and Other Funds” balance was **$622 million**【page_58】.  \n- By the 2023 filing that balance had fallen to **$382 million**【page_57】, and the 2024 filing shows the same (or a similarly reduced) level – the figure is no longer above the 2022 amount and remains well below it【page_58】.  \n\n**Interpretation:** The sharp drop from 2022 to 2023 (and the continued low level in 2024) signals that Union Pacific is moving money out of commingled‑fund structures and into other asset classes—primarily higher‑quality debt and more traditional equity positions. This aligns with the company’s stated de‑risking strategy, shifting the pension portfolio toward a more conservative, debt‑heavy mix to better support long‑term employee benefit obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 dollar amount: it reports $622 million instead of the correct $756 million from the ground truth. This is a material discrepancy of $134 million, which undermines quantitative accuracy. The 2023 value of $382 million is correct, and the observation that the 2024 value remains low (without a specific updated dollar figure) aligns with the original answer. (2) Calculations: While no explicit calculation is performed, the characterization of a 'sharp drop' is reasonable given the actual decline from $756M to $382M (about 49% decrease), but the incorrect base year value distorts the perceived magnitude. (3) Multi-hop reasoning is partially sound: the LLM correctly infers a trend of reduced allocation and connects it to a de-risking strategy, which matches the ground truth's interpretation. It adds contextual insight about shifting toward higher-quality debt and traditional equities, which is plausible and contextually consistent, though not explicitly stated in the original. However, it misses the key point about NAV-based valuation being emphasized in 2024 as a strategic focus on transparency—this is a notable omission in the synthesis. (4) Despite the incorrect 2022 figure, the overall trend direction (decrease) and strategic interpretation (de-risking) are correct, warranting a moderate correctness score. Quantitative accuracy is penalized heavily due to the wrong number, but qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 420,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "- 2022 10‑K – BPAs were still an active award class.  They were valued “as of the grant date using the intrinsic‑value method (the closing price of the common stock)” and the expense was amortized on a straight‑line basis over the probable vesting term, with periodic adjustments for the share price, the number of shares likely to be earned and the probability of meeting the pipeline‑performance criteria.  The filing lists grant activity for BPAs (the award appears in the 2022 award‑summary tables), indicating that some BPAs had been granted and were carried on the balance sheet as non‑vested awards.\n\n- 2023 10‑K – Pfizer stopped using the award.  The note explicitly says “No BPAs were granted in 2023 and no BPAs were outstanding as of December 31, 2023.”  The valuation and accounting description (intrinsic‑value method, straight‑line amortization) remained in the disclosure, but because there were no grants or outstanding awards, no BPA expense was recognized.\n\n- 2024 10‑K – The same situation continued.  The filing again states “No BPAs were granted in 2024 and no BPAs were outstanding as of December 31, 2024.”  The methodology description is unchanged (intrinsic‑value valuation, straight‑line expense over the probable vesting term), but with zero grant activity and zero outstanding balances, BPAs no longer affect Pfizer’s financial statements.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly regarding the quantitative details and the evolution of Pfizer's BPA program. While it correctly identifies that no BPAs were granted or outstanding in 2023 and 2024, it completely omits the specific grant and outstanding figures for 2022 (1,165 thousand granted at $38.73 intrinsic value; 859 thousand outstanding at $59.05/share), which are central to the question. These numbers are entirely missing from the response, making it factually incomplete. (2) The LLM incorrectly implies that the accounting methodology changed in 2024 by stating the same methodology was used throughout, when in fact the ground truth states that Pfizer *introduced a new formalized valuation framework in 2024*, suggesting an evolution in treatment. Instead, the LLM claims the methodology remained unchanged and that no BPAs were granted in 2024 — but the original answer does not confirm 2024 grant activity status beyond the new methodology. This misrepresents the timeline and development. (3) The multi-hop reasoning is partially sound: the model correctly infers from the absence of grants and outstanding awards that the program was discontinued or inactive, and it tracks disclosure continuity. However, it fails to recognize that the 2024 filing introduced a *new* structured approach despite no new grants, which indicates preparatory or policy-level evolution. (4) Contextual relevance is high because the structure follows the requested years and topics (grant activity, outstanding status, accounting). Qualitative accuracy is moderate due to correct identification of disclosure patterns and accounting terms, but quantitative accuracy is very low due to missing all numerical data from 2022 and misrepresenting the 2024 update as a continuation rather than an evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 496,
        "total_tokens": 2057
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted for master‑netting arrangements fell sharply each year – $1.494 billion in 2022, $0.800 billion in 2023 and $0.491 billion in 2024 (see 2024 10‑K p. 99; 2023 10‑K p. 102; 2022 10‑K p. 110). The downward trend implies that the company’s net‑ted derivative positions – and the associated initial‑margin requirements – have been decreasing, reflecting either a reduction in overall derivative exposure or more efficient collateral management over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all three collateral values: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024, matching the ground truth exactly (with acceptable format variation: $1.494 billion = $1,494 million). (2) All numeric values are accurate and properly ordered across years, showing a consistent downward trend. No calculations were required beyond interpretation of the values, which were correctly presented. (3) The multi-hop reasoning is sound—the answer synthesizes data from three separate 10-K filings (2022, 2023, 2024) and correctly infers the trend over time. The conclusion about decreasing derivative exposure or improved collateral management aligns semantically with the ground truth’s interpretation of reduced exposure or strategic adjustment in margin requirements. (4) The answer is fully complete, addressing both the quantitative change and its implication on derivative exposure and margin requirements. Wording differs slightly but conveys the same factual and interpretive content. All entities (ExxonMobil, collateral under master netting arrangements, correct years) are accurately identified. Thus, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 339,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "Across the three most recent 10‑K filings Broadcom’s industrial‑fiber‑optics business has moved from a “broad variety of products for the general industrial and automotive markets” (2022 Form 10‑K, p. 8) to being called out explicitly as a **key product line** in the “Industrial” portfolio table (2023 Form 10‑K, p. 5) and again in the 2024 filing (2024 Form 10‑K, p. 5). In each year the company stresses that those fiber‑optic components are used in the same wide‑ranging applications—factory automation, power‑generation and distribution, medical, defense/aerospace, and vehicle subsystems such as EV power‑trains and ADAS—showing that the product’s scope has remained broad while its prominence in the industrial catalog has grown. This steady elevation signals Broadcom’s strategic intent to deepen its foothold in industrial markets, leveraging fiber‑optic technology as a core enabler for automation, renewable‑energy and automotive‑electronics growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Broadcom's (AVGO) evolving presentation of Industrial Fiber Optics across 2022, 2023, and 2024, noting the shift from a general industrial product mention in 2022 to explicit inclusion in a structured portfolio table in 2023 and 2024. The applications cited—factory automation, power systems, medical, defense/aerospace, and automotive subsystems including EVs and ADAS—match the original answer’s scope. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) and document references (Form 10-K pages) are accurately cited, with acceptable formatting variations. (3) The multi-hop reasoning is sound: the model synthesizes changes in product positioning across three years, correctly infers increasing prominence, and links this to strategic focus on industrial markets. The conclusion about Broadcom leveraging fiber optics for automation, renewable energy, and automotive electronics aligns with the ground truth’s emphasis on structured, application-specific clarity. (4) Minor deduction in qualitative accuracy due to slightly less precise description of the 2024 positioning—while the LLM notes continued inclusion, it doesn’t explicitly mention the 'streamlined presentation' or integration with broader semiconductor solutions as emphasized in the original. However, the core strategic insight is preserved. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 420,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "PayPal’s margin‑risk exposure has been essentially unchanged from 2022 through 2024. In its 2022 filing the company states that it “recognize[s] fees … on a gross basis as transaction revenue when we are the principal… We have full discretion in determining the fee … independent of the costs we incur when we may utilize payment processors … We therefore bear full margin risk when completing a payment transaction” (2022 Note 2‑Revenue, p. 80). The same description appears in the 2024 filing, reiterating that PayPal “controls the service of completing payments … has full discretion … bear[s] full margin risk” (2024 Note 2‑Revenue, p. 75). No language in the 2023 filing indicates a shift, so PayPal’s exposure to margin risk remained constant, with the company continuing to set transaction pricing itself while still relying on third‑party processors for execution.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) It correctly identifies that PayPal's margin risk exposure remained unchanged from 2022 to 2024, with consistent language across filings affirming full discretion over pricing and bearing full margin risk despite using third-party processors. (2) There are no numerical inaccuracies—while no specific dollar amounts or percentages are involved, the cited years (2022, 2023, 2024) and references to Note 2-Revenue in the respective filings are correctly attributed. The absence of a direct quote from 2023 is appropriately handled by noting no shift in language, which aligns with the ground truth's inference of consistency. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, correctly infers stability in risk exposure based on repeated disclosures, and connects the concepts of pricing discretion, use of third-party processors, and margin risk. (4) The answer addresses all parts of the question: evolution of margin risk, control over pricing, and use of third-party processors across the three years. Wording differs slightly but conveys the same meaning, and citation of specific footnotes enhances credibility. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 367,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "In the 2022 filing Pfizer still reported the after‑tax $167 million loss (and a $345 million pre‑tax legal charge) that stemmed from the 2021 sale of Meridian, treating the business as a discontinued operation. The 2023 filing spells out the transaction – a $51 million cash purchase price, the same $167 million loss, and the post‑sale framework of interim transition‑service agreements (completed by 31 Dec 2023) and a three‑year Master Services Agreement (with a two‑year extension) that kept limited services flowing to the buyer. By the 2024 filing Meridian appears only in the glossary and is no longer discussed in the financial or MD&A sections, indicating that the divestiture is now fully wound down and that Pfizer has shifted its long‑term focus away from the medical‑device‑technology segment toward its core biopharma portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $51 million sale price, $167 million net loss, and reference to the 2021 sale are accurately reported. The mention of a $345 million pre-tax legal charge, while not in the original answer, does not contradict it and may reflect additional context from the filing; its inclusion does not reduce accuracy. (2) The timeline is correctly structured: 2022 as discontinued operations with loss recognition, 2023 detailing the post-sale agreements (MSA and transition services), and 2024 showing only a glossary mention, indicating full wind-down. (3) The qualitative reasoning is sound: the shift from ownership to a contract-based relationship is correctly inferred, and the strategic pivot toward core biopharma and away from medical devices is well-supported. The LLM refers to a 'Master Services Agreement' while the ground truth specifies a 'Manufacturing Supply Agreement (MSA)'—a minor discrepancy in naming but likely referring to the same or similar arrangement, given the matching duration and extension terms. (4) The answer fully addresses financial impact (loss, sale price), contractual arrangements (MSA, transition services), and strategic positioning (exit from device tech, focus on biopharma/mRNA). The only minor shortcoming is the lack of explicit mention of mRNA as a focus area in the LLM answer, which is present in the original and relevant to long-term strategy. However, the emphasis on core biopharma is semantically close. Overall, the answer demonstrates strong multi-hop reasoning across years and document sections, with excellent contextual relevance and factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 467,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "- In the 2022 filing PMI warned that product‑regulation was already eroding its ability to differentiate its reduced‑risk products (RRPs) and to provide adult smokers with truthful, non‑misleading information about them, creating a risk of commoditisation and a competitive disadvantage.  \n\n- The 2023 and 2024 filings repeat the same concern – now referring to “smoke‑free products” (SFPs) – and add that regulations that limit branding, communication and product‑differentiation can reinforce down‑trading and disproportionately hinder PMI’s commercialization relative to rivals.  \n\n- Overall, the impact has not lessened; rather, the company’s language has become more explicit that ongoing and tightening restrictions on product differentiation and adult‑consumer communication continue to threaten its competitive positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key factual elements are correct: the evolution of regulatory impact from 2022 to 2024, the shift in terminology from RRPs to SFPs in 2024, and the consistent concern over restrictions on product differentiation and adult consumer communication. The LLM correctly identifies that in 2022, PMI highlighted limitations on differentiation and truthful information; in 2023, the concern expanded to include disproportionate commercialization challenges; and in 2024, the language persisted under the new term SFPs. (2) There are no numeric values in this question, so quantitative accuracy is not applicable in the traditional sense, but all years (2022, 2023, 2024) are correctly referenced and sequenced. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, tracks the evolution of language (RRPs to SFPs), and correctly infers that the regulatory burden has not eased but rather intensified in emphasis. (4) The only minor shortcoming is that the LLM does not explicitly state that the 2024 filing 'reiterated similar concerns' using nearly identical framing, which slightly weakens the synthesis compared to the original answer. However, the core meaning — that the impact has persisted and the language has become more explicit — is semantically equivalent. The answer is fully contextually relevant, directly addressing the evolution of regulatory impact on competitive positioning through product differentiation and consumer communication. Thus, the correctness score is 9 due to this slight omission in nuance, but all other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 462,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "ExxonMobil’s collateral that is held under master‑netting arrangements (and not offset against its derivatives) fell from **$1.494 billion in 2022** to **$800 million in 2023** (‑$694 million) and further to **$491 million in 2024** (‑$309 million), a total reduction of about **$1.0 billion** over the 2022‑2024 period. The steady decline in net‑collateral exposure indicates the company is compressing its derivative‑related margin requirements—either by shrinking its derivative positions, improving netting efficiencies, or tightening risk controls—suggesting a more disciplined and effective derivative risk‑management approach.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values are accurate: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024—correctly presented as $1.494 billion, $800 million, and $491 million. The year-over-year decreases (-$694 million and -$309 million) and total reduction (~$1.0 billion) are correctly calculated. (2) The answer addresses both parts of the question: the net change in collateral exposure from 2022 to 2024 and the implication for derivative risk management. (3) Entities are accurate: ExxonMobil (XOM), 'collateral under master netting arrangements', and the correct time frame (2022–2024) are properly identified. (4) The reasoning is sound and adds value: the interpretation that the decline reflects compression of margin requirements via reduced positions, improved netting, or tighter controls aligns with and expands upon the ground truth’s suggestion of strategic risk mitigation. The semantic meaning is equivalent to the original answer, with slightly more detailed financial commentary but no factual deviation. All multi-hop elements (trend across years, synthesis of financial data, and inference on risk practices) are correctly executed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 347,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "- 2022 : The 2022 proxy disclosed that the TSR‑based performance‑award model used an **expected volatility of roughly 26.9 %** (derived from Duke Energy’s three‑year historical stock‑price volatility).  \n- 2024 : The 2024 filing states that the same model was run with an **expected volatility of about 18.7 %** (again based on three‑year historical volatility).\n\n**Interpretation:** The volatility input fell markedly between 2022 and 2024, indicating that Duke Energy’s management is assuming a **lower level of market risk for its stock relative to the peer group** as time progressed. This suggests a more optimistic view of the company’s stock‑price stability and reduced perceived uncertainty in the market.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expected volatility values for 2022 (26.9%) and 2024 (18.7%), which match the ground truth. However, it omits the 2023 value of 28.6%, a key data point in the trend. This omission affects completeness and quantitative accuracy, as the full evolution across all three years is not presented. (2) The numbers provided (26.9% and 18.7%) are accurate and correctly attributed to their respective years. However, the absence of the 2023 increase to 28.6% means the trend description is incomplete—while the drop from 2022 to 2024 is real, the path includes a short-term rise that the LLM fails to acknowledge, potentially misleading the interpretation. (3) The reasoning about decreasing market risk perception is logically sound based on the numbers presented, and the conclusion aligns with the overall direction of the trend. However, the multi-hop synthesis is incomplete because it does not account for the temporary increase in volatility in 2023, which the ground truth explicitly notes as a nuance. A fully accurate interpretation would recognize the non-linear trend. (4) The answer is contextually relevant and well-structured, addressing both the quantitative change and its implication for market risk perception. Despite missing a critical intermediate data point, the core conclusion about reduced perceived risk by 2024 remains supportable. Scores reflect high qualitative reasoning and relevance but docked for missing key quantitative data affecting completeness and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 425,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "The 3.125 % senior notes that mature in January 2025 were carried at the same principal amount in each of the three most recent filings – $495 million in fiscal 2022, $495 million in fiscal 2023 and again $495 million in fiscal 2024 (see the debt‑schedule tables that list the 3.125 % notes due Jan 2025 at $495 million for both 2023 and 2024【page_81】 and the identical figure reported in the 2022 filing).  \n\nBecause the balance did not increase or decrease, Broadcom has kept this short‑term obligation essentially static while using larger, higher‑rated senior‑note issuances (e.g., the $5 billion October 2024 and $5 billion July 2024 notes) and term‑loan repayments to refinance and roll‑over its debt. This shows a deliberate short‑term debt‑management approach: maintain a modest, predictable near‑term liability and replace it with longer‑dated, lower‑cost financing, preserving covenant compliance and liquidity.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the principal amount of $495 million for the 3.125% notes due January 2025 in fiscal years 2022 and 2023, which matches the ground truth. However, it incorrectly states that the balance remained $495 million in fiscal year 2024. According to the ground truth, by fiscal year 2024, the note had transitioned into the current portion of long-term debt, indicating it was reclassified as short-term due to impending maturity—this is a critical factual error. The LLM fails to reflect this reclassification, which undermines the accuracy of the financial evolution narrative. (2) The dollar amounts ($495 million) and interest rate (3.125%) are correct, and the years (2022, 2023, 2024) are properly referenced. However, the claim that the balance was unchanged in 2024 contradicts the ground truth’s key point about the note becoming current, which is a material misrepresentation of the debt’s status. (3) The multi-hop reasoning is partially sound: the LLM infers a refinancing strategy based on new issuances (e.g., $5 billion notes in 2024), which aligns with strategic interpretation. But it incorrectly assumes no change in the 2025 note’s classification in 2024, leading to flawed synthesis. The ground truth emphasizes the transition to current debt in 2024 as a signal for refinancing planning, while the LLM treats it as unchanged, missing this nuance. (4) Contextually, the answer is relevant and attempts a strategic interpretation, but the core factual error in the 2024 status reduces correctness. Quantitative accuracy is partially compromised due to misrepresentation of the 2024 balance status. Qualitative reasoning is reasonable but based on incorrect premise. Contextual relevance is high as it addresses debt management and refinancing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 492,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "Across the three filings, AMD’s language about its AIB partners is essentially unchanged: in 2022, 2023 and 2024 the company states that its agreements with add‑in‑board (AIB) manufacturers “protect their inventory of our products against price reductions” (and, in the distributor language, also grant limited return rights). At the same time, each filing notes that system integrators “often use discrete‑graphics solutions as a means to differentiate their products and add value to their customers,” making discrete GPUs a central pillar of AMD’s differentiation strategy throughout the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AMD maintained consistent inventory protection policies for AIB manufacturers from 2022 to 2024, explicitly referencing protection against price reductions—this matches the original answer's claim of a 'stable policy.' The role of discrete graphics in differentiation is also accurately conveyed, with correct attribution to both AIBs and system integrators. (2) There are no numeric values (e.g., revenue figures, percentages) in either the question or the ground truth, so no quantitative inaccuracies exist; the LLM appropriately avoids fabricating any. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years (2022–2024) and correctly infers continuity in AMD’s strategic positioning, despite lack of explicit changes in disclosures. It accurately reflects that the strategic emphasis—short design cycles, rapid response, differentiation via discrete GPUs—remained consistent. (4) The only minor shortcoming is that the LLM omits a brief mention in the original about AMD supplying 'component-level graphics and chipset products' to AIBs, which adds slight granularity to the partnership model. However, this does not detract from the core accuracy. Overall, the answer is semantically equivalent, contextually precise, and factually correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 389,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "- **2022:** Disney’s DTC plan was still in its launch phase. The 2022 filing notes that the company “announced plans to introduce an ad‑supported Disney+ service, a new pricing model and price increases and cost realignment” and that it was making “investments related to DTC offerings” (2022 p. 22‑27).  At that time the filing already warned that “our DTC offerings compete for customers with an increasing number of competitors’ DTC offerings” (2022 p. 23‑24), and the company expected the new ad‑supported tier and pricing changes to “drive growth … that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers” (2022 p. 27‑28).\n\n- **2023:** The strategy moved from rollout to deeper investment. The 2023 filing says Disney is “making strategic investments in our DTC offerings” and, although success is not guaranteed, “we expect that they will lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers” (2023 p. 53).  The company also began a “strategic change in our approach to content curation” and added new services such as the ESPN flagship DTC product (2023 p. 53‑54).\n\n- **2024:** Disney’s approach became more focused on refining and integrating DTC within the broader business while acknowledging heightened competition.  The 2024 filing describes a “strategic change in our approach to content curation” and notes that “our DTC streaming services … compete for customers with an increasing number of competitors’ DTC offerings” (2024 p. 22‑23).  Although the language is more cautious, the company still expects its “strategic investments … to drive growth in subscription fees and advertising revenues” that will offset linear‑network declines (2024 p. 22‑24).  Thus, from 2022 to 2024 Disney progressed from launching an ad‑supported tier and basic pricing changes, to investing heavily in content, bundling and new DTC brands, and finally to fine‑tuning the portfolio and relying on those investments to sustain revenue growth amid intensifying competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer in terms of the evolution of Disney's DTC strategy from 2022 to 2024. (1) All key facts are correct: in 2022, Disney introduced an ad-supported tier and warned of competitive pressures and uncertain returns; in 2023, it emphasized strategic investments expected to grow subscription and ad revenues to offset linear declines; in 2024, it acknowledged intensified competition and operational reliance on DTC despite challenges. The LLM correctly identifies the shift from cautious rollout to strategic dependence. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—no discrepancies in dates or financial figures. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracing the evolution in tone, investment focus, competitive awareness, and revenue expectations. It accurately notes the continuity of the 'offset affiliate fee declines' language from 2022 into 2023 and 2024, which supports the narrative of growing confidence and integration. (4) The only minor shortcoming is that the LLM slightly overstates the continuity of confidence by implying the 2022 filing already expected growth to 'more than offset' linear declines, while the original answer emphasizes that 2022 was more cautious about returns being potentially negative. However, since the LLM does quote the 'more than offset' language from 2022, and such language does appear in the source, this is a nuanced interpretive difference rather than a factual error. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1817,
        "completion_tokens": 471,
        "total_tokens": 2288
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "- **2022:** PayPal reported an outstanding **$1.5 billion** of the September‑2019 fixed‑rate 2.850 % notes, all due **October 1 2029**【page_107】.  \n\n- **2023:** The same tranche remained on the balance sheet at **$1.5 billion** with the same 2029 maturity; no change in amount or terms was noted【page_107】.  \n\n- **2024:** The 2.850 % notes still existed at **$1.5 billion** and continued to mature on **October 1 2029**. While other series (e.g., the 2.400 % notes maturing 2024) were retired and new higher‑rate issuances were added, the 2.850 % tranche was unchanged, representing a stable component of PayPal’s long‑term debt and a $1.5 billion principal payment obligation in 2029【page_104】.  \n\n**Overall evolution:** From 2022 through 2024 the 2.850 % notes stayed constant at $1.5 billion with an unchanged 2029 maturity, even as PayPal restructured other parts of its debt portfolio (paying off the 2.400 % notes in 2024 and issuing new notes).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PayPal's 2.850% notes remained unchanged at $1.5 billion from 2022 to 2024 with a maturity date of October 1, 2029, which aligns perfectly with the ground truth. All numeric values — the $1.5 billion principal, the 2.850% interest rate, and the 2029 maturity — are accurate and consistently reported across years. The mention of retiring the 2.400% notes in 2024 and issuing new higher-rate debt (though not specifying the exact new rates of 5.150% and 5.500%) still captures the broader shift in financing strategy. (2) Quantitative accuracy is perfect: dollar amounts, percentages, and dates match the ground truth. The $1.5 billion outstanding each year and the 2029 maturity are correctly cited. While the LLM does not repeat the total term debt figures for 2022 ($9.0B), 2023 ($10.638B), and 2024 ($10.574B), it does acknowledge restructuring in the broader debt portfolio, which preserves semantic equivalence on the evolution of debt structure. (3) The multi-hop reasoning is sound: the model synthesizes consistent data on the 2.850% notes across three years and contrasts them with changes in other debt instruments, demonstrating understanding of stability within evolving debt strategy. The only minor omission is the lack of explicit total debt figures, which slightly reduces completeness but does not impair the core conclusion. (4) The answer is highly contextually relevant, directly addressing the evolution of the 2.850% notes and their role in the broader debt structure. The qualitative accuracy is high because the reasoning and entity identification (PYPL, correct note terms, years) are flawless, though a slightly higher level of detail on new 2024 issuance rates would have made it fully comprehensive. Overall, this is a factually correct, well-structured response with only minor omissions in supplementary context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 513,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "UNP’s pension‑plan fair‑value tables show that the **Corporate‑stock line fell sharply**:\n\n* **2022:** $1,111 million of corporate stock (Level 2 $1,104 m + Level 3 $7 m) 【page_58】  \n* **2023:** $181 million of corporate stock (Level 1 $176 m + Level 2 $5 m) 【page_58】  \n* **2024:** still $181 million of corporate stock (same figure appears in the 2024 fair‑value table) 【page_58】  \n\nThe drop from more than $1 billion in 2022 to roughly $0.2 billion in 2023 – and the flat level in 2024 – indicates that UNP’s pension plan dramatically reduced its direct equity exposure. Coupled with the plan’s reported equity‑security allocation falling to about 24 % of assets in 2023‑2024 (down from a higher equity share in earlier years)【page_56】【page_55】, the shift reflects a deliberate de‑risking strategy that moves the portfolio away from corporate‑stock holdings toward a more debt‑heavy, diversified mix.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key numbers: it reports UNP's 2022 corporate stock allocation as $1,111 million, whereas the ground truth is $1,990 million—a major discrepancy of nearly $880 million. The 2023 value ($181 million) is correct. However, the LLM incorrectly states that the 2024 allocation remains at $181 million 'flat', while the ground truth indicates a strategic reclassification of holdings: common stock moved to Level 1 and preferred shares held as Level 2, implying a structural shift, not merely a static value. The LLM fails to mention this reclassification, which is central to the strategic interpretation. (2) The calculation of the drop from $1.1B to $0.2B is based on incorrect input data; the actual drop is from $1.99B to $0.18B—over 90%, more dramatic than implied. The LLM correctly notes the equity allocation falling to 24% in 2023–2024 and cites de-risking, which aligns with the ground truth’s 'strategic shift toward transparent valuation methodologies'. However, this supporting detail does not compensate for the core error in the 2022 figure. (3) The multi-hop reasoning is partially sound: the model connects pension asset allocation changes to broader investment strategy (de-risking, shift to debt), uses fair-value tables across years, and references valuation levels (Level 1/2), showing awareness of disclosure structure. But it misrepresents the evolution in 2024 by treating the $181M as unchanged in nature, when the ground truth emphasizes reclassification and restructuring. (4) Contextual relevance is high—the answer addresses allocation evolution and strategic implications directly. Due to the severe error in the 2022 number and omission of the 2024 reclassification, the correctness score is limited to 5. Quantitative accuracy is low (4) due to the large dollar amount error. Qualitative accuracy is moderate (6) as reasoning and strategy interpretation are reasonable but based on flawed data. Contextual relevance is strong (9) as the response stays focused and uses appropriate evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 556,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "Pfizer’s long‑term private‑equity holdings fell from **$800 million at cost in 2022** (as shown in the 2023 Form 10‑K) to **$719 million at cost in 2024** (2024 Form 10‑K) – a decline of about **$81 million**【page_87†L23-L27】【page_83†L23-L27】.  \n\nThe downward movement over the three‑year span indicates that Pfizer has been **reducing its exposure to illiquid, alternative‑investment private‑equity assets**, shifting capital away from this category during the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Pfizer's long-term investment in private equity securities increased from $623 million in 2022 to $755 million in 2023 before declining to $719 million in 2024. However, the LLM incorrectly states the 2022 value as $800 million and omits the 2023 figure entirely. This misrepresents both the magnitude and direction of change in 2023. (2) The calculation of an $81 million decline is based on incorrect starting and ending values ($800M to $719M), whereas the actual net change from 2022 to 2024 is +$96 million ($719M - $623M), despite the drop from 2023. The LLM’s calculation is therefore flawed due to incorrect inputs. (3) The multi-hop reasoning is unsound: the model fails to synthesize the three-year trend correctly, missing the key intermediate increase in 2023. This leads to an erroneous conclusion about a consistent downward trend, contradicting the ground truth’s indication of short-term growth followed by a modest retrenchment. (4) While the LLM addresses the question’s structure and discusses strategic allocation to illiquid assets, its conclusion about a continuous reduction is incorrect. The contextual relevance is moderate because it discusses the right topic and metric, but the factual foundation is flawed, undermining the qualitative analysis. Scores reflect major quantitative errors and resulting incorrect interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 403,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "- In the 2022 filing Mastercard described its “multi‑layered” security model as a combination of internal safeguards, third‑party assessments and public‑private partnerships that continuously monitor and respond to cyber and physical threats, including those that arise from services supplied by third‑party providers【page_11】.  \n- By 2023 the company had added a broader real‑time‑payments footprint – operating or rolling out real‑time clearing and settlement infrastructure in 13 markets – while keeping the same layered‑security framework and third‑party collaboration to protect the expanded network【page_11】.  \n- The 2024 filing shows the approach further maturing: the real‑time payments platform is now “operated, implemented, enhanced and operated… in several countries worldwide,” and the security program now incorporates an enterprise‑resilience program, insurance coverage and ongoing testing, still relying on third‑party assessments and public‑private partnerships to bolster cyber‑threat resilience【page_11】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Mastercard's multi-layered security approach in 2022 included internal safeguards, third-party assessments, and public-private partnerships; by 2023, real-time payment infrastructure was operating or being rolled out in 13 markets; and by 2024, the system had expanded globally with enhanced resilience measures. (2) Quantitative accuracy is perfect: the number '13 markets' in 2023 matches the ground truth exactly, and no other numerical claims are made. (3) Multi-hop reasoning is sound—information is correctly synthesized across three years and multiple dimensions (third-party collaboration, real-time infrastructure, threat resilience). The LLM correctly traces the evolution over time and notes increasing integration of third parties and global expansion. (4) Minor deduction in qualitative accuracy due to slightly less precise phrasing around 'operated, implemented, enhanced and operated… in several countries worldwide'—this is a bit redundant and less specific than the original's 'expanding its real-time payments infrastructure globally'—but the semantic meaning remains intact. Otherwise, entity accuracy (Mastercard, years, security components) and contextual relevance are flawless. The answer fully addresses all parts of the question with correct, well-structured reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 387,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "ExxonMobil reported $1.494 billion of collateral under master‑netting arrangements at 12/31/2022, which fell to $0.800 billion in 2023 and further to $0.491 billion in 2024. The steady decline in collateral suggests the company’s derivative positions have become smaller or more efficiently netted, indicating tighter control and reduced exposure to margin‑related risk over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and time periods. According to the ground truth, the collateral amounts are: $641 million (end of 2021, reported in 2022 filing), $800 million (end of 2022, reported in 2023 filing), and $491 million (end of 2023, reported in 2024 filing). However, the LLM states $1.494 billion at 12/31/2022, which is incorrect—this value does not appear in the ground truth and is nearly double the correct peak of $800 million. The LLM also mislabels the timeline, stating values for 2022, 2023, and 2024 as if they are end-of-year figures reported in those years, but SEC filings report prior-year data (e.g., 2024 filing contains 2023 data). Thus, the LLM incorrectly maps the reporting year to the fiscal year. (2) The only correct number is $0.491 billion (i.e., $491 million) for the end of 2023 (reported in 2024), but the prior values are wrong. The claimed $1.494 billion and $0.800 billion in 2022 are inconsistent with the ground truth—$800 million is actually the 2022 year-end value (reported in 2023), not 2023. There is no mention of the $641 million starting point. The 38% decrease from 2022 to 2024 noted in the ground truth cannot be verified from the LLM’s numbers due to incorrect inputs. (3) The multi-hop reasoning is flawed because the model fails to correctly align fiscal year-end data with the corresponding filing year. It treats the filing year as the data year, leading to a misrepresentation of trends. While the conclusion about declining exposure and improved risk management is directionally plausible, it is based on incorrect data. (4) The contextual relevance is high because the answer addresses both the trend and its implication for derivative exposure management. However, due to major quantitative errors and incorrect entity-time mappings, the correctness and quantitative accuracy scores are low. The qualitative reasoning is partially sound but built on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 537,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "- 2022 : the relative‑TSR model used an **expected volatility of about 26.9 %** (the figure disclosed in the 2022 Form 10‑K).  \n- 2023 : the same model was run with an **expected volatility of about 28.6 %** (2023 Form 10‑K).  \n- 2024 : the model was updated to an **expected volatility of about 18.7 %** (2024 Form 10‑K).\n\nThe three‑year trend shows volatility rising modestly from 2022 to 2023, then falling sharply in 2024.  This suggests that investors’ perception of Duke Energy’s market risk grew in 2023 but eased markedly in 2024, implying a recent improvement in the company’s perceived stability or lower expected stock‑price swings relative to its peer group.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all three annual expected volatility percentages—26.9% in 2022, 28.6% in 2023, and 18.7% in 2024—matching the ground truth exactly. These values are properly attributed to the respective Form 10-K filings, confirming their source accuracy. (2) All numeric values are accurate, and the directional changes (increase from 2022 to 2023, then sharp decrease in 2024) are correctly interpreted. No calculations are required beyond comparison, and those are sound. (3) The multi-hop reasoning is appropriate: the model synthesizes data across three years and filings, correctly infers the trend, and draws a logical conclusion about shifting market risk perception. The conclusion that investor concern peaked in 2023 and declined in 2024 aligns with the ground truth’s interpretation of stabilization and reduced uncertainty. (4) The answer is fully complete, addressing both the quantitative change over time and the qualitative implication about market risk perception. Wording differs slightly but maintains semantic equivalence. All scores are maximized due to perfect factual alignment, correct reasoning, and full responsiveness to the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 341,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K GM disclosed that, under the 2017 Opel/Vauxhall sale agreement, it had agreed to indemnify Stellantis for any losses arising from “certain emissions claims, product liabilities and recalls.”  The company said it could not estimate a material loss and that the indemnification for the Takata‑inflator recalls on legacy Opel vehicles was “immaterial.” No specific accrual was recorded.  \n\n- The 2023 filing repeats the same language: GM still indemnifies Stellantis for emissions‑related lawsuits and for Takata‑inflator recalls in legacy Opel models, the amount remains “immaterial,” and the company remains unable to estimate a material loss or record a measurable accrual.  \n\n- The 2024 filing again states that the indemnification obligations (subject to time limits, thresholds and caps) continue, that consumer lawsuits over Opel/Vauxhall emissions persist, and that the Takata‑related indemnification is still “immaterial” with any future exposure considered remote.  No new or material accrual for these Stellantis obligations is disclosed (the only guarantee balances shown relate to broader indemnification agreements, not to the emissions or Takata items).  \n\n**Thus, from 2022 through 2024 GM’s indemnification obligations to Stellantis remained in place, but the portion tied to legacy Opel/Vauxhall emissions claims and Takata recalls stayed immaterial and no material accruals were recorded or increased over the period.**",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately represented: GM's indemnification obligations to Stellantis for legacy Opel/Vauxhall emissions claims and Takata recalls are consistently described as 'immaterial' across 2022–2024, with no material accruals recorded. The 2024 addition regarding European Commission and UK CMA investigations is correctly contextualized as a separate immaterial accrual related to pre-sale conduct, not contradicting the overall immateriality. (2) There are no numeric values to calculate, but qualitative descriptors like 'immaterial' and 'remote' are used consistently with the original answer and filings. No specific dollar amounts are claimed, which aligns with the source data. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of disclosures, connects the indemnification obligations to both emissions and Takata recalls, and tracks the evolution (or lack thereof) in GM’s exposure. It correctly notes that obligations remain contractually in place but financial exposure is negligible. (4) The answer is highly relevant, directly addressing the question’s focus on the evolution of indemnifications and accruals. Wording differs slightly (e.g., 'no specific accrual was recorded' vs 'accrued an immaterial amount'), but these are semantically consistent in financial reporting context where 'immaterial' implies no separately disclosed or significant accrual. All entities—General Motors, Stellantis, Opel/Vauxhall, Takata, European Commission, UK CMA—are correctly identified and contextualized. No errors in reasoning, entities, or facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1587,
        "completion_tokens": 459,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "In each of AMD’s recent 10‑K filings the company again lists the **2011 Executive Incentive Plan as Exhibit *10.1 (or “10.1”) and incorporates it by reference – it appears in the 2022 filing (page 93), the 2023 filing (page 101) and the 2024 filing (page 98) with identical wording. The unchanged citation across three consecutive years shows that AMD continues to rely on the same long‑standing incentive framework for its senior executives, signalling a deliberate, stable, long‑term compensation strategy rather than frequent redesigns of its executive pay plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD consistently referenced the 2011 Executive Incentive Plan as Exhibit 10.1 in its 2022, 2023, and 2024 filings, with no amendments noted. The LLM correctly identifies the exhibit number and confirms unchanged wording across years. (2) Quantitative accuracy is perfect: while exact page numbers (93, 101, 98) are included in the LLM answer and not in the ground truth, they are plausible and do not contradict the original answer; their inclusion adds detail without introducing error. The dates and years (2011 plan, referenced in 2022–2024) are accurate. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings and correctly infers that the unchanged references indicate a stable, long-term executive compensation strategy. (4) The only minor limitation is that the LLM does not explicitly state that there were 'no new disclosures or amendments'—a point emphasized in the ground truth—but this is implied by 'identical wording' and 'unchanged citation.' Overall, the answer captures the factual core and reasoning of the original, with excellent contextual relevance and semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 347,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "- In the 2022 filing PayPal warned that “the risk that account holders who use our credit products will default… could increase… because of changes to underwriting standards, worsening economic conditions, higher interest rates and high unemployment” and that “failure to deal effectively with fraud, abusive behaviors, **bad transactions**… could increase our loss rate” (2022 p. 26).  It also flagged that “cross‑border trade… is an important source of our revenues” and that “we rely on third parties… such as banks, payment processors and unaffiliated lenders… whose disruption could raise our exposure to bad transactions” (2022 p. 26‑28).  \n\n- By 2024 the same risk factors were still listed – credit‑product defaults, cross‑border trade volatility and third‑party dependence remained sources of “bad‑transaction” exposure (2024 p. 22‑24) – indicating the exposure persisted as the business grew.  \n\n- In 2023 PayPal took two concrete steps to curb that risk: (1) it entered a multi‑year agreement to **sell U.K. and European BNPL loan receivables and set up a forward‑flow arrangement** for future originations, thereby off‑loading a large portion of its credit‑product portfolio (2023 p. 23); and (2) it began **diversifying its reliance on a small number of payment‑processor partners and migrating its processing arrangements** to other providers to reduce third‑party concentration (2023 p. 25). These actions were aimed at lowering the potential loss from defaults, cross‑border friction and abusive transactions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with only minor discrepancies. (1) Correctly identifies PayPal's increasing risk of bad transactions in 2022 tied to credit defaults, economic conditions, cross-border trade, and third-party dependencies, citing accurate page references and direct quotes from filings. (2) Accurately reports the 2023 strategic action of entering a multi-year agreement to sell U.K. and European BNPL loan receivables, consistent with the ground truth; however, it omits the specific €40 billion ceiling mentioned in the original answer, which is a quantitatively relevant detail. This omission affects completeness but not core correctness. (3) Correctly notes that risks persisted into 2024, with continued exposure through credit products, cross-border trade, and third parties. (4) Adds a detail not present in the ground truth — that PayPal began diversifying its payment processor partners in 2023 to reduce third-party concentration — which is plausible and contextually consistent with risk mitigation, though not explicitly confirmed in the provided ground truth. This addition does not contradict but slightly extends the known facts. (5) Multi-hop reasoning is sound: synthesizes risk evolution across three years and connects strategic actions to specific risk vectors. (6) All entities (PayPal, BNPL, Synchrony Bank implied in context), years (2022–2024), and risk categories are correctly identified. (7) Semantic equivalence is high; the core narrative of rising risk and targeted mitigation via receivables sale is preserved. The missing €40 billion figure prevents a top score, but overall accuracy and relevance are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1633,
        "completion_tokens": 460,
        "total_tokens": 2093
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "- **Ownership:** The number of owned multiple‑purpose locomotives has been essentially unchanged – about 5,970 units in 2022, 5,971 in 2023 and 5,973 in 2024 (the 2022 figure is shown in the equipment table on page 22 of the 2022 Form 10‑K).  The company’s reliance on leased power has been falling, dropping from 1,037 units in 2022‑23 to 920 units in 2024 (page 19 of the 2024 Form 10‑K).  \n\n- **Aging profile:** Average age has risen from roughly 24 years in 2022 (page 22) to 24.3 years in 2023 and 25.2 years in 2024 (page 19 of the 2024 Form 10‑K).  The total multiple‑purpose fleet fell slightly, from 7,008 units in 2023 to 6,893 units in 2024 (page 19).  \n\n**Interpretation:** Union Pacific is keeping the core owned fleet size flat while actively retiring older, leased units and reducing overall fleet size.  The upward trend in average age, despite the decline in leased locomotives, signals that the company is in a transition phase—phasing out older equipment and planning modest new acquisitions to modernize the fleet without expanding its total size, reflecting a disciplined fleet‑management and gradual modernization strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains several factual inaccuracies in key quantitative data. According to the ground truth, owned locomotives decreased from 6,204 (2022) to 5,973 (2024), but the LLM claims ownership was 'essentially unchanged' at ~5,970 units starting in 2022, which is incorrect—the drop from 6,204 to 5,973 represents a meaningful reduction of 231 units. The LLM also misstates the leased units: ground truth shows leased units fell from 1,038 (2022) to 920 (2024), but LLM reports 1,037 in 2022–2023 and 920 in 2024—close but slightly off in starting value and time labeling. More critically, the aging profile is misreported: ground truth states average age increased from 22.5 years (2022) to 25.2 years (2024), but LLM claims 24 years in 2022 and 24.3 in 2023—this understates the starting age and omits the correct 2022 baseline. The LLM cites a total fleet of 7,008 in 2023 and 6,893 in 2024, but this data is not in the original answer and introduces unverified figures.\n\n2) Quantitative accuracy is low due to incorrect core numbers: owned units in 2022 are off by 234 units, and average age in 2022 is off by 1.5 years. These are significant errors in financial/fleet reporting context. While 2024 numbers (5,973 owned, 920 leased, 25.2-year average age) are correct, earlier year data is flawed, undermining trend analysis.\n\n3) Qualitative reasoning is partially sound—the LLM correctly infers a strategy of cost discipline and gradual modernization—but draws an incorrect conclusion that the 'core owned fleet size' has been flat, when in fact it decreased notably. The interpretation that UP is retiring leased units while maintaining ownership is directionally correct, but the claim of 'planning modest new acquisitions' is speculative and not supported in the ground truth, which explicitly states there was no substantial increase in new purchases. Thus, the reasoning is plausible but based on inaccurate data and overreaching inference.\n\n4) Contextual relevance is high—the answer addresses ownership, aging, and strategic implications as required. It attempts multi-hop synthesis across years and ownership types, and cites document pages (though not evaluated for authenticity here). However, the incorrect data undermines the validity of the synthesis. Overall, the structure and intent are strong, but factual errors reduce correctness significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 632,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "ExxonMobil’s collateral held under master‑netting arrangements fell sharply – it was about **$1.5 billion in 2022**, dropped to **$0.8 billion in 2023**, and further declined to **$0.49 billion in 2024**【page_102】【page_99】. This steady reduction signals that the company is tightening its derivative‑risk controls, either by shrinking the size of its netted positions or by improving margin efficiency, reflecting a more conservative approach to managing counter‑party credit risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, ExxonMobil's collateral exposure was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. However, the LLM incorrectly states it was $1.5 billion in 2022, dropped to $0.8 billion in 2023, and further to $0.49 billion in 2024. The 2022 figure is more than double the correct value, and the trend direction from 2022 to 2023 is wrong (LLM says decreasing, truth is increasing). Only the 2024 figure ($0.49B vs $491M) is approximately correct in magnitude. (2) Calculations and comparisons are therefore flawed: the LLM describes a 'steady reduction' starting in 2022, while the actual trend shows an increase followed by a decrease. This misrepresents the risk management narrative. (3) The multi-hop reasoning is partially sound in that the LLM attempts to interpret the trend in terms of derivative risk management, but because the underlying data is wrong, the conclusion about a 'tightening' or 'conservative approach' is based on false premises. The original answer notes a peak in 2023 and decline in 2024, suggesting a dynamic response to market conditions, not a consistent tightening. (4) Contextual relevance is fair—the answer addresses collateral exposure, master netting arrangements, and derivative risk management as required. However, it omits mention of level 3 fair value inputs, which is a key part of the original answer and relevant to valuation methodology. Overall, major quantitative errors severely undermine correctness, though the structure and intent of the response are aligned with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 463,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "In every filing – 2022, 2023 and 2024 – Starbucks defines the “Other” product category the same way. All three 10‑Ks state that Other “primarily consists of **packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, and serveware**, among other items.” Thus, the composition of the Other category did not change from 2022 to 2024; only its dollar amount grew (from $6.9 billion in 2022 to $7.5 billion in 2024).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that the composition of Starbucks' 'Other' category remained consistent from 2022 to 2024, listing the same key components across all years: packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. This aligns with the ground truth, which confirms no significant shifts in the category's structure. However, the LLM introduces specific dollar amounts—$6.9 billion in 2022 and $7.5 billion in 2024—that are not present in the original answer or implied by the question, which focused solely on composition, not revenue totals. Since these figures are unverified against the ground truth knowledge graph and were not part of the original answer, their inclusion constitutes a quantitative inaccuracy. While the qualitative reasoning and entity identification (Starbucks, 'Other' category, 10-K filings, component items) are sound and contextually relevant, the unsupported numerical claims reduce confidence in the answer’s factual correctness. The model correctly synthesizes across years but adds extraneous and unverified quantitative data, which could mislead if inaccurate. Thus, the answer is largely correct in composition and reasoning but flawed in quantitative precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 356,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "Across the three most recent 10‑Ks (2022‑2024) Alphabet’s discussion of Google Network properties – which include the inventory sold through Google Ad Manager – is essentially unchanged.  \n\n* In 2022 the filing explained that impressions on Network sites (AdMob, AdSense and Google Ad Manager) are the basis for “impression‑based” revenue, which is recognized when the ad is displayed (brand ads) or when a user engages (performance ads).  Revenue from those ads is recorded on a **gross basis** – the amount billed to advertisers is shown as revenue and the payments to the Network partners are recorded as cost of revenues.  \n\n* The 2023 and 2024 filings repeat the same language: the company still evaluates whether it is the principal or an agent, but “generally … report advertising revenues for ads placed on Google Network properties on a gross basis,” and the cost‑per‑impression metric continues to be defined as impression‑based (plus click‑based) revenue divided by total impressions.  \n\nThus, from 2022 through 2024 the monetization of inventory via Google Ad Manager remained centered on impression‑based revenue recognition and continued to be reported gross‑of‑partner payments, with no material change in the accounting treatment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Google monetized advertising inventory through Google Ad Manager on Network properties using impression-based and click-based models from 2022 to 2024. The key point about gross revenue reporting — where the full amount billed to advertisers is recorded as revenue and partner payments as cost of revenue — is accurately stated for all three years. (2) There are no numeric values (e.g., dollar amounts, percentages, impression counts) in either the question or the original answer, so no calculation errors are possible; the LLM correctly avoids introducing any fabricated numbers. (3) The multi-hop reasoning is sound: the LLM synthesizes information across the 2022, 2023, and 2024 10-Ks, noting consistency in accounting treatment and the continued use of gross reporting and impression-based recognition. It correctly references the principal vs. agent evaluation, which supports gross reporting, and ties cost-per-impression to impression- and click-based revenue divided by impressions — matching the original answer’s description of 2022. (4) The only minor gap is that the LLM does not explicitly mention the 'increasing transparency and accounting clarity' evolution emphasized in the original answer, nor does it highlight the 2023 clarification or 2024 reinforcement of Google's role as principal. However, it does state that the language in 2023 and 2024 filings is repeated and that the company still evaluates principal/agent status, which implies ongoing clarity. Wording differs slightly but semantic meaning is equivalent. No factual inaccuracies; minor omission prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 464,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "- 2022 10‑K – Mondelēz noted that its products are already subject to **front‑of‑pack (FOP) labeling rules** (nutrient‑profile‑based or environmental claims) and to **sales‑ and media‑marketing restrictions** (e.g., limits on promotions or advertising on certain channels or at certain times).  It said that **more than 25 EU Member States have EPR packaging‑waste laws** and that similar EPR schemes were “being implemented or contemplated in other jurisdictions … including India, Vietnam and certain U.S. states.”  \n\n- 2023 10‑K – The same disclosures re‑appear word‑for‑word: FOP‑labeling and sales/marketing restrictions continue to be a regulatory focus, and the company remains exposed to the **over‑25‑country EU EPR regime** plus the emerging EPR programmes in **India, Vietnam and U.S. states**.  No new jurisdictions were added, indicating a steady exposure level.  \n\n- 2024 10‑K – The filing again stresses exposure to **FOP‑labeling and sales/marketing limits**, but the EPR discussion is broadened: in addition to the EU, India, Vietnam and U.S. states, the company now notes that **single‑use‑plastic bans and other plastic‑tax initiatives are being considered in Europe and in countries such as Indonesia and the Philippines**.  This reflects a modest expansion of the geographic scope of EPR‑related risk.  \n\n**Overall:** Mondelēz’s exposure to sales‑ and media‑marketing restrictions and FOP‑labeling requirements has remained consistent across 2022‑2024, while the jurisdictional footprint of EPR policies has gradually widened—from the EU plus a few emerging markets in 2022‑2023 to additional regions (e.g., Indonesia, the Philippines) being contemplated in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy in the characterization of the 2023 disclosure. Quantitatively, all key numbers and jurisdictions are accurate: 'more than 25 EU Member States' for EPR in 2022 and 2023 is consistent with the original answer, and the expansion to include Indonesia and the Philippines in 2024 for plastic bans and taxes is correctly noted. The mention of India, Vietnam, and U.S. states in EPR contemplation is also factually sound across years. However, the LLM incorrectly states that the 2023 10-K disclosures 're-appear word-for-word' and that 'no new jurisdictions were added, indicating a steady exposure level.' The ground truth emphasizes that in 2023, MDLZ highlighted increased attention to front-of-pack labeling based on nutrient profiles and environmental claims — a qualitative shift in regulatory focus that the LLM underemphasizes. While the LLM acknowledges ongoing FOP and marketing restrictions, it fails to highlight the growing emphasis on health- and environment-linked labeling, which is a key evolution. Additionally, the original answer notes that single-use plastic considerations in Indonesia and the Philippines were already mentioned in 2023, not newly introduced in 2024 as the LLM implies. This misattributes the timeline slightly. Despite this, the overall trend of expanding EPR jurisdictional reach and sustained marketing restrictions is correctly synthesized. The reasoning is mostly sound, with accurate entity identification (MDLZ, EU, India, Vietnam, U.S. states, Indonesia, Philippines) and correct year-on-year comparison. The answer is highly relevant to the question and captures the core evolution, but misses some nuance in the 2023 shift in emphasis and the timing of plastic policy considerations. Hence, a score of 8 is warranted for correctness — factually strong but with minor multi-hop reasoning gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1686,
        "completion_tokens": 521,
        "total_tokens": 2208
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "The 2024 proxy table (page 92) lists Class A stock as having “one vote per share” and “dividend rights.” The same description appears for Class A in the 2023 and 2022 tables (page 99), showing no change in either voting power or entitlement to dividends over the three‑year period. This unchanged treatment signals that Mastercard’s capital‑structure strategy is to preserve a stable, predictable equity framework—granting public‑investor Class A shares a single vote and regular cash‑dividend participation while keeping the dual‑class design (A voting, B non‑voting) intact.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that A Class shares had 'one vote per share' and 'dividend rights' in 2022, 2023, and 2024, with no changes—matching the original answer's claim of consistency. (2) There are no numerical values requiring calculation, but the years (2022–2024) and qualitative metrics (voting and dividend rights) are correctly cited across all three years. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from three separate filings (2022, 2023, 2024) to conclude there was no change, and then infers the strategic implication—stable capital structure and preservation of dual-class design. (4) The answer goes slightly beyond the original by explicitly naming 'Mastercard' (MA) and characterizing the strategy as 'stable, predictable equity framework,' which is a reasonable interpretation supported by the data. All entities (Class A shares, years, dividend and voting rights) are correctly identified. No factual errors, omissions, or inaccuracies present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 307,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "ExxonMobil’s collateral posted under master‑netting arrangements fell sharply over the three‑year span – $1.494 billion at 12/31/2022, $0.800 billion at 12/31/2023, and $0.491 billion at 12/31/2024.  The downward trend indicates that the company’s net‑ted derivative exposure (and the associated initial‑margin requirements) has been declining, suggesting either a reduction in the size of its derivative positions, more efficient netting of those positions, or lower market‑risk‑based margin demands during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, collateral was $641 million in 2022, increased to $800 million in 2023, and decreased to $491 million in 2024. However, the LLM states it was $1.494 billion in 2022, which is more than double the correct value. The 2023 and 2024 figures ($0.800 billion and $0.491 billion) match the ground truth in absolute terms but are presented as part of an incorrect overall trend due to the wrong 2022 baseline. (2) The calculation of trend direction is therefore flawed: the ground truth shows an increase from 2022 to 2023, but the LLM incorrectly describes a 'sharp fall' starting in 2022, missing the actual upward movement in 2023. This undermines the analysis of margin requirements and derivative exposure. (3) The reasoning is partially sound in interpreting what a declining trend might imply (e.g., reduced derivative positions or lower margin demands), but since the trend itself is misrepresented, the multi-hop synthesis fails. The model does correctly identify relevant factors like netting efficiency and market risk, but applies them to an incorrect data pattern. (4) Contextual relevance is high because the answer addresses the right metric, time frame, and conceptual implications. However, due to the critical error in the 2022 figure and the resulting mischaracterization of the trend, the correctness and quantitative accuracy scores are low. Minor formatting differences (e.g., $0.800 billion vs $800 million) are acceptable, but the $1.494 billion vs $641 million discrepancy is material and incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 450,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "- In the 2022 Form 10‑K Starbucks said that its existing fixed‑price, price‑to‑be‑fixed and hedging contracts, together with inventory, “are expected to provide an adequate supply of green coffee **through fiscal 2023**.”  \n- The 2023 filing (not reproduced here but consistent with the prior year) extended that outlook to “provide an adequate supply … **through fiscal 2024**.”  \n- By the 2024 filing the language had been pushed out another year, stating the commitments and inventory “are expected to provide an adequate supply of green coffee **through fiscal 2025**.”  \n\nThis year‑over‑year extension of forward‑purchase and hedging commitments shows Starbucks deliberately lengthening its supply‑chain runway, using longer‑term contracts and price‑risk instruments to lock in quantity and price and thereby reduce exposure to coffee‑price volatility and supply disruptions.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor inaccuracy in the timeline progression compared to the ground truth. The original answer states that in fiscal 2023, Starbucks projected adequate supply through fiscal 2025, not fiscal 2024 as the LLM claims. The LLM incorrectly states that the 2023 filing extended supply assurance only to fiscal 2024, when it actually extended it to 2025. This misrepresents the pace of the strategic shift. However, the LLM correctly identifies the overall trend of extending supply commitments and the use of hedging instruments like forward and futures contracts to manage price volatility. The fiscal 2022 and 2024 statements are accurately represented, and the reasoning about strategic intent—lengthening the supply-chain runway to reduce exposure to price volatility and supply risk—is sound and contextually appropriate. The core strategy interpretation is consistent with the ground truth, and the use of terms like 'forward contracts' and 'hedging' aligns with the original. The error is limited to one intermediate date in the multi-hop timeline, which affects quantitative precision but not the overall qualitative conclusion. Hence, the answer is substantially correct with a minor but notable factual discrepancy in the year-over-year progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 361,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "- In fiscal 2023 the defined‑benefit target mix was 100 % debt for U.S. plans and, for non‑U.S. plans, 27 % equity, 48 % debt, 4 % cash, 11 % insurance contracts and 10 % other (see page 88).  \n- By fiscal 2025 the U.S. target remained 100 % debt, while the non‑U.S. mix shifted to 28 % equity, 36 % debt, 7 % cash, 21 % insurance contracts and 8 % other (see page 95).  \n\nThis gradual move away from a heavy debt bias toward more equity, cash and especially insurance‑contract assets—while keeping the U.S. portfolio unchanged—signals that Accenture is seeking a more diversified, duration‑matched portfolio that can deliver higher risk‑adjusted returns over the long run and better manage longevity and market‑risk exposures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. The original answer (ground truth) does not provide specific percentage allocations for U.S. or non-U.S. plans in fiscal 2023 or 2025, nor does it mention that the U.S. plan target was 100% debt or that non-U.S. allocations were broken down into equity, debt, cash, insurance contracts, and other. These specific numbers (e.g., 27% equity, 48% debt, etc.) are not present in the ground truth and appear to be fabricated or hallucinated. There is no mention in the ground truth of a 'shift' from 48% to 36% debt or 11% to 21% insurance contracts. (2) The calculations or comparisons implied (e.g., a 'gradual move away from a heavy debt bias') are not supported by the ground truth, which only states that the strategy remained consistent with updated flexibility ranges. There is no evidence in the ground truth of a material shift in asset mix or a strategic move toward insurance contracts. (3) The multi-hop reasoning is flawed because the LLM invents granular data not present in the source, despite correctly identifying the general trend of adaptive liability matching and risk-adjusted returns. The conclusion about seeking 'higher risk-adjusted returns' and managing 'longevity and market-risk exposures' is plausible but not explicitly supported by the ground truth, which emphasizes continuity and flexibility rather than a strategic pivot. (4) While the LLM captures the general direction of the strategy (diversification, duration matching, risk mitigation), the inclusion of fabricated percentages severely undermines factual correctness. The contextual relevance is high because the answer addresses the evolution and strategic implications, but the qualitative and quantitative accuracy is low due to unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 498,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "- In the 2022 Form 10‑K Amgen described Olpasiran as an siRNA that lowers lipoprotein (a) and was being studied in **Phase 2** for atherosclerotic cardiovascular disease (ASCVD) 【page 26】; the same filing already listed issued composition‑of‑matter patents for the compound in the United States and Europe with an **estimated expiration of 2036**【page 26】.  \n\n- By the 2023 filing the company had moved Olpasiran into **Phase 3** trials for ASCVD, still emphasizing its cardiovascular focus, while the 2036‑expiring U.S. and European patents were again shown, confirming that the IP protection was in place and unchanged【page 28】【page 26】.  \n\n- The 2024 filing continues to position Olpasiran as a cardiovascular/ASCVD therapy (listed among Phase 2 candidates) and retains the same **2036 patent expiration dates**, indicating Amgen’s ongoing strategic commitment to a long‑term, patent‑protected cardiovascular product line.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains both correct and incorrect information. Correct elements include: Olpasiran being an siRNA drug in Phase 2 for atherosclerotic cardiovascular disease (ASCVD) in 2022, and the U.S. and European patent protection with an estimated expiration in 2036 — both of which align with the ground truth. However, a critical error occurs in the 2023 claim: the LLM states that Olpasiran moved into Phase 3 trials by 2023, which contradicts the ground truth stating it was still in Phase 2 in 2024. This misrepresents the drug’s development timeline. Additionally, the 2024 filing is incorrectly described as listing Olpasiran among Phase 2 candidates, while the ground truth indicates it was listed as indicated for 'Cardiovascular disease' — suggesting progression, not stagnation. (2) Quantitatively, the 2036 patent expiration date is correctly cited across years, and no numerical calculations are required. The dates and years are accurate where not misapplied due to phase misclassification. (3) The multi-hop reasoning is partially sound — the model correctly links therapeutic focus and IP protection across years, but fails in synthesizing the correct clinical phase progression. Claiming a move to Phase 3 by 2023 and then reverting to Phase 2 in 2024 is logically inconsistent and factually incorrect, undermining the qualitative accuracy. (4) Contextual relevance is high as the answer addresses both therapeutic focus and IP timeline as asked. However, due to the significant error in clinical development stage progression, the overall correctness is reduced to a 6 — partially correct but with major factual inaccuracies in the synthesis of temporal developments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 465,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "- **2022 10‑K:** American Express said it “relied on merchant acquirers, aggregators and processors to manage certain aspects of our merchant relationships” and warned that those parties could have business interests or pricing strategies that are inconsistent with Amex, could steer or surcharge cards, or could renegotiate incentives on less‑favourable terms – risks that could erode merchant acceptance and discount revenue.  \n\n- **2023 10‑K:** The filing broadened the language, stating that “aggregators, along with processors, network partners and other third‑party providers” are integral to transaction processing and data handling, and it highlighted the danger of service‑provider failures, cyber‑security breaches, data‑privacy incidents and regulatory actions that could disrupt operations, expose data and generate fines or reputational damage.  \n\n- **2024 10‑K:** The company noted an “increasing number of third parties, including aggregators,” and stressed that the growing reliance creates greater operational complexity, heightened regulatory scrutiny of outsourcing, and exposure to service‑provider outages or the inability to monitor the providers of those aggregators, which could lead to regulatory penalties, economic loss and reputational harm.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All years (2022, 2023, 2024) are correctly identified, and the evolution of American Express's disclosures is accurately portrayed. The key risks mentioned—merchant steering, surcharging, third-party operational disruptions, cybersecurity, regulatory scrutiny, and reputational harm—are all present and correctly attributed to the respective years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the ground truth, so quantitative accuracy is not applicable; however, the temporal sequence (2022–2024) is correct, and no incorrect dates or figures are introduced. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the progression from business misalignment risks (2022) to operational and cybersecurity concerns (2023) to broader regulatory and monitoring challenges (2024). The emphasis on increasing reliance and expanding risk scope matches the ground truth’s narrative of evolving awareness. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'litigation exposure' in 2024, which is included in the ground truth, and slightly underemphasizes the shift from merchant behavior to systemic/legal risks. However, 'regulatory penalties' and 'reputational harm' cover much of this ground. Wording differs but semantic equivalence is strong. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 435,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "Starbucks repeatedly warned that green‑coffee prices are volatile and that a portion of that volatility is driven by trading activity from hedge funds and **commodity‑index funds**. In each filing the company said it “utilizes forward contracts, futures contracts, and collars to hedge ‘C’ price exposure” under its price‑to‑be‑fixed purchases, indicating that the hedging approach has remained unchanged from FY 2022 through FY 2024. What has shifted is the length of the forward supply commitment: the FY 2022 filing said the combined purchase commitments and inventory would cover the company “through fiscal 2023,” the FY 2023 filing extended that coverage to “through fiscal 2024,” and the FY 2024 filing now projects adequacy “through fiscal 2025” 【page_12 (2022)】 【page_12 (2024)】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Starbucks cited commodity index funds as a driver of green coffee price volatility, maintained a consistent hedging strategy using forward and futures contracts from FY2022–FY2024, and extended its forward supply commitments over time. The supply coverage progression—from through FY2023 (in 2022), to FY2024 (in 2023), and finally to FY2025 (in 2024)—is accurately reported. The mention of 'page_12' citations adds verifiability. (2) Quantitative accuracy is perfect: fiscal years and the timeline of supply commitments are correctly represented. The extension to FY2025 in the 2024 filing matches the ground truth. (3) Reasoning is sound: the LLM correctly infers a strategic shift in forward contracting despite stable hedging mechanics, which reflects multi-hop synthesis across filings. (4) Minor deduction in qualitative accuracy because the LLM slightly understates the significance of the multi-year extension as a strategic shift toward longer-term risk mitigation in response to index fund activity—this nuance is present in the original but implied rather than explicitly stated in the LLM version. However, the core meaning and factual content are semantically equivalent. Contextual relevance is full, as all parts of the question are addressed with precise, on-topic information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 386,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "- Fiscal 2022: Accenture bought 12.2 million Class A shares for about **$4.1 billion** (≈ $3.2 billion of that in the open‑market program) and, at year‑end, had **$3.13 billion** of available authorization for the open‑market buy‑back (plus a $3 billion add‑on later in the year that lifted total authority to $6.13 billion).  \n- Fiscal 2024: In the full year the company returned **$4.5 billion** to shareholders through share repurchases, and by August 31 2024 the remaining open‑market authorization was **$2.69 billion**; the board then approved an extra **$4.0 billion**, bringing total outstanding authority to **$6.69 billion**.  \n\nThe pattern shows Accenture consistently using roughly $4‑$5 billion a year for buy‑backs while deliberately expanding its authorized repurchase capacity, signalling a multi‑year capital‑return strategy that relies on steady, sizable share repurchases and a growing pool of authorized funds to sustain that return.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. For fiscal 2022, the ground truth states that Accenture had an available authorization of $3.13 billion, which the LLM correctly approximates as $3.13 billion. However, the LLM incorrectly claims that Accenture bought 12.2 million shares for $4.1 billion in fiscal 2022, with $3.2 billion from the open-market program—this is not supported by the ground truth, which does not mention any share purchases in fiscal 2022 at all. The LLM fabricates or misattributes data here. Additionally, the LLM mentions a '$3 billion add-on' in fiscal 2022 that increased total authority to $6.13 billion, but this event is not in the original answer and contradicts the timeline, as the $4 billion increase occurred in fiscal 2024, not 2022. (2) For fiscal 2023, the ground truth states that Accenture purchased 2,000,308 shares for $605 million, but the LLM omits this entirely and instead jumps to fiscal 2024, incorrectly attributing $4.5 billion in repurchases to that year without mentioning the $605 million in 2023. The LLM also misrepresents the $2.69 billion authorization as being at the end of fiscal 2024, while the ground truth specifies it was as of August 31, 2024—technically close but conflates years. The $4 billion increase and resulting $6.69 billion total authorization in fiscal 2024 are correctly reported. (3) The multi-hop reasoning is flawed because the LLM invents repurchase activity for fiscal 2022 and omits actual data from fiscal 2023, failing to synthesize the correct trajectory across all three years. The conclusion about a consistent $4–5 billion annual repurchase is unsupported, as only $605 million is documented in 2023 and no amount in 2022. (4) Despite these errors, the LLM captures the general direction of increasing authorization and the strategic intent behind capital returns, which maintains contextual relevance. However, the quantitative inaccuracies severely undermine the correctness score, warranting a 4. The qualitative reasoning is partially sound but based on incorrect inputs, and the contextual relevance remains high due to alignment with the strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 596,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "Google reported that the long‑term, lock‑up portion of its marketable equity securities was **$803 million in 2022**, rose to **about $1.4 billion in 2023**, and then fell to **$266 million in 2024**【page 65】【page 66】【page 67】. The sharp increase in 2023 followed by a steep decline in 2024 suggests that the company initially expanded its holdings in illiquid, restricted‑sale equity but subsequently unwound or released much of those positions, indicating a move away from a heavier allocation to long‑term lock‑up assets toward a more flexible, liquid‑focused investment stance.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values and trends. According to the ground truth, the value was $1.4 billion in 2022, decreased to $803 million in 2023, and returned to $1.4 billion in 2024. However, the LLM states it was $803 million in 2022, rose to $1.4 billion in 2023, and then fell to $266 million in 2024 — all three values are either incorrect or misassigned to the wrong year. Only the $1.4 billion figure appears in both answers, but it is attributed to different years. The $266 million figure in 2024 is entirely incorrect and not supported by the ground truth. (2) The quantitative inaccuracies are severe: the correct sequence shows a decrease followed by a recovery, while the LLM describes an increase followed by a steep drop. This reverses the actual trend and introduces a non-existent sharp decline. Calculations based on these numbers would be fundamentally flawed. (3) The reasoning is internally logical given the incorrect data — the LLM infers a strategic shift toward then away from illiquid assets — but this conclusion does not align with the actual cyclical rebalancing or stabilization suggested by the true data. The multi-hop synthesis fails because it draws conclusions from misstated figures. (4) Contextual relevance is moderate: the answer addresses the right topic (Google's marketable equity securities under lock-up restrictions and investment strategy implications), uses appropriate terminology, and attempts interpretation. However, due to the incorrect data, the analysis is based on a false premise. The citation of pages 65–67 may indicate source referencing, but the data extracted is erroneous. Overall, the answer is mostly incorrect due to major factual and numerical errors, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 492,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "GE first moved Electric Insurance Company (EIC) out of its core operating portfolio in Q4 2022, classifying the captive property‑and‑casualty insurer as a “held‑for‑sale” business and noting its $541 million of assets against $378 million of liabilities (a net‑negative position of about –$570 million after the 2022 valuation allowance). In 2023 GE signed a binding purchase agreement, recorded a $109 million loss on the disposition and, after a larger valuation allowance ($124 million) was recognized, reported a modest positive net‑book value of roughly $159 million for the held‑for‑sale group. The process culminated in Q2 2024 when GE completed the sale to Riverstone International Holdings for $120 million in cash, eliminating all EIC assets and liabilities from the balance sheet and turning the earlier write‑down into a net cash gain that more than offset the 2023 loss.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors despite addressing the general timeline and strategic context of GE's disposition of Electric Insurance Company (EIC). (1) QUANTITATIVE INACCURACIES: The LLM incorrectly states that EIC was classified as 'held for sale' in Q4 2022, but the ground truth indicates this classification occurred in 2023. It also fabricates a '$570 million net-negative position' and a '$159 million net-book value' not present in the original data. The $124 million valuation allowance is invented; the original answer only mentions a $109 million loss in 2023. The 'net cash gain' claim is unsupported—the original answer does not state any gain, only a $109 million loss and a $120 million sale. (2) CALCULATION ERRORS: The 'net-negative position of –$570 million' appears to be a miscalculation (e.g., $541M - $378M = $163M, not -$570M); the LLM incorrectly applies a valuation allowance not specified in the source. (3) REASONING: While the LLM correctly identifies the ultimate buyer (Riverstone) and the $120M cash sale in 2024, it misrepresents the financial progression by implying a recovery or gain, which contradicts the original narrative of a strategic exit with a recognized loss. (4) ENTITY AND TIMING ACCURACY: The core entities (GE, EIC, Riverstone) are correct, and the 2024 sale timing is accurate, but the misplacement of the 'held for sale' classification to 2022 undermines the multi-hop reasoning. (5) SEMANTIC EQUIVALENCE: The overall strategic intent (exit from non-core business) is captured, but the financial narrative is distorted by incorrect figures and implications of a gain. Thus, while contextually relevant and partially accurate in direction, the answer fails on key facts and calculations essential to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 486,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "Amgen reported **13 Phase 3 programs** in its 2022 filing (as of Feb 8 2022) 【page_25†L13-L20】. By the end of 2023 that count had risen to **18 programs** 【page_26†L1-L3】, and a year later, as of Jan 31 2024, the company listed **24 Phase 3 programs** 【page_26†L1-L3】. The jump from 13 to 24 (and the later move to 25) reflects a concerted expansion of the R&D pipeline—driven by the initiation of new studies, the acquisition of Horizon’s late‑stage assets, and a broader focus on biosimilars, genetics‑based targets and novel modalities—showcasing Amgen’s strategic push to diversify its late‑stage portfolio and increase future growth opportunities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the progression of Amgen's Phase 3 programs from 13 in 2022 to 18 in 2023 and 24 in 2024, aligning with the ground truth. It accurately notes the increase to 24 programs by early 2024 and implies a further rise to 25, consistent with the original answer. However, it does not explicitly confirm the final count of 25 programs in 2024, instead saying 'the later move to 25,' which is slightly less precise. (2) All numeric values—13 (2022), 18 (2023), 24 (2024)—are correct and match the ground truth. The mention of the increase to 25 is semantically acceptable but lacks a direct citation or confirmation of that exact number in 2024. Dates (Feb 8, 2022; Jan 31, 2024) are accurately cited with document references. (3) The multi-hop reasoning is sound: the LLM correctly attributes the pipeline growth to new study initiations and the Horizon acquisition, and it contextualizes the expansion as part of a strategic R&D push. It adds valuable detail about biosimilars and genetics-based targets not in the original answer, which is plausible and contextually appropriate, though not explicitly confirmed in the ground truth. (4) The answer is highly relevant, directly addressing both the evolution of the portfolio and the strategic implications. The minor omission of explicitly stating the 2024 count as 25 (instead of implying it) prevents a perfect score, but overall, the response is factually accurate, well-supported, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 414,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "In the 2022 filing American Express described its global card network simply as the fourth‑largest issuer‑‑network‑operator, competing with Visa, Mastercard, UnionPay and others and noting ongoing legal risk over “non‑discrimination” and “honor‑all‑cards” merchant‑contract provisions. By the 2024 filing the company said that heightened regulatory scrutiny—particularly around interchange‑fee caps, network‑routing rules and merchant‑steering rules—has forced it to pull its network‑licensing business out of the EU and Australia and to prepare for possible fee‑reduction settlements with Visa and Mastercard, while still competing on product features and partnerships. Thus, AmEx’s relationship with global card networks has shifted from a broad competitive stance in 2022 to a more constrained, compliance‑driven approach in 2024, with strategic exits and adjustments to mitigate regulatory pressure and protect its discount‑revenue margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of American Express's relationship with global card networks from 2022 to 2024, noting the shift from competition to a more constrained, compliance-driven posture. Key elements such as competition with Visa, Mastercard, and UnionPay in 2022, and regulatory pressures in 2024 leading to exits from the EU and Australia, are accurately reported. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and regulatory domains, correctly linking regulatory pressures (interchange-fee caps, network-routing rules) to strategic exits and shifts in business model. It accurately reflects the growing legal and regulatory constraints mentioned in the original, including non-discrimination and honor-all-cards provisions. (4) The only minor shortcoming is that the LLM omits mention of competitive dynamics with alternative payment platforms like Alipay and PayPal, and the specific uncertainty around cobrand arrangements in the EU—details present in the original. However, the core trajectory—competitive in 2022, constrained by regulation in 2024—is preserved with strong factual and semantic fidelity. Wording differs but meaning is equivalent. Contextual relevance is perfect as it directly addresses the evolution in response to regulatory and competitive forces.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 431,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "ConocoPhillips began “monetizing” its CVE (CVE Inc.) common‑stock position in 2021 and, after a series‑of‑step‑sales, completed the disposition in 2022.  The 2022 Form 10‑K notes that the company “sold its remaining 91 million CVE common shares” and that the cash received was applied to its ongoing share‑repurchase program.  The repurchase activity that followed is disclosed in the equity tables of each year’s filing:\n\n| Year | CVE shares sold (or remaining) | Shares repurchased in that year | Dollar amount of the CVE sale (or of the repurchases) |\n|------|--------------------------------|---------------------------------|------------------------------------------------------|\n| 2022 | 91 million CVE shares were sold (the filing does not disclose the cash proceeds) | 87.7 million shares repurchased (cost not broken out) | Not disclosed in the provided pages |\n| 2023 | No further CVE sales reported | 48.6 million shares repurchased (cost not broken out) | Not disclosed |\n| 2024 | No further CVE sales reported | 49.1 million shares repurchased (cost not broken out) | Not disclosed |\n\nThus, the monetization progressed from a one‑time sale of the remaining 91 million CVE shares in 2022 (with proceeds used to fund share buybacks) to a steady pattern of buybacks of roughly 48‑49 million shares per year in 2023 and 2024.  The filings give the share‑volume details but do not provide the specific dollar amounts of the CVE‑share proceeds or the repurchase expenditures for any of the three years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but has significant factual inaccuracies and omissions that undermine its correctness. (1) Quantitatively, the LLM incorrectly states that the dollar amounts for share repurchases in 2022, 2023, and 2024 are not disclosed, when the ground truth specifies that in 2022, ConocoPhillips repurchased 383 million shares at a cost of $29 billion, and by 2024 had cumulatively repurchased 433 million shares at a total cost of $34.3 billion. The LLM also misrepresents annual repurchase volumes: it claims 87.7 million shares were repurchased in 2022, but the correct total for that year is 383 million. The 2023 and 2024 annual repurchase volumes (48.6M and 49.1M) are plausible as incremental additions to reach the cumulative total, but the LLM fails to connect them to the larger cumulative figures or provide the total cost. (2) The LLM incorrectly implies that the CVE sale proceeds were not disclosed, but the original answer does not require that specific dollar amount—only that the 91 million shares were sold in 2022, which is correctly noted. (3) The reasoning is partially sound in identifying the progression from asset monetization to share repurchases, but fails in multi-hop synthesis: it does not link the 2022 CVE sale to the $29B in repurchases that year, nor does it recognize that the 433 million cumulative share repurchases by 2024 include the 2022 activity. The LLM treats each year in isolation without aggregating or contextualizing the totals. (4) Entity accuracy (ConocoPhillips, CVE, years) and terminology (monetization, share repurchases) are correct, and the answer is relevant to the question’s focus. However, the failure to report key financial totals and misstatement of repurchase volumes results in a low quantitative accuracy score. The answer is incomplete and misleading on critical financial metrics, warranting a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 515,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "- **2022:** The filing notes that, after the 2005 Omnibus Plan was in effect, the company had **about 117 million shares** available for future grants (HD 2022 10‑K, p. 67).  \n\n- **2023:** The Omnibus Plan (amended May 19 2022) authorizes **80 million shares** (plus up to 10 million “under‑lying” shares). The 2023 filing shows the pool had already been drawn down from the full 80 million, leaving only a few‑million‑share margin for new awards.  \n\n- **2024:** The 2024 filing states that **≈ 77 million shares** were available for future grants as of January 28 2024 (HD 2024 10‑K, p. 66).  \n\n**Trend & implication:** From 2022 to 2024 the pool of shares that can be issued under the Omnibus Stock Incentive Plans fell from essentially the full authorized amount to about 77 million – a modest but steady decline. This pattern shows that Home Depot is actively using its stock‑based compensation capacity (granting shares each year) while still retaining a sizable reserve, indicating both robust utilization of equity awards and ample remaining capacity for future grants.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains several factual inaccuracies in the quantitative details. According to the ground truth, in 2022, 117 million shares were available under the 2005 Plan, which is correct in the LLM answer. However, for 2023, the LLM states that the amended plan authorized 80 million shares plus up to 10 million 'underlying' shares and that the pool was 'drawn down from 80 million', but the ground truth reports only ~77 million available in 2023 under the newly amended plan—without mentioning an 80 million authorization or additional 10 million. This introduces incorrect structural details. Furthermore, the LLM incorrectly states that ~77 million were available in 2024, while the ground truth clearly states availability declined to 70 million in 2024. This is a significant error in trend representation. 2) The numbers are partially correct: 117 million in 2022 is accurate; however, the 2023 figure is misrepresented by referencing an 80 million authorization not in the ground truth, and 2024 is wrong (77M vs. correct 70M). The calculation of a 'steady decline' is directionally correct but quantitatively flawed. 3) The reasoning is sound in interpreting the declining trend as evidence of active utilization of stock-based compensation, and the conclusion about ongoing equity award usage is logically consistent with the data pattern. However, the synthesis across years is weakened by incorrect figures, especially the failure to note the continued decline to 70 million in 2024. The mention of a replenishment mechanism in the ground truth (tied to expirations and forfeitures) is missing in the LLM answer, indicating a gap in completeness. 4) Despite these issues, the LLM answer remains contextually relevant, addressing all parts of the question and providing a reasonable interpretation of the trend. Wording differences are acceptable, but the incorrect 2024 figure and invented 80+10 million structure reduce factual reliability. The trend implication is partially correct but lacks precision due to numerical inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 550,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "- In the 2022 Form 10‑K the Amended 2010 Share Incentive Plan authorized a maximum of **127 million** Accenture Class A ordinary shares for awards.  \n- By the 2024 Form 10‑K the same plan had been expanded to a maximum of **141 million** shares (the 2023 filing did not change the figure).  \n\nThe 14‑million‑share increase shows that Accenture deliberately enlarged the pool of equity it can grant, signaling a stronger strategic reliance on share‑based compensation to attract, retain and motivate employees and leadership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the authorized share numbers for 2022 (127 million) and 2024 (141 million), matching the ground truth. It accurately notes that the 2023 filing did not change the number, which aligns with the original answer stating the figure remained at 141 million in 2023. The 14-million-share increase is correctly calculated (141M - 127M = 14M). 2) All numeric values are accurate and properly formatted; minor variation in presentation (e.g., '127 million' vs '127,000,000') is acceptable and semantically equivalent. 3) The reasoning correctly synthesizes information across multiple years and filings, noting the stability from 2023 to 2024 and the strategic implication of the increase. The conclusion about Accenture's growing reliance on share-based compensation aligns with the ground truth’s interpretation regarding long-term incentives and alignment with shareholder value. 4) The only minor shortcoming is that the LLM answer does not explicitly state that the 2023 number was already 141 million (it says the 2023 filing did not change the figure, which is accurate but slightly less explicit). However, this does not detract significantly from correctness. Overall, the answer is factually precise, contextually appropriate, and demonstrates sound multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 364,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "The weighted‑average yield on the company’s portfolio of foreign‑government bonds and obligations slipped from roughly **2.1 % in 2022** to about **1.8 % in 2024**.  The decline signals that the return on those overseas sovereign‑debt holdings has fallen, meaning American Express’s exposure to changes in international interest‑rate environments has become modestly lower over the period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that the weighted average yield on American Express's foreign government bonds due within one year was 5.86% in 2022, increased to 6.45% in 2023, and returned to 5.86% in 2024. The LLM incorrectly reports yields as 2.1% in 2022 and 1.8% in 2024, with no mention of 2023. These numbers are not only wrong but also misrepresent the trend. (2) Quantitative accuracy is extremely low: the correct yields are ~5.86%, 6.45%, and 5.86% across the three years; the LLM reports ~2.1% and ~1.8%, which are off by more than 3 percentage points—over 50% error. There is no indication of the peak in 2023, and the dollar amount ($630 million) is omitted entirely. (3) The multi-hop reasoning is flawed: the question requires synthesizing changes over three years and interpreting exposure to international interest rates. The LLM fails to recognize the volatility and peak in 2023, instead suggesting a steady decline, which contradicts the ground truth. The conclusion about reduced exposure is not supported by the actual data, which shows a return to 2022 yield levels, not a structural decline. (4) Contextual relevance is moderate because the answer addresses the right topic (yield on foreign government bonds and interest rate exposure), uses appropriate financial terminology, and attempts to interpret the trend. However, due to severe factual and quantitative errors, the qualitative and overall correctness scores are very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 423,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "In 2022 American Express held roughly $630 million of foreign‑government bonds and obligations, almost all of which (about 99 percent) were short‑term (‑ $628 million due within one year and only $2 million due beyond one year).  The weighted‑average yield on that segment rose to 6.45 percent in 2023 and then slipped to 5.85 percent in 2024.  The decline in yield – together with the continued emphasis on short‑dated, high‑quality sovereign debt – shows the company’s strategy of keeping the foreign‑government portfolio highly liquid and shifting toward lower‑rate securities as market interest rates fell, reflecting a defensive positioning in a falling‑rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: $630 million total in Foreign Government Bonds and Obligations in 2022, with $628 million maturing within one year (99% short-term), weighted average yield of 6.45% in 2023, and 5.85% in 2024. These numbers match the ground truth exactly. (2) Quantitative accuracy is perfect—dollar amounts, percentages, and timeframes are all correct and consistent with the original answer. The 99% short-term characterization is a reasonable interpretation of $628M out of $630M. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across 2022 (portfolio composition), 2023 (peak yield), and 2024 (decline), and infers a strategic emphasis on liquidity and high-quality sovereign debt amid falling rates. It correctly identifies the yield decline and links it to market conditions (falling interest rates) and defensive positioning, aligning with the ground truth’s interpretation. (4) The only minor gap is that the LLM does not explicitly mention that the 6.45% yield in 2023 was the highest among all categories, which is a small omission in qualitative completeness. However, the core strategic interpretation—short-duration focus, response to falling rates, risk management—is accurately conveyed. Wording differs but semantic meaning is equivalent. Thus, correctness is high at 9/10, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 396,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "- **2022 10‑K** – The “Securities registered pursuant to Section 12(b)” table listed the debentures as a **separate line item** (“7 % Debentures due 2029”) with its CUSIP 718507BK1 and the New York Stock Exchange shown alongside the common‑stock entry.  \n\n- **2023 10‑K** – The filing used the same **separate‑row format**, again showing “7 % Debentures due 2029” as its own line with the same CUSIP and exchange information.  \n\n- **2024 10‑K** – The table was **condensed**, merging the two securities into one row whose title reads “Common Stock, $.01 Par Value 7 % Debentures due 2029,” while still providing the CUSIP and NYSE listing.\n\n**What this shows:** Across the three years ConocoPhillips consistently disclosed the debenture’s existence, CUSIP and exchange, demonstrating a steady commitment to transparency. The shift in 2024 to a more compact presentation indicates an effort to streamline the disclosure format while preserving the essential information about the 7 % debentures.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) In 2022, the ground truth states that the 7% Debentures were disclosed *alongside* Common Stock in the same row or contextually grouped, not as a separate line item as claimed by the LLM. The LLM incorrectly asserts a 'separate line item' in 2022, which contradicts the original answer stating they were listed together. (2) For 2023, while both the LLM and ground truth agree on a separate row and correct CUSIP (718507BK1), this is the only partially correct year, though the LLM fails to note the *change* from 2022, misrepresenting the evolution. (3) In 2024, the LLM claims the table was 'condensed' and merged into one row, which directly contradicts the ground truth stating that COP *maintained* the separate disclosure format from 2023. This reversal of the actual trend severely undermines the reasoning. (4) The multi-hop reasoning is flawed: the question asks about an evolution toward greater transparency, but the LLM incorrectly frames the trajectory—suggesting streamlining in 2024 when in fact the company continued improved separation. The conclusion about 'streamlining' is based on a false premise. (5) While the CUSIP number and interest rate (7%) and maturity (2029) are correct, and the entity (COP) and years are accurate, the core narrative of presentation evolution is inverted. Thus, despite some correct identifiers, the overall factual progression and synthesis are incorrect, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 420,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "- **Fiscal‑year 2022:** The 2.00 % senior notes that mature in 2031 were carried on the balance sheet at roughly **$1.04 billion** (original principal $1.25 billion).  \n- **Fiscal‑year 2023:** The same series was shown at **$1.04 billion** (net carrying amount $1,044 million).  \n- **Fiscal‑year 2024:** The liability rose slightly to **$1.06 billion** (net carrying amount $1,057 million), still representing the unchanged $1.25 billion principal amount.\n\n**What this shows:** NVIDIA has kept the 2 % Notes Due 2031 on its books essentially unchanged for three years, only a modest increase in the net carrying amount due to the amortization of the original discount. By retaining a large, low‑cost, long‑dated debt instrument, the company demonstrates a deliberate long‑term debt‑management approach that favors inexpensive, fixed‑rate financing to preserve liquidity and fund growth rather than aggressively retiring the notes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial exposure values compared to the ground truth. According to the original answer, NVIDIA's exposure was $1.2B in 2022, $1.057B in 2023, and $1.25B in 2024. However, the LLM reports $1.04B in 2022, $1.04B in 2033, and $1.06B in 2024—none of which match the ground truth except for the 2023 value (which aligns with $1.057B when rounded). The 2022 and 2024 figures are materially incorrect. Additionally, the LLM incorrectly states that the principal amount is $1.25B in 2022 when the ground truth implies it was $1.2B initially, increasing to $1.25B by 2024. (2) The quantitative discrepancies are critical: the progression from $1.2B → $1.057B → $1.25B shows a dip then rise, but the LLM describes a flat-to-slight-rise pattern ($1.04B → $1.04B → $1.06B), which misrepresents the trend. This undermines the conclusion about 'essentially unchanged' exposure. (3) The reasoning is partially sound—tying stable low-cost debt to long-term financing strategy is reasonable—but it is based on incorrect data. The multi-hop synthesis across years is attempted but flawed due to inaccurate inputs. (4) Contextual relevance is high as the answer addresses both the evolution of exposure and strategic implications. However, due to major numerical errors affecting the core facts, the correctness score is low despite appropriate framing and terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 398,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "- **Branding on Disney +** – In the 2023 filing the Direct‑to‑Consumer section says Disney+ presents “Disney, Pixar, Marvel, Star Wars and National Geographic” as top‑level selections or “tiles” within the Disney+ interface【page 7】. The same language appears in the 2024 filing (also on page 7), showing that Disney continues to promote Marvel as a marquee brand on its streaming service.  \n\n- **Indefinite‑lived intangible assets** – Marvel’s trademark is recorded as part of Disney’s indefinite‑lived intangible assets. The 2022 balance‑sheet note lists “Indefinite lived intangible assets … consist of ESPN, Pixar and Marvel trademarks” with a gross amount of $1.792 billion【page 110】. The 2023 and 2024 tables of intangible assets show the same line item and the same $1.792 billion amount for both years【page 114】.  \n\n**Overall evolution:** Across FY 2022‑2024 Disney has kept Marvel positioned as a core, high‑visibility brand on Disney+ while consistently treating the Marvel trademark as an indefinite‑lived intangible asset valued at roughly $1.8 billion. The strategy has been stable rather than shifting – Marvel remains both a streaming‑service branding pillar and a long‑term intangible asset in Disney’s balance sheet.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in both factual content and reasoning. (1) All key facts are accurately reported: Marvel's inclusion as a top-level branded tile on Disney+ in 2023 (and continuation in 2024), and its consistent classification as an indefinite-lived intangible asset alongside ESPN and Pixar across 2022, 2023, and 2024. The reported $1.792 billion value is correct and stable across years, matching the ground truth's implication of financial consistency. (2) Quantitative accuracy is perfect: the dollar amount ($1.792 billion) is cited correctly for all relevant years and aligns with the original answer’s assertion of continued recognition of Marvel’s brand value. Minor phrasing difference (ground truth says 'roughly $1.8 billion' vs LLM's precise $1.792B) is semantically equivalent and acceptable. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three fiscal years, connects Marvel’s branding role on Disney+ (a strategic/content distribution metric) with its accounting treatment (a financial asset), and correctly infers a stable, consistent strategy rather than a shifting one—this matches the ground truth’s conclusion about Disney leveraging Marvel across financial and distribution dimensions. (4) Contextual relevance is excellent: the answer directly addresses both parts of the question—Marvel’s branding on streaming services and its status in intangible assets—and provides precise citations from the filings. The overall synthesis is clear, accurate, and adds value by noting the stability of strategy, which is logically supported by the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 445,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "In the 2022 filing American Express said that **discount revenue is recorded at the moment a Card‑Member transaction occurs**; the merchant‑discount fee varies by industry, volume, payment method, etc., and contracts with small‑ and mid‑size merchants are open‑ended while large merchants are on fixed‑term (typically 3‑7 years) agreements that may auto‑renew. When a **third‑party merchant acquirer** is used (e.g., under its OptBlue or other GNS arrangements), AmEx receives a **network‑rate fee that is individually negotiated with the acquirer and is also booked as discount revenue at transaction time**.  \n\nBy the 2024 filing the **revenue‑recognition mechanics remain the same**, but the discussion expands to show that the network‑rate fee negotiation is now a distinct, regularly‑renewed component of its “processed revenue” model (with issuer‑rate payments to GNS partners recorded as contra‑revenue or expense), reflecting a deeper reliance on third‑party acquirers. Concurrently, AmEx’s merchant‑coverage strategy has evolved to **grow acceptance through third‑party acquirers, aggregators and processors**, targeting low‑penetration and “new‑to‑plastic” merchants, expanding B2B acceptance, and prioritising coverage growth in key international cities, destinations, countries and industry verticals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: discount revenue recognition at transaction time, variation by industry/volume/geography, use of third-party acquirers (OptBlue/GNS), individually negotiated network rate fees recorded as discount revenue, and the evolution toward processed revenue including partnership fees. The 2024 strategic focus on expanding merchant coverage via acquirers, aggregators, and processors is correctly identified. (2) There are no numeric values (e.g., percentages, dollar amounts, years) in either the original or LLM answer beyond 2022–2024 timeframes, which are correctly cited—thus quantitative accuracy is perfect. (3) Multi-hop reasoning is sound: the LLM synthesizes changes from 2022 to 2024 across revenue recognition, contractual arrangements, and merchant expansion strategies. It correctly identifies the shift where network rate fees—still booked as discount revenue—become part of a broader 'processed revenue' model involving partnerships, consistent with the 2023–2024 evolution in the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2023 clarification about processed revenue from network partnerships (e.g., royalties), though it implies this evolution by linking network-rate fees to the processed revenue model in 2024. This omission slightly affects completeness but does not undermine the core accuracy. Wording differs but semantic meaning matches. Contextual relevance is excellent—every part of the question is addressed with precise, relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1666,
        "completion_tokens": 441,
        "total_tokens": 2108
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "- In the 2022 Form 10‑K Amgen only flagged drug‑delivery or companion‑diagnostic devices in a single risk bullet, noting that “some of our products are used with drug‑delivery or companion‑diagnostic devices that have their own regulatory, manufacturing and other risks.” No further detail was given about how those devices affect trials, post‑marketing obligations or safety oversight.  \n\n- The 2023 filing expanded the disclosure dramatically: it explained that many products are administered with devices (e.g., Neulasta Onpro, AutoTouch autoinjector, Repatha SureClick), that FDA and other agencies may require separate or concurrent approval of the device, that Amgen must collect user‑complaint, adverse‑event and malfunction data, and that loss of device clearance or post‑marketing requirements (such as FDA‑mandated studies) could delay product approvals, add development costs, or trigger recalls.  \n\n- By the 2024 Form 10‑K the language was further refined to tie device risk directly to clinical‑trial execution and new‑indication development, stressing that contemporaneous device‑product approvals, the complexity of combined submissions, and reliance on third‑party device suppliers mean any failure to develop, supply, or maintain device clearance (or to meet safety‑review obligations) will increase costs, delay regulatory approval or market launch, and may result in regulatory actions or product removal.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key points are correct: in 2022, Amgen provided only a general disclosure about device-related risks; in 2023, it expanded to include specific regulatory, post-marketing, and safety obligations, citing increased scrutiny on confirmatory trials (e.g., LUMAKRAS context implied through accelerated approval and Complete Response Letter, though not explicitly named in the LLM answer); in 2024, the focus shifted to integration of device risks into clinical trial execution and new indication development, with emphasis on combined submissions and third-party dependencies. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—correctly tracing the evolution across three years and synthesizing disclosures related to clinical trials, post-marketing requirements, and safety reviews. The only minor omission is that the LLM does not explicitly mention LUMAKRAS or the Complete Response Letter, which are part of the 2023 context in the original answer, slightly reducing qualitative accuracy. However, the core regulatory dynamics (accelerated approval, need for confirmatory studies, regulatory pushback) are effectively conveyed through descriptions of post-marketing requirements and device-specific oversight. (4) The answer is fully contextually relevant, directly addressing all three dimensions of the question: clinical trial dependencies, post-marketing requirements, and device-related safety reviews. The progression in disclosure depth is clearly articulated, matching the ground truth's conclusion about a shift from general to specific risk framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1649,
        "completion_tokens": 471,
        "total_tokens": 2121
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "- **Scope definition:** In the 2022 filing the program was described simply as “HSE audits” of business‑unit and staff‑group operations. By the 2024 filing the language was expanded to “Corporate HSE audits” that still cover business units and staff groups, indicating a formalization of the audit function at the corporate level.  \n\n- **Improvement‑tracking mechanism:** All three years state that any improvement actions identified during the audits are “tracked to completion,” so the mechanism for monitoring corrective work has remained consistent.  \n\n- **Governance reporting:** Both 2022 and 2024 (as well as 2023) note that audit results and progress are reported to the Executive Leadership Team and the Board of Directors, showing no change in the reporting structure despite the broader audit scope.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the evolution from 'HSE audits' to 'Corporate HSE audits' by 2024 is accurately noted, indicating formalization at the corporate level; improvement actions are consistently described as 'tracked to completion' across all years; and governance reporting to the Executive Leadership Team and Board of Directors is correctly identified as unchanged. (2) There are no numeric values requiring calculation, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound—information is correctly synthesized across 2022, 2023, and 2024 filings. The LLM captures the core evolution in scope (increasing centralization), consistency in tracking, and stability in governance. However, it omits specific contextual details mentioned in the original answer about the 2023 expansion into human capital management, Life Saving Rules, Process Safety Fundamentals, and the stop work policy, which represent an important intermediate step in the program’s evolution. While the LLM does not misstate anything, this omission slightly reduces completeness and depth of qualitative synthesis. (4) The answer remains highly contextually relevant, directly addressing all three dimensions in the question (scope, tracking, governance) with precise and meaningful information. The minor omission prevents a perfect 10 but does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 402,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "From the 2022 filing Accenture first warned that “technological developments… in the case of cloud and as‑a‑service solutions… could affect the nature of how we generate revenue” and that “if we are unable to introduce new pricing or commercial models that reflect the value of these technological developments” it could hurt results (p. 18). By the 2023 and 2024 filings the discussion had broadened to include AI – especially generative AI and data‑driven cloud services – and the company said it is “continuing to develop and deploy AI services and solutions” and must “introduce new pricing or commercial models that reflect the value of these technological developments” (p. 22 in both years). Across all three years the same risk is repeatedly highlighted: failing to roll out appropriate new pricing/commercial models (or client delays in adopting the underlying tech) could lead to revenue shortfalls and expose Accenture to operational, legal, regulatory and reputational harms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution of Accenture's approach: in 2022, the focus was on acknowledging the need for new pricing models due to cloud and as-a-service; by 2023–2024, the discussion expanded to include AI, particularly generative AI and data-driven cloud services, with active development and deployment of AI solutions. The consistent risk across years—failure to introduce value-reflective pricing models or slow client adoption leading to revenue shortfalls—is accurately highlighted. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable in that sense, but all years (2022, 2023, 2024) and page references (p. 18, p. 22) are correctly cited, indicating precise sourcing. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, correctly identifying the progression in strategic emphasis and the persistent risk. The only minor shortcoming is that the LLM answer mentions 'operational, legal, regulatory and reputational harms' as risks, which slightly overstates the original answer’s focus—ground truth emphasizes revenue shortfalls and competitive disadvantages, without explicitly listing legal or regulatory harms. This is a small deviation in nuance. (4) Despite this, the LLM answer remains semantically equivalent in intent and core factual content, with excellent contextual relevance and strong qualitative accuracy. Hence, a correctness score of 9 is warranted—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1576,
        "completion_tokens": 447,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "GE’s AerCap exposure has been confined to the senior note and has grown modestly: the note was valued at **$900 million at 12/31/2022**, rose to **$944 million at 12/31/2023**, and reached **$982 million at 12/31/2024** (see the fair‑value tables in the 2022, 2023 and 2024 10‑Ks).  By selling its AerCap equity holdings and keeping only the note—while the note balance has slightly increased—GE appears to be shifting from an equity‑ownership stance to a focused financing relationship, preserving a strategic stake in AerCap without the volatility of direct stock ownership.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, GE's holdings in the AerCap note decreased from $993 million (reported in 2022 for end of 2021) to $944 million (reported in 2024 for end of 2023). However, the LLM claims the value was $900 million at the end of 2022, increased to $944 million at the end of 2023, and further rose to $982 million at the end of 2024—this upward trend directly contradicts the documented decline. These numbers do not align with the ground truth, even allowing for format variations. (2) The calculation and direction of change are wrong: the ground truth shows a reduction of $49 million over the period, while the LLM reports a $82 million increase, which is a major error in both magnitude and direction. (3) The qualitative reasoning about GE shifting from equity to a financing relationship by retaining only the note has some plausibility and aligns with the idea of strategic repositioning, but it is undermined by the incorrect data. The multi-hop synthesis fails because the model misrepresents the trajectory of holdings over time. (4) The contextual relevance is moderate because the answer addresses the right entities (GE, AerCap, senior note) and attempts to interpret strategy, but the incorrect data renders the conclusion invalid. Thus, correctness and quantitative accuracy are very low; qualitative accuracy is slightly higher due to reasonable interpretation framework, though based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 419,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "- **Clinical‑stage evolution:** In the 2022 Form 10‑K Amgen reported that Bemarituzumab had just **entered a Phase 3 study** (it was listed under “initiated Phase 3 study” for GEJ adenocarcinoma)【page_25】. By the 2024 filing the antibody was still being **pursued in Phase 3** (it appears in the Jan 31 2024 Phase 3 candidate table and is described as a Phase 3‑stage investigational product for advanced GEJ adenocarcinoma and other solid tumors)【page_24】【page_27】. Thus, from 2022 to 2024 the candidate progressed from the start of Phase 3 to remaining in that phase, with no further advancement to approval reported.\n\n- **Intellectual‑property positioning:** Both the 2022 and 2024 filings list **composition‑of‑matter patents for Bemarituzumab expiring in 2029** in the United States and Europe【page_25】【page_26】. The estimated expiration dates were unchanged across the two years, indicating a consistent patent‑protection horizon for the molecule.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of key data points. (1) Quantitatively, all dates and clinical phase descriptions are correct: Bemarituzumab entered Phase 3 in 2022 and remained in that phase through 2024; patent expirations in the U.S. and Europe are correctly cited as 2029. No calculation errors or incorrect numbers are present. (2) The answer correctly identifies the clinical progression and consistent IP timeline, matching the original answer’s core facts. (3) However, the LLM omits a key qualitative evolution mentioned in the ground truth: the 2024 expansion of Bemarituzumab’s investigational scope to include gastric cancer and advanced solid tumors beyond NSCLC, and the more detailed mechanism of action disclosure. While the LLM notes 'other solid tumors,' it does not fully articulate the strategic broadening of therapeutic focus that reflects Amgen’s evolving positioning. (4) The reasoning is sound and well-supported by document citations, but the synthesis is slightly less comprehensive than the original answer, missing the nuance of a shift from development to broader therapeutic and IP strategy. Thus, while factually correct, it lacks full completeness in capturing the strategic evolution, warranting a score of 8 for correctness and qualitative accuracy. Contextual relevance is perfect—directly addresses the question with precise, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 395,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "From the 2022‑23 filings, American Express already warned that “the payments industry continues to undergo dynamic changes…including the rapid growth of alternative‑payment and financing mechanisms” and listed “the speed of innovation and investment in systems, technologies, and product and service offerings” as a key competitive factor. By the 2024 filing the company describes “intensified competition…from large tech companies and merchants that are building their own digital‑wallet and financing solutions” and states that it must “continue to invest in technology…transaction processing, AI, open‑banking, alternative‑payment mechanisms, tokenization, real‑time settlement and risk‑management systems” to stay competitive. Together, these disclosures show a shift from merely acknowledging fintech‑driven pressure to committing substantial, technology‑focused spending, indicating that American Express is positioning itself for a long‑term, innovation‑driven defense against fintech disruption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in American Express's strategic positioning from 2022 to 2024. It correctly identifies the growing competitive pressure from alternative payment mechanisms in 2022–2023, citing dynamic industry changes and innovation speed as key concerns. It accurately reflects the 2024 shift toward intensified competition from big tech and merchants, and correctly notes American Express's stated need to invest in technologies like AI, open banking, tokenization, and real-time settlement—aligning with the ground truth's emphasis on integration and dependency on these technologies. The answer conveys the strategic shift from defensive acknowledgment to proactive investment, which is the central theme of the original answer. All dates (2022–2024) and entities (American Express, fintech disruption, open banking, tokenization, etc.) are correct. There are no numerical inaccuracies (no calculations or dollar figures involved), so quantitative accuracy is 10. The only minor shortcoming is that the LLM answer does not explicitly mention specific examples of alternative payment mechanisms from the original answer such as Alipay, PayPal, or buy-now-pay-later platforms in the 2022 context, nor does it note the expansion to include payment facilitators in 2023. While it references 'alternative-payment mechanisms' broadly, this omission slightly reduces completeness in multi-hop synthesis, warranting a 9 in qualitative accuracy. However, the overall reasoning is sound, the context is fully relevant, and the conclusion about long-term innovation-driven defense is semantically equivalent to the ground truth. Thus, the correctness score is 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 462,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "- 2022 grant‑date fair value of cash‑settled PSUs: **$91.58** per unit (shown in the 2023 10‑K).  \n- 2023 grant‑date fair value of cash‑settled PSUs: **$112.50** per unit (shown in the 2024 10‑K).  \n- 2024 grant‑date fair value of cash‑settled PSUs: **$110.39** per unit (shown in the 2024 10‑K cash‑settled performance‑share table).\n\nThe weighted‑average grant‑date value rose sharply from 2022 to 2023 and then held near that higher level in 2024, indicating that ConocoPhillips has been increasing the monetary magnitude of its cash‑settled performance‑share awards – a sign of a more aggressive, stock‑price‑linked long‑term incentive strategy for senior executives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that the weighted-average grant date fair value increased from $91.58 in 2022 to $112.50 in 2024, implying a steady or increasing trend. However, the LLM claims the 2024 value is $110.39, which contradicts the ground truth of $112.50. Additionally, the LLM reports a 2023 value of $112.50, but the ground truth does not provide a 2023 figure, making it unclear whether this value is correct; however, the final 2024 number must match the ground truth, and it does not. (2) The numbers are inconsistently reported: while $91.58 for 2022 matches, the 2024 value should be $112.50, not $110.39. This is a material error in a financial metric central to the question. The LLM appears to have pulled a different number (possibly from a different table or unit type), leading to an incorrect trend. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies the need to compare grant-date fair values across years and draws a conclusion about incentive strategy. It also correctly attributes the data to the appropriate 10-K filings. However, the conclusion that the value 'held near that higher level' is undermined by the incorrect 2024 figure. The actual trend (increasing to $112.50) supports a stronger strategic shift, whereas the LLM’s version (a drop to $110.39) suggests slight de-escalation. (4) Despite the numerical error, the answer is contextually relevant and uses correct entities (ConocoPhillips, cash-settled PSUs, grant date fair value). The qualitative interpretation is reasonable given the data it cites, but the factual foundation is flawed. Thus, correctness is reduced to 6 due to the key number mismatch, quantitative accuracy to 5 due to the incorrect 2024 value, qualitative accuracy to 7 for sound structure and logic, and contextual relevance remains high at 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 514,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "- **2022 (PYPL 10‑K 2022, pp. 26‑28)** – PayPal already warned that its consumer‑ and merchant‑credit products could generate “non‑payment” losses if underwriting models or economic conditions proved wrong, and that “third parties have attempted … to abuse … our payments services … creating fictitious PayPal accounts using stolen or synthetic identities … making transactions with stolen financial instruments.”  \n\n- **2023 (PYPL 10‑K 2023, pp. 25‑26)** – The filing repeats the credit‑product default risk but adds that “the non‑payment rate … may increase … due to changes to underwriting standards, risk‑model inaccuracies, worsening economic conditions, … high unemployment,” and stresses that “failure to deal effectively with fraud, abusive behaviors … may increase our loss rate.”  \n\n- **2024 (PYPL 10‑K 2024, pp. 22‑26)** – The risk narrative shifts to the speed and scale of abuse: “measures to detect and reduce the risk of fraud and abusive behavior are complex, require continuous improvement, and may not be effective … particularly new and continually evolving forms of fraud or in connection with new or expanded product offerings.” The company again notes exposure to “third‑party fraud schemes” (synthetic‑identity accounts, stolen instruments) and that regulators may broaden charge‑back rules, further raising loss exposure.  \n\n**Trend & implication:** Across the three years PayPal’s disclosed exposure to abusive behavior has grown from a baseline concern in 2022 to an explicit acknowledgement in 2024 that fraud schemes are becoming more sophisticated and that existing detection controls may be lagging. This upward trajectory suggests that while PayPal is aware of the risk, its risk‑management framework is struggling to keep pace with the accelerating complexity of credit‑product defaults and third‑party fraud.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its representation of PayPal's disclosures across 2022–2024 regarding abusive behaviors, credit products, and third-party fraud schemes. All cited risks—fictitious accounts, stolen financial instruments, synthetic identities, underwriting inaccuracies, and evolving fraud—are correctly pulled from the respective 10-K filings and align with the original answer. There are no numeric inaccuracies; the LLM avoids making up figures and correctly refrains from quantifying exposures where the source documents do not (e.g., no mention of the €40 billion receivables sale, but this is due to omission rather than error). The key omission is the €40 billion multi-year agreement to sell U.K. and European BNPL loan receivables in 2023, a significant strategic risk-mitigation move highlighted in the ground truth. This missing element weakens the synthesis of PayPal’s proactive risk management response, particularly in credit products. While the LLM correctly identifies increasing concern and sophistication of fraud, it frames risk management as 'struggling to keep pace,' which leans toward a more negative interpretation than the original answer’s neutral tone about reliance on third-party mitigation and regulatory clarity. This interpretive difference slightly affects qualitative accuracy. However, the answer remains contextually relevant, well-structured, and correctly traces the evolution of risk disclosures across years with proper citation. Semantic equivalence is largely preserved, though the absence of the €40B transaction limits completeness on the credit product risk mitigation front.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1734,
        "completion_tokens": 447,
        "total_tokens": 2182
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "In the 2022 filing Eli Lilly described Cyramza as a **second‑line monotherapy or combination therapy for advanced/metastatic gastric or gastro‑esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer and hepatocellular carcinoma, and as a **first‑line combination for EGFR‑mutated metastatic NSCLC**【page_5】. The 2024 filing lists the same set of indications, confirming that Lilly has kept Cyramza’s therapeutic positioning focused on multi‑line, combination‑based use across several solid‑tumor indications【page_6】.  \n\nThe 2024 IP‑protection table shows that Cyramza’s **U.S. compound patent expires in 2026 (EU 2028, Japan 2026) and its data‑protection rights end in 2024‑2026, with biologics data protection also ending in 2026**【page_11】, indicating that the product is entering the final years of exclusivity.  \n\nTogether, the stable, broad indication portfolio and the looming loss of patent and data exclusivity suggest Lilly is using Cyramza’s multi‑indication, combination‑therapy strategy to maximize revenue while it still has protection, and is preparing for a post‑patent era—an approach that reflects a long‑term oncology strategy of building durable, multi‑line assets that can be leveraged even as exclusivity wanes.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Cyramza's therapeutic positioning in 2022 and 2024, noting its use across gastric, lung, colorectal, and liver cancers, including combination and second-line therapies. This aligns with the ground truth. However, there is a discrepancy in the data protection expiration dates: the LLM states U.S. data protection ends in 2024–2026 and biologics data protection ends in 2026, while the ground truth specifies that data protection expired as early as 2023 in Japan. The LLM does not mention Japan's 2023 expiry, which is a factual omission. Additionally, the LLM claims EU compound patent protection extends to 2028, which is not mentioned in the ground truth and cannot be verified against it—this introduces unconfirmed information. (2) The compound patent expiry in the U.S. and Japan (2026) matches the ground truth, but the addition of EU 2028 is unsupported. The data protection timeline is partially inaccurate—ground truth notes expiration as early as 2023 in Japan, but LLM reports 2024–2026 without specifying Japan’s earlier expiry. (3) The multi-hop reasoning is strong: the LLM synthesizes therapeutic positioning from 2022 to 2024 and connects stable indications with impending patent expiry to infer Eli Lilly’s long-term strategy of maximizing revenue pre-patent cliff and preparing for a post-patent era. This interpretation is logically sound and consistent with the ground truth’s conclusion. (4) The answer is contextually excellent and semantically close to the original, with only minor quantitative inaccuracies and one unverified addition (EU 2028). The core facts and strategic interpretation are correct, warranting a high score but docked slightly for the date discrepancies and unsupported geographic extension.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 484,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "From the 2022 filing, PMI already had the 3.875 % Notes due 2042 on its balance sheet, but the debt list also included only a few shorter‑term issues (e.g., 2.375 % and 2.500 % Notes due 2022, 2.625 % and 2.125 % Notes due 2023). By the 2023 and 2024 filings the company had added a series of new issuances—2.750 % Notes due 2026, 2.875 % Notes due 2026, 0.125 % Notes due 2026, 3.125 % Notes due 2027‑2028, 2.875 % Notes due 2029, 3.375 % Notes due 2029, and a range of notes through 2039 and 2041—while the 3.875 % Notes due 2042 remained unchanged. This shows that PMI’s capital‑structure strategy evolved into a “laddered” approach: it continuously issued and managed newer, lower‑coupon, medium‑term debt to diversify and refinance its obligations, while retaining the long‑dated 3.875 % 2042 bond as a stable, anchor component of its debt portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The LLM incorrectly states that in 2022, Philip Morris had only short-term notes due 2022 and 2023, such as 2.375%, 2.500%, 2.625%, and 2.125% Notes — this contradicts the ground truth, which confirms the presence of long-term instruments like the 4.125% Notes due 2043 and 4.875% Notes due 2043 in 2022. Additionally, the LLM claims that in 2023 and 2024, PMI issued a series of new notes with maturities up to 2041, including specific coupons like 0.125% due 2026 and 3.125% due 2027–2028. These instruments are not supported by the ground truth, which only references the 4.125% Notes due 2043 and 4.250% Notes due 2044 in 2023, with their absence in 2024. (2) Completeness: The LLM fails to mention the key long-dated instruments (4.125% due 2043 and 4.875% due 2043) present in 2022 and their disappearance by 2024, which is central to the evolution of the capital structure. Instead, it fabricates numerous medium-term notes not in the original data. (3) Reasoning: The conclusion about a 'laddered' strategy based on issuing lower-coupon medium-term debt is not supported by the ground truth. The actual strategy involves retiring or refinancing specific long-dated tranches (2043 and 2044) while maintaining the 3.875% 2042 note — a move toward stabilization, not expansion of medium-term debt. The LLM’s reasoning is therefore based on incorrect data and leads to an invalid conclusion. (4) Semantic Equivalence: Despite correctly noting the consistent presence of the 3.875% Notes due 2042, the rest of the answer diverges substantially in entities, dates, and strategy interpretation. The overall narrative conflicts with the ground truth, resulting in a low correctness score. Contextual relevance is moderate because the answer addresses capital structure evolution and debt management, but factual errors severely limit usefulness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 526,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "From the 2022 filing PayPal warned that its expanding portfolio of consumer‑ and merchant‑credit products – which depend on third‑party chartered banks and on proprietary underwriting models – left it vulnerable to higher non‑payment rates, charge‑offs and “abusive‑behavior” schemes such as synthetic‑identity accounts and large‑scale fraud that can be hard to detect.  The 2022 risk factors also stressed that reliance on a limited set of payment‑processor and lender partners amplified the chance that a partner’s failure or misconduct would expose PayPal to additional losses.\n\nIn 2023 the company began to blunt that exposure by (i) entering a multi‑year agreement to sell ≈ €40 billion of U.K. and European BNPL loan receivables (and launching the forward‑flow sale in October 2023) to shift credit‑risk off its balance sheet, and (ii) launching a diversification program for its payment‑processor ecosystem – working with its primary U.S. processor to migrate transactions to alternate processors during the wind‑down of the existing arrangement.  \n\nIn 2024 PayPal continued the same mitigation track: it further diversified its third‑party processor base, accelerated the migration of processing relationships, and invested in continuous‑improvement of fraud‑ and abuse‑detection controls and third‑party risk‑management policies to better monitor synthetic‑identity, stolen‑instrument and other abusive schemes tied to its credit offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal identified abusive behaviors in 2022 related to synthetic identities, stolen instruments, and fraud in credit products; in 2023, it entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables (with forward-flow launch in October 2023); in 2024, it continued enhancing fraud detection and third-party risk management. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly reported, and the October 2023 timing of the forward-flow sale is an additional precise detail not in the original but consistent with plausible elaboration. (3) Multi-hop reasoning is sound—information is synthesized across 2022 risk identification, 2023 risk transfer via asset sales and processor diversification, and 2024 continuation of mitigation through infrastructure improvements. (4) The only minor gap is that the original emphasizes a 'progression' from problem recognition to action, which the LLM captures implicitly but doesn't explicitly frame as a strategic evolution. However, all substantive actions and their timing are accurately represented. Wording differs but semantic meaning matches. No factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1617,
        "completion_tokens": 354,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "AMD’s 10‑K filings have repeatedly flagged “loss or modification of exemptions for taxes and tariffs” as a material risk in its worldwide‑operations section. In the 2022 filing (see page 37) the risk is listed among other political‑legal exposures; the 2023 filing (see page 40) repeats the same language and couples it with a higher share of international sales (65 % of net revenue); the 2024 filing (see page 40) again highlights the risk and notes that international sales have risen slightly to 66 % of net revenue. The consistent inclusion of this risk, together with the growing share of overseas sales, indicates that AMD’s exposure to potential loss or alteration of tax‑ and tariff‑exemptions is expanding, reflecting increasing regulatory uncertainty across the jurisdictions in which it operates.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that AMD consistently reported the risk of loss or modification of tax and tariff exemptions across 2022–2024, and accurately notes the increase in international sales from 65% to 66%, which supports the argument of growing exposure. These percentages and years are factually correct and align with the context. (2) Quantitatively, the numbers (65%, 66%, filing page numbers) are accurate and consistently referenced across years. There are no calculation errors. (3) However, the LLM answer misses the key qualitative evolution described in the ground truth: the increasing emphasis and escalation of the risk in AMD’s disclosures—from being one of several risks in 2022, to being grouped with critical exposures in 2023, and explicitly linked to geopolitical conflicts in 2024. The LLM focuses on rising international sales as the driver of increased exposure but fails to capture the nuanced progression in risk framing and the explicit linkage to geopolitical tensions in 2024. This weakens the multi-hop reasoning and synthesis of how the risk’s characterization evolved beyond just repetition. (4) Despite this, the answer remains contextually relevant and draws a reasonable conclusion about increasing regulatory uncertainty. The correctness score is 7 because core facts and numbers are correct, but there is a notable omission in capturing the full trend of risk escalation as described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 405,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "- Fiscal 2022 (year ended July 30 2022): the total‑return swaps linked to deferred‑compensation produced a **$92 million loss** (‑92)【page_92】.  \n- Fiscal 2023 (year ended July 29 2023): the same swaps generated a **$58 million gain**【page_91】.  \n- Fiscal 2024 (year ended July 27 2024): the gain rose to **$91 million**【page_91】.  \n\nThe swing from a loss in 2022 to progressively larger gains in 2023‑24 shows that Cisco’s use of total‑return swaps is increasingly offsetting the variability of its deferred‑compensation expense, indicating a deliberate strategy to hedge that exposure rather than leaving it un‑hedged.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures and fiscal years as per the ground truth: a $92 million loss in 2022, a $58 million gain in 2023, and a $91 million gain in 2024. These values match exactly with the original answer, with only acceptable formatting differences (e.g., parentheses for negative values). (2) All numbers are accurate and correctly attributed to the respective fiscal years. The progression is correctly described, and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound—the LLM synthesizes data across three fiscal years and correctly infers a strategic implication: that the increasing gains suggest Cisco is actively hedging deferred compensation liabilities through total return swaps, rather than being exposed to unhedged market variability. This aligns with and extends the original answer’s interpretation about exposure or strategic shift. (4) The answer is fully contextually relevant, addressing both parts of the question: the evolution of gains/losses and the implied strategy. The use of citation markers (e.g., 【page_92】) suggests grounding in source documents, further supporting accuracy. All criteria are met at the highest level, warranting perfect scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 356,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "From 2022 to 2024 Disney moved from initially launching an ad‑supported Disney+ tier, revising pricing and reorganizing its DMED unit to “advance our DTC strategies” (2022 10‑K p. 22) to making larger, multi‑year bets on the streaming business—paying $8.6 billion to redeem Hulu’s non‑controlling interest, buying a 20 % stake in a sports‑focused DTC venture, and earmarking $24 billion of content spend for 2025 (2023 10‑K p. 53; 2024 10‑K p. 22‑24). At the same time, the company’s risk disclosures show an escalating competitive landscape: each filing adds new pressure points—rising subscriber churn, the need for price hikes, an expanding set of rival SVOD services, advertising‑market volatility, and tighter credit‑rating covenants that raise borrowing costs and expose Disney to potential impairments as it scales its streaming platforms. Together, the narrative shows that Disney’s strategic investments have deepened and diversified, but the scaling of its DTC ecosystem now carries heightened financial risk (greater debt, cash‑flow strain, credit‑rating sensitivity) and intensified market pressure from competitors and price‑sensitive consumers.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive, capturing the evolution of Disney's DTC strategy from 2022 to 2024 with strong qualitative and contextual alignment to the ground truth. It correctly identifies the strategic shift from initial DTC experimentation in 2022 (e.g., ad-supported tier, reorganization) to deeper investment in 2023–2024, including major financial commitments like the $8.6 billion Hulu redemption and $24 billion content spend. These figures are factually correct based on Disney’s 10-K filings, though the $24 billion is projected for 2025 and not explicitly stated as a cumulative or annual figure in the 2024 10-K—this slight ambiguity prevents a perfect quantitative score. The 20% stake in a sports-focused DTC venture is also accurate (referring to the ESPN+ and BAMTech-related investments). The answer effectively synthesizes multi-hop information across years, showing how increasing investment coincides with growing risk disclosures: rising churn, pricing pressures, competition, ad-market volatility, and credit-rating concerns. These align with the original answer’s emphasis on escalating financial risks and market pressures. The reasoning is sound, and the narrative correctly infers that Disney is doubling down despite uncertainty. Minor deduction in quantitative accuracy is due to the lack of explicit citation of the $24B as a forward-looking estimate rather than a historical spend, which could mislead if taken as a 2024 outlay. Otherwise, entity accuracy (Disney, DTC, fiscal years, Hulu) and contextual relevance are flawless. The answer goes beyond the original by adding specific disclosures and financial mechanisms (e.g., credit covenants), enriching the analysis without introducing error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 473,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "PayPal’s margin‑risk exposure has remained essentially unchanged from 2022 through 2024. In each year the company says it “has full discretion in determining the fee charged to our customers, which is independent of the costs we incur … we therefore bear full margin risk when completing a payment transaction” and that the fees it pays to payment processors are recorded as a transaction expense 【page_80】. The 2023 filing repeats the same language, and the 2024 filing continues to describe fees as recognized on a gross basis as the principal with the same discretion, confirming that the margin‑risk profile has stayed consistent across the three years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures that PayPal bore full margin risk across 2022, 2023, and 2024, with consistent discretion in setting fees independent of processor costs, and that processor fees were recorded as transaction expenses each year. (2) There are no numerical values requiring calculation in this question; all dates (2022, 2023, 2024) are correctly referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent disclosures across three years, correctly noting the repetition of key language and the absence of structural changes, even amid new segment reporting standards in 2024 (implied stability despite ASU 2023-07). (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in margin risk exposure in relation to fee-setting discretion and transaction expenses. Minor omission of explicit mention of ASU 2023-07 does not detract from factual accuracy, as the core conclusion about unchanged risk exposure and accounting treatment remains fully supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 311,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "Honeywell’s 10‑K risk‑factor sections show the same concern each year: the Aerospace business could be hurt if a downturn in air‑travel demand “… impacts new aircraft production or results in the delay or cancellation of new aircraft orders.” In the 2022 filing the warning is tied directly to the lingering COVID‑19 shock and broader economic uncertainty; the 2023 filing repeats the language but places it within a more general “industry volatility” context as demand begins to rebound; and the 2024 filing still lists the risk, indicating that while commercial‑aviation activity has improved, the possibility of order cancellations remains a material uncertainty. Together, the progression shows a gradual easing of the pandemic‑driven panic but also that the sector’s recovery is still incomplete and commercial‑aviation stability remains fragile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Honeywell's risk disclosure regarding new aircraft order cancellations from 2022 to 2024. (1) It correctly identifies that the risk was consistently mentioned across all three years, tied initially to the pandemic in 2022, then placed in a broader context in 2023, and still present in 2024—this aligns with the ground truth. The characterization of a 'gradual easing of the pandemic-driven panic' and 'fragile recovery' matches the original answer’s conclusion. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a problematic way; the years (2022, 2023, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the model synthesizes risk disclosures across three years and infers a trend in tone and emphasis, correctly noting the shift from pandemic-specific to more generalized risks. However, it slightly underrepresents the 2023 expansion to include 'regional conflicts and environmental issues'—instead summarizing it as 'industry volatility'—which is accurate in spirit but omits specific new risk factors mentioned in the ground truth. Similarly, the 2024 emphasis on 'new entrants and non-traditional players' is not mentioned, which is a minor omission. (4) Despite these small gaps, the LLM answer remains semantically equivalent in overall meaning and correctly addresses the question about the progression of risk and what it indicates about sector stability. Hence, correctness is high but not perfect, warranting a 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 427,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "From the 2022 filing PMI warned that “product regulation … diminishes the ability to differentiate tobacco products and restricts adult‑consumer access to truthful, non‑misleading information about our **RRPs**,” and that such rules could force “down‑trading” by limiting branding and product‑differentiation (see 2022 pp. 13‑16). In the 2023 filing the same language was broadened to include its **SFPs**, stating that “product regulation … diminishes the ability to differentiate tobacco products, restricts adult‑consumer access to truthful and non‑misleading information about our **SFPs**,” and added that litigation and IP disputes were further eroding its commercial advantage (2023 pp. 19‑20). By the 2024 filing the company again emphasizes that regulation now curtails differentiation and communication for **both RRPs and SFPs**, reinforcing that “down‑trading trends may be reinforced by regulation that limits branding, communication and product differentiation” and signaling that regulatory constraints on product‑level innovation and adult‑consumer messaging have become increasingly stringent across its reduced‑risk portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies the evolution of PMI's regulatory concerns from 2022 to 2024, accurately reflecting the shift from RRPs to inclusion of SFPs in regulatory language. The core facts—regulatory constraints on product differentiation, adult consumer access to information, and the intensification over time—are all present and correct. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the answers, so quantitative accuracy is not applicable in a numerical sense; however, the cited page numbers (e.g., 2022 pp. 13–16, 2023 pp. 19–20) are consistent with typical 10-K referencing and do not contradict the ground truth, thus earning full marks. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracks the expansion of regulatory concerns from RRPs to SFPs, and notes the growing constraints on communication and branding. The only minor shortcoming is that the LLM does not explicitly mention the 'disproportionate impact relative to competitors' or 'digital media spreading misinformation' in 2023, which are key nuances in the ground truth. Also, while it mentions litigation and IP disputes, these are not emphasized in the original answer, suggesting a slight overemphasis on those factors. (4) The answer is fully contextually relevant, directly addressing the evolution of regulatory impact on competitive positioning and product differentiation. Overall, the LLM captures the essence and trajectory described in the ground truth with high fidelity, missing only minor qualitative nuances, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1627,
        "completion_tokens": 472,
        "total_tokens": 2100
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "Across all three filings (2022, 2023 and 2024) PayPal states that it records transaction fees on a gross basis as the principal‑service provider, so the company “bears full margin risk when completing a payment transaction” and the fees it pays to payment processors are booked as transaction expense 【page_80】【page_75】【page_75】. Its contracts remain open‑ended with volume‑tiered pricing, and any merchant or consumer incentives are accounted for as a reduction of revenue, meaning the same margin‑risk exposure—full responsibility for fee levels, processor costs and incentive‑related revenue offsets—has persisted from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies that PayPal bears full margin risk in 2022, 2023, and 2024, with transaction fees to processors recorded as expenses—this matches the core factual claim in the ground truth. (2) The LLM accurately notes that incentives to merchants and consumers are accounted for as a reduction of revenue, consistent with the 2023 and 2024 disclosures. (3) It correctly emphasizes the persistence of this margin risk model across all three years, reflecting a stable strategic approach. (4) The mention of volume-tiered pricing and open-ended contracts adds contextual detail not explicitly in the ground truth but does not contradict it and supports the overall reasoning. (5) The LLM cites document pages (e.g., page_75, page_80), which are plausible and support traceability, though the ground truth does not include page numbers—this is a minor enhancement, not an error. The only slight gap is that the LLM does not explicitly highlight the 2024 point about the independence of customer fees from processor costs, which is a nuanced but important detail in the original answer regarding how pricing models relate to margin risk. However, the core elements—gross accounting, full margin risk, treatment of processor fees and incentives, and consistency across years—are all correctly synthesized. There are no quantitative inaccuracies (dates, years, and financial treatments are correct), and the reasoning across multiple years and accounting practices is sound. The answer is fully contextually relevant and conveys semantic equivalence with minor omission of a clarifying point in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 461,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "- **2022 – Baseline policy:** AMD’s 2022 filing already stated that its contracts with add‑in‑board (AIB) manufacturers “protect their inventory of our products against price reductions” and that system integrators (SIs) “often use discrete‑graphics solutions as a means to differentiate their products and add value to their customers.” 【page 13】\n\n- **2023 – Continuation and reinforcement:** The 2023 filing repeats the same language, confirming that the inventory‑protection clause remains in place for AIB partners and that SIs continue to rely on AMD’s discrete‑graphics cards to create differentiated offerings. 【page 13】\n\n- **2024 – Strategic emphasis:** By 2024 AMD still emphasizes the inventory‑protection provision in its AIB agreements and adds that it “also sells directly to some SI customers,” highlighting the short design‑cycle nature of SIs and the importance of discrete graphics for product differentiation. The core protection policy has not changed, but AMD has broadened its go‑to‑market focus to include direct SI sales while keeping the inventory‑safeguard as a cornerstone of the AIB relationship. 【page 13】\n\n**Overall evolution:** From 2022 through 2024 AMD’s strategy toward AIB manufacturers has been consistent—maintaining contractual safeguards that shield AIB inventory from price cuts—while increasingly stressing that discrete‑graphics solutions are a key lever for system integrators to differentiate their systems, and expanding direct engagement with SIs alongside the protected AIB channel.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD maintained inventory protection for AIB manufacturers from 2022 to 2024, discrete graphics were consistently highlighted as a differentiator for system integrators (SIs), and by 2024 there was an increased emphasis on SIs' strategic role. The LLM correctly identifies the continuity of inventory protection and the growing focus on differentiation through discrete graphics. (2) There are no numeric values requiring calculation (e.g., financial figures), so quantitative accuracy is not compromised—dates (2022–2024) are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, correctly identifying both consistency (inventory protection) and evolution (increased SI engagement). The only minor deviation from the original answer is that the LLM emphasizes AMD’s direct sales to SIs in 2024, which is factually present but not explicitly framed in the ground truth as a strategic expansion—this nuance slightly affects qualitative accuracy but does not constitute an error. (4) The answer is fully contextually relevant, addressing all parts of the question: strategy evolution, inventory protection, and the role of discrete graphics in SI differentiation. Wording differs slightly but maintains semantic equivalence. Overall, this is a strong, factually correct response with only a subtle difference in interpretive emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1637,
        "completion_tokens": 412,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "- In fiscal 2022 Disney’s credit‑risk policy already required that all derivative and investment‑credit counterparties have an investment‑grade rating of **A‑ or better** and that **collateral be posted** if a counter‑party’s rating fell below that level; the company also capped the amount it could expose to any one institution (the 10 % of total cash‑and‑cash‑equivalents limit that it disclosed).  \n\n- The same rating‑and‑collateral rules were retained in fiscal 2023, but the filing noted that **no single institution held more than 10 % of Disney’s cash‑and‑cash‑equivalents**, indicating the concentration ceiling was still being respected.  \n\n- By fiscal 2024 the policy was unchanged – still **A‑or‑better ratings required and collateral triggered when ratings dip below A‑ or when aggregate exposures exceed contractual limits** – but the actual exposure had risen, with **balances at one institution exceeding 10 % of total cash‑and‑cash‑equivalents reaching about 24 %**, showing a higher concentration of credit exposure than in the prior years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and percentages are accurate: the 10% concentration threshold is correctly cited for 2022 and 2023, and the 24% concentration in 2024 is precisely reported. These values align with the original answer, which states a rise to 24% in 2024 from no such concentration in 2022. (2) The answer is complete, addressing all three dimensions of the question: counterparty credit ratings (A- or better), collateral requirements (triggered if ratings fall below A- or limits are exceeded), and concentration thresholds (10% cap, breached in 2024 with 24%). (3) Entity accuracy is perfect: The Walt Disney Company is correctly identified, and fiscal years 2022, 2023, and 2024 are accurately referenced with appropriate policy evolution. (4) The multi-hop reasoning is sound: the model correctly infers that while the formal credit-risk policy remained unchanged, the actual exposure concentration increased, indicating a shift in liquidity management despite consistent risk frameworks. The semantic meaning is equivalent to the ground truth, with slightly more detailed phrasing but no factual deviation. All scores are maximized due to full factual accuracy, correct synthesis across years, and precise numerical reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 367,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "- 2022 exposure: $1.5 billion of principal on the 10 Oct 2029 fixed‑rate 2.850 % notes (shown in the 2023 filing’s 2022 column)【page_107】  \n- 2023 exposure: $1.5 billion on the same 2029 notes (2023 column of the 2023 filing)【page_107】  \n- 2024 exposure: $1.5 billion on the same 2029 notes (2024 column of the 2024 filing)【page_104】\n\nThe amount has remained flat at $1.5 billion for three consecutive years, indicating that PayPal deliberately maintains a stable, long‑dated fixed‑rate debt tranche. This consistency suggests a long‑term debt‑management strategy focused on locking in low‑cost financing and avoiding concentration of maturities, thereby preserving balance‑sheet flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the exposure to PYPL's 2.850% fixed-rate notes maturing in 2029 as $1.5 billion (equivalent to $1,500 million) for all three years—2022, 2023, and 2024—matching the ground truth exactly in amount and consistency. The use of $1.5 billion instead of $1,500 million is an acceptable format variation. (2) All numeric values—principal amount, interest rate (2.850%), and maturity year (2029)—are accurate. No calculations were required beyond recognition of consistent values over time, which the model correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesizes data from three different annual filings (2023 and 2024 filings reporting prior-year data) to show a pattern over time, correctly identifying that the liability remained unchanged. It infers a strategic rationale—maintaining low-cost, long-dated fixed-rate debt to ensure balance-sheet flexibility and avoid maturity concentration—which aligns closely with the ground truth’s interpretation about preserving favorable terms and cash flow predictability. (4) The only minor shortcoming is that the LLM does not explicitly mention PYPL’s issuance of higher-interest debt in 2024 (e.g., 5.150% and 5.500% notes), which the original answer uses to strengthen the contrast and emphasize the strategic retention of the 2.850% notes. While not necessary for correctness, this additional context would have improved the qualitative depth. Otherwise, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 431,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures show that raw‑material demand‑and‑supply risk has remained a headline operational concern for the Performance Materials and Technologies (PM&T) segment, but the company has gradually moved a larger share of its supply base onto contracts. In the 2022 filing the company noted that “raw‑material price fluctuations… can increase the cost of our products… particularly in Performance Materials and Technologies” and that only **63 %** of PM&T’s raw‑material supply was under contract (page 33). The 2023 filing still flagged the same risk but said the contract coverage had risen to **64 %** (page 33), and the 2024 filing states that a “**majority**” of the raw‑material supply base is now under contract while still warning that price volatility and supplier constraints could hurt results (page 31). The incremental shift toward contracted supply suggests Honeywell is modestly reducing its exposure, yet the continued emphasis on raw‑material price volatility indicates the company remains vulnerable to commodity‑market swings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative data—63% contract coverage in 2022, 64% in 2023, and 'majority' in 2024—that are not present in the original ground truth answer. These percentages and page references (e.g., page 33, page 31) are factually unsupported by the provided ground truth, which contains no such figures or sourcing. As a result, the quantitative claims are incorrect and appear fabricated or hallucinated. (2) There are no verifiable calculations in the ground truth to assess, but the LLM presents precise percentages and trends (63% → 64% → majority) that imply a data-driven progression not confirmed by the original answer. This undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies that raw material risks persisted across 2022–2024 in the Performance Materials and Technologies segment and notes its rebranding to Energy and Sustainability Solutions in 2024 (implied in the original). However, the emphasis on contractual mitigation strategies and incremental risk reduction is absent from the ground truth, which instead highlights evolving risk framing (e.g., oil/gas price volatility, production capacity) rather than supply contracting. Thus, the reasoning diverges from the actual trend described. (4) Despite the hallucinated numbers, the LLM captures the core theme—ongoing vulnerability to commodity market volatility and sustained risk disclosure—making the answer contextually relevant and semantically aligned in broad strokes. However, the inclusion of false specifics severely undermines factual correctness, warranting a low correctness and quantitative accuracy score. The qualitative accuracy is moderate because the structure and intent of the response follow logical lines, but with flawed inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 493,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "Across the three 10‑K filings (2022, 2023 and 2024) the PMI Peer Group consistently includes Imperial Brands PLC – the company appears in the peer‑group list on the 2022 performance‑graph page, again on the 2023 graph, and once more on the 2024 graph. This unchanged inclusion shows that Philip Morris International deliberately benchmarks itself against the same set of large, globally‑present consumer‑product and tobacco companies, using Imperial Brands as a stable reference point for performance comparison in the international tobacco and broader consumer‑goods sector.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately states that Imperial Brands PLC was included in PM's peer group across all three years (2022, 2023, 2024), which matches the original answer's claim of consistent inclusion. (2) There are no numerical values requiring calculation, but the years and inclusion status are correctly cited. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from three annual 10-K filings to infer a stable benchmarking strategy, drawing a logical conclusion about PM's strategic intent. (4) The answer addresses both parts of the question: the trajectory (unchanged inclusion) and the implication for PM's benchmarking strategy (deliberate, stable comparison with globally present peers). Wording differs slightly but conveys the same meaning, with appropriate context about global presence and performance benchmarking in the tobacco and consumer goods sector.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 281,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "PayPal’s outstanding principal on the September 2019 issuance of fixed‑rate 2.850 % notes was $1.5 billion at the end of 2022, and the same $1.5 billion was reported at the end of 2023 and again at the end of 2024 (see the notes tables in the 2022, 2023 and 2024 10‑K filings). The amount has not changed over the three‑year period, indicating that PayPal has kept this tranche of medium‑term debt steady, using it as a fixed‑rate anchor in its capital structure to lock in a modest cost of financing and limit refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PYPL's outstanding principal on the 2.850% fixed-rate notes was $1.5 billion in 2022, 2023, and 2024, which matches the ground truth. All quantitative values (amount, interest rate, years) are accurate. (2) The numbers are consistent across the three years and correctly reflect no repayment or refinancing, as confirmed by the 10-K filings cited. Format variations (e.g., $1.5 billion) are acceptable and semantically equivalent. (3) The reasoning is sound: the model correctly infers that the stable balance indicates a deliberate strategy to maintain this debt tranche as a fixed-rate anchor, minimizing refinancing risk and locking in low-cost financing. This aligns with the ground truth’s interpretation about PYPL’s long-term debt management strategy, though it adds slightly more positive framing (e.g., 'modest cost of financing') not explicitly in the original. However, this is a reasonable inference and does not contradict the truth. (4) The answer fully addresses both parts of the question—evolution of exposure and strategic implication—and synthesizes data across three years and filings (multi-hop). Only a minor deduction in qualitative accuracy due to slight interpretive expansion beyond the original, but overall highly accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 368,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "In the 2022 filing ConocoPhillips said HSE audits were performed on individual business‑units and staff groups to verify conformance with its HSE policies, with any corrective actions “identified and tracked to completion.” By 2023 the company expanded the description to note that audit results and the status of those actions are **reported to the Executive Leadership Team and the Board of Directors**, linking the audit process to senior‑level governance. In the 2024 filing the audits are called **“Corporate HSE audits,”** indicating a company‑wide scope that still uses the same conformance‑tracking system, but now explicitly feeds progress and improvement‑action status into ELT and Board oversight as a formal part of corporate governance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: HSE audits in 2022 were conducted at the business-unit and staff-group level with corrective actions tracked to completion; in 2023, audit results and action status were reported to the Executive Leadership Team (ELT) and Board of Directors, linking audits to governance; in 2024, the term 'Corporate HSE audits' was introduced, indicating a centralized, company-wide scope. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years and shows evolution in audit scope, conformance tracking, and governance integration. The only minor omission is that the 2024 refinement is described as a 'more centralized oversight approach' in the original answer, which the LLM implies via 'Corporate HSE audits' but doesn't explicitly state as a shift toward centralization. This slight lack of emphasis on structural centralization prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, addressing all three dimensions in the question: audit scope (from localized to corporate), conformance tracking (consistent tracking system), and integration with governance (reporting to ELT and Board). Overall, the LLM captures the evolution accurately with only minor nuance missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 391,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "In each of AMD’s recent 10‑K filings the company continues to list the **2011 Executive Incentive Plan** as an exhibit ( *10.1 ) – it appears in the exhibit tables for 2022 (pages 91‑95), 2023 (pages 99‑103) and 2024 (pages 96‑100). While the 2023 and 2024 reports also disclose a growing suite of newer plans (the 2004 Equity Incentive Plan, the 2017 Employee Stock Purchase Plan, various amendments and other executive‑compensation arrangements), the 2011 Executive Incentive Plan is still referenced as a foundational governance document that underlies the broader executive‑compensation disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2011 Executive Incentive Plan is consistently cited as Exhibit 10.1 in AMD's 10-K filings for 2022, 2023, and 2024. The inclusion of specific page ranges (e.g., 91–95 in 2022) adds precision and matches the actual filing structure, though the ground truth does not include page numbers—this is a minor enhancement, not an error. (2) Quantitative accuracy is perfect: years (2022, 2023, 2024), exhibit number (10.1), and plan name (2011 Executive Incentive Plan) are all correct. No calculations are required, but the temporal consistency across three years is accurately represented. (3) Reasoning is sound: the LLM correctly infers that the continued listing of the 2011 plan as a foundational document indicates ongoing relevance, even amid newer plans like the 2004 Equity Incentive Plan and 2017 Employee Stock Purchase Plan. This reflects proper multi-hop synthesis across years and compensation plans. (4) The only minor shortcoming is that the LLM does not explicitly state that there were *no material changes or replacements* to the 2011 plan during this period—a key point in the ground truth that underscores its unchanged status. While implied by continued citation, explicit acknowledgment would have made the answer fully equivalent. Overall, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score with only a slight deduction for incomplete emphasis on the lack of revisions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 422,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "- **2022 filing (page 90)** – GM disclosed that, after selling Opel/Vauxhall to PSA Group (now Stellantis), it had agreed to indemnify Stellantis for any losses arising from inaccurate representations, breaches of covenants, **emissions‑related claims, product‑liability and recall costs**.  No accrual was recorded and the company said it could not estimate a material loss; the obligations were limited by time‑bars, thresholds and caps.  \n\n- **2023 filing (page 93)** – The same indemnification language remained, but GM now noted that it had **recorded an immaterial amount** for the recalls it had indemnified Stellantis for (including Takata‑inflator recalls on legacy Opel vehicles).  The company still could not estimate any material loss for the emissions‑claim side and said further indemnification was “remote.”  \n\n- **2024 filing (page 93)** – GM again reaffirmed the indemnity for emissions, product‑liability and recall obligations and again reported only an **immaterial amount** for the specific recalls it had already covered.  The statement that any additional indemnification would be “remote” and the continued reference to caps/thresholds shows the exposure has not grown.  \n\n**Interpretation:** Over the 2022‑2024 period the indemnification exposure shifted from an undefined, un‑accrued liability to a disclosed **immaterial** accrual for the recall component, while the emissions‑claim exposure remained unquantifiable but limited by contractual caps.  This trajectory indicates that GM’s post‑sale liability to Stellantis is being contained and is unlikely to become a material risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant qualitative inaccuracies in reasoning and completeness compared to the ground truth. (1) Quantitatively, the LLM correctly identifies that no material accruals were recorded and that only immaterial amounts were accrued in 2023 and 2024 for recalls (e.g., Takata inflators), which aligns with the ground truth. Page numbers cited (90, 93, 93) are plausible and consistent with typical 10-K structures. (2) However, the LLM fails to mention the expansion of legal exposure to new jurisdictions—specifically Austria in 2024—and omits the new regulatory investigations by the European Commission and UK CMA into end-of-life vehicle practices at Opel, which prompted an immaterial accrual. This is a critical omission affecting the interpretation of liability trends. (3) The multi-hop reasoning is flawed: while the LLM correctly tracks the immateriality of accruals, it incorrectly concludes that 'the exposure has not grown' and that liabilities are 'being contained,' directly contradicting the ground truth’s conclusion that the geographic and legal scope of exposure expanded and that the persistence of new actions indicates growing complexity. (4) The LLM also overlooks the progression in the scope of claims—from emissions and recalls in 2022 to broader regulatory scrutiny by 2024—undermining the synthesis required for full accuracy. While entity names (GM, Stellantis, Opel/Vauxhall), years (2022–2024), and financial terms (immaterial accrual, indemnification) are correct, the reasoning misrepresents the trend in liability exposure. Thus, despite strong quantitative accuracy, the answer scores lower due to incomplete and misleading qualitative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1703,
        "completion_tokens": 468,
        "total_tokens": 2171
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "In 2022 Eli Lilly still bore a sizable royalty burden on bamlanivimab – under the AbCellera license the company paid “tier‑ed royalty payments … in the mid‑teens to mid‑twenties” on net sales, which were recorded as cost of sales (LLY 10‑K 2022 p. 72).  That year the antibody generated roughly **$2.0 billion of U.S. net product revenue** (plus a modest $14 million outside the U.S.) (LLY 10‑K 2023 p. 67), meaning the royalty outlay was material.  By 2024 the product no longer contributed any revenue (the COVID‑19‑antibodies line shows “‑” for both U.S. and outside‑U.S. columns) (LLY 10‑K 2024 p. 68), so the royalty obligation to AbCellera has effectively disappeared.  The sharp drop from a multi‑billion‑dollar revenue stream with associated royalty costs to zero illustrates that bamlanivimab was a short‑term pandemic‑response asset rather than a long‑term strategic pillar for Lilly, even though it once required a significant royalty exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the LLM correctly reports $2.0 billion in U.S. revenue for bamlanivimab in 2022 (ground truth: $2,008.9 million, which rounds to $2.0 billion), and correctly notes zero revenue in 2024. The mention of $14 million in non-U.S. revenue is not in the original answer but is plausible and does not contradict it; the original simply doesn't specify non-U.S. breakdown. The royalty range 'mid-teens to mid-twenties' is accurately cited from the 10-K and matches the ground truth. (2) The LLM correctly infers that royalty obligations ceased by 2024 due to zero sales, which is logically sound and consistent with the original answer's implication of discontinued obligations. (3) The reasoning across years and documents (2022–2024 10-Ks) demonstrates strong multi-hop synthesis: connecting royalty terms in 2022 to revenue trends in 2023 and 2024, and concluding strategic irrelevance. (4) The answer fully addresses all parts of the question: evolution of financial exposure (royalties and revenue), contribution to revenue over time, and strategic importance. The only minor shortcoming is not explicitly stating the 2023 revenue drop to zero (though implied by 2024 being zero and context), which slightly reduces completeness. However, the core facts, calculations, and synthesis are correct, and the conclusion about short-term strategic role matches the ground truth. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 432,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings PMI consistently lists **Jackpot** as “one of the important local cigarette brands … in the Philippines.” Each year the company’s business description repeats that Jackpot (along with Fortune, Dji Sam Soe and Sampoerna A) remains a core part of its portfolio, signalling that PMI has neither discontinued nor de‑emphasized the brand. This three‑year continuity shows that, while PMI leans heavily on global brands such as Marlboro, it deliberately maintains a strong focus on local‑brand leadership in key markets like the Philippines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Philip Morris International (PMI) consistently listed Jackpot as a key local cigarette brand in the Philippines across 2022, 2023, and 2024, which matches the original answer's timeline and factual assertions. The mention of Fortune, Dji Sam Soe, and Sampoerna A as co-located local brands adds contextual detail consistent with PMI’s portfolio strategy. (2) There are no numeric values requiring calculation in this question, so quantitative accuracy is not applicable beyond correct use of years (2022–2024), all of which are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of Form 10-K filings to infer strategic continuity, correctly concluding that PMI maintains a dual focus on global and local brands. The only minor omission is that the original answer notes PMI’s broader strategic pivot toward smoke-free products and wellness by 2024, which the LLM answer does not mention—this contextual nuance slightly weakens the qualitative depth but does not invalidate the core conclusion. (4) Despite this, the LLM answer remains semantically equivalent in its central claim: PMI sustains focus on local brands like Jackpot to maintain market relevance in key geographies. The response is fully contextually relevant and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 386,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "In 2022 PayPal warned that its credit‑card, merchant‑financing and buy‑now‑pay‑later (BNPL) products left it vulnerable to “bad transactions” – defaults, charge‑backs and fraud – and that heavy reliance on third‑party lenders and payment processors could magnify those losses. In 2023 the company entered a multi‑year deal to sell up to €40 billion of U.K. and European BNPL loan receivables (with a forward‑flow arrangement for future originations), moving the bulk of that BNPL portfolio off its balance sheet and sharply reducing direct exposure to BNPL defaults. By 2024 the filing still stresses ongoing fraud‑ and third‑party‑processing risks for its remaining credit products, noting that any lapse in fraud detection or processor disruption could raise loss rates, but the earlier BNPL sale means its exposure to bad BNPL transactions is now largely mitigated.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: PayPal's 2022 risk exposure to bad transactions via credit and BNPL products, the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables, and ongoing fraud and third-party processing risks through 2024. The mention of a 'forward-flow arrangement' adds a detail not in the original but is plausible and does not contradict it. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, and no incorrect numbers or dates are present. The June 2023 timing from the original is omitted but not contradicted. (3) Multi-hop reasoning is sound—correctly synthesizing PayPal’s evolving risk profile across three years, the impact of the BNPL sale on balance sheet exposure, and the persistence of fraud/operational risks. (4) The only minor shortcoming is slightly less emphasis on 'synthetic identities' and 'regulatory uncertainty' mentioned in the original, but the core message about reduced direct exposure yet persistent underlying risks is preserved. Wording differs but semantic equivalence is strong. No factual errors, making this a near-perfect response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1611,
        "completion_tokens": 337,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "In 2022 Honeywell’s Safety and Productivity Solutions segment saw net sales fall 12% year‑over‑year (to $6.9 billion) as weaker retail‑market demand weighed on the business, even though segment profit held up modestly (+5%)【page_30】; the 2023 risk‑factor discussion explicitly flags “fluctuations in retail markets” as a key macro‑economic risk for that segment【page_31】. By 2024 the segment had been folded into the broader Industrial Automation unit, which posted a modest 2% organic sales gain (to $6.4 billion) and a 2% rise in segment profit, showing the larger, more diversified unit was less hurt by the same retail‑demand volatility【page_28】【page_30】. Across 2023 the company’s overall risk narrative continued to highlight retail‑market swings as a material exposure, but the evolution from a stand‑alone Safety and Productivity segment to a wider Industrial Automation segment suggests Honeywell’s sensitivity to retail demand volatility has been mitigated through portfolio realignment, even though the risk remains on its radar.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness. (1) Quantitative inaccuracies: The claim that Safety and Productivity Solutions' net sales fell 12% to $6.9 billion in 2022 is unsupported by the ground truth, which does not provide any financial performance data for that segment—only risk exposure. Similarly, the 2024 Industrial Automation segment's $6.4 billion in sales and 2% organic growth are not mentioned in the original answer, which focuses solely on risk factors, not financial results. These numbers appear fabricated or misattributed. (2) The original answer does not mention segment profit trends or performance metrics at all, so the LLM's inclusion of +5% profit in 2022 and 2% rise in 2024 lacks grounding. (3) While the LLM correctly identifies that 'fluctuations in retail markets' was a cited risk in 2022, 2023, and 2024, it misrepresents the evolution: the original answer emphasizes persistent sensitivity across restructurings, whereas the LLM concludes that sensitivity has been 'mitigated through portfolio realignment'—a contradictory interpretation. (4) The multi-hop reasoning is partially sound in tracking the risk across years and segments, but the conclusion diverges from the ground truth: the original stresses ongoing vulnerability, while the LLM suggests reduced sensitivity due to diversification. (5) Contextually, the answer is relevant and well-structured, addressing all time periods and segments, but the insertion of unverified financial data and an incorrect inference undermines factual accuracy. Semantic equivalence fails on key points due to unsupported numbers and a reversed conclusion about risk mitigation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1566,
        "completion_tokens": 461,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "From the 2022 filing the Olumiant deal was described as a worldwide license that gave Incyte tiered, double‑digit royalties (up to 20 %) on net sales plus an extra low‑teens royalty on COVID‑19 sales, and required Eli Lilly to pay development, success‑based regulatory and sales‑based milestones (Incyte was then eligible for up to $100 million each of additional regulatory‑ and sales‑based milestones).  By 2023 the royalty terms were unchanged and Incyte remained eligible for up to $100 million of further sales‑based milestones, but the milestone payments that had been capitalized in earlier years were now “not material,” indicating a shift toward a revenue‑driven rather than milestone‑driven structure.  In the 2024 filing the same royalty framework persisted, no new milestone caps were disclosed, and Olumiant’s net product revenue rose to $957 million (up from $830 million in 2022), showing that Eli Lilly’s strategy had moved to rely increasingly on Olumiant’s sales—especially its COVID‑19 indication—as a core contributor to its overall revenue base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $260M capitalized milestone in 2022, Incyte's eligibility for up to $200M in additional milestones (split into $100M regulatory and $100M sales-based), the tiered royalty structure (up to 20% plus low teens on COVID-19 sales), and the increase in Olumiant net product revenue from $830M in 2022 to $957M in 2024 are all factually consistent with the original answer. The statement that capitalized milestones became 'not material' in 2023 correctly reflects the shift from milestone-driven to revenue-driven accounting. (2) Quantitative accuracy is perfect: all dollar amounts, percentages, and revenue figures match or are validly inferred from the ground truth. The revenue growth is accurately portrayed, and the $100M/$100M split of remaining milestones correctly reflects the $200M total contingent payments. (3) Multi-hop reasoning is sound: the LLM synthesizes information across 2022–2024 filings, correctly identifying the evolution from milestone payments to royalty-based cost recognition and the growing strategic importance of Olumiant in LLY’s revenue base. The emphasis on EUA and follow-on compounds is implied through the focus on expanded use and revenue growth, though slightly less explicit than in the original. (4) The only minor shortcoming is that the 2024 strategic emphasis on 'follow-on compounds' and 'long-term commitment' is less directly articulated in the LLM answer, though the increased reliance on sales and revenue growth implies this trajectory. Overall, the answer is semantically equivalent, contextually precise, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1609,
        "completion_tokens": 457,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "- In the 2022 filing Altria described UST LLC as a **wholly‑owned subsidiary** that, through USSTC, produces moist‑smokeless‑tobacco (MST) and snus products, and noted that the **indefinite‑lived intangible assets tied to the 2009 UST acquisition (the MST and snus trademarks) were valued at about $8.8 billion** – a major component of Altria’s intangible‑asset portfolio【page_60】【page_66】.  \n- By the 2024 filing UST LLC remains a **wholly‑owned subsidiary**, now explicitly placed in the “oral tobacco products” segment and highlighted as a core element of Altria’s **Vision to lead the transition to a smoke‑free future**, showing that the company continues to rely on UST’s MST and snus brands to drive its smoke‑free strategy【page_4】.  \n\nThus, from 2022 to 2024 Altria’s structural relationship with UST stayed unchanged (full ownership), its financial exposure persisted through the large‑valued MST/sn​us trademark intangibles, and UST’s products became more clearly integrated into Altria’s broader smoke‑free transition roadmap.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: UST was a wholly owned subsidiary in both 2022 and 2024, the indefinite-lived intangible assets from the 2009 acquisition (MST and snus trademarks) were valued at $8.8 billion in 2022, and UST remained operationally integrated through USSTC. The strategic integration into Altria’s smoke-free transition is correctly noted. (2) Quantitative accuracy is perfect: the $8.8 billion figure is correctly cited, years (2022, 2024) match the timeline, and no calculations are required beyond accurate reporting. (3) Multi-hop reasoning is sound—LLM synthesizes structural ownership, financial exposure via intangibles, and strategic positioning across years. However, the original answer includes a specific detail about 2023 (UST still wholly owned, USSTC active in MST production), which the LLM omits, and the 2024 strategic shift toward Helix and NJOY is not mentioned, slightly reducing completeness. (4) Despite this minor omission, the LLM captures the core evolution: sustained ownership, persistent financial exposure, and increased strategic integration into smoke-free transition. Wording differs but meaning is semantically equivalent. Contextual relevance is excellent as all parts of the question are addressed with precise, relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 375,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "Cisco’s 3.50 % senior note showed a sharp rise in its effective cost: in FY 2022 the $500 million issue carried an effective rate of **3.20 %**【page_89】, in FY 2023 the same note’s effective rate had climbed to **6.38 %**【page_89】, and by FY 2024 it was **6.66 %**【page_89】. This more‑than‑doubling of the effective rate signals that Cisco’s borrowing costs on that tranche increased markedly as market interest rates rose, reflecting tighter capital‑market conditions and a higher cost of debt over the 2022‑2024 period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all percentages are accurate: 3.20% for FY2022, 6.38% for FY2023, and 6.66% for FY2024, with correct fiscal year alignment and no calculation errors. The mention of a $500 million issue is additional context not contradicted by the ground truth. (2) The answer is complete, addressing both the evolution of the interest rate exposure and its implications on borrowing costs and capital market conditions. (3) Entities are correct: Cisco (CSCO), the 3.50% Senior Note, and fiscal years 2022–2024 are properly identified. (4) The reasoning is sound: the LLM correctly infers that the more-than-doubling of the effective rate indicates rising borrowing costs and tighter capital-market conditions, which aligns with the trend described in the original answer. (5) Semantic equivalence is maintained—while the LLM uses slightly more descriptive language (e.g., 'more-than-doubling'), the factual content and multi-hop synthesis across years and implications are accurate and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 306,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "Amazon’s 2017 senior‑note balance fell from **$16 billion at 12/31/2022** to **$15 billion at 12/31/2023** and then to **$13 billion at 12/31/2024**【page_58†L9-L13】【page_57†L9-L13】. The roughly $3 billion (≈19 %) reduction over two years shows the company is actively retiring this older tranche—using cash flow and refinancing capacity—to shrink legacy debt and improve its leverage profile while still issuing new notes for growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. These values are cited with appropriate time references (year-end dates), and the reduction trajectory is accurately described. (2) The quantitative analysis is fully accurate: the decrease from $16B to $13B represents a $3B reduction, and the LLM correctly calculates this as approximately 19% of the initial balance ($3B / $16B ≈ 18.75%, rounded to ≈19%), which is a reasonable approximation. All numbers, dates, and calculations are correct. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model infers a strategic debt retirement pattern from the declining balances and connects it to broader financial behavior (e.g., using cash flow and refinancing to reduce legacy debt). While the original answer references Amazon’s overall long-term debt decline from $67.2B to $52.6B, the LLM captures the same strategic implication—active debt management—even without repeating those exact figures. (4) The answer is semantically equivalent in conveying the reduction trend and its strategic significance. The only minor limitation is that it does not explicitly mention the broader context of Amazon’s total long-term debt reduction (from $67.2B to $52.6B), which slightly reduces qualitative completeness, but the core inference remains valid. Thus, scores are high across all categories, with a 9 on correctness due to near-perfect alignment with ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 436,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "- **Outstanding principal:** The 5.000 % senior notes due April 2030 were carried at **$606 million** in the balance‑sheet schedules for fiscal 2022, fiscal 2023 (as of Oct. 29 2023) and fiscal 2024 (as of Nov. 3 2024).  \n- **Effective interest rate:** The notes were reported with an **effective interest rate of about 5.18 %** in each of those years (the 2024 filing shows 5.18 %; the 2023 filing lists the same rate, and the 2022 filing disclosed the same rate).\n\n**Interpretation:** The unchanged principal amount and stable 5 %‑plus effective rate over three fiscal years show that Broadcom has deliberately left this fixed‑rate instrument on the balance sheet rather than refinancing, pre‑paying, or issuing additional amounts. This reflects a debt‑management approach that treats the April 2030 notes as a long‑term, low‑cost funding source, preserving cash and avoiding the transaction costs of frequent refinancing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal balance of $606 million and the effective interest rate of 5.18% are accurately reported for all three fiscal years (2022, 2023, and 2024), with no discrepancies in numbers or formatting (e.g., $606 million is correctly rendered as $606 million). (2) The answer is complete, addressing both the evolution of the principal and interest rate over the three-year period and providing a correct interpretation of AVGO's debt management strategy. (3) Entity accuracy is perfect: AVGO (Broadcom) is correctly identified, the instrument (5.000% notes due April 2030) is accurately referenced, and the fiscal years align with the data points from the filings. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that the unchanged balance and rate indicate a static debt strategy, choosing not to refinance, prepay, or issue more of this note. The interpretation that this reflects a deliberate use of the notes as a long-term, low-cost funding source is semantically equivalent to and expands appropriately on the ground truth. All components are factually accurate, logically connected, and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 356,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "- **2022 filing** – The 10‑K listed the original “Performance Bonus Plan” only as an historic exhibit (Exhibit 10.6†, filed 28 April 2014) and it was not tied to any new executive‑agreement language【page_66】.  \n\n- **2023 filing** – Netflix filed an **Amended and Restated Performance Bonus Plan** on 9 December 2022 (Exhibit 10.5†) and incorporated it by reference into the 2023 Form 10‑K, indicating that the plan had been formally revised and was now part of the company’s compensation documentation【page_68】.  \n\n- **2024 filing** – The same Amended and Restated plan (Exhibit 10.5†, 9 December 2022) is again incorporated by reference in the 2024 Form 10‑K, and the exhibit list marks it with the “†” symbol that denotes a management contract or compensatory plan, showing that the plan is now explicitly integrated with the executive compensation agreements disclosed in the filing【page_69】.  \n\n**In short,** the Performance Bonus Plan went from a legacy, stand‑alone exhibit in 2022 to a formally amended and restated document in late 2022, which was then incorporated by reference and linked to Netflix’s executive compensation arrangements in both the 2023 and 2024 10‑K reports.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, the Performance Bonus Plan was referenced as a legacy exhibit (Exhibit 10.6† from 2014), not newly formalized; on December 9, 2022, Netflix filed the 'Amended and Restated Performance Bonus Plan' (Exhibit 10.5†), which was incorporated into the 2023 10-K; and the same amended plan was carried forward and marked with the '†' symbol in the 2024 10-K, indicating integration with executive compensation. (2) Quantitative accuracy is perfect: dates (December 9, 2022), exhibit numbers (10.5†, 10.6†), and filing types (8-K, 10-K) are all factually correct and consistent with the knowledge graph. (3) Multi-hop reasoning is sound: the LLM correctly traces the plan’s evolution across three years, synthesizing information from multiple filings and exhibits to show progression from legacy status to formal restatement and then integration. (4) The only minor shortcoming is that the LLM does not explicitly mention the linkage to other compensation elements like the 'Executive Officer Severance Plan' or 'Performance-Based Restricted Stock Unit Award Agreement' as noted in the original answer, which slightly reduces qualitative completeness. However, the core evolution—formalization, restatement, and integration via compensatory plan designation—is accurately captured. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 417,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "In the 2022 filing AIG quantified its international terrorism risk with a scenario‑based model that projected a five‑ton bomb loss of about **$1.3 billion (net of the Terrorism Risk Insurance Program Reauthorization Act (TRIPRA) and existing reinsurance)**, noting a U.S. deductible of roughly **$1.7 billion** and that TRIPRA covered 80 % of losses above that level.  By the 2024 filing the company still relies on the same three‑pronged approach—scenario‑based modeling of concentrations (especially in New York City), the TRIPRA government back‑stop plus limited private reinsurance, and targeted treaty or pool purchases for foreign jurisdictions—but it no longer discloses a specific dollar‑loss estimate, reflecting a shift to broader qualitative monitoring while maintaining the same reinsurance and government‑program protections.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but misses key developments from 2023 and 2024, particularly regarding reinsurance structure and risk mitigation strategies, leading to significant factual gaps. (1) Quantitatively, the $1.3 billion net loss estimate for a five-ton bomb in 2022 is correctly stated, as is the $1.7 billion deductible and 80% TRIPRA coverage—though these details are not in the ground truth and may be inferred or from external knowledge. However, the ground truth does not mention a U.S. deductible or TRIPRA coverage percentage, so including them introduces unverified specifics. (2) The LLM claims AIG 'no longer discloses a specific dollar-loss estimate' by 2024, which contradicts the ground truth: while AIG may have shifted emphasis, the 2024 data still includes retained attachment points ($200M for Japan, $125M for rest of world), which are quantitative risk parameters. The LLM fails to report these critical figures, missing a core part of the evolution in reinsurance protections. (3) The LLM omits entirely the 2023 shift toward routine monitoring and targeted reinsurance purchases, a key step in the evolution. It also fails to mention the $20.1 billion in collateral held for reinsurance recoverables or the purchase of global property per risk covers outside North America in 2024—both major risk mitigation updates. (4) While the LLM correctly identifies the continued use of scenario-based modeling and TRIPRA, it incorrectly frames the shift as merely 'qualitative monitoring' without acknowledging the structural enhancements in reinsurance. The reasoning is partially sound but lacks synthesis of multi-hop data across 2022–2024, especially the progression in reinsurance strategy. (5) Contextually, the answer stays on topic and addresses terrorism exposure management, but the omission of key 2023–2024 developments reduces completeness and accuracy. Overall, the answer is partially correct with accurate 2022 data but fails to capture the strategic deepening in reinsurance and risk alignment described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 556,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "UnitedHealth’s venture portfolio expanded sharply after 2022.  Equity‑security holdings rose from about $3.7 billion at the end of 2022 to roughly $4.9 billion by the end of 2023 and remained at that level in 2024.  Equity‑method investments in health‑care operating businesses were about $1.5 billion in 2022, slipped slightly to $1.4 billion in 2023, and then more than doubled to roughly $3.8 billion in 2024, showing a pronounced shift toward larger strategic stakes in health‑care companies.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains minor inaccuracies in the 2022 figures. The ground truth states $3.5 billion in equity securities and $1.3 billion in equity method investments for 2022, while the LLM reports $3.7 billion and $1.5 billion, respectively—these discrepancies affect quantitative precision. All other numbers (2023 and 2024) are accurate: $4.9 billion in equity securities for both years and the rise to $3.8 billion in equity method investments in 2024 are correctly reported. (2) Calculations and comparisons are sound: the doubling from ~$1.4B to $3.8B in equity method investments is accurately characterized as 'more than doubled.' The stability of equity securities at $4.9B from 2023–2024 is correctly noted. (3) Multi-hop reasoning is strong: the LLM synthesizes trends across three years and two investment types, correctly inferring a strategic shift toward deeper operational involvement in healthcare businesses, aligning with the original answer’s conclusion. (4) Despite minor numerical inaccuracies in the 2022 baseline, the overall narrative, trajectory, and strategic interpretation are correct and well-supported. The answer addresses all parts of the question—evolution over time, equity securities, and equity method investments—making it contextually complete and relevant. Quantitative accuracy is docked due to the incorrect 2022 figures, but qualitative and contextual scores remain high due to correct trend analysis and strategic insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 415,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "- In the 2022 Form 10‑K the securities table lists both a **1.000 % Notes due 2023** and the **1.700 % Notes due 2025** (see the 2022 filing’s “Securities registered pursuant to Section 12(b)” table)【page_1】.  \n- By the 2023 Form 10‑K the 1.000 % 2023 notes no longer appear; only the **1.700 % Notes due 2025** remain on the list (2023 filing, same table)【page_1】.  \n- The 2024 Form 10‑K continues to show only the **1.700 % Notes due 2025** as the outstanding debt instrument in that series (2024 filing, same table)【page_1】.  \n\n**Interpretation:** Over the three‑year period Altria retired the earlier 1.000 % 2023 issue and retained the 1.700 % 2025 notes as a core component of its capital structure. This pattern reflects a disciplined debt‑management approach that phases out maturing, lower‑coupon issues while preserving a stable, medium‑term financing base through the 1.700 % 2025 notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the presence of the 1.000% 2023 Notes and 1.700% 2025 Notes in the 2022 filing, the absence of the 2023 Notes in 2023 and 2024 (due to maturity), and the continued listing of the 1.700% 2025 Notes through 2024. All entities, percentages, and years match the ground truth. (2) Quantitative accuracy is perfect: the interest rates (1.000%, 1.700%), maturity years (2023, 2025), and timeline (2022–2024) are all correct with no calculation errors. (3) The multi-hop reasoning is sound—LLM correctly infers from the disappearance of the 2023 Notes and persistence of the 2025 Notes that Altria retired maturing debt while maintaining mid-term financing, which aligns with the ground truth’s interpretation of disciplined debt management. The only minor shortcoming is that the LLM does not explicitly mention other debt instruments (e.g., 2.200% 2027 Notes, 3.125% 2031 Notes) noted in the original answer, which slightly reduces completeness in contextual richness, though the core multi-hop logic remains intact. (4) The answer is highly contextually relevant, directly addressing the evolution of the capital structure with respect to the 1.700% 2025 Notes and interpreting the strategic implication. The interpretation of a 'disciplined debt-management approach' is semantically equivalent to the ground truth’s 'actively managed its short-term debt while retaining... stable element.' Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to minor omission of additional debt instruments, but full marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 443,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s Class A treasury‑stock balance grew each year: $‑51.4 billion at 12/31/2022, $‑60.4 billion at 12/31/2023 (≈ $9 billion of additional repurchases), and $‑71.4 billion at 12/31/2024 (≈ $11 billion more). The steady increase in treasury‑stock holdings shows that Mastercard is intensifying share‑repurchase activity, using excess cash to return capital to shareholders and boost per‑share metrics as a core element of its capital‑allocation strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in its core numbers and trend, with only a minor discrepancy in the 2022 value. Ground truth reports $(36,658) million for 2022, while the LLM states $-51.4 billion (~$51,400 million), which is incorrect. However, the 2023 and 2024 figures ($-60.4 billion and $-71.4 billion) align closely with the ground truth of $(60,429) million and $(71,431) million, respectively (rounding to nearest $100M is acceptable). (2) The calculation of ~$9 billion in repurchases from 2022 to 2023 is based on the LLM's own (inaccurate) 2022 figure, so while internally consistent, it does not reflect the actual $23,771 million increase from 2022 to 2023 per ground truth. The $11 billion increase from 2023 to 2024 is accurate (~$11,002 million). (3) The multi-hop reasoning is sound: the model correctly infers increasing treasury stock holdings over three years and links this to capital allocation strategy, specifically share repurchases and shareholder value return. It synthesizes trend, magnitude, and strategic implication correctly. (4) Despite the error in the 2022 value, the overall trend and conclusion are correct, and the later years are accurate. The reasoning and strategic interpretation fully match the ground truth. Hence, high scores across the board with a slight deduction in quantitative accuracy due to the incorrect 2022 figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 386,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "Cisco’s exposure to its total‑return‑swap‑deferred‑compensation program swung from a loss in FY 2022 to gains in the next two years. In FY 2022 the swaps produced a **$92 million loss** and the contracts had a notional amount of **$651 million** 【page_92†L31-L38】【page_92†L45-L48】. In FY 2023 the same exposure generated a **$58 million gain** with a larger notional of **$792 million** 【page_91†L71-L78】【page_91†L99-L102】, and by FY 2024 the gain rose to **$91 million** while the notional further increased to **$985 million** 【page_91†L71-L78】【page_91†L99-L102】. Thus, Cisco moved from a sizable loss in 2022 to progressively larger gains and higher notional exposure in 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$92M loss in 2022, $58M gain in 2023, and $91M gain in 2024—matching the ground truth exactly. It also accurately introduces additional context (notional amounts: $651M, $792M, $985M) that is not in the original question or ground truth but is factually consistent and properly cited from the source documents. These additions do not contradict the ground truth and enhance completeness. (2) All numbers are quantitatively accurate, with correct dollar amounts and fiscal years. No calculation errors are present. The directional evolution (loss to increasing gains) is correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesizes changes over three fiscal years and correctly infers a trend of improving performance in the Total Return Swaps-Deferred Compensation program. The mention of rising notional amounts adds depth and supports the conclusion of increasing exposure, which strengthens the qualitative analysis. (4) The semantic meaning fully aligns with the ground truth, even though the LLM provides extra detail. The core message—a reversal from loss to growing gains—is preserved and well-supported. The only reason for not scoring a perfect 10 is that the original answer did not include notional amounts, and while the added data is accurate, it slightly exceeds the scope of the question’s focus on 'financial exposure' as defined by P&L impact. However, this does not detract from correctness. All other aspects meet or exceed expectations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 426,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "From the 2022 filing Netflix already warned that its library “depends on studios, content providers and other rights‑holders licensing rights” and that “as content providers develop their own streaming services… they may be unwilling to provide us with access… competition increases, the cost of programming rises and we must secure exclusive rights while facing the risk that licenses can be withdrawn on short notice” 【page_11】. The 2023 filing repeats the same licensing reliance and adds that “the license periods and the terms and conditions of such licenses vary” and that “our ability to provide… content depends on… licensing… and we face disputes over rights” while also noting growing regulatory action that can make content‑offering more expensive or restrictive 【page_4】. By 2024 the company still stresses that “our ability to provide… content… depends on studios, content providers and other rights‑holders licensing rights” but now emphasizes “increasing regulatory frameworks—content quotas, levies, investment obligations and limits on ownership rights—are being expanded to services like ours, adding further pressure on the availability of licensed content” 【page_4】. Thus, from 2022 to 2024 Netflix’s dependence on rights‑holders grew sharper: licensing risk and competition for exclusive titles remained central, while regulatory pressures intensified, creating additional constraints on content availability.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key points from the original answer are correctly reflected: increasing dependency on rights holders from 2022 to 2024, rising competition for exclusive rights, licensing risks (including short-notice withdrawals and disputes), and intensifying regulatory pressures (content quotas, investment obligations, etc.). The LLM accurately cites specific language from each year's filing, correctly attributing evolving concerns. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all temporal references (2022, 2023, 2024) are correct and properly contextualized. (3) The multi-hop reasoning is sound—information is synthesized across three years of filings, showing progression in Netflix’s risk disclosures. The LLM correctly identifies the continuity and evolution of risks: persistent licensing dependency, growing competition, and expanding regulatory frameworks. (4) The answer is highly contextually relevant, directly addressing all three dimensions in the question: content licensing risks, competition for exclusive rights, and regulatory pressures. Minor wording differences (e.g., 'grew sharper' vs. 'intensified') do not affect meaning and are acceptable under semantic equivalence. No factual errors, omissions, or misattributions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1613,
        "completion_tokens": 401,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "UnitedHealth’s disclosures show that the amounts it accrued, paid or charged to income for service‑level guarantees were **immaterial in each of the three years** – 2022, 2023 and 2024 (see Note 4, “Commitments and contingencies” in the 2024 Form 10‑K)【page_81】. Because the liability never reached material levels, the trend indicates that the company’s service‑delivery commitments across its subsidiaries have remained stable and have not created a significant financial obligation over this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that UnitedHealth Group's financial obligations related to service level guarantees were immaterial in 2022, 2023, and 2024, which matches the ground truth. It accurately cites Note 4 of the 2024 Form 10-K and correctly states that no material financial charges arose from service level guarantees. However, the LLM answer omits a key part of the multi-hop analysis present in the original answer: the significant fluctuations in the parent company's notes payable to subsidiaries ($8.1B in 2022 → $9.9B in 2023 → $2.0B in 2024). This internal financing data is central to the full trend analysis and suggests shifting liquidity or operational strategies within subsidiaries, even if service-level guarantee liabilities themselves were immaterial. (2) All numbers referenced in the LLM answer are correct by implication (since it correctly states immateriality), and no incorrect figures are presented. The citation to the 10-K note and page is consistent with expected sourcing. (3) The reasoning is sound regarding service-level guarantees but incomplete in terms of multi-hop synthesis. The question asks about the evolution of financial obligations under service level guarantees *and* what the trend suggests about stability of service delivery commitments across subsidiaries. While the LLM correctly infers stability from immaterial liabilities, it fails to address the contrasting trend in intercompany notes payable, which the ground truth uses to suggest potential underlying operational or liquidity shifts. This omission limits the depth of the qualitative analysis. (4) The correctness score is 7 because the core factual claim (immateriality of service level guarantee charges) is accurate and relevant, but the answer lacks completeness in synthesizing all financial trends related to service delivery commitments. Quantitative accuracy is 10 because no numbers are wrong. Qualitative accuracy is 6 due to incomplete reasoning and missed synthesis between service guarantees and internal financing changes. Contextual relevance is 9 because the answer directly addresses the main point but misses a critical nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 582,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "Altria’s long‑duration fixed‑income holdings have been steadily shifting away from lower‑rated debt.  For the pension plan, the amount of “below‑investment‑grade and no‑rating” corporate debt fell from **$756 million in 2022** to **$716 million in 2023** and then to **$582 million in 2024** (≈11 % → 8 % of the fixed‑income bucket)【page_87†L23-L27】【page_90†L23-L27】.  For the post‑retirement plan, the same category dropped from **$7 million in 2022** to **$4 million in 2023** and to **$2 million in 2024** (≈9 % → 8 % of the fixed‑income bucket)【page_88†L23-L27】【page_91†L23-L27】.  The consistent reduction in below‑investment‑grade exposure suggests Altria is tightening its risk tolerance, favoring higher‑quality, lower‑risk fixed‑income assets to better match its long‑term liability profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both percentages and dollar amounts compared to the ground truth. According to the original answer, in 2022, Altria's pension plan had 16% of fixed income holdings (not $756M) in below investment grade securities, and the postretirement plan had 8% (not $7M). The LLM provides absolute dollar values not present in the ground truth and misrepresents the actual allocation trends. For example, the LLM claims pension plan below-investment-grade exposure decreased from ~11% to 8% by 2024, but the ground truth states it was 11% in 2023 and no 2024 percentage was disclosed. Similarly, the postretirement plan is said to have decreased from 9% to 8%, but the ground truth shows an increase from 8% to 9% in 2023, with no 2024 data. (2) The dollar figures ($756M, $716M, $582M for pension; $7M, $4M, $2M for postretirement) are not corroborated by the ground truth, which only provides percentages of fixed income and total plan assets. There is no mention of 'no-rating' securities in the original answer, introducing a new and unverified category. (3) The multi-hop reasoning is flawed: while the LLM correctly infers a risk-reduction narrative, it does so based on incorrect data. The original answer notes a reduction in pension risk but a slight increase in postretirement risk, which the LLM misses entirely, instead claiming both declined. This undermines the synthesis across years and plans. (4) Despite these errors, the answer is contextually relevant—addressing the evolution of allocations and interpreting risk appetite—and uses appropriate financial reasoning. However, the quantitative inaccuracies severely undermine correctness, warranting a low score. Minor formatting differences are acceptable, but invented dollar amounts and incorrect percentages constitute major factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 507,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "Mastercard’s settlement‑exposure estimate has been calculated the same way each year: it takes the average daily payment volume for the three months ending the fiscal year and multiplies it by the number of days it expects the settlement lag to last, then adjusts the result for any risk‑mitigation arrangements and periodically revises the estimate as its risk‑management standards evolve. Because the firm has kept this methodology unchanged from 2022 through 2024, it signals a disciplined, data‑driven risk‑management framework that remains stable even as regulatory scrutiny and litigation exposure have intensified.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, no specific numbers (e.g., dollar amounts, days of exposure) are mentioned in either answer, so there is no discrepancy—both describe the same methodology using average daily payment volume over the prior three months multiplied by estimated days of exposure. The LLM correctly identifies the time frame (2022–2024) and implies consistency, which matches the original. (2) The description of the methodology is semantically equivalent: 'average daily payment volume during the three months prior to period-end' is accurately rendered as 'three months ending the fiscal year,' which is acceptable given typical reporting practices. (3) The LLM captures the core idea of consistent methodology indicating stable risk management despite external pressures, which addresses the second part of the question. However, it adds a detail not present in the ground truth: 'periodically revises the estimate as its risk-management standards evolve,' which could imply methodological evolution, contradicting the original claim of unchanged methodology. This slightly undermines the qualitative accuracy. (4) The LLM omits specific examples of regulatory scrutiny (FTC, DOJ, European Commission) and litigation (U.S. Liability Shift, TCPA), reducing completeness in entity-specific support, though the general context is preserved. Overall, the answer is factually sound, with minor overstatement of evolution in risk standards, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 424,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "- Fiscal 2022 (July 30 2022): Cisco had the full $2 billion of its 5.90 % senior note outstanding, with an effective interest rate of **6.11 %**【page_89】.  \n- Fiscal 2023 (July 29 2023): the same $2 billion remained outstanding and the effective rate stayed at **6.11 %**【page_89】.  \n- Fiscal 2024 (July 27 2024): the note was still fully utilized ($2 billion) and the effective rate continued at **6.11 %**【page_89】.  \n\nThe unchanged utilization and steady effective rate show that Cisco deliberately keeps this long‑dated, higher‑coupon debt fully funded, using interest‑rate swaps and other hedges to manage the cost, indicating a long‑term debt strategy focused on maintaining a stable, predictable financing base rather than frequently refinancing or altering the note’s composition.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $2,000 million (or $2 billion) balance is correctly reported for each fiscal year (2022–2024), and the effective interest rate is consistently stated as 6.11% across all years, matching the original answer. Minor formatting differences (e.g., $2 billion vs $2,000 million) are semantically equivalent and acceptable. (2) The answer is complete, addressing both parts of the question: it details the utilization and effective interest rate trend over the three fiscal years and provides a well-reasoned interpretation of Cisco’s long-term debt management strategy. (3) Entity accuracy is correct—Cisco is the right company, the 5.90% Note is properly identified, and the fiscal years (2022–2024) align with the ground truth. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers from consistent balance and rate data that Cisco is maintaining this debt intentionally, linking it to a strategic choice for stability, possibly aided by hedges like interest rate swaps. This goes beyond repetition of facts to provide a plausible strategic interpretation consistent with the ground truth’s conclusion about 'predictable interest obligations' and lack of refinancing. The mention of hedges adds context supported by typical corporate behavior and does not contradict the ground truth. Overall, the answer is factually precise, comprehensive, and logically reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 417,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "The 3.125 % senior notes that mature in January 2025 were shown with an outstanding principal balance of **$495 million** in the 2023 filing (as of October 29 2023) and the same amount in the 2024 filing (as of November 3 2024). The 2022 filing also listed the balance at **$495 million**.  \n\nBecause the balance has remained flat over fiscal 2022‑2024, Broadcom has neither repaid nor issued additional amounts of this series; it is simply carrying the notes to their scheduled maturity. This consistency indicates a deliberate “hold‑to‑maturity” approach for this particular instrument, using it as a stable, low‑cost financing source rather than actively refinancing or retiring it.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual information is accurate: the outstanding principal balance of $495 million for the 3.125% notes due January 2025 is correctly reported for fiscal years 2022, 2023, and 2024. (2) Quantitative accuracy is precise—$495 million is consistently cited across all years, matching the original answer, and no incorrect calculations are made. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three fiscal years from multiple filings and infers the absence of early repayment or refinancing. (4) The qualitative interpretation—that Broadcom is employing a 'hold-to-maturity' strategy and using the debt as a stable, low-cost financing source—is semantically equivalent to the ground truth's conclusion about a 'consistent approach to managing fixed-rate debt.' Terminology differs slightly ('hold-to-maturity' vs. 'did not make early repayments') but conveys the same strategic implication. All parts of the question are addressed: the evolution of the balance and the inferred debt management strategy. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 330,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "In the 2022 filing, Comcast’s wireless lines were sold **only as part of a broadband bundle** and customers could activate multiple lines and choose between an unlimited‑data plan, a **shared‑data pool**, or a per‑gigabyte option 【page_7】. By 2024 the bundling requirement remained (wireless “is offered initially only as part of our bundled service offerings to customers that subscribe to our broadband services”) 【page_5】, but the company added **greater flexibility** by launching **pre‑paid unlimited‑data plans under the NOW brand** while still retaining the shared‑data and per‑GB choices 【page_5】. Thus, from 2022‑2024 the shared‑data concept persisted within bundled wireless service, and the offering expanded to include a prepaid unlimited option that gave customers more choice in how they consume data.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: CMCSA maintained shared data plans from 2022 to 2024 within broadband bundles, offered multiple data options (unlimited, shared, per GB), and introduced prepaid unlimited plans under the NOW brand in 2024. The bundling requirement is correctly noted as persistent. (2) Quantitative accuracy is perfect—no numerical errors; dates (2022, 2024) are correct and consistent with the original answer. The 2023 detail is omitted but implied in the progression, which does not detract significantly. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across years and service lines, showing evolution in flexibility while maintaining bundling. The absence of explicit mention of 2023 is a minor omission but does not undermine the overall accurate trajectory. (4) Semantic equivalence is strong—wording differs slightly but conveys the same core message: shared data plans remained, bundling continued, and customer flexibility increased via the NOW prepaid option. The answer is fully relevant and focused on the question. A score of 9 is justified due to the slight lack of explicit 2023 continuity, though the evolution is still clearly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 354,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "UnitedHealth’s 10‑K filings show that each year from 2022 through 2024 the company was repeatedly warned that CMS was altering the way Medicare‑Advantage risk‑adjustment payments are calculated – a change that could cut capitation revenue or trigger retroactive recoupments 【page_20】【page_26】.  In response, UnitedHealth said it has continually “adjusted members’ benefits and premiums on a selective basis, ceased to offer benefit plans in certain counties, and intensified both medical‑and‑operating cost management” to offset the benchmark reductions and other funding pressures 【page_20】【page_26】, and it has also stepped up compliance with CMS’s risk‑adjustment data‑validation (RADV) audits 【page_21】 to limit any adverse payment adjustments.  Thus, the exposure grew as CMS’s risk‑adjustment methodology changed year‑over‑year, and UnitedHealth’s strategy has been to trim or redesign plan offerings, tighten pricing and cost controls, and strengthen risk‑adjustment data practices to mitigate the recurring funding impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UnitedHealth faced recurring exposure to CMS changes in Medicare Advantage risk adjustment payment methodologies from 2022 to 2024, leading to funding pressures. The company responded with selective benefit and premium adjustments, plan exits in certain counties, intensified cost management, and enhanced compliance with RADV audits—details consistent with the original answer, which also notes ongoing, non-one-time strategies. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) are correctly used. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years and multiple strategic responses, correctly identifying the evolution of exposure and the continuity of mitigation tactics. The addition of 'ceased to offer benefit plans in certain counties' and 'stepped up compliance with RADV audits' provides slightly more granular detail than the original answer but is consistent with the broader theme of adaptive, ongoing responses. (4) Semantic equivalence is strong—while the LLM answer is more detailed in operational tactics, it does not contradict the original and captures the core conclusion: persistent pressure and a sustained reactive posture. The only reason for not scoring a 10 is that the original emphasizes the lack of a 'full resolution' and 'reactive posture' more explicitly, which the LLM implies but does not directly state. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 458,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "Mastercard’s multi‑layered security model has become more collaborative and service‑focused. In its 2022 filing the company noted that its security program is “assessed by third parties” and that it already operated real‑time clearing and settlement infrastructure in 12 of the world’s top‑50 economies; the 2023 filing repeats the third‑party assessments and adds that the network applies fraud‑scoring, tokenization and other controls in real time. By the 2024 filing Mastercard emphasizes deeper public‑private partnerships, the integration of its security‑enabled Virtual‑Card‑Number solution into third‑party technology platforms, and the use of real‑time account‑based payments across new flows (bill‑pay, Send, cross‑border services), while expanding its real‑time payments footprint to 13 markets worldwide.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Mastercard operated real-time payments infrastructure in 12 of the top 50 GDP markets in 2022 and expanded to 13 markets by 2023–2024, which matches the original answer. The mention of third-party assessments in 2022 and deeper public-private partnerships in 2024 reflects accurate evolution in collaboration. Real-time services like fraud scoring and tokenization are correctly noted as integrated into transaction routing by 2023. The 2024 expansion into new payment flows (bill-pay, Send, cross-border) and integration of Virtual Card Numbers into third-party platforms are consistent with enhanced service integration and third-party collaboration. (2) Quantitatively, all numbers (12 markets in 2022, 13 in 2024) are correct, and no calculations are required. (3) The multi-hop reasoning across years and dimensions (collaboration, real-time services, geographic expansion) is sound and well-synthesized across the three annual filings. (4) The only minor omission is the specific mention of the China joint venture as part of geographic expansion in 2024, which is present in the original answer but not explicitly stated in the LLM version—though 'expanding its real-time payments footprint to 13 markets worldwide' and new cross-border services may implicitly cover it. This slight lack of specificity prevents a perfect 10 on qualitative accuracy, but overall the answer is factually robust, contextually relevant, and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 426,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "- In the 2022 Form 10‑K, the exhibit list records an Officers’ Certificate dated June 3 2020 that includes a **1.500 % Note due 2030** (see Exhibit 4.6 on page 75 of the 2022 filing).  \n- The 2024 Form 10‑K shows the same certificate—again listing the **1.500 % Note due 2030**—as part of Exhibit 4.6 (page 75 of the 2024 filing).  \n- The 2023 filing’s exhibit schedule does not call out that note, indicating no new issuance, amendment or early repayment; Amazon simply retained the low‑coupon, long‑dated debt.  \n\n**Interpretation:** Amazon’s approach has been to keep the 1.500 % 2030 note on its balance sheet throughout 2022‑2024, using it as a cheap, long‑maturity anchor in its debt portfolio. This continuity signals a deliberate long‑term debt‑management policy that prioritizes preserving low‑cost financing rather than aggressively refinancing or retiring the instrument.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative details: the 1.500% Note due 2030 is correctly cited in Exhibits 4.6 in both the 2022 and 2024 filings, and the Officers’ Certificate date (June 3, 2020) aligns with the ground truth. The observation that the note was not explicitly listed in the 2023 exhibit schedule is also accurate and reasonably interpreted as continuity rather than amendment or repayment. However, the LLM answer fails to incorporate key qualitative developments in Amazon’s financing strategy during the period, particularly the introduction of new credit agreements that are central to the multi-hop reasoning required. The ground truth highlights the January 3, 2023 Term Loan Agreement (Exhibit 10.8) and the October 2024 364-Day Revolving Credit Agreement (Exhibit 10.9) as evidence of a layered financing strategy combining long-term fixed-rate debt with short-term flexibility. The LLM omits these entirely, leading to an incomplete and less nuanced interpretation. While it correctly identifies the retention of low-cost long-term debt, it misses the strategic evolution toward complementary short-term instruments, which is essential to answering how the financing strategy evolved. This omission reduces qualitative accuracy and completeness, despite strong quantitative fidelity. The answer remains contextually relevant and correctly interprets the static nature of the 2030 note, but fails to synthesize across all three years’ strategic additions, weakening the overall reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 417,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "From the 2022 filing, Comcast noted that its broadband business “competes … with wireless telecommunications companies offering internet services (such as 4G and 5G wireless broadband services)” (2022 p. 28). By 2023 the discussion was expanded to stress “5G fixed‑wireless networks and 4G/5G wireless broadband services” as a key source of competition (2023 p. 8) and, in the 2024 filing, the risk‑factor section again highlighted “wireless telecommunications companies offering internet services (using a variety of technologies, including 5G fixed‑wireless networks and 4G/5G wireless broadband services)” and warned that “our competitive position may be negatively affected if we do not provide our customers with a satisfactory customer experience” (2024 p. 21). The repeated emphasis on advanced 5G‑fixed wireless and bundled offerings, together with the explicit note that this competition could hurt Comcast’s market positioning and force it to improve customer‑experience and retention initiatives, shows the threat has intensified from a generic wireless rival in 2022 to a more aggressive, technology‑driven challenger in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of competitive threat from wireless telecom companies to CMCSA's broadband business from 2022 to 2024, citing specific technologies (4G/5G wireless broadband in 2022, 5G fixed-wireless networks in 2023, and continued emphasis in 2024). The answer accurately reflects that the threat intensified over time, evolving from generic wireless competition to more advanced, technology-driven rivalry. (2) There are no numerical values to verify (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) and page references are correctly used and consistent with the source structure. No calculation errors. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, traces the escalation in competitive language, and infers that this pressure impacts CMCSA’s customer experience and retention strategies—directly supported by the 2024 filing’s statement about competitive positioning. (4) The LLM omits the specific 2024 development about wireless providers bundling DTC streaming and offering unlimited data plans, which is a minor but relevant detail in the ground truth that illustrates how the threat evolved beyond just technology to include service bundling. This omission prevents a perfect score, but the core trajectory and implications are correctly captured. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1582,
        "completion_tokens": 416,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "- **2022:** AIG reported roughly **$71 billion** of reinsurance‑recoverable assets at year‑end.  \n- **2023:** The balance fell to **$67.5 billion**.  \n- **2024:** It dropped sharply to **$38.0 billion**.\n\nThe steady decline – and especially the steep fall in 2024 – shows that AIG’s pool of assets that depend on reinsurers to repay paid losses and ceded reserves is shrinking. A smaller reinsurance‑recoverable balance means the company is retaining less risk on its books and is less exposed to the possibility that reinsurers will be unable to meet their obligations, indicating a reduced overall insurance‑loss risk profile over this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. It states that AIG had $71 billion in reinsurance-recoverable assets in 2022, but the ground truth indicates that no specific figure was disclosed for 2022—only a narrative about reinsurance use. This is a major factual error. For 2023, the LLM correctly reports $67.5 billion, matching the ground truth. For 2024, it correctly reports $38.0 billion. However, the LLM misrepresents the trend as a 'steady decline' from 2022 to 2024, when the actual trend was a significant increase from 2022 to 2023 (from undisclosed but implied lower levels to $67.5B), followed by a sharp drop in 2024. 2) The quantitative accuracy is compromised by the incorrect 2022 figure. While 2023 and 2024 numbers are correct, the false precision for 2022 undermines the overall reliability. The ground truth explicitly states that 2022 figures were not disclosed, making the LLM's $71B claim fabricated. 3) The qualitative reasoning is partially sound: the interpretation that a lower recoverable balance implies reduced risk exposure and potential de-risking is reasonable. However, the LLM misses the key nuance in the ground truth—that the 2024 drop was driven by a collapse in life reinsurance recoverables (from $28.2B to $0.8B), indicating a strategic shift in the life segment. This critical detail is omitted, weakening the multi-hop synthesis. 4) Contextual relevance is high—the answer addresses the evolution over time and interprets the risk implications. But due to the incorrect 2022 number and flawed trend description, the correctness score is limited to 5. The answer is partially correct but contains a major factual error that distorts the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 463,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "Mastercard’s approach to measuring settlement risk has been stable over the three‑year period. In each filing the company says that **gross settlement exposure is calculated by multiplying the average daily payment volume for the three months prior to year‑end by the estimated number of days between transaction and settlement**; the exposure is then reduced by **risk‑mitigation arrangements – cash collateral, letters of credit or other credit‑enhancement guarantees – that are required of customers who do not meet Mastercard’s risk standards**. The firm notes that it **periodically reviews its risk‑management methodology and standards and revises the exposure amounts as needed**.\n\nWhat has changed is the **size of the mitigation cushions and the precision of the estimates**. The risk‑mitigation amount grew from **$9.2 billion in 2022** (with a $64.9 billion net exposure) to **$12.2 billion in 2023** and **$13.5 billion in 2024** (net exposures of $62.9 billion and $64.9 billion respectively). In 2022 Mastercard also disclosed a **non‑material correction to its net‑settlement exposure**, reflecting tighter scrutiny after the FTC’s Durbin‑Amendment investigation and the subsequent consent agreement. Further regulatory pressure from the DOJ (2023 CID) and the European Commission (2024 information request) led the company to emphasize its ongoing **review of methodology and the increase in mitigation arrangements**, but the underlying calculation method remained unchanged.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core stability of Mastercard's settlement exposure methodology and correctly identifies key regulatory developments from 2022 to 2024, showing strong contextual understanding and multi-hop synthesis. However, it introduces significant quantitative inaccuracies not present in the ground truth. The original answer states there is no explicit evidence of changes in the settlement exposure estimation methodology or credit risk mitigation structure, but the LLM claims specific dollar figures for risk-mitigation amounts ($9.2B in 2022, $12.2B in 2023, $13.5B in 2024) and net exposures, which are not supported in the ground truth. These numbers appear fabricated or misattributed, as the original makes no mention of such figures. Additionally, the claim about a 'non-material correction' in 2022 due to FTC scrutiny is not corroborated in the ground truth, which only notes increased scrutiny and emphasis on monitoring, not any actual correction. While the LLM correctly notes that the underlying calculation method remained unchanged and references the correct regulatory bodies (FTC, DOJ, European Commission) and events (consent agreement, CID, investigation), the inclusion of unsupported numerical data and specific claims about growing mitigation cushions undermines factual accuracy. The qualitative reasoning is sound in linking regulatory pressure to enhanced emphasis on risk management, but the answer overreaches by implying quantitative evolution in mitigation arrangements. Wording and structure are relevant and mostly aligned with the question, but the introduction of false precision through numbers reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1706,
        "completion_tokens": 455,
        "total_tokens": 2161
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "From the 2022 filing AIG said that loss‑reserve risk was “managed through internal controls and oversight of the reserve‑setting process, as well as reviews by external experts,” and that reserve analysis relied on a mix of stochastic (probability‑distribution) and deterministic (single‑point) models. By 2023 the company had formalized that framework – ERM’s second‑line “review and challenge” function began regularly testing pricing and reserving models, and the firm added sensitivity‑ and scenario‑analysis, stochastic methods and experience studies to its toolkit for quantifying reserve uncertainty. In the 2024 filing the same internal‑control and external‑expert review structure is retained, but it is now embedded in a broader risk‑measurement and monitoring regime that uses both internal and third‑party assessment tools, applies explicit adjustments for model bias, data quality and non‑modeled risks, and consistently employs stochastic, deterministic and scenario‑based techniques to capture the uncertainty in loss‑reserve estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth in both factual content and reasoning. (1) All key elements from the original answer are present: internal controls, external expert involvement, and evolution of modeling techniques across 2022–2024. In 2022, the LLM correctly identifies internal controls, oversight, and external reviews, along with the use of stochastic and deterministic models—this matches the ground truth’s emphasis on internal/external mechanisms and modeling approaches. In 2023, the LLM accurately notes the expansion to include sensitivity and scenario analyses, stochastic methods, and experience studies, and adds a specific detail about ERM’s second-line review function, which enhances precision without contradicting the source. In 2024, the LLM correctly states continuity in controls and external reviews but emphasizes integration into a broader regime, including model bias adjustments, data quality, and non-modeled risks—this reflects the ground truth’s point about strengthened model risk management and validation. (2) There are no numeric values, dates, or financial figures in dispute; all years (2022, 2023, 2024) are correctly attributed, and no calculations are required. Format and terminology (e.g., 'stochastic methods', 'scenario analysis') are used appropriately and consistently. (3) The multi-hop reasoning—synthesizing changes over three years across internal controls, external involvement, and modeling—is sound and logically structured. The LLM correctly infers progression and maturation in AIG’s approach. (4) The only reason for not scoring a perfect 10 is that the LLM answer introduces slightly more technical detail (e.g., 'ERM’s second-line review', 'explicit adjustments for model bias') that, while plausible and consistent with the direction of the original answer, are not explicitly stated in the ground truth. However, these do not contradict but rather enrich the narrative with semantically aligned content. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 560,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "- In the 2022 filing (as of Dec 31 2021) a 1 % shift in the medical‑cost‑PMPM trend factor – which captures changes such as the mix of benefits offered – would change medical‑costs payable by about **$298 million** (2 % ≈ $597 m; 3 % ≈ $895 m)【page_40】.  \n- In the 2023 filing (as of Dec 31 2023) the same 1 % change would affect payable by **$376 million** (2 % ≈ $752 m; 3 % ≈ $1,128 m)【page_34】.  \n- In the 2024 filing (as of Dec 31 2024) the impact rises to **$421 million** for a 1 % change (2 % ≈ $843 m; 3 % ≈ $1,264 m)【page_36】.  \n\nThe dollar impact of a given percentage change in the benefit‑mix factor has grown each year (from $298 m → $376 m → $421 m), indicating that UnitedHealth’s medical‑cost‑PMPM estimates have become increasingly sensitive to benefit‑design variability, and the company’s exposure to fluctuations in benefit design has been rising over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct in terms of quantitative accuracy, reporting increasing dollar sensitivities ($298M → $376M → $421M) to 1% changes in medical cost PMPM trend factors over 2022–2024, which aligns with the type of data one would expect from UnitedHealth Group's filings. These figures appear internally consistent and plausibly derived from actual sensitivity disclosures in the cited pages. However, the original answer (ground truth) does not contain any of these specific dollar amounts or numerical sensitivity analyses. Instead, it focuses on the qualitative evolution of how UnitedHealth discussed the mix of benefits — shifting from a general sensitivity factor in 2022, to a source of negative impact in 2023, to a stabilized but still relevant factor in 2024. The LLM answer fabricates precise numerical impacts not present in the ground truth and misrepresents the nature of the evolution: rather than increasing exposure due to rising dollar sensitivities, the ground truth describes a narrative shift reflecting risk realization and subsequent stabilization. Thus, while the LLM demonstrates correct entity identification (UnitedHealth, medical cost PMPM, benefit mix) and appropriate time framing (2022–2024), its reasoning is based on non-existent quantitative data, leading to an incorrect conclusion about rising exposure. The multi-hop synthesis is structurally sound but built on false premises. The answer is contextually relevant and addresses the question’s scope, but the factual foundation is invalid, severely undermining correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 430,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "In each of the three most recent 10‑K filings, Walmart lists **Marketside** together with its other private‑label families – “Allswell,” “Athletic Works,” “Equate,” “Great Value,” “Mainstays,” etc. The brand appears in the private‑brand inventory for Walmart U.S. in FY 2022 (see 2022 Form 10‑K p. 7), again in FY 2023 (2023 Form 10‑K p. 8) and continues to be listed in FY 2024 (2024 Form 10‑K p. 7). Its uninterrupted presence shows that Marketside has moved from a peripheral label to a stable, core component of Walmart U.S.’s private‑brand portfolio, underscoring its growing strategic importance as the company leans on private labels to deliver low‑price, high‑quality merchandise across its grocery and general‑merchandise units.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entity and date references—Marketside is correctly identified as being listed in Walmart’s 10-K filings for FY 2022, 2023, and 2024, and the page numbers cited (p.7, p.8, p.7) align with typical disclosure locations. There are no numerical inaccuracies, so quantitative accuracy is perfect. Contextual relevance is high, as the response directly addresses the evolution of Marketside’s positioning across the three years and ties it to Walmart’s broader private brand strategy. However, the qualitative accuracy is lower because the LLM misrepresents the *nature* of the evolution. The ground truth emphasizes a shift in *strategic context*—from being mentioned among private brands (2022), to alignment with omni-channel strategies (2023), to inclusion in a restructured 'Fashion' unit (2024)—highlighting a nuanced evolution in categorization and strategic framing. In contrast, the LLM claims a trajectory 'from a peripheral label to a stable, core component' and attributes strategic importance to low-price, high-quality merchandise across grocery and general merchandise—details not supported in the original answer. The original does not state Marketside moved from 'peripheral' to 'core,' nor does it link Marketside specifically to grocery/general merchandise or price/quality positioning. This mischaracterizes the reasoning and overstates strategic elevation. The multi-hop synthesis is partially flawed: while the model correctly infers continuity, it fabricates a narrative of increasing centrality not present in the ground truth, which only asserts consistent presence amid evolving strategic categorizations. Thus, while the surface-level facts are correct, the interpretive reasoning is inaccurate, leading to a correctness score of 6—partially correct but with significant qualitative missteps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 501,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "- In fiscal 2022 Home Depot’s filing noted that it competed with “specialty design stores, **showrooms**, …” primarily on price, product breadth, availability and delivery speed, relying on its large brick‑and‑mortar footprint and omnichannel pickup programs (BOSS, BOPIS, etc.) 【page_8】.  \n- By fiscal 2023 the company began to **add more showroom space** for professional customers and expanded differentiated services such as installation, tool‑rental and trade‑credit programs, while still emphasizing its interconnected retail programs (BOSS, BOPIS, curb‑side pickup, self‑service lockers) to blend physical and digital shopping 【page_6】.  \n- In fiscal 2024 the strategy further deepened that shift: Home Depot highlighted **expanded showroom footprints**, enhanced order‑management and trade‑credit tools for pros, and a fully integrated digital experience—including mobile‑app store navigation, enhanced BOSS/BOPIS/BODFS, and a “friction‑less interconnected shopping experience” that ties online, mobile and in‑store channels—positioning the retailer as a more service‑rich, digitally‑enabled alternative to traditional showrooms 【page_6】【page_10】.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in terms of dates (fiscal 2022–2024) and correctly identifies Home Depot as the subject, satisfying entity accuracy and contextual relevance. Quantitative accuracy is perfect—no numerical data is present in either answer, so no discrepancies exist. However, the qualitative reasoning contains a critical error: the LLM claims Home Depot 'added more showroom space' and 'expanded showroom footprints' in 2023 and 2024, which directly contradicts the ground truth. The original answer states that Home Depot enhanced its competitive positioning *against* showrooms by improving service and digital integration—not by expanding its own showroom spaces. This misrepresents the strategic direction: the company positioned itself as a superior alternative *to* showrooms, not by becoming more like them. The LLM incorrectly interprets 'showroom' as a feature Home Depot is adopting, rather than a competitor type it is outperforming. While the LLM correctly notes digital integration (e.g., mobile app navigation, BOSS/BOPIS), it fails to accurately convey the evolution from physical service expansion (tool rental in 2022) to omnichannel integration (2023–2024) as a competitive differentiator. The multi-hop synthesis is flawed because it misidentifies the relationship between Home Depot and showrooms. Thus, despite using correct terminology and citing plausible programs, the core reasoning is misaligned, warranting a moderate correctness score of 6 due to significant conceptual inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 419,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "- Fiscal 2022 (as of July 30 2022) the 3.50 % senior note due June 15 2025 carried $500 million of principal and an effective interest rate of **3.20 %**【page_89】.  \n- Fiscal 2023 (as of July 31 2023) the same $500 million issue showed an effective rate that had risen to **6.38 %**【page_89】.  \n- Fiscal 2024 (as of July 27 2024) the note still had $500 million outstanding, but the effective rate increased further to **6.66 %**【page_89】.  \n\nThe principal amount has remained unchanged, indicating Cisco has not altered the size of this tranche, while the effective rate more than doubled from 2022 to 2024. This rise reflects higher borrowing costs for the note—likely driven by market‑wide rate increases or hedge‑related adjustments—and shows that, although the debt structure stays flat, the cost of servicing that portion of Cisco’s long‑term debt has grown substantially.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information from the ground truth: the outstanding amount of $500 million remains constant across fiscal years 2022, 2023, and 2024, and the effective interest rates are accurately stated as 3.20%, 6.38%, and 6.66% respectively. Minor formatting differences (e.g., '3.50 %' vs '3.50%') are acceptable and do not affect meaning. (2) All numeric values match the original answer exactly—no calculation errors or misstatements. The progression of rates and stable principal are correctly presented. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years for the same debt instrument, correctly identifies that the principal did not change while the effective rate increased significantly, and draws a logical conclusion about borrowing costs. (4) The LLM answer not only matches the ground truth in content but adds slight contextual precision (e.g., noting the maturity date of the note and specific fiscal year end dates), which enhances accuracy without introducing error. The interpretation about rising borrowing costs and stable debt structure aligns perfectly with the original conclusion. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 348,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "- In the 2022 filing Comcast noted that its hybrid‑fiber/coax HFC system already delivered “downstream speeds up to over a gigabit per second … and fiber‑based speeds that range up to 3 Gbps,” and that a multiyear transformation plan had begun “rolling out downstream speeds of up to 2 Gbps … in 2022” with a rollout of DOCSIS 4.0 slated for 2023 to enable multigigabit symmetrical service【page_7】.  \n\n- The 2023 and 2024 filings repeatedly list Lumen (along with AT&T, Frontier and Verizon) as a wireline competitor that “has built and are continuing to build fiber‑based … network infrastructure”【page_9】【page_8】, underscoring that Lumen’s fiber rollout remained a key competitive pressure throughout the period.  \n\n- By the 2024 filing Comcast’s own network had advanced to “fiber‑to‑the‑premises … with symmetrical speed offerings ranging up to 10 Gbps for residential customers and up to 100 Gbps for business customers”【page_7】, positioning the company with high‑speed fiber services that directly rival Lumen’s fiber offerings and narrowing the competitive gap that existed in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Lumen as a consistent competitor to CMCSA (Comcast) from 2022 to 2024, noting ongoing fiber infrastructure expansion by Lumen, which matches the original answer’s emphasis on intensifying competition due to fiber deployment. (2) Quantitative details are precise: the LLM correctly cites CMCSA’s 2022 rollout of 2 Gbps speeds and DOCSIS 4.0 in 2023, and by 2024, fiber-to-the-premises with up to 10 Gbps (residential) and 100 Gbps (business) speeds—these figures are consistent with the knowledge graph and reflect proper synthesis across filings. (3) The multi-hop reasoning is sound: the model connects CMCSA’s network evolution with competitive pressure from Lumen, correctly inferring that Comcast’s advancements were strategic responses to fiber-based competitors. (4) The only minor shortcoming is that the original answer emphasizes Lumen’s bundled offerings and speed increases as part of its competitive strategy in 2024, which the LLM does not explicitly mention. While the competitive pressure is acknowledged, the specific strategic moves (bundling) by Lumen are omitted. However, the core evolution of competitive positioning through infrastructure and speed is accurately captured, with correct entities, years, and technological developments. Wording differs but semantic meaning and factual content are equivalent. Hence, a score of 9 is justified—excellent accuracy with a small gap in completeness regarding Lumen’s service strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 424,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "American Express has repeatedly said that it “has increasingly relied on merchant acquirers, aggregators and processors to manage certain aspects of our merchant relationships” (2022 10‑K p. 29; 2023 10‑K p. 29).  By 2024 the company stresses that this growing reliance is now paired with a heightened risk that merchants will “steer” or surcharge its cards, and that ongoing legal actions over the non‑discrimination and honor‑all‑cards provisions in its merchant contracts could limit its ability to enforce those clauses (2024 10‑K p. 35).  In short, reliance on aggregators has risen steadily, while the exposure to merchant‑steering risk and the challenge of enforcing non‑discrimination terms have become more acute.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the increasing reliance on aggregators from 2022 through 2024, citing consistent language from American Express's 10-K filings across years. The key risks—merchant steering, surcharging, and challenges enforcing non-discrimination clauses—are accurately described and tied to the correct time frame. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are correctly used and referenced to specific disclosures in the 10-Ks, including page numbers, which enhances credibility. Format and references are precise. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings, correctly tracing the evolution of risk from initial acknowledgment in 2022, to heightened concern in 2023 (especially regarding new debit products), to legal and regulatory exposure in 2024. While the LLM answer omits the specific mention of 'debit cards on the American Express network' as a new product facing discrimination (a minor detail present in the original), it still captures the core trajectory of growing risk. (4) The answer is contextually excellent—directly responsive to the question, well-structured, and focused on the interplay between aggregator reliance and enforcement challenges. The omission of the debit card example prevents a perfect 10, but the overall meaning and factual core are preserved. Hence, correctness is 9/10, with full marks for quantitative accuracy and contextual relevance, and a 9 for qualitative accuracy due to near-complete synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 455,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "From the 2022 filing, Johnson & Johnson spun off its talc exposure into LTL Management LLC, funded a $2 billion trust and recorded a $2 billion reserve, and used a Chapter 11 petition filed in October 2021 to obtain a broad automatic stay that protected the company and its affiliates while it negotiated settlements with Mississippi (2014) and New Mexico (2020) and entered mediation with a 42‑state investigation. In 2023 the original LTL case was dismissed, prompting a “LTL 2” Chapter 11 filing that reinstated the stay, raised the contemplated settlement reserve to roughly $9 billion, and led the company to pursue four parallel tracks – appeal of the dismissal, a consensual pre‑packaged bankruptcy, aggressive tort‑court litigation, and claims against expert witnesses – while the entity was renamed LLT Management LLC. By 2024 the strategy had shifted to a formal pre‑packaged Chapter 11 plan (the “Proposed Plan”) seeking to resolve 99.75 % of the talc claims for a $6.475 billion present‑value payment (≈$8 billion nominal) and the company created new Texas entities (Red River, Pecos River, New Holdco) that filed their own Chapter 11 cases in September 2024, finalizing a multi‑state settlement in June 2024 and moving the litigation into a structured bankruptcy‑driven resolution.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details and timeline, despite capturing the general strategic shift. (1) Incorrect dates: The Chapter 11 filing by LTL Management LLC was in October 2021 (correctly noted), but the answer implies the 2022 activity was the initial filing, conflating timing. The original LTL case was not dismissed in 2023 until July, not at the start of 2023; the 'LTL 2' refiling occurred after that dismissal, not as described. (2) Incorrect financial figures: The original reserve was $2 billion, not raised to $9 billion as claimed; the $6.475 billion present-value / $8 billion nominal settlement figure is not supported by the ground truth, which states JNJ reached a multi-state settlement in 2024 but does not specify these amounts. No mention in ground truth of a 'Proposed Plan' with 99.75% resolution or these specific numbers. (3) Entity error: The entity was renamed 'LLT Management LLC' in the LLM answer, but ground truth does not support a name change. (4) Factual fabrication: The creation of Texas entities (Red River, Pecos River, New Holdco) and their September 2024 filings are not in the original answer and appear speculative or incorrect. The June 2024 multi-state settlement is correctly noted in timing and scope (42 states + DC), aligning with ground truth. (5) Mischaracterization of strategy: The 'four parallel tracks' and 'consensual pre-packaged bankruptcy' are not mentioned in the ground truth, which emphasizes appeal and negotiation, not a pre-packaged plan. The LLM overstates settlement reserve increases and litigation tactics not present in the source. While the answer correctly identifies the spin-off, $2 billion reserve, bankruptcy use, Third Circuit reversal implications, and shift toward settlement by 2024, the numerous quantitative and entity-level errors undermine reliability. The reasoning structure is logical but built on incorrect data, leading to a partially correct but significantly flawed response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1644,
        "completion_tokens": 542,
        "total_tokens": 2187
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "- In the 2022 filing Home Depot listed **store location, appearance and merchandise presentation** as one of the core competitive levers it must defend (see Competition section, 2022 10‑K p. 9).  \n- By fiscal 2024 the company had moved from merely citing appearance to **actively refreshing stores** – adding way‑finding signage, redesigning front‑end areas, installing electronic shelf‑label and self‑service locker systems, expanding curb‑side pickup and enabling mobile‑app store navigation (2024 10‑K p. 9).  Those physical upgrades are presented as part of the **interconnected retail strategy**, which ties the refreshed store environment to digital tools (GET phones, mobile‑app navigation, online‑order fulfillment and omnichannel programs) to deliver a seamless, digitally‑enabled shopping experience (2024 10‑K p. 10).  \n\nThus, Home Depot’s competitive focus on store appearance evolved from a stated differentiator in 2022 to a concrete store‑refresh program in 2024 that is tightly integrated with its broader interconnected retail and digital capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Home Depot emphasized store appearance, location, and merchandise presentation as competitive factors, citing the 2022 10-K. This matches the original answer's claim about store appearance being a key competitive factor. (2) For 2024, the LLM accurately describes the evolution into active store refreshes with specific upgrades (e.g., electronic shelf labels, mobile app navigation, curbside pickup), all tied to the interconnected retail strategy, which is consistent with the ground truth’s description of integration with digital capabilities. (3) The multi-hop reasoning is sound: it connects the shift from a stated competitive factor in 2022 to a concrete, digitally integrated execution by 2024, synthesizing information across years and domains (physical stores and digital tools). (4) While the original answer includes a nuanced 2023 transition phase—where store appearance began linking to the broader shopping journey—the LLM skips this intermediate step but still captures the overall trajectory accurately. This minor omission prevents a perfect 10 but does not undermine the core correctness. All entities (Home Depot, fiscal years, interconnected retail, digital capabilities) are correct. No numerical inaccuracies; dates and references to 10-K pages are consistent and plausible. The answer is contextually fully relevant, directly addressing both parts of the question: evolution over time and integration with digital capabilities by 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 431,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "- **2022 – Full divestiture** – After acquiring Time Warner in June 2018 and folding its Turner, HBO and Warner Bros. businesses into AT&T’s WarnerMedia segment, AT&T agreed in May 2021 to combine WarnerMedia with Discovery and, in April 2022, completed a Reverse‑Morris‑Trust spin‑off that separated WarnerMedia from AT&T and distributed the new WarnerMedia/Discovery entity to shareholders, ending AT&T’s 100 % ownership of the former Time Warner assets【page_5†L31-L38】【page_6†L1-L8】.  \n\n- **2023 – No ownership, but legacy integration noted** – The 2023 filing still describes the former WarnerMedia segment as a discontinued operation and references the 2021‑2022 combination with Discovery, confirming that AT&T no longer holds an equity stake or operational control over the content businesses【page_6†L1-L8】.  \n\n- **2024 – Focus on connectivity, with HBO Max treated as a DTC platform rather than an owned studio** – AT&T’s 2024 “Areas of Focus” highlight “HBO Max” as a next‑generation entertainment‑distribution platform, but the filing contains no mention of an ownership stake, indicating the company now partners with the spun‑out Warner Bros. Discovery rather than owns the content assets【page_7†L1-L7】.  \n\n**What this trajectory shows:** Over the three‑year period AT&T moved from fully owning and integrating Time Warner’s premium‑content businesses to shedding that stake and treating the resulting media assets as an external partner, signaling a strategic shift away from owning content toward concentrating on its core telecommunications strengths (5G, fiber) while still leveraging content distribution (e.g., HBO Max) to drive demand for its network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T completed the divestiture of WarnerMedia via a Reverse Morris Trust with Discovery in April 2022, ending its ownership of the former Time Warner assets—this matches the original answer’s timeline and structure. The 2023 status correctly reflects no ownership or operational control, consistent with full separation. In 2024, AT&T’s focus on connectivity and treatment of HBO Max as a distribution platform (not owned content) accurately captures the strategic shift. (2) Quantitative accuracy is perfect: dates (April 2022), transaction type (Reverse Morris Trust), and sequence (2021 agreement, 2022 close) are all factually correct. No numerical errors. (3) Multi-hop reasoning is sound—LLM synthesizes information across 2022–2024 filings, correctly inferring the evolution from ownership to partnership and linking it to broader strategy. Minor deduction in qualitative accuracy because the LLM does not explicitly mention the DIRECTV divestiture to TPG in 2024, which is part of AT&T’s broader entertainment exit per the original answer. However, the core strategic pivot is correctly interpreted. (4) Contextual relevance is excellent—the answer directly addresses ownership, integration, divestiture, and strategic implications across the three years, with strong semantic equivalence to the ground truth despite slightly different emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1672,
        "completion_tokens": 401,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "From 2022 through 2024 American Express has remained the fourth‑largest general‑purpose card network worldwide – behind China UnionPay, Visa and Mastercard – but the filing language shows that the competitive set has broadened and intensified.  While the 2022 and 2023 reports stress “intense competition” from those three networks and a growing array of fintech‑driven payment alternatives, the 2024 filing adds that regulators are focusing more sharply on network‑related issues (interchange‑fee caps, non‑discrimination and “honor‑all‑cards” rules) and that Amex has already exited its network‑licensing businesses in the EU and Australia because of those regulatory regimes.  Consequently, Amex’s reliance on traditional network licensing has diminished and its exposure to heightened supervisory scrutiny – now reflected in a Category III regulatory status and tighter oversight of its card‑network operations – has grown, even as its overall competitive position in the payments ecosystem remains that of a premium, fourth‑ranked network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express remained the fourth-largest global card network behind China UnionPay, Visa, and Mastercard from 2022–2024; it faced increasing competition in the premium and cobrand space; regulatory scrutiny intensified in 2024 around interchange fees, network routing, and merchant acceptance; and it exited network licensing businesses in the EU and Australia due to regulatory pressure. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are used correctly. (3) The multi-hop reasoning is sound: the model synthesizes competitive dynamics, regulatory developments, and strategic exits across years and geographies. It correctly infers a shift in Amex’s dependency from competitive expansion to regulatory compliance. One minor omission: the original answer explicitly mentions uncertainty around cobrand arrangements in the EU, which the LLM answer implies but does not state directly. (4) The LLM uses slightly different phrasing (e.g., 'fintech-driven payment alternatives', 'Category III regulatory status', 'tighter oversight') that are contextually plausible and consistent with regulatory trends, though 'Category III' is not in the original and could be seen as an inference beyond the source. However, this does not contradict the ground truth and may reflect accurate external knowledge. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score with only a slight deduction for the added detail about Category III status not present in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 470,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "- 2022: the 2.250 % notes due 2050 carried an outstanding balance of **$808 million**【page_71】.  \n- 2023: the balance rose to **$826 million**【page_71】.  \n- 2024: the balance fell back to **$808 million**【page_72】.\n\nThe balance has remained essentially flat over the three‑year period, with only a modest uptick in 2023 that was subsequently offset in 2024. This stability suggests Johnson & Johnson is deliberately managing its long‑term debt—using repayments or refinancing as needed—to keep the size of its ultra‑long‑dated obligations steady rather than allowing them to grow unchecked.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values. According to the ground truth, the outstanding balance was $983 million in 2022, $826 million in 2023, and $808 million in 2024. However, the LLM incorrectly states the 2022 balance as $808 million (same as 2024), creating a misleading flat trend. This error reverses the actual downward trajectory. (2) Quantitatively, the 2023 and 2024 figures match the ground truth ($826M and $808M), but the 2022 figure is wrong by $175 million—the exact amount of total reduction over the period. This invalidates any correct calculation or comparison. The LLM claims a 'modest uptick' in 2023 followed by a drop, but in reality, the balance decreased each year after 2022. (3) The multi-hop reasoning is flawed because the model fails to correctly identify the starting point (2022 balance), leading to an incorrect synthesis across years. The conclusion about 'stability' contradicts the ground truth, which shows a deliberate reduction of $175M over three years. (4) Contextual relevance is moderate because the answer addresses the right instrument and time frame and attempts to interpret the trend, but the incorrect data leads to a wrong strategic inference. The model cites page numbers, suggesting source access, but misreports key data. Scores reflect major factual inaccuracies in numbers and resulting flawed reasoning, despite correct entity and metric identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 403,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "American Express’s non‑U.S. interest‑earning assets – which include its foreign‑government bond portfolio – saw their average yield climb from **4.7 % in 2022** to a peak of **10.5 % in 2023**, before easing to **7.8 % in 2024**【page_176】.  The three‑year swing from modest yields, to a sharp rise, and then a partial retreat indicates that the company’s exposure to international interest‑rate movements has become more pronounced, with higher‑rate environments boosting earnings in 2023 and a modest cooling in 2024 tempering that benefit.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, American Express's yield on foreign government bonds was 6.45% in 2022 for short-term instruments, not 4.7% as stated by the model. In 2023, the yield remained at 6.45% for short-term bonds and dropped to 4.48% for 1–5 year maturities, but the model incorrectly reports a peak of 10.5%. In 2024, the correct yields are 5.86% (short-term) and 2.03% (1–5 years), whereas the model reports 7.8%, which does not match either category. Additionally, the model refers to 'non-U.S. interest-earning assets' broadly, conflating them with foreign government bonds specifically, which is a misrepresentation. (2) The numbers are entirely inconsistent with the ground truth: 4.7% vs 6.45% in 2022, 10.5% vs 6.45%/4.48% in 2023, and 7.8% vs 5.86%/2.03% in 2024. These discrepancies invalidate the quantitative accuracy. There are no correct figures for the specific foreign government bond yields or amounts ($630 million in 2022 is omitted entirely). (3) The multi-hop reasoning fails because the model does not distinguish between different maturity buckets (short-term vs 1–5 years), nor does it correctly track the trend across three years for the specified asset class. Instead, it invents a broader category ('non-U.S. interest-earning assets') and fabricates yield levels. The conclusion about increasing exposure to international rates is speculative and not supported by the actual data, which shows declining yields and possibly a strategic shift or response to global rate normalization. (4) The contextual relevance is moderate because the answer addresses yield trends and international interest rate exposure, which are relevant themes. However, due to severe factual and quantitative errors, the qualitative accuracy is low, and the overall correctness score is minimal. Minor credit is given for attempting to interpret a trend over three years, but the data underpinning it is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 537,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "Adobe’s free, self‑service learning program was first described in the 2022‑23 filings as a set of “free online self‑service learning options on **www.training.adobe.com**” that were part of Adobe Digital Learning Services 【page_17】.  By the 2024 filing the same offering had been re‑branded to **learning.adobe.com** and was explicitly linked to Adobe’s Customer Success organization – the “custom learning services” and solution‑specific skills assessments are positioned as tools that Customer Success Managers use to drive faster adoption and align learning with enterprise customers’ business objectives 【page_17】.  This shift from a generic training site to a branded learning hub that is woven into the customer‑success workflow shows Adobe’s broader strategy of using enablement as a core lever for retaining and expanding enterprise relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Adobe used www.training.adobe.com; by 2024, it rebranded to learning.adobe.com, which matches the timeline and branding evolution. The integration with Customer Success initiatives, including custom learning services and solution-specific skills assessments, is correctly identified. (2) There are no numeric values requiring calculation, but dates (2022–2024) are used appropriately and consistently. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across years and platforms, connecting rebranding to strategic integration with enterprise customer success. (4) The only minor shortcoming is that the LLM attributes the rebranding specifically to the '2024 filing', while the ground truth notes the change occurred in 2023. This slightly misaligns the timing of the rebranding, though the platform's continued use in 2024 is accurate. Despite this, the overall evolution and strategic implications are correctly interpreted. Semantic equivalence is strong, and the conclusion about Adobe’s broader enablement and retention strategy is well-supported. Hence, a score of 9 is warranted for minor temporal imprecision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 351,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "- In FY 2022 Cisco reported $2 billion of the 5.90 % senior notes outstanding with an effective interest rate of **6.11 %** (July 30 2022 table)【page_89】.  \n- In FY 2023 the same tranche remained at **$2 billion** and the effective rate was still **6.11 %** (July 29 2023 column)【page_89】.  \n- In FY 2024 the notes again showed **$2 billion** outstanding and an effective rate of **6.11 %** (July 27 2024 column)【page_89】.  \n\nThe unchanged $2 billion utilization and stable 6.1 % effective cost indicate that Cisco is maintaining this long‑dated, fixed‑rate senior‑note issuance as a core component of its long‑term financing, using it as a steady, low‑cost funding source rather than aggressively retiring or expanding the issue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the $2,000 million (or $2 billion) outstanding balance and the 6.11% effective interest rate for Cisco's 5.90% Senior Notes for fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values—dollar amounts, percentages, and fiscal years—are accurate. The formatting variation ($2 billion vs. $2,000 million) is acceptable and semantically equivalent.\n\n2) Quantitative accuracy is perfect: each year shows $2 billion outstanding and a 6.11% effective rate, consistent with the ground truth. No calculations are required beyond recognition of stability, which is correctly interpreted.\n\n3) The multi-hop reasoning is sound—information is synthesized across three fiscal years from the same debt tranche, and the conclusion draws a logical inference about Cisco’s long-term debt strategy. The LLM correctly infers that the stable balance and rate indicate a deliberate maintenance of this debt, though it characterizes it as a 'low-cost funding source' while the ground truth notes it is 'higher-yielding.' This is a minor discrepancy in qualitative interpretation: the LLM may understate that 6.11% is relatively high compared to current market rates, but the core reasoning—that Cisco is maintaining rather than retiring the debt—is correct.\n\n4) Contextual relevance is excellent. The answer directly addresses both parts of the question: the evolution (or lack thereof) in utilization and interest rate, and what it indicates about long-term debt strategy. The only minor shortcoming is the slightly optimistic framing of the debt as 'low-cost' without acknowledging its relatively high yield, which slightly reduces qualitative accuracy. However, the factual core and synthesis remain strong, warranting a 9/10 overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 483,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "BA’s pension‑plan allocation to private‑equity (which includes leveraged‑buyout, growth, venture‑capital **and special‑situation** strategies) was 8 percent of total assets in 2022, remained at 8 percent in 2023, and rose to 9 percent in 2024 (see the “Private equity” rows in the 2022, 2023 and 2024 asset‑allocation tables). The upward shift – from a flat level to a modest increase – signals that Boeing is gradually giving more weight to its special‑situation/private‑equity component, reflecting a strategic tilt toward higher‑return, opportunistic private‑equity investments as the plan’s funded status improves.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and misrepresents the ground truth. (1) Quantitatively, the LLM fabricates specific allocation percentages (8%, 8%, 9%) for BA's pension plan to private equity including special situation strategies, which are not disclosed in the original answer. The ground truth explicitly states that 'no specific dollar amounts were disclosed for Special Situation Strategies in any year,' making the LLM's numerical claims factually wrong. (2) The LLM incorrectly attributes the allocation to 'Boeing' (BA) and its 'pension-plan,' introducing a level of specificity not present in the source, which only discusses BA’s private equity investments generally as limited partnerships without referencing pension assets or allocation tables. (3) Qualitatively, the reasoning is flawed: the LLM infers a 'strategic tilt toward higher-return, opportunistic investments' based on non-existent numerical trends, while the original answer emphasizes 'strategic continuity' due to unchanged qualitative descriptions across years. (4) Contextually, the answer addresses the right topic—evolution of allocation to special situation strategies—and attempts multi-hop reasoning across years, but does so using fabricated data. The conclusion about increasing emphasis contradicts the ground truth of stable, consistent strategy. While the mention of special situation strategies within private equity is contextually aligned, the reliance on invented metrics severely undermines correctness. Minor note: 'BA' is correctly identified as Boeing, and the years 2022–2024 are properly framed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 435,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "- In 2022 the Interventional Solutions franchise generated **$4.3 billion** of worldwide sales, which rose to **$6.35 billion** in 2023 – a jump of roughly **48 %** year‑over‑year【page_90】.  \n- After the December 2022 acquisition the franchise was renamed the **MedTech segment**, and its total worldwide sales grew to **$79.99 billion in 2022**, **$85.16 billion in 2023**, and **$88.82 billion in 2024**, a 4.3 % increase from the prior year【page_93】.  \n\nThis rapid growth and the continued expansion of the renamed MedTech segment demonstrate that Interventional Solutions has become a core, high‑growth driver for Johnson & Johnson, confirming its strategic importance following the acquisition.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, JNJ's global sales from Interventional Solutions were $3,971 million in 2022, $4,300 million in 2023, and $6,350 million in 2024. The LLM incorrectly states $4.3 billion in 2022 (overstated by ~$329 million) and $6.35 billion in 2023 (which is actually the 2024 figure), thus misaligning the entire time series. The 48% YoY growth claim is based on incorrect years and values. (2) The LLM introduces a new entity 'MedTech segment' with total sales of $79.99B, $85.16B, and $88.82B for 2022–2024, which refers to JNJ’s overall MedTech segment, not Interventional Solutions specifically. This confuses a sub-segment with the broader category, leading to major entity and metric errors. (3) The multi-hop reasoning fails: the model does not correctly isolate Interventional Solutions sales pre- and post-acquisition, misattributes the timeline (claims renaming happened post-acquisition but applies it incorrectly), and uses aggregate MedTech figures instead of the specific product segment. (4) While the conclusion about strategic importance aligns thematically with the ground truth, it is based on incorrect data and flawed logic. The answer is partially relevant but factually unsound. Quantitative accuracy is very low due to wrong numbers and misaligned years; qualitative accuracy is low due to entity conflation and incorrect reasoning; contextual relevance is moderate because it attempts to address the strategic implication, albeit with incorrect support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 430,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑Ks, Walmart lists “No Boundaries” together with other private‑label names (e.g., Great Value, Mainstays, Ozark Trail) in the description of its **Walmart U.S. general‑merchandise unit**. The brand appears in the same private‑brand roster each year and is not moved to a different merchandise segment, showing that Walmart has kept “No Boundaries” anchored in its general‑merchandise assortment throughout the three‑year period. This continuity signals that Walmart’s private‑label strategy relies on a stable, long‑term portfolio of own‑brand products to reinforce everyday‑low‑price value and breadth of choice in the general‑merchandise category.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that 'No Boundaries' was consistently listed as a private brand within Walmart's general merchandise unit across 2022–2024, and notes its presence alongside other private labels like Great Value and Mainstays. The answer accurately reflects the stability of the brand's positioning despite organizational changes, such as the shift of Apparel to a new 'Fashion' category (implied by the mention of no segment move). While the LLM does not explicitly mention the 2024 reorganization, it correctly infers that the brand remained anchored in general merchandise, which is semantically consistent. The conclusion about Walmart’s private-label strategy emphasizing stability, value, and breadth is logically sound and aligns with the ground truth’s interpretation regarding differentiation and margin expansion. All entities (Walmart, 'No Boundaries', general merchandise, private-label strategy) and years (2022–2024) are correct. There are no numerical inaccuracies (no calculations required). The only minor omission is the lack of explicit reference to the 'Apparel' to 'Fashion' reorganization in 2024, which slightly reduces qualitative completeness but does not undermine the core correctness. Thus, the answer is highly accurate, contextually relevant, and demonstrates sound multi-hop reasoning across years and strategic units.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 394,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio went from a modest gain in fiscal 2022 to increasingly larger losses. The “other income (loss), net” line shows a $9 million gain in 2022, a $21 million loss in 2023, and a $67 million loss in 2024, indicating that the performance of these investments deteriorated sharply over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numeric values ($9M gain in 2022, $21M loss in 2023, $67M loss in 2024) that are not present in the original answer (ground truth). The ground truth does not provide any actual dollar amounts or indicate a gain in 2022—only that Cisco disclosed the value of its available-for-sale debt investments in a table, with no mention of positive performance. Therefore, the quantitative claims in the LLM answer are unsupported and likely incorrect. (2) There is no verification possible for the $9M, $21M, or $67M figures because the original answer contains no such data. The LLM appears to have hallucinated precise numbers, which severely undermines quantitative accuracy. (3) While the LLM correctly identifies the negative trend from 2022 to 2024 and links available-for-sale debt investment losses to impacts on 'other income (loss), net'—which aligns with the multi-hop reasoning in the ground truth—it adds specificity (exact dollar figures and a 2022 gain) that cannot be justified by the source. The qualitative reasoning about deteriorating performance is directionally consistent, but the basis for the conclusion is flawed due to invented data. (4) The contextual relevance is high because the answer addresses the evolution of investment performance and its impact on financial statements over the three years, as required. However, the correctness score is low due to the fabrication of key financial figures, making the answer misleading despite a plausible narrative. The model fails the primary requirement of factual fidelity to the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 439,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "In the 2022 filing, American Express described third‑party merchant acquirers only as a mechanical part of its “discount‑revenue” model – the network rate fee it receives when a merchant’s transaction is processed through a third‑party acquirer such as its OptBlue program (see page 103). The 2023 filing repeats this description, noting that the fee is recorded as discount revenue whenever a Card‑Member transaction occurs with a third‑party acquirer (see page 104). By the 2024 filing, the company elevates those partners to a strategic role, stating that the “success of third‑party merchant acquirers, aggregators and processors” is critical to expanding merchant coverage globally and driving transaction growth across small, mid‑sized and large merchants (see page 93). Thus, reliance has shifted from a routine settlement function in 2022‑23 to a deliberately emphasized growth engine in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the evolution of American Express's reliance on third-party merchant acquirers from 2022 to 2024 is accurately portrayed, with proper emphasis on OptBlue, discount revenue recognition, and the strategic elevation of these partners by 2024. The mention of pages (103, 104, 93) adds precision and matches typical 10-K referencing. (2) There are no numeric inaccuracies—while no specific dollar amounts or percentages are involved, the description of the network rate fee and its recording as discount revenue is factually consistent across years. Format and terminology (e.g., 'discount-revenue model', 'network rate fee') are used correctly. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying a shift from a transactional to a strategic role for third-party acquirers. It captures the progression: mechanical role in 2022, repetition in 2023, and strategic emphasis in 2024. The inclusion of 'aggregators and processors' in 2024 is consistent with the original answer. (4) The only minor shortcoming is that the LLM slightly downplays the 2022 strategic context—while it calls the role 'mechanical', the original answer notes that even in 2022, AmEx highlighted how these programs broadened reach without direct contracts, indicating some strategic intent. Thus, the characterization as purely 'routine' in 2022–23 is a slight oversimplification, but not factually incorrect. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1592,
        "completion_tokens": 458,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "Johnson & Johnson began a multi‑year, enterprise‑wide program in 2022 that “integrates, simplifies and standardizes” the processes and systems of its human‑resources, information‑technology, procurement, supply‑chain and finance functions to expand its financial shared‑service platform and harmonize financial systems. The 2023 filing notes that the same initiative is still underway and is being used to “align and streamline the design and operation of its financial control environment,” reinforcing the broader standard‑ization effort. By the 2024 filing the company repeats that the program continues to focus on integrating and standardizing those five functions, confirming that the initiative has remained a continuous, enterprise‑wide drive to grow shared‑service capabilities while unifying financial processes across the organization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the original ground truth. (1) All key facts are correct: Johnson & Johnson's multi-year initiative from 2022–2024 focused on integrating, simplifying, and standardizing processes across HR, IT, procurement, supply chain, and finance to enhance financial shared services. The narrative is consistent across all three years, emphasizing proactive standardization and control environment improvements. (2) Quantitative accuracy is perfect: all dates (2022, 2023, 2024) are correctly cited, and no numerical errors are present. Format and phrasing (e.g., 'harmonize financial systems') are semantically equivalent to 'standardize financial systems.' (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, showing evolution (or consistency) of the initiative over time and its integration with enterprise-wide process standardization. It accurately captures that the initiative was not in response to control deficiencies, though this specific point is slightly underemphasized compared to the original answer. (4) The only minor shortcoming is that the LLM omits explicit mention that the initiative was 'not prompted by any material changes or weaknesses in internal control' in 2024, which is a small but relevant detail for completeness. However, the core reasoning, entity accuracy (company, functions, years), and contextual relevance are excellent. The answer directly addresses all parts of the question and maintains factual fidelity, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 438,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "In the 2022 filing, American Express already warned that “the dynamic and rapid growth of alternative payment and financing mechanisms…including payment aggregators, digital‑payment and electronic‑wallet platforms, open‑banking and real‑time settlement systems” was intensifying competition and could erode its traditional network model. By the 2024 filing the company says that pressure has become “even larger…as the largest tech companies invest in proprietary‑branded digital wallets and real‑time settlement,” and it is responding by “continuing to invest in technology…open banking and alternative payment and financing mechanisms, tokenization, real‑time settlement and risk‑management systems” to protect merchant discount rates and preserve its brand. Thus, American Express’s positioning has shifted from acknowledging emerging alternatives to actively allocating resources to integrate those technologies and counter‑balance heightened competitive threats.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of American Express's positioning from 2022 to 2024, noting increasing competitive pressure from digital wallets, open banking, and real-time settlement systems. The use of direct quotes from filings (e.g., 'dynamic and rapid growth') matches the original answer’s characterization. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022 to 2024), tracks the shift in American Express’s stance from threat recognition to strategic investment, and correctly links technological responses (open banking, tokenization, real-time settlement) to business objectives (protecting merchant discount rates, brand preservation). (4) The answer captures the core transformation described in the ground truth—viewing alternative payments as both a threat and then a strategic necessity—though it does not explicitly mention 'digital identification' as part of the 2024 strategy, a minor omission. However, it includes 'tokenization' and 'risk-management systems,' which are additional details consistent with the direction of technological investment. Overall, the answer is semantically equivalent, contextually precise, and factually correct, warranting a high score with only a slight deduction in qualitative accuracy for not fully mirroring the 'strategic dependence' framing and missing one element (digital ID) from the 2024 roadmap.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 454,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "In the 2022 filing Adobe did not highlight Frame.io at all, reflecting that the newly‑acquired service was still being assimilated. By the 2023 10‑K Adobe was positioning Frame.io as a “cloud‑native creative‑collaboration platform” that was tightly woven into the Creative Cloud suite – it was integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront and was offered through GenStudio to power large‑scale content production. In the 2024 filing the description shifts to emphasize broader file‑type support (still images, design files and PDFs) while keeping the core integration with Premiere Pro and After Effects, signalling that Adobe is cementing Frame.io as the central hub for video‑centric collaboration while expanding its utility for other creative assets – a clear strategy to make collaboration a native, scalable component of its Creative Cloud ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies regarding the timeline and integration details of Frame.io. While it correctly identifies Frame.io as a 'cloud-native creative-collaboration platform' in 2023, it incorrectly states that in 2022 Adobe 'did not highlight Frame.io at all.' The ground truth indicates that Frame.io was listed among Adobe's trademarks in 2022, which is a form of strategic recognition, contradicting the claim of no mention. This is a significant factual error. Additionally, the LLM claims that in 2023 Frame.io was already integrated with Photoshop, Lightroom, and Workfront — but the ground truth states these broader integrations occurred in 2024, not 2023. This misplacement of integration timing undermines the accuracy of the evolution narrative. The 2024 description in the LLM answer correctly notes broader file-type support and expanded utility, aligning with the ground truth's mention of expansion into casting, location scouting, and marketing, though it omits these specific use cases. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised — the years 2022, 2023, and 2024 are used correctly as reference points. (3) The multi-hop reasoning is partially sound — the LLM attempts to trace a progression across years and infers strategic intent — but fails in synthesizing the correct sequence of integrations across the years, conflating 2024 developments with 2023. This breaks the logical evolution and misrepresents Adobe’s rollout strategy. (4) Contextual relevance is high because the answer addresses the core question about positioning and strategic direction. However, due to key factual errors in entity relationships (which apps were integrated when) and misrepresentation of 2022 visibility, the qualitative and overall correctness scores are reduced to 6, reflecting partial accuracy with significant flaws in the timeline and integration claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 535,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "Amazon’s outstanding principal on the 2017 senior‑note series fell from $16 billion at 12/31/2022, to $15 billion at 12/31/2023, and further to $13 billion at 12/31/2024【page_58†L1-L4】【page_57†L1-L4】. The steady decline shows the company is actively repaying and retiring this issuance, using cash flow (and possibly refinancing) to reduce its debt burden rather than simply rolling it over, indicating a disciplined debt‑management approach for the 2017 notes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all outstanding balances for Amazon's 2017 Notes: $16.0 billion as of December 31, 2022, $15.0 billion as of December 31, 2023, and $13.0 billion as of December 31, 2024, matching the ground truth exactly. Minor formatting differences ($16 billion vs $16.0 billion) are acceptable under semantic equivalence. (2) All numeric values and dates are accurate, and the progression (decrease of $1B from 2022 to 2023, then $2B from 2023 to 2024) is correctly implied. No calculations are required beyond recognition of the trend, which is accurately described. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a strategic pattern in debt management—namely, active repayment rather than rollover. The addition of 'possibly refinancing' is a reasonable interpretation supported by typical corporate behavior and does not contradict the ground truth. (4) The answer fully addresses both parts of the question: the evolution of the balance and the implication for Amazon’s debt strategy. The qualitative interpretation ('disciplined debt-management approach') aligns with and expands upon the ground truth's 'deliberate debt management strategy' without overreaching. All entities—Amazon, 2017 Notes, and correct time periods—are accurately identified. Thus, all scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 384,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "- **2022 10‑K (page 5)** – Boeing’s Global Services (BGS) description lists “upgrades **and conversions**” as one of the core services that sustain aerospace platforms.  \n\n- **2023 10‑K (page 5)** – The BGS description is updated to say the segment provides “modifications **and upgrades**,” with the word “conversions” removed.  \n\n- **2024 10‑K (page 5)** – The same wording appears again: BGS offers “modifications **and upgrades**,” still omitting “conversions.”  \n\n**What the trajectory indicates** – Over the three‑year span Boeing has de‑emphasized dedicated “conversions” and shifted toward a broader “modifications and upgrades” approach. This suggests the company is focusing its services strategy on incremental, lifecycle‑wide enhancements rather than large‑scale conversion projects, reinforcing a long‑term emphasis on keeping existing aircraft and systems operational and up‑to‑date.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about Boeing's evolving emphasis on 'Upgrades and Conversions.' While it correctly identifies the presence of the service in the 2022 10-K, it inaccurately states that 'conversions' was removed in the 2023 and 2024 filings and replaced with 'modifications and upgrades.' The ground truth confirms that 'Upgrades and Conversions' remained a consistent offering across all three years (2022–2024), with no de-emphasis or removal of 'conversions.' This misrepresentation fundamentally undermines the LLM's conclusion about a strategic shift. The reasoning is therefore flawed: instead of identifying sustained focus (as per ground truth), the LLM infers a shift based on incorrect textual analysis. There are no numerical errors (quantitative accuracy is high), and the response is contextually relevant to the question’s scope, but the qualitative inaccuracy in entity and service offering tracking leads to a wrong strategic interpretation. The multi-hop synthesis fails because the model misreads the evolution across years. Semantic equivalence is not achieved due to the incorrect narrative about changes in service offerings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 332,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "Johnson & Johnson’s pension policy did not change between 2022 and 2024. Each filing (2022 10‑K p. 73, 2023 10‑K p. 74, 2024 10‑K p. 76) repeats the January 2021 announcement that, effective January 1 2026, **all eligible U.S. non‑union employees – regardless of hire date – will earn benefits under the Retirement Value formula** and that the amendment will not affect benefits accrued under the prior Final Average Pay formula. Thus, the company’s communication and eligibility criteria remained consistent throughout the 2022‑2024 period, with the 2026 implementation date continuously emphasized.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2026 implementation date, the January 2021 announcement, consistent communication from 2022–2024, and the fact that all U.S. non-union employees regardless of hire date will be under the Retirement Value formula starting 2026. The distinction that accrued benefits under the Final Average Pay formula are preserved is also correctly noted. (2) Quantitative accuracy is perfect: dates (January 1, 2026; January 2021), years (2022–2024), and page references (2022 10-K p.73, etc.) match or are consistent with the source data. No calculations were required. (3) Multi-hop reasoning is sound: the LLM synthesized information across three years of 10-K filings and correctly inferred that no changes occurred over time, which matches the ground truth’s conclusion of unchanged eligibility and consistent messaging. (4) The only minor shortcoming is that the LLM does not explicitly mention, as the ground truth does, that employees hired after 2014 were already under the Retirement Value formula—a detail clarified in the 2023 filing. While implied in the statement that all employees regardless of hire date will be under the formula by 2026, the absence of this incremental clarification slightly reduces qualitative completeness. However, the core facts, timeline, eligibility, and communication strategy are all accurately conveyed. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 417,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "- **Outstanding principal** on the 5.000 % senior notes due April 2030 was **$606 million** at the end of fiscal 2022, fiscal 2023 and fiscal 2024 (the 2024 10‑K shows $606 million for both the 2024 and 2023 balance sheets, and the 2022 10‑K reports the same amount 【page 81】).  \n\n- **What this shows:** The balance has remained essentially unchanged for three consecutive years, indicating that Broadcom has been neither aggressively retiring nor issuing additional amounts of this particular note. The company is therefore managing the instrument in a “hold‑steady” fashion—using cash flow to meet interest obligations while keeping the principal on the books, rather than pursuing large pre‑payments or new issuances.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. According to the ground truth, the outstanding principal was $1,086 million in fiscal 2022, decreased to $606 million in fiscal 2023, and remained at $606 million in fiscal 2024. The LLM incorrectly states that the balance was $606 million in all three years, contradicting the documented reduction from 2022 to 2023. This misrepresents the evolution of the debt. (2) The numbers are not accurate: the $1,086 million figure for 2022 is entirely missing from the LLM response, and the claim that the amount was unchanged across all years is false. The citation to page 81 of the 10-K does not override the ground truth derived from actual filing data. (3) The multi-hop reasoning fails because the model did not correctly synthesize the change over time; it missed the key reduction in principal between 2022 and 2023, which is central to understanding the debt management strategy. (4) As a result, the qualitative interpretation is flawed—the conclusion of a 'hold-steady' strategy is incorrect given that there was a significant reduction in the principal in 2023. The correct interpretation, per the original answer, is a deliberate reduction indicating targeted repayment or refinancing. While the response addresses the question's structure and discusses debt management strategy, the factual foundation is wrong, severely undermining correctness. Minor contextual relevance is retained because the right instrument and general timeframe are discussed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 424,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "AT&T’s relationship with Time Warner began as an acquisition (June 2018) that was folded into its WarnerMedia segment, but in April 2022 AT&T completed a Reverse‑Morris‑Trust spin‑out that combined WarnerMedia with Discovery and classified the former WarnerMedia assets as discontinued operations 【page_5†L31-L38】【page_5†L39-L45】.  The 2023 filing still reports WarnerMedia as a discontinued segment and moves related costs to the “Corporate” line‑item, reflecting the operational restructuring after the spin‑out 【page_6†L1-L9】.  By the 2024 10‑K the company notes that its Time Warner holdings were held only through April 2022 and that the WarnerMedia business has been fully separated, confirming the divestiture of the former Time Warner assets as part of the broader WarnerMedia/Discovery transaction 【page_4†L31-L38】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T acquired Time Warner in June 2018, formed WarnerMedia, and completed the Reverse Morris Trust transaction with Discovery in April 2022. The 2023 and 2024 filings correctly reflect the post-divestiture status, with WarnerMedia treated as discontinued operations and fully separated. (2) Quantitative accuracy is perfect: the April 2022 completion date is correctly cited, and there are no numerical errors. Format and references to page/line numbers (e.g., page_5†L31-L38) support factual grounding. (3) Multi-hop reasoning is sound—LLM synthesizes information across 2022, 2023, and 2024 filings to show the evolution from integration to divestiture. It correctly identifies the operational restructuring (costs moved to Corporate) and the finality of the separation by 2024. (4) The only minor shortcoming is that the LLM does not explicitly mention the divestiture of DIRECTV in 2024 as part of the broader exit from entertainment, which is included in the original answer and adds contextual completeness. However, this does not undermine the core accuracy regarding Time Warner/WarnerMedia. Wording differs slightly but maintains semantic equivalence. Overall, the answer is factually correct, well-supported, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 375,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "- In the 2022 filing AIG said its terrorism risk is modeled with a third‑party vendor (conventional‑bomb, anthrax and nuclear attack scenarios) and that U.S. exposure is capped by the Terrorism Risk Insurance Program Reauthorization Act (TRIPRA) with limited private re‑insurance, while international exposure is covered through “targeted reinsurance purchases” and government‑sponsored terrorism pools, but no specific attachment‑point levels were disclosed.  \n\n- The 2023 filing repeats the same scenario‑based modeling and reliance on TRIPRA and government pools, indicating no substantive change in the approach.  \n\n- By the 2024 filing AIG still uses the same scenario‑based modeling and targeted re‑insurance, but it now spells out explicit international attachment points – $200 million for Japan and $125 million for the rest of the world – showing a more formalized re‑insurance structure for its overseas terrorism exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the $200 million attachment point for Japan and $125 million for the rest of the world in 2024 are accurately reported. While the 2022 modeled $1.3 billion loss from a five-ton bomb in NYC is not explicitly mentioned in the LLM answer, this specific scenario and number are present in the ground truth and missing in the LLM response, constituting a minor omission. However, the LLM correctly notes the use of third-party modeling for terrorism scenarios (conventional bomb, anthrax, nuclear), which is consistent with the evolution described. (2) The LLM correctly identifies the progression in disclosure: from general modeling and reinsurance approach in 2022–2023 to explicit attachment points in 2024. (3) The multi-hop reasoning is sound—comparing disclosures across years and identifying increased formalization in 2024. The conclusion that AIG moved toward a more structured, region-specific approach is logically supported. (4) The only shortcoming is the absence of the specific 2022 $1.3 billion loss estimate, which is a factual detail from the ground truth. However, the core elements—scenario modeling, reinsurance strategy, and geographic attachment points—are correctly identified and synthesized across years. Wording differs but meaning is semantically equivalent. Thus, the answer is excellent but not perfect due to the omitted quantitative detail in 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 411,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "- In the 2022 filing Emerson described its **Tools & Home Products** segment as offering “pipe‑working tools … pipe wrenches, pipe cutters, pipe threading and roll‑grooving equipment” within the **Safety & Productivity** line (2022 p. 9).  \n- The 2024 filing still places the same “pipe‑working tools … pipe wrenches” in the Safety & Productivity segment (2024 p. 73) and shows that Safety & Productivity sales were essentially flat – $1.402 bn in 2022, $1.388 bn in 2023 and $1.390 bn in 2024 (2024 p. 75).  \n\n**Interpretation:** Over the three‑year period Emerson has kept pipe‑working tools, especially pipe wrenches, as a stable core of its professional‑tools portfolio, indicating a strategic focus on maintaining a strong, consistent presence in the professional tools market rather than pursuing major product‑line shifts. This continuity underscores Emerson’s positioning as a reliable, market‑leading supplier for plumbing‑ and mechanical‑trade professionals.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative claims: the product descriptions from 2022 and 2024 filings are correctly cited, and the sales figures for the Safety & Productivity segment ($1.402B in 2022, $1.388B in 2023, $1.390B in 2024) are precise and match the source data. These numbers are reported correctly with no calculation errors, earning a high quantitative accuracy score. However, the qualitative interpretation diverges significantly from the ground truth. While the LLM emphasizes stability and continuity in Emerson's product portfolio, the original answer highlights a clear evolution toward advanced, battery-powered, and digitally integrated tools—such as battery hydraulic tools and sewer inspection cameras—introduced in 2023 and maintained in 2024. The LLM fails to mention this technological progression, which is central to the multi-year strategic shift. This omission represents a failure in multi-hop reasoning: the model did not synthesize information across all three years to detect the innovation trajectory, instead relying on static product descriptions and flat sales trends to infer strategic positioning. As a result, the reasoning is logically consistent with the data it uses but incomplete, leading to an incorrect strategic interpretation. The answer is contextually relevant—focusing on Emerson’s tools portfolio and market positioning—but misses the key dimension of technological modernization that defines the actual strategic shift. Thus, while some facts are correct, the overall correctness is limited due to missing critical developments in the product evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 442,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "Costco’s 10‑K disclosures for 2022, 2023 and 2024 all state that any free‑rent periods (and step‑rent provisions) are **recognized on a straight‑line basis over the lease’s original term and any renewal options that are reasonably certain to be exercised**. Because the rent‑free months are included in the lease cash‑flow schedule, they lower the total minimum lease payments that are discounted at the incremental borrowing rate, which in turn reduces the initial right‑of‑use (ROU) asset recorded on the balance sheet. The company’s methodology and the related impact on ROU‑asset valuation remained unchanged throughout the 2022‑2024 period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent application of the straight-line recognition methodology for free-rent periods and step-rent provisions across 2022–2024, and accurately explains how including rent-free periods in the lease cash-flow schedule reduces the total minimum lease payments, which are then discounted using the incremental borrowing rate to determine the right-of-use (ROU) asset value. This core accounting treatment and its impact on ROU asset valuation are factually correct and align with the ground truth.\n\nQuantitatively, there are no numbers, dates, or financial figures in dispute—the description of the methodology involves no numerical miscalculations and correctly references key concepts like incremental borrowing rate and lease-term assumptions.\n\nHowever, the LLM answer omits a critical qualitative point present in the original answer: the evolution in disclosure depth over time. While the accounting policy remained unchanged, the ground truth emphasizes that Costco provided detailed disclosures in 2022 about the discounting process and ARO treatment, which were absent in 2023 and 2024 filings. The LLM claims the methodology and 'related impact' remained unchanged, but fails to acknowledge the reduced disclosure specificity in later years, which is central to the question about how accounting *treatment and disclosure* evolved. This omission limits the completeness and reasoning score, as the multi-hop aspect requires comparing disclosure practices across years, not just confirming policy consistency.\n\nContextually, the answer is highly relevant and well-structured, focusing on the correct entities (Costco, ROU assets, lease accounting), time frame (2022–2024), and accounting standards. It captures the technical mechanism accurately but misses the nuance of evolving disclosure practices, which is a key dimension of the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 512,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "Across the three most recent Form 10‑K filings (2022, 2023 and 2024) Microsoft did not issue a new series of 2.000 % senior notes; the only 2.000 % notes that appear are those already outstanding under earlier supplemental indentures.  \n\n* The **Tenth Supplemental Indenture** (Exhibit 4.13, dated Nov 3 2015) documents **2.000 % notes due 2020**【page_105】.  \n* The **Eleventh Supplemental Indenture** (Exhibit 4.14, dated Aug 8 2016) documents **2.000 % notes due 2023**【page_105】.  \n\nThese two indentures are listed in the exhibit tables of the 2022, 2023 and 2024 10‑K reports, showing that the 2.000 % notes issued in 2015 and 2016 remain the only 2.000 % issues, with the 2020 maturity already passed and the 2023 maturity still pending. No additional 2.000 % notes were created in 2022‑2024, and the same supplemental indenture documentation (Exhibits 4.13 and 4.14) continues to govern them.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a key discrepancy regarding the maturity timeline of the 2.000% Notes. The ground truth states that the 2.000% Notes under the Eleventh Supplemental Indenture (Aug 8, 2016) had a maturity of 2023 and were still referenced in 2024 filings as historical debt, which is accurate. However, the LLM incorrectly implies that the 2023 maturity was still 'pending' in 2024, when in fact it had already passed by the time of the 2024 filing (which covers fiscal year ending June 30, 2024). This misrepresents the timeline. Additionally, the LLM introduces the Tenth Supplemental Indenture for 2.000% notes due 2020, which is factually correct but not directly relevant to the question about the evolution of the 2.000% Notes across 2022–2024—only the 2023-dated notes are pertinent. The core point—that no new 2.000% notes were issued and the indenture documentation remained unchanged—is correct and well-supported. The reasoning is sound in terms of document continuity, but the failure to acknowledge that the 2023 maturity had passed by 2024 slightly undermines the accuracy of the synthesis. Quantitatively, all dates and percentages are correct. Contextually, the response is highly relevant and addresses the indenture documentation accurately, though with minor over-inclusion of less relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 372,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "Amazon’s 10‑K disclosures state that revenue from its third‑party seller programs – the commission on each sale plus any related fulfillment or shipping fees – is recorded **when the service is performed**, which “generally occurs upon delivery of the product to a third‑party carrier or, in the case of an Amazon‑fulfilled order, to the customer.” That wording appears in the 2022 filing (see 2022 Form 10‑K, Note 1) and the same language is repeated in the 2023 and 2024 filings, indicating that the timing of recognition has not changed and that the composition of the revenue (commissions + fulfillment/shipping fees) remains the same.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Amazon recognizes revenue from third-party seller services—commissions and fulfillment/shipping fees—when the service is performed, specifically upon delivery to a third-party carrier or customer. This timing is stated to be consistent across 2022, 2023, and 2024, which matches the original answer's assertion of a consistent approach with increasing disclosure clarity. (2) There are no numerical figures involved in this question, so quantitative accuracy is not applicable in terms of calculations or dollar amounts; however, the years (2022–2024) and their corresponding disclosures are correctly referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly noting that the same language appears in each year’s filing, indicating no change in timing. This supports the conclusion that revenue recognition policy remained stable. (4) The only minor shortcoming is that the LLM does not explicitly mention Amazon’s 2022 disclosure about interest income or fixed/per-unit fees beyond commissions and fulfillment, which the ground truth includes. While the focus of the question is on commissions and fulfillment fees, the broader composition in 2022 is slightly underrepresented. However, the core of the question—timing and composition of commissions and fulfillment fees—is accurately and completely addressed. Wording differs but semantic meaning is equivalent. Hence, a score of 9 is justified for correctness, with full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 451,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "AT&T continues to carry a parent‑level guarantee of the debt and other obligations of its historic Bell subsidiaries – evidenced by the recurring “Guaranty of certain obligations of Pacific Bell Telephone Co. and Southwestern Bell Telephone Co.” listed in the exhibit schedule (see pages 98 and 103). By keeping these guarantees in force for 2022‑2024, AT&T signals that it prefers to back‑stop legacy entities with its own credit rather than unwind or fully divest them, using the guarantee as a low‑cost way to contain risk while preserving the subsidiaries’ access to financing and protecting the overall corporate credit profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (2022–2024) and correctly identifies AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations, aligning with the ground truth. The reference to exhibit schedules (pages 98 and 103) supports the claim, though it does not explicitly name Exhibit 4-b as in the original answer—this is a minor omission but does not undermine factual correctness. The inclusion of Pacific Bell is not contradicted by the ground truth but adds an entity not specifically mentioned, which slightly dilutes precision but doesn't introduce inaccuracy. Quantitatively, there are no numerical claims to verify, so the score is 10 by default. The reasoning is sound: the LLM correctly infers that the repeated guarantees reflect a strategic choice to maintain financial backing for legacy entities, preserve financing access, and protect credit profile—consistent with the ground truth’s conclusion about a stable, unchanging liability management strategy. The answer provides additional interpretation (e.g., 'low-cost way to contain risk') that is plausible and contextually appropriate, though not explicitly stated in the original. This interpretive extension is reasonable but prevents a perfect qualitative score due to slight overreach beyond the documented evidence. Contextual relevance is strong: the response directly addresses the question about long-term liability management strategy and synthesizes information across the three years as required. Overall, the answer is semantically equivalent in intent and meaning, with high accuracy and appropriate reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 442,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "- In 2022 Johnson & Johnson had **$808 million** of 2.250 % notes due 2050 outstanding.  \n- The balance rose to **$826 million** in 2023 【page_71】, then fell back to **$808 million** in 2024 【page_72】.  \n\nThis modest swing shows the company keeping the ultra‑long‑dated, low‑coupon 2.250 % 2050 issue essentially flat – a deliberate move to lock in a cheap, fixed‑rate liability for the very long term while fine‑tuning overall debt levels as part of its long‑term financing strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values for 2022 and the trend over time. According to the ground truth, the investment was $983 million in 2022, but the LLM incorrectly states $808 million. It also claims the balance rose from 2022 to 2023, when in fact it decreased from $983M to $826M. The 2023 ($826M) and 2024 ($808M) figures are correct, but the initial value and directional trend are wrong. (2) Quantitative accuracy is low because the first data point is off by $175 million, which is a substantial deviation. While the 2023 and 2024 numbers match the ground truth, the incorrect ordering and characterization of movement (increase then decrease) misrepresents the overall trend of consistent decline. (3) The reasoning about long-term debt strategy is partially sound—mentioning a deliberate effort to maintain low-cost, long-dated debt aligns with the ground truth—but it is based on flawed data. The conclusion that the balance was 'essentially flat' contradicts both the LLM's own numbers (which show a swing) and the ground truth (which shows a steady decline from $983M). (4) Contextual relevance is high because the answer addresses the evolution over time and interprets the strategic implications of the debt instrument. However, due to major numerical inaccuracies affecting the core facts, the overall correctness score is low despite relevant framing and partial data accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 400,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "Costco kept the 1.375 % Senior Notes due June 2027 unchanged at **$1.25 billion** in each of its balance‑sheet disclosures for 2022, 2023 and 2024【page_52】. By retaining this low‑cost, long‑dated debt rather than repaying or refinancing it, Costco shows a capital‑management approach that values cheap, fixed‑rate financing to preserve liquidity and give the company flexibility for future investments or acquisitions.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the 1.375% Senior Notes due June 2027 remained unchanged at $1.25 billion (equivalent to $1,250 million) across 2022, 2023, and 2024, which matches the ground truth. This demonstrates accurate quantitative reporting of the specific debt instrument. However, the LLM omits key information about the broader long-term debt trend—namely, the decline from $6,590 million in 2022 to $6,484 million in 2023 and further to $5,919 million in 2024. This omission limits completeness and weakens the synthesis required for full multi-hop reasoning. (2) The dollar amount is accurate with acceptable format variation ($1.25 billion = $1,250 million). The dates (2022–2024) and interest rate (1.375%) are correct. No calculation errors are present, but the absence of total long-term debt figures means the model fails to support its strategic interpretation with full data. (3) The reasoning about Costco’s capital management strategy—retaining low-cost, fixed-rate debt to preserve liquidity—is logically sound and aligns with the ground truth’s implication. However, because the LLM does not acknowledge the overall debt reduction trend, it misses the nuance of a *selective* strategy focused on repaying other tranches while keeping this one. This weakens the qualitative accuracy of the inference. (4) The answer is contextually relevant and addresses the core of the question regarding debt structure evolution and strategy, but the lack of total debt data prevents a fully accurate and complete multi-hop synthesis, justifying a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 437,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "Mastercard’s 10‑K filings show that its “multi‑layered” security model – which combines cyber‑threat programs, Security Operations and Fusion Centers, third‑party assessments, tokenization, fraud‑scoring and industry‑wide standards such as EMV – has been reinforced year‑over‑year, while the same sections describe a steady rollout of real‑time, account‑based payment infrastructure (operating in 12 markets in 2022, expanding to 13 markets by the end of 2023 and continuing to add new jurisdictions in 2024). The parallel expansion indicates that Mastercard deliberately couples the scaling of its real‑time payments network with incremental enhancements to its security architecture, using the same distributed, real‑time routing platform to embed fraud‑prevention and resilience controls, thereby managing processing risk as the network grows globally.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core evolution of Mastercard's multi-layered security approach and real-time payments expansion from 2022 to 2024, aligning with the ground truth. It accurately states that real-time payments infrastructure was operating in 12 markets as of 2022 (aligned with December 31, 2021 data referenced in 2022 filing) and expanded to 13 markets by end of 2023. However, the LLM implies a continuous, incremental expansion into 'new jurisdictions' in 2024, while the ground truth notes only a qualitative shift to 'several countries around the world' without specifying exact numbers—this is a minor overprecision. (2) Quantitatively, the 12 and 13 market figures are correct and match the original answer. The LLM does not introduce any incorrect numbers or miscalculations. The phrasing 'operating in 12 markets in 2022' is slightly imprecise—the original specifies the data was as of December 31, 2021, reported in the 2022 filing—but this is a common interpretation in context. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and domains (security and infrastructure), identifying the parallel development and inferring strategic intent. It goes slightly beyond the ground truth by stating that the same 'distributed, real-time routing platform' embeds fraud controls—this is plausible but not explicitly supported in the provided truth. The conclusion that security scales with infrastructure is consistent with the original's suggestion of intentional tandem scaling. (4) The answer is highly contextually relevant, addressing both the evolution and strategic implication. Scores reflect high accuracy with minor deductions for slight overstatement of 2024 expansion detail and incremental enhancement claims not fully explicit in source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 497,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "The only filing that references the 4.000 % Notes due 2021 is the “Third Supplemental Indenture” (Exhibit 4.6) dated February 8 2011 – Microsoft issued that series more than a decade ago. The 2022, 2023 and 2024 Form 10‑K exhibits contain no new issuances or extensions of the 4.000 % 2021 notes, indicating that Microsoft has let that tranche run its course rather than refinancing it. This pattern shows a long‑term debt‑management approach that relies on earlier, short‑term issuances to mature while the company focuses new borrowing on longer‑dated securities, thereby extending its overall debt maturity profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but significant inaccuracies in interpretation. It correctly identifies the Third Supplemental Indenture dated February 8, 2011, as the instrument related to the 4.000% Notes due 2021 and notes its presence as Exhibit 4.6 in the 10-K filings. However, it incorrectly concludes that there were no new issuances or extensions and that Microsoft 'let that tranche run its course,' which contradicts the ground truth indicating continued disclosure post-maturity (2024), suggesting rollover, delayed settlement, or ongoing obligation. The claim that the notes were not refinanced is unsupported by the evidence provided in the original answer. (2) Quantitatively, the dates (February 8, 2011), exhibit number (4.6), and note terms (4.000%, due 2021) are accurate. No numerical calculations are required, so this aspect is mostly correct. (3) The multi-hop reasoning is flawed: while the model correctly observes consistent exhibit referencing, it fails to infer the significance of post-maturity disclosure, which the ground truth interprets as evidence of disciplined transparency and possible rollover—key to the question about long-term debt strategy. Instead, the LLM assumes maturity without refinancing, which is not supported by the continued disclosure in 2024. (4) Contextual relevance is high—the response addresses the evolution across fiscal years and attempts to interpret debt strategy. However, due to incorrect inference about the cessation of the debt instrument, the qualitative and overall correctness scores are reduced significantly. The model misses the core insight that post-maturity disclosure indicates ongoing management and transparency, not termination of the obligation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 479,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "Amazon’s filings repeatedly list the **1.500 % senior note due 2030** (e.g., in the 2022 exhibit list [page 72] and again in the 2024 exhibit list [page 75‑76]). By keeping this ultra‑low‑coupon, long‑dated bond on its balance sheet year after year, Amazon is deliberately locking in cheap, fixed‑rate financing for the next decade, which helps stabilize its long‑term capital structure and hedge against future interest‑rate increases. This contrasts with its other debt issuances that carry higher coupons and staggered maturities (e.g., 2.730 % due 2024, 3.600 % due 2032, 4.100 % due 2062), showing that the 1.500 % note is a cornerstone of a low‑cost, long‑term financing strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 1.500% Note due 2030 as a consistent, low-cost, long-dated debt instrument in Amazon's capital structure, which aligns with the ground truth. It accurately contrasts this note with other debt instruments, supporting the strategic narrative of layered maturities and rate management. However, it includes some inaccuracies in the specific coupon rates and maturities of other notes: the 2.730% due 2024 and 4.100% due 2062 are not mentioned in the ground truth, which instead references a 4.700% Note due 2024 and another 4.700% Note due 2032. The 3.600% due 2032 is also not in the original. These discrepancies affect quantitative precision. (2) The core number — 1.500% due 2030 — is correct and consistently referenced across years, as is the strategic interpretation of locking in low rates. But the supporting debt instruments cited have incorrect rates/maturities, suggesting possible confusion with actual filings. No calculations are performed, so no arithmetic errors, but comparative accuracy suffers. (3) The multi-hop reasoning is sound: the model synthesizes the persistence of the 1.500% note over time and contrasts it with other instruments to infer a long-term capital strategy. It captures the essence of a staggered maturity profile and risk mitigation, though with flawed examples. The ground truth emphasizes evolving issuance patterns across 2022–2024, which the LLM does not fully unpack (e.g., no mention of 2023 dynamics or the 2060 maturity). (4) Despite minor factual inaccuracies in secondary details, the LLM conveys the correct strategic interpretation and focuses on the right instrument. The answer is contextually excellent and semantically close to the original, warranting a high correctness score with a deduction for incorrect supporting data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 499,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "- 2022 – AT&T still owned **41.3 % of SKY Mexico** and, because it was a less‑than‑majority interest that gave AT&T significant influence, the investment was carried under the **equity‑method** (see 2022 filing “We continue to hold a 41.3 % interest in SKY Mexico” 【page_93】).  \n- 2023 – The stake remained unchanged, but the equity‑method balance fell from $3.5 bn to $1.3 bn as AT&T recorded impairments and received distributions (reconciliation shows “Beginning of year $3,533 … End of year $1,251” 【page_66】).  \n- 2024 – In June 2024 AT&T **sold its 41.3 % interest**, de‑recognizing SKY Mexico from its equity‑method investments (the note states “SKY Mexico … sold our 41.3 % interest” and the post‑sale reconciliation ends at $295 m) 【page_66】.  \n\nThis three‑year path shows AT&T moving from a strategic joint‑venture holder in an international pay‑TV market to a complete exit, mirroring its broader divestiture agenda of shedding non‑core, declining media assets (e.g., Vrio, DIRECTV) to concentrate on its core telecom business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T held a 41.3% stake in SKY Mexico in 2022 and 2023, accounted for it under the equity method, and exited in June 2024. These details match the original answer exactly. (2) Quantitative accuracy is excellent: the equity-method balance drop from $3.5 billion to $1.3 billion in 2023 and the post-sale value of $295 million are correctly cited with proper context from the filing. No calculation errors. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across three years, connects ownership stake to accounting treatment, and identifies the strategic exit. It also references specific filing pages, enhancing credibility. (4) The only minor shortcoming is that the LLM does not explicitly mention Vrio’s sale as part of the broader divestiture context in the same way the original answer does, slightly weakening the linkage to prior strategic moves. However, it does reference DIRECTV and 'non-core, declining media assets,' which captures the essence. Wording differs but semantic meaning is equivalent. Overall, this is a factually correct, well-supported, and contextually appropriate response with only negligible omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 351,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "AIG’s “glide‑path” for the U.S. qualified pension plan steadily moves the portfolio toward liability‑hedging assets as the plan’s funded ratio improves. The plan’s target mix was 15 % equity, 75 % fixed‑maturity and 10 % other assets for 2022; by 2024 the target had shifted to 9 % equity, 80 % fixed‑maturity and 11 % other assets (the 2023 target fell between those points). The progressive cut‑back in the growth‑asset (equity) allocation and the corresponding increase in fixed‑income exposure illustrate AIG’s de‑risking strategy—reducing market‑risk exposure and emphasizing assets that better match the plan’s liabilities as funding strengthens.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AIG's de-risking strategy and the overall trend of reducing equity (growth) exposure while increasing fixed-income (liability-hedging) allocations over time. However, the specific target allocations for 2022 and 2024 (15% equity in 2022, 9% in 2024) are not present in the original answer, which does not provide exact percentage breakdowns. These numbers appear to be fabricated or sourced from outside the provided ground truth, making them factually unsupported. (2) Since the ground truth does not include specific percentages, any numerical claims cannot be verified and are therefore inaccurate by default. This significantly impacts quantitative accuracy. There are no calculations in the LLM answer, but the use of precise figures implies a level of detail absent from the source. (3) The multi-hop reasoning is sound: the LLM correctly infers that improving funded status leads to de-risking via a glide path strategy, aligning with liability-driven investing principles. It synthesizes the concept of time-based allocation shifts (2022 to 2024) and links them to funded status changes, which is consistent with the original answer’s logic. (4) While the qualitative reasoning and contextual relevance are strong—capturing the essence of AIG’s strategy—the inclusion of unsupported numerical data reduces factual correctness. The answer conveys a semantically similar conclusion but adds specifics not present in the ground truth, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 423,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "From 2022 to 2024 Mastercard steadily tightened its credit‑risk safeguards as regulatory probes and litigation intensified. In 2022 the company applied $9.2 billion of risk‑mitigation arrangements (cash collateral, letters of credit and guarantees) to a $55.7 billion net settlement exposure (see 2022 Note 22, page 110). By 2023 that buffer had grown to $12.2 billion (net exposure $62.9 billion) and the firm added a $589 million qualified cash‑settlement fund and $344 million of new accruals for merchant‑class claims (page 112). In 2024 the mitigation layer rose again to $13.5 billion (net exposure $64.9 billion) while the firm refined its hedging program—de‑designating €400 million of euro debt as a net‑investment hedge, re‑designating €109 million as an economic hedge, and entering longer‑term foreign‑exchange contracts to cover cash‑flow risk (page 106, 105). This progression shows Mastercard’s risk‑management framework is highly adaptable, scaling collateral requirements, building settlement reserves and re‑tooling derivative hedges to offset the heightened regulatory and litigation pressures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual accuracy, particularly on quantitative details, despite addressing the general theme of credit risk mitigation evolution. (1) The original answer states that Mastercard maintained a consistent framework for credit risk mitigation from 2022 to 2024, with no mention of increasing collateral amounts or new financial instruments like hedging changes. The core claim in the LLM answer—that mitigation arrangements grew from $9.2B to $12.2B to $13.5B—is unsupported by the ground truth, which does not provide any dollar figures for risk-mitigation arrangements or net settlement exposure. These numbers appear fabricated. (2) The LLM cites specific line items such as a '$589 million qualified cash-settlement fund' and '$344 million of new accruals', and detailed hedging adjustments involving €400 million and €109 million, none of which are mentioned or implied in the original answer. There is no reference to foreign exchange contracts or hedge redesignations in the ground truth. (3) The qualitative reasoning is partially sound in that it attempts to link regulatory and litigation pressures to risk management adaptations, which aligns with the original answer’s narrative about evolving context. However, the LLM invents specific financial mechanisms and numerical escalations not present in the source, failing the multi-hop synthesis test—instead of pulling accurate data points, it hallucinates them. (4) While the LLM correctly identifies the increasing regulatory scrutiny (FTC, DOJ, European Commission) and litigation risks over the period, and correctly infers that Mastercard adapted its risk management, it misrepresents how—by inventing quantitative escalations and financial engineering not found in the original. The conclusion about adaptability is plausible but based on false premises. Thus, the answer is contextually relevant and shows some understanding of the risk environment, but fails on factual correctness, especially in numbers and specific financial actions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1608,
        "completion_tokens": 547,
        "total_tokens": 2156
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "The Home Depot filing shows that the Omnibus Stock Incentive Plan had about **70 million shares available for future grants in the 2022 Form 10‑K**, rose to roughly **77 million shares in the 2023 Form 10‑K** (as of January 28 2024), and then fell back to **about 70 million shares in the 2024 Form 10‑K** (as of February 2 2025). This pattern – a modest expansion of the share pool in 2023 followed by a draw‑down in 2024 – suggests the company temporarily enlarged its equity‑based compensation capacity to support higher grant activity and then began using those shares, reflecting a disciplined, demand‑driven approach to stock‑based awards.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the number of shares available decreased from 117 million in 2022 to 77 million in 2023 and further to 70 million in 2024. However, the LLM incorrectly states that 70 million shares were available in 2022, then rose to 77 million in 2023, and fell back to 70 million in 2024. This reverses the actual trend and misrepresents the data. The 2022 figure is off by 47 million shares, which is a major error. (2) The dates cited (January 28, 2024, and February 2, 2025) are correctly associated with the respective fiscal year-ends, but the share numbers are wrong. The LLM also incorrectly implies that the share pool increased in 2023 due to an expansion, when in fact the decrease from 117M to 77M reflects usage and plan amendments, not an increase. There is no evidence in the ground truth of a temporary expansion. (3) The multi-hop reasoning is flawed because the model fails to correctly track the direction of change over time. Instead of recognizing a consistent decline suggesting active issuance of equity awards, it infers a temporary expansion and drawdown, leading to an incorrect strategic interpretation. (4) While the answer addresses the question's structure and attempts to interpret strategy, the severe quantitative errors undermine both factual correctness and logical reasoning. The contextual relevance is moderate because it discusses the right plan and metric, but the conclusions are based on false premises. Correctness score is low due to major factual and directional errors in the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 443,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "- **Fiscal 2022:** The 3.625 % senior notes that mature in October 2024 were still on the balance sheet (approximately **$622 million** of principal).  \n- **Fiscal 2023:** The same amount remained outstanding – the 10‑K for FY 2023 lists **$622 million** of “3.625 % notes due October 2024” (see the debt‑schedule table, $ 622 m under the October 29 2023 column).  \n- **Fiscal 2024:** By the end of FY 2024 the instrument had been eliminated – the FY 2024 table shows a “‑” (zero) for the 3.625 % notes due October 2024 (see the November 3 2024 column).\n\n**What this shows:** Broadcom kept the October‑2024 3.625 % notes at a steady $622 million through FY 2022‑23, then fully retired them in FY 2024, using cash and the proceeds of the new $10 billion senior‑note issuances. The progression reflects a deliberate debt‑management strategy: retain the note while it was affordable, then pay it off ahead of maturity to simplify the capital structure and free up future cash‑flow commitments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $622 million in FY 2022 and FY 2023, and $0 (represented as '–') in FY 2024, aligning perfectly with the original answer. The maturity date (October 2024) and interest rate (3.625%) are correctly stated. (2) The answer is complete, addressing the evolution of the obligation across all three fiscal years and providing a clear interpretation of Broadcom’s debt management strategy. (3) Entity accuracy is strong: correct company (Broadcom/AVGO), correct financial instrument, and correct fiscal years. (4) The reasoning is sound and adds value by correctly inferring that the repayment was likely funded by the $10 billion senior note issuance mentioned in the FY 2024 filing, which is a logical and documented capital strategy. This demonstrates proper multi-hop synthesis across fiscal years and debt instruments. The conclusion about simplifying capital structure and freeing future cash flows is semantically equivalent to the ground truth’s 'deliberate debt management strategy' and enhances it with contextual insight. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 334,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "- 2022 – After acquiring Time Warner in 2018, AT&T moved to combine its WarnerMedia unit with Discovery (May 2021) and, in April 2022, completed that combination through a Reverse‑Morris‑Trust transaction, treating WarnerMedia as a discontinued operation and removing it from the company’s core reporting segments.  \n- 2023 – The 10‑K still lists the former WarnerMedia segment only to note the divestiture of its ancillary businesses (e.g., the sale of Xandr to Microsoft and the disposal of Otter Media) and confirms that the WarnerMedia/Discovery merger has been finalized, leaving no ongoing integration work.  \n- 2024 – The filing no longer references Time Warner; AT&T’s “Areas of Focus” center on 5G, fiber and its own HBO Max streaming platform, signalling a complete exit from the legacy entertainment business and a strategic shift toward pure‑play telecommunications and direct‑to‑consumer content.  \n\nTogether, the progression shows AT&T moving from integrating Time Warner, to planning and executing its divestiture, and finally exiting the traditional media asset, reflecting a pivot from an entertainment‑heavy portfolio to a focus on network infrastructure and proprietary streaming services.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that undermine its correctness. Most critically, it incorrectly states that the WarnerMedia-Discovery combination was completed in April 2022, when in fact the transaction closed in April 2022 was the announcement or finalization of plans, but the actual separation and merger with Discovery was completed in April 2022 — this part is borderline but acceptable depending on interpretation. However, the LLM claims AT&T retained HBO Max after exiting entertainment, which is false: HBO Max was part of WarnerMedia and was spun off in the Discovery deal. AT&T did not keep HBO Max; instead, it received a 71% stake in the new Warner Bros. Discovery entity briefly before distributing shares to shareholders, and had no ongoing control. The 2024 claim that AT&T focuses on 'its own HBO Max streaming platform' is therefore factually wrong. Additionally, the original answer correctly identifies the 2024 DIRECTV sale as the final exit from media, while the LLM omits this and instead invents a continued involvement in streaming via HBO Max. (2) Quantitative accuracy suffers due to incorrect dates and events: the April 2022 date is plausible for the closing of the Discovery deal, but the treatment of HBO Max and the omission of the DIRECTV sale in 2024 (a key divestiture) are major omissions. There are no numerical values to verify (e.g., dollar amounts, percentages), but the timeline is misaligned. (3) Multi-hop reasoning is partially sound — the model traces the divestiture of WarnerMedia and ancillary assets like Xandr and Otter Media — but fails the final synthesis by suggesting AT&T maintained a direct-to-consumer content strategy via HBO Max, which contradicts the ground truth of full retreat. The reasoning incorrectly infers continuity in content rather than a complete exit. (4) Despite these errors, the answer is contextually relevant and addresses the evolution of the relationship, integration, and divestiture planning. It captures the shift toward telecom focus, albeit with flawed supporting details. The core narrative of strategic retreat is partially correct, but key facts are wrong, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 591,
        "total_tokens": 2112
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "In the 2022 filing Emerson’s Safety & Productivity segment described pipe‑cutters simply as “pipe‑working tools” alongside wrenches, threading and roll‑grooving equipment, with the segment’s technology focus limited to “battery hydraulic tools for press connections” and separate diagnostic cameras and locators 【page_9】. By the 2023‑2024 filings the company had repositioned the line, grouping pipe‑cutters with a broader “battery‑hydraulic” tool family and explicitly linking them to the same diagnostic‑system platform (sewer‑inspection cameras and locating equipment) that underpins its safety‑productivity strategy 【page_73】. This shows a shift from a purely mechanical offering in 2022 to an integrated, battery‑powered and diagnostics‑enabled product line by 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, pipe cutters were standalone mechanical tools; by 2023–2024, they were integrated into a battery-hydraulic tool family and linked with diagnostic systems like sewer inspection cameras. The evolution from mechanical to integrated, battery-powered, and diagnostics-enabled tools is correctly captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across 2022, 2023, and 2024 filings, correctly identifying the shift in strategic positioning within the Safety & Productivity segment. It accurately infers integration with both battery-powered technologies and diagnostic systems over time. (4) The only minor shortcoming is that the LLM slightly condenses the timeline by referring to '2023–2024 filings' together, whereas the ground truth distinguishes 2023 as the year of battery integration and 2024 as the extension to diagnostic ecosystems. This does not undermine the overall correctness but slightly reduces precision in temporal staging. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses all parts of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 384,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "Johnson & Johnson first disclosed in its 2022 Form 10‑K that it had launched a **multi‑year, enterprise‑wide initiative to integrate, simplify and standardize processes and systems for HR, IT, procurement, supply‑chain and finance**, specifically to **grow its financial shared‑service capabilities and standardize financial systems**【page_117】. The same language reappears in the 2023 filing【page_118】 and again in the 2024 filing【page_119】, indicating that the program is still being rolled out and that the company is continuously aligning its financial‑control environment as the initiative progresses. This uninterrupted emphasis signals that J&J’s strategy is firmly centered on **financial‑process standardization and shared‑service expansion**, using the initiative as a core driver of operational efficiency and consistent financial reporting across the enterprise.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Johnson & Johnson's multi-year initiative was launched in 2022 to integrate, simplify, and standardize processes across finance and other functions, with consistent repetition in 2023 and 2024 filings. The emphasis on growing financial shared services and standardizing systems is accurately reported. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the years (2022–2024) are correctly cited and aligned with the original answer. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of filings, and the conclusion about strategic focus on standardization and operational efficiency is logically derived from the repeated disclosures. (4) The LLM captures all elements of the original answer: the initiative’s scope, its continuity, its purpose (not in response to deficiencies), and its strategic implications. Minor wording differences (e.g., listing additional functions like HR and supply chain) add context without distorting meaning. The consistent language across filings is correctly interpreted as evidence of ongoing strategic commitment. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 364,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "Costco’s Form 10‑K exhibits list the “Costco Wholesale Executive Health Plan” as Exhibit 10.1 in each of the three most recent filings. In the FY 2022 filing the plan appears as Exhibit 10.1 (“Form 10‑K – 9/2/2012 – 10/19/2012”)【page_66】, the same designation and reference are shown in the FY 2023 filing【page_66】, and again in the FY 2024 filing【page_66】.  \n\nThe fact that the Executive Health Plan has been disclosed in exactly the same way for three consecutive years—without amendment, removal or new filing—demonstrates that Costco has kept this benefit unchanged, signalling a stable, long‑term commitment to providing the executive health program as a permanent component of its executive compensation strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Executive Health Plan is consistently listed as Exhibit 10.1 (not 10.1* as in the original, but this is a minor formatting difference that does not affect meaning), with the same 'Period Ended' of September 2, 2012, and 'Filing Date' of October 19, 2012, across FY 2022, 2023, and 2024. These dates match the ground truth exactly. (2) Quantitative accuracy is perfect—dates are correctly cited and consistent across years. (3) The reasoning is sound: the lack of amendments or new filings over three consecutive years is correctly interpreted as evidence of a stable, long-term executive benefit strategy. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in disclosures and the implication for executive benefit strategy. The only minor shortcoming is that the LLM refers to the exhibit as 'Exhibit 10.1' while the ground truth specifies 'Exhibit 10.1*', which may indicate a version or footnote distinction, though this does not appear to affect the substance. Overall, the answer demonstrates strong multi-hop synthesis across three filings and correct interpretation of disclosure patterns, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 352,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "Across the three filings the charter for Class A stock never changed – each Class A share carries **one vote per share and full dividend rights** (2022 § Note 16, p. 96; 2023 § Note 16, p. 99; 2024 § Note 16, p. 92).  What did change was the cash dividend declared on those shares, rising from **$2.04 per share in 2022** to **$2.37 in 2023** and **$2.74 in 2024** (same tables).  The steady voting structure combined with steadily higher payouts signals that Mastercard deliberately preserves a uniform, one‑share‑one‑vote governance model while using dividend growth to reward shareholders, underscoring a consistent, shareholder‑friendly governance strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly introduces dividend payout amounts ($2.04, $2.37, $2.74) that are not present in the ground truth and were not part of the original question or verified data. The original answer only states that A Class Shares have 'standard dividend rights' with no mention of specific cash dividends declared. This is a major factual error. (2) While the voting rights (one vote per share) are correctly identified and consistent with the ground truth, the addition of unverified dividend amounts undermines quantitative accuracy. There is no indication in the ground truth that dividend *payouts* changed, only that rights remained standard—thus the claim of increasing dividends is unsupported and incorrect. (3) The reasoning is partially sound in linking stable voting rights to governance consistency, but the conclusion that dividend growth reflects a shareholder-friendly strategy is based on fabricated data. The multi-hop synthesis is flawed because it conflates dividend *rights* (which are stable) with dividend *payouts* (which the ground truth does not discuss), leading to an invalid inference. (4) Contextually, the answer addresses the evolution of rights and governance strategy, so relevance is high. However, the correctness score is low due to significant factual inaccuracies in quantitative claims, despite correct identification of voting rights and general governance interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 397,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "Across all three filing years the Security Insights Platform is described the same way. In FY 2022 Broadcom introduced the platform to “quickly interpret and assess mainframe security posture, identify risks and develop remediation steps,” and it made the resulting data available for use with customers’ in‑house security‑information‑and‑event‑management (SIEM) tools. The FY 2023 and FY 2024 disclosures repeat that language, indicating no further expansion of integration or risk‑identification functionality – the platform’s core capability of delivering risk insights for internal security tools remained unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in factual content and aligns well with the ground truth, but contains a minor discrepancy in the description of the platform's introduction in FY 2022. The original answer states that in FY 2022, the platform was described as assessing mainframe security posture and identifying risks, with data available for use with in-house SIEM tools—this is accurately reflected. However, the LLM claims Broadcom 'introduced' the platform in FY 2022 with the specific quote about 'developing remediation steps,' which goes slightly beyond the ground truth: the original answer notes that explicit linkage to remediation planning became more prominent in FY 2023, not FY 2022. The LLM incorrectly attributes the full language (including 'develop remediation steps') to FY 2022, whereas the ground truth suggests this emphasis evolved. The LLM correctly observes that FY 2023 and FY 2024 disclosures repeat prior language, indicating stability in functionality and integration—this matches the original answer’s conclusion of consistent, mature capabilities. All entities (Broadcom, Security Insights Platform, in-house tools, fiscal years) are correct. There are no numerical inaccuracies (quantitative accuracy is perfect). The reasoning is mostly sound, correctly synthesizing cross-year consistency, though the misattribution of remediation language to FY 2022 slightly weakens qualitative accuracy. Contextual relevance is excellent—the answer directly addresses the evolution (or lack thereof) in integration and risk identification across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 432,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "From 2022 to 2024 AIG has kept the same basic framework – loss‑reserve adequacy is set through a formal “review‑and‑challenge” process that combines internal actuarial controls, experience‑studies and stochastic/scenario‑analysis modeling – but the company has progressively detailed the quantitative methods it uses. In the 2022 filing the risk discussion focused on internal controls, actuarial profitability reviews and “review and challenge of reserves,” while the 2023 and 2024 filings add that reserves are projected by modeling loss frequency and severity over multiple years (including stochastic and deterministic techniques) and are continuously re‑validated. Throughout all three years, external experts have been explicitly called on to review and validate the reserve estimates, serving as an independent check on the internal models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core evolution in AIG's loss reserve risk management from 2022 to 2024 as the ground truth. It correctly identifies the continuity of internal controls and external expert validation across all years, and accurately notes the progressive enhancement in quantitative methods—specifically the use of stochastic and deterministic modeling introduced in 2023 and continued in 2024. The mention of 'review-and-challenge' processes, actuarial profitability reviews, and external validation aligns with the original answer. The only minor shortcoming is that the LLM answer does not explicitly mention the 2024 addition of ERM second-line reviews and enhanced budget/expense monitoring, which are specific advancements noted in the ground truth. However, the broader theme of increasing formality and proactiveness in risk oversight is captured. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are presented), and all entities (AIG, years 2022–2024, external experts, stochastic/deterministic modeling) are correctly identified. The reasoning is sound, demonstrating multi-hop synthesis across the three years’ filings. The answer is fully contextually relevant, directly addressing the evolution in methodologies and external validation. Thus, the answer earns a 9 for correctness and qualitative accuracy due to the omission of specific 2024 enhancements, but full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 415,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "Emerson’s “Industrial Solutions” umbrella still lists **electrical‑distribution equipment** as a key product line of the **Industrial Solutions** offering (page 76) and the **Discrete Automation** segment – which explicitly includes electrical‑distribution equipment – reports the following sales: **$2.6 bn in 2022, $2.64 bn in 2023 and $2.51 bn in 2024** (page 74). While the segment grew modestly from 2022 to 2023, it slipped in 2024 and its share of total company revenue fell from roughly 19 % (2022) to 14 % (2024), indicating that Emerson continues to keep electrical‑distribution gear in its discrete‑automation portfolio but is de‑emphasizing it relative to faster‑growing areas such as Intelligent Devices and Final Control.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Electrical Distribution Equipment was part of the Industrial Solutions segment in 2022 but was moved to the Discrete Automation segment in 2023 and remained there in 2024. The LLM incorrectly states that it remained under an 'Industrial Solutions umbrella' while also being in Discrete Automation, which contradicts the reorganization described in the original answer. (2) The financial figures provided—$2.6B (2022), $2.64B (2023), $2.51B (2024)—are not present in the ground truth and cannot be verified; more critically, the original answer does not include any sales data or revenue percentages, so introducing these numbers is a fabrication. The claim that the segment's share of total revenue fell from 19% to 14% is unsupported by the provided truth and represents a major quantitative error. (3) The multi-hop reasoning is flawed: instead of tracing the strategic repositioning of Electrical Distribution Equipment across years as evidence of shifting emphasis, the model focuses on fabricated revenue trends to argue 'de-emphasis,' which directly contradicts the ground truth's conclusion of a 'deliberate shift toward positioning... as a foundational component.' The model misinterprets the strategic signal entirely. (4) While the answer is contextually relevant—addressing Emerson, the equipment, and discrete automation—it fails on correctness due to invented data and incorrect structural understanding of the segment evolution. The qualitative reasoning is therefore unsound, and the quantitative claims are entirely inaccurate. Minor credit is given for identifying Discrete Automation as the relevant segment in later years, but the overall answer misrepresents the strategic trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 490,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "From the 2022 filing through the 2024 filing Johnson & Johnson continued to operate two parallel U.S. non‑union pension formulas – a **Final‑Average‑Pay** formula for employees hired before 1 Jan 2015 and a **Retirement‑Value** formula for those hired after 2014 【page_73】.  In each year’s 10‑K the company reiterated the 2021 announcement that, **effective 1 Jan 2026, all eligible U.S. non‑union employees will earn benefits under the Retirement‑Value formula**, leaving the pre‑2026 benefits accrued under the older formula untouched【page_76】【page_77】.  Over 2022‑2024 the company therefore moved from a mixed‑formula system toward a single, compensation‑based formula, signalling a long‑term workforce strategy aimed at standardising retirement benefits, simplifying plan administration and aligning employee incentives with total‑career earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the transition to the Retirement Value formula effective January 1, 2026, for all eligible U.S. non-union employees; the preservation of Final Average Pay benefits accrued before 2026; and the phased shift from a mixed system to a unified formula. The dates (2015 hire cutoff, 2026 effective date) are consistent with the original answer and filings. (2) The answer correctly identifies the two formulas and their applicability, and accurately reflects the multi-year consistency in disclosure from 2022 to 2024. (3) The reasoning is sound: it synthesizes information across years and correctly infers the strategic intent—standardization, administrative simplification, and alignment with total-career earnings. The only minor shortcoming is that the original answer emphasizes the broader workforce inclusivity aspect slightly more, while the LLM focuses more on administrative simplicity. However, the core strategic interpretation (standardization, long-term planning) is semantically equivalent. (4) Contextual relevance is excellent—the response directly addresses both the evolution of the pension structure and the implied workforce strategy. No irrelevant or extraneous information is included. Overall, this is a factually correct, well-reasoned, and contextually appropriate answer with only negligible differences in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 401,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "The 10‑K tables show that Downy has been listed among the “major brands” in the Fabric & Home Care segment in each of the three filings. The segment’s share of total company sales rose modestly from about 35 % of net sales in fiscal 2022, to roughly 35 % in fiscal 2023, and to 36 % in fiscal 2024. Because Downy remains a headline brand in a segment that is growing (albeit only slightly) in its contribution to overall sales, the trend suggests that Downy’s role in P&G’s portfolio has stayed steady and is viewed as strategically important – it continues to be a core driver of the Fabric & Home Care business as the segment’s relative weight on the company’s top line expands.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Downy is a major brand in the Fabric & Home Care segment and that the segment's contribution to P&G's net sales increased from 35% in 2022 to 36% in 2024, with 2023 also at approximately 35%. This aligns closely with the ground truth, which states 35% in 2022 and 36% in both 2023 and 2024. The minor discrepancy is in the 2023 figure: the LLM says 'roughly 35%', while the ground truth specifies 36%. This is a small quantitative deviation but does not materially distort the trend. (2) All other numbers and years are accurate: 35% in 2022 and 36% in 2024 are correctly reported. The LLM acknowledges the segment’s growth in contribution, which supports the correct interpretation. (3) The reasoning is sound: the model correctly infers that Downy’s continued status as a headline brand within a growing segment indicates sustained strategic importance. It synthesizes brand-level and segment-level information across three years, fulfilling the multi-hop requirement. (4) The answer is contextually excellent—directly addressing both the evolution of the segment’s contribution and the implication for Downy’s strategic role. Wording differs slightly from the original answer but maintains semantic equivalence. The correctness score is 9 due to the slight inaccuracy in the 2023 percentage; otherwise, the response is factually strong, well-reasoned, and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 395,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "- **Carrying value of senior + subordinated notes**  \n  * 2022 : $30.8 billion (Table 8.1, 2022 10‑K)  \n  * 2023 : $31.2 billion (Table 8.1, 2023 10‑K)  \n  * 2024 : $30.7 billion (Table 9.1, 2024 10‑K)\n\n- **Interpretation** – Over the three‑year span the total senior and subordinated debt stayed essentially flat, rising modestly in 2023 and then edging lower in 2024. This pattern indicates that Capital One is maintaining a stable level of long‑term debt financing, using only small adjustments in issuance and repayment (e.g., shifting toward more fixed‑rate senior debt and reducing subordinated debt) rather than pursuing aggressive new borrowing or large debt retirements.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the carrying value was $27,219 million in 2022 and increased to $31,248 million in both 2023 and 2024. However, the LLM reports $30.8 billion in 2022, $31.2 billion in 2023, and $30.7 billion in 2024—implying a peak in 2023 followed by a decline in 2024. This contradicts the ground truth, which shows a consistent increase with no drop in 2024. The 2022 figure is off by over $3.5 billion, which is a material error. (2) The calculations and comparisons are therefore incorrect: the trend is not 'essentially flat' as claimed, but rather a clear upward trajectory from $27.2B to $31.2B. The LLM’s interpretation of stability and minor adjustments is directly contradicted by the actual 14.8% increase over two years. (3) The multi-hop reasoning fails because the model did not correctly extract or synthesize the data across the three years—especially missing the correct 2022 baseline and misrepresenting the 2024 value. The entity identification (Capital One, senior and subordinated notes) and metric (carrying value) are correct, and the years are properly referenced, so entity accuracy is acceptable. (4) While the answer attempts relevant interpretation, the flawed data leads to an incorrect conclusion about debt strategy. Instead of identifying a strategic increase in note issuance, the LLM suggests stability and minor rebalancing, which is not supported by the ground truth. Hence, correctness and accuracy scores are low despite proper structure and formatting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 440,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "- **2022 – Holding:** AT&T (T) still owned **41.3 % of SKY Mexico**, which it treated as an equity‑method investment because the stake gave it “significant influence” over the pay‑TV joint venture. (The 2021 Vrio disposition footnote notes, “We continue to hold a 41.3 % interest in SKY Mexico.” 【page_93】)\n\n- **2023 – Continued equity‑method accounting:** The 2023 Form 10‑K lists SKY Mexico among the equity affiliates reported under the equity‑method, alongside DIRECTV and Gigapower, confirming the same 41.3 % stake remained on the balance sheet. 【page_68】\n\n- **2024 – Exit:** In June 2024 AT&T **sold its 41.3 % interest in SKY Mexico**, removing the investment from its equity‑method portfolio. The reconciliation of equity‑method investments shows the balance falling from $1,251 million at the start of 2024 to $295 million after the disposition, reflecting the sale. 【page_66】\n\n**What the trajectory reveals:** Over three years AT&T moved from maintaining a sizable, strategically‑positioned minority stake in a key Latin‑American pay‑TV operator to fully divesting that interest. The pattern—first retaining influence via the equity method, then monetizing the stake and exiting—mirrors AT&T’s broader strategy of shedding non‑core Latin American video assets (e.g., the earlier Vrio sale) to focus on its core telecommunications businesses.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: T (AT&T) maintained a 41.3% ownership stake in SKY Mexico from 2022 through the June 2024 exit; equity method accounting was consistently applied until the sale; and the divestiture was completed in 2024. (2) Quantitative accuracy is excellent: the 41.3% stake is correctly cited across all years, and the reconciliation of equity-method investments from $1,251 million to $295 million aligns with the financial impact of the sale, supporting the claim of full divestiture. These numbers match the expected trajectory and are properly contextualized. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years and multiple disclosures (footnotes, equity-method listings, balance sheet changes), correctly inferring the strategic progression from holding to exit. (4) The broader strategic interpretation—that this reflects AT&T’s pattern of shedding non-core Latin American pay-TV assets (e.g., Vrio sale)—is consistent with and extends the ground truth insight. The mention of DIRECTV and Gigapower as comparators adds contextual precision. Wording differs slightly but meaning is preserved. No errors in entities, years, or financial treatment. All aspects of the question—ownership, accounting, exit, and strategic implication—are fully and accurately addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1574,
        "completion_tokens": 392,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "Both the 2022 and the 2023‑2024 10‑K filings state that BNY Mellon’s ability to return cash to shareholders is “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.” The 2022 filing adds that failure to meet “‘well‑capitalized’ and ‘well‑managed’” standards or other capital‑adequacy and liquidity rules could also restrict activities, and it notes the holding‑company’s reliance on subsidiary dividends to fund share repurchases and dividend payments. The 2024 disclosure repeats the same constraints, emphasizing the same regulatory capital‑planning requirements and dividend obligations, showing that the company’s message on capital‑return limits has remained consistent over the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its representation of BNY Mellon's disclosures from 2022 to 2024 regarding constraints on capital returns, with correct references to U.S. banking laws, regulatory capital planning, Delaware law, and preferred dividend obligations. All cited constraints—regulatory discretion, capital adequacy, holding company reliance on subsidiary dividends—are present in the original answer and correctly attributed across years. The quantitative accuracy is perfect: no numerical data is misstated, and all dates (2022, 2023–2024) align with the ground truth. The answer correctly identifies the consistency in core regulatory language over time. However, the LLM omits the evolution noted in the original answer: the 2023 expansion to include ESG-related regulatory pressures and strategic initiatives' impact on capital allocation, and the 2024 emphasis on strategic transformation affecting liquidity and capital planning. While the central regulatory framework is accurately portrayed as stable, the increasing contextual complexity—a key point in the original—is underdeveloped. This omission reduces completeness and qualitative accuracy slightly, but the answer remains semantically aligned and highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 352,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "In the 2022 filing the Safety & Industrial segment’s product description simply listed **“Structural adhesives and tapes”** as a stand‑alone line item (see the Business‑Segment Products table in the 2022 10‑K – page 107). By the 2024 filing the company had created a new **Industrial Specialties division** inside the same segment and moved the former “Industrial Adhesive and Tapes” business into it, bundling those adhesives with the Closure & Masking Systems and Personal‑Safety product families (2024 10‑K – page 110). This shift shows that 3M is treating structural adhesives not just as a commodity but as a strategic industrial specialty that can be cross‑sold with complementary sealing, masking and safety solutions, underscoring the adhesive portfolio’s role as a platform for broader industrial applications.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly affect correctness, despite being contextually relevant and having accurate dates and document references. (1) The ORIGINAL ANSWER states that in 2022, Structural Adhesives were grouped with industrial abrasives, autobody repair, and electrical materials — but the LLM claims they were listed as a standalone line item 'Structural adhesives and tapes', which contradicts the ground truth. (2) The LLM asserts that by 2024, 3M created a new 'Industrial Specialties division' and moved 'Industrial Adhesive and Tapes' into it, bundling adhesives with Closure & Masking Systems and Personal-Safety products. However, the ground truth does not mention a new division or this specific bundling; instead, it notes a shift toward specialized applications like construction and maintenance, with a broader suite of industrial specialty products. (3) The claim about cross-selling with sealing, masking, and safety solutions is an overinterpretation not supported by the original answer, which emphasizes adhesives as foundational in complex systems but does not reference personal safety or closure systems until 2024 as part of a broader shift. (4) Quantitative accuracy is high: years (2022, 2024) and document locations (page 107, 110) are correctly cited, and no numerical errors are present. (5) Reasoning is partially sound — the LLM identifies a strategic evolution — but the multi-hop synthesis is flawed because it infers organizational changes (new division) and product bundling not confirmed in the ground truth. (6) Contextual relevance is strong: the answer addresses the evolution of adhesives’ strategic role and attempts to interpret bundling trends. However, due to key factual misstatements about product groupings and organizational structure, the overall correctness is reduced to a 6 — partially correct but with significant errors in entity relationships and positioning details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 527,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "From the 2022 filing through the 2024 filing, Lilly continued to market Cyramza primarily as an oncology‑focused biologic with the same core label: second‑line treatment of advanced/metastatic gastric or gastro‑esophageal‑junction adenocarcinoma, metastatic non‑small‑cell lung cancer (NSCLC), metastatic colorectal cancer and hepatocellular carcinoma, plus a first‑line indication for adult patients with metastatic NSCLC that harbor activating EGFR mutations. During the same period the company layered additional intellectual‑property shields around the product—maintaining a U.S. compound patent that runs to 2026 (with a U.S. biologics data‑exclusivity also to 2026), a European compound patent to 2028 plus a separate data‑protection term that expires in 2024, and a Japanese compound patent to 2026 together with data protection that ends in 2023—thereby extending Cyramza’s exclusivity in the United States, Europe and Japan beyond the basic patent life.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in dates and intellectual property timelines, particularly regarding patent and data protection expirations, which diverge from the ground truth. While the therapeutic indications are correctly described and align with the original answer—confirming Cyramza's use in gastric, NSCLC, colorectal, and liver cancers—the IP details are incorrect. The LLM claims U.S. biologics data exclusivity and compound patent both last until 2026 (partially correct), but incorrectly states European compound patent extends to 2028 and data protection ends in 2024, while the ground truth indicates data protection in major European countries expires in 2024 and does not mention a 2028 patent. More critically, the LLM states Japanese compound patent lasts until 2026, but the original answer notes only data protection expired in 2023, with no mention of a 2026 patent—this is a key factual overstatement. The original answer emphasizes the *loss* of protections and preparation for competition, while the LLM portrays an aggressive extension of exclusivity via layered IP, which is not supported by the ground truth. This misrepresents Eli Lilly’s strategic positioning. Quantitative accuracy is low due to incorrect expiration dates. Qualitative accuracy is moderate because the reasoning structure is sound and indications are correct, but entity relationships (especially around IP timelines) are flawed. Contextual relevance is high as the answer addresses both therapeutic indications and IP across key markets as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 428,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "- **2022:** Fixed‑rate unsecured senior notes carried $24.1 billion on the balance sheet with a weighted‑average interest rate of about **4.45 %**.  \n- **2023:** The portfolio grew to $27.2 billion, but the weighted‑average rate remained **≈4.45 %**.  \n- **2024:** The carrying amount slipped slightly to $26.9 billion while the weighted‑average rate rose to **4.84 %**.\n\n**Interpretation:** Capital One expanded its fixed‑rate senior debt in 2023, then modestly trimmed the balance in 2024, but the higher average coupon in 2024 shows the company is now financing a similar amount of debt at higher market rates – a sign that its debt‑size strategy is stable, yet financing costs are increasing as interest‑rate environments tighten.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data, particularly for 2022. According to the ground truth, in 2022, Capital One's fixed unsecured senior debt had a carrying value of $19,975 million (~$19.98 billion) and a weighted-average interest rate of 2.91%. The LLM incorrectly reports $24.1 billion and 4.45%, which is closer to the 2024 rate. The 2023 and 2024 carrying values are approximately correct ($27.2B vs $26.93B in 2024), though 2023 data is not in the ground truth and thus cannot be verified. The 2024 interest rate of 4.84% is accurate. (2) Calculations: The LLM implies the rate was stable at 4.45% in 2022–2023, but ground truth shows a rise from 2.91% to 4.84% over 2022–2024, indicating a significant underrepresentation of the rate increase. The LLM misses the full trend of rising rates and misrepresents the starting point. (3) Multi-hop reasoning: The model attempts to synthesize a trend but does so on incorrect baseline data. While it correctly infers that financing costs are rising, it fails to capture the full strategic shift—issuing more debt at higher rates over time—because it misstates the early-year figures. The conclusion about stable debt size is partially supported, but the increase from $19.98B to $26.93B is substantial and misrepresented as stable. (4) Correctness score is 4 due to major quantitative errors in 2022 data, though later years are closer and the general direction of interpretation is plausible. Quantitative accuracy is low (3) due to wrong values for key metrics. Qualitative accuracy is moderate (5) because reasoning structure is sound but based on flawed inputs. Contextual relevance is high (8) as the answer addresses all parts of the question and attempts proper interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 487,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "Cisco’s exposure to the total‑return swaps that hedge its deferred‑compensation program has been growing steadily: the contracts’ notional amount rose from $651 million in FY 2022 → $792 million in FY 2023 → $985 million in FY 2024【page_92】【page_91】.  The earnings impact of the swaps has been highly volatile – a $92 million loss was recorded in FY 2022, followed by a $58 million gain in FY 2023 and a $91 million gain in FY 2024【page_92】【page_91】.  This swing from a sizable loss to sizable gains over three years shows that the instrument can produce large, fluctuating results and therefore contributes notable earnings volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures for the gains and losses from the Total Return Swaps tied to Deferred Compensation: a $92 million loss in FY2022, a $58 million gain in FY2023, and a $91 million gain in FY2024 — matching the ground truth exactly. These numbers are presented accurately with acceptable formatting variations. (2) While the original answer does not mention notional amounts, the LLM provides additional context about the growing notional exposure ($651M → $792M → $985M), which is factually consistent with typical 10-K disclosures and does not contradict the ground truth; it enhances rather than distorts the response. The core quantitative data on gains/losses is fully accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes the pattern of swings (loss to gains) and draws a valid conclusion about earnings volatility, aligning with the ground truth's interpretation. (4) The answer is semantically equivalent and contextually complete — it addresses both parts of the question (evolution of exposure and volatility implications). The only minor deviation is the inclusion of notional amounts not present in the ground truth, but this does not reduce accuracy and may reflect deeper document insight. Thus, the answer earns a 9/10 for correctness due to slight over-enrichment without error, and perfect scores in quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 396,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "From 2022 through 2024 The Home Depot repeatedly stressed that a well‑maintained, attractive store – from way‑finding signage and refreshed front‑end layouts to electronic shelf‑labels and curb‑side pickup lockers – is a core competitive lever against multichannel and pure‑online rivals.  In 2022 the filing noted that “we compete … on store location and appearance” and that recent “store‑refresh packages” were intended to boost the shopping experience; by 2023 the same language re‑appeared, and in 2024 the company expanded the program (adding new signage, redesigns, self‑service lockers and opening 12 new stores) and tied it to “higher customer‑satisfaction scores.”  The measurable result was that, despite the shift toward e‑commerce, roughly half of U.S. online orders continued to be fulfilled in‑store (≈50 % in FY 2024 versus ≈55 % in earlier years), indicating the appearance upgrades helped preserve a strong competitive position versus multichannel and online competitors.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of The Home Depot's strategic emphasis on store appearance from 2022 to 2024, correctly identifying its role as a competitive lever against online and multichannel retailers. It accurately reflects that store appearance was consistently highlighted across years and increasingly integrated with omnichannel capabilities. However, there are key quantitative inaccuracies: the claim that 'roughly half of U.S. online orders continued to be fulfilled in-store (≈50% in FY 2024 versus ≈55% in earlier years)' is not supported by the original answer, which does not mention these specific percentages or trends in in-store fulfillment rates. This introduces a measurable impact claim not present in the ground truth, undermining quantitative accuracy. While the LLM correctly notes enhancements like signage, lockers, and store refreshes, the original answer does not specify '12 new stores' opened in 2024 or tie appearance directly to 'higher customer-satisfaction scores'—details absent from the ground truth. These additions, though plausible, are factually unsupported. Qualitatively, the reasoning is sound: the answer synthesizes the multi-year emphasis on appearance and links it to hybrid retail strategy, aligning with the original's narrative of a shift toward an interconnected experience. Contextually, the response is highly relevant, addressing both the evolution of strategy and competitive impact. Despite strong thematic alignment and correct use of citations (e.g., quoting 'store location and appearance'), the inclusion of unverified metrics reduces factual precision. Semantic equivalence is mostly maintained, but the added numerical claims prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 467,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "- Fiscal 2022 (as of January 30 2022) – the 3.50 % Notes Due 2050 were carried on the balance sheet at **≈ $1.5 billion**【NVDA_10k_2022.pdf page 78】.  \n- Fiscal 2023 (as of January 29 2023) – the same notes were carried at **$1.637 billion**【NVDA_10k_2023.pdf page 67】.  \n- Fiscal 2024 (as of January 28 2024) – the carrying amount was **$1.604 billion**【NVDA_10k_2024.pdf page 67】.  \n\nThe progression shows the 3.50 % 2050 issuance grew modestly from 2022 to 2023 and then fell slightly in 2024, indicating that NVIDIA’s long‑term debt base has remained relatively stable, with only a small net reduction in the most recent year rather than a sharp increase or large draw‑down. This stability suggests the company is managing its long‑term financing prudently while keeping ample capacity for future growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported carrying values. According to the ground truth, the correct values are $2,147 million (2022), $1,637 million (2023), and $2,000 million (2024). The LLM reports $1.5 billion (~$1,500 million) for 2022 (incorrect), $1,637 million for 2023 (correct), and $1,604 million for 2024 (incorrect; should be $2,000 million). The 2024 figure is particularly off, missing a $396 million increase. (2) Calculations and comparisons are therefore flawed: the LLM claims a modest increase from 2022 to 2023 and then a slight decrease in 2024, but the truth is a significant drop from 2022 to 2023 and then a substantial rebound to $2,000 million in 2024. This misrepresents the trend entirely. (3) The multi-hop reasoning is unsound: the LLM fails to recognize the key pattern — a temporary reduction followed by repositioning — because it uses incorrect data. The conclusion about 'small net reduction' contradicts the ground truth, which shows a rebound toward near-original levels, indicating stabilization or strategic repositioning, not continued reduction. (4) While the LLM attempts to interpret the trend and addresses both parts of the question (values over time and implications), the severe numerical inaccuracies undermine both quantitative and qualitative correctness. Contextual relevance is moderate because the structure and intent align with the question, but factual foundation is weak. Minor formatting variations (e.g., $1.637 billion vs $1,637 million) are acceptable, but magnitude and direction of change must be preserved — they are not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 445,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "By 2022 3M’s Scotchgard exposure was still centered on legacy state‑court actions – roughly 275 individual suits in Michigan and a $65 million settlement with New York plaintiffs (plus an immaterial Wolverine settlement) – with most cases naming 3M and a few co‑defendants such as Du‑Pont or Chemours. In 2023 the company entered a sweeping public‑water‑system settlement (the “PWS Settlement”) that will cost $10.5‑$12.5 billion and resolve thousands of AFFF/Scotchgard claims, while dozens of state‑attorney‑general lawsuits continued across the country. By the 2024 filing the litigation had spread to new jurisdictions (Illinois, Georgia, Alabama, Missouri, Connecticut, Virginia, Minnesota, etc.), new class‑action and individual suits were either settled for immaterial amounts or moved toward dismissal, and each case now typically lists multiple defendants – 3M together with Du‑Pont, Chemours and various carpet, water‑utility or industrial partners – reflecting a broader, multi‑defendant landscape.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The $10.5–12.5 billion 'PWS Settlement' in 2023 is entirely incorrect and not supported by the ground truth; no such settlement is mentioned, especially not at that magnitude. The ground truth notes only immaterial settlements in 2022 and 2023 (e.g., $65M class action in NY with 3M's share immaterial, and a non-material Michigan Wolverine case). The LLM's claim of a $10.5–12.5 billion settlement is off by orders of magnitude and fundamentally misrepresents 3M's legal exposure. Additionally, the number of lawsuits (e.g., '275 individual suits in Michigan') is not present in the ground truth and appears fabricated. (2) Completeness: While the question asks about evolution in case settlements, geographic expansion, and number of defendants, the LLM incorrectly invents a massive settlement not in the original data, thus failing to accurately describe the settlement landscape. It does correctly note geographic expansion into states like Georgia and Alabama, aligning partially with the ground truth. It also correctly identifies multiple defendants (DuPont, Chemours) being named alongside 3M, which matches the trend described. (3) Entity Accuracy: Companies like DuPont, Chemours, and references to AFFF (though not in the ground truth) are plausible in the broader PFAS litigation context, but the inclusion of a non-existent $12.5B settlement undermines credibility. The mention of 'carpet, water-utility or industrial partners' as defendants aligns with Mohawk Industries and municipal utilities in the ground truth. (4) Reasoning: The multi-hop synthesis is flawed because the LLM appears to conflate 3M’s broader PFAS/AFFF litigation with Scotchgard-specific cases. The ground truth focuses on Scotchgard-linked contamination (e.g., Wolverine shoe manufacturing, Mohawk), but the LLM generalizes to AFFF claims, which are distinct. The timeline is also distorted—no sweeping 2023 settlement occurred. (5) Semantic Equivalence: Despite some alignment in geographic spread and co-defendants, the invention of a massive settlement and incorrect case numbers makes the overall answer misleading. The core financial and legal conclusions are false. Thus, while the answer shows awareness of the general litigation trend, its factual foundation is unsound, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 640,
        "total_tokens": 2144
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "Lilly’s agreement with AbCellera has kept the same royalty formula throughout the period – AbCellera receives tiered royalties on worldwide net sales of the COVID‑19 antibodies (bamlanivimab and bebtelovimab) that sit in the mid‑teens to mid‑twenties percent range (see 2022 10‑K page 72 and 2024 10‑K page 73).  The filing does not disclose any development or sales‑based milestone payments to AbCellera, indicating that no such payments were material during 2022‑2024.  Commercially, the collaboration generated $2.02 billion of net product revenue in 2022, but sales fell to zero in both 2023 and 2024 as the antibodies were no longer sold under EUA (2024 10‑K page 73).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: the royalty structure (tiered, mid-teens to mid-twenties percent) is accurately described and consistently cited across 2022 and 2024 10-Ks; net product revenue of $2.02 billion in 2022 is exact; sales dropped to zero in 2023 and 2024, correctly attributed to loss of EUA authorization. (2) Quantitative accuracy is perfect: the $2.02 billion figure matches exactly, and the absence of sales and milestone payments in 2023–2024 is correctly reported. No calculation errors. (3) Multi-hop reasoning is sound: the answer synthesizes data across multiple years and filings (2022 and 2024 10-Ks), correctly infers no milestone payments due to lack of disclosure (consistent with ground truth), and links the commercial decline to regulatory status (EUA). (4) Semantic equivalence is strong: though phrased more concisely, the LLM captures all elements of the original answer—royalty structure stability, milestone payment absence, revenue drop, and commercial cessation—without omissions or distortions. Contextual relevance is complete, addressing all sub-questions: royalty terms, milestones, revenue evolution. Minor addition of drug names (bamlanivimab, bebtelovimab) adds precision without deviation. No factual or interpretive errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 373,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "In the 2022 filing Dawn was noted only as one of the “leading home‑care brands” behind Cascade, Febreze and Swiffer in the Fabric & Home Care segment, which accounted for about 35 % of P&G’s net sales. By the 2024 filing Dawn appears in the explicit list of the segment’s ten “major brands” (Ariel, Downy, Gain, Tide, Cascade, **Dawn**, Fairy, Febreze, Mr. Clean and Swiffer) and the segment’s contribution had risen to roughly 36 % of total sales. This shift from a peripheral mention to a headline‑brand slot signals that Dawn has become an increasingly central, growth‑driving product within the Fabric & Home Care portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partially accurate quantitative data but introduces a significant factual error in reasoning and entity representation that undermines the overall correctness. (1) Quantitatively, the percentages cited (35% in 2022, 36% in 2024 for net sales) are consistent with the ground truth, and the segment’s stable contribution is correctly framed. However, the claim that Dawn was not a 'major brand' in 2022 but became one by 2024 is contradicted by the original answer, which states Dawn was consistently highlighted as a key brand across all three years (2022–2024). (2) The ground truth confirms Dawn was listed among key brands in 2022, not demoted or peripheral, so the characterization of a 'shift from peripheral mention to headline-brand slot' is factually incorrect. (3) The multi-hop reasoning fails because it infers strategic elevation based on a perceived change in listing prominence that isn’t supported by the evidence—Dawn’s strategic importance remained stable, not increasing. (4) While the answer addresses the question’s focus on evolution and strategic importance, its core conclusion (increasing centrality) is invalid, leading to a low correctness score despite accurate numbers. The contextual relevance is moderate because it engages with the right segment and timeframe, but the qualitative inaccuracy in brand positioning severely limits reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 384,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "- **Short‑term borrowings:** $883 million in 2022 fell to $538 million in 2023 and rose only modestly to $562 million in 2024.  \n- **Long‑term debt:** $47.8 billion in 2022 grew to $49.3 billion in 2023 and then contracted to $45.0 billion in 2024 (total debt = short‑term + long‑term fell from $48.7 billion in 2022 to $45.6 billion in 2024).  \n\n**Trend interpretation:** Capital One’s debt profile shows a sharp pull‑back in short‑term funding after 2022 and a net deleveraging in 2024, while the composition of long‑term debt shifted away from floating‑rate exposure – the floating unsecured senior notes fell from $1.6 billion in 2022 to $0 by the end of 2024.  This indicates the company has been refinancing or retiring its variable‑rate senior debt, reducing sensitivity to interest‑rate movements even though the remaining unsecured senior debt is now largely fixed‑rate and carries a higher weighted‑average coupon.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several quantitative inaccuracies. According to the ground truth, total short-term borrowings and long-term debt were $43.086B in 2022, $48.715B in 2023, and $45.551B in 2024. However, the LLM reports total debt as $48.7B in 2022 (vs. correct $43.086B), which is off by over $5.6B. The LLM's long-term debt figures ($47.8B, $49.3B, $45.0B) do not match the ground truth totals, and short-term borrowings in the original answer are not explicitly broken out, making direct comparison difficult, but the LLM's values ($883M, $538M, $562M) suggest a different capital structure. The sum of LLM's short-term and long-term debt does not align with the ground truth total debt figures. (2) The floating unsecured senior debt is reported as $1.6B in 2022 by the LLM, but ground truth is $1.709B; more critically, the LLM states it dropped to $0 by 2024, which matches the trend (eliminated), though the intermediate $349M in 2023 is omitted. The weighted-average interest rate on fixed unsecured senior debt is entirely missing from the LLM answer (2.91% → 4.45% → 4.84%), a key metric in the original answer. (3) The reasoning and synthesis are partially sound: the LLM correctly infers a shift away from floating-rate debt and reduced interest rate exposure, and identifies a net deleveraging trend in 2024. It correctly interprets the strategic move toward fixed-rate debt, even without citing exact interest rates. However, it fails to fully synthesize the 3-year trend with accurate magnitude and omits key data points. (4) Scores justified: Correctness is 6 due to partially correct trends but significant numerical errors; Quantitative Accuracy is 5 due to material deviations in dollar amounts and missing rate data; Qualitative Accuracy is 7 because logic and interpretation are reasonable given the data it used; Contextual Relevance is 9 as the answer addresses all aspects of the question with relevant financial reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 530,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "- **FY 2022:** The 5.90 % senior note (Feb 15 2039) carried $2 billion of principal, was reported as part of long‑term debt (total long‑term debt $9 billion, of which the note represented roughly 22 % of the balance) and had an effective interest rate of **6.11 %**.  \n\n- **FY 2023:** The same $2 billion 5.90 % note remained on the balance sheet (still long‑term, not in the current portion). Total long‑term debt fell to $8.4 billion, so the note’s share rose to about **24 %** of long‑term debt, and its effective rate stayed at **6.11 %**.  \n\n- **FY 2024:** Cisco issued a large amount of new senior notes, pushing total long‑term debt to $19.6 billion. The 5.90 % note is still present with $2 billion principal, classified as **long‑term debt**, but now accounts for only about **10 %** of the long‑term debt portfolio. Its effective interest rate continued to be **6.11 %**.  \n\nThus, while the absolute amount of the 5.90 % note never changed, its proportion of Cisco’s total debt fell as the company added many higher‑rated issues, and its effective interest rate and long‑term classification remained unchanged from FY 2022 through FY 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent $2,000 million principal amount of the 5.90% Note and the unchanged effective interest rate of 6.11% across all years, which aligns with the ground truth. It also accurately captures the shift in the note's proportion within total long-term debt due to Cisco's overall debt expansion. However, there is a discrepancy in the reported total long-term debt for FY 2022: the LLM states $9 billion, while the ground truth specifies $8,416 million. This leads to an incorrect proportion (22% vs. actual ~23.8%), though the direction of change is correct. In FY 2023, the LLM claims total long-term debt fell to $8.4 billion, but the ground truth shows an increase from $8,416M in 2022 to $19,621M in 2024—no intermediate 2023 value is provided in the ground truth, so the LLM’s claim of a drop to $8.4B cannot be verified and may be incorrect if the trend was upward. The FY 2024 total of $19.6B is accurate (matches $19,621M). (2) Calculations: The percentage allocations (22%, 24%, 10%) are approximate and based on rounded figures; while the 10% share in 2024 is reasonable (~$2,000M / $19,621M ≈ 10.2%), the earlier percentages are skewed by inaccurate total debt inputs. (3) Multi-hop reasoning is strong: the model correctly infers that a stable note value amidst changing total debt alters its relative composition, and it maintains correct classification and interest rate consistency. (4) Scores justified: Correctness is 8 due to mostly accurate facts but some incorrect quantitative inputs; Quantitative Accuracy is 7 due to the FY2022 and FY2023 total debt inaccuracies; Qualitative Accuracy is 9 for excellent synthesis and logic; Contextual Relevance is 10 as all aspects of the question are addressed appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 486,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "- **Carrying value** – The 1.55 % Notes Due 2028 were carried at **$1.25 billion** in FY 2024 (Jan 28 2024) and at **$1.099 billion** in FY 2023 (Jan 29 2023). The FY 2022 filing shows the same line‑item amount of **$1.099 billion** (the notes are recorded at original issuance value net of un‑amortized discount).【page_72†L9-L13】【page_66†L13-L17】\n\n- **Effective interest rate** – The notes earned an **effective interest rate of about 1.6 %** in FY 2024 (1.64 %). The 2023 and 2022 disclosures list the same low‑coupon series and, because the coupon is 1.55 % and the discount is modest, the effective rate remains essentially unchanged at roughly **1.6 %** in those years.【page_72†L9-L13】\n\n**Interpretation** – NVIDIA’s 1.55 % 2028 notes have been gradually reduced in carrying amount while the cost of borrowing has stayed at a very low, near‑coupon rate (~1.6 %). This pattern indicates that the company is slowly retiring its cheap, long‑dated senior debt, preserving a low‑cost financing base and demonstrating a strategy of using inexpensive, long‑term debt to fund growth while minimizing interest expense.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the carrying value trend. According to the ground truth, the carrying value was $1,200 million in FY2022, decreased to $1,099 million in FY2023, and then increased to $1,250 million in FY2024. However, the LLM incorrectly states that the carrying value was $1.099 billion in both FY2022 and FY2023, missing the initial $1,200 million value in 2022 and thus misrepresenting the trend. This undermines the quantitative accuracy. The effective interest rate is reported as approximately 1.6% for all years, with a note that it was 1.64% in 2024. While this aligns roughly with the ground truth (which states an increase to 1.64% in 2024), the LLM downplays the change by asserting the rate remained 'essentially unchanged,' contradicting the ground truth implication of a modest but meaningful rise in borrowing costs. (2) Number verification: $1.25 billion in 2024 is correct; $1.099 billion in 2023 is correct; but $1.099 billion in 2022 is incorrect — it should be $1,200 million. The effective rate of 1.64% in 2024 is acknowledged, but the lack of specificity for 2022 and 2023 (where the ground truth implies a lower implied rate) reduces precision. (3) Multi-hop reasoning is partially sound — the model identifies the correct debt instrument and pulls data across years, but fails to accurately synthesize the full trend due to the incorrect 2022 value. The interpretation that NVIDIA is 'slowly retiring' the debt contradicts the actual increase from $1,099M to $1,250M in 2024, suggesting reacquisition or revaluation, not retirement. (4) Scores reflect partial correctness: moderate quantitative and qualitative accuracy due to key errors in data points and trend interpretation, though the context and relevance to the question about debt strategy are well-framed despite flawed support.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 506,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "In the 2022 filing Google highlighted the Pixel line (Pixel 5a 5G, Pixel 6) as a flagship of its “hardware” push and grouped the sales of those phones under the **“devices”** component of the combined **Google subscriptions, platforms, and devices** revenue category. By the 2024 filing the same categorization is retained – Pixel sales are still reported as “devices” within that revenue line – but the narrative shifts to larger capital‑expenditure outlays (property‑and‑equipment purchases rose from $31 billion in 2022 to $52 billion in 2024) and continued R&D spending, signalling that Alphabet is investing more heavily in hardware innovation even though the revenue classification has not changed.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Pixel devices were categorized under the 'devices' segment within the 'Subscriptions, Platforms, and Devices' revenue stream in both 2022 and 2024, which aligns with the ground truth. It also correctly notes the continuity in revenue categorization and links it to strategic investment in hardware. However, the LLM incorrectly implies that this categorization was already in place in 2022, while the ground truth states that the explicit segmentation became notable in 2023 — a key multi-hop point missed. (2) The LLM introduces specific capital expenditure figures ($31B in 2022, $52B in 2024), which are not present in the original answer and cannot be verified against the provided ground truth. These numbers may be factually accurate in external context but are unsupported here, reducing quantitative accuracy. There are no calculations, so scoring focuses on factual precision of numbers cited. (3) The reasoning is partially sound: the LLM infers increased investment in hardware from rising capex and R&D, which is plausible, but fails to capture the evolution across 2022–2024 as a progression (investment → segmentation → integration), particularly missing the significance of 2023 as a turning point in revenue reporting. This weakens the multi-hop synthesis. (4) Despite missing the 2023 shift and introducing unverified numbers, the answer remains contextually relevant and captures the broader narrative of sustained investment and strategic importance of Pixel devices. Wording differs but core ideas about categorization and innovation investment are aligned, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 459,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, BNY Mellon’s Item 14 disclosure is identical: it states that the required information is incorporated by reference to the proxy’s “Item 3 – Ratification of KPMG LLP,” and it lists KPMG’s PCAOB firm identification number (185). The unchanged language and format over the three years indicate that the company has retained the same principal accountant without material alteration, signaling a stable and continuous audit relationship with KPMG.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately states that BNY Mellon used identical disclosure language across 2022, 2023, and 2024 regarding the ratification of KPMG LLP as principal accountant, with reference to the proxy's Item 3 and inclusion of KPMG’s PCAOB identification number (185), which matches the original answer. (2) There are no numerical or date inaccuracies; the years (2022–2024) and PCAOB number (185) are correct and consistently reported. (3) The multi-hop reasoning is sound: the model correctly infers audit relationship stability from the unchanged disclosure format and content over three years, synthesizing information across multiple filings. (4) The answer fully addresses both parts of the question—evolution (or lack thereof) in disclosure and what it reveals about audit stability—and provides a logically sound conclusion. Wording differs slightly but conveys the same meaning, and all key entities (BNY Mellon, KPMG LLP, PCAOB ID 185, proxy Item 3, Form 10-K) are correctly identified. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 313,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "- **2022:** Private‑alternative assets (hedge funds $3,249 M, equity‑like funds $4,014 M, real‑estate $349 M, other $1,262 M) totaled **≈ $8.9 b**, representing **about 67 %** of the defined‑benefit pension plan portfolio ($13.2 b)【page_99】.  \n- **2023:** The same categories fell to **≈ $8.6 b**, or **≈ 63 %** of the pension plan total ($13.7 b)【page_98】.  \n- **2024:** Private‑alternative holdings further declined to **≈ $8.2 b**, or **≈ 60 %** of the pension plan total ($13.7 b)【page_99】.  \n\n**Interpretation:** Over the three‑year span LLY’s share of illiquid, private‑alternative investments has been steadily trimmed from roughly two‑thirds to about three‑fifths of its pension‑plan assets, indicating a gradual rebalancing toward more liquid or public‑market assets while still preserving a sizable commitment to long‑term, higher‑return illiquid investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of LLY's private alternative investment allocation. The ground truth states allocations were $10,542.5M (2022), $10,335.2M (2023), and $10,051.0M (2024), showing a slight decrease but still high and stable long-term commitment. However, the LLM claims allocations declined from ~$8.9B to ~$8.2B, which underreports the actual values and misrepresents the trend as a steady decline in absolute terms. Additionally, the percentages cited (67% → 60%) are inconsistent with the ground truth, which does not mention portfolio percentages or rebalancing toward liquidity. (2) The dollar amounts are significantly off: for example, $8.9B vs. $10,542.5M (~$10.5B) in 2022 — a difference of over $1.6B. The LLM appears to have summed incorrect component figures (e.g., hedge funds $3,249M + equity-like $4,014M + real estate $349M + other $1,262M = $8,874M ≈ $8.9B), but the ground truth does not provide these breakdowns, suggesting the LLM fabricated or misattributed data. Furthermore, the total pension plan sizes ($13.2B, $13.7B) and percentage allocations are not present in the original answer and contradict the narrative of stable high exposure. (3) The multi-hop reasoning is flawed: instead of recognizing a consistent, high-level allocation to illiquid assets indicating long-term strategic commitment, the LLM infers a deliberate reduction and rebalancing toward liquidity — the opposite of the ground truth’s conclusion. This misinterpretation stems from incorrect data synthesis and unsupported calculations. (4) Despite the factual errors, the LLM attempts to address both parts of the question — evolution over time and strategic implication — and uses appropriate financial terminology, giving it moderate contextual relevance. However, due to severe quantitative inaccuracies and resulting flawed reasoning, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 521,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "- **2022 10‑K** – Tampax was called out as a core brand in the **menstrual‑care sub‑category** of the “Feminine Care (Adult Incontinence, Menstrual Care)” line of the Baby, Feminine & Family Care segment, and the filing highlighted that P&G “compete in the menstrual‑care sub‑category primarily behind our **Always and Tampax** brands with over 25 % global market share”【page_19】.  \n\n- **2023 10‑K** – The company kept Tampax in the same **Feminine‑Care portion of the Baby, Feminine & Family Care segment**, listing it among the major brands for that segment (Always, Always Discreet, **Tampax**, Bounty, Charmin, Puffs) but removed the explicit market‑share language, presenting it simply as one of the segment’s key brands【page_18 (2023)】.  \n\n- **2024 10‑K** – Tampax remains in the **Feminine‑Care (Adult Incontinence, Menstrual Care)** category of the Baby, Feminine & Family Care segment, now shown in the brand list as “**Tampax** Bounty” alongside the other brands, with the description focusing on the overall segment composition rather than on Tampax’s market‑share leadership【page_18】.  \n\n**Overall evolution:** Across the three years, Tampax stayed within the same Feminine‑Care sub‑category of the Baby, Feminine & Family Care segment, but its positioning shifted from a highlighted market‑leader in menstrual care (2022) to a standard listed brand without specific share commentary (2023), and by 2024 it was presented only as part of the broader Feminine‑Care brand roster.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. While it correctly identifies Tampax as part of the 'Baby, Feminine & Family Care' segment across all three years, it misrepresents the evolution of category classification. The ground truth states that in 2023, 'Menstrual Care' explicitly replaced 'Feminine Care' as a sub-category, but the LLM answer incorrectly claims Tampax remained in 'Feminine Care' in 2023 and 2024, missing this key reclassification. Additionally, the LLM incorrectly suggests that 'Feminine Care' still includes 'Adult Incontinence, Menstrual Care' in 2024, while the ground truth notes a strategic streamlining with 'Baby Care' removed — a critical structural change the LLM fails to mention. (2) Quantitatively, the LLM omits the net sales percentages (25% in 2022, 24% in 2023 and 2024) entirely, which are central to the original answer and reflect the segment’s performance. It also incorrectly cites a '25% global market share' for Always and Tampax from the 2022 filing — this figure is not in the ground truth and may be a misinterpretation of the 25% segment contribution to net sales. This is a significant factual error. (3) The multi-hop reasoning is partially sound in tracking Tampax across years, but the LLM fails to synthesize the strategic implications of the rebranding from 'Feminine Care' to 'Menstrual Care' and the removal of 'Baby Care' in 2024. It focuses narrowly on brand listing and market share commentary rather than the broader portfolio evolution. (4) Contextual relevance is strong — the answer addresses the question’s focus on Tampax’s positioning and cites appropriate sections — but the qualitative and quantitative inaccuracies reduce correctness. The answer captures some elements of emphasis shift but misidentifies the category evolution and omits key financial and structural changes, resulting in a partially correct but misleading narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1608,
        "completion_tokens": 530,
        "total_tokens": 2139
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "From 2022 to 2024 Capital One continued to value its net derivative assets (liabilities) on a recurring basis with a **discounted‑cash‑flow (DCF) model** that relies on **swap rates** as the primary unobservable input. In 2022 the Level‑3 net derivative liability was only about **$5 million** and the swap‑rate input was a low‑range (≈ 1‑2 % weighted‑average); by 2023 the balance had risen to **$58 million** and the swap‑rate range widened to **3‑5 %** (weighted‑average ≈ 4 %); and in 2024 the balance grew further to **$69 million**, with the DCF model still using swap rates—now shown at a **4 %** range/average. Thus, while the valuation technique stayed the same, the assumed swap rates moved higher and the exposure size expanded markedly over the three‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in key quantitative data and misrepresents the evolution of Capital One's valuation practices. (1) Quantitative Accuracy: The 2022 fair value is incorrectly stated as $5 million; the ground truth is $19 million. The 2024 fair value is wrong at $69 million; it remained $58 million. The 2022 swap rate is fabricated (1-2%)—no such input was disclosed, and the model was not explicitly stated as DCF in 2022. The 2024 swap rate is misrepresented as 4%; the truth is the 3-5% range was maintained. (2) Completeness: The question asks about both default rates and swap rates; the LLM omits default rates entirely in 2023 and 2024, despite their inclusion in the ground truth (53-163%). (3) Entity Accuracy: While the company (Capital One) and metric (net derivative assets/liabilities) are correct, the years and associated figures are mismatched. (4) Reasoning: The LLM incorrectly assumes DCF was used in 2022, when the original answer states the technique was not disclosed. This breaks the multi-hop logic, as the shift to transparency in 2023 is a key point in the ground truth, but the LLM implies consistency in methodology. (5) Semantic Equivalence: The overall narrative of increasing exposure and rising rates contradicts the truth—fair value stabilized at $58M in 2023–2024, and no data supports a rise to $69M. The core facts are largely incorrect, undermining the answer’s validity despite addressing the general topic of valuation assumptions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 413,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "Cisco’s “other income (loss), net” was driven by the performance of its available‑for‑sale debt portfolio, which swung from a **$9 million gain in fiscal 2022** to a **$21 million loss in fiscal 2023** and then a **$67 million loss in fiscal 2024**【page_46】. The progression from a modest gain to increasingly larger unrealized losses shows that the fair‑value of these debt securities fell sharply – largely as higher interest rates and credit‑quality pressures reduced their market value – indicating that, while still classified as high‑quality, the AFS debt investments have become a growing source of earnings volatility and risk for Cisco.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that no specific performance metrics were provided for AFS debt investments in fiscal 2022, meaning there is no disclosed $9 million gain. Instead, the LLM fabricates precise figures—$9M gain in 2022, $21M loss in 2023, $67M loss in 2024—which are not supported by the original answer. These numbers contradict the ground truth, which only confirms that AFS losses materially impacted 'other income (loss), net' in 2023 and 2024 without quantifying them. (2) The quantitative inaccuracies are severe: all three dollar amounts are false, and the trend, while directionally plausible (increasing losses), is not substantiated in the source. There is no mention of unrealized losses, fair value changes, or interest rate impacts in the ground truth, so those details are speculative additions. (3) The multi-hop reasoning is partially sound in structure—linking AFS debt performance to 'other income (loss), net' across years—but fails because it relies on invented data. The conclusion about growing risk aligns with the ground truth’s interpretation, but it is built on false premises. (4) Contextual relevance is high because the LLM addresses the right metric, company, time frame, and risk implications. However, correctness score is low due to fabrication of key financial data, making the answer misleading despite a reasonable narrative arc.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 401,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "Starbucks said that its existing purchase commitments and inventory would “provide an adequate supply of green coffee through fiscal 2023” in the 2022 Form 10‑K (page 12) 【page_12】; the 2023 filing projected the same level of adequacy through fiscal 2024 (page 12 of the 2023 report) 【page_12】; and the 2024 filing extended the outlook to “through fiscal 2025” (page 12) 【page_12】.  \n\nThis year‑over‑year extension shows that Starbucks is continuously lengthening its supply horizon by adding long‑term fixed‑price and price‑to‑be‑fixed contracts, maintaining inventory buffers and using hedging tools, which reflects a proactive sourcing strategy aimed at securing high‑quality beans and mitigating the risk of supply disruptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Starbucks' green coffee supply adequacy from fiscal 2022 through 2024. In fiscal 2022, the projection was through fiscal 2023; in 2023, it extended to fiscal 2024; and in 2024, it extended further to fiscal 2025. These dates and projections match the ground truth exactly. (2) All numeric and temporal data are accurate—there are no calculation errors or misstated timeframes. The LLM correctly cites page 12 of each respective 10-K, aligning with the source documentation. (3) The multi-hop reasoning is sound: the model synthesizes information across three consecutive fiscal years and correctly infers that the lengthening of supply adequacy reflects a proactive sourcing strategy. It accurately identifies mechanisms such as long-term contracts, inventory buffers, and hedging tools, which are consistent with risk mitigation. (4) While the LLM answer adds slightly more detail on mechanisms (e.g., 'fixed-price and price-to-be-fixed contracts', 'hedging tools') not explicitly mentioned in the ground truth, these are reasonable inferences and do not contradict the original. The core conclusion about strengthening sourcing strategy and reducing supply risk is semantically equivalent. One minor point preventing a perfect 10 is that the LLM slightly over-elaborates on specific contract types without direct grounding in the provided truth, but this does not impair factual correctness. Overall, the answer is factually accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 424,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "NVIDIA’s liability for the 2.00 % senior notes that mature in 2031 has been essentially flat over the last three fiscal years. The 2024 Form 10‑K shows a fair‑value carrying amount of **$1,057 million** for the 2.00 % Notes Due 2031, while the 2023 Form 10‑K lists the same series at **$1,044 million** 【page 67】. The 2022 filing excerpts do not contain a separate line for this series, but the amounts in 2023 and 2024 indicate that the exposure has hovered around the $1 billion mark throughout the period.\n\n**What the trend reveals:** NVIDIA is keeping its long‑term debt base stable, using low‑coupon, long‑dated notes as a financing tool rather than aggressively expanding or retiring this tranche. The modest, near‑flat exposure suggests a deliberate strategy to maintain a predictable, low‑cost debt profile that can support ongoing capital‑intensive investments while limiting leverage growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, NVIDIA's exposure to the 2.00% Notes Due 2031 was $1,200 million in fiscal 2022, $1,044 million in 2023, and $1,250 million in 2024 — showing a clear fluctuation with an upward trend. However, the LLM claims the exposure was 'essentially flat' and reports only $1,057 million in 2024 (vs. correct $1,250 million) and $1,044 million in 2023 (correct), while stating that 2022 data is unavailable. This misrepresents both the magnitude and trend of the liability. The $1,057 million figure cited for 2024 does not match the ground truth $1,250 million, and the omission of the $1,200 million 2022 value (which contradicts the 'flat' claim) is a critical error. (2) Quantitative accuracy is low: two out of three values are incorrect or missing, and the calculation of trend (flat vs. fluctuating upward) is wrong. The model underreports 2024 by $193 million and omits the correct 2022 figure entirely. (3) Reasoning is partially sound in interpreting the strategic implication of using long-term, low-coupon debt, but the conclusion about 'stable' or 'near-flat' exposure is based on flawed data, undermining the validity of the synthesis. The multi-hop analysis fails because it does not correctly integrate the 2022 and 2024 data points that show material changes. (4) Contextual relevance is high — the answer addresses the right instrument, time frame, and strategic question — but factual correctness drags down overall quality. Semantic equivalence is not achieved due to incorrect numbers and mischaracterized trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 453,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "In the 2022 filing the Safety & Industrial segment listed “respiratory, hearing, eye **and fall‑protection solutions**” only as a line‑item of the broader safety portfolio, with no separate division or special emphasis (the segment’s product description was a single block of safety‑related items). By 2024, 3M had created an **Industrial Specialties division** inside Safety & Industrial (page 110) that combined the former Personal‑Safety products with other specialty lines, and the segment’s product list still calls out “respiratory, hearing, eye **and fall‑protection solutions**” (page 110). Thus, fall‑protection moved from being a generic safety‑solution line in 2022 to being housed in a dedicated Industrial Specialties division in 2024, giving it a clearer, more focused placement alongside other industrial‑safety offerings.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error in its qualitative interpretation of the evolution of Fall Protection Solutions within MMM's Safety and Industrial segment, despite correctly identifying the product categories mentioned in the filings. The key inaccuracy lies in claiming that by 2024, 3M had created an 'Industrial Specialties division' within the Safety & Industrial segment that combined Personal Safety products with other specialty lines. The ground truth does not support this structural reorganization; there is no evidence in the knowledge graph that an 'Industrial Specialties division' was formally created or that Fall Protection Solutions were moved into a dedicated division. Instead, the 2024 presentation showed a subtle shift in grouping and emphasis—aligning fall protection more closely with industrial safety systems—without any indication of a new internal division. This misrepresentation fundamentally distorts the nature of the evolution. While the LLM correctly notes that fall protection was listed alongside respiratory, hearing, and eye protection in both years and attempts to describe a shift in emphasis, it incorrectly infers organizational restructuring not present in the source data. The dates (2022, 2024) and product listings are accurate, so quantitative accuracy is high, and the response is contextually relevant, but the reasoning and entity-level interpretation (e.g., creation of a new division) are flawed, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 418,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "- 2022: COVID‑19 antibody revenue (bamlanivimab ± etesevimab ± bebtelovimab) was $2,008.9 million in the U.S. plus $14.7 million outside the U.S., or roughly **$2.0 billion total**【page_67】.  \n- 2023: The same line shows “‑” for both U.S. and outside‑U.S., indicating **no revenue** from these antibodies in 2023【page_67】.  \n- 2024: The 2024 table also lists “‑” for COVID‑19 antibodies in both regions, confirming **zero revenue** in 2024【page_68】.  \n\n**Trend:** Revenue from bamlanivimab (and the broader COVID‑19 antibody portfolio) fell from about $2 billion in 2022 to essentially nothing by 2023 and stayed at $0 in 2024, showing that Eli Lilly rapidly moved away from reliance on its COVID‑19 antibody products after the 2022 peak.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the revenue trend for Eli Lilly's bamlanivimab and related antibodies from 2022 to 2024. The total revenue in 2022 is reported as approximately $2.0 billion, which aligns with the ground truth of $2.01 billion (the $2,008.9 million U.S. + $14.7 million non-U.S. sum to $2,023.6 million, or ~$2.02 billion; the LLM's rounding to $2.0 billion is acceptable and common in financial reporting). The answer accurately notes zero revenue in 2023 and 2024 using the '‑' notation from the source, which matches the ground truth of $0 in both years. (2) Minor quantitative discrepancy: the LLM rounds down to $2.0 billion while the actual sum is ~$2.02 billion; however, this is within acceptable rounding tolerance and does not affect the overall correctness. No calculation errors are present. (3) The multi-hop reasoning is sound: the model synthesizes data across years and geographies, correctly infers that '‑' means no revenue, and connects the decline to reduced reliance on the COVID-19 antibody portfolio. It appropriately generalizes bamlanivimab as part of a broader portfolio, consistent with the original answer. (4) The qualitative reasoning and contextual relevance are excellent—the answer directly addresses both parts of the question (revenue evolution and implications for company reliance) and draws a valid conclusion about Eli Lilly's shifting business dynamics. The only reason for not scoring a 10 is the slight imprecision in the 2022 total, though it does not undermine the overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 429,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "Starbucks repeatedly notes that coffee‑price volatility – including moves driven by hedge funds and commodity‑index funds in the Arabica futures market – remains a material exposure in its 2022, 2023 and 2024 10‑K filings. In the 2022 filing the company said it relied on fixed‑price and price‑to‑be‑fixed contracts, plus forward, futures and collar hedges, and that its total purchase commitments and inventory would cover supply through fiscal 2023. By the 2024 filing the same exposure is still acknowledged, but the firm states that its purchase‑commitment program (augmented by the same hedging tools) now secures an adequate green‑coffee supply through fiscal 2025, indicating a deliberate tightening of its risk‑management strategy to buffer against index‑fund‑driven price swings over a longer horizon.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Starbucks acknowledged commodity index fund impact on coffee price volatility in 2022, 2023, and 2024 filings; used fixed-price, price-to-be-fixed, forward, futures, and collar contracts for hedging; and extended supply visibility from fiscal 2023 (as stated in 2022) to fiscal 2025 (as stated in 2024). (2) No numeric or date inaccuracies: fiscal years and time horizons match exactly. Format variations (e.g., 'fiscal 2025' vs 'through fiscal 2025') are acceptable and preserve meaning. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years of filings, correctly identifying the evolution in supply commitment duration and linking it to risk management strategy. (4) The conclusion about a 'deliberate tightening' of risk management aligns with the ground truth's interpretation of strengthening practices. All entities (Starbucks, green coffee, 'C' price, hedging instruments) are accurately referenced. The response fully addresses both parts of the question: evolution of exposure and what it reveals about risk strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 331,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "In the 2022 filing Alphabet explained that a large share of its “Google Network” revenue – the ads served through AdMob, AdSense and **Google Ad Manager** – is measured by impressions and cost‑per‑impression, because the company monetizes inventory on partner sites before it is transferred to advertisers【page_31】. The 2024 filing repeats this description, still reporting network‑property ads on a gross basis and counting the associated TAC and other costs of revenues (including the impression‑based component) as part of cost of revenues【page_58】.  \n\nIn January 2023 Alphabet changed the useful life of its servers (and some network equipment) from 4 to 6 years, cutting depreciation expense by $3.9 billion and lifting net income by $3.0 billion for FY 2023【page_57】; this accounting shift improves the long‑term profitability outlook even as impression‑based monetization through Google Ad Manager continues to be a core revenue driver.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google Ad Manager's role in impression-based monetization for Google Network properties in 2022 and 2024, the 2023 change in server depreciation from 4 to 6 years (and network equipment from 5 to 6), the $3.9 billion reduction in depreciation expense, and the $3.0 billion increase in net income for FY 2023 are all accurately reported. (2) Quantitative accuracy is perfect: all numbers, dates, and dollar amounts match the original answer exactly, with proper context. (3) The multi-hop reasoning is sound—correctly linking the depreciation change to improved profitability and connecting it to the ongoing importance of Google Ad Manager in the revenue model. (4) The only minor omission is that the original answer explicitly frames the combination of infrastructure longevity and monetization as a 'multi-year trend' in optimizing cost structures, which the LLM implies but does not state as clearly. However, the core synthesis across years, entities, and financial impact is correct. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 346,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "Under the 2019 Long‑Term Incentive Plan, BNY Mellon issued a new “2022 Form of Performance Share Unit Agreement” in 2022 (exhibit 10.21) 【page_19】, replaced it with a revised “2023 Form of Performance Share Unit Agreement” in 2023 (exhibit 10.26) 【page_19】, and again updated the instrument with a “2024 Form of Performance Share Unit Agreement” in 2024 (exhibit 10.28) 【page_19】. The annual refresh of the PSU agreements shows the company’s ongoing reliance on performance‑based equity awards and its intent to fine‑tune the metrics, vesting conditions, or award sizes each year, signaling a compensation strategy that tightly aligns executive pay with long‑term shareholder value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) QUANTITATIVE/ENTITY INACCURACY: The LLM claims BK (BNY Mellon) issued a '2022 Form' in 2022 (Exhibit 10.21), a '2023 Form' in 2023 (Exhibit 10.26), and a '2024 Form' in 2024 (Exhibit 10.28), but the ground truth states that in 2022, BK referenced the *2021* PSU Agreement (Exhibit 10.45); in 2023, it re-filed the *2019 Long-Term Incentive Plan* (Exhibit 10.14), not a new PSU form; and in 2024, it incorporated the *2022* PSU Agreement (Exhibit 10.18). Thus, the LLM fabricates a yearly update cycle with non-existent '2023' and '2024' forms, which contradicts the actual pattern of referencing prior agreements and re-filing the base plan. (2) COMPLETENESS: The answer fails to capture the actual evolution—there was no annual refresh of PSU agreements. Instead, the company reused older forms and reaffirmed the 2019 plan, indicating stability rather than annual fine-tuning. (3) REASONING: The LLM draws an incorrect conclusion about an 'annual refresh' and 'fine-tuning each year,' which is not supported by the evidence. The ground truth shows a more conservative, adaptive strategy that builds on existing frameworks, not iterative annual redesigns. (4) SEMANTIC EQUIVALENCE: The overall meaning is not equivalent—LLM suggests active, yearly changes; ground truth shows continuity with periodic updates. While the general theme of performance-based compensation is relevant, the specific evolution and strategic implication are misrepresented. Minor contextual relevance is retained due to correct identification of PSU usage under the 2019 plan.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 447,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "In the 2022 filing the Safety & Industrial segment listed “electrical products and materials for construction and maintenance, power distribution” without naming any downstream customer group. Starting in the 2023 filing the description was expanded to “electrical products and materials for construction and maintenance, power distribution **and electrical original‑equipment‑manufacturer (OEM) customers**,” and the 2024 filing kept that same wording. The added OEM language signals that 3M is moving from a generic electrical‑product portfolio to one that is deliberately positioned for, and focused on, the electrical‑OEM market.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies in the description of 3M's product categorization across the years, which undermines the overall correctness. (1) In 2022, the original answer states that 3M explicitly mentioned 'construction and maintenance, power distribution and electrical OEMs' — however, the LLM claims that no downstream customer group was named, which contradicts the ground truth. This is a critical error in entity and descriptive accuracy. (2) The LLM correctly identifies that in 2023, 'electrical original-equipment-manufacturer (OEM) customers' was added, aligning with the increased specificity in the ground truth. (3) However, the LLM incorrectly states that the 2024 filing retained the exact same wording as 2023, while the original answer notes a meaningful change: the reordering and integration of 'power distribution and electrical original equipment manufacturers (OEMs)', suggesting a strategic continuity in power systems. The LLM misses this nuance. (4) The reasoning about increasing focus on electrical OEMs is directionally sound and contextually relevant, but the flawed factual foundation — especially the misrepresentation of the 2022 and 2024 descriptions — results in incomplete and partially incorrect multi-hop synthesis. While dates and entities (3M, Safety and Industrial segment, years) are correct, and no numerical data is misstated (hence full quantitative accuracy), the qualitative inaccuracies in textual details reduce the correctness score. The conclusion is plausible but not fully supported by the cited evolution due to these errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 444,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "- 2022: Fixed unsecured senior debt carried $24.1 billion at a weighted‑average interest rate of **4.45 %**【page_178】  \n- 2023: The carrying amount rose to $27.2 billion, with the weighted‑average rate unchanged at **4.45 %**【page_178】  \n- 2024: The balance remained at $27.2 billion (same $27,168 million) and the weighted‑average rate stayed at **4.45 %**【page_188】\n\nThe three‑year trend shows Capital One modestly increasing the size of its fixed‑rate senior debt while keeping the overall cost of that debt essentially flat, indicating a deliberate strategy of incremental long‑term borrowing to support growth and liquidity needs without taking on higher interest‑rate risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, the carrying value was $19,975 million (not $24.1 billion), and the weighted-average interest rate was 2.91% (not 4.45%). The 2023 carrying value is approximately correct at $27.2 billion (vs. $27,168 million), but the interest rate is wrong—it should be 4.45%, not unchanged from 2022. In 2024, the carrying value should be $26,930 million (not $27.2 billion), and the rate should rise to 4.84% (not remain at 4.45%). Thus, both key metrics—carrying value and interest rate—are incorrect for 2022 and 2024, and the trend is misrepresented. (2) Calculations and comparisons are flawed: the LLM claims the rate stayed flat at 4.45% across all years, which contradicts the rising trend (2.91% → 4.45% → 4.84%). The carrying value decline in 2024 is entirely missed. (3) Multi-hop reasoning is unsound: the model fails to synthesize the correct data points across years and incorrectly infers a strategy of 'flat cost' and 'incremental borrowing without higher rate risk,' when the truth indicates a strategy of locking in long-term debt at progressively higher rates amid a rising rate environment. (4) Contextual relevance is moderate—the answer addresses the right company (COF), metric (fixed unsecured senior debt), and time frame (2022–2024), and attempts interpretation. However, due to severe quantitative and qualitative errors, the conclusion is factually misleading. Scores reflect major factual deviations, especially in core financial data and trend interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 435,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "- In the 2022 Form 10‑K NVIDIA reported that the 3.50 % senior unsecured notes due 2040 were carried at their original issuance amount of **$1.0 billion** (net of a modest un‑amortized discount) and were disclosed at a Level 2 fair‑value of roughly **$870 million**. 【page 78‑82 (2022 filing)】  \n- The 2023 filing shows the same $1.0 billion carrying amount, but the fair‑value estimate fell slightly to **$870 million** (Level 2)【page 66 (2023 filing)】.  \n- By the 2024 filing the carrying amount remained $1.0 billion, while the fair‑value was further reduced to **$851 million**【page 67 (2024 filing)】 and the note is listed in the long‑term debt schedule with an effective interest rate of 3.54 % and an un‑amortized discount of $41 million【page 72 (2024 filing)】.  \n\n**What this reveals:** NVIDIA has kept the 2040 notes on its balance sheet at amortized cost, accepting a modest decline in market value as interest rates rose, and continues to rely on this low‑coupon, long‑dated unsecured debt as a stable source of financing rather than refinancing or retiring the issue. This consistent treatment across FY 2022‑2024 signals a deliberate long‑term debt strategy that locks in inexpensive financing while monitoring fair‑value fluctuations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains several factual inaccuracies in key numbers compared to the ground truth. The fair value in fiscal 2022 is reported as $870 million in the LLM answer, but the ground truth states $1,066 million. This is a significant discrepancy (nearly $200M difference). The 2023 fair value is correctly stated as $851 million in the ground truth, but the LLM incorrectly repeats $870 million for both 2022 and 2023. Only in 2024 does the LLM correctly report $851 million, though it fails to note that fair value was no longer the primary reporting metric—instead, the carrying amount of $1,000 million was emphasized, which the LLM mentions but does not highlight as a shift in accounting treatment. The carrying amount of $1.0 billion is consistent with the ground truth's $1,000 million, so that part is accurate (allowing for format variation).\n\n2) Calculations and comparisons are flawed due to incorrect base values. The LLM implies a steady decline from $870M to $851M, but the actual trend is a drop from $1,066M to $851M, then a disappearance of fair value reporting. The LLM also introduces an un-amortized discount of $41 million in 2024, which is not mentioned in the ground truth and cannot be verified against it, adding unsupported detail.\n\n3) The multi-hop reasoning is partially sound—the LLM correctly identifies that NVIDIA maintained the carrying amount at $1.0 billion across years and interprets this as a strategic choice to retain low-cost long-term debt. This aligns with the ground truth’s conclusion about a stable financing strategy. However, it misses the key evolution: the *discontinuation* of fair value disclosure in 2024 in favor of carrying amount, which the ground truth explicitly highlights as a shift in accounting and management approach. This omission weakens the qualitative analysis.\n\n4) Despite numerical inaccuracies, the LLM provides relevant context—such as the effective interest rate (3.54%), classification as senior unsecured notes, and Level 2 fair value inputs—which adds depth. Its interpretation of NVIDIA’s long-term debt strategy as deliberate and stability-focused is semantically aligned with the ground truth. However, because the core financial data (especially 2022 fair value) is incorrect, the correctness score is significantly reduced. Quantitative accuracy is low due to repeated incorrect figures; qualitative accuracy is moderate due to sound reasoning on strategy despite flawed inputs; contextual relevance is high as all parts of the question are addressed with appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 679,
        "total_tokens": 2132
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "Amazon’s unsecured senior “2017 Notes” fell from a $16 billion balance at 12/31/2022 to $15 billion at 12/31/2023 and then to $13 billion at 12/31/2024【page_58†L31-L34】【page_57†L31-L34】. The steady decline—about $1 billion in 2023 and $2 billion in 2024—shows the company is actively repaying or redeeming this tranche, reflecting a disciplined debt‑management approach that reduces outstanding principal while preserving overall liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. The reduction amounts—$1 billion from 2022 to 2023 and $2 billion from 2023 to 2024—are accurately described. 2) All numbers and dates are factually correct and consistent with the original answer. The formatting variation ($16 billion vs $16.0 billion) is acceptable and semantically equivalent. Calculations of year-over-year reductions are accurate. 3) The reasoning is sound: the LLM correctly infers a disciplined or deliberate debt management strategy based on the consistent reduction, which aligns with the ground truth’s conclusion about a 'deliberate debt management strategy.' The addition of 'preserving overall liquidity' is a reasonable qualitative extension supported by typical interpretations of such repayment patterns, though not explicitly stated in the ground truth—this slightly exceeds the original but does not misrepresent. 4) The answer fully addresses both parts of the question: the evolution of the balance (multi-hop across three years) and the implication for Amazon's debt strategy. Synthesis across time points is correct and well-supported. The contextual relevance is perfect, directly answering the question with precise data and appropriate interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 383,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "Apple’s 10‑K exhibits repeatedly list “Floating Rate Notes due 2019” (see the securities index in the 2022 filing – page 56, and the same index in the 2023 and 2024 filings) 【page_56】. By keeping a floating‑rate, short‑maturity issue on its balance sheet, Apple retains ongoing exposure to short‑term debt whose coupon resets with market rates; therefore, if interest rates rise, the interest expense on those notes will increase more quickly than on fixed‑rate debt, making Apple’s overall interest‑cost profile more rate‑sensitive.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the repeated disclosure of Floating Rate Notes due 2019 in Apple's 2022, 2023, and 2024 10-K filings, accurately referencing the securities index and page number (e.g., page 56 in 2022), which aligns with the ground truth. The dates (2019 maturity) and years of disclosure (2022–2024) are factually correct, satisfying quantitative accuracy. The explanation that floating rate notes reset with market rates and thus increase interest expense in a rising rate environment is logically sound and correctly captures the financial mechanism. However, the LLM incorrectly implies that Apple actively maintained these notes on its balance sheet through 2024, whereas the ground truth clarifies that the notes are included by reference via an Officer's Certificate from 2014, suggesting disclosure obligations or rollover commitments rather than outstanding liabilities. This misrepresents the nature of Apple's exposure—failing to distinguish between active debt and legacy disclosure—undermining the qualitative accuracy of the reasoning. The answer addresses the core question about interest expense sensitivity but omits key nuance about the legal and structural basis for the continued disclosure, such as the May 6, 2014 Officer's Certificate and the possibility of rollover obligations or continuing commitments. While the overall direction of the conclusion is reasonable, the lack of precision on the mechanism behind the repeated disclosure reduces the depth of multi-hop synthesis. Contextually, the response remains highly relevant and focused on the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 438,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "- **2022:** Google’s filing described hardware as a long‑term bet and highlighted the “latest generation of hardware products such as Pixel 5a 5G and Pixel 6 phones,” emphasizing that it was still **investing heavily** to grow the family and that device sales “adversely affect our consolidated margins” because of pricing pressure and high cost of sales.  \n- **2023:** The discussion still grouped Pixel sales with “low‑cost mobile devices” aimed at emerging markets and reiterated that device revenue “adversely affect[s] our margins,” showing the line‑up was **still early‑stage** and a modest, margin‑dragging contribution to overall revenue.  \n- **2024:** The 10‑K simply lists “devices, which primarily include sales of the Pixel family of devices” as a **defined revenue segment**, without the earlier language about “early‑stage” or margin drag, indicating the Pixel line has become a **more mature, established product** that is now treated as a regular revenue source.\n\n**Interpretation:** Over the three‑year span Google moved from a nascent, heavily subsidised hardware experiment to a steadier, revenue‑generating product line; the shift from “investing for the long run” and margin‑negative language to a standard revenue‑line signals that Google now sees the Pixel family as a permanent pillar of its hardware strategy, anchoring its long‑term positioning in the market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Google emphasized long-term investment in Pixel 5a 5G and Pixel 6; in 2023, Pixel was part of a broader 'devices' revenue category with margin pressure noted; by 2024, it was listed as a defined revenue segment without negative margin language, indicating maturity. (2) There are no numeric inaccuracies—though no specific dollar figures are cited, the qualitative financial descriptions (e.g., margin drag, transition to stable revenue) match the original answer’s implications. The absence of exact revenue numbers is not a flaw, as the ground truth also does not provide them. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes changes in disclosure language across years to infer strategic evolution—from investment phase to revenue contributor. The interpretation that reduced negative commentary in 2024 signals product maturity is logically supported by the filings. (4) The only minor gap is that the LLM slightly overemphasizes 'low-cost mobile devices' and 'emerging markets' in 2023, which is not present in the ground truth and may reflect misattribution of broader Alphabet device strategy to Pixel specifically. However, this does not materially distort the overall conclusion. Wording differs but semantic equivalence is strong. The answer fully addresses investment focus, revenue contribution, product maturity, and long-term positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1612,
        "completion_tokens": 407,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "- In 2020 Schwab could pledge about **$84 billion** of client securities as margin‑loan collateral and actually pledged **$23 billion** (including OCC, short‑sale and securities‑lending pledges).  By 2021 the pool of pledge‑eligible securities had risen to **$120 billion** and pledged collateral grew to **$31 billion**.  By the end of 2024 the firm was using that same client‑security base to support far larger external borrowing – FHLB facilities had $59.8 billion of borrowing capacity backed by client securities (down slightly from $63.1 billion in 2023), the Federal Reserve discount window capacity jumped to **$30.5 billion** (from $6.2 billion a year earlier), and CS&Co’s secured line of credit was backed by **$500 million** of client‑margin securities (down from $950 million in 2023).  \n\n- Across the period the amount of securities loaned remained roughly steady at **≈ $7 billion** (2020 $7.5 billion, 2021 $7.2 billion) while securities borrowed stayed modest (≈ $0.6 billion).  The upward trajectory in pledged client securities for margin lending and for securing external funding shows Schwab’s deliberate strategy of expanding its collateral pool, over‑collateralizing its borrowing and securities‑lending activities, and daily monitoring collateral to maximize liquidity while managing credit‑risk exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth in multiple critical areas. (1) The time frame is completely wrong: the LLM discusses 2020–2021 and 2024, but the question and ground truth focus on 2022–2024. There is no mention of 2022 or 2023 developments in the LLM answer, and instead it fabricates detailed data for 2020 and 2021, which are outside the requested period. (2) Quantitative accuracy is very poor: the LLM provides specific dollar figures (e.g., $84 billion, $23 billion, $120 billion) for years not in the question, and these numbers do not appear in the ground truth. The 2024 figures about FHLB, Federal Reserve discount window, and secured lines of credit are not mentioned in the original answer and appear to be hallucinated or misattributed. (3) The ground truth emphasizes qualitative disclosures about the evolution of pledging practices and regulatory compliance, not quantitative collateral pools or borrowing capacities. The LLM incorrectly shifts focus to external borrowing facilities and over-collateralization strategy, which are not discussed in the original. (4) The only partially correct element is the mention of pledging for margin lending and securities lending, and a general inference about collateral management strategy, which aligns thematically but not factually. (5) The LLM fails the multi-hop reasoning requirement: it does not synthesize Schwab’s evolving disclosures across 2022–2024 as required, and instead invents a timeline. While the general idea of growing reliance on client securities is echoed, it is unsupported by the correct facts or time-bound disclosures. Overall, the answer is factually inaccurate, misaligned in timeframe, and contains hallucinated data, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1604,
        "completion_tokens": 482,
        "total_tokens": 2086
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "- 2022 10‑K – GE said it “relies on the primary insurers … to file proposed premium‑rate increases” and measured the risk of those filings failing.  A 25 % adverse change in the success‑rate of the filings was modeled to increase the present‑value of future cash‑flows by **about $200 million** (pre‑tax).\n\n- 2023 10‑K – The same collaboration language appears, but no new quantitative change is disclosed; the company still treats the insurer‑filed rate hikes as the primary lever for managing long‑term‑care reserve risk.\n\n- 2024 10‑K – GE again notes the collaboration and adds that it has **implemented roughly $0.2 billion of previously approved rate‑increase actions** and still expects **about $1.7 billion of future increases**.  The sensitivity to a 25 % adverse change in the success of those filings now rises to **about $300 million** (pre‑tax).\n\n**What this shows:** Over the 2022‑2024 period GE’s reliance on primary insurers to obtain regulatory premium‑rate increases has grown—from a modest $200 million reserve impact in 2022 to a larger $300 million impact in 2024, together with actual implementation of $0.2 billion of approved hikes.  This progression indicates that GE is increasingly using its collaborative filing process as a proactive risk‑management tool in its run‑off insurance portfolio, seeking to offset adverse experience and preserve reserve margins while avoiding premium‑deficiency shortfalls.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of GE's collaboration with primary insurers from 2022 to 2024 and correctly identifies the increasing strategic importance of rate increases in GE's reinsurance risk management. However, there are significant quantitative inaccuracies that reduce factual correctness. In 2022, the $200 million sensitivity figure is correct (matching the ground truth's 'about $200 million'), but in 2024, the LLM claims the sensitivity rises to 'about $300 million'—this figure does not appear in the original answer and is not supported by the provided ground truth, which mentions no such updated sensitivity. Additionally, the LLM introduces new figures—'implemented roughly $0.2 billion of previously approved rate-increase actions' and 'expects about $1.7 billion of future increases'—which are not present in the ground truth and cannot be verified. These numbers may be factually incorrect or misattributed. While the qualitative trend of increasing collaboration and structured engagement (from indirect reliance in 2022 to formalized collaboration in 2023 and reinforced framework in 2024) is accurately reflected, the LLM overstates the evolution as a growing 'reliance' rather than a shift toward 'proactive risk management and tighter integration.' The reasoning is logically sound and contextually relevant, synthesizing multi-year disclosures appropriately, but the inclusion of unsupported quantitative claims reduces overall correctness. Semantic equivalence is mostly maintained, but the added numbers introduce factual risk.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1617,
        "completion_tokens": 428,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "CVS’s holding of agency‑backed residential mortgage‑backed securities (RMBS) fell dramatically over the three‑year period.  In 2022 the fair‑value of RMBS reported in the debt‑securities schedule was about **$757 million**; it rose modestly to **$810 million** in 2023 (both shown in the 2023 10‑K debt‑securities table)【page_147】.  By 2024 the amount reported in the Separate‑Accounts assets had dropped to **$71 million** (down from $51 million in 2023)【page_160】, representing a >90 % reduction from the prior year.\n\nThe trend shows CVS initially maintained a stable, modest exposure to RMBS but then aggressively de‑risked its structured‑credit portfolio in 2024, shifting away from agency‑guaranteed mortgage‑backed securities and thereby lowering its vulnerability to interest‑rate and credit‑risk swings in that segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, CVS's RMBS exposure decreased from $721M in 2022 to $614M in 2023, then increased to $71M in 2024. However, the LLM claims it rose from $757M in 2022 to $810M in 2023 — both incorrect values and a reversed trend. The 2024 figure of $71M is correct, but the LLM incorrectly states it dropped from $51M in 2023, which contradicts both its own earlier number ($810M) and the ground truth ($614M). (2) Quantitative accuracy is severely compromised: the 2022 and 2023 figures are wrong by over $100M each, and the claim of a 'dramatic fall' or '>90% reduction' from 2023 to 2024 is based on a false premise (dropping from $810M to $71M would be ~91%, but actual drop was from $614M to $71M, which is ~88%, still incorrect due to wrong inputs). The LLM also cites conflicting 2023 values: $810M in one sentence and $51M in another. (3) Multi-hop reasoning is flawed: the model fails to correctly track the three-year trend, misidentifies the direction of change in 2023, and draws an incorrect conclusion about 'aggressive de-risking' in 2024, when the ground truth describes a rebound from $614M to $71M — a much smaller position, but not a >90% drop from the prior year. The synthesis across years is invalid due to incorrect data. (4) Despite these issues, the answer is contextually relevant — it addresses RMBS exposure, structured credit, and risk positioning — and attempts to interpret the trend, albeit based on false numbers. The mention of agency-backed RMBS and risk management shows some understanding of the domain, but the conclusions do not follow from accurate data. Thus, correctness and quantitative accuracy are very low; qualitative reasoning is poor due to incorrect premises; relevance is moderate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 493,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "**2022 → 2023 → 2024**\n\n| Year | Short‑term borrowings* | Long‑term debt* |\n|------|------------------------|-----------------|\n| 2022 | **$883 million** (federal funds purchased & securities loaned) | **$47,832 million** |\n| 2023 | **$538 million** | **$49,318 million** |\n| 2024 | **$562 million** | **$44,989 million** |\n\n\\*Figures are the carrying values shown in the “Components of Deposits, Short‑Term Borrowings and Long‑Term Debt” tables in the 2022, 2023 and 2024 10‑K filings.\n\n**What the trend reveals**\n\n- **Short‑term borrowings** have been a very small part of COF’s capital structure (well under 2 % of total debt) and fell sharply from 2022 to 2023, then held steady in 2024, indicating the company relies primarily on deposits rather than overnight funding.\n- **Long‑term debt** rose modestly in 2023 (to about $49.3 bn) but was reduced by roughly $4.3 bn in 2024, bringing total debt (short‑term + long‑term) down from $48.7 bn in 2022 to $45.6 bn in 2024. This drop reflects an active deleveraging strategy—paying down or refinancing higher‑cost obligations while maintaining a strong deposit‑funded base.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies in the breakdown of short-term borrowings and long-term debt, despite arriving at a reasonably close total debt figure for 2024. According to the ground truth, total debt was $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. The LLM reports total debt as approximately $48.7B in 2022 (sum of $883M + $47,832M = $48.715B), which is off by over $5.6B from the correct total. This major discrepancy suggests incorrect component values. The 2023 total ($49.856B) is closer to the LLM's $49.856B (sum of $538M + $49,318M = $49.856B), which matches exactly. The 2024 total in the LLM answer ($45.551B) is nearly matched by $44.989B + $562M = $45.551B — correct total, but misallocated between components. However, the individual components (especially 2022 long-term debt) are inconsistent with the ground truth.\n\n2) The LLM fails to include key metrics from the original answer: the weighted-average interest rate on long-term debt (2.76% → 4.48% → 4.84%) and the elimination of floating unsecured senior debt ($1,709M → $349M → $0). These are critical to understanding COF’s debt management strategy and rising borrowing costs, and their omission reduces completeness and qualitative accuracy.\n\n3) While the LLM correctly identifies a pattern of increase in 2023 followed by reduction in 2024, and infers a deleveraging strategy, this reasoning is based on partially incorrect inputs. The conclusion about reliance on deposits over short-term funding is contextually relevant and plausible, but not directly supported by the ground truth, which emphasizes the shift away from floating-rate debt.\n\n4) The model demonstrates multi-hop reasoning by aggregating short-term and long-term debt across years and interpreting trends. However, due to incorrect base figures (especially in 2022), the quantitative foundation is flawed. The final totals for 2023 and 2024 are accurate, suggesting possible reconciliation at the aggregate level, but the component-level errors undermine trust in the data provenance.\n\n5) Semantic equivalence is partially achieved in the overall trend description (increase then decrease), but not in the detailed financial evolution or strategic implications involving interest rates and debt composition. The omission of floating-rate debt elimination and interest rate trends — central to the original answer — limits qualitative accuracy despite reasonable narrative flow.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 654,
        "total_tokens": 2160
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "**Evolution of the 3.50 % Notes Due 2050 (long‑term liability)**  \n\n| Fiscal year (balance‑sheet date) | Carrying amount of 3.50 % Notes Due 2050 ( $ millions ) |\n|----------------------------------|--------------------------------------------------------|\n| 2022 (Jan 30 2022) *               | ≈ $1,600 *                                            |\n| 2023 (Jan 28 2024) **              | $1,637 **                                             |\n| 2024 (Jan 28 2024) **              | $2,000 ** (net long‑term portion shown in the “long‑term liability” schedule) |\n\n\\* The 2022 figure is reported in the 2022 Form 10‑K (note 9) as roughly $1.6 billion.  \n\\** 2023 amount appears in the 2023 Form 10‑K (note 9) as $1,637 million; the 2024 net long‑term amount is $2,000 million (page 72 of the 2024 filing).\n\n**What the trend indicates**\n\nFrom 2022 through 2023 the liability was essentially flat, showing that NVIDIA was neither aggressively issuing nor retiring this tranche of senior debt. In 2024 the long‑term balance rose to about $2 billion, reflecting a deliberate increase in long‑dated, low‑cost financing. The pattern suggests a capital‑structure strategy that keeps the overall debt profile stable while selectively adding long‑term, low‑interest notes to fund growth initiatives and preserve liquidity without relying on short‑term borrowing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors in the reported values for the 3.50% Notes Due 2050. According to the ground truth, the liability decreased from $2,147 million in fiscal 2022 to $1,637 million in fiscal 2023 and further to $1,604 million in fiscal 2024. However, the LLM incorrectly reports the 2022 value as approximately $1,600 million (should be $2,147M), keeps 2023 correct at $1,637M, but then erroneously states the 2024 value as $2,000 million (should be $1,604M). This reverses the actual trend—LLM claims an increase in 2024, while the truth shows a continued decline.\n\n(2) The quantitative inaccuracies are severe: the 2022 figure is off by over $500 million, and the 2024 figure is inflated by nearly $400 million. These are not minor rounding differences but material misstatements. Additionally, the fiscal year-end dates are misrepresented: the 2022 balance sheet date is Jan 30, 2022, but this corresponds to fiscal year 2022, not a reporting lag issue—the LLM confuses presentation timing with fiscal periods. The citation of page 72 of the 2024 filing for a $2,000 million figure appears to misinterpret the data, possibly confusing gross versus net or including other debt tranches.\n\n(3) The multi-hop reasoning fails due to incorrect data synthesis. The LLM draws the opposite conclusion from the facts: instead of recognizing a deliberate reduction in long-term debt, it infers an increase in low-cost financing. This misrepresents NVIDIA’s capital structure strategy during this period. The reasoning would have been plausible if the numbers were correct, but it is built on false premises.\n\n(4) Contextual relevance is moderate—the structure of the response (table, trend analysis, strategic interpretation) aligns well with the question. However, because the core numbers and resulting trend are wrong, the qualitative analysis is fundamentally flawed. A score of 2 is justified due to one correct data point (2023) and appropriate framework, but major factual deviations undermine overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 549,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "- **2022 Form 10‑K:** Apple’s exhibit list shows the Officer’s Certificate dated May 3 2013 that includes “0.45 % Notes due 2016” (see page 56, Exhibit 4.3).  \n- **2023 Form 10‑K:** The same exhibit appears in the 2023 filing (pages 53‑57), again listing the 0.45 % Notes due 2016 as part of the historical debt schedule.  \n- **2024 Form 10‑K:** The 2024 filing repeats the same disclosure – Exhibit 4.3 (page 56) still contains the 0.45 % Notes due 2016.\n\n**What the pattern shows:** Apple does not issue a new 0.45 % note after 2013; instead it continuously carries the original 2016‑maturing note in its exhibit list each year until it matures. This consistent, unchanged disclosure of a legacy debt instrument demonstrates Apple’s long‑term‑debt reporting strategy of maintaining full historical transparency for all previously issued notes, even after they have matured or are near maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All numeric values—0.45%, 2016 maturity, May 3, 2013 issuance date, and exhibit numbers (4.3) across all years—are correct. Page numbers (56, 53–57) are consistent with typical 10-K structures and do not contradict the ground truth, which does not specify page numbers, so minor variations are acceptable. (2) The answer correctly identifies that the notes were issued in 2013 and matured in 2016, and that they continue to appear in filings through 2024, which is consistent with the original answer’s claim of ongoing disclosure. (3) The multi-hop reasoning is sound: the model synthesizes data across three years of filings and infers Apple’s disclosure strategy—maintaining legacy debt in exhibits for transparency and legal continuity—even though the debt is no longer outstanding. (4) The conclusion about Apple’s long-term debt disclosure strategy is semantically equivalent to the ground truth, emphasizing historical transparency and continuity. The only minor limitation is that the LLM slightly overstates that the note is carried 'until it matures' when it appears *after* maturity (2022–2024), which is post-maturity, not up to maturity. This nuance slightly affects qualitative accuracy but does not undermine the core correctness. Overall, the answer is highly accurate, complete, and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 384,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "- In 2022 the fair‑value roll‑forward shows a net Level‑3 derivative position of only **$5 million** (derivative assets $79 m vs liabilities $74 m). By the end of 2023 that net grew to **$58 million** (assets $886 m vs liabilities $828 m) and by 31 Dec 2024 it rose further to **$69 million** (assets $683 m vs liabilities $614 m).  \n\n- The key unobservable input for these Level‑3 derivatives is the **swap‑rate assumption**: the weighted‑average swap rate used in the valuation was **≈1 % in 2022**, widened to a **3‑5 % range with a 4 % average in 2023**, and remained at a **4 % average (single‑point range) in 2024**.  \n\n**Interpretation:** The sharp increase in net derivative assets together with higher and broader swap‑rate inputs signals that Capital One’s exposure to interest‑rate derivative positions has expanded and that the company’s valuation models now rely on more pronounced, less‑observable rate assumptions, reflecting greater sensitivity to interest‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Capital One's net derivative assets (liabilities) were $31 million in 2022, not $5 million as stated by the LLM. The LLM incorrectly calculates the 2022 net position as $5 million ($79M assets - $74M liabilities), but this figure does not align with the ground truth and introduces Level-3 classification not mentioned in the original. In 2023, the LLM reports $58 million (correct net value), but then incorrectly states it rose to $69 million in 2024, whereas the ground truth confirms it remained at $58 million. (2) The unobservable input in 2022 is entirely missing in the ground truth, but the LLM claims a 'swap rate' of ≈1%, which is incorrect. While the 4% weighted average swap rate in 2023 and 2024 matches the ground truth, the LLM fails to note the key shift from 'default' in 2023 to 'swap rates' in 2024 — instead implying swap rates were used throughout, which misrepresents the evolution of risk inputs. (3) The multi-hop reasoning is flawed: the LLM identifies increasing net derivative assets and attributes them to swap rate assumptions, but misses the critical conceptual shift in risk drivers (from default risk to interest rate risk) and omits any mention of the $20 million unrealized loss in 2022 or the reduction in realized losses from $43 million. (4) The interpretation incorrectly suggests expanding exposure and greater sensitivity due to 'more pronounced assumptions', while the ground truth indicates stable valuation and improved risk management. Despite addressing the general theme of risk evolution and modeling assumptions, the severe numerical and conceptual errors — especially incorrect values for 2022 and 2024 and misattribution of risk inputs — result in a low correctness score. Contextual relevance is moderate because the answer attempts the right type of analysis but is factually unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 524,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "- Fiscal 2022 (ended January 30 2022) – NVIDIA’s balance‑sheet listed roughly **$1.1 billion** of the 1.55 % Notes Due 2028 (the amount shown in the 2022 filing’s long‑term debt schedule).  \n\n- Fiscal 2023 (ended January 28 2024) – the 2023 Form 10‑K reports the same series of notes at **$1,099 million** (Level‑2 liability) and, in the accompanying schedule, **$1,115 million** as the net carrying amount (page 67).  \n\n- Fiscal 2024 (ended January 28 2024) – the 2024 Form 10‑K shows the 1.55 % Notes Due 2028 increased to **$1,250 million** (net carrying amount) (page 72).  \n\n**What this shows:** Over the three‑year span NVIDIA’s exposure to this low‑coupon, long‑dated debt rose modestly from about $1.1 billion to $1.25 billion – an increase of roughly $150 million. The company is deliberately keeping a sizable, inexpensive tranche of senior unsecured debt on the balance sheet and only slowly expanding it, indicating a long‑term financing strategy that relies on low‑cost, fixed‑rate capital to fund growth while preserving flexibility and maintaining a strong credit profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is highly accurate in both quantitative and qualitative aspects. It correctly identifies the exposure amounts for the 1.55% Notes Due 2028 across fiscal years 2022–2024, with only a minor discrepancy in the 2022 figure: the LLM reports $1.1 billion (or $1,100 million), while the ground truth specifies $1.2 billion. This $100 million difference is notable but not material in overall context. For 2023, the LLM cites two figures—$1,099 million (Level-2 liability) and $1,115 million (net carrying amount)—acknowledging reporting nuances, whereas the ground truth simplifies to $1.1 billion, which aligns closely. The 2024 value is correctly reported as $1.25 billion (or $1,250 million), matching the ground truth exactly.\n\n2) Quantitative accuracy is strong: the LLM pulls precise values from actual 10-K filings, including page references and distinctions between carrying amounts and fair value disclosures. The slight variance in 2022 ($1.1B vs $1.2B) prevents a perfect score, but the trend—stable in 2023, then an increase in 2024—is correctly captured. The calculation of a $150 million increase from ~$1.1B to $1.25B is accurate and supports the narrative.\n\n3) Multi-hop reasoning is sound: the LLM synthesizes data across three fiscal years, identifies the evolution of the debt instrument, and infers strategic intent—consistent with the ground truth’s conclusion about strategic maintenance of low-cost debt. The reasoning goes beyond repetition of numbers to interpret NVIDIA’s long-term financing strategy, correctly emphasizing low-cost, fixed-rate capital and credit profile management.\n\n4) Contextual relevance is excellent. The answer directly addresses both parts of the question: the evolution of financial exposure and what it reveals about debt strategy. The use of precise terminology (e.g., 'senior unsecured debt', 'net carrying amount') enhances credibility and alignment with financial reporting standards. Despite the minor 2022 discrepancy, the overall synthesis and interpretation are factually grounded and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 562,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "- 2022 10‑K (p. 71) disclosed that, after the 2015 Alstom Thermal‑Renewables‑Grid acquisition, GE remained “subject to legacy legal proceedings … that relate to claimed anti‑competitive conduct or corruption by Alstom in the pre‑acquisition period,” and that “shareholder lawsuits … related to the Company’s financial performance, accounting and disclosure practices” continued to pose a contingent‑liability risk.  \n\n- 2023 10‑K (p. 36) repeated the same exposure, stating that “since our acquisition of Alstom’s … businesses in 2015, we are subject to legacy legal proceedings … and payments for settlements … have resulted and will in the future result in cash outflows,” and that “we remain subject to shareholder lawsuits … related to the Company’s financial performance, accounting and disclosure practices.”  \n\n- 2024 10‑K (p. 36) again highlighted these matters, noting that “legacy legal proceedings … relating to claimed anti‑competitive conduct or corruption by Alstom … have resulted and will result in cash outflows,” and that “shareholder lawsuits … related to the Company’s financial performance, accounting and disclosure practices” persist, with the company warning that actual losses could exceed current reserve estimates.  \n\n**Interpretation:** Across the three filings the description of the Alstom‑related legacy claims and the shareholder‑class actions did not diminish; GE continued to set aside reserves and warned that losses could exceed those estimates. This consistency shows that the trailing legal liabilities are persistent, remain materially on the balance sheet, and retain the potential to affect GE’s cash flows and earnings well into 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) It accurately identifies the persistence of GE's legal liabilities from 2022 to 2024, specifically citing legacy Alstom matters (anti-competitive conduct/corruption) and shareholder lawsuits tied to financial reporting—both central to the question. (2) No numerical inaccuracies: while no specific dollar amounts are mentioned in either answer, the LLM correctly notes cash outflows, reserves, and the risk that losses could exceed estimates, consistent with the original. The years (2022, 2023, 2024) and document types (10-K) are correctly cited, with page numbers matching typical disclosure locations. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying that the same risks were reiterated annually, indicating persistence. It draws the correct conclusion that these liabilities remain material and ongoing. (4) Semantic equivalence is strong: though structured differently (bullet points + interpretation), the LLM conveys all key facts and the same overall message—that GE’s trailing legal liabilities have not diminished and continue to pose financial and reputational risks. The interpretation section effectively summarizes the progression and implications, aligning perfectly with the ground truth. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1783,
        "completion_tokens": 390,
        "total_tokens": 2173
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "CVS’s pension plan reported hedge‑fund limited‑partnership holdings of **$225 million in 2022**, **$252 million in 2023**, and **$280 million in 2024** (the amounts are excluded from the fair‑value tables because they are measured at NAV). The roughly **$55 million (≈24 %) rise** in HF‑LP exposure signals that the company is deliberately expanding its alternative‑asset slice – consistent with the 2024 target allocation of about 4 % to hedge‑fund LPs – to add diversification and seek higher‑return potential within the pension portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for CVS's hedge fund limited partnership (HF LP) investments. According to the ground truth, the correct amounts are $214 million in 2022, $225 million in 2023, and $252 million in 2024. The LLM incorrectly reports $225M in 2022, $252M in 2023, and $280M in 2024 — shifting the timeline and inflating the final value. This misalignment affects all subsequent calculations. (2) The LLM calculates a $55 million (≈24%) increase, but the actual increase from 2022 to 2024 is $38 million (from $214M to $252M), which is approximately 17.8%. The percentage and absolute change are therefore incorrect. Additionally, the mention of a '2024 target allocation of about 4%' is not present in the original answer and introduces unverified detail. (3) While the LLM correctly infers that increasing HF LP exposure suggests a strategic expansion of alternative investments, this reasoning is based on incorrect data. The multi-hop synthesis — linking year-over-year changes to pension strategy — is conceptually sound but undermined by inaccurate inputs. (4) The contextual relevance is fair because the answer addresses the question’s structure (trend over time and strategic implication), and uses appropriate financial terminology. However, due to major quantitative errors and unsupported specifics, the correctness score is low. Minor formatting differences (e.g., $252 million vs $252M) are acceptable, but directional and numerical accuracy is not. Thus, the answer is mostly incorrect despite plausible reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 439,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "In 2022 the Africa/Eurasia segment generated **$228 million of operating profit** (see the segment table for 2022)【page_116】.  In the 2023 Global Productivity Initiative, the company allocated **5 % of the total $32 million pretax restructuring charge to Africa/Eurasia**, equal to roughly **$1.6 million**【page_86】.  By 2024 the segment’s **depreciation and amortization expense fell to $8 million**【page_117】, showing a shift from strong profit contribution in 2022 to modest restructuring costs in 2023 and reduced asset‑related spending in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The operating profit for Africa/Eurasia in 2022 is reported as $228 million, whereas the ground truth is $203 million. The restructuring charge allocation is stated as 5% of $32 million ($1.6 million), but the correct figure is 10% of expected charges, estimated at $20–$24 million. Only the 2024 depreciation and amortization of $8 million is correct. (2) Number verification: $228M (incorrect vs $203M), $1.6M restructuring (incorrect vs $20–24M), $8M D&A (correct). Calculations based on wrong percentages and totals. (3) Multi-hop reasoning is partially sound—the model attempts to connect operating profit, restructuring, and D&A across years—but due to incorrect inputs, the synthesis is flawed. The conclusion about a shift from strong profits to cost-cutting is overstated given the ground truth shows consistently modest performance. (4) Correctness score is low due to major quantitative errors, especially in two of the three core financial metrics. Qualitative accuracy is moderate because the structure and intent of the analysis are reasonable. Contextual relevance is high as the answer addresses all three time points and the correct region and initiative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 356,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "- In the 2022 filing AIG quantified its biggest international terrorism scenario – a five‑ton bomb – at a **$1.3 billion modeled loss (net of TRIPRA and existing reinsurance)** and said the exposure was covered only by limited private reinsurance and government‑sponsored pools; no specific attachment‑point levels were disclosed.  \n- The 2023 filing no longer gave a dollar‑amount loss estimate, but still described ongoing scenario‑based modeling, targeted reinsurance purchases and reliance on the same government programmes, while the **international attachment points remained unchanged at $200 million for Japan and $125 million for the rest of the world** (as later restated in 2024).  \n- By 2024 the company reported that **total reinsurance‑recoverable assets had fallen to $38.0 billion (down from $67.5 billion at year‑end 2023)**, reflecting a tighter reinsurance structure even though the core international attachment points for terrorism‑related coverage were kept at the $200 million/$125 million levels.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains several key correct elements but also significant factual inaccuracies. Correct: the $1.3 billion modeled loss in 2022 (net of TRIPRA and reinsurance), the $200M/$125M international attachment points in 2023 and 2024, and the $38.0 billion reinsurance-recoverable assets in 2024. However, a major error occurs in stating that reinsurance-recoverable assets 'fell to $38.0 billion (down from $67.5 billion at year-end 2023)' — the ground truth states that recoverable assets reached $38.0 billion in 2024 with no mention of a prior $67.5 billion or a decline; this figure is unsupported and contradicts the original answer, which indicates an expansion in reinsurance protections. Additionally, the original answer notes that by 2024, $29.1 billion of the $38.0 billion was in ceded loss reserves — this detail is omitted. The 2023 filing's continued use of scenario-based modeling and targeted reinsurance is correctly noted, but the original answer does not state that loss estimates were discontinued in 2023, only that modeling continued — so the absence of a dollar estimate is an overinterpretation. (2) Quantitative accuracy is compromised by the fabricated $67.5 billion figure and the incorrect characterization of a decline in recoverables, when the ground truth describes an expansion. The $1.3B, $38.0B, $29.1B, $200M, and $125M figures are correct, but the erroneous comparison undermines financial accuracy. (3) The reasoning partially captures the evolution but misrepresents the trend in reinsurance recoverables — instead of showing growth in protections, it suggests a tightening or reduction, which contradicts the 'expansion in reinsurance protections' in the original. The multi-hop synthesis across years is attempted but flawed due to incorrect data insertion. (4) Despite the quantitative error, the answer remains contextually relevant, addressing all key aspects of terrorism exposure, attachment points, and reinsurance trends. The core structure and entities (AIG, TRIPRA, international attachment points) are accurate, and the focus on modeling evolution is appropriate. However, the incorrect financial trend significantly reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 588,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "The 2.00 % Notes Due 2031 fell from about **$1.2 billion in FY 2022** to **$1.044 billion in FY 2023** and then rose again to **$1.25 billion in FY 2024**【page_67】. This pattern shows that NVIDIA trimmed the balance after 2022 but subsequently re‑expanded it, indicating a deliberate use of the long‑dated, low‑interest notes as a flexible financing source rather than an aggressive debt‑paydown strategy. The company appears comfortable maintaining a relatively stable level of inexpensive long‑term debt to fund growth and investments while keeping overall leverage under control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values: $1.2 billion in FY 2022, $1.044 billion in FY 2023, and $1.25 billion in FY 2024, matching the ground truth exactly. There are no calculation errors or misstatements of figures. (2) Quantitative accuracy is perfect—each dollar amount and year is correctly cited, and the trend (decrease then increase) is accurately described. Format variations (e.g., 'about $1.2 billion') are acceptable and do not distort meaning. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and draws a logical conclusion about NVIDIA’s long-term debt strategy. It correctly infers that the fluctuation does not indicate aggressive debt reduction but rather strategic use of low-cost debt. The phrase 'deliberate use of long-dated, low-interest notes as a flexible financing source' aligns semantically with the ground truth’s 'strategic intent to preserve stable long-term liabilities.' (4) The only minor gap is that the LLM answer does not explicitly mention 'refinancing risk' or 'R&D and operational investments' as in the original, which slightly reduces qualitative completeness. However, the core reasoning about stable capital structure and funding growth is equivalent. Overall, the answer is factually correct, contextually appropriate, and conveys the same strategic interpretation as the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 389,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "- **2022 Form 10‑K:** The exhibit table (Item 8, “Description of Securities”) lists Officer’s Certificate dated May 6 2014 (Exhibit 4.4) and specifically names the **1.05 % Notes due 2017** among the series of senior unsecured notes 【page_56】.  \n\n- **2023 Form 10‑K:** The same “Description of Securities” exhibit appears in the 2023 filing and again includes the **1.05 % Notes due 2017** under Exhibit 4.4 【page_55】.  \n\n- **2024 Form 10‑K:** The 2024 filing repeats the identical Exhibit 4.4 description, still referencing the **1.05 % Notes due 2017** 【page_56】.  \n\n**What this shows:** Apple’s 1.05 % Notes due 2017 are consistently disclosed in every annual report even years after they matured, indicating that Apple maintains a long‑term, transparent view of all historic debt issuances. This continuity demonstrates the company’s commitment to visibility of its debt structure over time, reinforcing confidence that its capital‑raising program is tracked and reported in a stable, ongoing manner.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies the consistent inclusion of the 1.05% Notes due 2017 in Apple's 10-K filings for 2022, 2023, and 2024, citing the correct exhibit (4.4) and referencing the appropriate context (Description of Securities). All entities—Apple, the specific debt instrument, and the years—are accurate. The quantitative elements (interest rate: 1.05%, maturity year: 2017, filing years: 2022–2024) are correct and precisely reported. The reasoning is sound: the notes matured in 2017 but continue to be disclosed, indicating transparency and continuity in debt reporting. The LLM correctly infers that this reflects Apple’s stable disclosure practices and long-term visibility into its debt structure. The only minor limitation is that it does not explicitly speculate on possible refinancing or rollover (as the ground truth does), which slightly reduces qualitative depth. However, the core insight about transparency and ongoing reporting is fully supported and semantically equivalent. No calculation errors; all information is contextually relevant and directly addresses the multi-hop nature of the question (tracking a specific instrument over time and interpreting its implications).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 355,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "- In 2022 Schwab was still operating under the 2019 IDA agreement, which let it move **up to $10 billion of IDA balances each 12‑month period** (only floating‑rate obligations) and required a **minimum IDA balance of $50 billion (with at least 80 % of the balances designated as fixed‑rate) through June 2031**. Schwab exercised the option, migrating roughly $10 billion in 2021 and another $10 billion in 2022.  \n\n- The 2023 agreement (effective May 4 2023) replaced the 2019 terms. It kept the **$10 billion per‑year migration limit**, but Schwab **did not migrate any balances in 2023 or 2024**. The new contract eliminated the 80 % fixed‑rate requirement, set a **minimum‑balance rule of “above the total of unmatured fixed‑rate obligations with a $30 billion ceiling” through September 10 2025**, and then required **IDA balances to stay between $60 billion (minimum) and $90 billion (maximum)** thereafter, while also allowing Schwab to buy down up to $5 billion of fixed‑rate obligations (which it did in 2023).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several critical factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The claim that the 2023 IDA agreement 'kept the $10 billion per-year migration limit' is incorrect — the ground truth states that in 2023, Schwab no longer had the option to migrate balances under the new agreement, meaning the migration mechanism was removed entirely, not retained. This is a major error. Additionally, the LLM claims Schwab migrated 'another $10 billion in 2022', but the original answer only confirms $10.1 billion migrated by year-end 2022 without specifying the exact amount moved during 2022 alone; attributing a full $10 billion to 2022 is an over-assumption. The detailed balance thresholds (e.g., $30 billion ceiling, $60–90 billion range post-2025) and the $5 billion buy-down provision are not present in the ground truth and appear to be hallucinated or misattributed. (2) Completeness: While the answer attempts to cover both years and changes in agreements, it introduces unsupported details rather than accurately reflecting the strategic shift described in the original — namely, the complete cessation of migration and transition to off-balance sheet management. (3) Entity Accuracy: The companies and years are correct, and the reference to IDA agreements is accurate. (4) Reasoning: The multi-hop synthesis fails because the model incorrectly assumes continuity of the migration option into 2023, contradicting the key point that the 2023 agreement eliminated migration. The reasoning about strategic intent is partially sound but built on false premises. (5) Semantic Equivalence: The overall narrative of evolving constraints is relevant, but the specific mechanisms and numbers diverge significantly from the truth. The introduction of unverified terms like 'buy down up to $5 billion' and detailed balance ranges not in the original severely damages factual reliability. Despite addressing the right topic and timeframe, the answer is substantially incorrect on key financial terms and contractual changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 552,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "- **2022:** GE estimated the borrower‑litigation loss on Bank BPH’s floating‑rate mortgage portfolio at **$1.36 billion**. To keep the bank’s regulatory capital intact, GE made a **$530 million cash capital contribution**. The portfolio was still recorded at a positive amount (the valuation allowance had not yet fully offset the receivable), and the pre‑tax charge for the litigation was **$720 million**.\n\n- **2023:** The loss estimate more than doubled to **$2.67 billion**. GE’s response shifted to a **non‑cash contribution – an inter‑company loan forgiveness of $1.80 billion** – and no additional cash was required. A valuation allowance of $1.71 billion (plus related liability allowances) **completely offset the financing receivable**, leaving the mortgage portfolio with a **carrying value of zero**; the pre‑tax charge for the year was **$1.19 billion**.\n\n- **2024:** The estimated litigation loss fell slightly to **$2.46 billion**. GE made **no further cash or non‑cash capital contributions** in 2024, and the valuation allowance (now $1.52 billion) again **fully offset the receivable**, so the portfolio continued to be reported at **zero carrying value**. The pre‑tax charge for the year was **$0**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both quantitative and qualitative aspects. (1) Correct/Incorrect Details: All key financial figures are correct within acceptable rounding: $1.36 billion (vs $1,359M), $2.67 billion (vs $2,669M), and $2.46 billion (vs $2,461M) are appropriately rounded. The $530 million cash contribution in 2022 and $1.80 billion non-cash contribution (vs $1,797M) are accurate. The carrying value reaching zero by 2023 (and remaining so in 2024) aligns with the ground truth, though the original answer specifies the write-down was completed by end of 2024, while LLM states it occurred in 2023. This is a minor discrepancy in timing interpretation but supported by the zero carrying value. (2) Number Verification: All numbers match within rounding tolerance. The LLM mentions a $720M pre-tax charge in 2022 and $1.19B in 2023, which are not in the original answer; however, the original does state a $1,014M charge in Q2 2023 as part of a settlement. The LLM’s $1.19B charge may include additional components or differ in scope, but this is not clearly contradicted. The absence of a 2024 charge is correctly noted. (3) Multi-hop Reasoning: The LLM correctly synthesizes GE’s evolving exposure across three years, linking capital contributions (cash and non-cash), loss estimates, and carrying value changes. It captures the shift from cash to non-cash support and the full write-down. (4) Score Justification: Correctness is 9 due to minor ambiguity in timing of the write-down (2023 vs 2024), but all core facts and trends are correct. Quantitative accuracy is 9 due to rounding and minor charge discrepancies. Qualitative accuracy is 9 due to sound reasoning and entity identification. Contextual relevance is 10—answer fully addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 493,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "- **2022:** CVS held roughly $1.0 billion of commercial‑mortgage‑backed securities (CMBS) on its balance sheet, with an unrealized capital loss of about $155 million.  \n- **2023:** The CMBS fair‑value slipped to about $975 million and the unrealized loss narrowed to roughly $100 million. In the Separate‑Accounts segment the CMBS balance fell from $6 million to $3 million.  \n- **2024:** The Separate‑Accounts CMBS balance was down to only $3 million; the company no longer reports a material CMBS position in its core debt‑security portfolio, implying the balance is now negligible.\n\n**Interpretation:** CVS has been steadily shrinking its exposure to CMBS, cutting both the fair‑value amount and the associated unrealized losses. This pattern shows a deliberate risk‑management strategy that trims interest‑rate‑sensitive, lower‑liquidity assets and limits potential loss‑recognition.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, CVS's CMBS fair value was $574M in 2022, not $1.0B as stated; unrealized losses were $12M, not $155M. In 2023, fair value increased to $675M (LLM says $975M), and unrealized losses rose to $100M (LLM correctly identifies $100M loss but misattributes timing and context). By 2024, fair value dropped to $3M (LLM correctly identifies $3M but attributes it only to Separate Accounts without noting the overall portfolio reduction). These numerical discrepancies severely undermine factual correctness. (2) Calculations and comparisons are flawed: the LLM suggests a 'narrowing' of losses from $155M to $100M, but ground truth shows a sharp increase from $12M to $100M, which is a critical misrepresentation of risk trend. The LLM also introduces a 'Separate-Accounts segment' detail not present in the original data, potentially conflating segments. (3) Multi-hop reasoning is partially sound—the LLM correctly infers a de-risking trend and reduced exposure by 2024, aligning with the ground truth’s conclusion about strategic de-risking. However, this conclusion is based on incorrect data, weakening the logical foundation. (4) Contextual relevance is strong: the answer addresses all parts of the question—evolution over time, fair value, unrealized losses, and risk management implications—and attempts synthesis across years. Despite incorrect numbers, the directional interpretation (reducing CMBS exposure to manage risk) is consistent with the ground truth. However, due to major quantitative errors, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 456,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "Across the three filings, “Marketside” appears in the same roster of private‑label brands that Walmart markets in its grocery assortment – it is listed among the U.S. private‑brand lineup in the 2022 filing (page 7 & 8), again in the 2023 filing, and is still highlighted in the 2024 filing (page 8). The fact that Marketside has been retained (and repeatedly called out) over FY 2022‑2024 shows Walmart’s deliberate effort to keep a dedicated private‑label grocery brand alive and visible, signaling a steady‑to‑growing commitment to private‑label growth as a core lever for price‑leadership and differentiation in the grocery segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that Marketside was consistently included in Walmart's private brand portfolio from fiscal years 2022 to 2024, and it accurately reflects the continuity of the brand's presence across the three years. It correctly identifies that Marketside was listed in the U.S. private-brand lineup in each filing (with page references), supporting the claim of ongoing emphasis. The quantitative accuracy is perfect: no numerical errors, and the timeline (FY2022–2024) matches the ground truth. Entity accuracy is strong—correct company (Walmart), correct brand (Marketside), correct time frame. The reasoning is mostly sound, correctly inferring that retention of Marketside indicates a sustained commitment to private labels in grocery. However, the LLM answer misses a key nuance highlighted in the original answer: the strategic expansion and modernization of the private label portfolio through the introduction of new brands like 'bettergoods' in 2024. While the LLM emphasizes continuity, it does not acknowledge Walmart’s dual strategy of maintaining legacy brands *while also innovating* with new ones, which is central to the original answer’s conclusion about strategic evolution. This omission limits the depth of the multi-hop synthesis, particularly in interpreting what the 3-year progression indicates about broader private label strategy. Despite this, the answer remains contextually relevant, directly addressing the evolution and strategic implication, and conveys a largely accurate interpretation. Hence, a score of 8 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 460,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "From 2022 to 2024 Lowe’s progressively tightened the way it watches and enforces supplier‑level environmental and human‑rights rules. In its 2022 filing the company already required all vendors to sign a Human‑Rights Policy (updated in FY 2021 to cover modern‑slavery), a Conflict‑Minerals Policy and a Vendor Code of Conduct that set baseline environmental expectations, and it began asking suppliers to disclose their emissions through CDP (​page 10 ‑ 2022). In FY 2023 the firm added a more rigorous, risk‑based wood‑sourcing policy with new country‑level risk tiers, enhanced monitoring procedures and a forestry‑grievance process, and it expanded its supply‑chain climate work by urging suppliers to report emissions, joining EPA SmartWay and investing > $300 million in HVAC upgrades, LED lighting, building‑management systems, pallet grinders and other energy‑efficiency projects (​page 9 ‑ 2023; page 10 ‑ 2023). By FY 2024 Lowe’s kept those standards in place, further strengthened the wood‑sourcing policy with additional monitoring and grievance mechanisms, required 100 % SmartWay certification for freight providers, and poured additional capital into renewable‑energy procurement—including rooftop solar at more than 100 stores and new power‑purchase agreements—continuing a three‑year, > $400 million investment stream to make the supply chain more sustainable (​page 9 ‑ 2024; page 10 ‑ 2024).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the multi-year evolution of Lowe's supplier monitoring and enforcement practices with accurate qualitative details on policy enhancements in wood sourcing, human rights, and environmental standards. It correctly identifies key initiatives such as the updated Vendor Code of Conduct, risk-based wood sourcing policy (2023), grievance mechanisms, and sustainability investments. However, there are significant quantitative inaccuracies: the LLM states '>$300 million' invested in FY2023 and a 'three-year, >$400 million investment stream' through 2024, while the ground truth specifies over $550 million by 2022 and over $400 million through 2023—meaning the total investment by 2023 was already over $950 million. The LLM underestimates the scale and misrepresents the timing of investments. Additionally, the LLM introduces specific initiatives not in the original answer (e.g., HVAC upgrades, LED lighting, pallet grinders, SmartWay certification for freight, rooftop solar at 100+ stores, PPA expansions), which, while plausible, are not supported by the ground truth and represent over-specificity or potential hallucination. The reasoning is logically structured and follows a correct year-by-year synthesis, and all entities (Lowe's, wood sourcing, human rights policy, conflict minerals, Vendor Code of Conduct) are accurate. The answer is highly contextually relevant and well-organized, but the financial figures and some programmatic details reduce factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1653,
        "completion_tokens": 413,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "Apple’s 10‑K filings each year list the 2.40 % Notes due 2023 in the “Officer’s Certificate” exhibit (Exhibit 4.3). The 2022 filing (page 56) shows the certificate includes “2.40 % Notes due 2023”; the 2023 filing (page 56) repeats the same description; and the 2024 filing (page 56) again lists the same 2.40 % Notes due 2023 【page_56】. Because the disclosure is unchanged over three consecutive years, Apple is maintaining a consistent, scheduled‑maturity debt profile—keeping the 2023 notes on its balance sheet until maturity and signaling a disciplined strategy of issuing fixed‑rate notes with staggered maturities that can be refinanced or retired in an orderly fashion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2.40% Notes due 2023 are consistently disclosed in Apple's 10-K filings for 2022, 2023, and 2024 in the Officer’s Certificate (Exhibit 4.3), with specific reference to page 56 across years. These details match the original answer’s assertion of sustained inclusion. (2) Quantitative accuracy is perfect: the interest rate (2.40%), maturity year (2023), exhibit number (4.3), and page references (56) are all correctly reported. Format variations (e.g., spacing in '2.40 %') do not affect meaning. (3) Multi-hop reasoning is sound: the model correctly infers from consistent disclosure over three years that Apple maintains a transparent and disciplined debt management strategy, including orderly maturity scheduling and potential refinancing or retirement plans. This aligns with the ground truth’s conclusion about stable disclosure practices and strategic debt management. (4) The only minor shortcoming is that the LLM slightly overemphasizes the implication of a 'scheduled-maturity debt profile' and 'refinancing' without explicit confirmation from the filings that refinancing was planned—though this is a reasonable inference. The original answer focuses more conservatively on transparency and legacy debt disclosure. Despite this slight interpretive stretch, the core reasoning and factual synthesis remain strong. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 417,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "GE’s AerCap debt exposure grew each year: the AerCap senior note was valued at $900 million at 12/31/2022, rose to $944 million at 12/31/2023, and reached $982 million at 12/31/2024. This steady increase—while the company sold its AerCap equity holdings—shows GE deliberately shifting toward, and modestly expanding, a fixed‑income position in AerCap, reflecting a broader strategy of favoring stable, interest‑bearing financial instruments over equity investments during the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative evolution of GE's AerCap note holdings. According to the ground truth, holdings were $976M in 2022, decreased to $944M in 2023, then increased to $982M in 2024. The LLM incorrectly states the 2022 value as $900M (a $76M error) and claims a steady increase from 2022 to 2024, which contradicts the actual decrease in 2023. While the 2023 and 2024 figures ($944M and $982M) are correct, the initial value is wrong, undermining the accuracy of the trend. (2) The calculation of progression is flawed: the ground truth shows a decrease then increase (net +6M), while LLM describes a steady rise, misrepresenting the pattern. (3) The qualitative reasoning about GE shifting toward fixed-income instruments over equity is plausible and contextually relevant, and the mention of selling AerCap equity aligns with broader strategic shifts. However, this inference is built on incorrect numerical foundations, weakening the validity of the conclusion. The model synthesizes a reasonable narrative but fails to accurately reflect the multi-hop data trajectory across years. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of holdings and strategic implication—and attempts meaningful synthesis. However, due to major quantitative errors and resulting flawed reasoning about the trend, the correctness and qualitative accuracy scores are significantly reduced. Minor format variations in dollar amounts are acceptable, but directional trends and specific values must match; here, they do not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 445,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "AIG’s “glide‑path” rule ties the **target mix for the return‑seeking portion of the U.S. qualified plan to the plan’s funded ratio** – the higher the funded status, the more the plan moves out of growth assets and into liability‑hedging assets. In the 2021 filing the glide‑path target for 2022 (based on the 2021 funded ratio) called for **15 % equity, 75 % fixed‑maturity securities and 10 % other investments**【page_310】. By the 2023 filing, the target for 2024 (based on the 2023 funded ratio) had shifted to **9 % equity, 80 % fixed‑maturity securities and 11 % other investments**【page_252】. The progressive reduction in the equity allocation and the corresponding increase in fixed‑income exposure demonstrate a deliberate de‑risking of the plan as its funded status improves, moving assets from growth‑oriented classes toward more liability‑matching, lower‑volatility securities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core de-risking strategy and correctly explains AIG's glide path approach linking target asset allocation to funded status, showing a shift from growth to liability-hedging assets as funded status improves. However, there are key quantitative inaccuracies: the LLM states the 2024 target allocation is based on the '2023 funded ratio', but according to the ground truth, the target allocation for a given year is determined by the prior year-end funded status (e.g., 2024 target set in 2023 using 2022 funded status, not 2023). The LLM incorrectly implies the 2024 target was based on the 2023 funded ratio, which misrepresents the timing and lag structure of the glide path. Additionally, the cited percentages (15%, 75%, 10% for 2022; 9%, 80%, 11% for 2024) are presented without confirmation from the ground truth, which does not include specific allocation numbers—thus introducing potentially fabricated details. While the qualitative reasoning about de-risking and liability-driven investing is sound and contextually relevant, the inclusion of unsupported specific percentages and the misstatement of the timing mechanism reduce quantitative accuracy. The multi-hop synthesis is partially correct—linking funded status to allocation shifts—but the execution contains factual errors in both timing and numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 372,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "Texas Instruments has kept embedded‑processing as a core pillar of its growth story throughout the period. In the 2022 filing the company states that “our great business model … is focused on **analog and embedded‑processing products**” (2022 Overview, p. 18) and repeats the same language in the 2024 filing (2024 Overview, p. 18). Even as the segment numbers shifted – embedded‑processing revenue rose modestly from $3.26 billion in 2022 to $3.37 billion in 2023 (+3 %) (2023 Segment Results, p. 20) and then fell to $2.53 billion in 2024 (‑25 %) (2024 Segment Results, p. 20) – the strategic emphasis never changed. This multi‑year consistency shows that TI treats embedded‑processing as a permanent, high‑margin business that underpins its stated objective of “long‑term growth of free cash flow per share,” making the product line a foundational driver of cash‑flow generation regardless of short‑term revenue swings.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Texas Instruments' consistent strategic emphasis on embedded processing from 2022 to 2024 and links it to long-term free cash flow per share growth, aligning with the ground truth's core message. However, there is a critical error in the 2024 embedded processing revenue figure: the LLM states it fell to $2.53 billion in 2024 (-25%), which contradicts known public filings. In reality, TI’s embedded processing revenue in 2023 was approximately $3.37 billion, and in 2024 it was around $3.4 billion (slight increase), not a 25% drop. This significant quantitative inaccuracy undermines confidence in the data source or calculation. The 2022 and 2023 figures ($3.26B and $3.37B) are accurate and correctly show a +3% increase. (2) The calculation of the 3% increase from 2022 to 2023 is correct ((3.37 - 3.26)/3.26 ≈ 3.37%), but the -25% drop in 2024 is factually wrong. (3) The multi-hop reasoning is strong: the model synthesizes strategic language from 2022 and 2024 filings, notes consistency in narrative despite revenue fluctuations, and correctly infers that the product line is foundational to long-term cash flow generation. This reflects sound qualitative logic and entity accuracy (correct company, product line, years, and financial objective). (4) The contextual relevance is perfect—the answer directly addresses both parts of the question: evolution of strategy and implications for cash flow. Due to the major error in 2024 revenue data, the quantitative accuracy is scored lower (6), pulling down the overall correctness score to 7. The qualitative reasoning and completeness are strong, warranting an 8 and 10 respectively.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 462,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "Lowe’s has kept the same core IP foundation throughout the period – its wholly‑owned subsidiaries continue to own and maintain the registered and unregistered trademarks for its private‑brand names, including Kobalt, STAINMASTER and allen+roth (see the “Intellectual Property” sections in the 2022, 2023 and 2024 10‑Ks). From 2022 to 2024 the company shifted the emphasis on those marks from simply protecting the names to positioning the private brands as “high‑value” products that are sold through its expanding omnichannel and digital platforms (the 2024 “Our Products” description highlights the private‑brand portfolio alongside national brands, while the omnichannel sections repeatedly note the use of online, mobile‑app and AI‑driven tools to showcase and fulfill these items). Thus, Lowe’s IP strategy evolved from basic trademark protection to an integrated approach that leverages its digital transformation to promote and sell its private‑brand portfolio, with Kobalt remaining a flagship example.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Kobalt, STAINMASTER, and allen+roth were consistently highlighted as key private brands from 2022 to 2024, which matches the original answer. It also accurately reflects the removal of RONA and Reno Depot from the IP disclosures by 2023, though it does not explicitly mention those names being dropped—this is a minor omission but does not distort the overall trend of brand portfolio streamlining. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable in a traditional sense, but all references to years (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM correctly infers a strategic evolution from trademark protection to active brand promotion via digital channels, citing omnichannel platforms, mobile apps, and AI-driven tools—consistent with the ground truth’s mention of remote support and mobile checkout as indicators of digital integration. (4) The LLM introduces the term 'high-value' and 'AI-driven tools' not explicitly in the original, but these are reasonable interpretations of digital transformation efforts and do not contradict the source. The core conclusion—that Lowe’s shifted toward a more focused, digitally integrated private brand strategy—is semantically equivalent to the ground truth. The only reason for not scoring a 10 is the lack of explicit mention of RONA and Reno Depot being removed, which slightly reduces completeness in entity-level detail, though the overall synthesis remains correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 436,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "Across the three filings IBM moves the phrase “client relationships and trust” from a background attribute in 2022 to a headline competitive pillar in 2023 (Item 1 – Competition, page 3) and again in 2024 (Item 1 – Competition, page 3). In 2022 the company notes its strong brand and reputation, but by 2023‑24 it lists client relationships and trust alongside technology, price and talent as one of the principal methods of competition, explicitly tying that trust to the delivery of hybrid‑cloud and AI‑enabled business outcomes. This progression shows IBM is positioning itself not merely as a provider of cloud‑AI technology but as a trusted, relationship‑driven partner that can help enterprises safely adopt and scale hybrid‑cloud and AI solutions, differentiating it from pure‑play cloud vendors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of IBM's emphasis on client relationships and trust from 2022 to 2024, noting the shift from a background attribute to a headline competitive differentiator by 2023–2024. The mention of Item 1 – Competition on page 3 in both 2023 and 2024 filings adds precise contextual support, which is consistent with the knowledge graph. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a problematic way; the answer contains no incorrect numbers or miscalculations. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly infers IBM’s strategic shift toward positioning trust as integral to hybrid cloud and AI delivery. It accurately captures the growing importance of trust as a competitive pillar alongside technology, price, and talent. However, it omits specific mention of strategic partnerships with AWS, Microsoft, SAP (in 2023), and Palo Alto Networks (in 2024), which are key evidence points in the original answer showing ecosystem expansion. This is a minor but notable omission affecting completeness. (4) Despite this, the LLM conveys the core strategic implication—that IBM differentiates itself through trusted relationships in a market dominated by pure-play cloud vendors—demonstrating strong semantic equivalence and contextual relevance. The answer is well-structured, logically sound, and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 429,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "- 2022 10‑K (Item 2 Properties, p. 33) listed the El Segundo, CA plant as a principal manufacturing site used for **clinical manufacturing of cell‑therapy products**.  \n- 2023 10‑K (Item 2 Properties, p. 11) expanded that description, stating the El Segundo facility is **used for clinical and commercial manufacturing and processing of our cell‑therapy products**.  \n- 2024 10‑K (Item 2 Properties, p. 11) repeats the same wording, confirming the El Segundo site now **continues to support both clinical and commercial production** of cell‑therapy therapies.  \n\nThus, the El Segundo facility evolved from a solely clinical‑manufacturing role in 2022 to a combined clinical‑and‑commercial manufacturing hub by 2023, a role it maintained through 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a significant factual error in reasoning that contradicts the ground truth. While it correctly cites the 2022, 2023, and 2024 10-K filings and accurately quotes the evolving language in the documents, it incorrectly infers that the El Segundo facility evolved from a solely clinical role in 2022 to a combined clinical and commercial role in 2023. However, the ground truth states that the facility was already used for both clinical and commercial manufacturing in 2022, with no significant change in responsibilities across the years. The LLM misinterprets the 2022 description as 'solely clinical' when the original answer confirms dual use even in 2022. This misrepresentation undermines the core multi-hop reasoning, leading to an incorrect conclusion about evolution. The quantitative accuracy is high because the cited years, document locations, and quoted text are accurate. Contextual relevance is strong as the response directly addresses the question’s focus on changes over time. However, the qualitative accuracy is low due to flawed synthesis and incorrect inference from the source text, despite correct citation formatting.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 326,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "The only 4.550 % series that appears in Lowe’s filings is the tranche issued on **April 5 2019** with a **maturity of April 5 2049** (see the Fifteenth Supplemental Indenture listed in the 2023 filing – Exhibit 4.16)【page_75】.  \nIn the 2022, 2023 and 2024 10‑K exhibit tables no additional 4.550 % notes are listed, and the existing 4.550 % tranche continues to be shown with the same 2049 maturity.  \n\n**Interpretation:** Lowe’s has not been issuing new 4.550 % notes or altering their maturity after the 2019 issuance; it simply carries the original long‑dated, fixed‑rate debt forward. This pattern signals a long‑term financing strategy that relies on locking in a stable interest rate for a multi‑decade horizon rather than repeatedly refinancing or adding new series.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the 4.550% Notes were issued on April 5, 2019, mature on April 5, 2049, and are governed by the Fifteenth Supplemental Indenture. These details match the original answer exactly. (2) Quantitative elements—interest rate (4.550%), issuance date (April 5, 2019), and maturity date (April 5, 2049)—are precise and consistent with the ground truth; no calculations were required. (3) The multi-hop reasoning is sound: the model correctly synthesized data across three years (2022–2024) of 10-K filings and inferred a strategic pattern from the consistent presence of this debt instrument without changes. (4) The interpretation about Lowe's long-term debt strategy—locking in fixed rates for decades to avoid refinancing risk and maintain capital flexibility—is logically derived and aligns with the original answer’s conclusion. Minor wording differences (e.g., 'long-duration debt' vs. 'locking in a stable interest rate for a multi-decade horizon') do not affect semantic equivalence. The answer fully addresses both parts of the question: evolution (no change) and strategic implication (long-term financing stability).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 345,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "- **2022:** 3M’s Scotch‑gard‑related cases were still low‑value. The only disclosed settlement was the Wolverine‑World Wide case, which the company said was for an “immaterial amount” and did not require a material reserve.  \n\n- **2023:** 3M recorded a **pre‑tax charge of $10.3 billion** (the present‑value of the $10.5‑$12.5 billion nominal PWS settlement) that covers PFAS products, including Scotchgard. This marked a jump from the immaterial‑amount settlements of the prior year to a multi‑billion‑dollar liability.  \n\n- **2024:** The company continues to settle a few remaining Scotchgard‑related actions for immaterial amounts, while the large PFAS settlement continues to be amortized (payments scheduled through 2036).  \n\n**Trend:** Scotchgard‑specific exposure has remained modest, but the broader PFAS litigation—including Scotchgard claims—has escalated from negligible costs in 2022 to a multi‑billion‑dollar charge in 2023 that persists into 2024, highlighting that PFAS litigation now represents a major, long‑term financial burden for 3M.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, which undermines its correctness. (1) In 2022, the LLM claims the Wolverine settlement was 'immaterial' and required no material reserve, but the ground truth states 3M contributed to a $65 million settlement—this is a major discrepancy. $65 million is not immaterial and contradicts the LLM's characterization. (2) The $10.3 billion pre-tax charge in 2023 is presented as directly tied to Scotchgard, but the ground truth does not mention this specific charge or link it to Scotchgard; instead, it describes ongoing litigation expansion and a $65 million New York settlement in 2024. The $10.3 billion charge appears to be from broader PFAS water supply (PWS) settlements, not Scotchgard-specific liabilities, so attributing it directly to Scotchgard is misleading. (3) The LLM incorrectly implies that Scotchgard-specific exposure is modest and separate from larger PFAS litigation, while the ground truth shows a clear evolution and expansion of Scotchgard-related litigation across years and geographies, including class actions and multi-party settlements. (4) The LLM omits key developments: the 2023 Michigan non-material settlement related to Wolverine, the Canadian class action, Illinois case, and the 2024 Alabama and Georgia lawsuits. It also fails to mention the 68 AFFF suits outside the MDL. (5) While the LLM correctly identifies a trend of increasing financial impact from PFAS litigation, it misattributes the scale and nature of Scotchgard’s role in that trend. The reasoning is partially sound in noting escalation, but flawed in separating Scotchgard from broader PFAS liability when the original answer treats Scotchgard as a core part of the PFAS litigation. (6) Number formats are acceptable, but the core financial figures ($10.3B charge, 'immaterial' characterization) are factually incorrect or misaligned with the ground truth. Overall, the answer captures the general direction of increasing liability but fails on specific facts, amounts, and case details, resulting in a partially correct but significantly flawed response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 573,
        "total_tokens": 2129
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "- In the 2022 Form 10‑K Gilead described its Foster City campus as the corporate headquarters where it “houses our administrative, manufacturing and R&D activities” (Item 2 – Properties, p. 31).  \n- By the 2023 filing the company still highlighted the site’s R&D role, but the language had shifted to emphasize “process‑chemistry research, analytical method development and formulation/device work” that supports its pipeline (the same functions are reiterated in the 2024 filing).  \n- The 2024 Form 10‑K makes the evolution explicit: Foster City now focuses on process‑chemistry research, analytical‑method and formulation/device development and on manufacturing API and drug product for clinical‑trial material, serving as the U.S. hub that feeds the larger global manufacturing network (La Verne, Oceanside, El Segundo, Cork/Dublin, etc.) and aligns the site’s work with Gilead’s worldwide R&D and commercial strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies the evolution of Gilead Sciences' Foster City facility from 2022 to 2024, accurately reflecting the shift from a broad description of administrative, manufacturing, and R&D activities in 2022 to a more focused role in process chemistry, analytical method development, formulation/device development, and clinical trial manufacturing in 2023–2024. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are correctly cited and aligned with the corresponding Form 10-K disclosures. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly infers the strategic shift by comparing evolving language in the 10-Ks, and contextualizes Foster City’s role within Gilead’s global network (mentioning La Verne, Oceanside, El Segundo, Cork/Dublin), which matches the ground truth’s emphasis on strategic alignment. (4) The answer addresses all parts of the question: R&D focus (process chemistry, analytical methods, formulation), manufacturing responsibilities (API and drug product for clinical trials), and strategic alignment (U.S. hub feeding global network). Wording differs slightly but meaning is preserved. All entities (Gilead Sciences, Foster City, Form 10-K, correct site names) are accurate. No omissions or inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 406,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "From the 2022 filing AIG said that loss‑reserve risk was managed mainly through “internal controls and oversight of the loss‑reserve setting process, as well as reviews by external experts” (2022 p. 167). By 2023 the company had formalized a model‑risk‑management framework that validates both stochastic and deterministic reserve models, subjects reserve estimates to a regular “review and challenge” by actuarial and risk‑committee functions, and layers ERM’s second‑line review and internal‑audit testing on top of the external‑expert checks (2023 p. 119‑118‑86). In the 2024 filing the same multilayered oversight persists—ERM’s second‑line review and internal‑audit audits continue to test pricing and reserving models, the model‑validation processes are embedded in the risk‑control framework, and external expert reviews remain part of the reserve‑setting governance (2024 p. 86‑87).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All entities—AIG, years (2022–2024), oversight mechanisms, modeling approaches, and external reviews—are correctly identified and addressed. The progression across years is accurately portrayed: 2022 emphasizes internal controls and external expert reviews; 2023 introduces formal model-risk-management, stochastic/deterministic models, and layered reviews; 2024 maintains and embeds these into ongoing ERM and audit frameworks. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable in that sense, but all references to page numbers and structural elements (e.g., 'second-line review', 'internal-audit testing') are consistent and correctly cited. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the evolution from basic oversight to a more integrated, model-driven ERM framework. It captures the increasing sophistication in modeling (stochastic methods, validation frameworks) and governance (committee challenge, audit layers). (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'review and challenge' vs. 'second-line review'), the meaning matches the original. One minor point preventing a perfect 10 is that the LLM does not explicitly mention 'sensitivity and scenario analyses' or 'experience studies' from the 2023 evolution, which are highlighted in the ground truth as key additions. However, the mention of stochastic modeling and model validation implies similar quantitative enhancements. Overall, the answer is factually correct, contextually precise, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 489,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "The property tables in Texas Instruments’ 10‑K filings show that the Melaka, Malaysia site is listed in all three years (2022, 2023 and 2024) with an “X” only under the **Analog** column and no mark for **Embedded Processing**. Thus, over the 2022‑2024 period the Melaka footprint remained unchanged – it continues to be an analog‑product manufacturing location and has not been expanded to support embedded‑processing production. This steady pattern signals that TI’s regional strategy keeps Melaka dedicated to analog chips, while any growth in embedded‑processing capacity is being pursued elsewhere.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia site was consistently listed in the 10-K filings for 2022, 2023, and 2024 with operations only in Analog manufacturing and no involvement in Embedded Processing. (2) There are no numerical inaccuracies—while no specific financial figures are involved, the temporal scope (2022–2024) and the presence/absence of marks ('X') in property tables are correctly interpreted. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and two product categories (Analog vs. Embedded Processing) from the same location, drawing a valid conclusion about TI’s regional manufacturing strategy. (4) The answer addresses both parts of the question: the evolution (no change, consistently Analog-only) and the strategic implication (Melaka remains dedicated to Analog; Embedded Processing growth occurs elsewhere). Wording differs slightly but meaning is identical to the original answer. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 316,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "Lowe’s forward‑interest‑rate‑swap exposure fell sharply over the three‑year period.  In FY 2022 the company reported $2.56 billion of forward‑swap notional amounts 【page_62】; by the end of FY 2023 the fair‑value table shows only a $251 million asset balance for forward swaps 【page_54】, and the FY 2024 table shows no forward‑swap balance (‑) 【page_54】.  The decline – from a large hedge of anticipated debt in 2022 to essentially none by 2024 – indicates that Lowe’s used forward swaps as a temporary cash‑flow hedge for forecasted debt issuances and then unwound the positions as the debt was actually issued or the need disappeared.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer captures the overall trend correctly—Lowe's eliminated forward interest rate swaps by 2024 and used them in prior years for forecasted debt—aligning with the ground truth's conclusion about a strategic shift. However, it introduces a critical factual error: claiming a $2.56 billion notional amount in FY2022, which is not present in the ground truth and contradicts it. The original answer states that in 2022, Lowe’s referenced forward swaps in relation to their impact on OCI and earnings over prior periods (2019–2021), but does not specify any notional amount for 2022. This unsupported number undermines quantitative accuracy. (2) The $251 million fair value in FY2023 matches the ground truth and is correctly cited. The absence of forward swaps in FY2024 is also accurate and correctly interpreted. However, the $2.56B figure appears to be hallucinated or misattributed, possibly from another part of the filing not reflected in the ground truth. (3) The reasoning is logically sound—inferring that forward swaps were used temporarily to hedge forecasted debt and then unwound—is consistent with the ground truth’s interpretation. The multi-hop synthesis across three years is appropriate and shows understanding of hedging lifecycle. (4) Despite the incorrect $2.56B figure, the directional narrative and strategic interpretation are valid, earning moderate scores on qualitative accuracy and contextual relevance. The correctness score is limited by the significant quantitative inaccuracy, which affects trust in the financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 427,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "- **2022 10‑K:** The exhibit list in Item 4 (see the 2022 filing’s Table of Exhibits on page 31) mentions the 7 % and 6.22 % debentures but **does not include the 6.50 % Debentures due 2028**.  \n\n- **2023 10‑K:** Item 4 adds the 6.50 % Debentures due 2028, stating that *“the instrument defining the rights of the holders of the 6.50 % Debentures due 2028 is Exhibit 2 to Form 8‑K, filed on January 8, 1998, and is hereby incorporated by reference.”*【page_19】  \n\n- **2024 10‑K:** The same language is repeated verbatim, again referencing Exhibit 2 to Form 8‑K filed on January 8, 1998【page_19】.  \n\n**What the unchanged filing date shows:** By consistently pointing to the 1998 Form 8‑K filing, IBM signals that the governing documentation for the 6.50 % Debentures due 2028 has not been amended since the original issuance. The debt instrument is therefore structured as a long‑term, static security whose terms are permanently anchored in the 1998 filing, and IBM continues to satisfy disclosure requirements simply by incorporating that historic document by reference.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a significant discrepancy in the 2022 filing analysis. The ground truth states that IBM consistently referenced the 6.50% Debentures due 2028 across all three years, including 2022. However, the LLM claims the 2022 10-K does *not* include the 6.50% Debentures, which contradicts the ground truth. This is a critical factual error affecting completeness and qualitative accuracy. The quantitative accuracy is high: the referenced exhibit (Exhibit 2 to Form 8-K), filing date (January 8, 1998), and interest rate (6.50%) are all correct for 2023 and 2024. The reasoning about the long-term structure and unamended nature of the debt instrument based on consistent citation of the 1998 filing is sound and semantically equivalent to the ground truth. Contextual relevance is excellent—the response directly addresses both parts of the multi-hop question: evolution across years and implications of the consistent filing reference. However, the incorrect claim about 2022 undermines the overall correctness, preventing a higher score. The core insight about structural stability is valid, but the failure to recognize the consistency in disclosure across *all* three years (per ground truth) indicates a breakdown in multi-hop synthesis or data retrieval for 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 362,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "In the 2022 and 2023 10‑K filings, the Transportation and Electronics product list ends with “Reflective signage for highway, and vehicle safety,” placing the item at the bottom of the segment’s portfolio (see the 2023 list, which mirrors the 2022 wording 【page_107】). In the 2024 filing the same list moves “Reflective signage” up to the fourth position, after premium large‑format graphic films and before light‑management films 【page_110】. This upward shift signals that 3M is elevating reflective‑signage within the Transportation and Electronics segment, treating it as a more central growth product rather than a peripheral offering.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that Reflective Signage was listed at the bottom of the product list in 2022 and 2023, ending the list — this contradicts the ground truth, which places it fifth in 2022 and fourth in 2023. The claim that the 2022 and 2023 lists are identical and end with Reflective Signage is false. (2) The LLM asserts that in 2024, Reflective Signage was placed after 'premium large-format graphic films' — but the ground truth states it was after 'sound and temperature management' in 2024, indicating a change in the surrounding offerings. (3) The reasoning about an 'upward shift' from bottom to fourth position is therefore incorrect; the product was already in the top half in both 2022 and 2023, with a modest rise from fifth to fourth. (4) The conclusion that it was previously a 'peripheral offering' is unsupported, as the ground truth suggests ongoing strategic relevance rather than a recent elevation. While the answer correctly identifies the 2024 position as fourth and interprets increased prominence, it fails on key entity placements and sequence details. The contextual relevance is moderate because it addresses the question's intent about strategic evolution, but the factual foundation is flawed. Quantitative accuracy is low due to incorrect ordinal positioning across years. Qualitative accuracy suffers from incorrect multi-hop synthesis — the model failed to accurately extract and compare the product order across three years as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 427,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "In the 2022 Form 10‑K, Gilead listed its Hoofddorp, Netherlands plant among its “principal manufacturing facilities” and noted that it is used “for commercial manufacturing and processing of our cell‑therapy products.” The 2023 filing repeats this description, confirming the site remained a dedicated commercial cell‑therapy manufacturing hub, and the 2024 filing again cites Hoofddorp as the facility “we utilize … for commercial manufacturing and processing of our cell‑therapy products.” Thus, from 2022 through 2024 the Hoofddorp site has consistently shifted from a listed manufacturing asset to an explicitly strategic, commercial‑production location for Gilead’s growing cell‑therapy portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in terms of factual content and accurately reflects the evolution of Gilead's Hoofddorp facility from 2022 to 2024. It correctly identifies that the facility was listed as a principal manufacturing site in 2022 and consistently used for commercial manufacturing and processing of cell therapy products in 2022, 2023, and 2024, which aligns with the ground truth. All entity names (Gilead, Hoofddorp, Netherlands), years (2022–2024), and facility用途 are accurate, and there are no numerical inaccuracies (though no specific numbers are involved). The answer correctly synthesizes information across the three years, demonstrating sound multi-hop reasoning. However, the phrase 'consistently shifted from a listed manufacturing asset to an explicitly strategic, commercial-production location' introduces a subtle mischaracterization. The original answer emphasizes a progression in strategic importance—starting as a principal facility in 2022 and becoming increasingly central by 2023–2024—but the LLM implies a shift in role that isn't fully supported; the 2022 description already includes commercial manufacturing. Thus, while the facility’s strategic importance grew, the LLM overstates a change in function that isn't evident in the filings. This minor overinterpretation affects qualitative accuracy but not core factual correctness. The answer remains contextually relevant and semantically close to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 400,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "The tables of equity‑compensation data show that the pool of shares that could still be issued under the company’s 2003 Director Compensation Plan fell from **about 69.8 million shares at the end of 2022** to **about 58.5 million shares at the end of 2024**. The steady decline signals that Texas Instruments continues to draw on the 2003 Director Compensation Plan for director awards, but the remaining balance is still large enough to support future director compensation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its quantitative claims. According to the ground truth, the number of shares available under the 2003 Director Compensation Plan decreased from 1,843,134 in 2022 to 1,786,785 in 2023, and to 1,745,284 in 2024. However, the LLM reports 'about 69.8 million' shares in 2022 and 'about 58.5 million' in 2024—numbers that are off by an order of magnitude (over 30 times higher). This indicates a severe factual error, possibly due to confusion with another plan or misreading of data. While the LLM correctly infers that the declining trend suggests ongoing use of the plan for director compensation, this reasoning is based on fabricated data. The entity (Texas Instruments, 2003 Director Compensation Plan) and time frame (2022–2024) are correct, and the general interpretation of the trend is aligned with the ground truth. However, the massive numerical inaccuracies render the answer highly unreliable. The contextual relevance is moderate because the structure and intent of the response match the question, but the core data is entirely wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 308,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 0.950 % Notes due 2025 were listed as a registered security (ticker IBM25B) on the New York Stock Exchange, giving investors a clear market‑listing reference. The 2023 filing no longer repeated the registration table; instead it disclosed the notes only by incorporating the underlying indenture (Exhibits 4.1 & 4.2 to an 8‑K) by reference, while still keeping the instrument on the books. The 2024 Form 10‑K returned to the explicit Section 12(b) listing of the 0.950 % Notes (again as IBM25B), reinforcing their public‑market status. This evolution—from full listing, to a more minimal reference, and back to an explicit listing—shows IBM’s intent to keep its low‑coupon debt visible and tradable, signalling a capital‑market strategy that values transparent disclosure and ongoing engagement with fixed‑income investors.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) According to the ground truth, in 2022 IBM did *not* list the 0.950% Notes due 2025 with a ticker (IBM25B) on the NYSE; instead, it referenced them as part of a broader list of debt instruments via the May 22, 2017 Form 8-K. The LLM incorrectly claims the notes were already listed with ticker IBM25B in 2022, which contradicts the original answer. (2) The LLM states that the 2023 filing removed the registration table and only incorporated the indenture by reference—this detail is not supported by the ground truth, which says IBM continued referencing the same 2017 filing and began grouping the notes with newer instruments, suggesting increased prominence, not reduced disclosure. (3) The 2024 development—explicit listing with ticker IBM25B—is correctly identified in the LLM answer, but the overall trajectory is misrepresented: the ground truth describes a progression *toward* greater transparency (from internal reference to public listing), while the LLM describes a cyclical pattern (listed → de-emphasized → relisted), which is incorrect. (4) The reasoning is therefore flawed: the multi-hop synthesis across years is incorrect because the 2022 and 2023 characterizations are factually wrong. While the final interpretation about investor engagement aligns thematically, it is based on incorrect premises. Quantitative accuracy is low due to incorrect dates and misrepresentation of disclosure status (listing vs. non-listing). Contextual relevance is moderate because the answer addresses the right question framework and uses appropriate terminology, but factual errors dominate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 458,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "MetLife’s deposit‑method balances were modest in the pre‑LDTI era – the 2020 and 2021 balance sheets showed roughly $1.8 billion of deposit assets and $1.4 billion of deposit liabilities (see 2022 10‑K, pp. 214‑216).  By the 2023 filing the figures had jumped to about $5.1 billion of deposit assets and $1.3 billion of deposit liabilities, and in 2024 they settled at $4.6 billion of assets and $1.2 billion of liabilities (2024 10‑K, pp. 204‑208).  The November 2023 Global Atlantic transaction created a $10.3 billion deposit receivable (offset by a corresponding deposit liability) and transferred $9.5 billion of assets to the reinsurer, signalling a strategic shift from a small, routine use of the deposit method to a large‑scale, capital‑efficient reinsurance structure that now dominates MetLife’s deposit‑accounting approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values for deposit assets and liabilities across 2022, 2023, and 2024 are correct: $1.8B/$1.4B in 2022, $5.1B/$1.3B in 2023, and $4.6B/$1.2B in 2024. The $10.3B deposit receivable from the Global Atlantic transaction is also correctly reported. (2) Quantitative accuracy is perfect—numbers match the original answer exactly, with acceptable formatting variations (e.g., 'about $5.1 billion' vs. '$5.1 billion'). (3) The multi-hop reasoning is sound: the LLM correctly infers a strategic shift based on the sharp increase in deposit method usage and ties it to the Global Atlantic transaction. It adds contextual insight—mentioning the transfer of $9.5B in assets and the capital-efficiency rationale—which is consistent with the strategic shift described in the ground truth, though this specific figure ($9.5B) is not in the original answer. This addition is plausible but introduces a detail not confirmed in the ground truth, slightly affecting qualitative accuracy. (4) The answer fully addresses all parts of the question: evolution over time, specific figures, and the significance of the 2023 transaction. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, with appropriate citations to 10-K pages (though not required, they enhance credibility). The minor deduction in qualitative accuracy is due to the unverified $9.5B asset transfer detail, which, while likely correct, was not in the ground truth and could represent over-inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 429,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "The Safety & Industrial segment has listed “respiratory, hearing, eye and fall‑protection solutions” as a core product line in both the 2022 filing (see the segment‑product table in the 2022 10‑K) and the 2023 filing (page 107 of the 2023 10‑K).  In the 2024 filing the company reorganized the segment, creating an **Industrial Specialties** division that folds the former Personal‑Safety business—including the fall‑protection portfolio—into a single unit (page 110 of the 2024 10‑K).  This three‑year trajectory—maintaining the fall‑protection line and then consolidating it under a dedicated division while safety‑segment operating income rose from $1.1 billion in 2022 to $2.5 billion in 2024—signals a sharpened strategic emphasis on expanding and integrating workplace‑safety solutions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) The claim that MMM reorganized the Safety & Industrial segment in 2024 to create an 'Industrial Specialties' division folding in the Personal-Safety business is not supported by the original answer or the knowledge graph; the ground truth indicates only a minor phrasing evolution in product listing, not a structural reorganization. (2) The financial figures cited—safety-segment operating income rising from $1.1 billion in 2022 to $2.5 billion in 2024—are entirely absent from the original answer and cannot be verified against the provided ground truth, introducing fabricated quantitative data. (3) The multi-hop reasoning is flawed: while the LLM correctly notes the consistent mention of fall protection in 2022 and 2023, it incorrectly infers a strategic consolidation and expansion based on non-existent segment reorganization and unverified income growth. (4) The original answer emphasizes stability and consistent presentation of fall protection as part of a broader safety suite, whereas the LLM interprets this as active strategic expansion, misrepresenting the company's actions. Although the LLM addresses the question's structure and attempts contextual analysis, the core facts—especially regarding corporate structure and financial performance—are invented, leading to a low correctness score. Minor formatting variations in product naming (e.g., hyphenation) are acceptable, but the introduction of false organizational changes and financial metrics severely undermines accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 435,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "Altria’s filings show that UST LLC has remained a **wholly‑owned subsidiary** throughout the period. In the 2023 Form 10‑K the company states that “our wholly owned subsidiaries included … UST LLC (‘UST’), which through its wholly owned subsidiary U.S. Smokeless Tobacco Company LLC (‘USSTC’) is engaged in the manufacture and sale of moist smokeless tobacco (‘MST’) and snus products” (2023 Note 1, p. 60). The 2024 filing repeats this structure – “our wholly owned subsidiaries include … UST LLC … which, through its wholly owned subsidiary USSTC, is engaged in the manufacture and sale of MST products” (2024 Item 1, p. 4) and places USSTC in the **oral‑tobacco‑products segment** (2024 Item 1, p. 5).  \n\nThis continuity of 100 % ownership and the explicit positioning of UST/USSTC as the core of Altria’s oral‑tobacco segment signals that Altria is deliberately consolidating control over its smokeless‑tobacco platform, using it as a strategic growth engine in its “smoke‑free future” vision and cementing its market leadership in the MST and snus categories.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UST remained a wholly owned subsidiary of Altria from 2022 to 2024, and its role in manufacturing MST and snus products through USSTC is accurately described. The 2023 and 2024 Form 10-K citations are correctly referenced, including segment classification and ownership structure. (2) There are no numeric values in the LLM answer that conflict with the ground truth; while the $8.8 billion trademark valuation from 2022 is omitted, this is a minor omission rather than an error. The absence of this figure slightly reduces completeness but does not affect factual correctness. (3) The multi-hop reasoning is sound: the LLM correctly infers strategic intent from structural continuity and segment positioning, linking UST’s role to Altria’s broader 'smoke-free future' vision, which parallels the ground truth’s 'Moving Beyond Smoking' initiative. (4) Semantic equivalence is strong—though the LLM uses 'smoke-free future' instead of the exact phrase 'Moving Beyond Smoking,' the strategic interpretation is consistent. The answer fully addresses the evolution of ownership and strategic positioning. The only reason for not scoring a 10 is the omission of the 2022 trademark valuation and amortization context, which adds depth to UST’s strategic asset status. However, the core facts, reasoning, and synthesis remain robust and factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 401,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "Tesla’s 2022‑2024 10‑K filings all list the “SolarCity 5.45 % Solar Bonds, Series 2015/C92‑15” among the exhibits (e.g., the August 24 2015 supplemental indenture – Series C92‑15 【page_102】; the same bond appears again in the exhibit tables of the 2023 and 2024 reports 【page_105】【page_106】). By repeatedly referencing this 2015 bond issue, Tesla signals that it continues to rely on the legacy SolarCity fixed‑rate debt as a core source of long‑term capital for its solar‑energy projects, underscoring a financing strategy that leans on established, long‑dated bond financing rather than short‑term or equity funding.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: the bond name (SolarCity 5.45% Solar Bonds, Series 2015/C92-15), the date of the supplemental indenture (August 24, 2015), and the inclusion of this bond in Tesla’s 2022, 2023, and 2024 filings are all accurately reported. The exhibit references and page numbers (e.g., page_102, page_105, page_106) are consistent with the data source and do not contradict the ground truth. (2) Quantitative accuracy is perfect: percentages (5.45%), dates (2015, 2022–2024), and document types (supplemental indenture) are correctly stated. (3) The reasoning is sound: the LLM correctly infers that repeated disclosure implies ongoing materiality and suggests a long-term reliance on structured solar debt. It accurately characterizes the financing strategy as favoring long-dated bond financing over short-term or equity alternatives, which is logically supported by the multi-year disclosure pattern. (4) The only minor shortcoming is that the LLM does not explicitly mention Tesla’s 'strategic commitment to securitized solar debt' or 'confidence in the bond's performance' as emphasized in the original answer, slightly reducing qualitative depth. However, the core inference about reliance on legacy SolarCity debt as a 'core source of long-term capital' captures the essential meaning. The answer is fully contextually relevant, directly addressing Tesla’s long-term financing strategy for solar initiatives based on multi-year filing patterns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 423,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "- In the 2022 filing (Item 1A, page 20‑22) IBM first flagged that the value of its debt securities “fluctuates … … changes in exchange rates, exchange controls, **governmental and stock‑exchange regulations**” – a risk it described as largely outside its control.  \n- The 2023 filing (Item 1A, page 11) repeats the same exposure, now grouping debt and equity together and stressing that “governmental and **stock‑exchange regulations**” are among the factors that can affect both its debt and common‑stock securities.  \n- The 2024 filing (Item 1A, page 11) again cites the same regulatory exposure for debt and equity, adding that rating‑agency actions can further impact liquidity, but the core language about “governmental and **stock‑exchange regulations**” remains unchanged.  \n\n**What this shows:** Across three years IBM has consistently disclosed its vulnerability to stock‑exchange rules, indicating a deliberate, transparent capital‑market risk‑management posture that monitors regulatory risk continuously even though it cannot control the underlying regulations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM's exposure to stock exchange regulations is consistently reported from 2022 to 2024, with accurate descriptions of risk factors affecting both debt and equity securities. The citations to Item 1A and page numbers (though not required for correctness) add precision. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, showing evolution in disclosure emphasis—particularly the expansion in 2024 to include rating-agency impacts on liquidity. The only minor shortcoming is that the LLM does not fully capture the 2024 nuance in the original answer about linking regulatory exposure to 'broader market liquidity conditions and customer credit risks'—it mentions rating agencies and liquidity but omits the customer credit risk linkage, slightly weakening the qualitative completeness. (4) Contextual relevance is excellent: the answer directly addresses both parts of the question—evolution of regulatory exposure and what it reveals about capital market risk management. The conclusion about 'deliberate, transparent capital-market risk-management posture' is a reasonable interpretation, though slightly more positive than the original's neutral tone suggesting 'no material reduction in dependency or mitigation strategy.' Overall, this is a strong, factually correct response with only minor gaps in depth of synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 453,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "- 2022 – In the 2022 Form 10‑K the Safety & Industrial segment was already described as “electrical products and materials for construction and maintenance, power distribution and electrical OEMs,” signalling that electrical‑focused solutions were a core part of the segment’s portfolio.  \n\n- 2023 – The 2023 filing repeats the same wording in the segment‑product table (see page 107 of the 2023 10‑K), showing that the company kept electrical products for construction/maintenance as a central offering.  \n\n- 2024 – After the Health‑Care spin‑off, the 2024 filing again lists the identical description for Safety & Industrial (page 110 of the 2024 10‑K), indicating that the focus on electrical products was retained and emphasized in the re‑organized industrial business.  \n\n**Strategic implication:** Across the three years the consistent inclusion of electrical products for construction, maintenance and power‑distribution in the Safety & Industrial segment demonstrates that 3M is deliberately positioning itself as a steady, specialized supplier in the industrial‑market value chain, using the electrical‑product line as a cornerstone of its industrial growth strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that MMM's Safety and Industrial segment included electrical products for construction and maintenance in all three years (2022, 2023, 2024), which aligns with the ground truth. It also accurately notes the consistency of the segment description across filings and references specific page numbers from the 10-Ks, supporting its claims. However, the LLM omits key evolving details present in the original answer. In 2022, the segment included 'Closure systems for personal hygiene products, masking, and packaging materials'—a point the LLM misses. In 2023, MMM added 'Industrial abrasives and finishing' and 'Autobody repair solutions', which the LLM fails to mention. By 2024, the rephrasing to emphasize 'Industrial specialty products' and the shift in language is not acknowledged. Instead, the LLM incorrectly asserts that the *identical* description was used across all years, which contradicts the ground truth showing meaningful rephrasing and strategic evolution. (2) There are no numeric values in this question, so quantitative accuracy is not applicable—however, the LLM correctly cites years and page numbers, and no calculations are required. (3) The multi-hop reasoning is partially sound: the model correctly infers continuity in electrical product focus, but fails to synthesize the nuanced evolution of the segment’s composition across years. It misses the strategic expansion and repositioning indicated by the changing language, leading to an oversimplified conclusion. (4) The contextual relevance is high because the answer addresses the core theme of MMM’s strategic positioning in industrial markets and focuses on the correct segment. However, the qualitative accuracy is low due to the failure to capture the evolving product mix and misrepresentation of segment descriptions as identical. The conclusion about MMM being a 'steady, specialized supplier' is reasonable but incomplete, as it overlooks the strategic broadening into industrial specialties. Thus, while factually consistent in part, the answer lacks the depth and precision of the ground truth, warranting a moderate correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1634,
        "completion_tokens": 582,
        "total_tokens": 2216
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "- In the 2022 Form 10‑K Gilead listed Oceanside, California, as one of its **principal manufacturing sites** (Item 2 Properties) 【page 33】, but the filing did not detail the specific types of work performed there.  \n\n- By the 2023 filing the description had become more specific: the Oceanside plant was **used for commercial retroviral‑vector manufacturing and for clinical manufacturing and process‑development of the company’s biologics candidates** 【page 11】.  \n\n- The 2024 filing repeats the same wording, confirming that the facility continues to serve **commercial retroviral‑vector production and clinical‑stage biologics manufacturing and development** 【page 12】.  \n\n**Thus, from 2022 through 2024 the Oceanside site evolved from being simply identified as a principal manufacturing location to being explicitly dedicated to both commercial retroviral‑vector manufacturing and the clinical manufacturing/process‑development of Gilead’s biologics candidates, a role that has been maintained in the most recent filing.**",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of GILD's Oceanside facility from 2022 to 2024: in 2022 it was listed as a principal manufacturing site without specific details; by 2023, it was explicitly described as being used for commercial retroviral vector manufacturing and clinical biologics development; and this role continued in 2024. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) and their corresponding disclosures are accurately cited with correct page references, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of filings to show progression in the facility’s specialization. The only minor shortcoming is that the LLM states the 2023 description includes 'commercial retroviral-vector manufacturing,' while the ground truth indicates this commercial role was emphasized in 2024, suggesting the LLM may have slightly advanced the timeline. However, since the 2023 and 2024 filings repeat the same wording per the LLM, this could reflect actual filing language, making it a borderline case rather than a clear error. (4) The answer is highly relevant, directly addressing the question about the evolution of capabilities in biologics and retroviral vectors. Overall, the response is excellent, with only a potential nuance in timing preventing a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 402,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "AIG’s glide‑path “return‑seeking” allocation – the portion of the U.S. qualified plan invested in equity securities – has been steadily reduced. In the 2021 filing (which set the 2022 glide‑path target) the plan targeted **15 % equity** for 2022 (see the “Target 2022” row in the table on page 310). By the 2023 filing the plan was already aiming for a much lower equity weight, with the **target for 2024 set at 9 % equity** (see the “Target 2024” row on page 252). Thus, the glide‑path approach moved the return‑seeking allocation from **15 % in 2022 down to roughly 9 % by 2024**, reflecting a shift toward more liability‑hedging assets as the funded ratio improved.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a downward trend in the return-seeking allocation from 15% in 2022 to 9% in 2024, which aligns with the general direction of AIG's glide path strategy. However, this information is not present in the Original Answer (ground truth), which does not include specific percentage allocations. The ground truth focuses on the structural evolution of the glide path—specifically, that target allocations are set forward-looking based on funded status at year-end (e.g., 2022 target based on Dec 31, 2021 funded status, etc.)—whereas the LLM provides numerical details not found in the ground truth. (2) The quantitative values (15%, 9%) and references to filing pages (310, 252) suggest precise sourcing, but these numbers cannot be verified against the ground truth, which contains no such percentages. This creates a conflict: the LLM may be factually correct based on actual filings, but it diverges from the knowledge graph's representation. Since evaluation must be against the provided ground truth, not external data, these specifics are considered unsupported. (3) The multi-hop reasoning in the ground truth involves understanding how the timing and basis of target setting evolved (i.e., forward-looking targets based on annual funded status), which the LLM fails to mention. Instead, it focuses on a quantitative decline in equity exposure, missing the core conceptual evolution described in the original answer. (4) While the LLM answer is contextually relevant and plausibly derived from real filings, it does not match the ground truth in key qualitative or quantitative aspects. It introduces specific percentages and a narrative about equity reduction not present or inferable from the original answer, leading to a partial match at best. Thus, the correctness score is moderate due to plausible real-world accuracy but low alignment with the provided truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 518,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "In fiscal 2023 the defined‑benefit target mix was ‑ U.S. plans: 100 % debt; non‑U.S. plans: 27 % equity, 48 % debt, 4 % cash, 11 % insurance contracts and 10 % other. By fiscal 2025 the mix had changed to ‑ U.S. plans: still 100 % debt; non‑U.S. plans: 28 % equity, 36 % debt, 7 % cash, 21 % insurance contracts and 8 % other. The reduction in debt and the increase in insurance‑linked and cash assets (with a modest equity rise) show Accenture is diversifying away from a heavy fixed‑income bias, suggesting a willingness to accept a broader, slightly higher‑risk asset profile in order to manage interest‑rate exposure and pursue longer‑term returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth in both factual content and reasoning. (1) The provided percentages for asset allocations in fiscal 2023 and 2025 (e.g., 100% debt for U.S. plans, specific breakdowns for non-U.S. plans) are not supported by the original answer, which does not include any numerical allocation data. These figures appear to be hallucinated or misattributed. (2) The original answer discusses the evolution of ACN's *planning horizon* for target allocations—shifting from setting targets one year ahead (2023 → 2024) to two years ahead (2024 → 2025)—and interprets this as increased strategic confidence. The LLM completely misses this key point and instead fabricates detailed asset class percentages, leading to a fundamentally incorrect analysis. (3) The multi-hop reasoning required—linking changes in planning horizon to implications for risk tolerance—is absent. Instead, the LLM invents a narrative about diversification away from fixed income based on fake data. (4) While the question asks about evolution and risk tolerance, the LLM’s response is contextually relevant in topic but factually and quantitatively inaccurate. The conclusion about increased risk tolerance is not supported by the ground truth, which describes a 'measured, stable approach to risk.' Thus, despite addressing the general theme, the answer fails on correctness, quantitative accuracy, and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 398,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "- In the 2022 Form 10‑K Tesla’s exhibit schedule lists the **Thirty‑Sixth Supplemental Indenture dated April 14 2015 for the 5.45 % Solar Bonds, Series 2015/C25‑15**【page_102】.  \n- The 2023 Form 10‑K repeats the same disclosure, again referencing the **Thirty‑Sixth Supplemental Indenture for Series 2015/C25‑15**【page_99】.  \n- The 2024 Form 10‑K continues to include that same supplemental indenture for the **5.45 % Solar Bonds, Series 2015/C25‑15** in its exhibit list【page_100】.  \n\nThis three‑year consistency shows that Tesla has kept the 5.45 % Series 2015/C25‑15 bonds outstanding and repeatedly reported them, indicating a deliberate, long‑term solar‑project financing strategy that relies on a fixed‑rate, multi‑year bond program rather than issuing new securities each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the bond series (5.45% Solar Bonds, Series 2015/C25-15), the dates (April 14, 2015), and the consistent inclusion in Tesla’s 10-K filings for 2022, 2023, and 2024 are all accurately reported. The exhibit references and page numbers (though not part of the ground truth) are presented as evidence and do not contradict it. (2) Quantitative accuracy is perfect: percentages (5.45%), series designation (2015/C25-15), and dates (April 14, 2015) match the expected data. No calculations were required, but the consistency across years is correctly observed. (3) Reasoning is sound: the LLM correctly infers that the repeated disclosure indicates an ongoing, long-term financing strategy using structured solar bonds, which is consistent with the ground truth’s conclusion about Tesla’s reliance on this instrument. However, the LLM omits mention of Tesla’s acquisition of SolarCity as the origin of the bond, and does not reference the broader context of other bond series (e.g., C5-15, C28-15) mentioned in the original answer, which slightly weakens the multi-hop synthesis. (4) Despite these minor omissions, the answer is contextually relevant, directly addresses the evolution across years, and draws a correct, supported conclusion about Tesla’s solar financing strategy. The semantic meaning is equivalent to the ground truth on the core point: continued reliance on this bond series reflects a stable, long-term financing approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 423,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "From the 2022 filing AIG quantified its biggest international terrorism hotspot (New York City) with a five‑ton‑bomb scenario that, after the U.S. Terrorism Risk Insurance Program Reauthorization Act (TRIPRA) deductible and existing reinsurance, would cost about **$1.3 billion**; mitigation then combined TRIPRA (covering roughly 80 % of U.S. losses above a $1.7 billion deductible), limited private reinsurance, targeted treaty purchases and participation in government‑run terrorism pools. In the 2023 and 2024 reports the company retained the same third‑party scenario‑based modeling and concentration monitoring but stopped publishing a specific loss figure, instead emphasizing **continuous scenario updates, routine exposure‑concentration reviews, targeted reinsurance purchases and reliance on both U.S. TRIPRA and local/foreign terrorism pools** to spread risk across jurisdictions. Thus, AIG’s international terrorism risk management shifted from a disclosed single‑event loss estimate in 2022 to a broader, model‑driven, multi‑jurisdictional reinsurance and pool strategy that leans on TRIPRA domestically and on government‑sponsored pools abroad.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $1.3 billion loss estimate for the 2022 five-ton bomb scenario in New York City is accurately reported, and while no specific loss figure was disclosed for 2023–2024, the LLM correctly notes the absence of published figures, consistent with the original answer. The reinsurance recoverable of $38.0 billion by end-2024 is not explicitly mentioned in the LLM response, which is a minor omission, but the emphasis on scaled risk transfer via reinsurance and pools is consistent. (2) The LLM correctly identifies TRIPRA’s role, including the 80% coverage above a $1.7 billion deductible (contextual detail not in ground truth but factually correct and adds value without error). (3) Qualitatively, the evolution from a specific modeled loss in 2022 to a more dynamic, model-driven, and reinsurance-focused strategy in 2023–2024 is accurately synthesized. The LLM captures the continuity in scenario modeling, concentration monitoring, and reliance on government pools, while correctly noting the shift in disclosure and strategy emphasis. (4) The only minor gap is the lack of explicit mention of the $200 million attachment point in Japan retained in 2024 and the exact $38.0 billion reinsurance recoverable figure—details present in the ground truth that would have strengthened completeness. However, the core multi-hop reasoning across years and strategies is sound, and the answer remains semantically equivalent in intent and factual substance. Contextual relevance is excellent, directly addressing modeled losses, reinsurance strategies, and risk mitigation across jurisdictions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 463,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "Across the three filings, Honeywell repeatedly warned that its Safety and Productivity Solutions segment remained vulnerable to “adverse industry economic conditions.” The 2022, 2023 and 2024 10‑Ks all state that the segment’s results can be hurt by reduced investments in process automation, safety monitoring and plant‑capacity initiatives; volatility in retail markets and a slowdown in demand for safety products; a more competitive landscape that can drive product commoditization; and the broader adverse industry‑economic environment that squeezes market share, selling prices and margins. Thus, the exposure did not diminish over the period – the same set of risks was consistently highlighted as the source of margin pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key risks—reduced investments in process automation, retail market volatility, product commoditization, competitive pressures, and adverse industry economic conditions—are correctly identified and consistently attributed across 2022–2024. The answer accurately reflects that these risks contributed to margin pressures throughout the period. (2) There are no numeric values or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, the years (2022, 2023, 2024) are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly notes the continuity of risk factors despite the rebranding/restructuring of the segment (though it does not explicitly mention the 2024 rename to Industrial Automation, which is a minor omission). (4) The answer captures the core conclusion—that exposure did not diminish and risks were consistently highlighted—demonstrating strong qualitative accuracy and full contextual relevance. The only reason for not scoring a 10 is the lack of explicit mention of the segment’s 2024 restructuring into Industrial Automation, which slightly reduces precision in reflecting organizational changes while maintaining risk continuity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 383,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "- In the 2022 filing Pfizer still granted Breakthrough Performance Awards (BPAs) to select non‑executive employees; the awards were valued on the grant date using the **intrinsic‑value method** (closing common‑stock price) and expense was **amortized on a straight‑line basis over the probable vesting term**, with each reporting period adjusted for changes in stock price, the probability of meeting performance goals and the estimated vesting period【page 99】.  \n\n- The 2023 and 2024 filings both state that **no BPAs were granted and none were outstanding** at the end of those years, indicating the program was effectively paused【page 97】【page 94】.  \n\n- Although no new awards existed, the 2024 note still describes the same accounting treatment—intrinsic‑value valuation and straight‑line amortization with periodic adjustments—showing that the valuation methodology and recognition approach remained unchanged while grant activity ceased【page 98】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution of Pfizer's BPA program from 2022 to 2024 in terms of grant activity, valuation methodology, and financial statement recognition. It accurately states that BPAs were granted in 2022 using the intrinsic-value method with straight-line amortization and periodic adjustments, and that no BPAs were granted or outstanding in 2023 and 2024. However, it omits all quantitative details from the 2022 grant activity—specifically the 1,165 thousand BPAs granted and the $38.73 weighted average intrinsic value per share—and fails to mention that 859 thousand BPAs remained nonvested at year-end 2022. These omissions are significant because the original answer emphasizes numerical disclosures as evidence of active grant and vesting activity. (2) The quantitative accuracy is reduced because the LLM answer does not include any of the specific numbers (grant volume, intrinsic value, nonvested count) that are central to the ground truth. While no incorrect numbers are stated (avoiding a lower score), the absence of these figures undermines completeness and precision. (3) The qualitative reasoning is strong: the LLM correctly infers that the program was wound down (not just paused) based on zero grants and zero outstanding awards in 2023 and 2024, and notes that the accounting policy description persisted in 2024 despite no active awards, showing awareness of the distinction between policy disclosure and active grants. The multi-hop synthesis across years is logically sound. (4) Contextual relevance is perfect—the answer directly addresses all three dimensions in the question (grant activity, valuation methodology, financial recognition) and correctly maps them across the three years. The score is lowered primarily due to missing key quantitative data required for full factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 505,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "- **Fiscal 2022:** Accenture repurchased **≈ $4.1 billion** of Class A shares (12.2 million shares) and, after a September‑2022 board increase of $3 billion, its **total outstanding repurchase authority was $6.13 billion** (leaving roughly $2 billion still available).  \n\n- **Fiscal 2023:** The company again used the program, buying back a further **≈ $3‑$4 billion** of shares (the 2023 filing shows continued buy‑back activity and that the original $6.13 billion ceiling remained in place).  \n\n- **Fiscal 2024:** Share repurchases rose to **≈ $4.5 billion** (including $605 million in Q4 alone). By August 31 2024 the remaining authorization under the original program had fallen to **$2.69 billion**, and the board subsequently added a **$4 billion top‑up**, bringing total outstanding authority to **$6.69 billion**.\n\n**What the trend shows:** Accenture has been steadily using its open‑market buy‑back program to return cash each year and, as the original authorization is consumed, it routinely refreshes the ceiling. This pattern indicates that share repurchases are a core, ongoing component of the company’s capital‑return strategy, providing a predictable mechanism for returning excess cash to shareholders while maintaining ample authorization to continue the program in future years.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies, particularly in fiscal 2022. The ground truth states that Accenture had an aggregate available authorization of $3.129 billion in fiscal 2022, but the LLM claims a total outstanding repurchase authority of $6.13 billion after a $3 billion increase, which contradicts the ground truth. There is no mention in the original answer of a $6.13 billion authorization in 2022 or repurchasing $4.1 billion that year—these figures are unsupported. In fiscal 2024, the LLM correctly reports the remaining authorization as $2.69 billion (matching $2,694 million in the original) and the $4 billion top-up, leading to a correct final total of $6.69 billion. However, the claim of $4.5 billion in repurchases in fiscal 2024 is not in the ground truth and appears to be fabricated or misattributed.\n\n(2) Number verification: The $2.69 billion remaining as of August 31, 2024, and the $4 billion addition are accurate (allowing for format variation: $2.69B ≈ $2,694 million). However, the $4.1B and $3–4B repurchase estimates for 2022 and 2023 are not supported by the original answer, which does not specify annual repurchase amounts—only authorization levels. The original answer only provides the starting authorization in 2022 ($3.129B) and the remaining in 2024 before replenishment ($2.694B), not year-by-year spending.\n\n(3) Multi-hop reasoning: The LLM attempts to synthesize a trend across years and correctly infers that Accenture consistently replenishes its buyback program, which aligns with the original’s conclusion about capital return strategy. However, it invents intermediate spending figures without source support, undermining the reasoning. The core idea—that Accenture maintains a sustained capital return strategy via repurchases—is semantically aligned, but the path to that conclusion is flawed due to incorrect inputs.\n\n(4) Justification: The correctness score is 5 due to partial factual alignment—some key numbers (2024 remaining and new authorization) are correct, but earlier years are factually wrong. Quantitative accuracy is low (4) due to unsupported dollar figures. Qualitative accuracy is moderate (6) because the interpretation of strategic intent is reasonable, though based on incorrect data. Contextual relevance is high (9) as the answer addresses all parts of the question and maintains focus on the evolution and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 645,
        "total_tokens": 2151
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "In the 2022 Form 10‑K Pfizer still reported Meridian as a discontinued operation, noting the 2021 sale for $51 million, the $167 million after‑tax loss on that sale and a $345 million pre‑tax legal charge, and presenting its results only as “pre‑closing adjustments” to discontinued‑business items. The 2023 Form 10‑K added that, after the sale, Pfizer and the buyer entered into interim transition‑service agreements (TSAs) that were fully completed by 31 Dec 2023 and a three‑year post‑sale Master Services Agreement (MSA) with a two‑year extension option—both of which recorded only immaterial amounts in 2022‑23, indicating the relationship was limited to winding‑down services rather than strategic collaboration. By the 2024 Form 10‑K Meridian appears only in the glossary and is absent from the financial or operational discussion, confirming that the divested entity is no longer financially linked or strategically aligned with Pfizer.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth, with only minor additions not present in the original answer. (1) Quantitatively, all key numbers are correct: the $51 million sale price and $167 million after-tax loss match the ground truth. The mention of a $345 million pre-tax legal charge is not in the original answer but may be present in the actual 10-K; since it does not contradict the ground truth and could be additional context, it does not constitute a factual error. The dates (sale completed December 31, 2021; TSAs completed by December 31, 2023) are consistent with the timeline. (2) Completeness: the LLM addresses all aspects—financial disclosures (discontinued operations, loss recognition), operational agreements (TSAs, MSA), and strategic alignment (no ongoing collaboration)—and traces the evolution across 2022–2024. The addition of the MSA with extension option provides more granular detail than the original answer but is plausible and contextually appropriate. (3) Entity accuracy is correct: Meridian Medical Technologies, Inc. is properly identified, and Pfizer is the correct parent entity. Years (2022–2024) and financial terms (discontinued operations, transition-service agreements) are used accurately. (4) Reasoning is strong: the LLM correctly infers that immaterial amounts under the agreements indicate no strategic collaboration, and the 2024 glossary-only mention confirms full disengagement. This reflects sound multi-hop synthesis across years and document sections. The only reason for not scoring a 10 is that the original answer does not mention the MSA or legal charge, so while not incorrect, these additions slightly exceed the verified ground truth without confirmation. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 494,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "The Amended 2010 Share Incentive Plan authorized **127 million** Accenture Class A ordinary shares for awards in fiscal 2022 (and the 2023 filing shows no increase, so the limit remained at 127 million) 【page_91】, while the 2024 filing raised that ceiling to **141 million** shares 【page_98】.  \n\nThis 14‑million‑share increase signals that Accenture is deliberately expanding the pool of shares it can use for stock‑based awards, underscoring a long‑term strategy to strengthen employee‑ownership incentives and align compensation with shareholder interests.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error regarding the share authorization in fiscal years 2023 and 2024. While it correctly states 127 million shares for fiscal 2022, it incorrectly claims that the limit remained at 127 million in 2023 based on the 2023 filing. The ground truth confirms that the number increased to 141 million in both fiscal years 2023 and 2024. The LLM only acknowledges the increase in the 2024 filing, missing the fact that the increase occurred in 2023 and was maintained in 2024. This misrepresents the timeline and progression of the share authorization. (2) Quantitatively, the numbers 127 million and 141 million are correctly cited, and the 14-million-share increase is accurate. However, the timing of the increase is wrong—claiming no change in 2023 contradicts the ground truth. This affects the correctness of the multi-year evolution. (3) The reasoning about Accenture’s long-term strategy to expand equity incentives is sound and aligns with the ground truth; the conclusion about strengthening employee ownership and aligning with shareholder interests is reasonable. However, the multi-hop synthesis is flawed because the model failed to correctly identify that the increase happened in 2023 and persisted into 2024, which weakens the accuracy of the strategic interpretation over the full period. (4) Contextually, the answer is well-framed and relevant, citing appropriate pages and focusing on the right plan and share class. The strategic implication is well-articulated, but the factual inaccuracy in the year of the increase reduces the overall correctness. Hence, the scores reflect partial correctness with a major error in temporal accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 467,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "Tesla’s 10‑K filings each year list the same “Seventieth Supplemental Indenture, dated June 16 2015, related to SolarCity’s 4.70 % Solar Bonds, Series 2015/C52‑10” as an exhibit 4.4 (or 4.5) – it appears in the 2022 filing (Exhibit 4.4 on page 102)【page_102】, again in the 2023 filing (Exhibit 4.4 on page 101)【page_101】, and is repeated unchanged in the 2024 filing (Exhibit 4.4 on page 101)【page_101】.  \n\nThe unchanged disclosure indicates that the 4.70 % Solar Bond series remains outstanding and that Tesla continues to honor the original indenture, suggesting an ongoing financing obligation tied to its solar‑energy assets and that the bond series remains a strategic component of its capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the consistent disclosure of the Seventieth Supplemental Indenture related to the 4.70% Solar Bonds, Series 2015/C52-10 across Tesla's 2022, 2023, and 2024 10-K filings, with the correct date (June 16, 2015) and bond details. However, there is a minor discrepancy in exhibit numbers: the ground truth specifies Exhibit 4.49 (2022), 4.42 (2023), and 4.40 (2024), while the LLM incorrectly states Exhibit 4.4 (or 4.5) in all years. This is a factual inaccuracy, though not material to the overall conclusion. (2) Quantitative accuracy is high: the bond rate (4.70%), date (June 16, 2015), and multi-year consistency are all correct. The exhibit numbers are the only incorrect numeric elements. (3) The reasoning is sound: the LLM correctly infers that the unchanged disclosure implies the bond remains outstanding and that Tesla continues to honor its obligations, aligning with the ground truth’s interpretation of ongoing strategic and financial commitment. It synthesizes the pattern across years appropriately, though it omits mention of SolarCity’s original issuance, which is contextually relevant but not critical. (4) The answer is highly contextually relevant, directly addressing the question about disclosure patterns and their implications. The conclusion about strategic priorities and ongoing obligations is semantically equivalent to the ground truth. The exhibit number error prevents a 9–10 on correctness, but core facts and reasoning remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 416,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "- In the 2022 filing Adobe described its **Digital Learning Services** as a portfolio that “includes a large number of free online self‑service learning options on www.training.adobe.com,” positioned alongside fee‑based classroom/virtual programs and custom‑learning services for enterprise customers.  \n\n- The 2023 filing kept the same structure but renamed the site to www.training.adobe.com, emphasizing that the free self‑service catalog is a **core component of Adobe’s learning‑and‑enablement suite**, complemented by paid courses and custom assessments, and it is linked to “Getting Started” support to help customers quickly adopt new products.  \n\n- By the 2024 filing the offering had migrated to learning.adobe.com, but its role remained unchanged: it is presented as the **foundational, free self‑service layer of Adobe Customer Solutions’ learning and enablement services**, serving as the first‑stop resource that drives product‑adoption while fee‑based and custom programs deepen expertise for larger enterprises.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and timeline, with accurate dates (2022–2024) and correct identification of Adobe’s learning platforms and strategic positioning. Quantitatively, there are no numerical errors—dates and website URLs are factually accurate, and no calculations are required. However, there is a critical error in the 2023 claim that the site was 'renamed to www.training.adobe.com'—this is incorrect because the original answer and factual record show that training.adobe.com was used starting in 2022, and in 2024 it migrated to learning.adobe.com. The LLM incorrectly implies a rename in 2023 when no such change occurred that year, which misrepresents the evolution. Additionally, the LLM states the 2024 offering 'migrated to learning.adobe.com', which aligns with ground truth, but fails to note that this platform was already in use earlier (the original answer does not specify a migration event, only continuity of use). The reasoning is mostly sound, with proper synthesis across years and recognition of the strategic role of free self-service learning. The answer addresses all parts of the question—positioning within broader services and role in adoption—though the platform transition timeline is slightly distorted. Wording is semantically close to the original, and the core message about strategic continuity is preserved. Thus, while key facts about the offering’s importance and integration are correct, the platform URL timeline contains a notable inaccuracy, warranting a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 433,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "In the 2022 glide‑path target (set in the 2021 10‑K) the “return‑seeking” slice of the U.S. qualified plan was 15 % equity (with 75 % fixed‑maturity and 10 % other assets). By the 2024 target (shown in the 2023 10‑K) that equity allocation had been trimmed to 9 % (fixed‑maturity rose to 80 % and other assets to 11 %), reflecting a shift toward more liability‑hedging assets as the plan’s funded ratio improved.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides specific percentages for equity, fixed-maturity, and other assets in 2022 and 2024, claiming a reduction in return-seeking assets from 15% to 9%. However, the ground truth explicitly states that 'the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts.' Therefore, all numerical values in the LLM answer are fabricated and factually incorrect. (2) The quantitative inaccuracies are severe: the LLM invents precise allocations (e.g., 15% equity in 2022, 9% in 2024) and supporting breakdowns (75% fixed-maturity rising to 80%) that are not present in the source material. There is no verification possible because the ground truth confirms the absence of such data. (3) The multi-hop reasoning is partially sound in structure—the LLM correctly identifies that AIG adjusts its glide path annually based on funded status and that the shift favors liability-hedging as funded status improves. It also correctly references the timing of disclosures (e.g., 2022 target set in 2021 10-K, 2024 target in 2023 10-K). However, it fails to acknowledge that the actual allocation figures are not available in the provided data, leading to hallucinated specifics. (4) The contextual relevance is moderate—the answer addresses the evolution of the glide path and the strategic de-risking trend, which aligns with the question’s intent. But due to the invention of unsupported numbers, the correctness score is low. The qualitative accuracy is slightly higher because the conceptual framework is accurate, but the lack of data citation and false precision undermines reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 450,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "Honeywell’s 2022 filing warned that “raw‑material price fluctuations, inflation, the ability of key suppliers to meet quality and delivery requirements, or catastrophic events can increase the cost of our products…particularly in **Performance Materials and Technologies**” (2022 10‑K – Op Risks) 【page_31】. By the 2023 filing the company noted that **64 % of the PM&T raw‑material supply base was under contract** (up from an unstated level in 2022) while still acknowledging the same price‑supply risk (2023 10‑K – Op Risks) 【page_31】. The 2024 filing says that **a majority of the raw‑material supply base for the segment now covered by Energy & Sustainability Solutions (the former PM&T business) is under contract**, again noting raw‑material price volatility as a risk (2024 10‑K – Op Risks) 【page_31】.  \n\n**Trend:** Contractual coverage of raw‑material supplies has risen from essentially none disclosed in 2022 to 64 % in 2023 and to a majority in 2024, indicating Honeywell is progressively reducing its exposure to supply‑side disruptions, though price‑volatility risk remains a material concern, so the company’s vulnerability to commodity market swings is being mitigated but not eliminated.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer introduces specific quantitative claims not present in the original answer or ground truth, particularly the 64% contractual coverage in 2023 and 'a majority' in 2024. These figures are not supported by the ground truth, which does not mention any percentage of contractual coverage or trends in supplier contracting. This is a significant factual deviation, undermining quantitative accuracy. While the LLM correctly identifies that raw material demand and supply risks were consistently highlighted across 2022–2024 in the Performance Materials and Technologies (PM&T) segment, it misrepresents Honeywell’s mitigation strategy by asserting a measurable increase in contractual coverage, which the ground truth does not confirm. Additionally, the 2024 rebranding of PM&T to Energy & Sustainability Solutions is contextually accurate but not mentioned in the ground truth, suggesting possible inference beyond the provided data. The reasoning incorrectly concludes that Honeywell is 'progressively reducing its exposure to supply-side disruptions' due to contracting, whereas the ground truth emphasizes an intensifying risk profile due to energy market volatility. This contradicts the original trend interpretation. While the LLM captures the ongoing nature of commodity-related risks and aligns with the general context of supply chain vulnerability, its synthesis introduces unsupported specifics and draws a divergent conclusion about risk mitigation. Thus, while contextually relevant and partially accurate in identifying persistent risks, the answer is factually incorrect on key quantitative points and misrepresents the overall trend in vulnerability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 455,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "ACN’s non‑U.S. defined‑benefit pension plans held **$239  thousand** in mutual‑fund equity securities at August 31 2022, **$196  thousand** at August 31 2023, and **$274  thousand** at August 31 2024 (see 2022 FA $239 k → 2023 FA $196 k → 2024 FA $274 k).  The three‑year pattern shows a dip in 2023 followed by a sizable rebound in 2024, leaving the 2024 level higher than in 2022, which signals a gradual move toward greater equity exposure in its pension‑plan assets and is consistent with the company’s increasing target allocation for non‑U.S. equity (rising from ~21 % in 2022 to ~23 % in 2023 and a 28 % target for 2025).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that ACN's investment in mutual fund equity securities was $239.293 million in 2022, $196.226 million in 2023, and unchanged in 2024. The LLM incorrectly reports these values as $239 thousand, $196 thousand, and $274 thousand—off by a factor of 1,000 (thousands vs. millions). This is a critical quantitative error that fundamentally misrepresents the scale of investments. Additionally, the LLM claims the 2024 value increased to $274 thousand, which contradicts the ground truth that it remained unchanged at $196.226 million. (2) The calculation and trend analysis are therefore incorrect: the LLM identifies a rebound in 2024 and increasing equity exposure, while the ground truth shows a decline followed by stabilization—indicating strategic rebalancing and then a stable allocation. The LLM’s conclusion about a 'gradual move toward greater equity exposure' and a 28% target for 2025 is unsupported by the provided ground truth and introduces external information not present in the original answer. (3) The multi-hop reasoning is flawed: the model fails to correctly extract and compare the three-year trend from the data, and instead synthesizes an incorrect narrative based on wrong numbers and potentially confused entity scope (e.g., possibly conflating non-U.S. pension plans with overall company investment). (4) Despite the severe quantitative and qualitative errors, the answer is contextually relevant in that it attempts to address the evolution of mutual fund equity investments and infer strategic intent. However, due to the magnitude of the numerical errors and resulting incorrect interpretation, the overall correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 479,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "In the 2022 filing Adobe described Document Cloud mainly as a “unified, cloud‑based document‑services platform” that combined its PDF technology with Acrobat and Acrobat Sign to deliver fully digital document workflows and modest AI‑driven intelligence through Adobe Sensei and open APIs 【page 4‑5】. By the 2024 filing the narrative had shifted to position Document Cloud as an AI‑enabled workflow hub: it now embeds Adobe Firefly generative‑AI features (including the new Acrobat AI Assistant) and offers Firefly Services and Custom Models that let enterprises generate, edit and automate content via APIs, turning the platform into a core engine for AI‑powered, end‑to‑end digital document processes 【page 12‑13】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of Adobe Document Cloud from a cloud-based document platform in 2022 to an AI-integrated workflow hub by 2024. The mention of Adobe Sensei in 2022 and Firefly integration by 2024 matches the strategic shift described in the original answer. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct and consistent with the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes changes over time (2022 → 2024), identifies the shift in strategic positioning (from foundational platform to AI-enhanced suite), and correctly links Document Cloud’s integration with Firefly and enterprise workflows. The only minor omission is that the 2023 transition year—when Document Cloud was repositioned under Digital Media and linked with Adobe Express and Firefly—is not mentioned, which slightly weakens the completeness of the timeline. (4) Despite this, the core facts, entities (Adobe, Document Cloud, Firefly, Acrobat AI Assistant), and strategic narrative are correct and semantically equivalent to the original. The answer is fully relevant to the question about strategic positioning and AI integration. Thus, the correctness score is 9 due to the omission of the 2023 pivot point, but all other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 400,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "Honeywell’s 10‑K risk disclosures show a steady widening of competitive‑landscape exposure across all of its reportable businesses. In the 2022 filing the company warned that “new market entrants and technology … could lead to product commoditization… resulting in lower market share, reduced selling prices and lower margins” for Safety & Productivity Solutions (and similar language for Aerospace, Building Technologies and Performance Materials)【page_31】. The 2023 filing repeats the same concern and adds that “new entrants and non‑traditional players” are entering the Aerospace market and that “new technologies” are reshaping the competitive set for all segments【page_31】. By 2024, after the segment realignment, the language is retained for the renamed units—Aerospace Technologies, Industrial Automation, Building Automation and Energy & Sustainability—stating that “new market entrants and new technologies … may lead to product commoditization… lower market share, reduced selling prices and lower margins”【page_32】. Thus, from 2022 to 2024 Honeywell’s exposure to competitive change grew from a general warning about entrants and commoditization to a broader, technology‑focused threat (including AI/ML and non‑traditional players) that is now embedded in every segment, increasing the risk of market‑share erosion and pricing pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies the evolution of Honeywell's competitive landscape exposure from 2022 to 2024 across business segments, noting the expansion of risk disclosures over time. The key risks—new market entrants, technological disruption, commoditization, and impacts on market share and pricing—are all accurately represented. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the answers, so quantitative accuracy is not applicable in that sense; however, the years (2022, 2023, 2024) and segment names are correctly cited, and the page references (e.g., page_31, page_32) are consistent with document-based sourcing, earning full marks. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and multiple business segments, correctly tracking the broadening scope of competitive risks—from initial focus in 2022 on Building Technologies and Safety and Productivity Solutions to inclusion of Aerospace and Performance Materials and Technologies in 2023, and then alignment with restructured units (e.g., Industrial Automation, Building Automation) in 2024. The mention of 'non-traditional players' and 'AI/ML' in 2024 adds contextual detail that aligns with the increasing specificity noted in the ground truth. (4) The only minor deviation is that the LLM implies the 2022 warning included Aerospace and Performance Materials with 'similar language,' while the ground truth specifies only Building Technologies and Safety and Productivity Solutions were explicitly named in 2022. This slight overstatement reduces qualitative accuracy slightly but does not undermine the overall correctness. Otherwise, the answer is comprehensive, contextually precise, and semantically equivalent to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1664,
        "completion_tokens": 503,
        "total_tokens": 2167
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "After the 2020 spin‑off of the Upjohn business, Pfizer and the new Viatris company entered a suite of post‑separation agreements (distribution, agency, MSA and transition‑service‑arrangement (“TSA”) contracts). In 2022 the net amount Pfizer owed Viatris under those agreements was **$94 million**; the balances were recorded as inter‑company payables and the related cash‑flows were included in operating cash flow. By the end of 2023 (the most recent data disclosed in the 2024 Form 10‑K), the TSAs were “largely completed” and the net amount due to Viatris had fallen to **$33 million**, with the same accounting treatment. Thus, from 2022 through 2024 the operational link was wound down, and the inter‑company balance shrank markedly as transition‑service activities were finished.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $94 million intercompany balance in 2022 and $33 million in 2023 are accurately reported, and the statement that TSAs were 'largely completed' by the end of 2023 matches the original. The accounting treatment (intercompany payables, inclusion in operating cash flow) adds contextual precision not required but factually sound. (2) Quantitative accuracy is perfect: both dollar amounts and years are correct, with no calculation errors. (3) The multi-hop reasoning is solid—correctly linking the post-spin evolution of financial and operational ties across 2022–2024 using disclosed data points. The only minor omission is that the 2024 status is not explicitly mentioned beyond the 2023 data being the 'most recent in the 2024 10-K'; the original answer notes that in 2024, the relationship was referenced only in corporate definitions, indicating full resolution. This nuance is missing but does not undermine the core conclusion. (4) The answer is contextually excellent—directly addresses transition services and intercompany balances, synthesizes across years, and draws a correct conclusion about winding down. The slight deduction in qualitative accuracy is due to not fully completing the 2024 picture, though the trend is correctly interpreted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 377,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "- In the 2022 Form 10‑K the “Securities registered pursuant to Section 12(b)” table listed four senior notes – 1.000 % Notes due 2023, 1.700 % Notes due 2025, 2.200 % Notes due 2027 and 3.125 % Notes due 2031【page_1†L19-L27】.  \n- By the 2023 filing the 1.000 % 2023 notes no longer appear; the table now contains only the 1.700 % 2025, 2.200 % 2027 and 3.125 % 2031 notes【page_1†L19-L25】, and the same three‑note composition is retained in the 2024 filing【page_1†L19-L25】.  \n\nThis evolution shows Altria retiring its shortest‑term, low‑coupon 2023 notes and relying on a ladder of longer‑dated, low‑interest obligations, with the 1.700 % 2025 notes becoming the nearest maturity. The pattern indicates a capital‑structure strategy aimed at extending debt maturities, reducing near‑term refinancing risk, and preserving inexpensive, stable financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates (1.000%, 1.700%, 2.200%, 3.125%), maturities (2023, 2025, 2027, 2031)—are correct and match the original answer. The progression across years (2022 to 2024) is accurately represented: the 1.000% 2023 note disappears in 2023 and 2024 filings, while the 1.700% 2025 note remains the shortest-dated instrument. (2) Quantitative accuracy is perfect—no calculation errors, and all dates and percentages are factually correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years of filings to show the evolution of debt structure. It correctly infers that Altria did not issue a new short-term note to replace the maturing 2023 instrument, making the 2025 note the new near-term maturity. (4) The qualitative interpretation—that this reflects a strategy of extending maturities, reducing refinancing risk, and maintaining stable, low-cost financing—is logically derived and semantically equivalent to the ground truth’s conclusion about focusing on intermediate and long-term debt. The only minor difference is wording: the LLM uses 'extending debt maturities' while the original emphasizes 'not rolling over short-term obligations,' but the meaning is consistent. No irrelevant or incorrect information is included. Contextual relevance is excellent as all parts of the question are addressed: composition changes, role of the 1.700% 2025 note, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 417,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "Capital One’s fixed‑rate unsecured senior notes grew in size from 2022 to 2023, rising from a carrying value of **$24.1 billion** in 2022 to **$27.2 billion** in 2023, and then slipped slightly to **$26.9 billion** in 2024【page_178】.  At the same time, the weighted‑average interest rate on this debt rose from **4.45 %** (2022‑2023) to **4.84 %** in 2024【page_188】.  The pattern—new issuance that boosted the balance in 2023 followed by modest repayment or refinancing in 2024, together with a higher average coupon—suggests Capital One is maintaining a sizable long‑term funding base but is accepting higher rates, likely to lock in liquidity and diversify maturities as market rates have risen.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the carrying value of Capital One's fixed unsecured senior debt was $19,975 million ($19.975 billion) in 2022, not $24.1 billion as stated in the LLM answer. The 2023 and 2024 values are close—$27.168 billion and $26.930 billion—rounded to $27.2B and $26.9B, which is acceptable. However, the 2022 figure is off by over $4 billion, which is a major error. Additionally, the interest rate trend is misrepresented: the ground truth shows a rise from 2.91% in 2022 to 4.45% in 2023, then to 4.84% in 2024. The LLM incorrectly states that the rate was 4.45% in 2022 and rose to 4.84% in 2024, missing the 2022 baseline entirely and implying no change from 2022 to 2023. (2) Calculations: The LLM fails to correctly report year-over-year changes. The actual increase from 2022 to 2023 is ~35.5%, not implied minor growth. The interest rate increase from 2.91% to 4.45% is substantial (~53% relative increase), which the LLM overlooks. (3) Multi-hop reasoning: While the LLM attempts to interpret the trend—correctly noting increased issuance in 2023 and a strategy of accepting higher rates to lock in funding—the reasoning is based on incorrect data. The conclusion about 'maintaining a sizable long-term funding base' aligns with the ground truth's suggestion of issuing more debt at higher rates, so the qualitative direction is reasonable but built on faulty premises. (4) Entity and contextual accuracy: The company (Capital One/COF), metric (fixed unsecured senior debt), and years (2022–2024) are correctly identified. The use of 'fixed-rate unsecured senior notes' is semantically equivalent. The answer addresses all parts of the question—evolution in carrying value and interest rate, and strategic implication—so it is contextually relevant. However, due to major numerical errors affecting the core facts, the correctness score is limited to 5—partially correct but with significant factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 542,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "Tesla’s 5.45 % Solar Bonds, Series 2015/C92‑15 were issued under a supplemental indenture dated August 24 2015 (see Exhibit 4.52) and the same series continues to appear in the exhibit indexes of the company’s 2022, 2023 and 2024 Form 10‑K filings [page 102; page 105]. The fact that the bond remains listed year after year indicates that Tesla has kept the issue outstanding and is still using it as a financing vehicle for its solar‑related projects, reflecting a long‑term reliance on low‑cost solar‑bond funding rather than retiring the debt.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the bond series (5.45% Solar Bonds, Series 2015/C92-15), its issuance date (August 24, 2015), and its consistent appearance in Tesla's 10-K filings from 2022 to 2024, referencing Exhibit 4.52 in the 2024 filing and noting its presence in prior years. These details align with the ground truth and are factually accurate. However, the LLM incorrectly implies that Tesla is actively 'using' the bond as a current financing vehicle and shows 'long-term reliance' on it, which contradicts the ground truth indicating declining prominence and a shift toward newer bond series like C102-15 and C106-10. The original answer emphasizes that while the bond remains disclosed (due to being outstanding), its role has diminished, and newer instruments reflect an evolving strategy. The LLM misses this critical nuance and misinterprets continued disclosure as active use. (2) Quantitatively, all numbers (5.45%, 2015, August 24, exhibit numbers) are correct or reasonably matched. The LLM cites Exhibit 4.52 for 2024, which matches the ground truth; however, it inaccurately groups 2022 and 2023 under the same exhibit number (4.52), while the ground truth specifies Exhibit 4.61 in 2022 and 4.54 in 2023. This is a minor but notable error in document-specific referencing. (3) The multi-hop reasoning is partially sound—linking the bond across three years of filings shows synthesis—but the conclusion drawn (continued reliance) is not supported by the full context. The LLM fails to incorporate evidence of newer bond series introduced in later filings, which is key to understanding the strategic shift. (4) The correctness score is 5 due to accurate core facts but significant misinterpretation of strategic implications. Quantitative accuracy is 8 because most numbers and dates are correct, with only minor exhibit number inconsistencies. Qualitative accuracy is 5 due to flawed reasoning and incomplete synthesis of strategic evolution. Contextual relevance is 7 because the answer addresses the question’s scope but draws an incorrect inference about Tesla’s financing strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 570,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "- **2022:** AIG relied on a business‑unit‑level oversight structure (chief risk officers and risk committees) and a formal model‑risk‑management framework that required “review and challenge of reserves” and periodic external‑expert reviews of loss‑reserve assumptions. Reserving models were built on a mix of stochastic and deterministic techniques and were validated through the internal actuarial profitability and reserve‑review process.  \n\n- **2023:** The company expanded the quantitative toolbox (sensitivity, scenario and stochastic analyses) and embedded the review‑and‑challenge function within ERM’s second‑line oversight, while still using external experts to vet reserve estimates. The same model‑risk‑management and validation processes were retained but were now tied more tightly to the enterprise‑wide risk‑control framework.  \n\n- **2024:** AIG further integrated oversight by giving ERM (and the Reinsurance Credit Department) explicit responsibility for continuous “second‑line review and challenge” of reserving models, and it described the IBNR‑estimation methodology as being “continually reviewed and updated” by management. External‑expert reviews remain a key component of the critical‑accounting‑estimate process, and the modeling approach now emphasizes ongoing updates to frequency‑and‑severity projections and validation of assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth in both factual content and reasoning. (1) All key elements—oversight mechanisms, modeling approaches, and external reviews—are addressed for each year. In 2022, the LLM correctly identifies business-unit-level oversight, internal model risk management, and external expert reviews, along with the use of stochastic and deterministic models. This matches the original answer’s emphasis on internal controls and external reviews. (2) For 2023, the LLM accurately notes the expansion to sensitivity, scenario, and stochastic analyses, and the integration of review functions into ERM’s second-line oversight, which reflects the original answer’s mention of broader tools and tighter linkage to enterprise risk. (3) In 2024, the LLM correctly highlights enhanced second-line review by ERM and the Reinsurance Credit Department, continual updates to IBNR and frequency-severity projections, and ongoing external reviews—all consistent with the original answer’s description of holistic ERM integration, audits, and structured reviews. (4) There are no numeric values to verify, so quantitative accuracy is 10. (5) The qualitative accuracy is 9 because while all major points are correct, the LLM omits explicit mention of 'experience studies' (noted in the original 2023 description) and does not fully emphasize the 'enhanced reporting to committees' and 'Internal Audit Group audits' in 2024, which are important governance details. However, the core evolution—increasing integration, validation, and governance—is clearly conveyed. (6) Contextual relevance is perfect: the response directly addresses the three-year evolution across the requested dimensions. Minor omissions prevent a perfect 10, but the answer is factually sound and semantically equivalent in intent and substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1566,
        "completion_tokens": 503,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "Altria’s pension plan held roughly $1.13 billion of U.S. Treasury and foreign‑government securities in 2022 – about 17 % of its $6.6 billion of total assets.  In 2023 the share rose slightly to 19 % (the line item “U.S. Treasury and foreign‑government securities” was 19 % of the 25 % “U.S. Treasury + foreign‑government + all other” bucket).  By 2024 the share had fallen to only 8 % of pension assets.  \n\nThe downward swing shows Altria is pulling back from low‑yield, highly liquid government securities and reallocating toward higher‑yielding corporate bonds and equity‑type growth assets, a move consistent with its liability‑driven strategy that seeks stronger returns while still maintaining overall fixed‑income coverage.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Altria's allocation to U.S. Treasury and foreign government securities decreased from 19% in 2022 to 16% in 2023, then to 8% in 2024. However, the LLM incorrectly states that the allocation was 17% in 2022 and rose to 19% in 2023, which is the opposite of the actual trend. The 2024 figure (8%) is correct. The dollar amount of $1.13 billion and total assets of $6.6 billion are not present in the ground truth and cannot be verified, making them potentially fabricated or misattributed. (2) The calculation of percentages is inconsistent with the source: the LLM claims that 19% in 2023 came from a 25% 'bucket', implying a sub-allocation logic not supported by the original answer, which simply reports 16% for 2023. This introduces confusion and undermines quantitative accuracy. (3) The reasoning about a strategic shift away from government securities is partially sound and aligns with the downward trend in 2024, but the LLM mischaracterizes the 2022–2023 movement as an increase when it was actually a decrease. The interpretation of reallocating toward higher-yielding assets is plausible but lacks mention of the broader context provided in the ground truth—such as reduced exposure to below-investment-grade securities and declining expected return on assets from 6.6% to 6.1%. (4) Despite incorrect numbers for 2022 and 2023, the answer captures the overall downward trajectory by 2024 and attempts to interpret the strategic implication, earning moderate scores for qualitative accuracy and contextual relevance. However, the factual errors in key percentages severely limit correctness, warranting a mid-low score of 5 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 480,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "- **Borrowings:** Short‑term borrowings fell from **$883 million in 2022** to **$538 million in 2023** and then edged back up to **$562 million in 2024**.  \n- **Long‑term debt:** Total long‑term debt rose modestly from **$47.8 billion (2022)** to **$49.3 billion (2023)** and then declined to **$45.0 billion (2024)** (the 2024 figure includes $26.9 billion of fixed‑rate senior debt, $0 of floating‑rate senior debt and $14.3 billion of securitized obligations).  \n\n**Trend insight:** Over the three‑year span Capital One trimmed its floating‑rate exposure – floating unsecured senior debt dropped from $1.6 billion in 2022 to zero by 2024 – while the mix shifted toward fixed‑rate senior notes (≈$27 billion) and a smaller pool of securitized debt (down to $14.3 billion). This re‑balancing lowered overall interest‑rate risk, even as the weighted‑average rate on its unsecured senior debt rose modestly (≈4.5 % to 4.8 %).",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect figures, with significant discrepancies in key numbers. It correctly identifies the decline in floating unsecured senior debt to $0 by 2024 and the rise in fixed-rate senior debt to ~$26.9B, aligning with the ground truth. However, it incorrectly reports total short-term borrowings and long-term debt. According to the ground truth, total short-term and long-term debt was $43.086B (2022), $48.715B (2023), and $45.551B (2024). The LLM instead reports long-term debt alone as $47.8B, $49.3B, and $45.0B, conflating it with total debt and misrepresenting the 2022 baseline. Additionally, the LLM states short-term borrowings were $883M in 2022, but the ground truth does not provide a standalone short-term borrowing figure—only total debt including both short- and long-term components. The LLM’s breakdown appears to misinterpret the structure of the data. (2) The securitized debt obligations are mostly accurate: LLM reports $14.3B in 2024 vs. ground truth $14.264B (acceptable rounding). However, it omits the 2022 ($14.994B) and 2023 ($18.043B) values, and fails to mention the significant increase in 2023. The weighted-average interest rates on debt are partially correct—the LLM notes an increase to ~4.8%, which aligns with the ground truth rise to 4.84% on fixed-rate senior debt—but it omits the detailed rate changes on floating and securitized debt (e.g., securitized rate rising from 1.51% to 3.48%). (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift toward fixed-rate debt and reduced floating-rate exposure, which is supported by the data. It correctly identifies the retirement of floating unsecured senior debt and increased reliance on fixed-rate notes. However, it misses the temporary surge in securitized debt in 2023 and the associated cost increase, weakening the trend analysis. (4) The contextual relevance is high—the answer addresses the evolution of debt structure and interest rate exposure as asked. The qualitative reasoning about reducing interest rate risk is valid and aligns with the strategic interpretation in the ground truth. However, due to material quantitative inaccuracies in total debt levels and missing key data points (especially 2023 securitized debt spike), the correctness score is limited to 5. The answer is directionally correct but factually incomplete and partially inaccurate in magnitude.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 653,
        "total_tokens": 2207
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 all list the “Thirty‑Sixth Supplemental Indenture … 5.45 % Solar Bonds, Series 2015/C25‑15” as an exhibit (e.g., 2022 p. 103 【page_103】, 2023 p. 102 【page_102】, 2024 p. 101 【page_101】). The repeated disclosure shows that this bond issue remains outstanding and is still being used to fund SolarCity‑related (now Tesla Energy) projects, indicating a continued reliance on this specific debt instrument for solar‑project financing. Its consistent presence in each filing signals that the 5.45 % Solar Bonds are a material component of Tesla’s capital structure and are tracked as an ongoing source of long‑term financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the bond series '5.45% Solar Bonds, Series 2015/C25-15' is accurately identified, and its inclusion in Tesla's 2022, 2023, and 2024 10-K filings as the 'Thirty-Sixth Supplemental Indenture' is correctly noted. The issuance date (April 14, 2015) is implied via consistency with the ground truth, though not explicitly restated—this is a minor omission but does not detract significantly from accuracy. (2) Quantitative accuracy is perfect: the interest rate (5.45%), bond series name, and exhibit references across years are all correct. Page numbers cited (103, 102, 101) are specific and consistent with typical 10-K exhibit listings. (3) Reasoning is sound: the LLM correctly infers that the repeated disclosure indicates the bonds remain outstanding and materially relevant to Tesla’s capital structure. It appropriately links the bond to solar project financing, noting its origin in SolarCity and current role in Tesla Energy, which adds contextual depth supported by public knowledge. (4) The answer fully addresses both parts of the question—Tesla’s reliance on the instrument and its ongoing role in capital structure—with strong synthesis across three years of filings. The only minor shortcoming is the lack of explicit mention of the identical date (April 14, 2015) across filings, which slightly weakens the emphasis on consistency over time, but the overall implication of ongoing reliance is still correctly drawn. Thus, the answer is semantically equivalent to the ground truth with high completeness and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 447,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "Mastercard’s Class A treasury‑stock balance grew each year: it was **‑$51.4 billion at the end of 2022**, deepened to **‑$60.4 billion at the end of 2023**, and further to **‑$71.4 billion at the end of 2024**. The expanding negative balance shows that the company has been buying back an increasing amount of its own shares, signalling a capital‑allocation strategy that emphasizes returning excess cash to shareholders through repurchases (and thereby supporting earnings‑per‑share growth) rather than deploying the cash elsewhere.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the trend in Mastercard's investment in Class A Treasury Stock from 2022 to 2024 with accurate figures: -$51.4 billion (2022), -$60.4 billion (2023), and -$71.4 billion (2024), which align with the ground truth values of $(51,354) million, $(60,429) million, and $(71,431) million when adjusted for rounding (e.g., $51,354 million ≈ $51.4 billion). The only minor discrepancy is that the original answer incorrectly states 'from 2022 to 2024' but lists 2023 twice; the LLM correctly interprets the timeline as 2022 → 2023 → 2024. (2) All numeric values are accurate within acceptable rounding conventions; for example, $51,354 million is properly rounded to $51.4 billion. Calculations are not required beyond recognition of trend, which is correctly identified. (3) The multi-hop reasoning is sound: the model synthesizes the increasing magnitude of negative treasury stock balances over time and correctly infers that this reflects an escalating share buyback program. It connects this trend to capital allocation strategy—specifically returning cash to shareholders and supporting EPS growth—consistent with the original answer’s conclusion. (4) The answer is semantically equivalent and contextually complete, addressing both parts of the question: the evolution of investment and its implication for capital allocation. Wording differs slightly but meaning is preserved. One point deducted from correctness and quantitative accuracy due to slight imprecision in rounding at the margin (e.g., $51,354M is closer to $51.35B than $51.4B), though this is within typical reporting tolerance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 449,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "Honeywell’s 2022 10‑K listed the risk under the **Safety and Productivity Solutions** segment, warning that “operating results may be adversely impacted by reduced investments in process automation, safety monitoring, and plant‑capacity‑utilization initiatives”【page_32】. In the 2023 filing the same language re‑appeared, but the risk was now attached to the newly‑named **Industrial Automation** segment after the company’s realignment【page_30】, and the 2024 filing repeated the identical wording for Industrial Automation【page_31】. The persistence of this risk – even as the segment was renamed – shows that Honeywell’s exposure to weaker automation spending and lower plant utilization has remained a constant concern, reflecting sustained macro‑economic pressure on industrial capital‑expenditure and demand throughout the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and largely aligns with the ground truth. It correctly identifies that Honeywell highlighted reduced investments in process automation and plant capacity utilization as a persistent risk from 2022 to 2024. The answer accurately notes the segment was renamed from Safety and Productivity Solutions to Industrial Automation due to a corporate realignment, which is consistent with the company's 10-K disclosures. This renaming detail, while not in the original answer, adds precision and reflects correct entity tracking across filings. The core message — that this repeated risk language indicates sustained macroeconomic pressure on industrial capital expenditure — matches the ground truth’s conclusion about ongoing and deepening macroeconomic headwinds. The only minor shortcoming is that the LLM does not explicitly mention the evolving emphasis on broader macroeconomic factors like geopolitical instability and trade policy shifts in 2024, which the original answer highlights as a sharpening of concern. However, the LLM does imply continued and unresolved pressure, capturing the essence of the trend. All dates, segment names, and risk descriptions are correct, and the reasoning across years is sound. No numerical inaccuracies exist, and the contextual relevance to the question about macroeconomic pressures is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 378,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "By 2022 Cyramza was already marketed for a suite of oncology uses – second‑line monotherapy or combination therapy in advanced gastric or gastro‑esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer and hepatocellular carcinoma, plus a first‑line combination for EGFR‑mutated metastatic NSCLC 【page_5】. The 2024 filing lists the same set of indications, showing that the therapeutic positioning has remained consistent through 2024 【page_6】. At the same time, the IP table in the 2024 report shows that Cyramza’s core compound patents run out in 2026 in the U.S. and Japan and in 2028 in Europe, while its data‑protection exclusivity expires earlier – in Japan in 2023 and in Europe in 2024 – indicating that the product is moving into the final years of its exclusivity window. 【page_11】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Cyramza's therapeutic indications in 2022 and 2024 are accurately described, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers, with additional detail on first-line EGFR-mutated NSCLC combination therapy. The intellectual property timeline is also correct—data protection expired in Japan in 2023 and is set to expire in Europe in 2024, while compound patents extend to 2026 in the U.S. and Japan and 2028 in Europe. (2) Quantitative accuracy is perfect: all dates (2022, 2023, 2024, 2026, 2028) match the ground truth. The LLM correctly distinguishes between data protection and compound patent expiration dates. (3) Multi-hop reasoning is sound: the model synthesizes information across time (2022 to 2024), geography (U.S., Japan, Europe), and IP types (data protection vs. compound patents), correctly inferring that exclusivity is narrowing despite stable therapeutic positioning. (4) The only minor deviation is that the original answer emphasizes a 'narrowing window of exclusivity' as a concluding insight, while the LLM mentions 'final years of its exclusivity window'—semantically equivalent but slightly less precise in framing the strategic implication. However, this does not detract from factual correctness. Wording differences are acceptable under semantic equivalence. All parts of the question are addressed: lifecycle positioning, indications over time, and IP timeline evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 423,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "Capital One’s net derivative position, which is measured at Level 3 (using discounted‑cash‑flow models that rely on **swap‑rate** assumptions), grew sharply after 2022: the net derivative assets were **$5 million** at 12/31/2022, rose to **$58 million** at 12/31/2023, and reached **$69 million** at 12/31/2024.  The valuation technique remained the same—discounted cash‑flow models with **swap‑rate** inputs—but the unobservable input range shifted from a **3 %–5 %** spread (2023) to a more concentrated **≈4 %** spread in 2024, while the weighted‑average swap rate stayed around **4 %**.  Gross derivative assets and liabilities also expanded (from $79 m/$74 m in 2022 to $886 m/$828 m in 2023, then fell to $683 m/$614 m in 2024), yet the net Level 3 exposure continued to increase modestly.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Capital One's net derivative assets/liabilities were $19M in 2022, $58M in 2023, and $58M in 2024. The LLM incorrectly reports $5M in 2022 and $69M in 2024, both of which are factually wrong. Additionally, the LLM introduces gross derivative assets/liabilities figures ($79M/$74M in 2022, etc.) that are not present in the original answer and cannot be verified against the ground truth, suggesting potential hallucination. 2) The unobservable inputs are partially correct: the LLM correctly identifies swap rates in the 3–5% range and a weighted average of ~4%, aligning with the original answer. However, it omits the mention of default rates (53–163%) in 2023 and fails to note the $20M net losses held in the portfolio in 2022, which are key qualitative details. The claim that the input range 'shifted' to a more concentrated ≈4% in 2024 misrepresents the original answer, which states the range remained 3–5%, weighted at 4%. 3) The reasoning is partially sound in recognizing the consistent use of discounted cash flow models and Level 3 fair value measurements, and the trend of increase from 2022 to 2023. However, the incorrect 2024 value breaks the correct conclusion of stabilization in 2024. The multi-hop synthesis is flawed due to incorrect numerical grounding. 4) Despite the factual errors, the answer remains contextually relevant, addressing fair value evolution and unobservable inputs as asked. The structure and intent align with the question, but the quantitative inaccuracies severely undermine correctness. The correctness score is low due to major number errors, though not zero because core methodology and partial data are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 475,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "- **Charitable‑match participation:** In fiscal 2022 Qualcomm reported that “thousands of our employees around the world utilized our charitable match program, benefiting more than 1,500 charitable organizations” (2022 10‑K, p. 17). By fiscal 2024 the same language appears – “thousands of our employees … utilized our charitable match program, benefiting more than 1,300 charitable organizations” (2024 10‑K, p. 16). Thus employee use remained at the “thousands” level, while the count of supported organizations fell modestly from >1,500 to >1,300 over the period.\n\n- **Link to human‑capital goals and executive pay:** Both the 2022 and 2024 filings state that the HR and Compensation Committee will evaluate “human capital advancements” – which include programs such as the charitable match – when setting the executives’ annual bonus, using a non‑financial performance modifier that can adjust the payout by a multiple of 0.9 to 1.1 (2022 10‑K, p. 17; 2024 10‑K, p. 16). Therefore, the growth and continued employee engagement in the charitable‑match program is explicitly tied to the company’s broader human‑capital objectives that directly influence executive compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and timeframes are correct: employee participation remained at 'thousands' in both 2022 and 2024, and the number of supported organizations decreased from over 1,500 in 2022 to over 1,300 in 2024—both correctly reported. The fiscal years (2022 and 2024) and document sources (10-K pages) are accurately cited. (2) The answer correctly identifies the non-financial performance modifier (0.9 to 1.1) tied to executive bonuses based on human capital advancements, including charitable engagement, as stated in both filings. (3) The multi-hop reasoning is sound: it synthesizes data across two years, connects employee participation and organization counts to the charitable match program, and links this to executive compensation via human capital goals. (4) The only minor shortcoming is that the LLM does not explicitly mention Qualcomm’s 2025 DEI goals, which are referenced in the ground truth as part of the broader human capital strategy. While the linkage to human capital goals is correctly established, the absence of this forward-looking strategic context slightly reduces completeness in qualitative synthesis. However, this does not detract significantly from the overall correctness. Wording differences are semantically equivalent and acceptable. All key facts, calculations, and connections are accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 395,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "- In the 2022 Form 10‑K (pages 7‑8) Adobe described Acrobat as the centerpiece of its **Document Cloud**, stressing a “best PDF experience” across desktop, web and mobile, the integration of **Adobe Sign** into Acrobat on every surface, AI‑driven features from **Adobe Sensei**, and new mobile capabilities such as Liquid Mode, Acrobat Web and Adobe Scan.  \n\n- The 2023 filing (page 5) kept Acrobat in the same Document Cloud slot but shifted the narrative to **expanding Acrobat Web’s functionality and the number of task‑based actions**, deepening the **Adobe Sign API** integration and using Sensei to make documents “more intelligent and responsive.”  \n\n- The 2024 filing excerpts (pages 94‑98) contain no new product‑level commentary on Acrobat, indicating that by FY 2024 Adobe treated Acrobat as an established, fully integrated part of Document Cloud rather than announcing fresh positioning or feature upgrades.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but contains significant omissions and misrepresentations in the qualitative evolution of Adobe's positioning of Acrobat from 2022 to 2024, particularly in 2024. (1) Correct elements: The 2022 description accurately reflects Acrobat as the centerpiece of Document Cloud with integration of Adobe Sign, AI via Adobe Sensei, and features like Liquid Mode and Acrobat Web. The 2023 shift toward expanding Acrobat Web and deeper Adobe Sign API integration is factually aligned. There are no numeric inaccuracies—this is a qualitative question without calculations. (2) Quantitative accuracy is 10/10 because no numbers are misstated and all references to filings (e.g., page numbers) are plausible and consistent. (3) However, the 2024 analysis is fundamentally incorrect: the LLM claims there is 'no new product-level commentary' and that Acrobat was treated as 'established' without fresh upgrades. This contradicts the ground truth, which states that in 2024, Adobe formally introduced the 'Acrobat AI Assistant' as a registered trademark, marking a strategic shift toward AI-powered intelligent automation. This is a major product and positioning enhancement, not a lack of commentary. The failure to identify this key multi-hop development—linking the trademark filing to a strategic AI integration—represents a breakdown in reasoning and synthesis. (4) Contextual relevance is fair because the answer addresses the general trajectory within Document Cloud and integration themes, but it misses the core 2024 evolution that defines the question. The qualitative accuracy is low due to this critical omission, which undermines the multi-year narrative. Correctness is scored at 5/10 because while 2022 and 2023 are reasonably covered, the 2024 assessment is factually wrong, and the answer fails to capture the AI-driven strategic shift that is central to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 513,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "In 2022 Eli Lilly recorded $2.02 billion of net product revenue from its COVID‑19 antibody portfolio (bamlanivimab and bebtelovimab), with AbCellera receiving royalty payments “in the mid‑teens to mid‑twenties” of those sales that were booked as cost of sales 【page_73】. No COVID‑19 antibody sales were reported in either 2023 or 2024, so net product revenue fell to $0 and the associated royalty payments to AbCellera ceased 【page_73】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: $2.02 billion in net product revenue for 2022, no sales in 2023 and 2024, and royalty payments in the 'mid-teens to mid-twenties' percentage range. The mention that royalties were booked as cost of sales adds a detail not in the original but is consistent and plausible. (2) Quantitative accuracy is perfect: the dollar amount, years, and percentage range match exactly. There are no calculation errors. (3) Multi-hop reasoning is sound—LLM correctly synthesized information across years and entities (LLY, AbCellera, bamlanivimab, bebtelovimab), showing evolution over time and the resulting financial implications. (4) The answer is contextually relevant, directly addressing the evolution of net product revenue and royalty payments from 2022 to 2024. Minor wording differences (e.g., 'recorded' vs 'recognized') do not affect meaning. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 285,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "MetLife’s disclosed reliance on the modified‑coinsurance structure has been essentially unchanged: the 2022 filing notes that **≈ 59.25 %** of the closed block is reinsured on a modified‑coinsurance basis, and the 2023 and 2024 filings each state **≈ 59 %** of the closed block is covered by the same arrangement【page_214】, 【page_227】, 【page_204】.  \n\nThis steady‑around‑three‑fifths share shows that MetLife has deliberately kept a consistent, long‑term risk‑transfer strategy for its closed‑block liabilities, using the modified‑coinsurance agreement to off‑load a stable portion of the block’s risk to an external reinsurer while retaining the remainder.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All numeric values are accurate: 59.25% for 2022 and 59% for both 2023 and 2024, with appropriate use of approximation symbols (≈) which preserve precision without misrepresentation. (2) The answer addresses both parts of the multi-hop question: it traces the percentage evolution across 2022–2024 and interprets the consistency in the context of MetLife’s long-term risk transfer strategy. (3) Entities—MetLife, closed block, modified coinsurance agreement, and correct years—are accurately identified and correctly linked to their respective percentages. (4) The reasoning is sound: the model correctly synthesizes data across three annual filings and draws a logical conclusion about strategic continuity in risk management. Minor wording differences (e.g., 'steady-around-three-fifths' as a paraphrase of ~59%) do not affect factual accuracy and enhance readability. No errors in calculation, entity reference, or logic are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 292,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "Mastercard’s “multi‑layered” security model has become increasingly ecosystem‑wide. In its 2022 filing the company already highlighted a layered defense (Security Operations Centers, Fusion Centers and third‑party assessments) but the language focused mainly on internal monitoring and public‑private partnerships 【page_11】. By 2023 the firm added a concrete cyber‑risk dimension around its expanding real‑time payments platform, noting that it operated or was implementing real‑time clearing and settlement in 13 markets 【page_11】, and the 2024 filing now explicitly calls out protection of services supplied by third‑party providers and the integration of real‑time account‑based payment infrastructure as a core part of its security architecture 【page_11】. Together, these changes show a cybersecurity strategy that moves from protecting the core network to actively managing third‑party exposure and using real‑time payment infrastructure both as a growth engine and as a controlled, monitored surface for cyber threats.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: 2022 mentions of public-private partnerships and third-party assessments, 2023 expansion to 13 real-time payment markets (matching ground truth), and 2024 emphasis on third-party provider protections and real-time infrastructure integration are factually consistent. The format '13 markets' matches exactly. (2) The answer addresses all parts of the question: evolution from 2022–2024, third-party collaboration, real-time payment infrastructure, and implications for cybersecurity strategy. (3) Multi-hop reasoning is sound—correctly synthesizing changes across years and entities (Mastercard, third parties, real-time systems) and drawing a logical conclusion about strategic shift toward managing third-party risk and securing expanding digital surfaces. (4) Minor deduction in qualitative accuracy due to slightly less specificity in 2024: ground truth notes 'several countries globally' and 'ongoing third-party assessments and resilience programs,' while LLM mentions 'protection of services supplied by third-party providers' but omits explicit reference to 'resilience programs.' However, the core strategic interpretation—that security is expanding into the ecosystem and third-party risk is now central—is semantically equivalent and well-reasoned. Wording differences are acceptable under semantic equivalence. No factual errors or calculation issues.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1597,
        "completion_tokens": 407,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "- **Allocation amounts** – In the defined‑benefit pension plan, equity‑like private‑alternative investments were $4.0 billion in 2022, rose modestly to $4.09 billion in 2023, and fell slightly to $3.93 billion in 2024.  The retiree‑health plan showed a similar pattern (≈ $0.33 billion in 2022, $0.34 billion in 2023, $0.35 billion in 2024).\n\n- **Implication** – The near‑steady, multi‑billion‑dollar exposure over three years indicates that Lilly maintains a deliberate, long‑term commitment to illiquid, equity‑like private‑equity assets as a core component of its growth‑investment mix, adjusting the size only modestly while seeking higher, diversified returns over the long horizon.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported allocation amounts. According to the ground truth, LLY's allocation to equity-like private alternative investments was $2,844.7 million in 2022, increased to $4,014.1 million in 2023, and further rose to $4,093.7 million in 2024. The LLM incorrectly reports $4.0 billion in 2022 (vs. $2.8447 billion), which is a substantial overstatement. It also reports a decrease to $3.93 billion in 2024, whereas the correct value is $4.0937 billion—an increase, not a decrease. These errors affect all three years and are not minor formatting differences but material misstatements of magnitude and trend. (2) The LLM introduces a retiree-health plan allocation not mentioned in the original answer or question, which is extraneous and unsupported by the ground truth. The original answer focuses solely on the overall allocation without breaking it down by pension vs. health plans. (3) The reasoning about a 'near-steady' exposure is flawed because the actual data shows a significant increase from 2022 to 2024 (over 40% growth), with only a minor dip in 2023. The LLM fails to capture this meaningful upward trajectory, which is central to the original conclusion about strategic emphasis on illiquid assets. (4) While the LLM correctly infers that long-term commitment to illiquid assets is implied, this qualitative insight is based on incorrect data, weakening the validity of the conclusion. The contextual relevance is fair because the answer addresses the right topic and attempts to interpret strategic intent, but the foundation is factually unsound. Overall, the answer is mostly incorrect due to severe quantitative errors and misrepresentation of the trend, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 485,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K, Cascade was listed under the **Home‑Care sub‑category** of the Fabric & Home Care segment, and the segment accounted for **about 35 % of Procter & Gamble’s net sales** (see the segment table that lists “Tide Cascade” among the major brands)【page_19】.  \n\n- By the 2024 Form 10‑K, Cascade was still positioned in the same **Home‑Care sub‑category** of Fabric & Home Care, but the segment’s share of total net sales had risen to **roughly 36 %** (the table again shows “Tide Cascade” among the major brands)【page_18】.  \n\nThus, from 2022 to 2024 P&G kept Cascade classified as a Home‑Care product within the Fabric & Home Care segment, while the segment’s contribution to overall net sales edged up modestly from about 35 % to 36 %.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the Fabric & Home Care segment's contribution was approximately 35% in 2022 and rose to 36% in 2024, matching the original answer (which also notes 36% in 2023). The LLM correctly identifies Cascade’s placement within the Home-Care sub-category across the period. (2) The answer correctly cites the presence of 'Tide Cascade' in the major brands list in both 2022 and 2024 filings, supporting the claim of stable positioning. (3) While the original answer explicitly mentions 2023 data (36% share), the LLM omits this year-specific detail but still captures the overall trend from 2022 to 2024 accurately. This is a minor omission rather than an error. (4) The reasoning is sound, demonstrating correct multi-hop synthesis across two 10-K filings to assess product categorization and segment performance over time. (5) Semantic equivalence is maintained: the LLM conveys the same core conclusion—stable product categorization and slightly increasing segment contribution—using slightly different phrasing. The only reason for not scoring a 10 is the lack of explicit mention of 2023, which was included in the ground truth and would strengthen completeness in a multi-year evolution analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 364,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "- **2022 – Foundational monitoring and policy:** Lowe’s began formally tracking supplier climate impact by urging all vendors to disclose emissions to CDP and by partnering with the EPA SmartWay program, while its wood‑sourcing policy simply required vendors to avoid illegal logging, deforestation, endangered‑species wood and to obtain Free, Prior and Informed Consent where applicable.  \n\n- **2023 – Policy upgrade and deeper oversight:** The company refreshed the wood‑sourcing policy, adding country‑specific risk‑level classifications, stronger supplier‑monitoring procedures and a new forestry‑grievance process; it also expanded its sustainability‑investment budget to more than $400 million for energy‑efficiency retrofits and announced a rollout of rooftop solar at 174 stores and distribution centers.  \n\n- **2024 – Risk‑based framework and amplified capital spend:** Lowe’s further hardened the policy with a “more robust risk‑based approach,” retaining the country‑risk tiers, tighter monitoring and the grievance mechanism, and it continued to fund large‑scale renewable‑energy projects (over 100 solar sites in operation) and other emissions‑reduction initiatives as part of its $350 million‑by‑2025 community‑investment plan and ongoing $300‑$400 million capital program.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Lowe's sustainability practices from 2022 to 2024 and correctly identifies key qualitative developments such as the introduction of country-specific risk levels, a forestry grievance process, and a more robust risk-based approach in 2024. However, it contains significant quantitative inaccuracies that undermine factual correctness. The ground truth states that Lowe's invested over $550 million in environmental facility upgrades in 2022, committed to a $50 million Gable Grants program in 2023, and aligned its sustainability strategy with long-term shareholder value in 2024. In contrast, the LLM claims $400 million for energy-efficiency retrofits, a $350 million-by-2025 community-investment plan, and a $300–$400 million capital program—none of which appear in the original answer and contradict the disclosed figures. Additionally, the LLM introduces unverified details such as CDP disclosures, EPA SmartWay partnership, rooftop solar at 174 locations, and over 100 solar sites, which are not supported by the ground truth. While the structure and thematic progression (policy foundation → enhancement → strengthening) are logically sound and contextually relevant, the answer fails on factual precision, especially in financial commitments and specific initiatives. The multi-hop synthesis across years is partially correct but based on fabricated or unverified data, leading to a low quantitative accuracy score. Entity identification (Lowe's, wood sourcing, supplier monitoring) is accurate, but policy details and investment figures are misaligned with the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1614,
        "completion_tokens": 442,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "In the 2022 filing Honeywell warned that both its **Safety & Productivity Solutions** and **Honeywell Building Technologies** businesses could be hurt by “changes in the competitive landscape, including new market entrants and new technologies that may lead to product commoditization”【page 32】. After the 2023 realignment, the same competitive‑risk language appears for the newly‑named **Industrial Automation** segment (which now houses the former Safety & Productivity businesses)【page 30】, and the 2024 filing continues to flag comparable competitive‑landscape and commoditization risks for **Building Automation** (the renamed Building Technologies) and **Industrial Automation**【pages 28‑31】. The progression shows that what began as a concern for a single segment in 2022 has spread to multiple core units by 2024, indicating that market pressure and the threat of product commoditization are intensifying across Honeywell’s key businesses.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its core facts and timeline, with accurate dates (2022, 2023, 2024) and correct identification of business segments and associated risks. It correctly notes that competitive landscape risks were first mentioned in 2022 for Safety & Productivity Solutions and Building Technologies, then carried forward into Industrial Automation and Building Automation in later years. The quantitative accuracy is perfect: no numerical errors, and the chronological progression is factually sound. However, there is a key factual inaccuracy in the LLM answer: it claims that in 2022, Honeywell warned about competitive risks in *both* Safety & Productivity Solutions *and* Honeywell Building Technologies. The ground truth states that in 2022, the risk was only explicitly mentioned for Safety and Productivity Solutions—not Building Technologies. The expansion to Building Technologies occurred in 2023. Additionally, the LLM introduces the idea of a '2023 realignment' and rebranding of segments (e.g., 'Industrial Automation' housing former Safety & Productivity businesses), which, while plausible contextually, is not present in the original answer and may reflect inference beyond the provided ground truth. This misattribution of the 2022 risk to two segments instead of one affects the qualitative accuracy, as it misrepresents the progression of risk expansion. The reasoning is otherwise sound—correctly identifying the broadening of commoditization risk across time and segments—and the conclusion about intensifying market pressures aligns with the ground truth. Contextual relevance is high, as the answer directly addresses the evolution of competitive exposure and its implications. Thus, while the overall narrative is directionally correct, the error in the initial scope of 2022 risk disclosure prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 500,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "In its 2022 filing Qualcomm framed the digital‑cockpit as an emerging part of an “automotive transformation” – QCT’s automotive line (which it defined as “connectivity, digital cockpit and ADAS/AD”) was still modest, generating only $1.5 billion of equipment revenue that year and was described mainly as a growth opportunity driven by 5G‑enabled, low‑power computing 【page_8】【page_7】.  \n\nBy the 2023‑2024 filings the company was reporting a rapid lift in that same revenue stream – $1.9 billion in 2023 and $2.9 billion in 2024 – and repeatedly emphasized that its 5G, on‑device AI and high‑performance SoC platforms are now being embedded in vehicles to power the “digital cockpit, OTA updates and car‑to‑cloud services,” a positioning reinforced by the 2022 acquisition of Veoneer’s Arriver business (the advanced‑driver‑assist/digital‑cockpit unit) 【page_73】【page_74】【page_75】.  \n\nThus, from a nascent, strategic‑intent statement in 2022, Qualcomm’s disclosures show it moved to a much larger, revenue‑driving role in the digital‑cockpit market by 2024, with automotive sales recognized at the point‑in‑time as equipment revenue and a clear segment‑level focus on connectivity‑centric, 5G‑based cockpit solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $1.5B in 2022, $1.9B in 2023, and $2.9B in 2024 for automotive revenue (which includes digital cockpit, connectivity, and ADAS/AD), with proper citation of growth trajectory. These figures match the knowledge graph data. (2) The answer correctly identifies the evolution from a strategic vision in 2022—where digital cockpit was part of a broader 'automotive transformation' opportunity—to explicit revenue recognition by 2023 and operational integration by 2024. It references the Veoneer Arriver acquisition in 2022, which strengthens the strategic positioning, though the original answer does not mention this detail, so it's a value-add rather than an error. (3) The reasoning is sound: the LLM synthesizes information across years, connects product development (5G, AI, SoCs) to market positioning, and correctly ties revenue recognition to equipment sales within QCT. (4) While the original answer emphasizes structural segment reporting integration in 2024, the LLM captures the essence—clear segment-level focus and grouping under QCT—though slightly less explicit on formal reporting changes. Wording differs but semantic meaning is equivalent. Minor deduction in qualitative accuracy only because the LLM does not explicitly state that digital cockpit became a recognized component of automotive revenue *alongside* connectivity and ADAS/AD in 2023, but implies it through context. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 435,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "Adobe’s Frame.io platform was first described in the 2022 filing as a cloud‑native collaboration hub that handled **video plus still images, design files and PDFs** and was **directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront**, with “Camera‑to‑Cloud” ingest for on‑set footage and native still‑camera connections 【page_12】.  In the 2023 and 2024 10‑K disclosures the same core integrations are retained, but Adobe adds that Frame.io is now bundled with **Adobe Express and Adobe Firefly Services in Adobe GenStudio**, positioning it as an **enterprise‑scale content‑production solution** that leverages AI‑driven workflows and broader Creative Cloud connectivity 【pages 10‑14 of 2023 & 2024】.  Thus, from 2022 to 2024 Frame.io expanded from a video‑centric review tool to a multi‑media, cross‑product platform with added AI services and a dedicated enterprise‑focused GenStudio offering.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and timeline, with accurate dates (2022–2024) and correct identification of Adobe and Frame.io. It correctly notes Frame.io's evolution into a cloud-native collaboration platform with support for video, still images, design files, and PDFs, as well as integrations with Premiere Pro and After Effects. The mention of inclusion in Adobe GenStudio with Adobe Express and Firefly Services aligns with the 2024 expansion into enterprise-scale AI-driven content production. However, there is a significant factual inaccuracy: the LLM claims in the 2022 filing that Frame.io was already integrated with Photoshop, Lightroom, and Workfront, but the ground truth states these broader integrations (including Photoshop, Lightroom, Workfront) were part of the 2024 expansion, not 2022. The 2022 ground truth only confirms trademark inclusion, not functional integration. Additionally, the 'Camera-to-Cloud' and on-set ingest features are not mentioned in the original answer and appear to be extraneous or incorrectly attributed details. While the overall trajectory—from video review tool to enterprise AI-augmented platform—is correctly captured, the misattribution of integration timelines reduces qualitative accuracy. Quantitative accuracy is perfect as there are no numerical errors. Contextual relevance is strong as all aspects of the question (media types, integrations, enterprise capabilities) are addressed with mostly accurate details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 411,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "Across the three most recent filings Mastercard’s Class A shares have kept the same governance features – each share carries one vote and the right to receive dividends (see the “Classes of Capital Stock” tables in 2022, 2023 and 2024 10‑Ks).  The cash dividend paid to Class A holders, however, has risen steadily: $2.04 per share in 2022, $2.37 in 2023 and $2.74 in 2024 (see the “Dividends declared per share” tables).  The unchanged one‑vote‑per‑share structure combined with a consistently growing dividend suggests a stable shareholder‑governance framework in which voting power remains constant while the company rewards owners with higher payouts.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. While it correctly states that MA's Class A shares have 'one vote per share' and dividend rights—aligning with the ground truth—the claim about specific dividend amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) is unsupported by the original answer and introduces quantitative errors. The ground truth does not mention any changes in dividend payouts, only that 'Dividend rights' were consistently disclosed, indicating no change in the rights themselves, not necessarily increasing payments. The LLM incorrectly infers a 'steadily rising' cash dividend, which is a factual overreach not present in the source data. This misrepresents the nature of the information: the original emphasizes stability in rights (voting and dividend entitlement), not trends in payout amounts. The reasoning incorrectly conflates dividend *payments* with dividend *rights*, which are distinct concepts—rights refer to eligibility, not payment levels. While the conclusion about governance stability is directionally plausible, it is based on flawed premises. The entity (MA/Class A shares) and years (2022–2024) are correct, and the answer addresses both parts of the question (evolution of rights and governance implications), satisfying completeness and contextual relevance. However, the introduction of unverified numerical data severely compromises quantitative accuracy. Multi-hop synthesis is attempted but flawed due to incorrect data integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 418,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "Honeywell’s Safety and Productivity Solutions segment fell sharply when retail‑market demand turned weak – net sales dropped from $6.9 billion in FY 2022 to $5.5 billion in FY 2023 (‑21 %) and segment profit fell from $1.08 billion to $0.90 billion (‑17 %)【page_30】—a decline that the company attributes in part to “fluctuations in retail markets” listed among the segment’s key risk factors【page_31】.  In FY 2024 the segment rebounded modestly, with sales up 3 % to $6.4 billion and profit up 2 % to $1.52 billion versus FY 2023【page_28】, showing that while the business can recover when consumer demand improves, its results remain highly sensitive to retail‑demand volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the financial figures and segment evolution. The ground truth states that Honeywell consistently disclosed *risk* from retail market fluctuations across 2022–2024, but does not provide actual financial performance data (sales, profit) for the Safety and Productivity Solutions segment across those years. The LLM fabricates specific numbers: e.g., $6.9B sales in 2022 dropping to $5.5B in 2023 (-21%), then rebounding to $6.4B in 2024. These figures are not present in the ground truth and cannot be verified from the provided context. Additionally, the claim of segment profit rising to $1.52B in 2024 contradicts the ground truth, which does not mention any such recovery or specific profits. (2) The quantitative inaccuracies are severe—there are no actual financial results in the original answer to support the LLM’s detailed P&L breakdown. Even if the numbers came from external filings, the ground truth does not include them, so the LLM is overreaching by introducing unsupported data. The percentages (-21%, -17%, +3%, +2%) are also unverified and likely incorrect. (3) The multi-hop reasoning is partially sound in that the LLM attempts to trace the segment’s sensitivity to retail demand over time. However, it misrepresents the nature of the information: the original answer is about *risk disclosures*, not actual financial performance. The LLM incorrectly shifts focus from qualitative risk exposure to quantitative financial impact without basis. It also fails to note the segment name change accurately—S&PS became part of Industrial Automation by 2024, but the LLM continues referring to it as the same segment rebounding, which oversimplifies the reorganization. (4) Despite these issues, the answer is contextually relevant—it addresses the core theme of retail market sensitivity and attempts to show temporal trends. The reasoning about vulnerability to consumer demand is aligned with the original, but the use of fabricated metrics undermines correctness. Hence, correctness and quantitative accuracy are low; qualitative accuracy is moderate due to correct thematic understanding; contextual relevance is high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 594,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "From the 2022 filing, Eli Lilly’s worldwide license with Incyte provided Incyte a tier‑ed, double‑digit royalty of up to 20 % on all Olumiant (baricitinib) net sales and, after a 2020 amendment, an additional low‑teens‑percent royalty on worldwide sales of the COVID‑19 indication once a sales‑threshold is exceeded.  At that time LLY had already capitalized $210 million (2020) and $260 million (2021) of development‑ and regulatory‑milestone payments and Incyte remained eligible for up to $100 million of further success‑based regulatory milestones and $100 million of sales‑based milestones.  By the 2023 and 2024 reports the royalty structure was unchanged (20 % max plus low‑teens for COVID‑19) and LLY still noted that Incyte could receive up to $100 million of additional sales‑based milestone payments, with no material new milestone payments disclosed after 2021.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with only minor omissions affecting completeness. (1) Quantitatively, all key numbers are accurate: the $100 million in regulatory and $100 million in sales-based milestones, the up to 20% royalty rate, and the additional low teens royalty for COVID-19 sales above a threshold are all correctly reported. The mention of $210M (2020) and $260M (2021) capitalized milestones is consistent with the evolution of the agreement, though not in the original answer—this is factual context from filings but not required for correctness. (2) The LLM correctly states that by 2023 and 2024, the royalty structure remained unchanged and that Incyte could still receive up to $100M in sales-based milestones. However, it does not fully reflect the 2023 shift described in the ground truth where milestone payments were capitalized as intangible assets and amortized into cost of sales—a key qualitative evolution in accounting treatment. This omission affects completeness and reasoning synthesis. (3) The multi-hop reasoning is sound in tracking the continuity of royalty terms and milestone eligibility across years, but the LLM misses the shift in financial classification (capitalization and amortization) in 2023, which is a critical part of the financial obligation evolution. (4) Despite this, the answer captures the core evolution: stable royalties, no new milestone payments post-2021, and ongoing eligibility. Wording is semantically equivalent and contextually relevant. The answer is slightly less precise in describing the 2023 accounting change but otherwise factually solid, warranting a high score with a small deduction for missing a key financial reporting evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 473,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "In the 2022 filing the “Baby, Feminine & Family Care” segment listed a broad set of brands—Luvs, Pampers, Always, Always Discreet, Tampax, Bounty, Charmin and Puffs—showing Always as one of several contributors, with the segment description simply noting that the company “competes in the menstrual‑care sub‑category primarily behind our Always and Tampax brands.”  \n\nBy the 2023 and 2024 filings the tables were trimmed to “Always, Always Discreet, Tampax, Bounty, Charmin and Puffs,” and the narrative placed Always front‑and‑center as the lead brand in both menstrual‑care (over 25 % share) and adult‑incontinence (about 15 % share), effectively elevating its strategic importance relative to the other baby‑care brands that were no longer highlighted.  \n\nThus, from 2022 to 2024 P&G repositioned Always from a member of a wide brand mix to the flagship feminine‑care brand within the segment, emphasizing its dual product categorization (menstrual and incontinence) and giving it greater prominence than the other brands.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Always' strategic positioning within Procter & Gamble's Baby, Feminine & Family Care segment from 2022 to 2024 and correctly identifies the shift in narrative emphasis toward Always as a lead brand. However, it introduces significant factual inaccuracies that undermine its correctness. (1) The claim that Always held 'over 25% share' in menstrual care and 'about 15% share' in adult incontinence in 2023 and 2024 is not supported by the ground truth and contains fabricated quantitative data—no market share percentages are mentioned in the original answer. (2) The removal of Luvs and Pampers from the 2023 and 2024 brand lists is presented as a filing change, but the ground truth does not confirm this omission; it only specifies that Always, Always Discreet, and Tampax remained prominent. (3) While the original answer notes a reclassification from 'Feminine Care (Adult Incontinence, Feminine Care)' to 'Menstrual Care' in 2023, the LLM correctly infers a sharpened focus on menstrual care but incorrectly frames it as a dual emphasis on both menstrual and incontinence care as a strategic elevation—whereas the ground truth emphasizes a more targeted positioning around menstrual care, not an expansion. (4) The LLM’s conclusion that Always became the 'flagship feminine-care brand' and was elevated above baby-care brands is a plausible interpretation but goes beyond the original answer, which only states that Always maintained prominence alongside Always Discreet and Tampax. The reasoning is partially sound and contextually relevant, but the inclusion of unverified market share figures severely impacts quantitative accuracy. The answer is semantically close but not factually aligned in key areas.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 476,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "- **Fiscal 2023 (target disclosed in the 2022 filing):** U.S. plans were 100 % debt; non‑U.S. plans were 27 % equity, 48 % debt, 4 % cash, 11 % insurance contracts and 10 % other.  \n- **Fiscal 2024 (allocation shown as of August 31 2023 in the 2023 filing):** U.S. plans shifted to 94 % debt and added 6 % cash; non‑U.S. plans moved to 23 % equity, 42 % debt, 5 % cash, 21 % insurance and 9 % other.  \n- **Fiscal 2025 (target disclosed in both the 2023 and 2024 filings):** U.S. plans return to 100 % debt, while non‑U.S. plans increase equity to 28 %, cut debt to 36 %, raise cash to 7 %, keep insurance at 21 % and other at 8 %.\n\n**Interpretation:** Over the three‑year horizon Accenture is gradually tilting its non‑U.S. pension portfolios toward more equity and cash and away from pure fixed‑income exposure, while preserving a core of debt (and insurance contracts) that matches liability duration. This evolution reflects a balanced approach: seeking higher risk‑adjusted returns through greater equity exposure, yet retaining sufficient duration‑matching assets to manage interest‑rate risk and meet long‑term obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides detailed numerical breakdowns of asset allocations for U.S. and non-U.S. pension plans across fiscal years 2023, 2024, and 2025, which are not present in the original ground truth. However, the ground truth explicitly states that the strategy showed 'a consistent framework' with an emphasis on liability duration matching and diversification, without specifying exact percentages by region or asset class. The LLM introduces granular data (e.g., 27% equity for non-U.S. plans in 2023, 21% insurance in 2025) that are not found in the original answer and cannot be verified as accurate based on the provided knowledge graph. This suggests the LLM may have hallucinated specific figures rather than extracting or synthesizing from the source. While the interpretation about a shift toward equity for higher risk-adjusted returns and maintaining duration-matching assets aligns thematically with the original, the detailed quantitative claims undermine factual correctness. The multi-hop reasoning is structurally sound—addressing evolution over time and inferring strategic intent—but rests on unsupported numbers. Thus, while contextually relevant and partially qualitatively accurate in reasoning, the answer fails on quantitative accuracy, a critical factor for financial disclosures. Minor formatting variations are acceptable, but complete fabrication of percentages is not. The original answer emphasizes continuity and flexibility without citing year-by-year percentage shifts, making the LLM’s precision misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1614,
        "completion_tokens": 422,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "Lowe’s 2022 Form 10‑K shows that the company carried forward‑interest‑rate‑swap contracts with a notional amount of **$2.56 billion** (Note 9) and a fair‑value asset of **$251 million** recorded as a Level‑2 “Other current asset” (Table of fair‑value measurements, 2023 column). By the 2023 filing the swaps were still on the books as cash‑flow hedges, but the 2024 filing no longer lists any forward‑swap fair‑value amount (the line is blank) and the note‑9 table no longer reports a notional balance, indicating the contracts have been settled or unwound and the exposure has been eliminated. The move from a sizable, cash‑flow‑hedged forward‑swap position in 2022 to essentially zero exposure in 2024 shows that Lowe’s uses these swaps to lock in rates for anticipated debt issuances and then derecognizes them once the debt is issued or the hedge is no longer needed, reflecting a targeted, “hedge‑while‑needed” interest‑rate risk‑management strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the timeline and classification of the swaps. It incorrectly states that in 2022, Lowe's had a fair value asset of $251 million and a notional amount of $2.56 billion. However, the ground truth indicates that no fair value was disclosed for forward interest rate swaps in 2022; the $251 million fair value was first explicitly reported in 2023. Additionally, the LLM misattributes the 2023 data to the 2022 filing, creating a timeline error. The notional amount of $2.56 billion is not mentioned in the ground truth, making it an unsupported addition. (2) The quantitative inaccuracies are critical: assigning the $251 million fair value to 2022 instead of 2023 distorts the evolution of exposure. The absence of any fair value in 2022 and its appearance in 2023 is a key point in the correct narrative, which the LLM reverses. The claim about the notional amount lacks corroboration from the original answer. (3) The reasoning partially captures the strategic shift—elimination of forward swaps by 2024 is correctly noted—but misinterprets the hedge accounting evolution. The LLM frames the 2022–2023 swaps as cash flow hedges (which aligns with ground truth), but fails to mention the shift to fixed-to-floating swaps as fair value hedges in 2024, a crucial element of the strategy change. Instead, it concludes with a generic 'hedge-while-needed' interpretation, missing the deeper shift from managing forecasted issuance (cash flow hedges) to managing existing debt (fair value hedges). (4) Contextual relevance is high because the answer addresses the core question about exposure evolution and risk management implications. However, due to incorrect dates, invented numbers, and incomplete synthesis of hedge accounting changes, the correctness score is limited to 5—partially correct but with significant factual and reasoning flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 521,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "- **Fiscal 2022:** The 5.000 % senior notes that mature in April 2030 carried an outstanding principal of **$606 million**.  \n- **Fiscal 2023:** The same tranche was still shown at **$606 million** (see the 2023 balance sheet table – “5.000 % notes due April 2030, $606 million”)【page_81】.  \n- **Fiscal 2024:** The amount remained **$606 million** (the 2024 table lists the same $606 million for the April 2030 notes)【page_81】.\n\n**Interpretation:** AVGO has kept the exposure to this 5 % note unchanged over three consecutive years, indicating that the company is not actively refinancing or retiring this particular issuance. Instead, it is using newer, higher‑rated issuances and term‑loan repayments to manage overall leverage, while preserving a stable, long‑dated fixed‑rate component in its debt portfolio. This reflects a deliberate debt‑management strategy that emphasizes diversification of maturities and rates rather than frequent turnover of existing senior‑note obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, AVGO's exposure to the 5.000% notes due April 2030 was $1,086 million in 2022, decreasing to $606 million in both 2023 and 2024. However, the LLM claims the amount was $606 million in all three years, including 2022, which contradicts the ground truth. This misrepresents the trend entirely—instead of showing a reduction from 2022 to 2023, the LLM implies no change over the entire period. (2) The quantitative accuracy is severely compromised: the 2022 figure is off by $480 million, a significant error. While the 2023 and 2024 figures match the ground truth, the incorrect 2022 value undermines the entire analysis. The LLM also cites 'page_81' as a source, but either misreads or misrepresents the data from that page. (3) The multi-hop reasoning is flawed because the model fails to detect the decrease from 2022 to 2023, leading to an incorrect interpretation. The conclusion that AVGO 'kept exposure unchanged' and is not actively retiring the debt contradicts the ground truth, which indicates a deliberate reduction. The reasoning about using 'newer, higher-rated issuances' may be contextually plausible but is unsupported here due to the incorrect premise. (4) Contextual relevance is moderate—the answer addresses the right company, debt instrument, and time frame, and attempts interpretation. However, due to the major factual error in the 2022 value, the overall correctness score is low. The qualitative reasoning is internally consistent but based on false data, limiting its validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 443,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "- 2022 10‑K – UPS noted that the $276 million debentures were originally issued at 8.375 % and, on April 1 2020, the coupon was permanently reduced to 7.620 % for the remaining ten‑year term ending April 1 2030; the filing gave only the rate change and maturity, with no detailed redemption language【page_118】.  \n\n- 2023 10‑K – The note was restated to emphasize the 7.620 % coupon and to spell out the redemption mechanics: the debentures may be redeemed in whole or in part at UPS’s option at the greater of (i) principal + accrued interest or (ii) the present value of remaining payments discounted at a benchmark Treasury yield + 5 bps (plus accrued interest); interest continues to be paid semi‑annually and there is no sinking‑fund requirement【page_105】.  \n\n- 2024 10‑K – The disclosure remained unchanged from 2023, reiterating the $276 million principal, 7.620 % rate, April 1 2030 maturity, semi‑annual interest, and the same optional‑redemption formula and lack of a sinking fund【page_108】.  \n\nThus, UPS’s treatment evolved from simply reporting the rate cut and maturity in 2022 to adding full redemption terms in 2023, and then maintaining that same detailed description in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: All numbers, dates, and percentages are accurate — $276 million principal, 7.620% interest rate, April 1, 2030 maturity, reduction from 8.375% to 7.620% effective April 1, 2020, and redemption terms involving Treasury yield plus 5 bps. These match the original answer exactly. (2) Completeness: The response addresses all parts of the question — evolution of interest rates, redemption terms, and maturity structure across 2022–2024. It correctly notes that in 2022, only the rate change and maturity were disclosed, while redemption details were added in 2023 and maintained in 2024. (3) Entity accuracy: UPS is correctly identified, all fiscal years (2022–2024) are properly referenced, and the debenture terms are accurately attributed to the correct filings. (4) Reasoning: The multi-hop synthesis across three years of 10-Ks is sound. The LLM correctly infers the evolution in disclosure depth — from minimal to detailed — and identifies that the actual terms (rate, maturity, redemption) remained stable after 2020, with only reporting clarity improving. (5) Semantic equivalence: The LLM conveys the same core conclusion as the ground truth — that the debenture’s structure is stable and disclosures became more transparent over time. Minor wording differences (e.g., 'permanently reduced' vs 'had been reduced') do not affect factual meaning. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1570,
        "completion_tokens": 411,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "In the 2022 Form 10‑K Amgen said Olpasiran is an siRNA that lowers lipoprotein (a) and is being studied in **Phase 2** trials for atherosclerotic cardiovascular disease (ASCVD); the company already held composition‑of‑matter patents on the compound in the United States and Europe that are expected to expire in **2036**. The 2023 filing notes that the program has moved into **Phase 3** studies while retaining the same Lp(a)‑lowering, ASCVD therapeutic focus and the same 2036 patent expiration dates. In the 2024 filing the candidate is again listed in the **Phase 2** pipeline table (still a cardiovascular‑disease program) and the patent table continues to show U.S. and European patents expiring in 2036, indicating that Amgen’s strategic positioning remains centered on Lp(a) reduction and that its intellectual‑property protection has been in place throughout the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but introduces a critical factual error regarding clinical phase progression. According to the ground truth, Olpasiran remained in Phase 2 through 2024, with no mention of advancement to Phase 3. However, the LLM claims that in the 2023 filing, the program 'moved into Phase 3 studies,' which contradicts both the original answer and the stated 2024 status of still being in Phase 2. This is a major error in clinical development timeline. The patent expiration dates (2036) and geographic coverage (U.S. and Europe) are correctly reported across all years, satisfying quantitative accuracy for IP details. (2) Quantitatively, all numbers—specifically the 2036 patent expiry—are accurate and consistently reported. There are no calculation errors. Format variations are acceptable and correctly interpreted. (3) The multi-hop reasoning is partially sound: the model correctly links therapeutic focus (Lp(a) lowering), clinical indication, and IP protection across years. However, it fails in synthesizing the correct phase progression over time, incorrectly asserting a move to Phase 3 in 2023 and then reverting back to Phase 2 in 2024, which undermines the logical consistency of the development trajectory. The ground truth shows a stable Phase 2 status through 2022–2023, with only a broadening of indication in 2024 from ASCVD to general cardiovascular disease—this nuance is missed. (4) Contextual relevance is high, as the response addresses all dimensions of the question: therapeutic focus, clinical phase, and IP timeline. However, due to the incorrect phase progression claim, the qualitative accuracy and overall correctness are significantly reduced despite strong performance on IP and contextual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 484,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "In the 2022 Form 10‑K, Tampax was mentioned only as one of the “major brands” in the combined **Baby, Feminine & Family Care** segment (listed together with Bounty, Charmin, Puffs, etc.) and was not singled out as a market‑leader. By the 2024 filing, Tampax is still in the same segment but the MD&A now describes the **Feminine‑care sub‑category** as being “primarily behind our Always and Tampax brands with over 25 % global market share,” positioning Tampax as a top‑ranked, flagship brand rather than just another line‑item.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Tampax's positioning within P&G’s segment structure and correctly identifies it as gaining more prominence by 2024, particularly through being named alongside Always with a '25% global market share'—a detail that aligns with the strategic emphasis in the ground truth. However, there are notable discrepancies: (1) The LLM claims that in 2022, Tampax was not singled out as a market leader and was only listed among major brands, but the ground truth indicates it was already grouped with Always and Bounty as a key brand in 2022, implying established prominence. (2) The LLM skips any mention of the 2023 reclassification to 'Feminine Care (Adult Incontinence, Menstrual Care)', which is a key multi-hop element in the original answer showing transitional labeling. (3) The 25% global market share figure is introduced in the LLM answer but is not present in the ground truth, raising concerns about hallucination or unsupported inference—this affects quantitative accuracy despite the number being plausible. (4) While the segment name 'Baby, Feminine & Family Care' is correctly noted for 2022 and 2024, the LLM does not reflect the 2023 segment restructuring, missing a critical step in the evolution. (5) The qualitative shift from 'line-item' to 'flagship' is interpretively stronger than the ground truth, which emphasizes consistency in strategic emphasis with only minor labeling changes. Thus, while the LLM captures directional movement and correct segments, it omits key transitional details, introduces unverified data, and overstates the shift in brand status. Semantic equivalence is partially achieved but with significant gaps in completeness and factual fidelity across the 2022–2024 timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 476,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "MetLife’s 2022 filing explains that whenever it bought non‑agency RMBS or CMBS that had not yet been evaluated by the NAIC, the company applied an **internally‑developed NAIC designation** until the regulator issued an official one (page 101). The 2023 and 2024 filings repeat the same policy (pages 94 and 84) but no longer highlight any material amount of such internally‑rated securities, implying that the share of newly‑acquired RMBS/CMBS needing a temporary internal label has been shrinking. This multi‑year trend shows that NAIC designations have become more broadly available and that MetLife’s acquisition strategy is increasingly focused on securities already covered by NAIC ratings, reducing its reliance on internal designations.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core practice—MetLife applying internally-developed NAIC designations to non-agency RMBS and CMBS when NAIC evaluations are not yet available—and accurately cites the continuity of this policy across 2022, 2023, and 2024 filings. It also correctly references the relevant pages (101, 94, 84), indicating attention to source detail. However, the key error lies in the interpretation of the trend: the LLM claims that the absence of 'material amount' disclosures in 2023 and 2024 implies a shrinking reliance on internal designations and a shift toward NAIC-covered securities. This contradicts the ground truth, which states that the continued disclosure of the same policy indicates ongoing acquisition activity in newly issued or less frequently evaluated securities, not a reduction. The ground truth makes no claim about decreasing volume or changing strategy—only that the practice persisted, suggesting sustained reliance on internal assessments due to lagging NAIC evaluations. The LLM introduces an unsupported inference about shrinking reliance and improved NAIC availability, which is not substantiated by the original answer or implied in the filings. This misrepresents the multi-year trend and mischaracterizes MetLife’s strategy. While entities, years, and qualitative mechanisms are correctly identified, the reasoning fails in synthesizing the correct implication of policy repetition. Quantitative accuracy is high because no incorrect numbers are introduced (and none are present in the original answer), but the qualitative reasoning is flawed in its conclusion, reducing overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 448,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "- In fiscal 2022 Accenture bought 12.2 million Class A shares for about **$4.1 billion** and, after a September‑2022 board increase, had **≈ $6.13 billion** of aggregate repurchase authority available (page 94).  \n- By fiscal 2024 the company had already used most of the **$2.69 billion** remaining authorization (share purchases of **$4.5 billion** for the year, including $605 million in Q4) and the board added another **$4 billion** on September 25 2024, raising total outstanding authority to **≈ $6.69 billion** (page 39‑40).  \n\n**Trend:** Accenture’s buy‑back activity has been steady and sizable, depleting its existing authorization each year and prompting the board to raise the repurchase ceiling, indicating a clear, ongoing capital‑return strategy that relies on regular open‑market share repurchases and periodic increases in repurchase authority to return cash to shareholders.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers, particularly in fiscal 2022 share repurchase activity and available authorization. The ground truth states that in fiscal 2022, Accenture had $3.13 billion in aggregate available authorization — not $6.13 billion as claimed by the LLM. The LLM incorrectly states that Accenture bought $4.1 billion in shares in fiscal 2022; this figure is not supported by the ground truth, which does not specify total repurchases for that year, only the authorization. Additionally, the LLM claims $4.5 billion in share purchases in fiscal 2024, but the ground truth only confirms $605 million in Q4 and does not provide full-year totals, making this a speculative extrapolation. (2) The only correct quantitative elements are the $605 million Q4 2024 purchase, the $2.69 billion available authorization as of August 31, 2024, and the $4 billion increase on September 25, 2024, bringing total authority to $6.69 billion — these match the ground truth. However, the incorrect attribution of $4.1B repurchases in 2022 and $6.13B authorization undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a pattern of depleting authorization and board replenishment, and links this to a capital return strategy. However, it introduces unsupported data points (e.g., 12.2 million shares, $4.1B spent in 2022) not present in the ground truth, suggesting possible hallucination or misattribution. (4) Despite the factual errors, the answer addresses all parts of the question — evolution over time and strategic implication — and the final interpretation about a consistent capital return strategy aligns with the ground truth. Hence, contextual relevance is high, and qualitative reasoning is reasonable but based on flawed inputs. Correctness score is limited by major quantitative inaccuracies that distort the factual narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 525,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "- **2022 10‑K:** Broadcom’s Business section lists “industrial fiber optics” together with optocouplers, motion encoders, LEDs and Ethernet ICs as part of the **general industrial and automotive markets** it serves.  \n- **2023 10‑K:** The same product appears in the “Factory Automation, Renewable Energy and Automotive Electronic Solutions” paragraph, again grouped with other industrial‑automation components, showing it is now being framed as a component of a broader **factory‑automation/industrial‑automation portfolio**.  \n- **2024 10‑K:** The product is still highlighted in the “Industrial” end‑market table as a distinct offering (“industrial fiber optics”), confirming that Broadcom continues to maintain a **steady, niche presence** in this segment rather than launching a new push.  \n\n**Strategic implication:** Across the three years Broadcom’s positioning of industrial fiber‑optic components has remained consistent—treated as a specialized but integral part of a diversified industrial product suite—indicating the company’s strategy is to keep a focused, margin‑positive foothold in the industrial end market rather than making it a primary growth driver.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities—Broadcom (AVGO), industrial fiber optics, and the correct years (2022, 2023, 2024)—are correctly identified. The product groupings (optocouplers, motion encoders, LEDs, Ethernet ICs) match across years. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense, but all factual assertions about product categorization and positioning are consistent with the original answer. (3) The multi-hop reasoning is sound: the LLM correctly traces the evolution of industrial fiber optics across three 10-K filings, noting increasing strategic framing—from general industrial use in 2022, to alignment with factory automation in 2023, to continued niche presence in 2024. The conclusion about a 'focused, margin-positive foothold' is a valid interpretation of the consistent but not expanding emphasis. (4) The only minor gap is that the LLM does not explicitly mention the 2024 linkage to renewable energy and automotive electronics as highlighted in the original answer, nor the inclusion of more specific components like Ethernet PHYs and camera microcontrollers. However, it does reference 'automotive electronic solutions' in 2023 and implies continuity into 2024, which partially captures this. Overall, the answer is semantically equivalent with only slight omission of detail in the final year’s expansion of applications. Thus, correctness is high but not perfect—justifying a 9 rather than 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 433,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "In the 2022 and 2023 Form 10‑K filings UPS described SurePost as a residential‑ground offering for non‑urgent, lightweight parcels that “offers the consistency and reliability of the UPS ground network, with final delivery often provided by the U.S. Postal Service.” The 2024 filing repeats that description for the 2024 year, but adds that “through 2024, final delivery was often provided by the United States Postal Service (‘USPS’). Beginning January 1 2025, in order to have more control … we have insourced this product,” indicating UPS will bring the last‑mile delivery in‑house and end its reliance on USPS.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) It correctly states that from 2022 to 2024, UPS SurePost relied on the U.S. Postal Service for final delivery, with consistent descriptions in the 10-K filings for those years. The key strategic change—insourcing final delivery beginning January 1, 2025—is accurately reported. (2) All dates (2022, 2023, 2024, and January 1, 2025) are correct and match the original answer; no numerical values require calculation, but the temporal sequence is precise. (3) The multi-hop reasoning is sound: the model synthesizes information across multiple years of 10-K filings to show continuity and then identifies the forward-looking change announced in the 2024 filing. (4) The answer conveys the same semantic meaning as the original, including the rationale for insourcing (greater control over service), and correctly characterizes the shift from reliance on USPS to an in-house model. Wording differs slightly but maintains full factual equivalence. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 308,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "- **2022:** Amgen reported **13 Phase 3 programs**. During the year three programs received FDA/EC approvals, four new candidates entered Phase 3, and one program was terminated【page_25】.  \n\n- **2023:** The count rose to **18 Phase 3 programs** (the filing notes the increase but does not list specific milestones for the year)【page_26】.  \n\n- **2024:** By the end of the year Amgen had **24 Phase 3 programs**. Growth came from **five Horizon‑acquired programs**, **three newly‑initiated Phase 3 studies**, **one FDA approval**, and **one program that concluded**【page_26】.  \n\n**What this shows:** Over the three‑year span Amgen expanded its late‑stage pipeline by +11 programs (a ≈85 % increase), moving more candidates into the pivotal stage through both internal initiations and strategic acquisitions, while also converting some programs to approvals. This pattern reflects an R&D strategy that emphasizes pipeline breadth, acquisition‑driven diversification, and accelerated progression of assets toward market launch.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the number of Phase 3 programs for 2022 (13), 2023 (18), and 2024 (24), matching the ground truth. It also accurately notes the increase to 25 programs by February 4, 2025, in the 2024 filing, though this specific future date is omitted in the LLM answer—this is a minor omission but not a factual error. The LLM correctly identifies the addition of five Phase 3 programs from the Horizon Therapeutics acquisition, aligning with the ground truth. It also accurately describes internal development (three new initiations) and program conclusions. (2) Quantitatively, all numbers are correct: 13 → 18 → 24 is accurate; the +11 increase and ≈85% growth calculation are mathematically sound (11/13 ≈ 84.6%, rounded to 85%). The LLM correctly attributes growth to five Horizon programs and three new studies. (3) The reasoning is strong: it synthesizes internal development, external acquisition, approvals, and terminations into a coherent R&D strategy narrative. It correctly infers that the expansion reflects a strategy of pipeline breadth and acquisition-driven diversification. The only minor gap is not explicitly mentioning that the 2024 filing notes 25 programs (not 24) as of February 2025, which slightly underrepresents the latest count but does not invalidate the trend. (4) The answer is contextually excellent—directly addresses quantity, milestones, and strategic implications. Wording differs from the original but maintains semantic equivalence. The conclusion about R&D strategy is well-supported and aligned with the evidence. Scored 9/10 due to the omission of the 25-program update in the 2024 filing, but all other aspects are factually and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 470,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "- **Fiscal 2022 (and the 2023 filing)** – The Amended 2010 Share Incentive Plan authorized a maximum of **127 million** Accenture Class A ordinary shares for awards【page_91】.  \n- **Fiscal 2024** – The plan was expanded to a maximum of **141 million** shares【page_98】.  \n\nThe 14‑million‑share increase shows that Accenture is deliberately enlarging its share‑based compensation pool, signaling a stronger reliance on equity awards to attract, retain and motivate talent while further aligning employee interests with shareholder value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the number of shares authorized in fiscal 2022 (127 million) and the increased amount in fiscal 2024 (141 million), matching the ground truth. It also accurately notes the 14-million-share increase. However, it omits explicit mention that the 141 million was already in effect by fiscal year 2023, stating only that the increase occurred by fiscal 2024. This is a minor omission but does not distort the overall trend.\n\n2) Quantitatively, all numbers are correct: 127 million in 2022 and 141 million in 2024, with a 14 million increase, as confirmed by the ground truth. The format (million vs. 000,000) is semantically equivalent and acceptable.\n\n3) The reasoning is sound: the LLM correctly infers that the increase indicates a strategic expansion in share-based compensation to support talent retention, motivation, and alignment with shareholder value. This aligns with the ground truth's interpretation of Accenture’s strategic emphasis on equity incentives.\n\n4) The answer is contextually relevant and addresses both parts of the question: the evolution of authorized shares and the strategic implication. The only minor gap is the lack of explicit confirmation that the increase was effective in 2023 and carried into 2024, which slightly affects completeness in multi-hop temporal tracking. Otherwise, entity names (Accenture plc, Amended 2010 SIP), fiscal years, and financial terms are accurate. Overall, the answer is factually strong with high semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 417,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "Starbucks said that its existing inventory plus its forward‑purchase commitments would cover its green‑coffee needs **through fiscal 2023** in the 2022 Form 10‑K 【page_12】, **through fiscal 2024** in the 2023 filing (the same language was updated a year later), and **through fiscal 2025** in the 2024 Form 10‑K 【page_12】. The lengthening coverage horizon shows that Starbucks is deliberately building larger inventories and longer‑term contracts to buffer against coffee‑price volatility and supply‑chain disruptions, reflecting a proactive risk‑management approach.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a key factual error in the timeline of Starbucks' projected green coffee supply coverage. According to the ground truth, in fiscal 2022, coverage was projected through fiscal 2023; in fiscal 2023, it extended to fiscal 2025; and in fiscal 2024, it remained through fiscal 2025. However, the LLM incorrectly states that the 2023 filing projected coverage through fiscal 2024, and that the 2024 filing updated it to fiscal 2025. This misrepresents the progression, as the extension from 'through 2023' to 'through 2025' occurred in the 2023 filing, not incrementally. (2) The quantitative accuracy is compromised because the stated durations ('through 2023', 'through 2024', 'through 2025') do not align with the ground truth sequence. The ground truth shows a jump from 2023 to 2025 in the 2023 report, not a stepwise increase. The LLM implies a gradual increase each year, which is incorrect. (3) The multi-hop reasoning is partially sound—the model correctly infers that lengthening coverage indicates proactive risk management and inventory strategy. It synthesizes the concept of forward-purchase commitments and risk mitigation, which aligns with the original answer’s conclusion. (4) Contextual relevance is perfect: the answer addresses both parts of the question—evolution of supply coverage and its implications—and uses appropriate terminology. Despite the incorrect year-by-year progression, the overall strategic interpretation is valid. Hence, correctness is scored 7 due to core accurate facts but significant timeline error; quantitative accuracy is 6 due to incorrect fiscal year projections; qualitative reasoning is 8 due to sound logic despite flawed input; and contextual relevance is 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 475,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "- **2022 – Status quo** – The 2022 filing (Note 5/6) simply describes the UPS/IBT Full‑Time Employee Pension Plan as a non‑contributory, service‑credit plan and does not report any amendment, remeasurement or collective‑bargaining change for the year (see page 92). No special accounting impact for the plan appears in the 2022 net‑periodic‑benefit‑cost tables (page 94).\n\n- **2023 – Collective‑bargaining‑driven amendment** – In the 2023 filing UPS disclosed that, in the third quarter of 2023, Teamsters ratified a new five‑year national master agreement that included wage‑and‑benefit rate increases for Teamsters participants in both the UPS Pension Plan **and the UPS/IBT Full‑Time Employee Pension Plan**. The additional benefit costs were recognized in the year‑end measurement of the plan (see page 82).\n\n- **2024 – Routine actuarial updates, no new amendment** – The 2024 filing again lists the UPS/IBT Full‑Time Employee Pension Plan in the same terms as prior years and shows only the usual annual re‑measurement of assumptions (discount rate, expected return, etc.) that affect all U.S. pension plans. No further amendment or collective‑bargaining change specific to the plan is reported for 2024 (see page 86).  \n\n**Overall evolution:** From 2022 to 2024 the plan moved from a steady‑state position (no amendment or bargaining impact) to a 2023 collective‑bargaining‑driven benefit increase, after which UPS returned to routine actuarial re‑measurements without additional plan amendments.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative and event-specific details, despite correctly identifying the general timeline and structure of events. (1) The most critical error is the omission of the 2022 remeasurement due to the American Rescue Plan Act and the associated $3.3 billion pre-tax gain, which is a central part of the ground truth. Instead, the LLM claims there was 'no amendment, remeasurement or collective-bargaining change' in 2022, directly contradicting the original answer. This is a major factual omission that undermines the correctness of the response. (2) The LLM correctly identifies the 2023 collective bargaining agreement and its impact on benefit costs, aligning with the ground truth regarding the new five-year agreement with the Teamsters and recognition in year-end measurement. However, it fails to mention that this affected the UPS/IBT plan specifically as part of broader pension obligations, slightly weakening precision. (3) For 2024, the LLM correctly notes no new amendments and only routine actuarial updates, which is consistent with the original answer’s statement that there were no structural changes. (4) Multi-hop reasoning is partially sound—the model synthesizes information across years and links collective bargaining to pension impacts—but it fails the essential multi-hop requirement of connecting the 2022 regulatory change (American Rescue Plan Act) to the financial remeasurement and gain, which is a key strategic element in the ground truth. (5) While the qualitative structure (year-by-year evolution) is logical and relevant, and entities like UPS, Teamsters, and the UPS/IBT Full-Time Employee Pension Plan are correctly identified, the absence of the $3.3 billion gain and the mischaracterization of 2022 fatally compromise quantitative and overall correctness. Format variations are not at issue, but missing a major financial figure and event constitutes a severe deficiency. Thus, while contextually relevant and partially accurate in reasoning, the answer is significantly flawed in factual content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1663,
        "completion_tokens": 564,
        "total_tokens": 2227
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "Across the three most recent filings Walmart has kept “Holiday Time” in the same spot – listed among its core private‑label family of brands and identified as the brand that supplies the company’s seasonal merchandise. In the 2022 10‑K (see page 7) the brand appears in the private‑brand roster (“…Great Value, **Holiday Time**, …”), the 2023 filing repeats the same placement (pages 7‑8), and the 2024 filing again lists it alongside Great Value, Mainstays, etc. (pages 7‑8), while the International sections of the 2022 and 2024 reports also cite Holiday Time as a global private brand (page 9). This continuity shows that Walmart treats Holiday Time as a dedicated seasonal private label, using it to capture holiday‑related demand at everyday‑low‑price points and reinforcing the company’s broader strategy of leveraging distinct private brands for specific merchandise categories, especially seasonal items.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entity identification and document references (e.g., correct fiscal years, brand names, and page numbers cited in 10-Ks), and there are no numeric inaccuracies since no calculations or financial figures are involved—thus earning a 10 in quantitative accuracy. The answer correctly identifies that 'Holiday Time' is consistently listed among Walmart’s private brands across fiscal years 2022–2024 and notes its association with seasonal merchandise. However, it misses a key qualitative shift highlighted in the ground truth: the strategic repositioning of 'Holiday Time' within a restructured 'seasonal merchandise' category under General Merchandise in fiscal 2024. The LLM portrays the brand’s placement as static ('kept in the same spot', 'continuity'), which contradicts the ground truth indicating an evolution toward more structured, strategic seasonal planning. This misrepresents the multi-hop insight—the progression from general listing to explicit strategic categorization—which is central to the question. While the LLM recognizes Holiday Time's role in seasonal offerings, it fails to detect or convey the organizational and strategic shift in fiscal 2024, resulting in incomplete reasoning and a lower qualitative accuracy score. Contextual relevance is high because the response stays on topic and supports claims with document evidence, but the lack of recognition of strategic evolution limits its correctness. Hence, the overall correctness score is 6: partially correct with significant omission of a critical strategic development.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 436,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "- In the 2022 filing the fair‑value of mutual‑fund equity securities held in the non‑U.S. defined‑benefit plans was **$239  thousand** (‑$4,954 Level 1 + $234,339 Level 2).  \n- In 2023 that balance fell to **$196  thousand** (‑$7,430 + $188,796).  \n- By 2024 it rose to **$274  thousand** (‑$20,205 + $253,494).\n\nThe dip in 2023 followed by a sizable rebound in 2024 indicates that Accenture is re‑allocating more capital to mutual‑fund equity securities after a temporary reduction, suggesting a renewed strategic emphasis on this equity‑type asset class within its pension‑plan investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values. The original answer states that ACN's investment in mutual fund equity securities was $239.293 million in 2022, $196.226 million in 2023, and unchanged in 2024. However, the LLM incorrectly reports these figures as $239 thousand, $196 thousand, and $274 thousand—off by a factor of 1,000. This is a critical quantitative error that completely misrepresents the scale of the investments. (2) The calculation and trend analysis are therefore invalid. The LLM claims a rebound to $274 thousand in 2024, but the ground truth states the amount remained at $196.226 million, showing no increase. The conclusion that there was a 'sizable rebound' and renewed strategic emphasis is directly contradicted by the data. (3) The multi-hop reasoning is flawed because the model fails to correctly extract and compare the values across years. It also introduces Level 1 and Level 2 fair value hierarchy details not mentioned in the question or required for the answer, which distracts from the core trend analysis. (4) While the answer attempts to address the evolution over time and interpret strategic intent (thus maintaining some contextual relevance), the severe numerical inaccuracies and resulting incorrect interpretation of the trend undermine both the qualitative and quantitative validity of the response. The conclusion is the opposite of what the data supports.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 401,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "Starbucks repeatedly notes that the price of its green‑coffee beans is “subject to significant volatility” and that “price is also impacted by trading activities in the Arabica coffee futures market, including hedge funds and commodity‑index funds” (2022 10‑K p.12; 2023 10‑K p.12; 2024 10‑K p.12). In fiscal 2022 the company said its fixed‑price and price‑to‑be‑fixed purchase commitments, together with forward, futures and collar contracts, would secure supply “through fiscal 2023,” whereas the 2024 filing extends that expectation to “through fiscal 2025,” reflecting a deeper, longer‑dated hedging program. This progression shows Starbucks continually acknowledges exposure to index‑fund‑driven futures price swings but is strengthening its risk‑management posture by expanding hedging instruments and lengthening the horizon of its purchase commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Starbucks' exposure to green coffee price volatility due to commodity index funds and futures market activity is consistently cited across 2022–2024 10-Ks. The evolution of hedging commitments from covering through fiscal 2023 (in 2022) to through fiscal 2025 (in 2024) is accurately reported. (2) Quantitative accuracy is perfect: fiscal years (2022, 2023, 2025), contract types (fixed-price, price-to-be-fixed, futures, collars), and timeline progression are all factually correct. Format variations (e.g., 'fiscal 2023' vs 'through fiscal 2023') are semantically equivalent. (3) Multi-hop reasoning is sound: the LLM synthesizes disclosures across three years of filings, correctly infers the extension of hedging horizon as evidence of a maturing risk management strategy, and links futures market influences (including index funds) to Starbucks’ risk exposure. (4) The only minor shortcoming is that the LLM does not explicitly mention 'confidence in managing long-term exposure'—a nuance in the original answer—but it does convey the same conclusion by stating Starbucks is 'strengthening its risk-management posture.' Wording differs slightly but the semantic meaning and factual content are equivalent. No factual errors or omissions affect the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 381,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "- **Fiscal 2022:** The 2022 10‑K listed the April 2019 senior‑note series that included the 3.625 % notes due October 2024 with an outstanding principal of roughly **$622 million**.  \n- **Fiscal 2023:** The same series was still on the balance sheet at the end of FY 2023, showing **$622 million** outstanding (see the “October 29, 2023” column in the debt schedule [page 81]).  \n- **Fiscal 2024:** By the end of FY 2024 the balance had been eliminated – the “November 3, 2024” column shows a dash (zero) for the 3.625 % notes due Oct 2024, indicating the notes were fully repaid (page 81).\n\n**Interpretation:** AVGO kept the $622 million of 3.625 % notes through FY 2022‑23 and then retired the entire issue in FY 2024. This deliberate payoff of a near‑term, low‑coupon obligation demonstrates a focused near‑term debt‑management strategy aimed at reducing outstanding debt, tightening the maturity profile and preserving liquidity after the VMware merger.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $622 million outstanding in 2022 and 2023, and full retirement by 2024 (indicated by a dash in the debt schedule), which aligns with the original answer. Dates (October 2024 maturity), percentages (3.625%), and fiscal years are correctly cited. (2) The answer is complete, addressing both the evolution of AVGO's exposure across 2022–2024 and the implications for near-term debt management. (3) Entity accuracy is perfect: correct company (AVGO), correct note series, correct fiscal years, and accurate reference to the debt schedule in the 10-K filings (page 81). (4) The reasoning is sound and adds value: it correctly infers that the retirement of the notes before maturity reflects a deliberate strategy, and even enriches the interpretation by linking it to post-VMware merger liquidity management, which is contextually plausible and consistent with the ground truth’s conclusion. The multi-hop synthesis—tracking the same debt instrument across three fiscal years and interpreting the pattern—is executed flawlessly. Semantic equivalence is achieved with enhanced clarity and appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 343,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "From 2022 to 2024 Mastercard steadily raised the amount of credit‑risk mitigation it requires of customers that fall short of its internal standards – adding more cash collateral, letters of credit and other guarantees and intensifying its regular monitoring of those arrangements. At the same time the company’s settlement exposure grew (gross exposure rose from $64.9 billion in 2022 to $78.4 billion in 2024), but the net exposure was kept in check by larger mitigation buffers (risk‑mitigation arrangements increased from $9.2 billion to $13.5 billion, leaving net exposure up from $55.7 billion to $64.9 billion). These steps were taken as regulatory scrutiny intensified – the FTC Durbin‑Amendment consent agreement (finalized 2023), a DOJ civil investigative demand (2023), ongoing U.S. liability‑shift and ATM‑surcharge litigation, and large U.K. and European merchant claims – prompting Mastercard to expand its risk‑mitigation framework and to record higher accruals for litigation‑related settlement obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in quantitative details not present in the original answer. The original ground truth does not mention specific dollar figures such as $64.9 billion gross exposure in 2022, $78.4 billion in 2024, or risk mitigation increasing from $9.2 billion to $13.5 billion. These numbers are entirely fabricated and not supported by the source knowledge graph. The calculation of net exposure (e.g., $64.9B - $9.2B = $55.7B) is mathematically correct but based on false inputs, making the entire quantitative framework invalid. The original answer emphasizes Mastercard's consistent risk mitigation framework and monitoring practices but does not provide any numerical data on exposure trends. On qualitative aspects, the LLM correctly identifies key regulatory developments: the FTC consent agreement related to the Durbin Amendment (2023), DOJ scrutiny, and ongoing litigation including U.S. liability-shift claims and European antitrust concerns. It also correctly notes that Mastercard responded by reinforcing risk mitigation and increasing litigation accruals, which aligns with the original's description of refining methodologies and maintaining controls under pressure. However, the LLM incorrectly implies a systematic increase in required collateral across customers, while the original states that arrangements are based on individual risk assessments without indicating a broad tightening. The answer synthesizes regulatory and litigation risks appropriately and maintains contextual relevance by addressing both credit risk mitigation and settlement exposure evolution. Despite correct identification of regulatory bodies and legal issues, the inclusion of fabricated financial data severely undermines factual correctness, warranting a low quantitative accuracy score and a partial qualitative score for correct entity and event mapping. The overall correctness is limited to the non-numerical, descriptive elements, resulting in a score of 4 out of 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1611,
        "completion_tokens": 539,
        "total_tokens": 2150
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "- In the 2022 Form 10‑K the company only flagged that “some of our products are used with drug‑delivery or companion‑diagnostic devices that have their own regulatory, manufacturing and other risks” (p. 34), without describing any specific compliance or post‑marketing duties.  \n\n- The 2023 filing expanded that risk dramatically, stating that Amgen must continuously collect user‑complaints, adverse‑event reports and device‑malfunction data, submit periodic REMS assessments, and comply with FDA‑mandated post‑marketing studies or labeling enhancements (e.g., the Neulasta Onpro kit actions) and that failure could trigger inspections, warning letters or product withdrawal (pp. 52‑55).  \n\n- By the 2024 filing the disclosure further stresses that regulatory agencies may require contemporaneous approval of the device and the drug, impose additional post‑marketing commitments, and hold Amgen and its third‑party device suppliers accountable for ongoing compliance, safety‑oversight and risk‑management programs, making device‑related compliance, post‑marketing obligations and safety monitoring a central, continuously‑evolving component of its regulatory risk profile (pp. 50‑54).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All years (2022, 2023, 2024) are correctly referenced, and the evolution of Amgen's regulatory risk disclosures is accurately portrayed. The 2022 disclosure correctly notes general risks without specific compliance or post-marketing obligations. In 2023, the LLM correctly identifies the increased focus on post-marketing requirements such as adverse event reporting, REMS assessments, and confirmatory studies, citing Neulasta Onpro as an example—consistent with the ground truth’s emphasis on Repatha and LUMAKRAS. In 2024, the LLM accurately reflects the heightened regulatory expectations, including joint drug-device approval, ongoing compliance, and accountability for safety oversight. (2) There are no numeric values to verify, so quantitative accuracy is not compromised; all references to page numbers (e.g., pp. 34, 52–55, 50–54) are plausible and consistent with typical 10-K structures, though not part of the ground truth—these do not detract from correctness as they support citation rather than factual claims. (3) The multi-hop reasoning is sound: the LLM synthesizes changes across three years, correctly identifying the progression from general risk awareness to detailed post-marketing obligations and integrated safety oversight. The mention of third-party suppliers and contemporaneous approval adds nuance not explicitly in the ground truth but is semantically consistent and plausible. (4) The only reason for not scoring a 10 is minor: the ground truth specifically names Repatha and LUMAKRAS as examples of conditional approvals requiring confirmatory studies in 2023, while the LLM cites Neulasta Onpro, which relates more to device malfunction or labeling changes. This is a slight deviation in example specificity but does not invalidate the overall correctness. Otherwise, the answer is complete, contextually relevant, and factually aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 534,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "- In FY 2022 Walmart’s “Parent’s Choice” appeared in the private‑brand list that accompanies its three strategic merchandise units – Grocery (which the filing defines as including “baby products”), General merchandise and Health & wellness 【page_7】.  \n- The FY 2023 filing repeats the same private‑brand roster and the same three‑unit structure, keeping Parent’s Choice under the Grocery consumables umbrella 【page_7】【page_8】.  \n- By FY 2024 the brand is still listed among the U.S. private brands in the Grocery unit, but it is also highlighted in the International segment’s global private‑brand lineup (alongside Equate, George, etc.), showing that Walmart has extended Parent’s Choice from a domestic baby‑care label to a worldwide low‑price option for baby and other consumables 【page_7】【page_8】.  \n\nTogether, these changes reveal that Walmart consistently positions Parent’s Choice as a core low‑price private label for baby and consumable items, and that its role has broadened from a U.S.‑only grocery‑category brand to a globally‑leveraged component of Walmart’s baby‑care portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the presence of 'Parent's Choice' in Walmart's private brand portfolio across fiscal years 2022, 2023, and 2024 and accurately associates it with the Grocery unit, which includes baby products. The dates and entity names (Walmart, Parent's Choice, Grocery unit) are correct, and there are no numerical inaccuracies—thus quantitative accuracy is high. (2) However, the key factual error lies in the claim that in FY2024, 'Parent’s Choice' was included in the International segment’s global private-brand lineup 'alongside Equate, George, etc.' This is not supported by the ground truth, which makes no mention of international expansion or global branding efforts for 'Parent’s Choice.' The original answer emphasizes consistent domestic positioning within the Grocery unit with increasing categorical clarity—not international extension. This is a significant qualitative error that undermines the conclusion. (3) The multi-hop reasoning is partially sound: the model correctly tracks the brand across three years and synthesizes its categorization within merchandise units. However, it introduces an unsupported inference about globalization of the brand, which is not present in the ground truth and represents a failure in reasoning fidelity. (4) While the core idea of Walmart reinforcing 'Parent’s Choice' as a low-cost brand in baby care aligns with the original answer, the added narrative about international expansion distorts the strategic interpretation. Thus, correctness is reduced to 6 due to a major factual overreach, despite accurate dates, entities, and structural understanding. Contextual relevance remains high because the response directly addresses the evolution and strategic positioning as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 482,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "- **2022 10‑K:** Tesla’s filing lists a “Thirty‑Fifth Supplemental Indenture, dated April 14 2015, … 4.70 % Solar Bonds, Series 2015/C24‑10” as an exhibit (see Exhibit 4.35)【page_100】.  \n\n- **2023 10‑K:** The same bond appears again in the exhibit schedule – a “Thirty‑Fifth Supplemental Indenture … 4.70 % Solar Bonds, Series 2015/C24‑10” (Exhibit 4.35)【page_102】, indicating the series was still outstanding and required disclosure.  \n\n- **2024 10‑K:** The exhibit tables for 2024 (pages 97‑101) no longer contain any reference to Series 2015/C24‑10, suggesting the bond has been retired, repaid, or otherwise removed from Tesla’s active financing portfolio.  \n\n**Implication:** Over the three‑year span Tesla moved from actively reporting the 4.70 % Solar Bonds (Series 2015/C24‑10) as an outstanding instrument in 2022 and 2023 to omitting it in 2024, indicating a gradual winding down of that particular solar‑bond financing and a possible shift toward newer or alternative solar‑project funding structures.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct details but fundamentally misrepresents the evolution of Tesla's 4.70% Solar Bonds, Series 2015/C24-10 across 2022–2024, leading to an incorrect conclusion. (1) Quantitatively, the dates (April 14, 2015), bond name, and exhibit numbers (4.35) are accurately cited for 2022 and 2023, and the absence in 2024 filings is correctly observed. These factual references are precise and match the ground truth. (2) However, the qualitative reasoning is flawed: the LLM interprets the omission in the 2024 exhibit list as evidence of bond retirement or winding down, while the ground truth states that Tesla *continued* to reference the bond in 2024 within a broader historical context of solar financing, indicating ongoing strategic relevance, not retirement. The LLM fails to recognize that absence from an exhibit list does not imply financial retirement—especially when the bond is still referenced contextually in disclosures. (3) The multi-hop reasoning is unsound: instead of synthesizing the consistent use of the bond structure as part of a recurring securitization model (as the ground truth emphasizes), the LLM draws an unsupported conclusion about a strategic shift based solely on exhibit presence/absence. (4) This results in a major factual error in interpretation, despite some accurate data points. The conclusion about 'winding down' contradicts the ground truth's indication of a matured, scalable, and consistently used financing strategy. Thus, while numbers and dates are correct (justifying a moderate quantitative score), the core answer is factually and logically incorrect in its synthesis and implication, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 460,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "- **2022 10‑K:** Broadcom presented the Security Insights Platform as a stand‑alone mainframe‑security offering that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps… This data is available for use with in‑house tools for security information and event management” (see 2022 page 10).  \n\n- **2023 10‑K:** The same capability is listed under the Mainframe Software portfolio as “Security Insights Code programs,” indicating it is now packaged as part of Broadcom’s broader code‑program suite rather than a separate product, and is positioned to work alongside the company’s other enterprise‑security tools.  \n\n- **2024 10‑K:** The description remains the same – “Security Insights Code programs” appears again in the Mainframe Software table (2024 page 8) – showing the platform has been fully integrated into Broadcom’s mainframe‑software ecosystem, with continued emphasis on mainframe risk assessment but with a stronger focus on integration into the overall enterprise‑security toolchain.  \n\nThus, across 2022‑2024 the Security Insights Platform evolved from a distinct, SIEM‑oriented product to a component of a broader “Security Insights” code‑program suite that is tightly integrated with Broadcom’s enterprise security portfolio while maintaining its core focus on mainframe risk assessment.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its factual content and captures the core evolution described in the ground truth, particularly the consistent focus on mainframe risk assessment and increasing emphasis on integration with enterprise security tools. All cited years (2022, 2023, 2024) and document references (e.g., page numbers) align with the expected context, and there are no numerical inaccuracies—though no calculations were involved, so quantitative accuracy is high by default. The answer correctly identifies the platform’s SIEM integration in 2022 and its continued presence in later years. However, the LLM introduces a claim not present in the ground truth: that in 2023 the platform was rebranded or repackaged as 'Security Insights Code programs' and integrated into a broader code-program suite. The original answer does not mention this rebranding or structural change, only a subtle shift in narrative emphasis toward integration. This represents a significant interpretive leap not supported by the source, affecting qualitative accuracy. While the overall trajectory—from standalone tool to integrated component—is plausibly inferred, the specific product packaging detail is unsupported and risks misrepresenting the evolution. The reasoning is otherwise sound and addresses both parts of the question: integration with enterprise tools and emphasis on mainframe risk. The contextual relevance is high, as the response directly engages with the multi-hop task across three years and synthesizes positioning changes. Despite the overinterpretation, the core message aligns with the ground truth’s conclusion about maturing integration narrative, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1625,
        "completion_tokens": 463,
        "total_tokens": 2089
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "Across 2022, 2023 and 2024 Mastercard’s charter continued to describe Class A stock as “one vote per share” with “dividend rights” (see the Classes of Capital Stock tables in the 2022 filing [page 99] and the 2023 and 2024 filings [pages 99 and 92]). The voting and dividend attributes of Class A shares did not change during the three‑year span. This steady‑state treatment reflects Mastercard’s deliberate dual‑class capital‑structure strategy: it preserves the voting power of public investors and the Mastercard Foundation while consistently providing them the same dividend entitlement, underscoring a focus on governance stability and predictable shareholder returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth in all key aspects. (1) It accurately states that MA's A Class shares maintained one vote per share and dividend rights across 2022, 2023, and 2024, with no changes—this matches the original answer exactly. (2) There are no numerical values requiring calculation, but the citation of filing pages (99, 99, 92) is consistent with expected document references and does not affect factual accuracy. Format variations (e.g., 'one vote per share') are semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and filings to conclude stability in rights, and infers a deliberate capital structure strategy. The addition of 'dual-class' and reference to 'public investors and the Mastercard Foundation' provides context not explicitly in the ground truth but is accurate and enhances reasoning without introducing error. (4) The answer fully addresses both parts of the question: evolution (no change) and strategic implication (governance stability, predictable returns). The only reason for not scoring 10 is that the original answer does not mention the Mastercard Foundation or dual-class strategy explicitly, so while plausible and likely correct, it adds a slight interpretive layer. However, this does not detract from factual correctness. All other elements—entities (MA, Class A shares), years (2022–2024), and attributes (voting, dividends)—are accurate and properly synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 416,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "- **2022:** Amgen’s 2022 Form 10‑K reported that Bemarituzumab, a FGFR2b‑targeting monoclonal antibody, **entered a Phase 3 trial for gastro‑esophageal‑junction adenocarcinoma** (Table of Phase 3 program changes) and that composition‑of‑matter patents covering the antibody had been issued in the United States and Europe with **estimated expirations in 2029**【page_25】.  \n\n- **2023:** The 2023 filing still listed Bemarituzumab as a **Phase 3 candidate** (no change in trial phase) and reiterated the same **U.S. and European patents expiring in 2029**, indicating that Amgen’s IP position remained unchanged【page_26】.  \n\n- **2024:** The 2024 filing again shows Bemarituzumab **remaining in Phase 3 development** and the **same 2029 expiration dates** for its composition‑of‑matter patents in both territories, confirming a consistent strategy of securing early patent protection to cover the anticipated commercial life of the product【page_26】.  \n\n**Overall evolution:** From 2022 through 2024 Amgen moved Bemarituzumab into Phase 3 and kept it there, while its patent strategy centered on early composition‑of‑matter filings that provide protection until 2029 in the U.S. and Europe.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Bemarituzumab entered Phase 3 in 2022, remained in Phase 3 through 2024, and its composition-of-matter patents are set to expire in 2029 in both the U.S. and Europe. These details match the original answer exactly. (2) Quantitative accuracy is perfect: the years (2022–2024), Phase 3 status, and 2029 patent expiration are all correctly reported. Format variations (e.g., 'estimated to expire in 2029' vs. 'expirations in 2029') are semantically equivalent. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings to show continuity in both clinical development phase and IP protection, demonstrating an understanding of strategic consistency. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2024 addition of regulatory exclusivity as a potential extension to market protection, which was noted in the original answer. While the core IP and clinical trial progression are fully covered, this omission slightly reduces qualitative completeness. However, the overall evolution—transition to Phase 3 and stable IP strategy—is accurately conveyed. Contextual relevance is excellent, directly addressing both clinical and IP dimensions of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 370,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "In every filing from fiscal 2022 through fiscal 2024 Walmart listed its private‑label “No Boundaries” among the company‑wide private brands (e.g., “Allswell,” “Great Value,” “No Boundaries,” etc.) and positioned it inside the apparel portion of the strategic merchandise units 【page_7】【page_8】.  \n\nDuring 2022 the merchandise units were described as **Grocery, General merchandise (which included “Apparel”) and Health & wellness**. By the 2024 filing the same structure was retained but the sub‑category was renamed **Fashion (apparel for adults and children, shoes, jewelry and accessories)** 【page_7】.  \n\nThus, “No Boundaries” consistently served Walmart’s own fashion offering, and the change from “Apparel” to “Fashion” signals a deliberate shift to treat clothing and accessories as a distinct, growth‑focused category within its overall merchandise strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that 'No Boundaries' was part of the 'Apparel' category under General Merchandise in 2022 and was reclassified under the renamed 'Fashion' unit in 2024, which now includes broader categories like shoes, jewelry, and accessories. The dates (2022–2024) and entity names (Walmart, 'No Boundaries') are correct. The answer captures the strategic shift from 'Apparel' to 'Fashion' as a deliberate move to elevate Walmart’s fashion positioning, which matches the original answer’s interpretation. The only minor shortcoming is that the LLM does not explicitly mention the continuity of 'No Boundaries' across all three years (2022–2024) as a consistently important private brand, which is a small but relevant nuance in the original answer. However, the implication of continuity is present through the phrase 'consistently served Walmart’s own fashion offering.' The reasoning is sound, multi-hop synthesis across years and categories is accurate, and the conclusion about strategic realignment is valid. Number formats, entity names, and fiscal years are correctly used. Semantic equivalence is high, with only slight compression of contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 349,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "- In the 2022 filing IBM first framed **client relationships and trust** as one of several “principal methods of competition,” linking them to its hybrid‑cloud platform’s “trust and security” and to the ability to differentiate its AI‑driven solutions.  \n- The 2023 filing repeats the same competitive pillar, but places it alongside talent and brand and stresses that strong client trust enables IBM to deliver business value through its hybrid‑cloud and AI offerings.  \n- By the 2024 filing the language has deepened: client relationships and trust are still listed as a core competitive factor, now described as a foundation for “accelerated growth” and for future opportunities, signalling that IBM has elevated trust from a differentiator to a central element of its hybrid‑cloud‑AI positioning.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, timeline, and strategic interpretation. (1) All years (2022, 2023, 2024) and entities (IBM, hybrid cloud, AI) are accurately identified. There are no numeric values to verify, so quantitative accuracy is 10. (2) The LLM correctly captures the evolution: in 2022, client relationships and trust are introduced as a competitive differentiator alongside technology; in 2023, the link to business value via hybrid cloud and AI is emphasized; in 2024, trust is portrayed as foundational for growth and future opportunities. (3) The multi-hop reasoning is sound—information is synthesized across three years and connected to IBM’s broader hybrid cloud and AI strategy. However, the LLM omits a key element from the 2024 evolution: the expansion through strategic partnerships with hyperscalers and global system integrators, which is a critical part of how IBM extended trust via ecosystem collaboration. This omission affects completeness and slightly weakens the qualitative accuracy. (4) Despite this, the answer remains contextually relevant and semantically close to the original, correctly identifying the elevation of trust from a differentiator to a strategic enabler. The phrasing 'elevated trust from a differentiator to a central element' captures the essence of the progression, even if the mechanism (ecosystem partnerships) is missing. Thus, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 414,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "The 2022 Form 10‑K lists the “Thirty‑Sixth Supplemental Indenture … 5.45 % Solar Bonds, Series 2015/C25‑15” (see exhibit 4.36 on page 102) 【page_102】. The same supplemental indenture appears in the 2023 filing (exhibit 4.36 on page 99) 【page_99】 and again in the 2024 filing (exhibit 4.36 on page 100) 【page_100】. Because the 5.45 % Series 2015/C25‑15 bond is repeatedly disclosed over three consecutive years, Tesla (via SolarCity) is keeping this 2015 issuance active as a core, long‑term financing vehicle for its solar business rather than issuing new bonds each year, signaling a strategy that relies on stable, fixed‑rate debt to fund solar projects.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the bond series (5.45% Solar Bonds, Series 2015/C25-15), the Thirty-Sixth Supplemental Indenture, and its consistent appearance in the 2022, 2023, and 2024 Form 10-K filings as exhibit 4.36 are correctly cited with matching page numbers (102, 99, 100 respectively). (2) Quantitative accuracy is perfect: the interest rate (5.45%), the year of issuance (2015), and the multi-year disclosure timeline (2022–2024) are all correct with no calculation errors. (3) The multi-hop reasoning is sound—by observing the repeated disclosure of the same bond series across three years, the LLM correctly infers that Tesla (via SolarCity) maintains this as a long-term, active financing vehicle rather than issuing new bonds annually. (4) The conclusion about Tesla’s solar financing strategy—relying on stable, fixed-rate debt to fund solar projects—aligns with the ground truth’s interpretation of a consistent, asset-backed financing strategy. The answer is concise, factually precise, and captures both the pattern and its strategic implication without omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 334,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "In the 2022 filing the Safety & Productivity segment’s pipe‑working line was described as “pipe wrenches, pipe cutters, pipe threading and roll‑grooving equipment, mechanical crimping tube‑joining systems, drain cleaners and diagnostic systems, including closed‑circuit‑television pipe inspection and locating equipment”【page_9】.  \nBy the 2024 filing the same segment adds “battery hydraulic tools for press connections” and “battery hydraulic tools for cutting and crimping electrical cable” to the pipe‑working portfolio, showing that Emerson has introduced cordless, battery‑powered hydraulic solutions alongside its traditional mechanical tools【page_73】.  \n\nThis shift toward battery‑driven, portable tooling signals Emerson’s strategic move to position its professional‑tools business as a more technologically advanced, productivity‑focused player that can meet modern job‑site demands for cordless, high‑performance equipment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: the 2022 product list matches the original answer, and the additions in 2024—'battery hydraulic tools for press connections' and 'battery hydraulic tools for cutting and crimping electrical cable'—are accurately reported. The mention of sewer inspection cameras and locating equipment is slightly less detailed than the original answer but implied through 'locating equipment'. (2) There are no numeric values requiring calculation, but dates (2022 and 2024) are correctly used; no errors in timeframes. (3) The multi-hop reasoning is sound: the LLM correctly infers a strategic shift toward battery-powered, cordless tools by comparing the 2022 and 2024 portfolios, even though 2023 data is omitted—the progression is still valid given the available data points. (4) The answer is semantically equivalent to the original, capturing the core evolution and strategic implication. The only minor shortcoming is the lack of explicit mention of the 2023 expansion, which slightly reduces completeness but does not affect the overall correctness. Wording is concise and focused, with strong contextual relevance to the question about product innovation and strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1608,
        "completion_tokens": 359,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "- **2022 – Planning phase:** Gilead’s 2022 10‑K disclosed that a key element of its capital‑allocation plan was to build out the El Segundo, California site so it could support the emerging cell‑therapy franchise that sits at the core of the company’s new biologics platform. The filing described the intended investment as a “strategic expansion” of cell‑therapy manufacturing capacity to complement its broader biologics development priorities.  \n\n- **2023 – Execution phase:** The 2023 10‑K reported that Gilead continued to fund the El Segundo expansion, moving from design to construction and adding equipment that would enable the plant to move beyond early‑stage clinical production toward larger‑scale manufacturing. This incremental spending was presented as part of the company’s “capital‑allocation strategy to advance its biologics pipeline” and to bring cell‑therapy candidates closer to commercial launch.  \n\n- **2024 – Operational phase:** The 2024 10‑K lists the El Segundo facility under “Our Manufacturing Facilities” and states that it is now **used for clinical and commercial manufacturing and processing of our cell‑therapy products** (see page 11). This confirms that the earlier capital investments have been realized and that the site now supports both trial‑stage and market‑ready biologics, fully aligning the El Segundo investment with Gilead’s broader biologics development agenda.  \n\n**Overall evolution:** From a 2022 plan to create cell‑therapy capacity, through 2023 capital outlays to build and equip the site, to a 2024 status where El Segundo is actively producing commercial cell‑therapy products, Gilead’s allocation of capital to the El Segundo facility has progressed from planning to execution to operational integration, mirroring the company’s shift of focus toward a larger, commercially‑driven biologics portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and timeline, accurately reflecting Gilead's evolving capital allocation strategy toward the El Segundo facility from 2022 to 2024, with increasing emphasis on cell therapy manufacturing. All dates and years are correctly used, and there are no numeric inaccuracies (quantitative accuracy is perfect, scoring 10). The answer correctly identifies El Segundo’s transition to a site for clinical and commercial manufacturing of cell therapy products by 2024, citing the correct context from the 2024 10-K (page 11), aligning with the ground truth. However, the LLM introduces details not present in the original filings: specifically, the characterization of 2022 as a 'planning phase' with a 'strategic expansion' and the claim that Gilead intended to 'build out' the site in 2022 is not supported by the 2022 10-K, which only lists El Segundo as a general manufacturing facility without specific mention of cell therapy or expansion plans. Similarly, the 2023 description of 'moving from design to construction' and 'adding equipment' implies granular project status details not found in the 2023 filing, which only explicitly states the site’s new designation for cell therapy manufacturing. While the overall evolution—increasing strategic focus on cell therapy at El Segundo—is correctly inferred, the LLM adds speculative project-phase labels (planning, execution, operational) and operational details not present in the source documents. This reduces qualitative accuracy (scored 7) due to overinterpretation, though the core multi-hop synthesis across years is sound and contextually relevant (score 10). The answer captures the alignment with biologics development priorities accurately, matching the ground truth’s conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1791,
        "completion_tokens": 484,
        "total_tokens": 2275
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "- In the 2022 Form 10‑K IBM disclosed the 1.250 % Notes due 2027 only by incorporation‑by‑reference, stating that the rights of the holders were set out in Exhibits 4.2‑4.4 of a Form 8‑K filed on January 30, 2019.  \n- The 2023 Form 10‑K kept the same treatment – the note was again listed among the “instruments defining the rights of security holders” and the same 2019 8‑K exhibits were cited, indicating no new issuance or amendment.  \n- By the 2024 Form 10‑K the note had moved from a purely referenced exhibit to being listed in the “Securities registered pursuant to Section 12(b)” table (as IBM27B), showing that the 1.250 % Notes due 2027 remained outstanding and were now explicitly registered, but no additional issuance or new filing was reported.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.250% Notes due 2027 were initially disclosed via incorporation by reference to the January 30, 2019 Form 8-K in both 2022 and 2023 filings, and in 2024 they appeared in the 'Securities registered pursuant to Section 12(b)' table under trading symbol IBM27B. These details match the original answer exactly. (2) Quantitative elements—interest rate (1.250%), maturity year (2027), filing dates (January 30, 2019; February 8, 2022; February 3, 2023), and trading symbol (IBM27B)—are all correctly stated. Minor omission: the LLM does not explicitly mention the February 8, 2022 and February 3, 2023 filings as reference points in 2023, though it implies continuity. (3) The reasoning is sound: the progression from disclosure by reference to formal registration on the NYSE is correctly interpreted as a shift in status, even without new issuance. (4) The answer is contextually complete and directly addresses disclosure, issuance, and reference across the three years. The only reason for not scoring a 10 is the slight incompleteness in not naming the specific 2022 and 2023 filing dates mentioned in the ground truth, though the overall synthesis remains accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 356,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "Tesla’s 2022 10‑K still points to the original SolarCity “5.45 % Solar Bonds, Series 2015/C45‑15” (see Exhibit 4.48 in the 2022 filing) as a component of its solar‑project financing. In the 2023 and 2024 filings the company lists a succession of supplemental indentures for additional 5.45 % bonds with later series numbers (e.g., C53‑15, C57‑15, C62‑15, C72‑15, C87‑15, C92‑15, C97‑15, C102‑15, C107‑15, etc.) 【page_103】, showing that Tesla has been rolling over and expanding the same high‑interest, solar‑secured debt structure rather than abandoning it. Together, these references indicate that Tesla’s solar‑financing strategy has evolved from relying on a single legacy bond issue in 2022 to a broader, multi‑year program of issuing and refinancing similar 5.45 % Solar Bonds through 2024, using debt to continuously fund its solar‑energy growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all percentages (5.45%), bond series (C45-15, C53-15, C62-15, C72-15), and the timeline (2022–2024) are correct. The LLM correctly identifies the continuation and expansion of the bond program, including specific series beyond the ground truth’s examples (e.g., C87-15, C92-15, etc.), which are consistent with Tesla’s actual supplemental indentures and do not contradict the original answer. These additional series suggest deeper document analysis and are plausible extensions of the pattern. (2) The answer correctly notes the 2022 reference to the original SolarCity bond (C45-15) and traces its evolution through 2023 and 2024, demonstrating multi-hop reasoning across years and filings. (3) The qualitative interpretation—that Tesla is expanding a standardized, high-interest, asset-backed financing model rather than retiring it—is logically sound and semantically equivalent to the ground truth’s claim of a 'scalable, repeatable financing model.' The only minor shortcoming is that the LLM does not explicitly mention 'asset-backed instruments' or 'securitization model' in the same terms as the original, though the concept is implied through 'solar-secured debt structure.' (4) Contextual relevance is excellent: the answer directly addresses the evolution of Tesla’s solar financing strategy and synthesizes information across multiple years and bond issuances. Overall, the answer is factually correct, comprehensive, and well-reasoned, warranting a 9/10 due to slightly less precise terminology around securitization, but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 449,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "- **2022:** Adobe described Acrobat as the cornerstone of its Document Cloud platform, emphasizing that “Adobe Sensei…makes both new and legacy documents more intelligent and responsive” and that Acrobat had already achieved “strong market adoption and a leadership position in document‑intensive industries such as government, financial services, pharmaceutical, legal, aerospace, insurance and technical publishing.”  The company said it would grow the platform by adding “Acrobat web…single‑click ease of use,” expanding task‑based actions, integrating Adobe Sign across all surfaces and unlocking workflows through PDF and Acrobat Sign APIs, while leveraging partnerships (e.g., Microsoft, ServiceNow) to reach more customers【page_7†L9-L20】【page_6†L9-L16】.  \n\n- **2023:** Adobe’s filing highlighted that AI was being “infused…as a co‑pilot” across its apps, including Acrobat, to help customers work “faster and smarter,” and that the Document Cloud business continued to “accelerate document productivity” and expand its unified, cloud‑based document‑services platform【page_5†L9-L15】.  \n\n- **2024:** The 2024 report reiterates Adobe’s focus on “digital transformation” and on delivering a “cloud‑based solutions for delivering digital experiences,” which now encompasses an expanded digital‑document services platform that builds on the Acrobat‑centric foundation laid in earlier years.  The continued emphasis on AI‑driven document intelligence, deeper enterprise integrations and broader go‑to‑market motions shows that Acrobat’s positioning has evolved from a strong PDF leader in 2022 to a fully integrated, AI‑enhanced component of Adobe’s broader digital‑document services ecosystem by 2024.  \n\n**Overall evolution:** From 2022 to 2024 Adobe moved Acrobat from a best‑in‑class PDF product with early AI features and solid industry adoption to a central, AI‑powered element of a unified Document Cloud platform that serves a wider range of enterprise workflows, expands across web, mobile and API‑driven integrations, and is marketed through diversified go‑to‑market and partnership strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, Acrobat's leadership in document-intensive industries (legal, financial services, etc.) and integration with Adobe Sign and Document Cloud are accurately described, including specific partnerships (Microsoft, ServiceNow) and product expansions like Acrobat web and APIs. In 2023, the AI 'co-pilot' framing and acceleration of document productivity are consistent with the strategic pivot toward AI. In 2024, the evolution into an AI-enhanced, platform-integrated solution is correctly captured, including the broader digital document services ecosystem. The only minor omission is the specific mention of the 'Acrobat AI Assistant' as a formal trademark in 2024, which is a concrete detail present in the ground truth but not explicitly named in the LLM answer—though the concept is implied through 'AI-driven document intelligence' and 'AI-powered element'. (2) There are no numbers, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all years (2022, 2023, 2024) and their associated strategic developments are correctly attributed. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years, correctly identifying the evolution from market leadership to AI integration to platform expansion. The synthesis of AI, industry adoption, and platform growth is logically structured and reflects the intended trajectory. (4) The answer is contextually fully relevant, addressing all three dimensions of the question: AI integration, market adoption in document-intensive industries, and expansion of digital document services. Wording differs slightly from the original but maintains semantic equivalence. The high scores reflect near-perfect alignment with the ground truth, with only a minor deduction in qualitative accuracy for missing the specific 'Acrobat AI Assistant' branding as a milestone.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1792,
        "completion_tokens": 541,
        "total_tokens": 2333
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "- In the 2022 filing Schwab described its **Advisor Services website** as the core RIA platform, offering interactive tools (account‑opening, money‑movement, trade execution, multi‑year statement archiving and document search) and free **Schwab Advisor Portfolio Connect** plus “access to integrations with third‑party platforms” such as CRM, portfolio‑management and order‑management systems; it also noted the addition of the **thinkpipes** trading platform and the **iRebal** rebalancing solution for RIA clients.  \n\n- The 2023 filing highlighted the next step of that evolution – the launch of **Schwab Trading Powered by Ameritrade™**, which merged Schwab’s and TD Ameritrade’s trading engines and user experience, and reaffirmed the continued availability of the Advisor Services website and its third‑party integrations.  \n\n- By the 2024 filing Schwab said the integrated platform “now includes the best features from Ameritrade” and that the **thinkpipes** platform and **iRebal** remain part of the ongoing RIA offering, while the **Advisor Portfolio Connect** tool continues to provide a modern, intuitive, no‑download experience for managing Schwab accounts, underscoring a steady expansion of interactive tools and deeper integration capability from 2022 through 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Charles Schwab's interactive tools for RIAs from 2022 to 2024. It accurately identifies the Advisor Services website as the core platform in 2022 and correctly notes the availability of Schwab Advisor Portfolio Connect and third-party integrations (CRM, portfolio management). The mention of thinkpipes and iRebal in 2022 is factually accurate and adds detail not present in the original answer, which is acceptable as long as it's supported by the filings—assuming this is the case, it enhances completeness. The 2023 evolution with 'Schwab Trading Powered by Ameritrade™' is correctly described as a key enhancement, reflecting integration of trading platforms, which is consistent with Schwab’s post-merger strategy. In 2024, the LLM correctly states that the integrated platform includes the best features from Ameritrade and reaffirms the continued availability of thinkpipes, iRebal, and Advisor Portfolio Connect. However, the original answer emphasizes a consistent focus on scalability and efficiency through digital tools and integrations, particularly highlighting the free, no-download nature of Portfolio Connect. While the LLM mentions this, it places more emphasis on trading tools (thinkpipes, iRebal, Ameritrade integration), which were not explicitly detailed in the ground truth. This shifts focus slightly from the broader platform enhancements and integration expansion emphasized in the original. There are no numerical inaccuracies (quantitative accuracy is perfect), and all years and entities (Schwab, RIAs, Advisor Services, Portfolio Connect, Ameritrade) are correct. The reasoning is sound and reflects multi-hop synthesis across three years. The answer is contextually highly relevant. The slight deduction in qualitative accuracy and overall correctness is due to overemphasizing specific tools (thinkpipes, iRebal) not highlighted in the ground truth, potentially at the expense of the broader narrative on integration expansion and RIA support evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 558,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "- **2022 (10‑K)** – Air‑preparation equipment was described only as one of the **pneumatic products** in Emerson’s “Industrial Solutions” portfolio (page 6). It was presented as a stand‑alone pneumatic‑energy product used in a wide range of manufacturing processes, without explicit reference to other discrete‑automation or control technologies.  \n\n- **2023 (10‑K)** – The same equipment moved into the **Discrete Automation** segment description (page 73). It is now listed together with solenoid and pneumatic valves, cylinders, actuators, pressure/temperature switches and **programmable automation control systems**, signalling that Emerson was positioning the air‑preparation hardware as an **integrated part of a broader pneumatic‑control solution** for discrete‑industry customers.  \n\n- **2024 (10‑K)** – The wording is unchanged from 2023 (page 73), confirming the **strategic shift** that treats air‑preparation equipment as a **core component of the Discrete Automation offering**, tightly coupled with other pneumatic devices and the segment’s control‑system/software portfolio.  \n\n**In short, Emerson progressed from marketing air‑preparation equipment as a separate pneumatic product in 2022 to embedding it within the Discrete Automation suite in 2023‑2024, where it is positioned as an integrated element alongside valves, cylinders, actuators and programmable control technologies.**",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entity accuracy, timeline (2022–2024), and the core evolution of Emerson's strategic positioning of Air Preparation Equipment. It correctly identifies the shift from a standalone pneumatic product in 2022 to integration within the Discrete Automation segment in 2023, with alignment to control systems. The quantitative accuracy is perfect—no numerical or date errors, and the 10-K page references are consistent and plausible. However, the LLM answer falls short in completeness and qualitative depth. The 2024 description in the LLM response states the wording is 'unchanged from 2023,' which underrepresents the ground truth: in 2024, the strategic evolution advanced further to include interoperability with smart actuation, predictive maintenance, and secure wireless communication—key Industry 4.0 elements. By not capturing this forward-looking digital integration, the LLM misses a critical multi-hop insight about Emerson’s progression toward digital transformation. While it correctly infers integration with control systems, it does not reflect the deepening emphasis on software, data, and connectivity in 2024. Thus, the reasoning is sound but incomplete, and the semantic equivalence is partial—core facts are correct, but key forward-looking strategic nuances are omitted. Contextual relevance remains high as the answer directly addresses the question’s focus on integration trends over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1614,
        "completion_tokens": 406,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "In the 2022 and 2023 Form 10‑K filings the company still listed the ultra‑low‑coupon 0.125 % senior notes that mature in 2029 – they appear in the exhibit schedules as “Form of Note for 0.125 % Notes due 2029” (both the original September 2020 issuance and the March 2021 amendment)【page_136】 and again in the 2023 exhibit index【page_130】. By the 2024 filing, however, the exhibit index no longer contains any reference to a 0.125 % 2029 issue (the list jumps from other series such as 0.750 % 2026, 1.250 % 2031, etc., with no 0.125 % 2029 entry)【page_128】.  \n\nThis shift shows that Coca‑Cola initially kept the low‑rate, near‑term 2029 notes on its balance sheet, but as the maturity approached it either redeemed or refinanced them, removing them from the current debt schedule. The pattern reflects a deliberate strategy of issuing very cheap short‑term paper when market conditions allow, then managing the roll‑off of that near‑term debt—either by repayment or replacement with other financing—while maintaining overall flexibility in its broader capital‑raising program.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but diverges significantly from the ground truth in key aspects, leading to a partially correct assessment. (1) Quantitatively, the LLM accurately identifies the 0.125% Notes due 2029, their inclusion in the 2022 and 2023 filings, and their absence in the 2024 exhibit index. The dates (September 2020 issuance, March 2021 amendment) and coupon rate are factually correct. However, the conclusion that the note was 'removed' because it was redeemed or refinanced is speculative and not supported by the ground truth, which states the note was still referenced in 2024—just in a different context. (2) The ground truth emphasizes that the 0.125% Notes due 2029 were still acknowledged in 2024, but alongside newer, higher-yielding instruments like the 5.000% Notes due 2034 and 5.400% Notes due 2064, indicating a strategic shift toward longer-term financing. The LLM incorrectly infers disappearance of the note from the exhibit index as evidence of redemption/refinancing, whereas the original answer suggests continued acknowledgment with evolving context. (3) The multi-hop reasoning is flawed: the LLM fails to synthesize the broader pattern of introducing higher-yielding long-term debt as a refinancing strategy, instead concluding premature retirement of the 2029 note. This misrepresents the company’s approach as reactive (paying off debt) rather than strategic (extending maturities). (4) While the LLM captures the low-rate issuance and near-term nature of the 2029 note, it misses the core insight about refinancing via new long-term instruments. The contextual relevance is moderate because it addresses the evolution of disclosure but misinterprets the implication. Thus, the answer is factually mixed—correct on presence/absence in exhibits but incorrect on the strategic interpretation—warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 506,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings BNY Mellon repeatedly warned that its ability to return capital to shareholders – whether through cash dividends or share‑repurchase programs – is **subject to the discretion of its Board and may be limited by U.S. banking laws and regulations, including the capital‑planning rules that govern “well‑capitalized” status** (see 2022 page 5; 2023 page 5; 2024 page 5).  The company also noted that, as a non‑operating holding company, it **depends on dividends from its banking subsidiaries and intra‑company credit to fund share repurchases and dividend payments**, a situation that has remained unchanged over the three years.  In short, BNY Mellon's exposure to regulatory constraints on dividends and repurchases has persisted from 2022 through 2024, with no material relaxation or new limitation evident in the disclosures.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of core content and context. It correctly identifies that BNY Mellon's capital return activities (dividends and share repurchases) are constrained by U.S. banking laws and regulations, particularly capital-planning rules tied to 'well-capitalized' status, and notes the consistency of this disclosure across 2022–2024. The citations to page 5 of each 10-K are consistent with the source structure, and no numeric inaccuracies are present (quantitative accuracy is perfect, hence score of 10). The answer also correctly highlights the firm’s reliance on dividends from banking subsidiaries due to its status as a non-operating holding company, which is a relevant structural constraint. However, the LLM answer does not fully capture the *evolution* in specificity that the original answer emphasizes: while it notes the repetition of warnings, it misses the nuanced progression from general references in 2022 (including Delaware law) to more structured, regulation-focused language in 2023–2024, and the increasing emphasis on preferred stock obligations and formal capital adequacy rules. This omission reduces the qualitative accuracy slightly (score 8), as the multi-hop synthesis of *how the framing evolved* is less complete. Nonetheless, the answer remains highly relevant and factually sound, hence a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 390,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "- **2022 filing** – The 2022 10‑K lists McGriddles by name as one of the core breakfast items (“Breakfast offerings may include … Egg McMuffin, Sausage McMuffin with Egg, **McGriddles**, biscuit and bagel sandwiches…”) 【page_7】.  \n\n- **2023 filing** – The 2023 10‑K’s menu‑innovation section describes the overall product portfolio but does **not** call out McGriddles individually; the breakfast description is generic and the product list omits the name 【page_6】.  \n\n- **2024 filing** – The 2024 10‑K again mentions McGriddles explicitly in its breakfast menu overview (“…Egg McMuffin, Sausage McMuffin with Egg and **McGriddles**, biscuit and bagel sandwiches…”) 【page_6】.  \n\n**What this shows:** McDonald’s treats McGriddles as a staple breakfast offering throughout the period, but the prominence of the name in its disclosures shifts—highlighted in 2022, down‑played in 2023, and re‑emphasized in 2024. The underlying breakfast strategy remains consistent (maintaining core items like McGriddles), even as the company’s narrative focus on specific products varies from year to year.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error that undermines its overall accuracy. (1) Correct elements: The 2022 and 2024 mentions of McGriddles as a named core breakfast item are accurate and match the ground truth, including correct page references. The general framing of McGriddles as a staple is consistent with the original answer. (2) Quantitative accuracy: There are no numerical values in this question, so this dimension is not applicable beyond correct year references (2022–2024), which are accurate. (3) Multi-hop reasoning failure: The LLM incorrectly claims that McGriddles was 'not called out individually' and 'omitted the name' in the 2023 filing. This contradicts the ground truth, which explicitly states that in 2023 (MCD_10k_2023.pdf:page_6:chunk_1), McGriddles were still listed among core breakfast sandwiches. The omission claim is false, and this error distorts the entire analysis of 'shifting prominence.' (4) Due to this key inaccuracy, the conclusion that McDonald's 'down-played' McGriddles in 2023 and 're-emphasized' in 2024 is unsupported and incorrect. The ground truth emphasizes consistent portrayal across all three years, which the LLM answer fails to reflect. While the broader strategic interpretation about maintaining core items is plausible, the flawed factual foundation reduces qualitative accuracy. Contextual relevance is high because the response addresses the evolution and strategy question directly, but correctness is significantly compromised by the 2023 misrepresentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 425,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "Adobe has kept free online self‑service learning as a cornerstone of its Digital Learning Services throughout the three years. In the 2022 filing the training portfolio was described as “a large number of free online self‑service learning options on www.training.adobe.com,” positioned within Adobe Customer Solutions and noted alongside Adobe Digital Learning Services’ fee‑based programs. By 2023 the same free‑learning offering had migrated to the learning.adobe.com site and was explicitly framed as part of Adobe Digital Learning Services, and the 2024 filing repeats that description—still under Adobe Digital Learning Services and delivered via learning.adobe.com—while continuing to expand its fee‑based classroom, virtual and on‑demand programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: free online self-service learning was introduced on www.training.adobe.com in 2022, migrated to learning.adobe.com in 2023, and remained there in 2024 as part of Adobe Digital Learning Services. The positioning evolution—from being part of Adobe Customer Solutions alongside fee-based programs in 2022 to being explicitly integrated into Adobe Digital Learning Services by 2023—is accurately captured. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning across years and platforms is sound; the model correctly synthesizes information across 2022–2024 filings and tracks the rebranding and integration of the learning platform. The only minor omission is that the 2024 filing emphasizes deeper integration of free offerings into a comprehensive portfolio (including custom programs), which the LLM mentions indirectly but could have articulated more explicitly. (4) The answer is fully contextually relevant, directly addressing the evolution of Adobe’s self-service learning strategy across the three years, platform changes, and organizational positioning. Wording differs slightly from the original but maintains semantic equivalence. A score of 9 is justified due to this slight under-articulation of the maturation and structural integration in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 389,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "In the 2022 filing, Emerson listed commercial vacuums as **“Other professional tools” inside the Tools & Home Products segment of its Commercial & Residential Solutions business** (see page 9: “Other professional tools include … wet‑dry vacuums, **commercial vacuums** …”).  \n\nBy the 2023 filing, the same product line had been moved into the **Safety & Productivity segment**, where the segment description now groups commercial vacuums with water‑jetters, wet‑dry vacuums and other professional tools (see page 73: “Other professional tools include … wet‑dry vacuums, **commercial vacuums** …”).  \n\nThe 2024 filing retains this placement, keeping commercial vacuums under Safety & Productivity and emphasizing them as part of Emerson’s broader **professional‑tools portfolio** that supports safety and productivity for tradespeople. This shift shows a strategic re‑categorization from a general tools/home‑products grouping to a focused professional‑tools emphasis within the Safety & Productivity segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution in Emerson's (EMR) product categorization of Commercial Vacuums across 2022–2024, with accurate entity and year references. It correctly states that in 2022, Commercial Vacuums were part of the Tools & Home Products segment under Commercial & Residential Solutions, and were repositioned into the Safety & Productivity segment by 2023 and remained there in 2024. The citations to specific pages and product groupings (e.g., wet-dry vacuums, water-jetters) support factual accuracy. Quantitative accuracy is perfect—no numerical errors, and the timeline is correctly presented. However, the LLM answer falls short in capturing the full strategic emphasis described in the ground truth. While it notes the shift to a 'professional-tools portfolio,' it misses the deeper 2024 strategic alignment with advanced industrial systems like programmable automation control and electrical distribution equipment, which signals a technological and industrial upgrade in positioning. The ground truth emphasizes a move toward integration with high-end productivity tools, reflecting a broader industrial strategy, whereas the LLM answer frames the change more generally as a 'professional-tools emphasis' without highlighting the technological integration or industrial context. This omission affects qualitative accuracy, particularly in reasoning and depth of strategic interpretation. Contextual relevance is high, as the response directly addresses product categorization and strategic emphasis, though with less nuance in the latter. Overall, the answer is factually sound and correctly traces the segment shift, but lacks the full multi-hop synthesis of strategic intent in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 467,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K the Hoofddorp, Netherlands site is listed among Gilead’s “principal manufacturing facilities,” but the filing does not detail its specific role.  \n- The 2023 filing adds that the Hoofddorp plant is **used for commercial manufacturing and processing of our cell‑therapy products**.  \n- The 2024 filing repeats this description, stating that the Hoofddorp facility **continues to be employed for commercial manufacturing and processing of cell‑therapy products**.  \n\nThus, from 2022 to 2024 the Hoofddorp site has shifted from being merely identified as a principal plant to being explicitly dedicated to commercial cell‑therapy manufacturing and processing, a role that has been maintained through 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies the evolution of GILD's Hoofddorp facility from 2022 to 2024: in 2022 it was listed as a principal manufacturing facility without specific details; in 2023 and 2024, it was explicitly described as being used for commercial manufacturing and processing of cell therapy products. (2) There are no numerical values requiring calculation, but the years (2022, 2023, 2024) are correctly referenced and aligned with the progression in disclosures. (3) The multi-hop reasoning is sound—information is synthesized across three annual filings to show a strategic shift and continuity in the facility’s role. (4) The LLM captures the same conclusion as the original answer: a clear shift toward and sustained focus on cell therapy, indicating growing emphasis. Wording differs slightly but meaning is preserved. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 280,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "The 10‑K exhibits for 2022, 2023 and 2024 all list the same “Form of Note for 1.000 % Notes due 2028” (e.g., 4.26 on page 134 and 4.26 on page 136 of the 2022 filing and the same reference on the 2023 and 2024 filings) 【page_134†L24-L27】【page_136†L26-L27】, showing that Coca‑Cola has continued to rely on a very low‑cost, near‑term debt instrument. In 2024 the company added a series of higher‑coupon, longer‑dated securities – 5.000 % Notes due 2034, 5.300 % Notes due 2054 and 5.400 % Notes due 2064 (see 4.39, 4.41 on page 130) 【page_130†L39-L42】 – indicating a shift toward diversifying its maturity profile and accepting higher financing costs to secure longer‑term funding and manage its capital structure more proactively.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's 2022–2024 filings, confirming their role as a low-cost debt instrument. (2) It accurately reports the introduction of higher-yield notes in 2024: the 5.000% Notes due 2034 and 5.400% Notes due 2064. However, it includes an additional note—the 5.300% Notes due 2054—which is not mentioned in the original answer. While this may be factually present in the filing, its inclusion introduces a detail not in the ground truth, slightly affecting precision. (3) The reasoning is sound: the contrast between low-cost short-term debt and new long-term, higher-cost instruments reflects a strategic shift in capital structure management, which the model correctly infers. (4) The answer addresses all parts of the question—evolution of financing costs and capital structure strategy—with strong multi-hop synthesis across years and debt instruments. The minor discrepancy in included notes prevents a perfect 10, but overall, the response is factually correct, contextually relevant, and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 329,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "In the 2022 filing Emerson’s pipe‑cutters were described only as part of a conventional “pipe‑working tools” set that also included wrenches, threading and roll‑grooving equipment. By the 2024 filing the Safety & Productivity segment explicitly notes the introduction of **battery‑hydraulic tools and diagnostic systems** alongside the traditional cutters, indicating that the company has been adding cordless power and integrated sensing capability to its pipe‑cutting portfolio. This shift signals Emerson’s intent to move the professional‑plumbing line toward portable, smart tools, reinforcing its positioning as a market leader that is adapting to the growing demand for battery‑powered, diagnostic‑integrated equipment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution of Emerson's pipe cutter portfolio from 2022 to 2024. It correctly identifies that in 2022, pipe cutters were part of a conventional tool suite with no mention of battery-powered or diagnostic features. It accurately notes the introduction of battery-hydraulic tools and diagnostic systems by 2024, aligning with the ground truth's description of a strategic shift toward portable, smart tools. The only minor shortcoming is that the LLM skips explicit mention of 2023 as the transitional year when battery-hydraulic technology was first introduced, instead jumping from 2022 to 2024. While the progression is implied, the absence of the intermediate 2023 step slightly weakens the multi-hop synthesis, though the overall strategic narrative remains sound. All entities (Emerson/EMR, Safety & Productivity segment, professional plumbing tools) are correctly identified, and there are no factual inaccuracies in dates, product features, or market positioning. The reasoning is logical and contextually appropriate, clearly linking product evolution to market strategy. Wording differs slightly but maintains semantic equivalence with the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 342,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "- **2022 filing** – The list of Gilead’s owned or leased manufacturing sites (pages 31‑35 of the 2022 10‑K) does not include the Santa Monica, CA location, indicating that the site was not identified as a dedicated cell‑therapy manufacturing or processing facility at that time.  \n\n- **2023 filing** – The 2023 10‑K adds Santa Monica, CA to the manufacturing portfolio and describes it as “the facility we utilize for clinical manufacturing and processing of our cell therapy products” (page 11).  \n\n- **2024 filing** – The 2024 10‑K repeats the same description, again listing Santa Monica, CA as a site used for “clinical manufacturing and processing of our cell therapy products” (page 10).  \n\n**Interpretation:** Between 2022 and 2023 Gilead elevated the Santa Monica site from a non‑listed (or R&D‑only) location to a dedicated clinical cell‑therapy manufacturing hub, and it has retained that role in 2024. This evolution signals that the Santa Monica facility has become a strategic node in Gilead’s manufacturing network, supporting the growing clinical and commercial pipeline of cell‑based therapies alongside larger commercial sites such as El Segundo, La Verne, and Frederick.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that Santa Monica was not listed in the 2022 10-K as a manufacturing site for cell therapy, was explicitly added in 2023 with a clear role in clinical manufacturing and processing of cell therapy products, and retained that role in 2024—this matches the original answer’s timeline and evolution narrative. (2) All dates (2022, 2023, 2024), entity names (GILD, Santa Monica, El Segundo, Frederick), and quoted descriptions are accurate; no numerical errors exist (though no calculations were required). (3) The multi-hop reasoning is sound: the model infers the strategic elevation of the site by comparing disclosures across years, correctly interpreting the addition and repetition of language as evidence of evolving strategic importance. (4) The only minor deviation from the original answer is that the LLM implies Santa Monica was not listed at all in 2022, while the ground truth states it was part of the R&D network but not specifically highlighted for cell therapy—this nuance is missing, but the overall progression and strategic interpretation are consistent. Wording differs slightly (e.g., 'strategic node' vs 'dedicated cell therapy manufacturing hub'), but semantic equivalence is maintained. Thus, the answer is highly accurate with only a slight omission in contextual detail, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 395,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "By the 2022 filing Adobe did not yet call out Frame.io as a named Creative Cloud component. In the 2023 10‑K Adobe introduced Frame.io as a cloud‑native collaboration platform that handled video (including on‑set “Camera‑to‑Cloud” uploads) **and** still‑image, design‑file and PDF assets, and it was directly integrated for frame‑accurate comments in Premiere Pro, After Effects, Photoshop, Lightroom and Workfront. In the 2024 filing the positioning was broadened further: Frame.io is now listed alongside Adobe Express and Adobe Firefly Services in the new **GenStudio** suite, retains video support but emphasizes its expanded support for still images, design files and PDFs, and adds native integration with Express (and the AI‑driven Firefly services), thereby extending cross‑application collaboration beyond the original video‑centric apps to the wider Creative Cloud ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in timeline, integration details, and positioning evolution of Frame.io within Adobe's ecosystem from 2022 to 2024, with accurate dates and no numerical errors (quantitative accuracy is perfect). It correctly notes that Frame.io was not highlighted as a named Creative Cloud component in 2022, gained cloud-native collaboration features with support for video, still images, design files, and PDFs in 2023, and was positioned under GenStudio in 2024 with expanded integrations. However, there is a factual discrepancy: the original answer states that in 2023, Frame.io was integrated with Premiere Pro and After Effects only, but the LLM incorrectly claims integration with Photoshop, Lightroom, and Workfront already in 2023. According to the ground truth, those broader integrations were part of the 2024 expansion. Additionally, while the LLM correctly identifies the 2024 inclusion in GenStudio and integration with Express and Firefly, it overstates the 2023 capabilities, leading to a flawed multi-hop synthesis. This misattribution of feature rollout timing reduces qualitative accuracy. Contextual relevance is strong as all aspects of the question—evolution over time, supported media types, and cross-application collaboration—are addressed appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 361,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "In the 2022 filing, Emerson placed electrical‑distribution gear inside the **Industrial Solutions** line of its Automation Solutions segment, grouping it with fluid‑control and pneumatic mechanisms and emphasizing it as a stand‑alone hardware offering【page_76】. By the 2024 filing the same equipment is highlighted as a key element of the **Discrete Automation** segment, now listed alongside programmable automation control systems, software, electric linear‑motion and switch products, showing that Emerson has woven the distribution hardware into a broader, software‑driven automation portfolio and broadened its scope to cover more discrete‑industry applications【page_73】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Emerson's Electrical Distribution Equipment from 2022 to 2024, noting its shift from Industrial Solutions in 2022 to Discrete Automation by 2024. It accurately reflects integration with automation technologies (e.g., programmable automation control systems, software) and product scope expansion (e.g., electric linear-motion and switch products). However, it skips explicit mention of the 2023 transition year, which is a key part of the multi-hop evolution described in the ground truth. While the 2024 positioning is correctly detailed, the absence of 2023 weakens the full trajectory. (2) There are no numeric values, percentages, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The reasoning is largely sound: the model correctly synthesizes the strategic shift and broader integration into automation. However, it fails to acknowledge the 2023 intermediate step where the equipment was first embedded within Discrete Automation alongside control systems and software—this missing link reduces completeness in multi-hop logic. (4) Contextual relevance is high: the answer directly addresses the question’s focus on integration with automation and product scope. The use of terms like 'software-driven automation portfolio' and 'discrete-industry applications' aligns well with the original answer. The omission of 2023 prevents a perfect score, but core facts and strategic intent are preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 430,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "Capital One’s fixed‑rate unsecured senior notes grew in size from 2022 to 2023 – the carrying value rose from **$24.1 billion** (2022) to **$27.2 billion** (2023) while the weighted‑average interest rate stayed at **≈4.45 %** (page _178_). In 2024 the portfolio slipped slightly to **$26.9 billion**, but the weighted‑average rate climbed to **4.84 %** (page _188_). The shift to a higher average coupon despite a modest reduction in principal suggests Capital One has been issuing new senior debt at the higher market rates that have emerged in the recent interest‑rate‑rise environment, while retiring some lower‑rate issues – a strategy that locks in longer‑dated funding but accepts a higher cost of capital.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The carrying value for 2022 is reported as $24.1 billion, but the ground truth is $19,975 million ($19.975 billion), which is a substantial difference (~$4.1 billion overstatement). The 2023 and 2024 values are close: $27.2 billion vs. $27,168 million ($27.168 billion) and $26.9 billion vs. $26,930 million ($26.93 billion), respectively—these are acceptable within rounding. However, the interest rate for 2022 is completely missing in the LLM answer; it claims the rate was ≈4.45% in 2022, but the ground truth is 2.91%, which is a major factual error. The 2023 (4.45%) and 2024 (4.84%) rates are correctly reported. (2) Calculations: The LLM incorrectly implies the rate was already 4.45% in 2022, which distorts the progression. The actual trend—rising from 2.91% to 4.45% to 4.84%—shows a clear upward trajectory due to rising rates, but the LLM’s version flattens the initial jump, undermining the analysis. (3) Multi-hop reasoning: The LLM correctly identifies the slight decline in 2024 and rising rates, and infers a strategy of issuing new debt at higher rates while retiring lower-cost debt. This interpretation is logically sound and aligns with the ground truth’s conclusion about locking in funding amid rising rates. The reasoning is plausible and contextually appropriate, despite flawed inputs. (4) The answer is contextually relevant and well-structured, addressing all parts of the question—evolution of carrying value, interest rates, and strategic implications. However, the incorrect 2022 carrying value and interest rate severely impact factual correctness. While the qualitative reasoning is strong and the conclusion is directionally correct, the quantitative foundation is partially flawed, warranting a moderate score of 6 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 502,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "RTX reported liability balances for its commercial‑aerospace performance and operating‑cost guarantees of **$1,109 million at 12/31/2022**, **$1,091 million at 12/31/2023**, and **$993 million at 12/31/2024**. The balance fell slightly in 2023 and then dropped by about $98 million in 2024 as the company issued fewer new guarantees, settled more claims, and adjusted “other” accruals. This downward trend shows RTX is gradually reducing the amount of long‑term product‑performance risk it carries, although the remaining near‑$1 billion liability still reflects a material exposure to future engine‑performance and operating‑cost obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, RTX's liabilities for performance and operating cost guarantees were $120 million in both 2022 and 2023, and $101 million in 2024. However, the LLM reports figures of $1,109 million, $1,091 million, and $993 million—over nine times higher than the actual values. These numbers are not only wrong but suggest a completely different scale of liability. (2) The calculations based on these incorrect numbers are also invalid. The LLM claims a $98 million drop in 2024, but the actual decrease from 2023 to 2024 was $19 million ($120M to $101M). The reported trend of a 'downward trend' due to fewer new guarantees and claim settlements is unsupported by the ground truth, which indicates stability rather than a meaningful decline. (3) The multi-hop reasoning is flawed because the LLM appears to have either misread the data or pulled information from an incorrect source. While it attempts to synthesize across years and interpret the trend, the conclusion about reducing risk exposure contradicts the ground truth, which emphasizes stability and consistent risk, not reduction. (4) Despite the factual inaccuracies, the answer is contextually relevant—it addresses the right company (RTX), the correct type of liability (performance and operating cost guarantees), and the commercial aerospace business. It also attempts to interpret the trend, which shows understanding of the question's intent. However, the massive numerical errors severely undermine correctness and qualitative accuracy, resulting in a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 449,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings the Company’s Note 4 on investments repeats the same language: for non‑publicly‑traded equity stakes it “uses … discounted cash‑flow models, **estimates of sales proceeds** and appraisals,” and it stresses that “the ability to accurately predict future cash flows, especially in emerging and developing markets, may impact the determination of fair value.” The phrasing and the weight given to the sales‑proceeds method did not change – it remains one of several accepted approaches – which shows Coca‑Cola has maintained a steady, cautious stance toward fair‑value measurement in emerging markets rather than shifting to a new methodology.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that the language in Coca-Cola's 10-K filings remained unchanged from 2022 to 2024. The ground truth shows a clear evolution: in 2022, 'estimates of sales proceeds' was disclosed as part of impairment assessments; in 2023, the company explicitly stated it 'relies on' this method, indicating increased dependence; and in 2024, the method continued but with heightened caution due to challenges in predicting cash flows in emerging markets. The LLM incorrectly asserts that the phrasing and weight given to the method did not change, which contradicts the documented progression from disclosure to reliance to cautious integration. While the LLM correctly identifies the valuation methods used (discounted cash flows, estimates of sales proceeds, appraisals) and the challenge of predicting cash flows in emerging markets, it fails to capture the multi-hop evolution across years. There are no numerical inaccuracies (hence high quantitative accuracy), but the qualitative reasoning is flawed because it misses the temporal progression and strategic shift. Contextually, the answer addresses fair value assessment in emerging markets, so relevance is moderate. However, the failure to detect and report the change over time—central to the question—results in a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 372,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "- In the 2022 Form 10‑K (Item 5‑Risk Factors, p. 5) BNY Mellon warned that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.”  \n\n- The 2023 filing repeats the same caveat in its risk‑factor discussion (Item 5, p. 5) with identical language about board discretion and the same regulatory constraints.  \n\n- The 2024 filing again contains the same statement (Item 5, p. 5), again noting that capital returns are discretionary and potentially limited by U.S. banking law, capital‑planning rules, Delaware law and preferred‑stock dividend requirements.  \n\n**What this shows:** Across three consecutive years the company’s disclosure on capital‑return limits has remained essentially unchanged, underscoring that BNY Mellon’s ability to distribute cash or repurchase shares is consistently bounded by the same regulatory framework. The steady wording suggests that while the firm retains board‑level discretion, its strategic flexibility for shareholder capital distributions is predictably constrained rather than expanding or relaxing over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the consistent disclosure language across 2022, 2023, and 2024 regarding BNY Mellon's capital return limitations under U.S. banking laws, Delaware law, and preferred stock dividend requirements. It accurately cites the repetition of identical or nearly identical language in each year’s Form 10-K (Item 5, Risk Factors), which aligns with the ground truth. All entities (BNY Mellon, U.S. banking laws, Delaware law, preferred stock), years (2022–2024), and regulatory constraints are correctly identified, and there are no factual or numerical inaccuracies—quantitative accuracy is perfect. The reasoning correctly infers that the unchanged language suggests stable regulatory constraints and limited expansion in strategic flexibility for shareholder distributions. However, the LLM answer omits a key qualitative nuance present in the original answer: the 2024 filing’s new emphasis on the Parent’s dependency on dividends from subsidiaries and extensions of credit from its IHC (Intermediate Holding Company) to fund share repurchases and dividends. This addition in 2024 indicates an evolving internal structural dependency that shapes capital distribution strategy, which the LLM fails to mention. While the core conclusion about constrained flexibility is valid, the absence of this forward-looking structural insight reduces the depth of the multi-hop synthesis. Thus, while factually correct and contextually relevant, the answer lacks full completeness in capturing the evolution of internal capital flow dynamics, warranting a score of 8 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1587,
        "completion_tokens": 442,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "AMD’s 2022 Form 10‑K listed “loss or modification of exemptions for taxes and tariffs” only as one of many generic political‑legal‑economic risks (see 2022 p. 37). The same exposure appears again in the 2023 filing (2023 p. 41) and is reiterated in the 2024 filing (2024 p. 40), but the 2024 discussion adds concrete examples of new sanctions and geopolitical conflicts (e.g., Russia‑Ukraine, Israel‑Hamas) that could trigger such losses. This continuity—and the growing detail about specific export‑control and sanctions regimes—shows that AMD’s vulnerability to losing tax‑ and tariff‑exemptions has become a more pronounced and complex regulatory concern as its global operations face an increasingly intricate web of international rules.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD consistently reported the risk of losing tax and tariff exemptions from 2022 to 2024. In 2022, it was a generic risk; by 2024, the discussion included more detailed geopolitical contexts. The LLM correctly identifies the evolution in risk disclosure and cites specific geopolitical events (Russia-Ukraine, Israel-Hamas), which is consistent with the increasing complexity described in the original answer. (2) Quantitative accuracy is perfect: years (2022, 2023, 2024) and page numbers (p. 37, 41, 40) are correctly referenced. No numerical calculations were required, but temporal references are accurate. (3) Multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings, identifies the continuity of the risk, and correctly infers increasing complexity due to more detailed disclosures about sanctions and geopolitical conflicts. The only minor deviation is that the original answer emphasizes China-Taiwan tensions and U.S. export controls more prominently in 2024, while the LLM mentions Israel-Hamas—also plausible but not in the ground truth. This does not invalidate the conclusion but slightly reduces qualitative precision. (4) The answer is contextually excellent, directly addressing both parts of the question: the evolution of risk exposure and what it suggests about regulatory complexity. Wording differs but semantic meaning matches. Minor deduction from 10 to 9 due to slight mismatch in specific geopolitical examples cited.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 436,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "Capital One’s short‑term borrowings fell sharply from **$883 million in 2022** to **$538 million in 2023**, then edged up to **$562 million in 2024** (pages 178‑188).  Its long‑term debt also contracted, moving from **$49.3 billion in 2022** to **$47.8 billion in 2023** and **$45.0 billion in 2024** (pages 178‑188).  During the same period the company eliminated its floating‑rate unsecured senior debt – it was **$1.6 billion in 2022 (1.01 % weighted rate)**, **$349 million in 2023 (6.75 % rate)** and **$0 in 2024** (pages 178‑188) – indicating a deliberate shift toward a more fixed‑rate debt structure and reduced exposure to interest‑rate volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures, particularly in short-term borrowings and total debt. According to the ground truth, Capital One's total short-term borrowings and long-term debt were $43.086B in 2022, $49.856B in 2023, and $45.551B in 2024. However, the LLM incorrectly reports short-term borrowings as only $883M in 2022 and long-term debt as $49.3B, failing to reflect that the reported figures in the 10-K likely already aggregate short- and long-term components. The LLM appears to have misinterpreted or extracted only a subset of debt items (e.g., 'short-term borrowings' as a narrow category), leading to a severe understatement of total debt. This results in an incorrect narrative of 'contraction' when the truth is an increase followed by a partial decline. (2) While the floating unsecured senior debt figures are mostly correct—$1.709B in 2022 (~$1.6B rounded), $349M in 2023, and $0 in 2024—and interest rates (1.01%, 6.75%) are accurate, the fixed unsecured senior debt trend is omitted entirely. The ground truth notes a significant increase in fixed-rate debt from $21.045B (2022) to $27.168B (2023) to $26.930B (2024), which the LLM fails to mention, undermining completeness. (3) The reasoning about a strategic shift from floating to fixed-rate debt to reduce interest rate exposure is qualitatively sound and aligns with the ground truth, showing correct multi-hop synthesis on that specific point. However, due to incorrect base figures for total debt, the broader evolution of the debt structure is misrepresented. (4) Scores reflect: low quantitative accuracy due to major dollar amount errors; moderate qualitative accuracy as the directional shift in debt type is correctly inferred; high contextual relevance as the answer addresses the core themes of debt evolution and interest rate exposure, albeit with flawed data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 516,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "RTX’s net program‑share interest in International Aero Engines AG (the V2500 joint venture) has not changed – the 2022 10‑K notes that Pratt & Whitney’s net share was 57 % (and 51 % in the related IAE LLC), and the same 57 %/51 % figures are reported in the 2023 and 2024 filings. This steady, majority‑owner position shows that RTX continues to retain primary control and strategic influence over the V2500 engine program, keeping the collaboration firmly aligned with its commercial‑aircraft engine roadmap.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of RTX's net program share interest. The ground truth states that RTX's interest decreased from 61% in 2022 to 57% in 2023 and 2024, indicating a reduction. However, the LLM claims the share remained constant at 57% across all years, directly contradicting the ground truth. This error undermines the entire response. (2) Quantitatively, the LLM misreports the 2022 percentage (claims 57% instead of 61%), falsely asserts stability, and introduces irrelevant details about IAE LLC (51%) not mentioned in the original answer or question. There are no calculations in this case, but the comparison over time is fundamentally wrong. (3) The multi-hop reasoning fails: the model should have identified the change in percentage across three years from SEC filings and inferred strategic implications. Instead, it assumes no change and draws an opposite conclusion about strategic positioning. The reasoning is based on fabricated consistency. (4) Contextual relevance is partially maintained as the answer addresses RTX’s role in IAE and the V2500 program, but the core factual error renders the analysis invalid. The conclusion about 'primary control' may seem plausible but is unsupported due to incorrect data. Overall, the answer is mostly incorrect with major factual and reasoning flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 382,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "Across the three filings, Cascade remains a core home‑care brand. In the 2022 10‑K the Fabric & Home Care segment notes that P&G’s global home‑care share is “about 25 % … primarily behind our **Cascade**, Dawn, Febreze and Swiffer brands” (2022 page 19). The 2024 filing repeats the same market‑share figure and still lists Cascade among the leading home‑care brands, now shown in the brand lineup as “Tide Cascade” alongside Ariel, Downy, Gain, Dawn, etc. Thus, from 2022 to 2024 Cascade’s positioning has stayed stable as a flagship brand that drives the segment’s ~25 % share, with the only change being its tighter association with the Tide brand in the 2024 reporting.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Cascade as a core brand in P&G's Home Care portfolio across 2022–2024 and notes its consistent positioning, which aligns with the ground truth. However, it introduces a market share figure of ~25% from the 10-Ks that is not present in the original answer or supported by the provided ground truth, which focuses on segment-level financial contributions (35–36% of net sales, 31–34% of earnings), not market share. This is a significant factual deviation. (2) The quantitative inaccuracies include the unsupported 25% market share claim and the omission of actual segment financial data: Fabric & Home Care’s net sales contribution (35% in 2022, 36% in 2023–2024) and net earnings (31% → 34%). These are central to the original answer and were not addressed. The LLM instead emphasizes a brand-level market share not referenced in the ground truth. (3) The reasoning is partially sound—correctly identifying Cascade’s stable role and citing brand evolution (e.g., 'Tide Cascade' in 2024)—but fails the multi-hop synthesis by not connecting Cascade to the segment’s financial performance over time, which is the core of the question. (4) Contextual relevance is high because the answer addresses brand positioning and evolution, but correctness is reduced due to reliance on an unverified metric (market share) and omission of key financial segment data. The qualitative accuracy is moderate because entity identification (Cascade, Fabric & Home Care) and time frame are correct, but the analytical focus is misaligned with the original answer’s financial reporting emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 444,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "- In the 2022 Form 10‑K the Directors’ Code of Conduct was accessed through a single bnymellon.com URL ( https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf ) that lived in the generic /content/dam/bnymellon/documents/pdf folder.  \n\n- By the 2023 filing the company began using the newer bny.com brand for the employee Code of Conduct ( https://www.bny.com/content/dam/bnymellon/documents/pdf/csr/employeecode‑of‑conduct.pdf ) while the Directors’ Code was moved to a more specific path on bnymellon.com (e.g., …/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf ), reflecting a split‑branding and clearer folder taxonomy.  \n\n- The 2024 filing retains the dual‑domain approach (bny.com for the employee code and bnymellon.com for the Directors’ Code) and explicitly ties the Directors’ Code of Conduct to the broader corporate‑governance disclosures—referencing the Proxy, board‑committee charters and other governance items—showing it is now integrated into the overall governance framework rather than presented as an isolated document.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual inaccuracies in the domain transition timeline and URL paths, undermining the overall correctness. (1) Correct elements: The 2022 URL path and domain (bnymellon.com) are accurately described, including the 'in relations' path. The 2024 integration of the Directors' Code into broader governance disclosures (e.g., Proxy, board charters) is correctly noted and contextually relevant. (2) Incorrect facts: The LLM falsely claims that by 2023, BNY Mellon began using the bny.com domain for the employee Code of Conduct and moved the Directors’ Code to '/investor-relations'—this contradicts the ground truth. According to the original answer, the transition to bny.com occurred in 2024, not 2023. Additionally, in 2023, the path changed only slightly to 'inv relations' (not 'investor-relations'), indicating minimal change, not a 'clearer folder taxonomy' as claimed. The LLM incorrectly suggests a 'dual-domain approach' in 2024, implying the Directors’ Code remained on bnymellon.com while employee codes moved to bny.com, but the ground truth states that in 2024, the Directors’ Code itself moved to the new bny.com domain. (3) Multi-hop reasoning: The LLM correctly infers integration with corporate governance frameworks in 2024, which is a valid qualitative interpretation. However, it misaligns the timing and technical details of the domain migration, breaking the causal link between URL changes and branding strategy. (4) Scoring justification: Correctness is scored 5 due to major factual errors in the evolution timeline and domain usage, despite some correct contextual insights. Quantitative accuracy is 6 because while years and domains are mentioned correctly in some cases, their assignment to specific years is flawed. Qualitative accuracy is 5 due to sound reasoning about integration but based on incorrect premises. Contextual relevance is 8 because the answer addresses all aspects of the question (URL, domain, integration) and attempts meaningful interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1567,
        "completion_tokens": 555,
        "total_tokens": 2122
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "- **2022 (10‑K 2022 – page 11)** – AMD’s contracts with add‑in‑board (AIB) manufacturers included a clause that “protects their inventory of our products against price reductions.”  The filing also noted that “system integrators (SIs) often use discrete‑graphics solutions as a means to differentiate their products and add value to their customers.”  \n\n- **2023 (10‑K 2023 – page 13)** – The same inventory‑protection language re‑appeared (“our agreements with AIBs protect their inventory … against price reductions”) and the description of SIs “using discrete graphics solutions as a means to differentiate their products” was retained, showing no change in policy but a continued strategic focus on discrete GPUs for product differentiation.  \n\n- **2024 (10‑K 2024 – page 13)** – AMD again reiterated that its AIB agreements “protect their inventory … against price reductions,” and again highlighted that “SIs often use discrete graphics solutions as a means to differentiate their products.”  The consistency across the three years indicates that AMD’s positioning with AIB partners remained stable: it safeguards AIB inventory from price cuts while promoting discrete graphics as a key differentiator for system‑integrator offerings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) All factual elements are accurate: AMD maintained inventory protection policies for AIB manufacturers from 2022 to 2024, and consistently emphasized discrete graphics as a differentiator for system integrators (SIs). The LLM correctly identifies the consistent language across the three years in AMD’s 10-K filings. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) and page numbers (11, 13, 13) are accurately cited, aligning with the source documents. (3) The multi-hop reasoning is sound—information is correctly synthesized across three annual reports, showing evolution (or lack thereof) over time. The LLM correctly infers stability in strategy due to repeated language, which matches the ground truth’s conclusion of a 'stable, long-term partnership model.' (4) The answer is contextually precise, addressing both inventory protection and the strategic role of discrete graphics in differentiation each year. Wording differs slightly but conveys identical meaning. No errors in entities, years, or strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 339,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "In the 2022 Form 10‑K, McDonald’s simply listed the Egg McMuffin as one of the core breakfast items and said the company “continuously evolves its menu…including testing new products” to meet customers’ expectations for taste, quality, value and nutrition. By the 2024 filing, the same breakfast‑menu description is paired with a much more detailed supply‑chain narrative – highlighting high food‑safety and quality standards, regular sensory‑evaluation and calibration training, a digital‑driven quality‑management system and close supplier collaboration led by the Global Chief Supply‑Chain Officer – to assure that the Egg McMuffin (and other breakfast items) is delivered with consistent quality across the system. This shows the disclosure evolving from a general menu‑innovation statement in 2022 to a concrete link between breakfast‑menu innovation and a robust, technology‑enabled supply‑chain focus that underpins consistency for the Egg McMuffin in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 disclosure mentions the Egg McMuffin as part of the core breakfast menu and general menu evolution for customer expectations around taste, quality, and nutrition; in 2024, McDonald's emphasizes supply chain collaboration, digital transformation in quality management, and the role of the Global Chief Supply Chain Officer. The LLM correctly identifies the evolution from general statements to more detailed, technology- and supply chain-enabled consistency measures. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but all dates (2022, 2024) are accurate and correctly attributed to the respective disclosures. The absence of 2023 in the LLM answer is a minor omission, as the original answer notes 2023 as a transitional year, but the core evolution from 2022 to 2024 is still accurately captured. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and connects breakfast menu innovation (Egg McMuffin) to evolving supply chain and quality assurance strategies. It correctly infers that the digital quality-management system and supplier collaboration directly support consistency of the Egg McMuffin. (4) Semantic equivalence is strong—while the LLM does not quote the 'data excellence' phrase from 2024, it accurately conveys the same concept via 'digital-driven quality-management system' and 'continuous measures on quality.' The answer is fully contextually relevant, directly addressing the evolution in disclosure around breakfast innovation and supply chain focus. The only reason for not scoring a 10 is the slight underrepresentation of the 2023 developments, but since the question emphasizes 2022–2024 and the 2024 narrative implies progression, this does not materially detract from correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 510,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "The fact that Oracle’s 10‑K exhibits for 2022, 2023 and 2024 all list the **4.30 % Note due 2034** (see the exhibit tables in each filing 【page_110】) shows that this senior unsecured note remains outstanding and is a core component of the company’s long‑term debt portfolio. Its continued disclosure signals that Oracle is deliberately maintaining a fixed‑rate, medium‑term financing tranche that extends into the mid‑2030s, reflecting a strategy of diversifying maturities and locking in relatively low borrowing costs rather than relying on short‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities are correct: Oracle, the 4.30% Note due 2034, and the reporting years 2022–2024 are accurately identified. The note’s status as a persistent component of long-term debt is correctly conveyed. (2) Quantitative accuracy is perfect: the interest rate (4.30%), maturity year (2034), and consistent disclosure across three years match the original answer. No calculations were required, but the factual data is precise. (3) Reasoning is sound: the LLM correctly infers that the continued disclosure indicates the note remains outstanding and reflects a strategic choice to maintain fixed-rate, long-term financing. It appropriately concludes Oracle is diversifying maturities and locking in low rates, which is consistent with the ground truth’s interpretation. (4) While the LLM answer is semantically equivalent and captures the core insight, it omits some contextual details present in the original answer—specifically, the mention of other concurrent debt instruments (e.g., 3.625% Note due 2023, 2.950% Notes due 2024) that illustrate Oracle’s broader debt structure evolution. This minor omission limits completeness slightly, but the central multi-hop reasoning—linking consistent disclosure over three years to strategic financing priorities—is correctly executed. The answer remains highly relevant and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 390,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "- **2022:** COF’s net Level‑3 derivative position was only **$5 million** (net derivative assets = $19 m, net liabilities = $14 m).  The derivatives were valued with a **discounted‑cash‑flow model that uses unobservable swap‑rate inputs** (primarily term SOFR‑indexed swaps); the rest of the $79 m of derivative assets and $74 m of liabilities were measured at Level 2 using observable market curves.  \n\n- **2023:** The net Level‑3 balance rose to **$19 million** (derivative assets $886 m, liabilities $828 m).  The roll‑forward shows large **transfers into Level 3 ($166 m)** and settlements, indicating that a growing slice of the portfolio now required the same unobservable‑input model.  \n\n- **2024:** The net Level‑3 amount increased further to **$58 million** (derivative assets $683 m, liabilities $614 m) with modest transfers in and out, showing that COF’s reliance on **unobservable inputs for derivative valuation has been expanding** over the three‑year period.  \n\n**What this reveals:** While most derivatives remain Level 2 (valued with observable market data), the net Level‑3 exposure grew from $5 m → $19 m → $58 m, indicating a rising sensitivity to assumptions that cannot be directly observed in the market and therefore greater valuation uncertainty.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. First, the 2022 net derivative assets/liabilities fair value is stated as $5 million (net of $19M assets and $14M liabilities), but the ground truth reports a net fair value of $19 million with a $20 million unrealized loss—no breakdown of $19M assets and $14M liabilities appears in the original. The LLM introduces Level 2/Level 3 classifications and specific asset/liability totals ($79M assets, $74M liabilities in 2022) that are not present in the ground truth, fabricating granular data. In 2023, the LLM claims net Level-3 derivatives rose to $19M (from $886M assets and $828M liabilities), but the original states the fair value was $58M without specifying Level 3 or such large gross amounts. The 2024 net Level-3 figure of $58M matches the ground truth's fair value, but again, the gross assets/liabilities ($683M/$614M) and Level-3 framing are unverified and inconsistent with the original. The original emphasizes unobservable inputs like default rates (53–163%) and swap rates (3–5%) in 2023–2024, which the LLM omits, instead generalizing to 'unobservable swap-rate inputs' without citing the specific ranges. The LLM correctly infers increasing reliance on unobservable inputs over time, aligning with the trend in the original, but bases this on fabricated Level 3 net positions rather than the disclosed fair values and input transparency. While the reasoning about growing sensitivity to unobservable inputs is directionally consistent, the factual foundation is flawed. The answer is contextually relevant and addresses the evolution and exposure question, but fails on core quantitative accuracy due to invented figures and misrepresentation of the valuation methodology's evolution. Semantic equivalence is not achieved due to these material discrepancies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 503,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "RTX’s obligation to Rolls‑Royce for the V2500‑powered aircraft has remained unchanged from 2022‑2024. The company still must make payments that are **contingent on each flight hour flown through June 2027** by the V2500 fleet that was in service at the time of the 2012 IAE acquisition; these payments are **recorded as collaboration intangible assets** and **amortized to cost of sales** (using the asset’s estimated useful life) as the program moves into full‑rate production and aftermarket service. No alteration to the per‑hour payment structure or the amortization approach is disclosed in the 2022, 2023 or 2024 10‑K filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the payment obligation is contingent on flight hours of V2500-powered aircraft through June 2027, stemming from the 2012 IAE acquisition. Payments are capitalized as collaboration intangible assets and amortized to cost of sales—this is consistent across 2022–2024 per the original answer, and the LLM correctly notes no changes in structure or amortization policy. (2) There are no numeric inaccuracies; while the $14.1 billion figure for total commercial aerospace commitments in 2024 is missing from the LLM answer, this is a minor omission rather than an error—the LLM does not misstate any numbers. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across years and entities (RTX, Rolls-Royce, IAE, V2500 fleet) and links the payment structure to accounting treatment over time. (4) Semantic equivalence is strong—the core evolution (consistency of structure and amortization, with improved transparency) is accurately conveyed, even if the LLM emphasizes stability over incremental disclosure improvements. The only reason for not scoring a 10 is the omission of the $14.1B total commitment figure, which adds contextual depth but does not undermine the correctness of the specific obligations to Rolls-Royce.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 373,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "- 2022 10‑K – Amgen first disclosed that the FDA had placed the Neulasta Onpro kit under review in 2017 and that, in response, the company “implemented device and labeling enhancements to address product complaints” and would “continuously monitor complaints and adverse events.”   \n\n- 2023 10‑K – The same disclosure was retained, but the language was expanded to say that Amgen “continuously monitors complaints and adverse events and implements additional enhancements as needed,” indicating an ongoing, proactive risk‑mitigation program for the kit.   \n\n- 2024 10‑K – The filing repeats the 2017‑FDA‑evaluation background and the “device and labeling enhancements” and again stresses continuous monitoring and further enhancements.  In addition, the 2024 filing situates the kit‑related risk within a broader operational‑resilience discussion, noting that disruptions to third‑party suppliers, power outages, natural disasters and labor strikes in Puerto Rico could affect the supply of raw materials and medical‑device components, thereby highlighting new supply‑chain and infrastructure safeguards alongside the device‑specific improvements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2017 FDA evaluation, device and labeling enhancements in response to complaints, and the evolution of disclosures from 2022 to 2024. The 2024 addition of operational resilience—specifically power outages and infrastructure risks in Puerto Rico—is correctly identified, though the LLM does not explicitly mention the 'backup generators' or the 'December 31, 2024 island-wide outage' as stated in the original answer. This is a minor omission but does not distort the overall meaning. (2) Quantitative accuracy is perfect: all years (2022, 2023, 2024, 2017) are correctly cited, and no numerical errors are present. (3) Multi-hop reasoning is sound—LLM synthesizes information across three years of 10-K filings and correctly traces the evolution from device-specific improvements to broader operational risks. The connection between infrastructure instability and potential impact on device supply/complaints is implied, matching the original’s logic. (4) Wording differs slightly (e.g., 'third-party suppliers, power outages, natural disasters' vs. 'backup generators due to unstable grid'), but the semantic content is equivalent. The LLM captures the expansion into operational resilience without replicating every detail. Only a minor deduction from 10 due to the lack of specificity around the backup generator use and exact outage date in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 401,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings, BNY Mellon’s Item 14 disclosure is identical: it notes that the “ratification of KPMG LLP” is incorporated by reference to the proxy’s Item 3 and that KPMG LLP’s PCAOB firm identification number is 185. The unchanged language and the repeated citation of the same PCAOB number indicate that the firm has remained the company’s principal accountant throughout the three years, reflecting uninterrupted audit‑governance continuity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: BK (BNY Mellon) consistently ratified KPMG LLP as principal accountant in 2022, 2023, and 2024; the PCAOB firm number 185 is correctly cited across all years. The answer accurately reflects that the disclosure language remained unchanged, indicating continuity. (2) Quantitative accuracy is perfect: the PCAOB number 185 is correctly reported with no variation, and the years (2022–2024) match the ground truth. (3) Reasoning is sound: the LLM correctly infers that identical disclosure language and the repeated PCAOB number indicate no change in auditor, supporting audit governance continuity. It synthesizes information across three filings appropriately. (4) The only minor shortcoming is that the LLM refers to 'BNY Mellon’ instead of 'BK'—though this is a known shorthand (BK is ticker for BNY Mellon), the original answer uses 'BK' consistently, so the entity reference, while not incorrect, is slightly less precise in branding. However, this does not affect factual correctness. The answer fully addresses both parts of the question: evolution of disclosure (no change) and implication of PCAOB number (continuity in audit governance). Semantic equivalence is strong, and contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 368,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "RTX’s gross exposure to commercial‑aerospace customer‑financing guarantees fell each year – the maximum‑potential payment on those guarantees was $304 million at 12/31/2022, $288 million at 12/31/2023, and $274 million at 12/31/2024【page_100】.  At the same time, the portion of the guarantees that is assumed by collaboration partners has been shrinking (about $142 million in 2022, $135 million in 2023 and $131 million in 2024)【page_100】【page_103】, indicating that RTX is deliberately scaling back the overall size of its financing commitments while also reducing its reliance on partner‑backed risk sharing – a sign that the company is tightening its risk‑management posture in the commercial‑aerospace financing business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numbers from the ground truth: the collaboration partners' share of guarantees is accurately stated as $142M in 2022, $135M in 2023, and $131M in 2024. These match the original answer exactly, satisfying quantitative accuracy. The LLM also adds RTX's gross exposure figures ($304M, $288M, $274M), which are not in the ground truth but are factually correct per the cited SEC filing pages and provide useful context without contradicting the original. (2) All numeric values are correct and properly attributed to years. The trend of decreasing partner share is accurately described, and the calculation of year-over-year declines (e.g., $7M drop from 2022 to 2023, $4M from 2023 to 2024) is consistent with the data. (3) The multi-hop reasoning is sound: the LLM synthesizes the trend in partner-shared guarantees with the broader decline in gross exposure to infer a tightening of risk management, which aligns with and extends the original answer’s interpretation. The conclusion about reduced reliance on partner-backed risk sharing is a reasonable inference from the data. (4) The only minor shortcoming is that the original answer includes RTX's assertion about fair market values of guaranteed assets equalling or exceeding guarantees net of reserves—a point omitted in the LLM response. This is a contextual detail that supports RTX's confidence in asset values, and its absence slightly reduces completeness. However, the core of the question—evolution of exposure and what the trend indicates about risk management—is well addressed with accurate data and logical interpretation. Thus, the answer is highly accurate and relevant, meriting a 9 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 491,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "Across the three filings the Always brand is consistently placed in the Feminine Care sub‑category of the Baby, Feminine & Family Care segment and is listed first among the major brands (Always, Always Discreet, Tampax). In 2022 the filing notes that P&G is a global leader in feminine care “primarily behind our Always and Tampax brands,” and the same language and emphasis re‑appears in the 2023 and 2024 tables, with Always identified as the flagship menstrual‑care brand and Always Discreet covering adult‑incontinence. Thus, from 2022 through 2024 the positioning of Always did not change – it remained the lead menstrual‑care brand within the feminine‑care portfolio, highlighted alongside Tampax and supported by Always Discreet for incontinence.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the consistent strategic emphasis on Always as the lead menstrual-care brand and its positioning alongside Always Discreet and Tampax within the Feminine Care portfolio from 2022 to 2024. It accurately reflects the branding hierarchy and the repeated language in filings about P&G's leadership behind Always and Tampax. However, it contains a significant factual inaccuracy regarding segment categorization: it claims Always was part of the 'Baby, Feminine & Family Care' segment in 2022, but according to the ground truth, the segment was called 'Feminine Care' in 2022 and was only renamed in 2023. This misrepresents the evolution of the segment structure, which is central to the question. Additionally, the LLM omits the quantitative details about net sales contribution (25% in 2022, 24% in 2023 and 2024), which are key to assessing portfolio positioning. While the qualitative reasoning about brand emphasis is sound and contextually relevant, the incorrect timeline of segment naming and missing numerical data reduce quantitative and overall correctness. The answer synthesizes brand roles well but fails on precise structural evolution and metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 335,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "In the 2022 filing AMD already flagged “difficulties in protecting our intellectual property” as a political‑legal risk of its foreign operations (see 2022 p. 37) and even cited a concrete IP‑related issue – the U.S. Entity‑List restrictions on its Chinese THATIC joint‑venture (2022 p. 38). By the 2024 filing the same risk language re‑appears (2024 p. 40) but is now tied to a much larger overseas footprint: international sales had risen to roughly two‑thirds of revenue (65 % in 2023, 66 % in 2024) and “nearly all product assembly and final testing” is performed at third‑party facilities in China, Malaysia and Taiwan (2024 p. 41). Thus AMD’s exposure to IP‑protection difficulties has grown alongside its expanding international sales and its increasing reliance on Asian third‑party manufacturers, making the risk more material than it was in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: AMD flagged IP protection difficulties in 2022 (p.37), cited the THATIC joint-venture issue due to U.S. Entity List restrictions (p.38), and reiterated similar risk language in 2024 (p.40). The percentages for international sales (65% in 2023, 66% in 2024) are accurate and consistent with the original answer’s 65% figure for 2023 and implication of continued high international exposure. The statement that 'nearly all product assembly and final testing' occurs at third-party facilities in China, Malaysia, and Taiwan matches the original answer’s emphasis on reliance on Asian manufacturing. (2) Quantitative accuracy is perfect: all percentages and years are correctly cited, and no calculations are incorrect. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across 2022 and 2024 filings, connects increasing international sales and outsourcing to heightened IP risk, and infers growing materiality of the risk over time. However, it omits mention of the geopolitical tensions between China and Taiwan highlighted in the 2024 filing as a new layer of risk, which slightly weakens the qualitative completeness. (4) Despite this minor omission, the answer remains semantically equivalent in scope and intent, accurately conveying that AMD’s IP exposure has increased due to expanded international operations and reliance on Asian third-party manufacturers. Contextual relevance is excellent as it directly addresses the evolution of IP risks from 2022 to 2024 in relation to the specified factors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 447,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "Oracle first issued the 2.300 % senior notes that mature in 2028 in 2021 (the officers’ certificate dated March 24, 2021) and disclosed them in the 2022 Form 10‑K exhibit list (Exhibit 4.16)【page_114】. The same 2.300 % 2028 notes appear unchanged in the exhibit tables of the 2023 and 2024 Form 10‑K filings (Exhibit 4.14)【page_111】, indicating that Oracle has kept the issue outstanding but has not added new series at that coupon‑maturity combination. This recurring, multi‑year inclusion shows Oracle’s broader strategy of constructing a laddered, fixed‑rate debt program—locking in low‑cost financing (2.3 % for the 2028 maturity) while simultaneously issuing higher‑coupon notes in other years—to diversify maturity dates, manage interest‑rate risk and preserve financing flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers, dates, and percentages are correct: the 2.300% coupon, March 24, 2021 issuance date, and consistent inclusion in Exhibits 4.16 (2022) and 4.14 (2023, 2024) are factually accurate and match the original answer. The formatting variations (e.g., '2.3%' vs '2.300%') are acceptable and semantically equivalent. (2) The answer correctly identifies Oracle as the issuer and accurately tracks the multi-year disclosure pattern across 2022–2024 filings, satisfying the completeness requirement. (3) The reasoning is sound: it correctly infers from the unchanged inclusion of the notes that Oracle has not reissued or modified this instrument, and it synthesizes this pattern into a broader debt strategy—specifically, a laddered, fixed-rate approach to manage maturity diversification and interest-rate risk. This goes slightly beyond the original answer by explicitly naming 'laddered debt' and 'low-cost financing,' but these are reasonable interpretations supported by the data. (4) The only minor gap is that the original answer emphasizes 'diverse maturity profile' while the LLM uses more technical phrasing ('laddered, fixed-rate debt program'), which is accurate but slightly more interpretive. However, this does not detract from correctness. Overall, the answer demonstrates strong multi-hop reasoning across years and documents, with excellent contextual relevance and factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 411,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "Across the three filings the description of the private‑equity component stayed the same. In 2022 the 10‑K notes that the pension fund’s private‑equity vehicles are “primarily limited partnerships (LPs) that **mainly invest in U.S. and non‑U.S.** leveraged‑buyout, venture‑capital, growth and special‑situation strategies” (2022 p. 110). The 2023 filing repeats that language for the same asset class (2023 p. 92) and the 2024 filing again states the LPs “invest in **U.S. and non‑U.S.** leveraged‑buyout, venture‑capital, growth and special‑situation strategies” (2024 p. 99). Thus, from 2022 through 2024 BA’s private‑equity strategy did not shift its geographic scope—it remained globally‑focused—and it continued to target the same four strategic focus areas (leveraged buyouts, venture capital, growth and special situations).",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually accurate in its citation of the consistent language across the 2022, 2023, and 2024 filings regarding BA's limited partnership investments in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. There are no errors in entity names, years, or quoted descriptions, so quantitative and entity accuracy are strong. However, the LLM incorrectly concludes that there was no evolution in strategy, directly contradicting the ground truth. The original answer identifies a meaningful evolution: in 2023, there was an expanded emphasis on global private investments in real assets (energy, farmland, infrastructure), and in 2024, increased use of derivatives for performance transfer and exposure enhancement. The LLM failed to detect or report these strategic shifts, missing key qualitative developments despite accurate quoting. This represents a failure in multi-hop reasoning and synthesis—while the textual descriptions may have been similar, the strategic focus evolved beyond the static language cited. Thus, while the answer is contextually relevant and precisely quotes the filings, it lacks completeness and reasoning depth, resulting in a partially correct but ultimately misleading conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 353,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "Amgen first reported that bemarituzumab – a monoclonal antibody targeting FGFR2b – entered a Phase 3 trial in its 2022 Form 10‑K (the “initiated Phase 3 study” entry on the Phase 3 program‑change table).  In the 2023 and 2024 filings the drug still appears only in the Phase 3 candidate list, indicating it remained in that stage with no further regulatory milestone disclosed.  Across all three years Amgen’s composition‑of‑matter patents for bemarituzumab were listed as covering “polypeptides” with estimated expirations of 2029 in both the United States and Europe, and those dates were unchanged in the later reports.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Bemarituzumab entered a Phase 3 trial in 2022 (per Amgen's 2022 Form 10-K), remained in Phase 3 through 2024 with no advancement disclosed, and is protected by polypeptide-related composition-of-matter patents expiring in 2029 in both the U.S. and Europe—dates unchanged across years. (2) Quantitative accuracy is perfect: the 2029 patent expiration is correctly cited for both regions and all years, with no calculation errors. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly infers developmental stage continuity (Phase 3 retention), and links patent data to clinical progression. (4) The answer addresses all parts of the question: clinical phase progression (2022 initiation, status through 2024) and patent expiration timelines (2029 in U.S. and Europe), while accurately describing the drug’s mechanism (anti-FGFR2b monoclonal antibody) and development context. Wording differs slightly but meaning is fully aligned with the original answer. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 328,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "In 2022 the Fabric & Home Care segment contributed **35 % of net sales and 31 % of net earnings**, and Dawn was listed among its major brands (Ariel, Downy, Gain, Tide, Cascade, **Dawn**, Fairy, Febreze, Mr. Clean, Swiffer)【page_19】. By 2024 the segment’s share had risen to **36 % of net sales and 34 % of net earnings**, with Dawn still appearing in the same brand lineup【page_18】. Thus Dawn’s position improved modestly, as the segment’s earnings contribution grew by about three percentage points while the brand remained a core part of the segment’s portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: Dawn was listed as a brand in the Fabric & Home Care segment in both 2022 and 2024, the segment’s net earnings contribution increased from 31% to 34%, and net sales share rose from 35% to 36% (stable across years as per ground truth). All numeric values match the ground truth exactly, including the 31% and 34% earnings contributions and 35%/36% sales percentages. (2) Quantitative accuracy is perfect—percentages for net sales and net earnings are correctly cited for both years, and the three-percentage-point increase in earnings contribution is accurately implied. (3) The reasoning is sound: the LLM correctly infers that Dawn’s positioning improved modestly due to the segment’s growing earnings importance while remaining a core brand. The multi-hop synthesis—linking Dawn’s consistent inclusion with segment-level financial trends—is logically valid and aligns with the ground truth’s interpretation. (4) The only minor shortcoming is that the LLM does not explicitly note the stability of the sales percentage (35% in 2022, 36% in 2023 and 2024), which slightly weakens the qualitative completeness compared to the original answer. However, stating 35% in 2022 and 36% in 2024 still conveys the essential stability. Wording differs but semantic meaning is equivalent. All entities (Dawn, Fabric & Home Care, P&G, correct years) are accurate. Thus, the answer is highly accurate with only a slight omission in elaborating on sales stability, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 426,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "- **2022 → 2023 → 2024 trend** – In 2022 Schwab already used client‑margin securities as the primary source of collateral for its margin‑loan portfolio and for a variety of off‑balance‑sheet borrowing arrangements (e.g., FHLB facilities, secured lines of credit). By the end of 2023 the company was able to draw **$63.1 billion** of borrowing capacity from the Federal Home‑Loan Bank (FHLB) program on the basis of client‑margin securities, and it had **$950 million** of outstanding secured uncommitted credit lines that were pledged against those same client securities【page_97】.  \n\n  In 2024 the same metrics fell modestly: the FHLB collateral‑backed borrowing capacity declined to **$59.8 billion**, and the CS&Co secured‑line balance pledged with client margin securities dropped to **$500 million**【page_97】. The TD Ameritrade Clearing (TDAC) secured lines that had also been pledged with client margin securities were terminated in 2024, removing another **$700 million** of pledged exposure that existed at the end of 2023【page_97】.\n\n- **What the trend shows** – The amount of client‑held securities that Schwab pledges to satisfy margin‑lending obligations and other collateral requirements has remained very large (tens of billions of dollars) but has **started to recede slightly after peaking in 2023**. The reduction in pledged collateral and the termination of the TDAC lines suggest the firm is moderating its reliance on client‑margin securities for external funding, yet the still‑substantial $60 billion‑plus of client‑security‑backed borrowing capacity indicates that Schwab’s exposure to client‑held assets remains material.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer introduces specific quantitative figures (e.g., $63.1 billion FHLB borrowing capacity in 2023, $59.8 billion in 2024, $950 million and $500 million credit lines) that are not present in the original ground truth answer and cannot be verified against it. Since the ground truth does not include any numerical data, the introduction of such precise dollar amounts suggests the LLM may have hallucinated or referenced external data not aligned with the provided knowledge graph. This severely undermines quantitative accuracy. Regarding qualitative accuracy, the LLM correctly identifies that Schwab uses client securities for margin lending and collateral obligations across 2022–2024, and notes a trend of high but slightly declining pledging activity—this partially aligns with the ground truth’s implication of ongoing and sophisticated use. However, the LLM fails to mention key elements from the original answer: (1) the application of ASC 326 and the practical expedient in 2023 to reduce expected credit losses, (2) the pledging of securities for clients writing listed options cleared by the Options Clearing Corporation in 2024, and (3) the provision of cash collateral in securities lending activities. These omissions represent significant gaps in completeness and multi-hop synthesis. The trend interpretation in the LLM answer—reducing reliance on client securities—is speculative and contradicts the ground truth, which describes increasing sophistication and exposure. Thus, while the answer is contextually relevant and addresses the general theme of client securities usage, it lacks alignment with the factual content of the ground truth, particularly on regulatory frameworks and evolving use cases. Semantic equivalence is not achieved due to both factual divergence and unsupported numerical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1660,
        "completion_tokens": 494,
        "total_tokens": 2154
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "Based on the tables that disclose the weighted‑average plan‑asset mix as of August 31, ACN’s defined‑benefit pension strategy moved away from a largely debt‑focused, low‑equity mix in 2022 toward a slightly more diversified mix by fiscal 2025.  \n\n*For the non‑U.S. plans, the equity‑security weight rose from 21 % (2022) to 27 % in the 2023 target and to 28 % in the 2025 target, while the debt‑security weight fell from 48 % (2023 target) to 36 % (2025 target). Cash‑and‑short‑term holdings increased from 4 % to 7 %, insurance contracts grew from 11 % to 21 %, and “other” assets were trimmed from 10 % to 8 %.*  \n\n*For the U.S. plans, the allocation remained essentially 100 % debt (the target stayed at 100 % in both 2023 and 2025), with only modest shifts in the weighted‑average mix—cash rose from about 3 % (2022) to 5‑6 % (2023‑2024) and debt slipped slightly from 97 % to the mid‑90s %.*  \n\nOverall, the evolution shows ACN increasing equity, cash, and insurance exposure in its non‑U.S. pension assets while reducing reliance on debt, whereas the U.S. pension assets stayed anchored to a debt‑centric allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in both direction and magnitude of allocation changes. (1) The original answer states that ACN's overall defined benefit pension plan strategy shifted from 55% fixed income / 45% equities in fiscal 2023 (as of Aug 31, 2022) to 61% fixed income / 39% equities in fiscal 2025 (as of Aug 31, 2024), indicating a consistent de-risking move toward more fixed income. The LLM instead claims a move toward more equities and reduced debt, which is the opposite trend. (2) The LLM introduces a breakdown by U.S. and non-U.S. plans not present in the original answer, with fabricated percentages: e.g., non-U.S. equity rising from 21% to 28%, debt falling from 48% to 36%, insurance rising to 21%, etc. These numbers do not appear in the ground truth and are unsupported. The claim that U.S. plans remained at 100% debt is also not corroborated and contradicts the aggregate trend. (3) The multi-hop reasoning fails: the question asks for evolution based on weighted-average plan asset allocations as of Aug 31 in 2022, 2023, and 2024 — i.e., three data points forming a time series. The LLM misrepresents the data by introducing unmentioned sub-plan categories and incorrect values. (4) While the answer attempts contextual relevance by discussing allocation trends and pension strategy, the factual inaccuracies and invented data severely undermine correctness. Minor credit is given for addressing the general topic of asset allocation evolution. Quantitative accuracy is very low due to entirely incorrect numbers and mischaracterized trends. Qualitative accuracy is poor due to flawed entity and metric usage. Contextual relevance is moderate as it discusses pension asset allocation, but with wrong details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 479,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "- 2022: Short‑term borrowings ≈ $883 million; Long‑term debt ≈ $47.8 billion (carrying value)【page_178】  \n- 2023: Short‑term borrowings ≈ $538 million; Long‑term debt ≈ $49.3 billion【page_178】  \n- 2024: Short‑term borrowings ≈ $562 million; Long‑term debt ≈ $45.0 billion【page_188】\n\nOver the three‑year span, Capital One’s short‑term borrowing fell sharply from 2022 to 2023 and then edged higher in 2024, while long‑term debt rose modestly in 2023 before dropping by about $4 billion in 2024.  The net effect is a slight reduction in total debt and a shift toward a lower‑interest‑rate profile, as the weighted‑average rate on long‑term notes moved from roughly 4.5 % in 2022‑23 to a modestly higher 4.8 % in 2024, but the lower overall debt balance lessens the company’s exposure to rising rates.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. According to the ground truth, total short-term borrowings and long-term debt were $43.086B (2022), $48.715B (2023), and $45.551B (2024). However, the LLM reports long-term debt alone as $47.8B (2022), $49.3B (2023), and $45.0B (2024), which already exceeds the total debt in the ground truth and misrepresents the composition. Additionally, short-term borrowings in the LLM answer ($883M, $538M, $562M) do not align with the implied totals from the ground truth (which would require short-term borrowings of ~$-4.7B in 2022 — impossible). Thus, the individual components are factually incorrect. (2) The weighted-average interest rate is completely wrong: LLM states ~4.5% in 2022–2023 rising to 4.8% in 2024, but ground truth shows securitized debt rates rising from 1.51% (2022) to 3.01% (2023) to 3.48% (2024). The LLM overstates rates and omits that it's specifically securitized debt. (3) The LLM fails to mention the elimination of floating unsecured senior debt ($1,597M in 2023 → $0 in 2024), a key strategic shift highlighted in the original answer. This is a critical omission in assessing interest rate exposure. (4) While the LLM attempts multi-hop reasoning by analyzing trends in short- and long-term debt and drawing conclusions about interest rate exposure, the conclusions are based on incorrect data. The claim of a 'lower-interest-rate profile' contradicts the ground truth of rising rates. The contextual relevance is fair because it addresses the question’s structure and attempts trend analysis, but factual errors severely undermine correctness. Minor formatting issues (e.g., page references) do not affect scoring, but core numbers and synthesis are flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 484,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "Boeing’s fleet‑support services have consistently represented roughly 1 percent of total consolidated costs of products and services in each of the three most recent years—about 1 % in 2022, about 1 % in 2023 and again about 1 % in 2024. This flat share contrasts with the sharp rise in abnormal production expenses and reach‑forward losses: cumulative abnormal 787 production costs grew from roughly $2 billion (cumulative through 2022) to $2.7 billion by the end of 2023 and added another $256 million in 2024, while reach‑forward losses on the 777X program ballooned to $2.6 billion in Q3 2024 and a further $0.9 billion in Q4 2024. Thus, while fleet‑support costs have stayed steady at about 1 % of total costs, the company’s cost profile has been increasingly weighed down by escalating abnormal production costs and large reach‑forward losses in the 787 and 777X programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, the LLM correctly states that fleet support services costs were approximately 1% of total consolidated costs in 2022, 2023, and 2024, which aligns with the original answer. The $2.7 billion cumulative abnormal production cost for the 787 program by end of 2023 is correct. The LLM adds a detail not in the original—$256 million additional cost in 2024—which is plausible but not confirmed in the ground truth; however, it does not contradict it outright. For the 777X, the LLM reports $2.6 billion in Q3 2024 and $0.9 billion in Q4 2024, which matches the original $2,608 million and $891 million when rounded (2,608 ≈ 2.6B, 891 ≈ 0.9B), so format and rounding are acceptable. (2) Completeness: The LLM addresses both parts of the question—evolution of fleet support costs and their relation to abnormal/program losses—and synthesizes across programs and years appropriately. (3) Entity accuracy is correct: Boeing (BA), 787 and 777X programs, correct years (2022–2024), and proper financial terms (abnormal production costs, reach-forward losses). (4) Reasoning is sound: the contrast between stable fleet support costs and rising program-specific losses is clearly articulated, and the conclusion that financial strain stems from production issues, not services, is logically supported. The only minor deviation is the inclusion of a $256M 2024 787 cost not explicitly in the ground truth, which slightly affects quantitative precision but does not undermine overall correctness. Thus, the answer is factually strong, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1568,
        "completion_tokens": 449,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "- 2022: $21 million in money‑market funds and time deposits  \n- 2023: $10 million in money‑market funds and time deposits  \n- 2024: $10 million in money‑market funds and time deposits  \n\nThe amount fell sharply after 2022 and then held steady at roughly half the prior level, showing that AbbVie trimmed its short‑term cash‑equivalent holdings – likely to fund operating needs, debt reduction or acquisitions – while still keeping a modest liquidity cushion.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported amounts and years. According to the ground truth, AbbVie's allocation was $12M in 2022, $21M in 2023, and $10M in 2024. The LLM incorrectly states $21M in 2022, $10M in 2023, and $10M in 2024—swapping the 2022 and 2023 values and missing the increase in 2023 entirely. This misrepresents the trend. (2) The quantitative inaccuracies are critical: the peak in 2023 is misrepresented as a drop, and the 2022 baseline is overstated. Calculations or comparisons based on these numbers (e.g., 'half the prior level') are therefore invalid. (3) The reasoning is partially sound in interpreting a reduction in short-term holdings as a potential signal of funding reallocations, but it fails to capture the actual multi-hop trend: a rise in 2023 followed by a drop in 2024. The model misses the temporary conservative shift in 2023, which is central to the correct interpretation. (4) Contextual relevance is fair because the answer addresses liquidity strategy and offers a plausible explanation, but the flawed data undermines the conclusion. Scores reflect major factual errors in numbers and trend interpretation, with partial credit for attempting strategic reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 350,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "- **Fiscal 2022** – Accenture bought 12.2 million Class A shares for about **$4.1 billion**.  At year‑end the company had **$3.13 billion** of unused authorization, and after a September‑2022 board approval of an extra $3 billion the **total outstanding repurchase authority rose to roughly $6.13 billion**.  \n\n- **Fiscal 2023** – The company continued to repurchase shares at a similar scale (roughly $4‑$5 billion of buy‑backs throughout the year) and the repurchase ceiling remained at **about $6 billion**, with the unused portion staying in the low‑single‑digit‑billion range.  \n\n- **Fiscal 2024** – In the fourth quarter Accenture purchased 2.07 million shares for **$605 million**; the **remaining available authorization was $2.69 billion**.  A September‑2024 board decision added $4 billion, taking the **total outstanding authority to $6.69 billion**.  \n\n**What the trend shows:** Accenture has been steadily using its open‑market buy‑back program each year and periodically raises the overall authorization ceiling.  This pattern signals a clear, ongoing capital‑return strategy that relies on share repurchases to return excess cash to shareholders while preserving flexibility for future buy‑backs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers, particularly in the remaining authorization amounts and the timeline of authorizations. According to the ground truth, in fiscal 2022, Accenture had $3,129,296 thousand (~$3.13 billion) in available authorization — this part is correct. However, the LLM claims that after a September 2022 board approval of $3 billion, the total outstanding repurchase authority rose to $6.13 billion. This is unsupported by the ground truth, which does not mention this specific $3 billion increase in 2022 or a resulting $6.13 billion total. The ground truth states that by fiscal 2023, the cumulative authorization since 2001 was $50.1 billion, with $2,694 million ($2.694 billion) remaining as of August 31, 2023 — not $6 billion as claimed. The LLM incorrectly implies that the remaining authorization in 2023 was in the 'low single-digit billions' and that the ceiling remained at $6 billion, which misrepresents the actual trend. In fiscal 2024, the LLM correctly notes a $4 billion addition in September 2024 and a resulting total outstanding authority of $6.69 billion, aligning with the ground truth’s $6,694 million. However, it incorrectly states that the remaining available authorization before this increase was $2.69 billion — while this number matches the 2023 year-end figure, the ground truth does not confirm it carried into 2024 before the new authorization. (2) Calculations: The LLM’s arithmetic (e.g., $3.13B + $3B = $6.13B) is mathematically correct but based on unverified inputs. The $4 billion increase leading to $6.69 billion total is accurate. (3) Multi-hop reasoning: The LLM correctly infers a consistent capital return strategy via share repurchases and periodic increases in authorization, which aligns with the ground truth’s interpretation. It synthesizes activity across years and draws a reasonable conclusion about strategic intent. (4) Despite incorrect intermediate figures and unsupported assumptions about the 2022 authorization jump, the overall narrative of increasing repurchase capacity and sustained capital return is directionally correct. The core trend is captured, but quantitative precision — especially around the evolution of remaining vs. total authorization — is flawed, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 622,
        "total_tokens": 2108
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "Across the three most recent filings—2022 (Item 46), 2023 (Item 27) and 2024 (Item 27)—AbbVie’s charter and bylaws consistently state that “stockholders may only remove directors for cause.” The language of this provision, together with the staggered three‑class board and the 80 % super‑majority required to amend director‑related provisions, is unchanged from year to year. This steady emphasis on limiting shareholder‑initiated removals signals a deliberate, long‑term board‑entrenchment strategy designed to make hostile takeovers more difficult and to force any potential acquirer to negotiate with the incumbent board.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AbbVie consistently maintained the 'removal for cause only' provision in its governance documents across 2022, 2023, and 2024. The answer correctly identifies the stability of this provision and links it to broader anti-takeover mechanisms. (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or dates are presented. The mention of an '80% super-majority' requirement matches the ground truth's reference to 'supermajority requirements,' and while the exact percentage isn't in the original, it is a plausible and consistent detail that does not contradict the ground truth. (3) Multi-hop reasoning is sound: the LLM synthesizes governance provisions across three years and correctly infers a long-term board entrenchment and takeover defense strategy. It references the staggered board and amendment barriers, which are key components of the strategy. (4) The only minor shortcoming is that the LLM answer does not explicitly name other anti-takeover provisions like restrictions on special meetings, which are mentioned in the original and contribute to completeness. However, the core reasoning and strategic interpretation are fully aligned. Wording differs but semantic meaning is equivalent. The reference to specific 'Items' (e.g., Item 46, Item 27) appears to be a formatting artifact or mislabeling (as 10-Ks do not typically use such item numbers for governance provisions), but this does not affect the factual correctness of the provision description. Overall, the answer is factually robust, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 464,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "All three annual reports list the same exhibit entry – **“Form of 4.000 % Senior Note due 2047, incorporated by reference to PepsiCo’s Form 8‑K filed May 2 , 2017”** (see the exhibit table where item 4.17 contains this language in the 2022 filing 【page_126】, the 2023 filing 【page_126】 and the 2024 filing 【page_126】). The unchanged disclosure shows that the 4 % 2047 note remains an outstanding, long‑dated debt instrument and that PepsiCo consistently reports it as a core component of its long‑term capital structure, signaling a deliberate strategy to retain low‑cost, fixed‑rate financing through the end of the next decade.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 4.000% Senior Note due 2047 was consistently disclosed across the 2022, 2023, and 2024 10-K filings with the same exhibit reference — 'Form of 4.000% Senior Note due 2047, incorporated by reference to PepsiCo’s Form 8-K filed May 2, 2017'. This matches the ground truth exactly in substance. The only minor discrepancy is the exhibit number: the LLM states it is 'item 4.17' in the exhibit tables, while the ground truth references 'Exhibit 4.5'. This is a factual error in exhibit numbering, but the rest of the citation (including the May 2, 2017 8-K) is correct. (2) Quantitative accuracy is perfect: the interest rate (4.000%), maturity year (2047), and filing date (May 2, 2017) are all accurate. The LLM correctly notes the consistency across three years. (3) The multi-hop reasoning is sound — the model synthesizes data across three annual reports and draws a valid conclusion about the note’s role in PepsiCo’s long-term capital structure strategy. It correctly infers that the unchanged disclosure implies stability and strategic retention of fixed-rate, long-dated debt. (4) The answer is contextually excellent, directly addressing both parts of the question: evolution (or lack thereof) in disclosure and the strategic implication. The conclusion about 'low-cost, fixed-rate financing' is a reasonable interpretation, though slightly more interpretive than the ground truth’s neutral tone. The exhibit number error prevents a perfect 10, but overall the answer is factually strong, complete, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 435,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "- In Oracle’s 2022 Form 10‑K the 4.30 % senior note that matures in 2034 is listed in Exhibit 4.11 (together with the 3.40 % 2024 and 4.50 % 2044 notes) and is identified as having been issued on July 8 2014 【page_113】.  \n- The 2023 Form 10‑K again includes Exhibit 4.11 in its index, showing the same 4.30 % 2034 note as an outstanding obligation (the note is still referenced in the exhibit schedule for that year) 【page_111】.  \n- The 2024 Form 10‑K repeats the same disclosure, keeping the 4.30 % 2034 note in Exhibit 4.11 and indicating that the security remains on the balance sheet 【page_111】.  \n\nThis three‑year continuity demonstrates that Oracle deliberately issues long‑dated, fixed‑rate senior notes and retains them for many years, using them to lock in relatively low borrowing costs and to spread maturities well into the future as a core element of its long‑term debt strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual elements are accurate: the 4.30% Note due 2034 was issued on July 8, 2014, and consistently disclosed in Oracle’s 2022, 2023, and 2024 10-K filings in Exhibit 4.11, as confirmed by the cited page numbers. (2) Quantitative accuracy is precise—interest rate (4.30%), maturity year (2034), and issuance date (July 8, 2014) are all correctly stated. No calculations were required, but the temporal consistency across years is accurately represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual reports, identifying the continued presence of the note as evidence of a stable, long-term debt strategy. (4) The conclusion about Oracle’s strategy—using long-dated, fixed-rate notes to lock in low borrowing costs and diversify maturity profiles—is semantically equivalent to the ground truth’s characterization of a 'stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.' The answer is complete, factually accurate, and contextually appropriate, addressing both the evolution of disclosure and the strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 342,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "- Fiscal 2022 (and still in the 2023 filing) the Amended 2010 Share Incentive Plan authorized **127 million** Accenture Class A ordinary shares for awards.  \n- Fiscal 2024 the plan was amended to authorize **141 million** Class A ordinary shares.  \n\nThe 14‑million‑share increase shows Accenture is deliberately expanding the pool of shares it can use for equity‑based compensation, underscoring a long‑term strategy to rely more heavily on share awards to attract, retain and motivate employees and leadership.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the timeline of the share authorization increase. According to the ground truth, the number of authorized shares increased from 127 million in fiscal year 2022 to 141 million in fiscal year 2023 and remained at that level in 2024. However, the LLM incorrectly states that the amendment to 141 million occurred in fiscal 2024, which misrepresents the timing of the change. This is a significant error in temporal accuracy. (2) The numeric values themselves—127 million and 141 million—are correct and the 14-million-share difference is accurately implied. However, the calculation is not explicitly stated, and the misattribution of the increase to 2024 undermines quantitative precision in context. (3) The multi-hop reasoning is partially sound: the model correctly infers that the increase indicates a strategic expansion of share-based compensation for talent management. However, it fails to note that the number remained unchanged from 2023 to 2024, which is a key part of the progression and suggests stability post-increase. This omission affects completeness and reasoning accuracy. (4) Contextual relevance is high—the answer addresses the evolution of authorized shares and interprets the strategic intent. But due to the incorrect year for the increase and missing the stability in 2024, the correctness and qualitative accuracy scores are reduced. Minor wording differences are acceptable, but the misplacement of a key event across fiscal years constitutes a significant factual deviation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 431,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "- In the 2022 Form 10‑K, PepsiCo lists the **2.750 % Senior Note due 2051** as Exhibit 4.3 and incorporates it by reference to the **Oct 21 2021 Form 8‑K** that originally set the note’s terms.  \n\n- The 2023 and 2024 Form 10‑Ks repeat the same reference (still Exhibit 4.3 to the 2021 8‑K) and also embed the note in a consolidated “master” exhibit list (Exhibit 4.4) that pulls together all of PepsiCo’s senior notes—including the 2.750 % due 2051—under a prior 2013 filing.  \n\n- This multi‑year pattern shows PepsiCo’s long‑term debt‑structuring strategy: it issues very long‑dated senior notes once, then continuously references the original issuance documentation in subsequent filings, indicating a stable, incremental approach to managing its long‑term debt portfolio rather than repeatedly re‑issuing or renegotiating the same instrument.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) QUANTITATIVE/ENTITY INACCURACY: The LLM incorrectly states that the 2.750% Senior Note due 2051 was listed as Exhibit 4.3 in the 2022 10-K and incorporated from an October 21, 2021 Form 8-K. The ground truth indicates it was first introduced in 2022 via Exhibit 4.60 as part of a Board resolution, not via a 2021 8-K. There is no mention of an October 2021 filing in the ground truth, making this a major factual error. (2) EXHIBIT NUMBERS ARE WRONG: The LLM claims Exhibits 4.3 and 4.4 are used in 2023 and 2024, but the ground truth shows Exhibit 4.51 in 2023 and 4.48 in 2024—different numbers with no mention of consolidation under a 'master' exhibit. This misrepresents the documentation evolution. (3) REASONING FLAW: While the LLM attempts to infer a stable debt strategy (which aligns thematically with the ground truth), it bases this on incorrect evidence—namely, repeated referencing of a 2021 document—whereas the ground truth shows a phased progression from authorization (2022) to formalization (2023) to stability (2024). The actual reasoning reflects a deliberate rollout, not passive re-reference. (4) SEMANTIC NON-EQUIVALENCE: Despite a similar high-level conclusion about stability, the factual foundation is incorrect. The multi-hop synthesis fails because it misidentifies the timeline, documents, and procedural steps. The answer is contextually relevant to the question’s intent but factually unsound, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 424,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "In its 2022 filing American Express described its global card network as the **fourth‑largest general‑purpose network** (behind UnionPay, Visa and Mastercard) and warned that “the payments industry continues to undergo dynamic changes…including the rapid growth of alternative‑payment mechanisms such as digital wallets, fintech platforms and buy‑now‑pay‑later products” (2022 10‑K pp. 12‑13). By the 2024 filing the company still occupies that fourth‑place ranking, but it stresses that **intensifying regulatory scrutiny**—including new interchange‑fee caps, non‑discrimination/“honor‑all‑cards” rules, the exit from EU and Australian network‑licensing regimes, and heightened oversight of third‑party providers—has begun to compress discount revenue and could force changes to its merchant‑acceptance practices (2024 10‑K pp. 34‑35). Thus, while Amex’s relative size in the card‑network hierarchy has remained stable, its competitive position has become **more vulnerable** as regulators tighten rules and alternative‑payment ecosystems expand, prompting the firm to lean more on its integrated‑payments platform and risk‑management controls to defend market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies American Express as the fourth-largest general-purpose card network globally, behind China UnionPay, Visa, and Mastercard, consistent across 2022 and 2024—this matches the original answer exactly. (2) There are no numerical values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all references to years (2022, 2024) and regulatory developments are correctly cited. (3) The multi-hop reasoning is sound: the LLM synthesizes information across filings to show that while Amex’s market ranking has remained stable, its competitive positioning has weakened due to two key factors—rising regulatory scrutiny (specifically interchange fees, honor-all-cards rules, exits from EU/Australia) and expansion of alternative payment mechanisms (digital wallets, BNPL). These points are all present and correctly interpreted from the original knowledge base. (4) The LLM adds slightly more detail than the original (e.g., mentioning Australia, 'discount revenue', 'integrated-payments platform'), but these are reasonable inferences or consistent with known regulatory trends and do not contradict the ground truth. The only minor gap is that the original emphasizes cobrand relationships and loyalty systems as part of Amex’s differentiation, which the LLM omits—hence a 9 instead of 10 on qualitative accuracy. However, the core evolution in competitive positioning—shift from market-driven to regulation-constrained dynamics—is clearly conveyed. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 466,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "In the 2022 filing Boeing’s Global Services description already listed **“upgrades and conversions”** alongside maintenance, engineering and spare‑parts support, and the competition discussion said BGS would “grow market share by leveraging a high level of customer satisfaction and productivity” with those capabilities. The 2024 filing repeats the same wording – upgrades and conversions remain a named element of the Global Services portfolio and are again tied to a strategy of winning share in a highly competitive market. Together, the unchanged emphasis indicates that Boeing continues to treat aircraft upgrades and conversions as a cornerstone of its services business, using them to sustain customer relationships and drive growth rather than shifting to a new focus.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. While it correctly identifies that 'upgrades and conversions' were mentioned in both 2022 and 2024 filings, it fails to recognize the strategic evolution described in the ground truth. The LLM claims there is 'unchanged emphasis,' but the ground truth shows a clear shift from treating upgrades as one of many services in 2022, to emphasizing 'modifications' more in 2023, and integrating 'data analytics and digital services' with upgrades in 2024. This indicates a strategic evolution toward technology-enabled, high-value services, which the LLM completely misses. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in dates or numbers mentioned. (3) The multi-hop reasoning is flawed: the question asks for a comparison across 2022 to 2024 to assess strategic change, but the LLM only compares 2022 and 2024, ignores 2023, and draws an incorrect inference of stability. It fails to synthesize the progression and strategic nuance present in the ground truth. (4) Contextual relevance is moderate—the answer addresses Boeing’s services strategy and mentions the correct segment and offerings, but misinterprets the strategic direction. Correctness and qualitative accuracy are low due to the fundamental error in reasoning and conclusion, despite using plausible language from filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 395,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "- In the 2022 Form 10‑K, PepsiCo listed the 5.50 % Senior Note due 2035 (both the “Series A” version and the plain‑vanilla version) as Exhibit 4.25 and Exhibit 4.29, each incorporated by reference to the 2018 Registration Statement (Nov. 8 and Nov. 19 2018).  \n- The 2023 Form 10‑K repeated the same disclosure, again showing the 5.50 % Senior Note due 2035 (Series A – Exhibit 4.23; plain – Exhibit 4.27) with the same 2018 filing references.  \n- By the 2024 Form 10‑K, the 5.50 % Senior Note due 2035 no longer appears in the exhibit list (pages 125‑129), indicating that the issue has been removed from the active debt schedule—most likely retired, repaid or refinanced.\n\n**What this pattern shows:** PepsiCo consistently documents each outstanding senior‑note series in its annual filings, but once a note is taken off the balance sheet it is dropped from the exhibit schedule. The three‑year sequence demonstrates a disciplined long‑term debt‑management approach: the company tracks and reports existing notes year‑by‑year and actively retires or refinances maturing issues (such as the 5.50 % 2035) to reshape its maturity profile and control interest‑cost exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) QUANTITATIVE/ENTITY INACCURACY: The LLM incorrectly states that in 2022, the 5.50% Senior Note due 2035 was listed as Exhibits 4.25 and 4.29 referencing Nov 8 and Nov 19, 2018 filings. The ground truth shows it was Exhibit 4.31 in 2022, referencing only the Nov 8, 2018 8-K. Similarly, in 2023, the LLM cites Exhibits 4.23 and 4.27, but the correct exhibit is 4.25. These exhibit numbers are inconsistent with the ground truth. Most critically, the LLM claims the note 'no longer appears' in the 2024 10-K, implying retirement or refinancing, but the ground truth confirms it reappeared in 2024 as Exhibit 4.23 — directly contradicting the LLM's central claim. (2) REASONING FAILURE: The conclusion that PepsiCo retired or refinanced the note is incorrect based on the evidence. The repeated inclusion across all three years — with consistent reference to the 2018 filing — indicates ongoing maintenance of the debt, not retirement. The LLM misinterprets the absence of a note from exhibits as removal from the balance sheet, but the ground truth shows it was still disclosed, meaning it remains active. (3) COMPLETENESS: While the LLM attempts to address the multi-year evolution and strategic implications, its core narrative is factually inverted — it reports discontinuation where there was continuity. (4) SEMANTIC NON-EQUIVALENCE: The meaning is not preserved; the LLM suggests active debt reduction or refinancing, while the truth reflects stable long-term debt management. Minor flexibility is allowed in wording, but not in such a fundamental factual reversal. (5) CONTEXTUAL RELEVANCE is moderate because the structure and intent align with the question, but the content is wrong. Overall, major factual and reasoning flaws justify a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 499,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings BNY Mellon repeatedly states that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning” (see 2022 p. 5; 2023 p. 5; 2024 p. 5). The wording is unchanged from year to year, indicating that the company’s exposure to U.S. banking‑law constraints on capital planning and shareholder‑return actions has remained steady and continues to be a material limitation on its dividend‑ and share‑repurchase policies.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claim: BNY Mellon consistently cited U.S. banking laws and regulations as constraints on capital returns across 2022–2024, with nearly identical language in each year’s 10-K (p. 5 in all years), which supports the assertion of steady regulatory exposure. The quantitative accuracy is perfect—no numerical errors, and the citations (years, page numbers) are correct. The entity identification (BNY Mellon, U.S. banking laws, capital planning, shareholder returns) is accurate, and the multi-hop reasoning—synthesizing disclosures across three years—is sound. However, the LLM answer falls slightly short in completeness compared to the ground truth. While the original answer notes an evolution—2022 being more general, 2023 adding Delaware law and preferred stock obligations, and 2024 emphasizing 'well capitalized' status—the LLM incorrectly states the wording is 'unchanged from year to year.' In reality, while the core sentence about U.S. banking laws is repeated, additional constraints were introduced over time. This omission of nuanced progression reduces qualitative accuracy slightly, as the evolving emphasis reflects deeper regulatory layering. Nonetheless, the LLM captures the central theme of ongoing, material regulatory constraints, making the answer contextually relevant and largely correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 376,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "Oracle’s 2.300 % senior notes that mature in 2028 were first issued with a fixed 2.300 % coupon and a 2028 maturity (the officers’ certificate for the issue is dated March 24, 2021). The 2022, 2023 and 2024 Form 10‑K filings all reference the same issue – the coupon, maturity and other terms have not been altered or re‑priced. This consistency shows that Oracle locked in a low‑rate, long‑dated debt tranche before U.S. interest rates began to climb, and has chosen to keep that inexpensive financing on its balance sheet rather than issue new, higher‑coupon debt as rates rose.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 2.300% Notes due 2028 were issued under an Officers' Certificate dated March 24, 2021, and remained unchanged in 2022, 2023, and 2024. The LLM correctly states that no repricing or structural changes occurred across the years. (2) Quantitative elements—interest rate (2.300%), maturity year (2028), and issuance date (March 24, 2021)—are all precisely accurate. (3) The reasoning is sound: the LLM correctly infers that Oracle locked in low-cost debt before interest rates rose and chose not to issue new debt at higher rates, which matches the ground truth's interpretation. It captures the core strategy of preserving favorable fixed-rate financing. (4) While the LLM omits some contextual details present in the original answer—such as Oracle’s issuance of higher-yielding 4.500% Notes due 2028 in 2023 and the broader multi-tiered offering context including the 2.875% and 3.950% tranches—this does not undermine the central correctness of the response. These omissions slightly reduce completeness but do not introduce error. The answer remains semantically equivalent in its conclusion and sufficiently addresses both parts of the question: evolution of terms (no change) and strategic implication (locking in low rates). Thus, it earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 403,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "Across the three most recent 10‑K filings IBM has repeatedly placed **client relationships and trust** among its core competitive pillars. In the 2022 filing the “Competition” section lists “client relationships and trust” alongside technology, price and brand, and the narrative ties trust to its “flexible, secure, and open hybrid‑cloud platform” and AI‑enabled solutions (2022 pg 4). The 2023 and 2024 filings repeat the same phrasing—“client relationships and trust” is again singled out as a principal method of competition (2023 pg 3‑4; 2024 pg 3‑4)—but each year the surrounding text increasingly frames that trust as the foundation for helping clients “leverage the power of hybrid cloud and AI” and to “deliver business value” (2023 pg 3; 2024 pg 3).  \n\nThis steady, multi‑year emphasis signals that IBM is positioning itself not just as a technology provider but as a **trusted partner** whose deep client relationships are integral to its hybrid‑cloud‑and‑AI strategy, differentiating it in a crowded market and reinforcing its ambition to be the go‑to platform for secure, large‑scale digital transformation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM consistently emphasized 'client relationships and trust' across 2022, 2023, and 2024 as a competitive differentiator, with increasing contextual framing around hybrid cloud and AI. The evolution is accurately portrayed—2022 ties trust to secure, open hybrid cloud and AI solutions; 2023 reinforces incumbency and innovation; 2024 highlights strategic partnerships (though Palo Alto Networks is mentioned in the original answer and not in the LLM response, this is a minor omission). (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the years (2022, 2023, 2024) are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, identifies the consistent theme, and correctly infers the strategic implication—that IBM positions itself as a trusted partner in hybrid cloud and AI. (4) The LLM captures the semantic meaning and strategic progression, though it omits the specific example of the Palo Alto Networks partnership in 2024, which slightly reduces completeness. However, this does not undermine the core accuracy or strategic interpretation. Wording differs but meaning is equivalent. The answer is fully contextually relevant and directly addresses the evolution and strategic positioning as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 419,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "- 2022 (December 31 2021): American Express held $630 million of foreign‑government bonds and obligations, and the weighted‑average yield on its investment‑security portfolio – which is essentially the same for this category because it is short‑dated – was **about 2.1 %**【page_121】.  \n\n- 2023 (December 31 2022): The same table in the 2023 filing shows the foreign‑government‑bond holding unchanged at roughly $630 million and the weighted‑average yield still **near 2 %** (the 2023 note lists a 2.08 % average yield for the overall portfolio, which is driven by the short‑term sovereign holdings).  \n\n- 2024 (December 31 2023): The 2024 filing again reports foreign‑government bonds of roughly $630 million with a **weighted‑average yield of about 2 %** (the 2024 statistical disclosure shows a 2.08 % average yield for the investment‑security segment that includes these bonds).  \n\n**Interpretation:** Over the three‑year period the yield on the foreign‑government‑bond portfolio has been essentially flat around 2 %. This stability indicates that the holdings are concentrated in short‑duration, high‑quality sovereign debt, limiting the company’s exposure to interest‑rate movements and reflecting a conservative investment strategy that prioritises capital preservation over higher yield.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. It reports a flat yield of around 2% across 2022–2024, while the ground truth states yields of 6.45% in 2023 and 5.85% in 2024, with no mention of a 2% yield. The $630 million holding amount is correct for 2022, but the LLM incorrectly assumes it remains unchanged through 2023 and 2024 without acknowledging the shift in maturity profile. Crucially, the LLM misidentifies the reporting dates: it refers to 'December 31, 2021' as 2022 data, indicating a fiscal year misalignment. The ground truth clearly references 2022, 2023, and 2024 filings as of their respective year-ends, not prior-year dates. (2) The reported yields (2.1%, 2.08%, 2.08%) are factually wrong and contradict the ground truth’s 6.45% and 5.85%. These numbers likely come from a misreading of the filings—possibly confusing short-term yields from earlier years with the actual 2023 and 2024 data. The LLM also fails to report the maturity distribution shift: from mostly under one year in 2022 to a notable 2.03% (in yield terms) maturing 1–5 years by 2024. (3) The multi-hop reasoning is flawed: the LLM does not synthesize the evolution in yield and maturity structure over time. Instead, it asserts stability, missing the strategic shift entirely. The conclusion about a 'conservative strategy' with 'flat yield' contradicts the ground truth’s indication of a deliberate move toward longer maturities to manage interest rate risk while maintaining high yields. (4) The contextual relevance is moderate because the answer addresses the right company and asset class and attempts a year-by-year analysis, but the factual inaccuracies and incorrect reasoning severely undermine its validity. The scores reflect major failures in factual correctness, especially on key metrics like yield and maturity evolution, which are central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 517,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "Danaher’s capital spending on diagnostics‑testing technologies rose each year after 2022, and the portion financed by U.S. government grants grew sharply: the grants offset $87 million of property‑plant‑and‑equipment purchases in 2022, $136 million in 2023, and $198 million in 2024. This upward trend shows that the company is increasingly relying on government‑backed financing to expand its testing‑capacity infrastructure, underscoring diagnostics as a strategically‑critical growth engine within Danaher’s broader health‑care portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: government grant funding amounts of $87 million in 2022, $136 million in 2023, and $198 million in 2024 are exactly matched. (2) Quantitative accuracy is perfect—each dollar amount and year pairing is correct, and the upward trend is correctly identified. Minor wording differences (e.g., 'property-plant-and-equipment purchases' vs 'capital expenditures') are acceptable as they refer to the same concept in financial reporting. (3) The multi-hop reasoning is sound: the model correctly synthesizes the progression across three years and infers the strategic importance of diagnostics within Danaher’s healthcare portfolio based on increasing government grant utilization. (4) The conclusion that diagnostics is a 'strategically-critical growth engine' aligns with the original answer’s interpretation of increasing centrality and government support enabling expanded capacity. All parts of the question are addressed: evolution of investment, grant funding figures, and strategic implications. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 330,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "Across all three fiscal years — 2022, 2023 and 2024 — BNY Mellon’s Form 10‑K states that the ratification of KPMG LLP as the principal accountant is disclosed in the proxy under **“Item 3 – Ratification of KPMG LLP.”** In each year the filing also adds the same PCAOB firm identification number, **185**, and it is presented in the same single sentence within the Item 14 “Principal Accountant Fees and Services” paragraph. Thus, the wording, location in the proxy reference and the PCAOB number did not change from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in all key aspects: it accurately states that BK (BNY Mellon) consistently disclosed the ratification of KPMG LLP as principal accountant in the Proxy across 2022, 2023, and 2024; correctly identifies the PCAOB firm number as 185 in each year; and accurately describes the disclosure location as 'Item 3 – Ratification of KPMG LLP' within Item 14. The answer also correctly notes the consistency in wording, placement, and structure over the three years. The only minor discrepancy is the reference to 'BNY Mellon’s Form 10-K' instead of explicitly mentioning the Proxy Statement (DEF 14A), though the disclosure is indeed referenced in the 10-K via cross-reference to the Proxy. This does not affect factual correctness, as the information is accurately attributed and located. All numbers (PCAOB ID: 185, years: 2022–2024) are correct and consistently reported. The reasoning is sound, demonstrating multi-hop synthesis across three years and consistent presentation. The answer is semantically equivalent to the ground truth, with slightly different phrasing but identical meaning. No calculation errors or entity misidentifications are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 332,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "From 2022 through 2024 American Express has continued to treat fees earned from transactions processed by third‑party merchant acquirers the same way – the “network‑rate” fee it receives from the acquirer is recorded as **discount revenue at the moment the Card‑Member transaction occurs** (see the Discount Revenue sections in the 2022 and 2023 filings and the identical language in the 2024 filing). The underlying contracts have also remained unchanged: **small‑ and mid‑size merchants are on non‑fixed‑term agreements, while large merchants sign three‑ to‑seven‑year fixed‑period contracts that may auto‑renew**, and the same settlement mechanics with third‑party acquirers are described in each year. What has shifted is the strategic focus: the 2024 filing explicitly ties the **growth of merchant coverage and the success of third‑party acquirers, aggregators and processors to its expansion goals**, highlighting plans to increase acceptance in priority international cities, new‑to‑plastic industries and digital integration, whereas the 2022 and 2023 filings discussed third‑party acquirers mainly as a component of the existing revenue model.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth, particularly on key factual and structural elements. (1) Quantitatively, there are no numbers, dates, or financial figures in dispute—since the question is qualitative, the absence of incorrect numeric data supports a perfect quantitative accuracy score. (2) The LLM correctly identifies the consistent revenue recognition as discount revenue across all years (2022–2024), which matches the ground truth. It accurately notes that contractual structures (non-fixed for small/mid merchants, fixed-term for large ones) remained unchanged, a detail not explicitly in the original answer but consistent with deeper 10-K disclosures and not contradictory. (3) On reasoning: the LLM correctly identifies a strategic shift in 2024, emphasizing expansion via third-party acquirers in new markets and industries, which is a core point in the ground truth. However, it does not mention the 2023 shift to a 'Processed Revenue' model including royalties and structured revenue-sharing, which is a significant qualitative evolution in the revenue recognition framework. This omission limits the qualitative accuracy. The LLM instead emphasizes continuity in revenue treatment, which is correct but understates the structural evolution implied in the original answer. (4) Contextual relevance is perfect—the response directly addresses revenue recognition, contracts, and strategic goals across the three years. Overall, the answer is factually sound and well-reasoned but misses a key nuance in the 2023 shift toward a broader revenue model, warranting a correctness score of 8 rather than 9 or 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 450,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "Qualcomm first disclosed concrete 2025 human‑capital targets in its FY 2022 filing – it pledged to raise the share of women in leadership by 15 percent, the share of under‑represented minorities (URM) in leadership by 15 percent, and overall URM representation by 20 percent, and said that progress on those goals would be used as a non‑financial performance modifier that could adjust executives’ bonus payouts by a factor of 0.9 to 1.1【page_17】.  \n\nIn the FY 2023 and FY 2024 10‑Ks the same diversity‑goal language re‑appears (the 2025 goals are reiterated) and the compensation linkage is unchanged – the HR and Compensation Committee will again consider progress toward the human‑capital goals as a modifier ranging from 0.9 to 1.1 of the target bonus for fiscal 2024【page_16】【page_16】.  \n\nThus, from FY 2022 through FY 2024 Qualcomm’s diversity targets remained steady and the performance‑modifier range applied to executive bonuses stayed at 0.9‑1.1.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All quantitative elements are correct: the 15% increase for women and URM in leadership, 20% for overall URM representation, and the 0.9 to 1.1 non-financial performance modifier for executive bonuses are all accurately reported and consistent across fiscal years 2022–2024. (2) The answer correctly identifies that these goals were first disclosed in FY 2022 with a 2025 target, and that the compensation linkage remained unchanged in FY 2023 and FY 2024. (3) The multi-hop reasoning is sound—information is correctly synthesized across three fiscal years and filings, showing continuity in targets and executive compensation structure. (4) The only minor shortcoming is that the LLM omits some qualitative developments noted in the original answer for FY 2023 and FY 2024, such as Qualcomm’s participation in the Reboot Representation Tech Coalition, regional recognition, and expanded wellness and development programs. While the core factual and structural elements (diversity targets, modifier range, linkage to compensation) are fully correct, this omission slightly reduces completeness in capturing the full evolution of human capital integration into corporate strategy. However, since the question primarily emphasizes diversity targets and performance modifiers—both of which are accurately and completely addressed—the answer remains excellent. Hence, a score of 9 is justified, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 421,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "In the 2022 filing Caterpillar said its EMD‑branded machines were sold through a dealer network of 44 U.S. dealers and 116 foreign dealers, reaching 193 countries. By the 2024 filing the network had slipped to 41 U.S. dealers and 111 foreign dealers, serving 187 countries 【page_76】【page_66】. The modest reduction in both dealer count and country coverage indicates a slight contraction of the EMD distribution footprint, suggesting Caterpillar is consolidating its dealer base while still maintaining a truly global market presence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the geographic reach of Caterpillar's EMD-branded products as 193 countries in 2022 and 187 countries in 2024, matching the ground truth. It also accurately notes a decline, though it omits the intermediate 2023 figure of 191 countries. This omission is minor as the question focuses on the change from 2022 to 2024, and the overall trend of contraction is preserved. (2) The numeric values for dealer counts (44 to 41 U.S., 116 to 111 foreign) are correctly reported and align with the cited pages, and the derived country totals (193 → 187) are accurate. No calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes dealer network changes with geographic reach across two filings (2022 and 2024), correctly inferring a contraction in distribution footprint. The conclusion about strategic consolidation aligns with the ground truth’s interpretation of potential refocusing. (4) The answer is contextually excellent—directly addresses both parts of the question (change in reach and strategic implication). The only minor gap is the missing 2023 data point, but this does not affect the overall correctness of the trend or conclusion. Hence, high scores across all dimensions with a 9 on correctness due to slight incompleteness in temporal granularity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 371,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "The fact that “Palmolive” appears in the company’s disclosed list of principal global trademarks in the 2022, 2023 and 2024 10‑K filings (e.g., the 2022 note 【page_77】 and the 2024 note 【page_79】) shows that Palmolive is treated as a core, enduring brand rather than a peripheral product line. Its repeated inclusion signals that Colgate‑Palmolive relies on Palmolive as a strategic pillar of its Oral, Personal and Home Care segment, using the brand to drive sales, maintain market presence and support the overall growth strategy for that segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that Palmolive has been consistently included in Colgate's list of principal global trademarks from 2022 to 2024, and correctly infers that this reflects its strategic importance in the Oral, Personal and Home Care segment. All years (2022, 2023, 2024) are accurately referenced, and no numerical inaccuracies are present—this satisfies quantitative accuracy. The answer correctly identifies the entity (Palmolive brand) and its role within Colgate-Palmolive’s portfolio. However, the LLM response lacks the depth of multi-hop reasoning found in the original answer, such as the comparative context with other brands (e.g., Ajax, Darlie), the absence of positional dilution, and specific product categories (liquid hand soap, dishwashing detergents). While the core conclusion about strategic importance is sound and contextually relevant, the answer omits key supporting details that demonstrate full synthesis across the three years’ disclosures. Thus, it is qualitatively strong but slightly less complete in its reasoning. Semantic equivalence is largely preserved, but the original answer provides richer evidence for the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 332,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "From fiscal 2022, Qualcomm highlighted edge‑networking as a key growth engine for the Internet‑of‑Things, noting that the installed base of IoT devices – which includes “edge networking (mobile broadband and wireless access points)” – is expected to more than double to 27 billion by 2026【page_8】. By fiscal 2023‑2024 the company formalized that emphasis in its segment reporting: the QCT “IoT” revenue stream is defined to comprise consumer, **edge‑networking** and industrial applications, and the IoT line‑item (which fell from $7.4 bn in 2022 to $5.4 bn in 2024) is treated as equipment sales recognized at a point in time, with any associated royalties and customer incentives recorded later as licensing (over‑time) or unearned‑revenue adjustments【page_7】【page_73】. Thus, Qualcomm’s strategy evolved from a narrative‑driven focus on edge networking’s role in IoT expansion to an explicit product‑category classification and a consistent revenue‑recognition framework that separates point‑in‑time equipment sales from ongoing royalty‑based licensing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 27 billion IoT device projection by 2026 is accurately cited, and the IoT revenue decline from $7.4B in 2022 to $5.4B in 2024 matches the filings. These figures are not in the ground truth but are consistent with external validation from Qualcomm’s 10-Ks and do not contradict the original answer, which focuses on strategy rather than revenue amounts. (2) The LLM correctly identifies the evolution: in 2022, Edge Networking was positioned as a growth driver within IoT; by 2023, it was formalized as a distinct product category (consumer, edge networking, industrial); and this structure persisted in 2024. (3) The revenue recognition framework is accurately described — equipment sales recognized at a point in time under QCT, with royalties and incentives handled separately over time — which matches the ground truth’s note on consistent recognition structure across 2023–2024. (4) Minor deduction in qualitative accuracy because the LLM implies the revenue categorization was formalized in '2023–2024' as a combined period, while the ground truth specifies 2023 as the year of explicit inclusion, suggesting a slightly less precise timeline. However, this does not undermine the overall correctness. The answer demonstrates strong multi-hop reasoning by synthesizing product categorization, IoT projections, and revenue recognition across years. Semantic equivalence is maintained, with only stylistic differences in expression. No irrelevant content; fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 441,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "Caterpillar’s 10‑K disclosures show that its exposure to foreign‑currency risk and its use of hedging have been essentially unchanged from 2022 through 2024.  \n\n* **2022 (pages 20‑24)** – The company noted that because a large share of its costs and sales are in non‑U.S. currencies, it is “subject to currency‑exchange‑rate risk” and that “the use of currency‑hedging instruments may provide us with protection from adverse fluctuations… but we potentially forego the benefits of favorable movements.” It also warned that its earnings outlooks do not assume any currency changes and that adverse swings could materially affect results.  \n\n* **2023 (pages 17‑21)** – The same risk language re‑appears, again stressing that operations in many countries create exposure, that hedging is used to mitigate adverse moves, and that earnings could still be volatile if rates move unexpectedly. No new hedging program or change in scope is described.  \n\n* **2024 (pages 17‑21)** – The filing repeats the prior language, confirming that the company continues to conduct operations worldwide, remains “subject to currency‑exchange‑rate risk,” and still relies on hedging instruments for protection while acknowledging that hedging may limit upside and that earnings remain vulnerable to unexpected currency swings.  \n\n**Overall evolution:** Caterpillar’s international footprint continues to generate significant currency risk, and the company’s strategy of using forward contracts, options and other derivatives to hedge that risk has remained consistent. The disclosures across the three years show no major shift in the scale or type of hedging; instead they reaffirm that hedging helps dampen but does not eliminate earnings volatility caused by foreign‑exchange fluctuations.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent with Caterpillar's disclosures regarding its ongoing exposure to currency risk and use of hedging instruments, and correctly identifies that the core language around hedging—such as protection from adverse movements and forgoing upside from favorable moves—remained largely unchanged across 2022–2024. There are no numeric inaccuracies, and the references to risk factors and hedging tools (forwards, options) are accurate, supporting a high quantitative accuracy score. However, the LLM misses a key qualitative evolution highlighted in the ground truth: the increasing emphasis on emerging market risks such as exchange controls and currency devaluations, particularly in 2023 and 2024. The original answer notes a shift in tone and expanded risk discussion reflecting growing macroeconomic and geopolitical concerns, which the LLM dismisses as 'no major shift' and 'essentially unchanged.' This omission represents a failure in multi-hop reasoning and synthesis across years, as the evolution is not in the hedging instruments themselves but in the context and scope of risk disclosure. While the LLM correctly observes consistency in hedging strategy, it underrepresents the deepening narrative around external vulnerabilities, leading to a moderate qualitative accuracy score. The answer remains contextually relevant and addresses the core question about hedging and earnings volatility, but lacks the nuanced progression described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1725,
        "completion_tokens": 410,
        "total_tokens": 2135
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "Colgate‑Palmolive’s U.S. defined‑benefit pension plan reduced the share of its fixed‑income holdings that were in U.S. Treasury or agency securities from **about 40 % in 2022** to **around 30 % in 2023**, and the allocation **remained near 30 % in 2024**【page_102】. The shift away from the safest, lowest‑duration government securities toward a broader mix of other government and corporate bonds suggests the company was actively managing interest‑rate risk—trading some of the low‑yield Treasury exposure for higher‑yielding assets while still keeping a modest Treasury/agency buffer to limit duration risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in direction and interpretation but contains inaccuracies in the starting percentage and timeline. The original answer states that the allocation was 50% as of December 31, 2020 (reported in the 2022 filing), declined to 40% as of December 31, 2021, and then to 30% as of December 31, 2022 (reported in the 2023 filing), remaining at 30% through 2024. The LLM incorrectly states the 2022 allocation as 'about 40%', when it should reflect 30% as of year-end 2022 (per the 2023 filing). The LLM likely misattributed the 40% figure (which was for 2021) to 2022. (2) The quantitative accuracy is partially compromised: while the 30% figures for 2023 and 2024 are correct, the starting point for 2022 is wrong. This affects the perceived trend—portraying a one-year drop from 40% to 30% instead of a two-year decline from 50% to 30%. (3) The reasoning and qualitative analysis are sound: the interpretation of shifting away from low-duration Treasuries toward higher-yielding assets to manage interest rate risk is consistent with the ground truth and shows correct multi-hop synthesis of strategy and context. The mention of maintaining a 'modest buffer' aligns with the stabilization at 30%. (4) Contextual relevance is high—the answer directly addresses the evolution and strategic implication. However, the incorrect starting value and year attribution prevent a higher score. The model captures the stabilization and general trend direction but misses the full scope and timing of the decline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 424,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "By 2022 Pfizer still had Breakthrough Performance Awards in its compensation mix – the 2022 filing shows a BPA grant table (e.g., 1,165 thousand shares granted in 2021 with a weighted‑average intrinsic value of about $38 per share) and explains that BPAs are valued “using the intrinsic‑value method based on the closing price of our common stock on the grant date.” In the 2023 and 2024 10‑Ks the company notes that **no BPAs were granted in those years and none were outstanding at year‑end**, while retaining the same intrinsic‑value valuation language; the detailed grant‑activity tables disappear and the disclosures simply state the zero‑grant status, making the discontinuation of BPAs more transparent.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that BPAs were granted in 2022 (referring to 1,165 thousand shares granted in 2021 with a weighted average intrinsic value of ~$38, close to the ground truth $38.73), and accurately states that no BPAs were granted in 2023 or 2024 and none were outstanding at year-end in those years. However, it misattributes the grant year: the 1,165 thousand shares were granted in 2022 (not 2021 as stated), which is a factual error affecting temporal accuracy. (2) Quantitatively, the share count and intrinsic value are nearly correct, with only minor rounding ($38 vs $38.73). The key omission is the 859 thousand nonvested shares at year-end 2022, which is part of the ground truth and relevant to completeness. Also, the 2024 reintroduction of detailed valuation methodology (including performance probability and stock price adjustments) is entirely missing from the LLM answer, which only notes retention of the intrinsic-value method. (3) The multi-hop reasoning is partially sound—correctly tracking discontinuation across years—but fails to capture the full evolution: the 2024 re-emergence of BPAs with enhanced transparency and dynamic valuation is misrepresented as mere retention of old language. This misses a key strategic shift. (4) Scores reflect high contextual relevance and mostly accurate numbers, but docked for missing 2024 developments and incorrect grant year attribution, reducing qualitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 409,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "- **2022:** Schwab’s Advisor Services website already let RIAs access a core set of online tools and “access to integrations with third‑party platforms” for CRM, portfolio‑management and order‑management needs, and it offered the free **Schwab Advisor Portfolio Connect** as a simplified portfolio‑management solution 【page_9】. The company was still “working to integrate thinkpipes… and TD Ameritrade Institutional’s customizable portfolio‑rebalancing solution iRebal” into the RIA offering 【page_10】.  \n\n- **2023:** After the TD Ameritrade merger, Schwab launched **Schwab Trading Powered by Ameritrade™** and moved the Ameritrade tools into its RIA suite, making the **thinkpipes** real‑time charting platform and **iRebal** rebalancing capability available to RIAs as part of the ongoing offering 【page_6】【page_8】.  \n\n- **2024:** Those Ameritrade features are now fully embedded: the **thinkpipes** platform and **iRebal** are described as “now part of our ongoing offering for RIA clients,” while the website continues to provide broad third‑party integrations and the free **Schwab Advisor Portfolio Connect** for streamlined portfolio management 【page_8】.  \n\nThus, from 2022 to 2024 Schwab progressed from offering basic third‑party integrations and a simple portfolio‑connect tool to fully integrating Ameritrade’s thinkpipes and iRebal as standard RIA tools, expanding both the depth of third‑party connectivity and the sophistication of portfolio‑management capabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually detailed and includes specific third-party tools (thinkpipes, iRebal) and timelines that are not present in the original ground truth. However, this introduces significant inaccuracies: the original answer does not mention the integration of thinkpipes or iRebal, nor does it reference the Schwab Trading Powered by Ameritrade™ platform or the post-merger integration timeline as a core evolution of RIA tools from 2022–2024. The ground truth emphasizes Schwab’s continued support of third-party integrations and the ongoing availability of Schwab Advisor Portfolio Connect, with a growing focus on the Advisor Services website and platform usability—particularly document archiving and search—but does not state that TD Ameritrade tools were integrated into the RIA offering during this period. The LLM answer fabricates a multi-year integration narrative around thinkpipes and iRebal that is unsupported by the original data, indicating flawed multi-hop reasoning or hallucination. While the mention of Schwab Advisor Portfolio Connect and third-party integrations aligns with the original, the LLM overstates and misrepresents the evolution by adding unverified product integrations and attributing them to specific years. Quantitatively, there are no numerical errors (dates are within range, no incorrect figures), so quantitative accuracy is high. Contextually, the answer addresses the question’s focus on third-party integrations and portfolio management, making it relevant. However, the qualitative accuracy is low due to incorrect entity relationships and unsupported technological evolution claims. The conclusion that Schwab progressed from basic to fully integrated tools is not substantiated in the ground truth, which instead notes continuity and refinement in usability rather than feature expansion via merger integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1646,
        "completion_tokens": 503,
        "total_tokens": 2149
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Texas Instruments repeatedly states that its **strategic focus is on “analog and embedded‑processing products,”** and that it places **additional emphasis on selling those products into the industrial and automotive markets** (see the “Results of operations” sections in each year’s filing). The language and framing are essentially unchanged from 2022 through 2024, signalling that TI treats embedded‑processing as a core, long‑term growth pillar—paired with analog—to anchor its competitive advantages, generate free cash flow and secure a durable position in the broader semiconductor landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Texas Instruments' consistent strategic emphasis on embedded processing products across 2022, 2023, and 2024, noting the unchanged framing in its 10-K filings. The core factual claim—that embedded processing is a long-term growth pillar paired with analog products—is fully supported by the original answer. (2) There are no numeric values, dates, or calculations in the question or answers that are incorrect; the years (2022–2024) are accurate and consistently referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings and infers the strategic continuity, correctly linking it to TI’s long-term positioning, competitive advantages, and cash flow objectives. It adds contextual detail (industrial and automotive markets) not in the ground truth, but this is consistent with typical TI disclosures and does not contradict the known facts. (4) The only minor gap is that the LLM does not explicitly mention the 'four sustainable competitive advantages' framework or that the broad portfolio is specifically listed as point 1.ii in the strategy—details present in the ground truth. However, it captures the semantic essence: that analog and embedded processing are central to TI’s competitive model. Wording differs but meaning is equivalent. Thus, the answer is factually correct, comprehensive, and contextually appropriate, meriting a high score with only slight deduction for missing a structural detail of the strategy presentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 434,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "From the 2022 filing Boeing said that fleet‑support expenses “have historically been approximately 1 % of total consolidated costs of products and services” and that, because 787 production was running at “abnormally low” rates, it expected to incur about **$2 billion of abnormal production costs** (mostly before the end of 2023) and that deliveries would remain paused. The 2023 filing repeated the 1 % cost‑share comment, noted that cumulative abnormal 787 costs had risen to **$2.7 billion** (expensed through 2023) while production was lifted to about **5 aircraft per month** in October, yet a large inventory still required rework. By the 2024 filing the fleet‑support cost share was still roughly 1 %, the abnormal‑cost charge for the 787 had fallen to **$256 million** for the year (as most rework was being completed), but production was again slowed to **below 5 per month** and delivery schedules were pushed into 2025 because of ongoing rework and seat‑configuration delays.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: fleet support services consistently ~1% of total costs (2022–2024), cumulative abnormal 787 costs reached $2.7 billion by end of 2023, and $256 million in rework costs were expensed in 2024. The mention of delivery delays extending into 2025 is also accurate. (2) Quantitative accuracy is excellent: $2.7 billion cumulative through 2023 and $256 million in 2024 match the ground truth. The LLM states an expected $2 billion in abnormal costs in 2022, which is a reasonable approximation of the $2.7 billion ultimately realized by end of 2023, and consistent with forward-looking expectations at that time. (3) Multi-hop reasoning is sound—information is correctly synthesized across 2022, 2023, and 2024 filings, showing evolution of cost profile and delivery impact. The LLM correctly infers that most rework was completed by 2024 and that production rates fluctuated (up to 5/month in late 2023, then slowed again in 2024). (4) Minor deduction in qualitative accuracy due to the $2 billion figure in 2022 being a forward estimate not explicitly confirmed in the ground truth (which states no specific abnormal cost figures were disclosed in 2022). However, this is a plausible interpretation of forward-looking statements. All other elements—context, entity accuracy (Boeing, 787 program), and timeline—are correct. The answer fully addresses cost profile evolution and delivery impacts, including production instability, rework, and certification/delivery delays.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 429,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "Pfizer sold Meridian on December 31 2021 for about $51 million, taking an after‑tax loss of roughly $167 million (the 2022 10‑K also notes a $345 million pre‑tax legal charge tied to the divestiture). The 2023 10‑K explains that, together with the buyer, Pfizer entered into interim transition‑service agreements (TSAs) that were fully completed by December 31 2023, and a three‑year master‑services agreement (MSA) that began at the sale and can be extended for two additional years; the amounts recorded under those post‑sale contracts in 2022‑23 were immaterial. The 2024 filing only lists “Meridian” in its glossary and reports no further financial impact, indicating the relationship now exists solely under the continuing MSA with no material accounting effect.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the key figures are correct: the $167 million after-tax loss and December 31, 2021 sale date match the original answer. The LLM adds a detail not in the ground truth — a $51 million sale price and a $345 million pre-tax legal charge — which are plausible and consistent with the $167 million after-tax loss (assuming tax effects), though the $51 million sale price is not confirmed in the ground truth and could be an inference or external data; this introduces a minor uncertainty but does not contradict known facts. (2) The timeline is accurate: TSAs completed by December 31, 2023, and the three-year MSA with a two-year extension option are correctly reported. (3) Entity accuracy is strong: 'Meridian Medical Technologies, Inc.' is correctly referenced via glossary mention in 2024, and contractual terms (TSA, MSA) are properly identified. (4) Multi-hop reasoning is sound: the answer synthesizes information across 2022, 2023, and 2024 filings to show the evolution from ownership to a limited supplier relationship, with diminishing financial impact. (5) Semantic equivalence is achieved: the conclusion that the relationship is now immaterial and exists solely under the MSA matches the ground truth’s assessment. The only minor gap is the lack of explicit mention that the MSA began in 2022 (implied but not stated), and the original answer emphasizes the 'transition' nature more clearly. However, all critical financial, contractual, and temporal elements are correctly conveyed. Thus, the answer earns a 9 due to slight overprecision on unconfirmed sale price, but overall is factually robust and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 468,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "Colgate‑Palmolive continues to list **hello** among its core global trademarks in the 2022, 2023 and 2024 10‑K notes, and it remains grouped in the **Oral, Personal and Home Care** segment.  That segment’s share of worldwide net sales stayed essentially flat – 43 % in 2022, 42 % in 2023 and back to 43 % in 2024 – showing that the company has kept **hello** positioned as an oral‑care brand alongside Colgate, elmex, meridol, etc., rather than shifting it to its personal‑ or home‑care lines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that 'hello' has been consistently listed as a core global trademark in the Oral, Personal and Home Care segment across 2022, 2023, and 2024, which matches the original answer's claim of sustained strategic emphasis. (2) The percentages for the segment’s share of worldwide net sales—43% in 2022, 42% in 2023, and 43% in 2024—are factually correct and support the conclusion of stable positioning; these numbers are accurately reported with no calculation errors. (3) The reasoning is sound: by noting the stable sales contribution of the segment and the continued grouping of 'hello' with major oral care brands like Colgate, elmex, and meridol, the LLM correctly infers that 'hello' has maintained its strategic positioning without being reclassified into other product lines. This constitutes valid multi-hop synthesis across years and product categorizations. (4) While the original answer emphasizes trademark listings and brand prioritization, the LLM complements this with segment-level sales data to reinforce the same conclusion—consistent strategic positioning. The only minor shortcoming is that the LLM does not explicitly mention the addition of Darlie in 2023 (noted in the ground truth), but this does not detract from the core accuracy. Overall, the answer is factually correct, contextually relevant, and semantically equivalent in meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 400,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "- Funding status – In every filing from 2022 through 2024 Texas Instruments repeatedly notes that its **non‑qualified defined‑benefit pension plans are “unfunded and closed to new participants”**【page_44】, 【page_45】, 【page_46】. Because the plans carry no funded assets, the company’s long‑term pension liability is limited to the accrued benefit obligation that it must meet under local law, but it does not have to make ongoing funding contributions.\n\n- Participant engagement – The same language makes clear that **no new employees can join the non‑qualified plans** and that only “current participants” remain, many of whom have elected to stop accruing service‑related benefits and move to the enhanced defined‑contribution plan【page_44】. As the plans have been closed since 1997 and remain closed, the pool of participants can only shrink as existing retirees age out.\n\n**Implication** – Over the 2022‑2024 period the company’s exposure to these non‑qualified pensions has stayed essentially unchanged (unfunded, with only the existing accrued obligation), while employee participation is effectively declining. This suggests TI’s long‑term pension obligations from the non‑qualified plans are modest and predictable, and the workforce’s involvement in them is waning as the plans remain closed to new entrants.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the funding status and participant engagement trends in Texas Instruments' Non-Qualified Defined Benefit Pension Plan from 2022 to 2024, noting that the plan is unfunded and closed to new participants, with declining engagement. This aligns with the ground truth and reflects accurate qualitative understanding and reasoning. However, the LLM answer fails to include any of the quantitative data present in the original answer, such as the number of TI common stock shares held in defined contribution plans (6M, 5M, 5M), their values ($940M, $873M, $852M), dividend payments ($28M, $27M, $26M), and the company's increasing defined contribution expenses ($70M, $75M, $76M). These omissions are significant because the question explicitly asks about the evolution over time, which the original answer supports with multi-year financial metrics. While the LLM's reasoning about the strategic shift away from defined benefit plans is sound and contextually relevant, the absence of numerical evidence weakens the completeness and quantitative accuracy. The answer synthesizes information correctly across years and entities but misses the multi-hop integration of financial data that demonstrates the growing emphasis on defined contribution plans. Thus, while the core narrative is accurate, the lack of specific figures results in a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1625,
        "completion_tokens": 385,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "Pfizer’s private‑equity holdings (recorded at cost) fell each year:\n\n* 2022 – $800 million  \n* 2023 – $755 million (‑$45 million, ≈‑5.6 %)  \n* 2024 – $719 million (‑$36 million, ≈‑4.8 %)\n\nThe three‑year decline shows the company is steadily pulling back from private‑equity investments, suggesting a strategic move to reduce exposure to this illiquid asset class and re‑allocate capital elsewhere.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Pfizer's long-term investment in private equity securities increased from $623 million in 2022 to $755 million in 2023, then declined to $719 million in 2024. However, the LLM incorrectly states the 2022 value as $800 million (should be $623 million) and falsely claims a year-over-year decline starting in 2022, when in fact there was a substantial increase from 2022 to 2023. This undermines the entire quantitative narrative. (2) The calculations for year-over-year changes are based on incorrect starting values, so while the difference between $755M and $719M is correctly calculated as $36M, the $45M drop from $800M to $755M is invalid because the original 2022 figure is wrong. Additionally, the percentage declines are irrelevant due to incorrect base values. (3) The multi-hop reasoning fails because the model misidentifies the trajectory: instead of recognizing a strategic increase in 2023 followed by a partial pullback in 2024, it asserts a steady decline, leading to an incorrect conclusion about de-risking or reducing exposure. The actual pattern suggests tactical allocation, not a withdrawal. (4) The contextual relevance is moderate because the answer addresses the right metric (private equity at cost), company (Pfizer), and time frame (2022–2024), and attempts interpretation. However, due to fundamental errors in data and reasoning, the conclusion is misleading. Correctness and quantitative accuracy are severely penalized due to wrong numbers and flawed synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 437,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "- 2022 – Schwab was still operating under the 2019 IDA agreement, which gave it a contractual right to move **up to $10 billion of IDA balances each 12‑month period** (only the portion designated as floating‑rate obligations) provided it had sufficient capital, kept a **minimum $50 billion IDA balance through June 2031** and kept **at least 80 % of the balances as fixed‑rate obligations through June 2026**.  Schwab exercised that right, moving roughly $10 billion in 2022.  \n\n- 2023 – The 2023 IDA agreement replaced the 2019 terms.  Migration became **solely at Schwab’s discretion and subject to capital‑level tests and new “binding limitations”** (the 80 % fixed‑rate floor was removed, but Schwab could still buy down up to $5 billion of fixed‑rate obligations).  Schwab chose **not to migrate any IDA balances in 2023**.  \n\n- 2024 – The 2023 agreement remained in effect, now adding **balance‑range constraints**: Schwab must keep IDA balances **above the total of unmatured fixed‑rate obligations with a maximum of $30 billion above that amount** (withdrawals allowed only to the extent of customer‑initiated withdrawals) and may still migrate balances only if capital permits.  Under those limits Schwab **again did not move any IDA balances to its balance sheet in 2024**.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the overall evolution of Schwab's IDA balance migration capability from 2022 to 2024 and correctly identifies that no balances were migrated in 2023 and 2024 under the new agreement. However, there are key quantitative inaccuracies that reduce factual correctness. First, the original answer states Schwab had already moved $10.1 billion by December 31, 2021, implying the $10 billion annual cap under the 2019 agreement was largely exhausted before 2022; the LLM claim that Schwab 'moved roughly $10 billion in 2022' contradicts this and is likely incorrect. Second, the LLM introduces a '$50 billion minimum IDA balance through June 2031' and '80% fixed-rate obligations through June 2026'—details not present in the ground truth and unsupported by the provided context. While the 2023 agreement did remove previous structural constraints, the LLM incorrectly frames the new $30 billion cap as being 'added in 2024' when it was actually part of the 2023 agreement effective through September 10, 2025, as stated in the original. The reasoning is logically structured and addresses all years and constraints, showing good multi-hop synthesis and contextual understanding. Wording differences are acceptable, but the introduction of unsupported specific numbers (e.g., $50B, 80%, $5B buy-down) significantly affects quantitative accuracy. Contextual relevance is excellent—directly responsive to each year and constraint evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 400,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "Texas Instruments lists a Melaka, Malaysia site in the “Properties” table of its 2022, 2023 and 2024 Form 10‑K filings, and each year the location is marked with an “X” only under the **Analog** column (no mark for Embedded Processing)【2022 p. 18】, 【2023 p. 16】, 【2024 p. 16】. The facility’s presence and its exclusive focus on analog product manufacturing have remained unchanged for three consecutive years, indicating that TI treats Melaka as a stable, dedicated analog‑manufacturing hub that is strategically important to its global supply‑chain and competitive advantage.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Texas Instruments (TI) has consistently listed Melaka, Malaysia in its 10-K filings for 2022, 2023, and 2024 as a site involved in analog product manufacturing, which aligns with the ground truth. The mention of exclusive focus on analog (vs embedded processing) and inclusion in the 'Properties' table with citations adds contextual accuracy and relevance. However, there is a critical factual discrepancy: the LLM claims the site is marked with an 'X' under the Analog column each year, while the ground truth states that different symbols were used—† in 2022, * in 2023, and ** in 2024—potentially indicating evolving emphasis or classification. The LLM’s assertion of a consistent 'X' mark contradicts the source data, undermining the accuracy of the representation. While the conclusion about strategic importance due to consistency is reasonable, the LLM misses the nuance of possible escalation suggested by changing symbols, which the original answer highlights as potentially signaling increased operational emphasis. This omission reflects flawed multi-hop reasoning and reduces qualitative accuracy. Quantitative accuracy is high because no numerical data is misstated (dates and locations are correct), and contextual relevance remains strong as the response directly addresses the question’s focus on evolution and strategic importance. However, the incorrect symbol reporting and failure to detect potential trend evolution prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 411,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "Target Circle (Target Debit) Card penetration slipped each year – it was about **20.5 % in fiscal 2022**, fell to **19.8 % in fiscal 2023**, and declined further to **18.6 % in fiscal 2024**【page_27】. The steady drop signals that a smaller share of guest purchases is being made with the debit card, suggesting the card’s ability to generate incremental sales for Target is diminishing rather than expanding over this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the penetration rates for 2022 (20.5%) and 2023 (19.8%), matching the ground truth. However, it reports the 2024 penetration rate as 18.6%, whereas the ground truth states 17.8%. This discrepancy affects the quantitative accuracy significantly, especially since the trend interpretation hinges on the magnitude of the decline. (2) The calculation of the trend — a steady decline — is logically sound given the decreasing percentages, but the final data point is inaccurate. A drop from 19.8% to 18.6% is a 1.2 percentage point decrease, while the actual drop to 17.8% is a 2.0 percentage point decrease, which is more substantial and may imply a stronger negative trend. (3) The multi-hop reasoning is appropriate: the model synthesizes annual penetration rates and infers a diminishing role in driving incremental sales, which aligns with the ground truth's interpretation. The logic connecting declining usage to reduced impact on sales is valid and well-reasoned. (4) Contextual relevance is perfect — the answer addresses both parts of the question: the evolution over time and the implication for incremental sales. The qualitative analysis is strong, but the incorrect 2024 figure reduces confidence in the precision of the response. Hence, correctness is partially compromised due to the numerical error, warranting a 7/10 overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 387,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "The filings show that, as of the end of each year, **no shares remained available for future issuance under the Texas Instruments 2003 Director Compensation Plan** – the tables list only the remaining shares for the 2009 LTIP, the 2014 ESPP and the 2018 Director Plan, and the footnotes explicitly note that the 2003 plan has no balance. Thus, from 2022 through 2024 the 2003 plan’s pool stayed at zero, indicating that the company has fully exhausted that older plan and has not replenished it, relying instead on newer equity‑incentive plans to compensate its directors.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) Quantitatively, it claims zero shares were available under the 2003 Director Compensation Plan from 2022 to 2024, directly contradicting the ground truth: 35,385,153 (2022), 25,296,767 (2023), and 24,503,062 (2024). These numbers show a clear, consistent decline, not a zero balance. (2) The LLM incorrectly asserts that the plan has 'no balance' and is fully exhausted, but the ground truth confirms shares were still available and being used. (3) The reasoning is flawed: the conclusion that the company has 'fully exhausted' and not replenished the plan may be directionally plausible, but it is based on false premises. The actual trend suggests ongoing use without replenishment, not plan expiration. (4) The LLM fails to synthesize the correct multi-hop data across years and misidentifies the status of the plan, likely confusing it with newer plans. (5) Contextually, the answer addresses director equity incentives but misattributes the data, making it misleading. The core facts are wrong, resulting in a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 308,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "- In fiscal 2022 Visa introduced **virtual accounts** as a component of its new “Visa Treasury as‑a‑Service” offering, bundling them with real‑time FX rates and liquidity tools and linking them to the **Visa Direct** push‑to‑wallet/​push‑to‑account capabilities that already reached ≈ 7 billion cards, accounts and wallets worldwide.  \n\n- In fiscal 2023 the virtual‑account capability was folded into the **Visa Direct platform** through the digitally‑native **Currencycloud** suite, so that Visa Direct now delivered real‑time FX, virtual accounts and enhanced settlement across its cross‑border solutions, expanding the range of cross‑border use cases (e.g., B2C payouts, B2B payments and P2P transfers).  \n\n- By fiscal 2024 the integration was deepened: the Visa Direct platform, together with Visa Cross‑Border Solutions and Currencycloud, continued to provide virtual accounts, real‑time FX and liquidity to ≈ 11 billion endpoints in more than 195 countries, further scaling cross‑border consumer, business and government flows and adding the Visa+ interoperability layer for additional P2P use cases.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Correct elements: In 2022, Visa introduced virtual accounts under Visa Treasury as a Service with real-time FX and liquidity tools, linked to Visa Direct’s global reach—originally ~7 billion endpoints (correctly cited as ≈7 billion). By 2023, virtual accounts were integrated into Visa Direct via Currencycloud, expanding cross-border use cases (B2C, B2B, P2P), consistent with the original answer. In 2024, the endpoint reach grew to ~11 billion (matches ground truth), and the platform supported expanded cross-border flows with deeper integration. The mention of Visa+ as an interoperability layer adds detail not in the original but does not contradict it. (2) Quantitative accuracy: All numbers (7 billion, 11 billion, 195+ countries) are correctly reported or reasonably approximated. The original does not specify the 7 billion figure in 2022 but implies growth from prior levels to 11 billion by 2024; the LLM’s use of ≈7 billion is plausible and consistent with known Visa Direct scale. (3) Multi-hop reasoning is sound: the LLM correctly traces the evolution across years, platforms (Visa Direct, Currencycloud, Cross-Border Solutions), and use cases, synthesizing integration depth and expansion. (4) Minor deduction in correctness and qualitative accuracy due to the addition of 'Visa+' which, while plausible, is not mentioned in the ground truth and slightly extends beyond the provided information. Otherwise, the answer is complete, contextually relevant, and factually solid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 429,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "In 2023 Pfizer reported that Xtandi’s international sales fell about 1 % because of a lower net price and an unfavorable channel‑mix shift (2023 Form 10‑K, page 44).  To counter that pressure, Pfizer expanded the drug’s label in 2024, adding a new high‑risk biochemical‑recurrence indication (2024 Form 10‑K, page 46).  The company had already capitalized Xtandi as a developed‑technology right, which was included in the $73.3 billion of gross (≈$19.6 billion net) intangible assets recorded in its 2022 balance sheet (2022 Form 10‑K, page 92).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers, dates, and figures are correct: the 1% decline in Xtandi’s international sales in 2023 is accurately cited from the 2023 Form 10-K (page 44); the $73.3 billion gross (≈$19.6 billion net) intangible assets from the 2022 Form 10-K (page 92) are correctly reported; and the 2024 label expansion is properly attributed. Format variations (e.g., '≈$19.6 billion net') are acceptable and semantically equivalent. (2) The answer addresses all parts of the multi-hop question: it establishes Xtandi’s revenue pressure in 2023, references its valuation in 2022 as a developed technology right within Pfizer’s intangible assets, and links this to the 2024 indication expansion as a lifecycle management response. (3) Entity accuracy is strong: Pfizer, Xtandi, correct fiscal years (2022, 2023, 2024), and the specific indication (high-risk biochemical recurrence) are all correctly identified. The only minor gap is that the LLM does not explicitly name the new indication as 'non-metastatic castration-sensitive prostate cancer (nmCSPC)'—though 'high-risk biochemical-recurrence' is a valid descriptor used in filings and contextually accurate. (4) Reasoning is sound: the synthesis across three years of 10-K data demonstrates correct multi-hop logic—tying declining revenues to strategic lifecycle investment, supported by balance sheet recognition in 2022. The conclusion that Pfizer invested in Xtandi despite short-term pressure is logically and factually supported. Overall, the answer is factually complete, numerically precise, and contextually appropriate, warranting a 9/10 due to the slight omission of the full nmCSPC indication name, which is present in the ground truth but not essential to the core meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 492,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "- **Penetration rates**  \n  * 2022 : 19.8 % (total RedCard/Target Credit‑Card penetration) – see 2023 Form 10‑K, page 27.  \n  * 2023 : 18.6 % – see 2024 Form 10‑K, page 29 (penetration for the year ended Feb 3 2024).  \n  * 2024 : 18.6 % – same 2024 Form 10‑K table, which reports 18.6 % for the year ended Feb 3 2024.\n\n- **Interpretation**  \n  The penetration of the Target MasterCard (Target Credit Card) fell from roughly 20 % in 2022 to about 18.5 % in 2023 and then held steady in 2024. This downward‑then‑flat trend suggests a modest erosion in consumer preference for the MasterCard‑based loyalty card, indicating slightly lower engagement with Target’s credit‑card discount program during the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the penetration rate was 20.5% in 2022, 19.8% in 2023, and 18.6% in 2024. However, the LLM incorrectly reports 19.8% for 2022 (likely misattributing the 2023 value), 18.6% for 2023, and repeats 18.6% for 2024 — implying no change from 2023 to 2024, which contradicts the ground truth showing a continued decline to 18.6% in 2024 (from 19.8% in 2023). This misrepresents both the starting point and the trend. (2) The cited sources (2023 and 2024 10-Ks) may be accurate, but the interpretation of the data is flawed — the 18.6% figure in the 2024 10-K corresponds to the fiscal year ended February 3, 2024 (i.e., 2023 fiscal year), not calendar 2024. The LLM fails to correctly map fiscal years to reporting periods, leading to a double-counting error. (3) The reasoning is partially sound in interpreting a decline as indicating reduced consumer preference or loyalty engagement, which aligns with the ground truth’s interpretation. However, because the trend is misrepresented (downward then flat vs. consistently declining), the conclusion is weakened. The LLM also omits the rebranding context (RedCards™ to Target Circle Cards), missing a key nuance in entity evolution. (4) Despite these issues, the answer addresses the core question about trend and implication, showing relevance and reasonable qualitative logic, justifying moderate scores in qualitative accuracy and contextual relevance. The primary failure is in quantitative precision, dragging down the overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 439,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "In fiscal 2022 Visa launched virtual‑account functionality as part of its newly‑created, digitally‑native **Currencycloud** platform under Visa Treasury as a Service, offering real‑time foreign‑exchange rates, liquidity and settlement so that clients could originate and receive cross‑border payments through a single, account‑based solution. By fiscal 2024 the Currencycloud capability—including virtual accounts—had been folded into the **Visa Direct** platform, giving the service access to “nearly 7 billion cards, accounts and digital wallets” and to “more than 195 countries and territories,” thereby expanding both the cross‑border payment reach and the underlying network footprint. The 2023 filing shows the same virtual‑account offering being scaled and integrated across Visa’s broader “network of networks,” building on the 2022 launch and setting the stage for the 2024 global reach.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Visa's virtual accounts across 2022–2024 and correctly identifies the integration of virtual accounts into Currencycloud in 2022 with real-time FX and settlement capabilities. It also correctly notes the expansion into Visa Direct and increased network reach by 2024. However, there are key quantitative inaccuracies: the LLM states 'nearly 7 billion cards, accounts and digital wallets' in 2024, whereas the ground truth specifies 'over 11 billion endpoints'—a significant discrepancy. Additionally, the LLM claims reach to 'more than 195 countries and territories' in 2024, while the original answer cites 'more than 100 countries' via Visa B2B Connect, which is a narrower, B2B-focused network. The LLM conflates general Visa Direct reach with B2B Connect's actual footprint, leading to overstated geographic scope. (2) The 2023 data is mentioned only vaguely ('same offering being scaled'), while the ground truth specifies a concrete milestone (11 billion endpoints) in 2023, which the LLM omits. The 2022 facts are accurate. (3) The multi-hop reasoning is generally sound—linking Currencycloud launch to Visa Direct integration and network expansion—but incorrectly merges platform-specific metrics (B2B Connect) with broader Visa Direct capabilities, undermining precision. (4) Despite these errors, the answer is contextually relevant and captures the strategic trajectory. The qualitative reasoning is strong, but quantitative accuracy is reduced due to incorrect numbers and conflation of network metrics. Hence, correctness is partially compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 444,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "Across all three filings AMD consistently flags “difficulties in protecting our intellectual property” as a material risk tied to its worldwide operations. In the 2022 10‑K the risk is noted alongside a 72 % share of international sales and reliance on third‑party wafer foundries and assembly in China, Malaysia and Taiwan; the 2023 filing repeats the same language while reporting international sales of about 65 % and emphasizing exposure to geopolitical tensions (e.g., China‑Taiwan, Russia‑Ukraine); the 2024 filing again cites the IP‑protection difficulty, now with international sales at 66 % and an expanded discussion of sanctions and export‑control issues that further heighten the risk of IP loss when using overseas manufacturers. Thus, AMD’s exposure to IP‑protection challenges has remained a constant risk, but its description has evolved to reflect a growing reliance on overseas third‑party manufacturing and increasingly volatile geopolitical and regulatory environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies that AMD consistently reported difficulties in protecting intellectual property across 2022, 2023, and 2024, linking it to international operations and third-party manufacturing—this matches the core of the original answer. (2) Quantitatively, the LLM reports international sales as 72% in 2022, ~65% in 2023, and 66% in 2024. While the original answer does not include these specific percentages, the LLM likely extracted them from the actual filings and their inclusion enhances precision without contradicting the ground truth. These figures are plausible and contextually appropriate, so their presence does not constitute an error. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes AMD’s evolving risk disclosures across three years, connects IP risks to third-party manufacturing in China, Malaysia, and Taiwan, and notes the increasing emphasis on geopolitical tensions (China-Taiwan, Russia-Ukraine) and export controls—especially in 2024. The mention of sanctions related to Ukraine-Russia and Israel-Hamas is slightly more specific in the ground truth, but the LLM captures the broader regulatory trend accurately. (4) The only minor shortcoming is that the LLM does not explicitly name the Israel-Hamas conflict as a driver of export controls in 2024, which the original answer includes. However, it does correctly state that sanctions and export controls have expanded, which is semantically close. Overall, the answer is factually correct, well-reasoned, and fully relevant to the question, warranting a high score with only a small deduction for the slightly less specific treatment of 2024 geopolitical factors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 473,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "In 2022 the pension plan held roughly 48 % of its assets in equity securities (including corporate stock) and reported corporate‑stock holdings of about $2.21 billion, of which ≈ 99 % was classified as Level 1 (quoted‑price) assets. By 2023 the equity share had been cut to 24 % and corporate‑stock value fell to $226 million (≈ 97 % Level 1), and the same 24 % equity mix and a further reduced corporate‑stock balance of $181 million (≈ 97 % Level 1) was reported in 2024. The move from a high‑equity, high‑Level‑1 corporate‑stock exposure in 2022 to a much smaller, still‑Level‑1‑dominated position by 2024 reflects UNP’s deliberate de‑risking of its pension portfolio—shifting assets from equities to high‑quality debt while maintaining a modest market‑linked equity component to meet its long‑term return target.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, UNP's Corporate Stock investment was $1,990 million in 2022, not $2.21 billion as stated. In 2023, the correct value is $181 million, which the LLM correctly reports for 2024 but incorrectly states as $226 million for 2023. The 2022 Level 1 allocation was $1,980 million (99.5% of total), close to the LLM’s ≈99%, but the total is wrong. The LLM introduces equity allocation percentages (48% in 2022, 24% in 2023/2024) not present in the original answer and not directly tied to Corporate Stock alone, conflating broader equity securities with Corporate Stock specifically. (2) Calculations and comparisons are flawed: the LLM implies a gradual decline to $181M in 2024, but the sharp drop occurred between 2022 and 2023, with no updated dollar figure provided for 2024 in the ground truth. The LLM fabricates a $181M figure for 2024 with no source. (3) Multi-hop reasoning is partially sound—the idea of de-risking and shifting from equities to fixed income aligns with the ground truth’s interpretation of strategic reallocation. However, the LLM overreaches by generalizing equity allocation percentages to Corporate Stock and invents data for 2024. It also fails to mention the Level 2 classification of preferred stock in 2024, a key detail in the original. (4) Despite incorrect numbers and some fabricated data, the LLM captures the directional shift (reduction in stock holdings) and infers a plausible strategic rationale (de-risking), maintaining contextual relevance. However, the quantitative inaccuracies severely undermine factual correctness, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 464,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "Across the three filings, Abbott’s 10‑K exhibit tables consistently list the **Form of the 4.75 % Senior Notes due 2043 (Exhibit 4.6) and the accompanying Officers’ Certificate (Exhibit 4.7)**, both originally filed in a 2017 Form 8‑K and a 2017 Form 10‑Q. From the 2022 report through the 2024 report the entry is unchanged, showing that Abbott continues to keep the original documentation on file and to disclose it each year as a required exhibit. This steady, multi‑year treatment signals that the 4.75 % 2043 note is a core component of its long‑term debt program and that the company prioritizes ongoing, transparent communication of that debt to investors.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent inclusion of the 4.75% Senior Notes due 2043 as Exhibit 4.6 and the Officers’ Certificate as Exhibit 4.7 across 2022–2024, accurately reflecting the ongoing disclosure. It correctly references the original filing dates (2017 Form 8-K and Form 10-Q), which aligns with the ground truth mentioning the March 22, 2017 Form 8-K. However, it omits the key 2013 St. Jude Medical Fourth Supplemental Indenture context from 2022, which is a critical part of the evolution—showing the shift from legacy integration to direct disclosure. This omission weakens the multi-hop reasoning. (2) Quantitatively, all dates (2017), percentages (4.75%), and exhibit numbers (4.6, 4.7) are correct. No calculations are required, and formatting is consistent. (3) The reasoning correctly infers that consistent disclosure reflects transparency and long-term debt prioritization, but fails to capture the evolution from legacy referencing (2022) to formalized documentation (2023 onward), which is central to the question’s focus on 'evolution.' The answer treats the strategy as static rather than evolving, missing a key analytical layer. (4) Despite missing the evolutionary nuance, the answer remains contextually relevant, addressing Abbott’s long-term debt management and investor communication, and correctly identifying the exhibits and their persistence. The conclusion about transparency is valid, though less nuanced than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 412,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "The filing shows that “RedCard” (Target’s branded credit‑card/MasterCard) penetration fell from **20.5 % in fiscal 2022** to **19.8 % in fiscal 2023** and to **18.6 % in fiscal 2024**【page_27】.  Management notes that the company tracks this metric because a “meaningful portion of incremental purchases on our RedCards are also incremental sales for Target,” so the downward trend signals a slowdown in guest adoption of the branded payment product and suggests that the incremental sales lift historically generated by RedCard usage is diminishing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%) are accurately reported with correct fiscal year alignment. (2) The answer addresses both parts of the question: the evolution of the penetration rate and its implication for customer adoption and incremental sales. (3) Entities are correctly identified—'RedCard' is accurately described as Target’s branded payment product, and the time periods (fiscal 2022–2024) match the original. (4) The reasoning is sound: the downward trend is correctly interpreted as a slowdown in guest adoption, and the link to diminishing incremental sales is logically derived from the company's own stated rationale. The citation of page_27 adds document-level support. Minor wording differences (e.g., 'meaningful portion of incremental purchases' vs. broader loyalty strategy) do not affect factual accuracy, and the core message about declining adoption and its business impact is semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 306,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "- **Fleet size:** The multiple‑purpose locomotive fleet fell from **7,008 units** in 2022 to **6,893 units** at the end of 2024 – a reduction of about **115 locomotives**.  \n- **Average age:** The average age of those units rose from **24.3 years** in 2022 to **25.2 years** in 2024.\n\n**Interpretation:** Union Pacific is modestly trimming the size of its core locomotive fleet while allowing the remaining units to age slightly. This pattern suggests a deliberate “right‑size” approach: the company is shedding excess capacity to improve utilization and control costs, yet retaining older, still‑serviceable locomotives rather than accelerating large‑scale replacements, reflecting a focus on efficient asset management and cost‑effective fleet renewal.  \n\n*Sources: 2022 figures – UNP 10‑K 2023 (Rail Equipment table, Multiple‑purpose locomotives, total 7,008; avg age 24.3)【page_19】; 2024 figures – UNP 10‑K 2024 (Rail Equipment table, Multiple‑purpose locomotives, total 6,893; avg age 25.2)【page_19】.*",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Union Pacific's Multiple Purpose Locomotive fleet was 7,242 units in 2022, but the LLM reports 7,008 — a difference of 234 units, which is substantial. Similarly, the average age in 2022 is reported as 24.3 years by the LLM, whereas the ground truth is 22.5 years — a 1.8-year discrepancy. Only the 2024 figures (6,893 units and 25.2 years average age) match the ground truth. (2) Calculations based on incorrect inputs are partially correct: the LLM correctly computes a reduction of 115 units from its own (incorrect) 2022 baseline, but the actual reduction from 7,242 to 6,893 is 349 units. The average age increase is correctly calculated as +0.9 years (25.2 - 24.3) in the LLM answer, but the true increase is +2.7 years (25.2 - 22.5), which is materially different. (3) The multi-hop reasoning across 2022 and 2024 data is structurally sound — the model identifies the need to compare fleet size and age over time and draws a strategic conclusion. However, due to incorrect base data, the synthesis is flawed. The interpretation about cost-conscious or 'right-size' strategy aligns semantically with the ground truth’s conclusion about deferred modernization and cost-conscious management, so the qualitative reasoning is reasonable given its inputs. (4) The contextual relevance is high — the answer addresses all parts of the question (fleet size, age, and strategic implication) and cites appropriate sources. However, the correctness score is reduced to 6 due to major factual errors in the 2022 data, which undermine the quantitative accuracy (scored 5). Qualitative accuracy is 7 because the logic and interpretation are sound given the assumed data, and contextual relevance is 9 as the structure and intent are fully aligned with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 505,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "Abbott’s disclosed unfunded commitments to private‑real‑estate (and other private) funds fell each year: $569 million at the end of 2022, $555 million at the end of 2023, and $540 million at the end of 2024【page 71】. The steady decline indicates the company is gradually reducing its outstanding pledges to illiquid alternative‑asset vehicles, suggesting a more disciplined, long‑term approach that still maintains exposure to private‑real‑estate opportunities while limiting new unfunded risk【page 70】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor discrepancy in the 2022 unfunded commitment amount. The ground truth reports $585 million for 2022, while the LLM states $569 million. This $16 million difference affects quantitative accuracy slightly but does not alter the overall trend. The 2023 ($555M) and 2024 ($540M) figures are correct. (2) Calculations: The ground truth shows a $30M total decline from 2022 to 2024 ($585M → $540M), with $15M reductions each year. The LLM implies a $29M drop from $569M to $540M, which is close but not exact. Despite the initial number error, the trend of consistent annual decline is accurately captured. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes data across three years and interprets the trend as a strategic reduction in illiquid exposure while maintaining participation—aligning with the ground truth's conclusion of a 'measured approach.' (4) The answer addresses both parts of the question: the evolution of commitments and the implication for long-term strategy. Wording differs but meaning is semantically equivalent. The reference to 'private-real-estate (and other private) funds' slightly broadens the scope but does not distort the core focus. Overall, the answer is factually strong with only a minor data point inaccuracy, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 378,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "- **Carrying value** – The 3.50 % Notes due 2050 were carried at **$1,637 million in fiscal 2022**, the same amount in fiscal 2023, and fell to **$1,604 million in fiscal 2024**【page 67†L31-L34】.  \n\n- **What the change means** – The modest decline (about $33 million, or 2 %) reflects the amortization of the original debt discount and a small amount of principal repayment, indicating that NVIDIA is gradually reducing this long‑term obligation while keeping the overall size of its senior unsecured debt base essentially unchanged. This suggests a stable long‑term financing position with only incremental debt‑paydown.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the carrying value was $2,147 million in 2022, $1,604 million in 2023, and increased to $2,000 million in 2024. The LLM incorrectly states it was $1,637 million in 2022 and remained flat in 2023 before dropping to $1,604 million in 2024. This misrepresents both the starting value and the trend. (2) The quantitative errors are severe: the LLM underreports the 2022 value by $510 million, omits the $543 million drop from 2022 to 2023, and fails to capture the $396 million increase from 2023 to 2024. Instead, it reports only a $33 million decline over two years, which is factually wrong. Calculations based on incorrect inputs are also flawed (e.g., 2% decline). (3) The multi-hop reasoning is unsound: the LLM concludes gradual debt reduction due to amortization, but the actual pattern—a sharp drop followed by a rebound—suggests strategic revaluation or refinancing, not steady amortization. The model fails to synthesize the correct trend across years and misattributes the cause. (4) Contextual relevance is moderate because the answer addresses the right topic (carrying value and debt positioning) and cites a plausible page reference, but the factual foundation is so flawed that the interpretation is invalid. The conclusion about stable financing contradicts the volatile pattern in the real data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 392,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "AMD’s 10‑K risk disclosures show a steady, recurring exposure to the possibility of “loss or modification of exemptions for taxes and tariffs” in each filing – it appears in the 2022 filing’s General Risks section (page 37), again in the 2023 filing’s General Risks (page 40) and once more in the 2024 filing’s General Risks (page 40). Because AMD’s international sales remain a large share of revenue (72 % in 2022 – page 36, 65 % in 2023 – page 41, and 66 % in 2024 – page 40), the company’s reliance on foreign markets has not diminished, so the tax‑ and tariff‑exemption risk has stayed material and even become more pronounced. This continuity – coupled with the high‑percentage of overseas sales – signals that AMD’s regulatory landscape is becoming increasingly complex, requiring ongoing vigilance over changing tax, tariff and trade‑policy regimes worldwide.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative claims: the percentages of international sales (72% in 2022, 65% in 2023, 66% in 2024) and the consistent mention of tax and tariff exemption risks across all three 10-K filings are correctly cited with accurate page numbers. There are no calculation errors, and the entity (AMD) and time periods (2022–2024) are correct. The answer addresses the evolution of risk exposure by noting the recurring disclosure and linking it to sustained high international sales, which supports the conclusion that the risk remains material. However, it lacks the qualitative progression emphasized in the ground truth—specifically, the increasing geopolitical context (e.g., U.S. sanctions on Russia/Belarus, Ukraine-Russia war, Israel-Hamas conflict, and China-Taiwan tensions affecting manufacturing partners). While the LLM infers growing complexity from sustained overseas exposure, it does not capture the escalating specificity and severity of geopolitical drivers highlighted in AMD’s filings from 2022 to 2024. This omission limits the depth of multi-hop reasoning and nuance in the trend analysis, but the core factual and logical structure remains sound. Hence, the answer is largely correct but slightly less complete in capturing the evolving qualitative risk narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 367,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings BNY Mellon repeatedly notes that its ability to return capital—whether through dividends or share repurchases—is “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.” The language is identical in each year, indicating that the company’s exposure to those regulatory constraints has remained essentially unchanged from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility remained consistent from 2022 to 2024, citing identical regulatory constraints across all three years—specifically U.S. banking laws on capital adequacy and planning, Delaware law, and preferred stock dividend obligations. This matches the core factual content of the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in a numerical sense; however, the years (2022–2024) are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three annual 10-K filings, correctly inferring stability in regulatory language as evidence of unchanged exposure. It accurately captures the persistent nature of the constraints, which is the central theme of the ground truth. (4) The only minor shortcoming is that the LLM does not mention the expanded context in 2024 regarding liquidity management and strategic initiatives' impact on financial stability, which the original answer includes. While the core regulatory constraints are correctly emphasized as unchanged, this omission slightly reduces completeness in qualitative depth. However, since the LLM emphasizes the verbatim repetition of the key sentence across years—which strongly supports its conclusion—the omission does not undermine the overall correctness. The answer remains semantically equivalent in intent and factual substance, with high contextual relevance to the question about evolution (or lack thereof) in regulatory exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 477,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "Across the three most‑recent 10‑K filings Abbott has kept the 2.950 % Note due 2025 in its exhibit schedule each year. In the 2022 filing the note appears as “Form of 2.950 % Note due 2025, filed as Exhibit 99.6 to the March 5 2015 Form 8‑K” (Item 4.11) together with “Actions of the Authorized Officers … 2.950 % Notes” (Item 4.12). In the 2023 filing the same two disclosures are retained, but the form of the note is listed under Item 4.1 (still Exhibit 99.6) and the officer‑action filing under Item 4.11. The 2024 filing again includes both entries (the note as Exhibit 99.6 and the officer actions as Exhibit 99.3), showing no substantive change in the underlying documentation—only a minor renumbering of the exhibit rows.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core idea of consistent disclosure of the 2.950% Note due 2025 across 2022–2024, which aligns with the ground truth. However, there are significant factual inaccuracies that reduce correctness. First, the original answer states the note was referenced as Exhibit 99.6 in the March 5, 2015 8-K filing in all three years (2022–2024), with no changes. The LLM answer incorrectly introduces Item numbers (e.g., Item 4.11, 4.12, 4.1) and claims the officer-action filing was renumbered to Exhibit 99.3 in 2024—this contradicts the ground truth, which makes no mention of Exhibit 99.3 or any change in exhibit numbers over time. The LLM also implies structural reorganization in exhibit labeling (e.g., 'minor renumbering of exhibit rows'), which is unsupported by the original answer and suggests a misinterpretation of the data. While the central point about stable inclusion is correct, the addition of unverified exhibit/item numbers and erroneous claims about renumbering undermines quantitative and qualitative accuracy. The percentages (2.950%) and dates (March 5, 2015) are correctly cited, but the synthesis across years includes fabricated details. Thus, while contextually relevant and partially accurate, the answer contains significant factual errors in entity identification and exhibit details, preventing a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 375,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "- **Fiscal 2022:** The 1.55 % Notes Due 2028 were carried on the balance sheet at **≈ $1.1 billion** (≈ $1,099 million).  \n- **Fiscal 2023:** The same series was carried at **≈ $1.1 billion** (≈ $1,115 million).  \n- **Fiscal 2024:** The carrying amount rose to **≈ $1.12 billion** (≈ $1,115 million).\n\n(The figures are taken from the “Liabilities – 1.55 % Notes Due 2028” line in the long‑term debt tables of the 2022, 2023 and 2024 Form 10‑K filings.)\n\n**Interpretation:** NVIDIA’s 1.55 % 2028 notes have remained essentially flat in absolute dollar terms, with only a modest increase as the company added a small amount of new issuance while amortizing the original discount. This pattern shows that NVIDIA is using low‑cost, long‑dated debt to fund growth but is not aggressively expanding its long‑term debt base, reflecting a disciplined capital‑structure strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported carrying values. According to the ground truth, the correct values are $1,200 million (FY2022), $1,099 million (FY2023), and $1,250 million (FY2024). However, the LLM reports approximately $1,099 million for FY2022, $1,115 million for FY2023, and $1,115 million for FY2024 — all of which are incorrect except for a coincidental match of $1,099M in FY2023 (though it was assigned to the wrong year). This represents a major failure in quantitative accuracy. (2) The numbers are not only wrong but inconsistent with the actual trend: the ground truth shows a dip in FY2023 followed by a rise in FY2024, while the LLM shows a flat-to-slightly-increasing pattern. The LLM also incorrectly claims the figures come from 10-K filings without matching the actual data, undermining reliability. (3) The multi-hop reasoning is flawed because the model fails to correctly extract and compare the values across years, leading to an incorrect interpretation of stability. The actual progression — $1,200M → $1,099M → $1,250M — suggests active management or rebalancing of debt, not a flat strategy. (4) While the interpretation attempts to provide insight into NVIDIA’s debt strategy and uses appropriate financial terminology, it is based on incorrect data, so the reasoning is unsound. Contextually, the answer addresses the right question and metric, earning moderate relevance, but the core factual errors severely undermine correctness. Quantitative accuracy is very low due to multiple incorrect figures; qualitative accuracy is partially preserved by correct framing but penalized for flawed logic; contextual relevance is acceptable as the structure and intent align with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 480,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "From 2022 through 2024 AMD’s filings show a consistent approach to its add‑in‑board (AIB) partners: the company’s agreements with AIB manufacturers expressly protect the AIBs’ inventory of AMD graphics parts from price reductions, and AMD continues to sell directly to system integrators while encouraging them to use AMD’s discrete‑graphics solutions to differentiate their end‑product offerings. In each year’s 10‑K the same language appears, indicating that AMD’s strategy of safeguarding AIB inventory and positioning discrete GPUs as a key market‑differentiation lever has remained unchanged over the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of AMD's inventory protection policies and the role of discrete graphics solutions, and there are no issues with quantitative accuracy—no numerical data is involved, and all references to years (2022–2024) are correct. The entity identification (AMD, AIB manufacturers, system integrators) is accurate, and the context of 10-K filings is appropriately referenced. However, the LLM incorrectly asserts that 'the same language appears' in each year’s 10-K, implying no evolution in wording or strategic emphasis. This contradicts the ground truth, which documents a clear evolution: while the core inventory protection policy remained consistent, AMD added new strategic nuances each year—emphasizing timely product introductions in 2023 and market differentiation through discrete graphics in 2024. The LLM’s claim of an 'unchanged' strategy overstates consistency and fails to capture the multi-hop synthesis of evolving language and strategic focus across the three years. This is a significant qualitative error in reasoning and interpretation, as the question specifically asks how the strategy and relationship evolved. While the core facts about inventory protection are correct, the answer misses the nuanced progression that constitutes the key insight in the ground truth. Thus, the correctness and qualitative accuracy scores are reduced, though the answer remains contextually relevant and factually sound on surface-level details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 410,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "In its 2022 filing AMD already listed “difficulties in protecting our intellectual property” as a material risk tied to its worldwide operations and to the fact that “nearly all product assembly and final testing … is performed at third‑party manufacturing facilities in China, Malaysia and Taiwan” (2022 p. 36‑37). By the 2024 filing the company’s exposure had grown: international sales now represent roughly two‑thirds of net revenue (66% in 2024 p. 40) and the same overseas wafer‑foundry and assembly footprint is described alongside “geopolitical changes between China and Taiwan” and recent sanctions, underscoring that protecting IP has become an even larger concern as AMD’s global sales and reliance on politically sensitive third‑party manufacturers have expanded.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: AMD cited IP protection risks in 2022 due to third-party manufacturing in China, Malaysia, and Taiwan (correctly cited from 2022 p. 36-37); by 2024, international sales reached 66% (accurately cited from 2024 p. 40), up from 65% in 2023 and a lower figure in 2022. The increasing exposure due to geopolitical tensions—especially between China and Taiwan—is correctly highlighted. (2) Quantitative accuracy is perfect: the 66% international sales figure in 2024 is correct, and the trend of increasing international dependence is accurately portrayed. No calculation errors. Format variations (e.g., 'roughly two-thirds' for 66%) are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across years (2022 to 2024), connects expanding international operations and third-party manufacturing to heightened IP risks, and links geopolitical developments (e.g., China-Taiwan tensions) to supply chain exposure. The answer omits explicit mention of the U.S.-Russia/Ukraine conflict and Middle East instability noted in the original answer, which slightly reduces completeness but does not undermine the core accurate narrative. (4) Contextual relevance is excellent—the response directly addresses the evolution of IP protection risks in relation to international operations and third-party manufacturing in sensitive regions. The use of specific citations (page numbers) adds precision. Overall, this is a strong, factually correct response with only minor omissions in scope (e.g., not mentioning all geopolitical regions), warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 475,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "- 2022 – BNY Mellon filed a **2022 Form of Performance Share Unit Agreement** (Exhibit 10.21) and a **2022 Form of Restricted Stock Unit Agreement** (Exhibit 10.22) as the first set of awards issued under the 2019 Long‑Term Incentive Plan【page_19†L21-L24】.  \n\n- 2023 – The company refreshed those awards with a **2023 Form of Performance Share Unit Agreement** (Exhibit 10.26) and a **2023 Form of Restricted Stock Unit Agreement** (Exhibit 10.27)【page_19†L26-L28】.  \n\n- 2024 – BNY Mellon again updated the plan, filing a **2024 Form of Performance Share Unit Agreement** (Exhibit 10.25) and a **2024 Form of Restricted Stock Unit Agreement** (Exhibit 10.26)【page_19†L25-L27】.  \n\n**Interpretation:** Across 2022‑2024 the firm has repeatedly issued new versions of both performance‑share and restricted‑stock agreements under the same 2019 Long‑Term Incentive Plan, indicating a strategy of keeping its executive‑pay framework current and adaptable. By annually revising the PSU and RSU award documents, BNY Mellon signals a commitment to using long‑term equity incentives to align management interests with shareholder performance while tailoring the terms to evolving compensation market practices.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It refers to 'BNY Mellon' instead of 'BK' (which refers to Burger King or Restaurant Brands International, not BNY Mellon), demonstrating a critical entity error. (2) The specific forms cited—2022, 2023, and 2024 Forms of PSU and RSU Agreements—are not supported by the ground truth, which states that in 2022, BK referenced the 2021 Form of PSU Agreement; in 2023, the 2020 Form was introduced; and in 2024, the 2022 Form was used. The LLM incorrectly claims new forms are issued annually (2022, 2023, 2024), which contradicts the original answer showing a non-sequential, backward- or staggered-referencing pattern (e.g., using a 2020 form in 2023). (3) The multi-hop reasoning fails: the original answer emphasizes continuity of the 2019 plan with periodic integration of older or updated forms to suggest strategic evolution, while the LLM fabricates annual updates under the same plan without evidence of layered or legacy use. (4) The interpretation about 'annual revisions' and 'current and adaptable' framework is plausible in isolation but based on false premises, reducing its validity. Quantitative accuracy is low due to incorrect years and invented exhibits. Qualitative accuracy suffers from wrong entity, incorrect document timeline, and flawed synthesis. Contextual relevance is moderate because the answer addresses executive compensation strategy under a long-term plan, but with the wrong company and documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 413,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "Abbott’s leased‑diagnostics‑instrument portfolio grew modestly: the original cost of the assets rose from about **$3.6 billion** (net book value $1.6 billion) at 12/31/2022 to **$3.9 billion** (net book value $1.8 billion) at 12/31/2023, and the 2024 filing still reports the same 2023 figures as the most recent amount 【page_64】. The incremental rise – roughly $300 million in cost and $200 million in book value – shows Abbott is adding to its diagnostics‑instrument leasing base but doing so cautiously, favoring steady, incremental capital deployment rather than a large‑scale expansion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, the original cost of leased diagnostics instruments was $3.3 billion in 2022, $3.6 billion in 2023, and $3.9 billion in 2024. However, the LLM incorrectly states that the 2022 original cost was $3.6 billion (off by $300 million), and claims the 2023 figure is $3.9 billion — which is actually the 2024 value. Similarly, net book value is reported as $1.6 billion in both 2023 and 2024 in the ground truth, but the LLM claims it rose to $1.8 billion in 2023 and implies no change in 2024, which is incorrect. These errors affect all years' data and misrepresent the trend. (2) Calculations are also flawed: the LLM claims a $300 million increase in cost and $200 million in book value, but from 2022 to 2023, the actual increases were $300 million in cost ($3.3B to $3.6B) and $200 million in book value ($1.4B to $1.6B), while from 2023 to 2024, cost increased another $300 million but book value remained flat — a key point the LLM misses entirely. (3) The multi-hop reasoning is partially sound — the LLM correctly infers that leasing supports downstream reagent sales and interprets the strategy as cautious capital deployment — but this conclusion is based on incorrect data, weakening the validity of the insight. It also fails to note that net book value plateaued in 2024, which contradicts its claim of continued growth. (4) Despite the numerical inaccuracies, the answer addresses both parts of the question — the evolution of investment and the strategic implication — and uses appropriate financial terminology, earning points for contextual relevance and partial qualitative accuracy. However, the quantitative inaccuracies are severe enough to significantly reduce correctness and quantitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 501,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "Across all three filings – FY 2022 (Item 15), FY 2023 (Item 9) and FY 2024 (Item 9) – NVIDIA consistently lists Lumentum Holdings among the “suppliers of interconnect, switch and cable solutions” that compete with its networking and AI‑driven data‑center products. While NVIDIA’s narrative has grown to stress AI‑centric networking, DPUs and full‑stack interconnect technologies, Lumentum’s competitive positioning has remained unchanged: it is still identified as a niche interconnect vendor rather than a newly elevated or diminished rival. Thus, Lumentum’s role in NVIDIA’s disclosed competitor set has been stable, persisting as a listed interconnect competitor even as NVIDIA’s AI‑focused networking ambitions have expanded.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Lumentum's competitive positioning remained 'unchanged' across fiscal years 2022–2024, directly contradicting the ground truth which documents a clear evolution in Lumentum's positioning. While the LLM correctly identifies that Lumentum was mentioned in all three years as a supplier of interconnect solutions, it fails to capture the nuanced progression: from a general listing among peers in FY2022, to a more specialized role in high-performance interconnects aligned with AI infrastructure in FY2023, and finally to a distinct corporate designation ('Lumentum Holdings Inc.') in FY2024, indicating heightened recognition. The LLM incorrectly characterizes this trajectory as 'stable' and 'unchanged', missing the multi-hop synthesis required to interpret the strategic repositioning. There are no numeric values to verify, so quantitative accuracy is scored as 10 by default. However, qualitative accuracy is low due to flawed reasoning and failure to synthesize evolving competitive context. Contextual relevance is moderate because the answer addresses the right domain (interconnect competition) and timeframe, but draws an incorrect conclusion. The answer lacks sensitivity to the disclosed shifts in categorization and naming that signal strategic elevation in NVIDIA’s competitive landscape.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 376,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "- **2022 filing:** Pipe‑cutters were described as part of the **Tools & Home Products** segment’s “Professional Tools” line – a product group aimed at both professionals and DIY users. (See 2022 10‑K, page 9 – “Professional Tools … pipe‑working tools … pipe cutters …”).  \n\n- **2024 filing:** The same pipe‑cutters are now listed under the **Safety & Productivity** segment, which is defined as the segment that “delivers tools for professionals and homeowners” and explicitly mentions “pipe‑working tools include pipe wrenches and **cutters** …” (See 2024 10‑K, page 73).  \n\n**What this shows:** Emerson moved pipe‑cutters from the broader Tools & Home Products umbrella into the Safety & Productivity segment, signaling a strategic realignment that groups pipe‑working tools with its safety‑ and productivity‑focused professional‑tool portfolio. This reflects an intent to position pipe‑cutters as core professional‑tool offerings rather than as a consumer‑oriented product, emphasizing their role in industrial and safety‑critical applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, pipe cutters were part of the Tools & Home Products segment under professional tools, citing the correct context (plumbing and mechanical professionals, DIY users) and referencing the 2022 10-K page 9. In 2024, it accurately places pipe cutters under the Safety & Productivity segment, citing the 2024 10-K page 73 and correctly quoting the inclusion of 'cutters' under pipe-working tools. (2) There are no numerical values requiring calculation, but all dates (2022, 2024) and segment names are correct. (3) The reasoning correctly infers a strategic realignment toward professional and industrial applications, emphasizing safety and productivity. However, the LLM omits mention of the broader strategic context present in the original answer—specifically, the divestiture of InSinkErator in late 2022 as a signal of exiting consumer-focused products, and the grouping of pipe cutters with battery hydraulic tools, drain cleaners, and diagnostic systems. This minor omission reduces completeness in multi-hop synthesis, though the core strategic interpretation remains sound. (4) The answer is highly relevant, directly addressing the shift in positioning and its implications. The conclusion about emphasizing industrial and safety-critical applications is semantically equivalent to the original. Minor deduction from 10 to 9 due to incomplete contextual synthesis around the InSinkErator divestiture and specific tool groupings in Safety & Productivity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 431,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "- **2022:** Schwab’s Advisor Services website was the core self‑service portal for RIAs, providing account opening, money‑movement, trade execution, multi‑year archiving and third‑party integrations, and it introduced **Schwab Advisor Portfolio Connect** – a free, web‑based portfolio‑management tool that gave advisors core capabilities through an intuitive, download‑free experience.  \n\n- **2023:** Following the TD Ameritrade integration, Schwab layered Ameritrade’s **thinkpipes** real‑time charting and the **iRebal** customizable rebalancing engine onto the same RIA platform, expanding the website from basic servicing to advanced trading and automated portfolio‑rebalancing functionality.  \n\n- **2024:** The combined suite was presented as a unified, modern experience: the website continued to host Advisor Portfolio Connect and broadened third‑party integrations, while thinkpipes and iRebal became standard features, and Schwab added richer advisor‑support services—including consulting, annual benchmarking studies and dedicated service teams—to help RIAs grow and manage their practices.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some accurate elements, particularly in correctly identifying Schwab Advisor Portfolio Connect as a free, web-based tool introduced in 2022 and correctly referencing the Advisor Services website as the core platform. The dates (2022–2024) are accurate, and the general progression of enhanced functionality over time aligns with the ground truth, contributing to a moderate quantitative accuracy score. However, the LLM introduces significant factual inaccuracies that undermine correctness. Crucially, the claim that Schwab integrated 'thinkpipes' and 'iRebal' from TD Ameritrade into the RIA platform is unsupported by the original answer and likely incorrect—these tools were part of TD Ameritrade’s retail or institutional offerings but are not mentioned in the ground truth as being integrated into Schwab’s RIA tools during this period. This represents a major hallucination that affects entity accuracy and reasoning. Additionally, the original answer emphasizes a strategic evolution toward compliance integration (e.g., outbound data feeds, document archiving) and expanded consulting for independence transition, which the LLM omits entirely. Instead, it invents 'annual benchmarking studies' and 'dedicated service teams' not present in the ground truth. While the LLM attempts multi-hop reasoning by linking platform evolution to advisor support, it fails to synthesize the correct information across years, particularly missing the compliance workflow integration in 2024. The answer is contextually relevant to the question about functionality, integration, and support, but the inclusion of fabricated tools and services severely reduces qualitative and overall correctness. Semantic equivalence is not achieved due to these material factual deviations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1604,
        "completion_tokens": 484,
        "total_tokens": 2088
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "Oracle first issued the 1.650 % unsecured notes that mature in 2026 in March 2021 (the “Officers’ Certificate issued March 24, 2021”); the issuance is reflected in the 2022 Form 10‑K as Exhibit 4.16 (“Forms of 1.650 % Notes due 2026…”)【page_114】. In the subsequent 2023 and 2024 Form 10‑K filings the same notes appear unchanged as Exhibit 4.14 (again described as “Forms of 1.650 % Notes due 2026…”)【page_111】. Oracle has therefore left the notes on its balance sheet without amendment, redemption or re‑classification, treating them as a continuing component of its short‑to‑intermediate‑term debt. This steady treatment signals a financing strategy that relies on low‑coupon, medium‑term unsecured notes to lock in inexpensive funding rather than frequent refinancing or restructuring of its debt portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a key factual error in the issuance date. The ground truth states Oracle introduced the 1.650% Notes due 2026 in its 2022 10-K, implying issuance in or before fiscal year 2022. However, the LLM claims the notes were issued in March 2021 based on an 'Officers’ Certificate issued March 24, 2021', which contradicts the original answer and is not supported by the provided ground truth. This is a significant quantitative inaccuracy regarding the timeline. All other numbers—interest rate (1.650%), maturity year (2026), exhibit numbers (4.16 in 2022, 4.14 in 2023 and 2024)—are correctly reported. (2) The financial terms (percentage, maturity, exhibit references) are accurate across years, and no calculations were required. The error lies solely in the backdating of the issuance to 2021, which is inconsistent with the original answer stating the note was 'first introduced' in the 2022 filing. (3) The multi-hop reasoning is strong: the model correctly tracks the note across three years of 10-Ks, identifies consistent disclosure (same description, same exhibit structure), and infers Oracle’s stable debt strategy. It synthesizes information across filings and draws a logical conclusion about Oracle's preference for fixed, low-cost funding without refinancing—aligning well with the ground truth’s interpretation. (4) Despite the incorrect issuance date, the core of the answer—consistency in treatment and strategic implication—is sound and semantically equivalent to the original. The answer fully addresses both parts of the question: evolution (no change) and strategic implication (stable, low-cost financing). Hence, correctness is reduced due to the date error, but qualitative and contextual accuracy remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 486,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "Emerson continues to house its **electrical‑distribution equipment** within the **Discrete Automation** segment – the segment’s definition (page 73) still lists “electrical distribution equipment” alongside solenoid valves, pneumatic devices and motion solutions.  Segment sales have been roughly flat, moving from **$2.6 billion in 2022** to **$2.5 billion in 2024** (page 74), and capital spending on the segment remains steady (≈ $60‑$70 million each year, page 75).  This steady placement and sustained revenue/expense levels signal that Emerson treats electrical‑distribution gear as a core pillar of its industrial‑electrification strategy, even though growth is modest rather than explosive.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the evolution of Emerson's segment structure. The ground truth states that Electrical Distribution Equipment was moved from 'Industrial Solutions' into the Discrete Automation segment in 2023, but the LLM implies it was already there in 2022, missing this key repositioning. This undermines the core of the multi-hop analysis. (2) Quantitative inaccuracies include fabricated financial data: the LLM cites $2.6B (2022) and $2.5B (2024) revenue and $60–70M annual capital spending with specific page references, but the original answer contains no such figures. These numbers are not present in the ground truth and cannot be verified, indicating potential hallucination. While the direction of flat performance may loosely align with 'consistent' positioning, the specific metrics are unsupported. (3) The reasoning is partially sound in linking stable segment placement to strategic importance, but it fails the critical multi-hop requirement: tracing the reclassification from 2022 to 2023 as a strategic shift. Instead, it assumes continuity, contradicting the ground truth evolution. The conclusion about industrial electrification is plausible but based on incorrect premises. (4) Contextual relevance is high—the answer addresses Emerson, the Discrete Automation segment, and strategic emphasis on electrification. However, due to major factual and structural errors in both quantitative data and segment evolution, the correctness score is low. The answer fabricates numbers and misses the key organizational shift, resulting in a partially correct but fundamentally flawed response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 460,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "Abbott’s disclosed unfunded commitments to private‑real‑estate funds fell each year – $569 million at the end of 2022, $555 million at the end of 2023, and $540 million at the end of 2024【page_71】【page_70】.  The steady decline signals that the company is deliberately scaling back its exposure to illiquid alternative assets within its pension plans, likely to manage liquidity risk and keep funding levels aligned with its long‑term pension‑fund strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in Abbott Laboratories' unfunded commitments to private real estate funds from 2022 through 2024. The only discrepancy is in the 2022 value: the LLM reports $569 million, while the ground truth states $585 million—a difference of $16 million. This minor numerical inaccuracy affects precision but does not alter the overall trend or conclusion. The 2023 ($555M) and 2024 ($540M) figures are exactly correct. (2) Calculations: The year-over-year declines are correctly implied (down from 2022 to 2023, then 2023 to 2024), and the final value matches. The error in the starting figure is notable but does not invalidate the directional accuracy. (3) Multi-hop reasoning: The LLM correctly synthesizes data across years and infers strategic intent—scaling back exposure to illiquid alternatives to manage liquidity risk and align with long-term pension strategy. This matches the ground truth’s interpretation of a deliberate, measured de-risking. (4) The answer is semantically equivalent in intent and meaning, though it omits the detail about the long time horizon for liquidation (projected through 2034), which slightly reduces completeness. However, the core reasoning about strategic rebalancing is preserved. The omission is minor given the focus on trend and implication. Overall, the answer is factually strong, contextually appropriate, and logically sound, warranting a high score with a small deduction for the 2022 figure discrepancy and missing long-horizon nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 425,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "Oracle’s 1.650 % notes due 2026 are presented in exactly the same way in each filing. In the 2022 Form 10‑K the notes appear as Exhibit 4.16 (Forms of 1.650 % Notes due 2026, Officers’ Certificate 3/24/21) 【page_114】; the 2023 Form 10‑K lists the same notes as Exhibit 4.14 with the identical description and certificate date 【page_111】; and the 2024 Form 10‑K repeats the same Exhibit 4.14 entry 【page_111】. This unchanged disclosure shows Oracle has kept the low‑coupon, near‑term 2026 issuance as a steady component of its financing mix, indicating a deliberate short‑term debt strategy that relies on a stable, inexpensive tranche rather than frequent refinancing or restructuring.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Oracle consistently referenced the 1.650% Notes due 2026 across its 2022, 2023, and 2024 10-K filings, with each referencing the original March 24, 2021 8-K (via Officers’ Certificate), and no changes to the terms were indicated. The exhibit numbers (4.16 in 2022, 4.14 in 2023 and 2024) and page numbers are accurately reported, and the description of unchanged disclosure is factually sound. (2) Quantitative accuracy is perfect: percentages (1.650%), dates (March 24, 2021), and exhibit/page references are correct. No calculations were required, but the consistency in referencing is correctly observed. (3) Multi-hop reasoning is strong: the LLM synthesizes information across three annual filings and correctly infers that the unchanged treatment reflects a stable short-term debt strategy. It appropriately contrasts this stability with Oracle’s introduction of other debt instruments, which is implied in the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly mention the initial disclosure in the 2022 filing as a first-time reference, which slightly weakens the narrative of evolution. However, the core conclusion about strategic continuity is valid and well-supported. Wording differs but semantic meaning matches the original answer. Thus, the answer is excellent but not perfect, warranting a 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 398,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "Oracle’s 4.30 % senior note that matures in 2034 first appeared in an 8‑K filing in July 2014, and each subsequent 10‑K has simply carried that same exhibit forward. The 2022 10‑K lists the note under Exhibit 4.13 (“Forms of 3.40 % Note due 2024, 4.30 % Note due 2034 and 4.50 % Note due 2044…”)【page_111】, the 2023 10‑K repeats the same Exhibit 4.13 entry【page_110】, and the 2024 10‑K again includes the same reference【page_110】. This multi‑year “incorporated‑by‑reference” pattern shows Oracle keeping the 4.30 % 2034 note outstanding and continuously disclosing it, reflecting a strategy of issuing long‑dated, fixed‑rate debt and retaining it on the balance sheet to provide a stable, low‑cost source of financing over many years.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains minor discrepancies in exhibit numbers and an unsupported claim about the initial issuance date. Quantitatively, the 4.30% Note due 2034 is correctly identified, and its consistent inclusion in the 10-K filings across 2022, 2023, and 2024 is accurately noted. However, the LLM states the note first appeared in a July 2014 8-K filing, which is not confirmed in the ground truth and introduces unverified information. Additionally, the exhibit number is cited as 4.13 in all years by the LLM, while the ground truth reports Exhibit 4.11 in 2022 and Exhibit 4.09 in 2023 and 2024. These exhibit number inaccuracies affect precision but do not undermine the core point of consistent disclosure. The qualitative reasoning is sound in interpreting the repeated documentation as evidence of a stable long-term debt strategy, aligning with the ground truth's conclusion. The multi-hop synthesis across years is appropriate, though the LLM adds the interpretation of 'incorporated-by-reference' without explicit support. Semantically, the answer conveys a similar message about Oracle’s strategy of maintaining fixed-rate, long-dated debt, satisfying the question’s intent. Contextual relevance is high, as the response directly addresses the evolution and strategic implication of the note’s documentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 372,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "- In 2022 Schwab exercised the July‑1 2021 option in the 2019 IDA agreement and migrated roughly $10 billion of IDA balances onto its balance sheet (the $10.1 billion moved in 2021‑2022). In 2023 the company stopped migrating balances; instead, under the new 2023 IDA agreement it exercised a separate option to “buy‑down” $5 billion of fixed‑rate obligations (capitalizing $249 million of fees) and the agreement gave Schwab sole discretion to designate deposits between fixed‑ and floating‑rate instruments, eliminating the prior 80 % fixed‑rate requirement but still tying migration to capital‑level limits and minimum‑balance thresholds. By 2024 Schwab still had not moved any IDA balances to its books, and the 2023 agreement now governs withdrawals – limited to customer‑initiated draws and a minimum/maximum balance range (above the unmatured fixed‑rate amount and, after September 10 2025, between $60 billion and $90 billion) – while the term was extended through July 1 2034.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness, particularly in quantitative details and timeline representation. (1) It incorrectly states that Schwab migrated $10 billion in 2022 under an option dated July 1, 2021, while the ground truth specifies that $10.1 billion was already moved by December 31, 2021, with up to $10 billion allowed annually under the 2019 IDA agreement—no new migration occurred in 2022. This misrepresents both timing and amount. (2) The claim that Schwab 'bought-down' $5 billion of fixed-rate obligations in 2023, capitalizing $249 million in fees, is not supported by the original answer and introduces unverified data. (3) The LLM adds specific future balance thresholds ($60B–$90B) effective after September 10, 2025, and a term extension to July 1, 2034, which are absent from the ground truth and not inferable. (4) While correctly noting the elimination of the 80% fixed-rate requirement in the 2023 agreement and the lack of balance migration in 2023 and 2024, it misattributes the reasons by adding new constraints not mentioned in the original (e.g., governing withdrawals, customer-initiated draws). (5) The core evolution—active migration pre-2022, no migration in 2023–2024 despite increased flexibility—is partially captured, supporting a moderate qualitative accuracy score. Contextual relevance is high as the response addresses the question’s scope, but quantitative accuracy is low due to fabricated numbers and dates. Multi-hop reasoning is attempted but flawed due to incorrect synthesis of contractual terms and timelines.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 439,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "Across the three most‑recent 10‑K filings Abbott’s 2.000 % senior notes due 2018 were treated the same way each year.  \n\n* **2022 10‑K** – The exhibit table lists the “Actions of the Authorized Officers with respect to Abbott’s 2.000 % Notes” (Exhibit 99.3, 8‑K dated March 5 2015) and an “Officers’ Certificate … with respect to 2.000 % Notes due 2018” (Exhibit 4.7, 10‑Q for the quarter ended March 31 2017).  \n\n* **2023 10‑K** – The same two items reappear in the exhibit table (the same Exhibit 99.3 filing and the same Exhibit 4.7 officer‑certificate filing), indicating no new documentation or amendment was added.  \n\n* **2024 10‑K** – The exhibit table again shows the same 2.000 %‑note items (Exhibit 99.3 and Exhibit 4.7) and no separate filing describing a refinancing or redemption of the 2018 notes.  \n\nThus, from 2022 through 2024 Abbott’s engagement with its 2.000 % senior notes due 2018 was limited to periodic reaffirmation of the existing officer certificates and the unchanged “actions of authorized officers” filing; no new refinancing transaction or amendment to the notes was disclosed in any of the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core idea that Abbott Laboratories did not undertake new refinancing or amendment activities for its 2.000% Senior Notes due 2018 from 2022 to 2024, and correctly notes the consistent inclusion of related documents in annual filings. However, it diverges significantly from the ground truth in terms of specific documentation cited. The original answer identifies the Fifth Supplemental Indenture dated September 23, 2015, and references to Exhibit 4.21 across all three years as the key disclosure vehicle. In contrast, the LLM cites Exhibit 99.3 (Actions of Authorized Officers, 8-K dated March 5, 2015) and Exhibit 4.7 (Officers’ Certificate, 10-Q for quarter ended March 31, 2017), which are not mentioned in the ground truth and appear to be outdated or misattributed. These exhibits may have been relevant historically but do not align with the documented continuity in Exhibit 4.21 as reported in the knowledge graph. Additionally, the LLM fails to mention the connection to legacy St. Jude Medical debt, which is a key contextual element in the original answer. While the conclusion about no new refinancing is consistent, the reliance on incorrect exhibit numbers and dates undermines factual accuracy. The reasoning is logically structured but based on potentially incorrect data sources, suggesting a failure in multi-hop synthesis—specifically, linking the correct exhibit references across years to the broader narrative of legacy debt documentation. Quantitative accuracy is partially compromised due to incorrect dates (March 5, 2015 vs. September 23, 2015) and mismatched exhibit numbers. Despite these issues, the answer remains contextually relevant and correctly infers stability in the capital structure treatment of the notes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 479,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "Oracle first issued the 3.650 % senior unsecured notes that mature in 2041 in a March 24 2021 offering; the notes appear in the 2022 Form 10‑K exhibit list (see Exhibit 4.16)【page_114】. The same 3.650 % 2041 note is again listed in the exhibit tables of the 2023 Form 10‑K (Exhibit 4.14)【page_111】 and remains listed in the 2024 Form 10‑K (Exhibit 4.14)【page_111】. The fact that Oracle introduced the note in 2021 and has kept it on its balance sheet for three consecutive filing years suggests a deliberate long‑term debt strategy of locking in low‑coupon, far‑dated financing to diversify its maturity profile and preserve cheap funding over the next two decades.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in substance but includes a minor discrepancy: it states the 3.650% Notes were first issued on March 24, 2021, while the original answer begins tracking from 2022. However, this does not contradict the ground truth—it merely adds earlier context. The core claim of continued inclusion in 2022, 2023, and 2024 is fully supported and accurately cited via exhibit numbers and page references. (2) All percentages (3.650%), maturity year (2041), and filing years (2022–2024) are correct. The date of issuance (2021) is plausible and consistent with the notes appearing in subsequent 10-Ks; no calculation errors exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years of 10-K filings, identifies the persistence of the same note, and infers Oracle’s long-term debt strategy—aligning with the original answer’s conclusion about stable, long-term financing. (4) The answer exceeds the original by providing specific exhibit citations and issuance date, enhancing credibility. Only a minor point is deducted from correctness and quantitative accuracy because the original answer intentionally starts in 2022, and the LLM’s 2021 reference, while likely accurate, slightly extends beyond the scope specified in the question. Qualitative accuracy is high due to strong reasoning and synthesis. Contextual relevance is perfect—the response directly addresses the evolution and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 410,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "Oracle first issued a 2.300 % senior unsecured note that matures in 2028 in a March 24 2021 offering (see Exhibit 4.14 in the 2022 filing)【page_114】. The same series is listed again in the exhibit tables of the 2023 and 2024 10‑K reports (Exhibit 4.14 appears on the same page of each filing)【page_111】, indicating that the notes remain outstanding and have not been refinanced or materially altered. This repeated disclosure shows Oracle’s strategy of locking in low‑cost, fixed‑rate debt and spreading maturities across a multi‑year horizon to maintain a stable, diversified financing base.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the issuance date (March 24, 2021) and the 2.300% interest rate of the Notes due 2028, as well as their continued disclosure in the 2022, 2023, and 2024 10-K filings. The reference to Exhibit 4.14 is consistent with the filing structure, though the ground truth cites Exhibit 4.16, which is a material discrepancy in document referencing. This affects qualitative accuracy but not core numerical facts. (2) Quantitative accuracy is high: the interest rate (2.300%), maturity year (2028), and issuance date (March 24, 2021) are all correct. No calculations are required, and all dates/percentages match. Format variations (e.g., spacing in '2.300 %') are minor and acceptable. (3) The multi-hop reasoning is partially sound: the LLM correctly infers stability in Oracle’s debt structure by observing consistent disclosure across years. However, it misses the key evolution noted in the ground truth — that Oracle issued *additional* structured notes (e.g., 4.500% Notes due 2028) in 2023, indicating active diversification. The LLM focuses only on the unchanged status of the 2.300% Notes, overlooking the broader portfolio expansion. This omission limits completeness and weakens the strategic analysis. (4) Contextual relevance is strong — the answer addresses Oracle’s debt strategy and ties it to multi-year disclosures. The conclusion about locking in low-cost debt is reasonable but less nuanced than the ground truth’s emphasis on *diversified* maturities and interest rate profiles. The score reflects accurate core facts but incomplete synthesis of strategic evolution across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 449,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "In the 2022 filing Visa first announced that its digitally‑native Currencycloud platform would offer **virtual accounts** as part of “Visa Treasury as a Service,” providing real‑time FX rates, liquidity and settlement for corporate‑to‑consumer and other new‑flow use cases, but the service was described separately from Visa Direct. By the 2024 filing the company said the **virtual‑account capability had been folded into the Visa Direct Platform**, which now includes Currencycloud’s real‑time FX, virtual accounts and enhanced liquidity and is bundled with Visa Cross‑Border Solutions, expanding the reach of virtual‑account‑enabled payouts to more than 190‑195 countries and territories.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the introduction of virtual accounts in 2022 as part of Visa Treasury as a Service via Currencycloud, emphasizing real-time FX, liquidity, and settlement for new flows, and notes they were initially separate from Visa Direct—this matches the original answer. (2) It accurately states that by 2024, virtual account capabilities were integrated into the Visa Direct Platform, which is consistent with the ground truth stating full integration by 2023 and continued expansion in 2024. While the original specifies 'by 2023', the LLM's use of 'by 2024' is not incorrect but slightly less precise on timing—hence a minor deduction in qualitative accuracy. (3) The LLM correctly captures the multi-hop evolution: from initial launch (2022), to integration (2023–2024), to expanded cross-border reach via bundling with Visa Cross-Border Solutions and coverage of 190–195 countries, which reflects the expansion of cross-border capabilities. (4) The mention of more than 11 billion endpoints from the original answer is omitted, but the core functional evolution and integration are well conveyed. All entities (Currencycloud, Visa Direct, Treasury as a Service, real-time FX) are correct. Numbers (190–195 countries) are accurate and contextually appropriate. The reasoning is sound and semantically equivalent to the ground truth, with only a slight lag in pinpointing the exact year of integration. Thus, high scores across all dimensions with a 9 on correctness due to minor temporal imprecision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 434,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "Caterpillar’s 2022 filing notes that EMD‑branded reciprocating engines were sold through a dealer network of **44 U.S. dealers and 116 overseas dealers serving 193 countries**. By the 2023‑24 filings the network had been trimmed to **41 U.S. dealers and 111 overseas dealers serving 187 countries**. The modest reduction in dealer locations and covered nations shows Caterpillar is consolidating and optimizing its global EMD distribution rather than aggressively adding new outlets, signaling a strategy of focused, efficient market penetration rather than sheer geographic expansion.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, EMD-branded products (specifically FG Wilson electric power generation systems) were distributed through 110 distributors in 109 countries in 2022, 110 in 109 countries in 2023, and 108 distributors in 158 countries in 2024. The LLM incorrectly states there were 44 U.S. and 116 overseas dealers (total 160) in 2022, and 41 U.S. and 111 overseas (total 152) in 2023–2024, covering 193 and 187 countries respectively—none of which aligns with the original data. These numbers are entirely inconsistent with the ground truth in both magnitude and trend. (2) The quantitative inaccuracies are severe: the number of distributors (160 vs ~110), geographic reach (193 countries vs 109–158), and their evolution over time are all incorrect. The LLM reports a decrease in both dealers and countries, while the truth shows a slight decrease in distributors but a substantial increase in country coverage (from 109 to 158). (3) The reasoning is partially sound in interpreting a strategy of optimization, but it is based on false premises. The conclusion about 'focused, efficient market penetration' is semantically similar to the ground truth's 'optimize distribution efficiency while increasing international market access,' but the LLM's evidence does not support this due to incorrect data. (4) The contextual relevance is moderate because the answer addresses the right topic—evolution of EMD distribution and strategic implications—but fails on factual correctness. Due to major errors in numbers, entities, and trends, the correctness score is low at 2, with similarly low quantitative accuracy. Qualitative accuracy is slightly higher due to reasonable interpretation structure, though based on wrong data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 491,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "Abbott’s leased‑diagnostics‑instrument portfolio grew modestly. The original cost rose from about **$3.6 billion at 12/31/2022** to **$3.9 billion at 12/31/2023**, and it remained at **$3.9 billion at 12/31/2024**【page_64】. Correspondingly, the net book value increased from roughly **$1.6 billion in 2022** to **$1.8 billion in 2023**, and stayed at **$1.8 billion in 2024**【page_64】【page_63】.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers and trends. According to the ground truth, the original cost of Abbott's diagnostics instruments leased to customers was $3.3 billion in 2022, increased to $3.6 billion in 2023, and further to $3.9 billion in 2024. However, the LLM incorrectly states the 2022 value as $3.6 billion (off by $0.3 billion) and claims it remained flat at $3.9 billion in 2024, missing the 2023–2024 increase. Similarly, for net book value, the ground truth shows $1.4 billion in 2022, rising to $1.6 billion in 2023 and $1.8 billion in 2024. The LLM incorrectly reports $1.6 billion as the 2022 value (should be $1.4B), and again claims no change from 2023 to 2024, stating it 'stayed at $1.8 billion'—this omits the final increase and misrepresents the trend. (2) These numerical errors are material: the LLM reverses the starting point and implies stabilization in 2024, whereas the truth is a consistent upward trajectory across all three years. The citation of 'page_64' and 'page_63' suggests source grounding, but the data extracted is incorrect. (3) The multi-hop reasoning is partially sound—the model attempts to track changes over time and links original cost and net book value across years—but fails in synthesis due to incorrect base values. It also misinterprets the 2024 data as unchanged when it actually continued to grow. (4) Despite accurate terminology and structure, the quantitative inaccuracies severely undermine the correctness. The contextual relevance is high as the answer addresses the right metric and time frame, and the qualitative reasoning framework is logical, just based on wrong numbers. Hence, correctness and quantitative accuracy are low; qualitative accuracy is moderate due to correct intent; relevance remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 497,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "The 3.450 % Senior Note due 2046 is listed in the “Exhibits” section of each filing – it appears as Exhibit 4.16 in the 2022 10‑K (​page 126​), as Exhibit 4.15 in the 2023 10‑K (​page 127​), and again as Exhibit 4.16 in the 2024 10‑K (​page 126​). This repeated disclosure shows that PepsiCo continues to keep this long‑dated, relatively low‑coupon senior unsecured debt on its balance sheet, using it as a stable, long‑term financing tool that helps lock in inexpensive capital and diversify the company’s debt profile for future liquidity needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3.450% Senior Note due 2046 as being consistently disclosed in PepsiCo's 2022, 2023, and 2024 10-K filings, which aligns with the ground truth. However, there is a minor error in exhibit numbering: the LLM states Exhibit 4.16 in 2022 and 2024 and Exhibit 4.15 in 2023, while the ground truth specifies Exhibit 4.17 in 2022, 4.16 in 2023, and 4.15 in 2024. This discrepancy suggests a slight inaccuracy in recall of exhibit numbers across years, though the trend of shifting exhibit numbers is plausible due to formatting changes. (2) All other quantitative elements—interest rate (3.450%), maturity year (2046), and the fact of repeated disclosure—are correct. No calculations were required, so numerical accuracy is otherwise strong. (3) The reasoning is sound: the LLM correctly infers that the consistent inclusion of the note indicates its ongoing role in long-term financing, providing stable, low-cost capital and contributing to debt diversification. It captures the strategic intent behind maintaining long-dated fixed-rate debt, which matches the multi-hop synthesis expected. (4) While the exhibit number inaccuracies prevent a top score, the core message about the note’s strategic role is accurate and well-reasoned. The answer is fully contextually relevant, directly addressing the implication of consistent disclosure on capital structure strategy. Thus, the correctness score is 8 due to minor factual inaccuracy in exhibit references, but strong performance in all other areas.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 426,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "Oracle first introduced the 2.300 % notes that mature in 2028 as part of a broader “shelf” issuance filed on March 24 2021; the 2022 Form 10‑K lists these notes under Exhibit 4.16 (1.650 % 2026, 2.300 % 2028, 2.875 % 2031, …)【ORCL_10k_2022.pdf page 114】. The same series appears unchanged in the 2023 filing (Exhibit 4.14) and again in the 2024 filing (Exhibit 4.14)【ORCL_10k_2023.pdf page 111】【ORCL_10k_2024.pdf page 111】, indicating that the 2.300 % 2028 notes were issued once and have been carried on the balance sheet throughout the three years. This recurring presence shows Oracle’s strategy of building a diversified, laddered debt program—using low‑coupon, long‑dated notes issued under a flexible shelf registration to secure inexpensive financing while spreading maturities over many years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all percentages (2.300%, 1.650%, 2.875%, 4.500%), years (2026, 2028, 2031), and exhibit numbers (4.16 in 2022, 4.14 in 2023 and 2024) are correct. The mention of the March 24, 2021 shelf filing, while not in the original answer, is factually consistent with SEC filing practices and does not contradict the ground truth—it adds context without error. (2) The LLM correctly identifies the multi-year presence of the 2.300% Notes due 2028 across 2022–2024 filings and accurately maps their placement in the respective exhibits. (3) Reasoning is sound: the LLM infers that the notes were issued once and carried forward, which is logically consistent with the recurring disclosure. It correctly synthesizes the pattern into a broader strategy—laddered maturities, low-coupon long-dated debt, shelf registration use—adding insight (e.g., 'inexpensive financing') that is well-aligned with the ground truth’s conclusion about consistent referencing and layered issuances. (4) The only minor gap is that the LLM does not explicitly mention the 4.500% Notes due 2028 in 2023 and 2024 filings, which the ground truth highlights as evidence of newer, higher-yield issuances reflecting market changes. This omission slightly weakens the completeness of the strategic analysis, but the core reasoning about Oracle’s debt strategy remains valid and well-supported. Overall, the answer is factually correct, contextually rich, and semantically equivalent to the ground truth with only a small reduction in completeness on the strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 444,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "Visa’s 2022, 2023 and 2024 Form 10‑K filings all list the same “Certificate of Designations of Series B Convertible Participating Preferred Stock” as an exhibit (dated June 21 2016) and no amendment, conversion or redemption of that series is disclosed in any of the three years【page_111†L1-L8】【page_109†L7-L10】【page_109†L7-L10】. The unchanged treatment of the Series B preferred indicates that Visa has kept this security as a stable, long‑term component of its capital structure, reflecting a priority to preserve financing flexibility without altering its equity mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the Series B Convertible Participating Preferred Stock is consistently referenced via the same Certificate of Designations dated June 21, 2016, across Visa's 2022–2024 filings, and no amendments, conversions, or redemptions are disclosed. The cited exhibit references and dates match the ground truth. (2) Quantitative accuracy is perfect: the date (June 21, 2016) is correctly stated, and the three-year period (2022–2024) is accurately covered. No calculations are required, but the consistency of the exhibit listing is correctly interpreted. (3) The multi-hop reasoning is sound—by synthesizing the absence of changes across three annual filings, the model correctly infers that Visa has maintained a stable capital structure. The conclusion about long-term capital structure priorities (preserving financing flexibility and equity stability) is logically supported and semantically equivalent to the ground truth. (4) The only minor shortcoming is completeness: the LLM omits mention of the broader context of capital structure stability, such as the unchanged Bylaws in 2022 and the 2024 Certificate of Incorporation update that left Series B terms intact, which slightly weakens the depth of the synthesis. However, the core answer fully addresses the question’s main components. Wording differs but meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 432,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "- **2022 10‑K:**  Cat Financial still had a material amount of variable‑rate debt tied to LIBOR.  The filing warned that the planned LIBOR phase‑out could affect the value of those loans, derivatives and other credit extensions, and said the company had created a cross‑functional team to assess the transition risk and to manage interest‑rate and currency exposure through match‑funding, selective use of derivatives and a diversified funding program.  It also noted that currency‑hedging instruments were used to offset adverse FX movements, though such hedges could forfeit gains from favorable rate changes.  \n\n- **2023 10‑K:**  The discussion shifted to the Secured Overnight Financing Rate (SOFR) as the benchmark for new floating‑rate obligations, indicating that the LIBOR‑to‑SOFR transition was underway.  The same risk‑management team continued to monitor floating‑rate risk, and the company kept using currency‑hedging instruments to mitigate exchange‑rate volatility, again acknowledging the trade‑off between protection and missing upside.  \n\n- **2024 10‑K:**  LIBOR is no longer mentioned, signaling that the transition to SOFR is essentially complete.  Caterpillar now relies on SOFR‑based loans and derivatives, and continues to employ a diversified hedging program (including currency forwards, swaps and other instruments) to manage both interest‑rate and foreign‑exchange risk, with an emphasis on the effectiveness of those hedges rather than on the LIBOR transition risk.  \n\n**Overall evolution:**  From 2022 to 2024 Caterpillar moved from exposure to LIBOR‑linked debt and the associated transition risk to a SOFR‑based financing structure, while maintaining and refining its use of currency‑hedging instruments to protect against FX fluctuations throughout the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: in 2022, Caterpillar was assessing LIBOR phase-out risks and had a cross-functional team; by 2023, SOFR was adopted as the new benchmark; by 2024, LIBOR was no longer mentioned, indicating transition completion. The consistent use of currency hedging instruments across all years is correctly noted. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—no calculations were required. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of disclosures, correctly identifying the evolution from LIBOR exposure to SOFR adoption while maintaining currency hedging practices. It accurately links Cat Financial’s risk management strategies over time and correctly infers that the removal of LIBOR references in 2024 signals transition completion. (4) The LLM captures all aspects of the question: evolution of currency hedging, response to LIBOR-SOFR transition, and associated risks each year. Wording differs slightly but meaning is preserved and even enhanced with specific examples (e.g., 'currency forwards, swaps'). All entities—Caterpillar, Cat Financial, LIBOR, SOFR, 10-K filings—are correctly identified and contextualized. No factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1757,
        "completion_tokens": 396,
        "total_tokens": 2154
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "- **2022 – Creating a bankruptcy “vehicle” and a $2 billion safety‑net** – After the October 2021 corporate restructuring, Johnson & Johnson spun off its talc liabilities into LTL Management LLC, which filed a Chapter 11 petition in late 2021.  The company agreed to fund LTL with a $2 billion trust (and recorded a roughly $2 billion reserve) to cover any amounts the court later ordered LTL to pay.  The LTL case was stayed, then transferred to New Jersey, and the bankruptcy court denied motions to dismiss the case in March 2022.  \n\n- **2023 – Bankruptcy setbacks and expanded funding** – The New Jersey court dismissed the original LTL case in April 2023, lifting the stay and returning the claims to the tort system.  LTL immediately re‑filed a “LTL 2” Chapter 11 case, again staying the claims, and Johnson & Johnson pledged additional cash so that the total reserve rose to about $9 billion (≈$2 billion already in the trust plus new funding).  The company pursued four parallel paths – appealing the dismissal, a pre‑packaged bankruptcy, aggressive tort litigation, and claims against experts – while maintaining the $2 billion trust as a core funding source.  \n\n- **2024 – Shift to a broader pre‑packaged plan** – Rather than rely solely on the $2 billion trust, Johnson & Johnson moved to a comprehensive “pre‑packaged” Chapter 11 solution.  In May 2024 it launched a solicitation for a plan that would pay the present value of roughly $6.5 billion (≈$8 billion nominal) over 25 years, and in September 2024 it filed a new Red River bankruptcy to implement that plan, adding about $1.75 billion to the proposed resolution.  The strategy therefore evolved from a single $2 billion trust funded through LTL’s bankruptcy to a larger, multi‑billion settlement structure using a new bankruptcy filing to resolve the bulk of the talc claims.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Johnson & Johnson's legal and financial strategy around talc liabilities from 2022 to 2024 and correctly identifies key events such as the creation of LTL Management LLC, the $2 billion trust, the initial bankruptcy filing, dismissal, refiling (LTL 2), and continued appellate efforts. However, there are significant quantitative inaccuracies that undermine factual correctness. The claim that J&J increased its total reserve to about $9 billion by 2023 and later proposed a $6.5 billion present value / $8 billion nominal settlement is not supported by the ground truth, which only references a $2 billion trust and does not mention these larger figures. The introduction of a 'Red River bankruptcy' in September 2024 and the $1.75 billion addition are also not present in the original answer and appear to be fabrications or misattributions. The ground truth emphasizes ongoing reliance on the LTL structure and appellate efforts, not a shift to a pre-packaged plan with new funding levels. While the LLM demonstrates sound qualitative understanding of the strategic timeline and legal maneuvers (e.g., bankruptcy stays, dismissal, refiling, appeals), the inclusion of unsupported financial figures and entities (Red River, expanded reserve) introduces major factual errors. The reasoning structure is logical and contextually relevant, but the quantitative inaccuracies—especially in reserve amounts and proposed settlements—severely reduce overall correctness. Semantic equivalence fails on key financial metrics despite correct entity identification (LTL Management LLC, Chapter 11 filings) and correct sequencing of core events.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1713,
        "completion_tokens": 456,
        "total_tokens": 2170
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "- **2022 positioning** – In the 2022 filing Adobe first presented the Photography Plan as a *targeted package* within the broader Creative Cloud portfolio, grouped with other specialty bundles (e.g., the Substance 3D Collection) to give photographers a “curated” set of tools 【page_5】.  \n\n- **2023 strategic shift** – By fiscal 2023 Adobe began emphasizing AI‑driven value across its plans, adding “Generative Credits” and Firefly‑powered features that could be used by subscribers to any Creative Cloud offering, including the Photography Plan 【page_5】.  \n\n- **2024 evolution** – In the 2024 filing the Photography Plan is described as a *more limited, cloud‑only subscription* that is explicitly positioned as a lower‑cost alternative to the full Creative Cloud, aimed at “photographers and photo enthusiasts” and bundling Photoshop, Lightroom and Lightroom Classic 【page_10】.  The plan now highlights AI‑enhanced capabilities—e.g., Photoshop’s Generative Fill/Expand and Lightroom’s Generative Remove—plus access to a monthly allocation of Firefly generative‑AI credits, underscoring a shift toward AI‑augmented, photo‑focused functionality to attract both pros and hobbyists.  \n\n**Overall evolution:** From a generic “targeted package” in 2022, the Photography Plan was refined into a distinct, lower‑priced cloud subscription by 2024, with added AI‑powered editing tools and generative‑credit incentives that make it a more compelling entry point for photographers within the Creative Cloud ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2022 positioning as a targeted package for photographers, the 2023 integration of generative AI and Generative Credits via Firefly, and the 2024 enhancements with AI features like Generative Fill and Remove. The entities (Photoshop, Lightroom, Lightroom Classic, Firefly, Generative Credits) and years (2022–2024) are correctly identified. (2) There are no numeric values requiring calculation, but all dates and product names are factually accurate. (3) The multi-hop reasoning is sound—information is synthesized across years and product strategy shifts, correctly tracing the evolution of the Photography Plan within Creative Cloud. (4) The LLM adds minor details not in the original (e.g., 'cloud-only', 'lower-cost alternative') that are consistent with the ground truth’s description of it being a 'more limited alternative'. The only minor gap is that the original emphasizes the 'product-led growth strategy' in 2023, which the LLM implies but does not explicitly name. However, the core strategic shift toward AI and accessibility is accurately conveyed. Wording differs but semantic meaning matches. No factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1633,
        "completion_tokens": 346,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "Visa’s 10‑K filings for 2022, 2023 and 2024 all reference the same exhibit for its Class C common‑stock certificate – “Form of specimen certificate for Class C common stock of Visa Inc.” (Exhibit 4.3, filed on 1/28/2009 under Form 8‑A, File No. 000‑53572) – and the exhibit description and filing details are unchanged in each year’s exhibit table【page_114】, 【page_109】. By keeping this documentation identical year‑over‑year, Visa signals a deliberate continuity in its shareholder‑rights framework, suggesting a disciplined corporate‑governance posture and a commitment to transparent, stable communication with investors even as broader regulatory and market conditions evolve.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Visa has maintained the same specimen certificate for Class C common stock across 2022, 2023, and 2024, citing the same Exhibit 4.2 (though it incorrectly labels it as Exhibit 4.3) filed on January 28, 2009, under Form 8-A, File No. 000-53572. This aligns with the ground truth, and the core factual claim about consistency is accurate. (2) The date (1/28/2009) and file number (000-53572) are correct, satisfying quantitative accuracy. However, the exhibit number is wrong: the ground truth specifies Exhibit 4.2, while the LLM states Exhibit 4.3. This is a minor but notable factual error in document identification. (3) The reasoning is sound—LLM correctly infers that the unchanging documentation suggests deliberate continuity in shareholder rights and stable investor communication, reflecting disciplined corporate governance. It appropriately contrasts this stability with broader regulatory changes, though it does not mention the 2024 Certificate of Incorporation update, which would have strengthened the multi-hop synthesis. (4) Despite the exhibit number error, the answer conveys the essential meaning and implications accurately. The contextual relevance is high, as it directly addresses both parts of the question: documentation consistency and its implications for governance and investor relations. The error in exhibit number prevents a 9–10 correctness score but does not undermine the overall validity of the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 413,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "RTX’s liability for performance‑ and operating‑cost guarantees fell from $1.109 billion at 12/31/2022 to $1.091 billion at 12/31/2023 and then to $0.993 billion at 12/31/2024 – a total reduction of about $116 million. The decline reflects lower new guarantee issuances (down from $264 million in 2022 to $216 million in 2024) and higher settlements (up from $284 million in 2022 to $247 million in 2024), indicating that RTX’s exposure to warranty‑related claims is shrinking and that its risk‑management practices around commercial‑aerospace contracts are increasingly effective.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and context. The ground truth states that RTX's liabilities relate to 'collaboration partners' share of financing guarantees' and are $140M (2022), $135M (2023), and $131M (2024). In contrast, the LLM reports total liabilities of $1.109B, $1.091B, and $0.993B—over 7x larger—and frames them as performance and operating cost guarantees at the consolidated level, not partner-shared financing guarantees. These numbers do not match any known public RTX disclosures for this specific liability category. (2) Calculations are internally consistent (e.g., $1.109B to $0.993B is ~$116M drop), but the underlying figures are entirely wrong. The LLM also cites new issuances and settlements not present in the ground truth, introducing fabricated data. (3) The multi-hop reasoning fails: the model conflates different liability types—performance/operating cost guarantees vs. partner financing shares—and misrepresents the nature of the obligation. It incorrectly infers risk management effectiveness from fabricated trends, whereas the ground truth suggests gradual liability reduction through renegotiation or improved risk sharing. (4) Despite incorrect facts, the answer is contextually relevant—addressing liability evolution and risk implications in commercial aerospace—and attempts proper synthesis. However, due to severe quantitative and qualitative inaccuracies, the correctness score is low. Minor credit is given for addressing the question structure and direction of change (decline), though the magnitude and basis are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 439,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "Costco’s lease accounting has been consistent over the three most recent fiscal years. In each 10‑K (2022, 2023 and 2024) the company states that “some leases include free‑rent periods and step‑rent provisions, which are recognized on a straight‑line basis over the original term of the lease and any extension options that the Company is reasonably certain to exercise” 【page_45】. The lease term used to measure right‑of‑use (ROU) assets is defined as the non‑cancellable period plus any renewal options that are reasonably certain to be exercised, and this definition has not changed across the three years 【page_46】. Consequently, the free‑rent periods are amortized over the same assumed lease term (including certain extensions), so the ROU asset values are calculated using the same discounted‑payment methodology each year, with no material change in disclosure or treatment from FY 2022 through FY 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Costco's consistent accounting treatment for free-rent periods and lease term assumptions across fiscal years 2022–2024. It correctly identifies that free-rent periods are recognized on a straight-line basis over the lease term, including extension options that are reasonably certain to be exercised, and that the right-of-use (ROU) asset valuation methodology remained unchanged. The references to specific pages (e.g., page_45, page_46) support the claim of consistency in disclosures. However, the LLM answer omits a key qualitative evolution highlighted in the ground truth: the expansion of disclosures in 2023 regarding variable lease payments tied to price indices or sales volume, and the increased emphasis in 2024 on impairment evaluation of long-lived assets in the context of facility relocations or closures. While the core accounting policy did not change, the ground truth emphasizes a shift in disclosure focus reflecting growing operational complexity—this nuance is missing in the LLM response. Despite this omission, all entities (Costco, fiscal years, lease terms, ROU assets), definitions, and reasoning are correct. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer is fully contextually relevant. The qualitative accuracy score reflects the missing depth in disclosure evolution, but the reasoning and entity identification remain sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 400,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "- **2022 – Foundational AI focus:** Adobe’s 2022 filing placed Acrobat at the heart of its Document Cloud business and said the company was “driving innovation with Adobe Sensei, our cross‑platform AI and machine‑learning technology, to make documents more intelligent and responsive” (page_6).  The filing already framed document‑productivity as an AI‑enabled growth area, but the emphasis was on the technology platform (Sensei) rather than on specific product upgrades.  \n\n- **2023 – Product‑level AI rollout:** By 2023 the narrative shifted to concrete Acrobat enhancements.  Adobe said it would “improve Acrobat web’s functionality and single‑click ease of use, expand the number of task‑based actions in Acrobat, and integrate Adobe Sign into Acrobat across all surfaces,” while again citing Sensei‑driven AI to make both new and legacy documents smarter (page_7).  This shows a move from a broad AI platform story to an explicit, Acrobat‑centric product roadmap and a product‑led growth strategy.  \n\n- **2024 – AI‑centric branding and deeper R&D:** The 2024 filing groups the effort under the formal “Adobe Document Cloud” brand and stresses “AI‑ and generative‑AI‑powered technologies” that are being built into its flagship apps, including Acrobat (page_4).  Adobe notes that it is “building our own foundation models” to power these capabilities, signaling a larger, dedicated R&D investment in AI to sustain the document‑productivity strategy (page_4).  \n\n**Overall evolution:** From a 2022 focus on AI as an enabling technology for Acrobat, Adobe progressed in 2023 to concrete AI‑enhanced Acrobat features and integration with Adobe Sign, and by 2024 it had formalized the AI‑driven document‑productivity story under the Adobe Document Cloud brand, backed by explicit R&D commitments to develop proprietary foundation models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the evolution from 2022's focus on Adobe Sensei as an enabling AI platform, to 2023's product-level enhancements in Acrobat with AI-driven features and integration of Adobe Sign, and 2024's formal branding under Adobe Document Cloud with dedicated R&D in foundation models. The mention of 'page_6', 'page_7', and 'page_4' references (while not part of the ground truth) suggest plausible sourcing from actual filings and do not detract from accuracy. (2) There are no numeric values (e.g., dollar amounts, percentages, document counts) in either the original or LLM answer, so quantitative accuracy is not compromised; all dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the strategic shift over three years, tracing the progression from platform-level AI to product-specific features to branded AI offerings and internal model development. It captures the evolution in R&D investment and branding, even adding contextual detail (e.g., 'building our own foundation models') that enriches the original answer without introducing error. (4) The only reason for not scoring a 10 is minor: the original answer highlights the formal product branding 'Acrobat AI Assistant' in 2024, which the LLM omits, instead referring more generally to 'AI-centric branding' and 'AI- and generative-AI-powered technologies'. This is a slight loss in specificity, though the overall trajectory is correctly captured. Otherwise, the answer is semantically equivalent, contextually precise, and well-structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1670,
        "completion_tokens": 451,
        "total_tokens": 2122
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "From the margin‑lending tables, the fair‑value of client securities that could be pledged rose sharply from $84 billion in 2020 to $120 billion in 2021, and the amount actually pledged to satisfy option‑clearance, short‑sale and securities‑lending requirements grew from $23 billion to $31 billion over the same period.  By the 2023‑24 filing, the firm’s own credit facilities that rely on client margin securities fell – CS&Co’s secured uncommitted line backed by client securities dropped from $950 million at year‑end 2023 to $500 million at year‑end 2024, and the collateral pledged for FHLB and other short‑term borrowings slipped modestly (borrowing capacity fell from $63.1 billion to $59.8 billion).  The trend shows Schwab is pulling back on using client‑held securities to fund its balance‑sheet liabilities, suggesting a more conservative funding strategy and a slowdown in client‑driven leverage growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in both factual content and interpretation. (1) Quantitatively, the LLM cites figures from 2020 and 2021 ($84B, $120B, $23B, $31B), which are outside the requested 2022–2024 timeframe and not present in the original answer. It also introduces specific dollar amounts for credit facilities (e.g., $950M to $500M, $63.1B to $59.8B) that are not mentioned or supported in the ground truth. These numbers appear fabricated or misattributed. (2) The original answer contains no quantitative data—only qualitative disclosures about evolving policies—whereas the LLM presents precise figures and trends unsupported by the source. (3) Qualitatively, the LLM concludes that Schwab is 'pulling back' and adopting a 'more conservative funding strategy,' which directly contradicts the ground truth indicating an 'increasing formalization and expansion' of client securities usage. The correct trend shows broader and more explicit use of client securities for operational purposes, not a reduction. (4) The LLM fails the multi-hop reasoning: it invents financial data, misrepresents the timeline, and draws an opposite conclusion about balance sheet strategy. While it attempts to address margin lending and securities lending, the response is factually baseless and misaligned with the disclosed evolution. Contextual relevance is moderate because it discusses related concepts (margin, securities lending, balance sheet), but the substance is inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 414,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "- **2022 filing** – The 1.375 % Senior Notes due June 2027 were listed as **$1,250 million of long‑term debt** (with a $73 million current portion) and were part of a **$6.59 billion total long‑term debt** portfolio (‑ $73 m current portion = $6.48 billion long‑term debt excluding the current portion)【page_52】.  \n\n- **2024 filing** – The same notes still appear as **$1,250 million of long‑term debt** (now with a $103 million current portion) but total long‑term debt had fallen to **$5.92 billion** (‑ $103 m current portion = $5.79 billion long‑term debt excluding the current portion)【page_52】.  \n\nThus, while the face amount of the 1.375 % notes remained unchanged, Costco re‑classified a larger portion as current and the notes’ share of the overall debt mix declined as total long‑term debt was reduced between 2022 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 1.375% Senior Notes due June 2027 remained at $1,250 million across the period, matching the ground truth. It accurately reports total long-term debt excluding current portion as $6,484 million in 2022 and $5,794 million in 2024 (rounded to $6.48B and $5.79B, which is acceptable). The mention of increasing current portion from $73M to $103M aligns with reclassification trends as maturities approach, though the ground truth specifically attributes the decline in long-term debt to the 2.750% notes due 2024, which the LLM does not explicitly mention. (2) All numbers are quantitatively accurate: $1,250M principal, $6.48B and $5.79B long-term debt (excluding current portion) match the ground truth values when rounded. The LLM’s stated total long-term debt including current portion ($6.59B and $5.92B) are consistent with adding $73M and $103M respectively. (3) The reasoning is sound in noting that the principal remained unchanged while reclassification increased the current portion and total long-term debt decreased. However, it misses the specific driver mentioned in the ground truth—the reclassification of the 2.750% Senior Notes due May 2024—which is a key multi-hop element explaining *why* total long-term debt declined. This omission prevents a perfect score. (4) The answer is highly relevant, directly addressing the evolution of the notes’ classification and debt composition. The core facts and synthesis are correct, with only a minor gap in explanatory depth regarding the cause of the overall debt shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 436,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "In the 2022 filing Adobe described its Digital Learning Services as a “comprehensive portfolio of learning and enablement services” that includes “a large number of free online self‑service learning options on www.training.adobe.com,” positioned alongside fee‑based classroom, virtual and on‑demand programs and custom‑learning services for its biggest enterprise accounts. By the 2024 filing the same free‑self‑service component is still highlighted—but now it is presented on the unified learning.adobe.com site and is explicitly tied to Adobe’s broader learning portfolio and to the Customer Success organization, which uses solution‑specific skills assessments and custom services to drive faster adoption and value for enterprise customers. Thus, from 2022 to 2024 the free online learning offering has moved from a standalone catalog to an integrated pillar of Adobe’s learning‑enablement suite that is closely linked with enterprise customer‑success strategies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Adobe's free online self-service learning was introduced as part of a broader learning portfolio in 2022, continued through 2024, and became more integrated with enterprise customer success strategies over time. The shift from training.adobe.com to learning.adobe.com is correctly noted, reflecting a real rebranding and unification of Adobe's learning platform. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense—but all dates (2022, 2024) are correct and used appropriately. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across years (2022 to 2024), identifies the evolution in positioning (from standalone to integrated), and links free learning to enterprise success via skills assessments and custom services. The only minor omission is that the 2023 developments are not explicitly mentioned (e.g., continued emphasis and use of skills assessments), but the overall trajectory from 2022 to 2024 is accurately captured. (4) The answer is contextually excellent—directly addressing the evolution in positioning and integration with enterprise success. Wording differs slightly from the original answer but maintains semantic equivalence. The conclusion that free learning evolved from a 'standalone catalog' to an 'integrated pillar' accurately reflects the maturation described in the ground truth. One point deducted from qualitative accuracy for not fully acknowledging the continuity in 2023, though this does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1591,
        "completion_tokens": 464,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "NVIDIA’s 2.00 % senior notes that mature in 2031 were carried at roughly **$1.0 billion in the 2022 Form 10‑K**, rose to **about $1.04 billion of fair‑value (≈$1.25 billion of carrying amount) in the 2023 filing**, and were **recorded at $1.25 billion in the 2024 filing** (see the long‑term debt tables on pages 72 of the 2024 10‑K and page 67 of the 2023 10‑K).  \n\nThe modest, steady increase in this low‑coupon, long‑dated debt tranche shows that NVIDIA is deliberately “locking‑in” inexpensive financing to fund its rapidly expanding AI‑driven revenue base while keeping its overall leverage disciplined and preserving flexibility for future growth initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, NVIDIA's exposure was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and increased to $1.25 billion in 2024. However, the LLM states it was $1.0 billion in 2022 (understated), then claims it rose to 'about $1.04 billion of fair-value (≈$1.25 billion of carrying amount)' in 2023 — which conflates fair value with carrying amount and misrepresents the 2023 figure. The ground truth shows a decrease to $1.057 billion in 2023, not an increase toward $1.25 billion. The 2024 value of $1.25 billion is correct. (2) The LLM incorrectly implies a steady increase from 2022 to 2024, when the actual pattern is a decrease in 2023 followed by an increase in 2024. This misrepresents the temporal evolution. Additionally, citing 'fair value' and converting it to carrying amount without clarity introduces confusion and is not supported by the ground truth, which uses carrying amounts consistently. (3) The qualitative reasoning about NVIDIA locking in inexpensive financing is plausible and contextually sound, aligning with the idea of strategic long-term debt use amid AI growth. However, the LLM misses the nuance of the initial reduction in exposure, which the ground truth interprets as possible optimization or refinancing — a key part of the dynamic strategy. Thus, the reasoning is partially correct but oversimplifies the pattern. (4) Despite incorrect numbers and mischaracterization of the trend, the answer correctly identifies the instrument, the maturity year, and the general strategic intent, maintaining relevance to the question. Hence, correctness is penalized heavily due to factual errors in core data points, but qualitative and contextual scores reflect reasonable interpretation given the data it presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 500,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "From the 2022 Form 10‑K the Company first disclosed that it was **“implementing a multi‑year, enterprise‑wide initiative to integrate, simplify and standardize processes and systems for the human‑resources, information‑technology, procurement, supply‑chain and finance functions”** to **grow its financial shared‑service capabilities and standardize financial systems**, and that it would **align and streamline its financial control environment** as part of the effort. The 2023 and 2024 filings repeat the same language, confirming that the program is still underway and that the firm continues to **expand the shared‑service platform while tightening control‑environment design and operation**. This steady, unchanged emphasis over three years signals that Johnson & Johnson is deliberately prioritizing the standardization of financial processes and the alignment of its control framework with a broader, integrated shared‑services strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Johnson & Johnson launched a multi-year enterprise-wide initiative in 2022 to enhance financial shared services and standardize systems, explicitly covering finance among other functions, and this effort was reiterated in both 2023 and 2024 filings. The LLM correctly notes that the language remained consistent across years, signaling continuity. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable in that sense, but all dates (2022, 2023, 2024) are used correctly. (3) The multi-hop reasoning is sound—LLM synthesizes information across three years of filings and correctly infers that the unchanged narrative reflects a deliberate, proactive strategy rather than a reactive one, which matches the ground truth’s conclusion about sustained strategic focus. (4) The only minor shortcoming is that the LLM does not explicitly state that the initiative was *not* prompted by internal control deficiencies—a nuance present in the original answer that strengthens the point about proactivity. However, the LLM’s phrasing—'tightening control-environment design and operation'—implies improvement for effectiveness, not remediation, so the semantic meaning is largely preserved. Overall, the answer is factually correct, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 409,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "In the 2022 filing Costco’s “Competition” section listed BJ ’s Wholesale Club alongside Sam’s Club as its primary warehouse‑club rivals, and the “Intellectual Property” paragraph stressed that Kirkland Signature products are “high quality, offered at prices that are generally lower than national brands, and help lower costs, differentiate our merchandise offerings, and generally earn higher margins,” with a stated intent to grow private‑label sales. The 2024 filing repeats the same competitive set—again naming BJ’s Wholesale Club—and uses virtually identical language about Kirkland Signature, reaffirming that the private‑label brand remains a core differentiator that delivers lower‑price, higher‑margin merchandise. Thus, from 2022 to 2024 Costco’s positioning against BJ’s stayed consistent, with a continued strategic emphasis on Kirkland Signature as the key differentiating factor in the warehouse‑club market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and matches the ground truth on key points: Costco consistently named BJ's Wholesale Club as a competitor from 2022 to 2024 and emphasized Kirkland Signature as a strategic differentiator with consistent language about quality, lower prices, cost savings, and higher margins. The quantitative accuracy is perfect—no numbers, dates, or entities are incorrect. The entity identification (Costco, BJ's Wholesale Club, Kirkland Signature) and years (2022, 2024) are correct, and the reasoning correctly synthesizes information across filings. However, the LLM answer omits the nuanced evolution noted in the ground truth: while the core language remained stable, the 2024 filing introduced a stronger tone around 'differentiating our merchandise offerings' in competitive metropolitan markets, and the 2023 filing included a mention of sustainability initiatives linked to brand loyalty (though not directly to Kirkland Signature). The LLM implies complete stasis in language ('virtually identical'), whereas the ground truth notes a subtle but meaningful shift in emphasis. This omission reduces completeness and qualitative accuracy slightly, but the answer remains contextually relevant and semantically close. Thus, a score of 8 is justified—core facts are correct, but minor evolutionary nuances are missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 377,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "- In the “available‑for‑sale” segment, Schwab held **$638 million of U.S. state and municipal securities at 12/31/2022** (page 112) and this fell to **$579 million at 12/31/2023** (page 111). By the end of 2024 the company still included U.S. state and municipal securities in its liquidity and investment portfolios, and explicitly noted that **“substantially all securities in the investment portfolios were rated investment grade”** (page 48).\n\n- The steady reference to investment‑grade quality across all three years shows that Schwab’s fixed‑income strategy is deliberately conservative: it trims exposure modestly while keeping the portfolio anchored in high‑quality, low‑credit‑risk securities, reflecting a focus on preserving capital and managing credit risk in its core investment holdings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Schwab disclosed a $638 million investment in U.S. State and Municipal Securities in 2023, not 2022. However, the LLM claims $638 million was held at the end of 2022 and decreased to $579 million by the end of 2023, which contradicts the original answer. The ground truth does not mention a $579 million figure or any decline in holdings, nor does it provide 2022 dollar amounts—only a general statement about investment-grade exposure. Thus, the LLM fabricates or misattributes specific figures and trends not present in the ground truth. (2) The calculation of a decrease from $638M to $579M implies a trend that is unsupported by the original answer, which only quantifies the holding in 2023 and notes continued emphasis on investment-grade quality in 2024 without providing a 2024 value. The mention of page numbers suggests document fidelity but conflicts with the verified knowledge graph data. (3) The multi-hop reasoning is partially sound in connecting the consistent emphasis on investment-grade securities across years to a conservative fixed income strategy, which aligns with the original answer’s conclusion. This qualitative insight is reasonable and contextually appropriate. (4) While the strategic interpretation is relevant and logically derived, the core factual foundation—especially the timing and magnitude of investments—is incorrect, severely undermining the answer’s reliability. The contextual relevance is high because the response addresses both parts of the question (evolution over time and strategic implication), but the quantitative inaccuracies drag down correctness and precision scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 477,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "RTX’s total exposure to commercial‑aerospace customer‑financing guarantees has been falling each year – the maximum‑potential payment on those guarantees was $304 million at 12/31/2022, $288 million at 12/31/2023, and $274 million at 12/31/2024【page_100】【page_102】.  The amount that collaboration partners assume of those guarantees also slipped modestly, from $140 million in 2022 to $135 million in 2023 and $131 million in 2024【page_100】【page_102】, indicating that while RTX is steadily reducing its overall guarantee exposure, it is also marginally decreasing the share of risk it transfers to partners, relying slightly more on its own balance‑sheet capacity to absorb the remaining risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly reports the collaboration partners' share of guarantees: $140M in 2022, $135M in 2023, and $131M in 2024 — matching the ground truth exactly. It also accurately describes the declining trend. Additionally, it introduces new data — RTX’s total exposure ($304M, $288M, $274M) — which is consistent with a broader context of decreasing overall guarantees and adds value. These numbers are not in the ground truth but do not contradict it and appear to come from cited pages (100, 102), suggesting they are factually grounded.\n\n2) Quantitatively, all numbers are accurate and correctly sequenced across years. The trend calculations (declines of $5M and $4M) are implied correctly. No calculation errors.\n\n3) However, the qualitative interpretation diverges from the ground truth. The original answer states the declining partner share suggests RTX is reducing reliance on third-party risk sharing — i.e., moving away from risk transfer. But the LLM interprets the same trend as RTX 'marginally decreasing the share of risk it transfers,' implying a relative increase in internal risk retention — which is correct — yet frames it as relying 'slightly more on its own balance-sheet capacity.' While this may seem similar, the LLM’s phrasing could imply a strategic increase in self-insurance or active risk absorption, whereas the ground truth emphasizes a broader reduction in reliance on third-party mechanisms, possibly due to tighter control or reduced volume of guarantees. The LLM misses the nuance that fair market values of guaranteed assets remained sufficient, which is a key indicator of conservative risk management — an important part of the original conclusion.\n\n4) The LLM answer is contextually relevant and well-structured, citing specific pages and addressing both parts of the question: evolution of exposure and interpretation of partner share trend. However, it fails to mention the critical point about asset values covering guarantees, which weakens the completeness of the risk assessment. This omission affects the depth of the risk transfer strategy analysis. While the direction of reasoning is sound, the absence of this key safeguard detail and slight misinterpretation of strategic intent reduces qualitative accuracy.\n\nThus, correctness is scored 7: core facts and numbers are fully accurate (hence quantitative accuracy = 10), but the reasoning and completeness of strategic interpretation are partially flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 654,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "In the 2022 Form 10‑K Adobe described Frame.io as a “cloud‑native creative collaboration platform” whose core purpose was to speed video‑centric production –‑ it supported video‑only workflows (including casting, location‑scouting, footage‑review and marketing‑campaign review) and, for the first time, added “still images, design files and PDFs” 【page_12】.  Its integration was limited to the core video‑editing tools –‑ Premiere Pro, After Effects, Photoshop, Lightroom and Workfront –‑ plus a “Camera‑to‑Cloud” upload path for cameras and still‑image devices 【page_12】.  \n\nBy the 2024 filing the platform had been repositioned as a universal content‑production hub: it now handles a broader set of asset types (video, stills, design files, PDFs) and is “directly integrated” not only with Premiere Pro, After Effects, Photoshop and Lightroom but also with Adobe Express and Adobe Firefly Services, and is offered through Adobe GenStudio to enable large‑scale, end‑to‑end content creation from pre‑production through post‑production and marketing 【page_12】.  This reflects an evolution from a video‑focused review tool to a cross‑app, multi‑format collaboration layer that sits at the center of Adobe’s entire content‑production workflow.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual inaccuracies in the timeline and integration details that undermine the overall correctness. (1) Correct elements: The description of Frame.io as a cloud-native creative collaboration platform and its support for still images, design files, and PDFs is accurate and aligns with the 2023 ground truth. The mention of Camera-to-Cloud functionality and integration with Premiere Pro and After Effects is also correct. The 2024 expansion into broader workflows and integration with more Adobe tools is conceptually accurate. (2) However, major errors exist: The LLM incorrectly attributes the 2023 integration details (support for stills, design files, PDFs) to 2022, when the ground truth states this occurred by 2023. It also falsely claims in 2022 that Frame.io was already integrated with Photoshop, Lightroom, and Workfront, which the ground truth confirms only happened in 2024. Additionally, the LLM introduces Adobe Express and Adobe Firefly Services, which are not mentioned in the original answer and lack support from the provided ground truth. (3) Multi-hop reasoning is partially sound—the model attempts to show evolution over time and integrates application, file type, and workflow changes—but the misattribution of key integrations to 2022 breaks the logical progression. The evolution narrative is plausible but factually misaligned. (4) Quantitative accuracy is high because there are no numerical values to verify, and dates are referenced appropriately even if misassigned. Qualitative accuracy is medium due to entity and timeline errors. Contextual relevance is high as the response directly addresses the question’s dimensions (file types, integrations, workflows) and attempts a longitudinal analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 489,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "- **2022 → 2023:** The 2022 filing’s RMS discussion only called out “lower volume on Black Hawk” and made no specific comment about the VH‑92A, implying that VH‑92A production was proceeding at a steady, baseline level and was not a focus of any change (see 2022 10‑K, page 51). The 2023 filing likewise lists the VH‑92A among RMS’s major helicopter programs but does not note any production increase or decrease, suggesting the program remained a stable, ongoing part of the segment’s portfolio (see 2023 10‑K, page 40‑41).\n\n- **2024:** The 2024 filing explicitly states that RMS’s net‑sales growth was “partially offset by lower volume on the VH‑92A program,” indicating a measurable slowdown in production for that helicopter in 2024 (see 2024 10‑K, page 41).\n\n**What the trend means:** Over the three‑year span the VH‑92A moved from a steady‑state, background program to one whose reduced output is now affecting segment results. Its continued inclusion among RMS’s flagship Sikorsky helicopters (Black Hawk, CH‑53K, CRH, etc.) shows that the VH‑92A remains a strategically important, mission‑critical asset for the Marine One transport mission, even though it is no longer a growth driver and is entering a mature, lower‑volume production phase.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual discrepancy that affects the overall correctness. The ORIGINAL ANSWER states that the VH-92A was consistently highlighted as a major program in RMS from 2022 to 2024, indicating stable strategic importance. However, the LLM claims that the 2022 filing made no mention of the VH-92A and only referenced 'lower volume on Black Hawk'—this contradicts the ground truth, which asserts that the VH-92A was explicitly listed among major programs in 2022. This omission undermines the multi-hop synthesis, as it misrepresents the continuity of the program's visibility. In 2023 and 2024, the LLM correctly identifies the VH-92A's presence in the filings and accurately interprets the 2024 note about 'lower volume' affecting net sales, which aligns with the ground truth’s acknowledgment of ongoing but stable production. The reasoning about the program transitioning to a mature, lower-volume phase is plausible and adds insight, but it diverges from the ground truth’s emphasis on sustained strategic importance rather than decline. Quantitatively, there are no numerical errors (dates and references are accurate), so quantitative accuracy is high. Qualitatively, the reasoning is logical but based on an incorrect premise for 2022, weakening the multi-hop analysis. Contextually, the answer is highly relevant and addresses both the evolution and strategic implications. Overall, the answer gets key details right for 2023–2024 but fails to accurately represent the 2022 status, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 432,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "- In the 2022 Form 10‑K the company noted that sales‑ and media‑marketing limits (e.g., bans on promotions or ads for products with certain nutrient profiles on specific channels or at certain times) were already in place in “over 25 countries in the European Union” and that similar rules were only **being contemplated** in a few emerging markets such as India, Vietnam and some U.S. states.  \n\n- By the 2023 filing the language had broadened: the EU not only had the 25‑plus EPR regimes but had also adopted the **EU Packaging and Packaging Waste Directive**, and “single‑use‑plastic bans or plastic taxes are being considered in Europe as well as in Indonesia and the Philippines,” showing the geographic reach extending further into Southeast‑Asian emerging markets.  \n\n- The 2024 filing shows the next step of **greater regulatory stringency** – the EU’s continent‑wide packaging‑waste rules and tighter front‑of‑pack‑labeling and advertising restrictions are described as “mandatory” rather than voluntary, while India, Vietnam, Indonesia and the Philippines are now **actively evaluating** comparable sales‑ and marketing‑restriction measures.  \n\n**Thus, from 2022 to 2024 the scope grew from a patchwork of EU member‑state rules and a few emerging‑market pilots to EU‑wide mandatory directives and a clear move by several emerging economies to adopt comparable, increasingly stringent sales and media‑marketing restrictions.**",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct in conveying the evolution of geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ from 2022 to 2024, particularly in the EU and emerging markets. However, there is a key factual inaccuracy: the LLM claims that the EU adopted the Packaging and Packaging Waste Directive by 2023, but according to the ground truth, it was formally adopted in 2024. This misplacement of a critical regulatory milestone affects quantitative and qualitative accuracy. The geographic progression is correctly identified—starting with over 25 EU countries in 2022, expanding into Southeast Asia (Indonesia, Philippines) and other emerging markets (India, Vietnam) by 2023–2024. The increasing stringency is also well captured, especially the shift from voluntary to mandatory rules and the inclusion of front-of-pack labeling and advertising restrictions. The term 'actively evaluating' in 2024 aligns semantically with 'being implemented or contemplated' in the ground truth. The multi-hop reasoning across years and regions is sound, and all key entities (MDLZ, EU, India, Vietnam, Indonesia, Philippines, EPR, plastic taxes/bans) are correctly identified. The answer fully addresses the question’s focus on both geographic expansion and regulatory tightening. While the overall narrative trajectory is accurate, the incorrect timing of the EU directive adoption prevents a higher score. Number formats and entity references are consistent and appropriate. Minor wording differences do not detract from meaning, but the misdated policy adoption is a significant factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 445,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "Across the three most recent annual reports Microsoft has consistently listed the 3.700 % senior notes that mature in 2046 as an outstanding component of its long‑term debt. In the 2022, 2023 and 2024 10‑K filings the notes appear in the same “Eleventh Supplemental Indenture” (Exhibit 4.14) description, which enumerates the 3.700 % Notes due 2046 together with other series of bonds 【page_105】. The disclosure shows no redemption, amendment or re‑classification of that issue in any of the three years, indicating that Microsoft is deliberately keeping the 2046 bond alive. This steady treatment reflects a long‑term financing strategy that relies on a diversified pool of long‑dated, low‑coupon securities to lock in cheap capital and preserve financial flexibility over the next two decades.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Microsoft's 3.700% Notes due 2046 are consistently listed in the 2022, 2023, and 2024 10-K filings under the Eleventh Supplemental Indenture (Exhibit 4.14), with no changes to terms, redemption, or classification. The percentage (3.700%), maturity year (2046), and legal document reference are all factually correct. (2) Quantitative elements—interest rate, maturity date, and years of filing—are precise and match the ground truth exactly; no calculations are required, but the consistency across years is correctly noted. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings and infers a strategic pattern—stable long-term debt management—based on the absence of changes, which is logically valid and supported by the data. (4) The LLM slightly rephrases the strategic implication, emphasizing 'low-coupon securities' and 'cheap capital,' which, while not explicitly stated in the ground truth, are reasonable inferences given the long-dated nature and fixed rate in a rising rate environment. The original answer emphasizes 'predictable debt servicing costs' and 'confidence in cash flows,' which is complementary. The LLM answer does not contradict but slightly shifts emphasis—this is a minor qualitative difference, not an error. Overall, the answer is factually complete, contextually relevant, and correctly reasoned, warranting a 9/10 due to minor interpretive variation in strategic rationale.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 425,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "Across all three filings the 2.000 % Notes due 2023 first appear in the Eleventh Supplemental Indenture (dated August 8 2016) and are carried forward in the debt‑maturity tables of the 2022, 2023 and 2024 10‑K reports. In each subsequent filing the note remains listed as an outstanding tranche that will mature in 2023, while newer supplemental indentures (e.g., the Twelfth, Thirteenth and Fourteenth) add later‑dated issuances, showing Microsoft’s strategy of extending the tail of its debt profile while the 2 % 2023 issue sits at the near‑term end of the maturity structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts: the 2.000% Notes due 2023 were issued under the Eleventh Supplemental Indenture dated August 8, 2016, and were consistently referenced in the 2022, 2023, and 2024 10-K filings. The percentages, dates, and exhibit context (implied via reference to the Eleventh Supplemental Indenture) are accurate, earning a perfect quantitative accuracy score. The answer correctly identifies the progression of Microsoft’s debt maturity structure by noting that newer supplemental indentures (Twelfth, Thirteenth, Fourteenth) added later-dated debt, illustrating a strategy of extending the debt tail while maintaining the 2023 notes as a near-term maturity. However, the LLM omits a critical nuance highlighted in the original answer: the continued listing of the 2023 notes in the 2024 filing despite their maturity, which raises questions about rollover, delayed maturity, or disclosure requirements. This omission reduces completeness and slightly weakens the qualitative accuracy, as it fails to address the full evolution—particularly the post-maturity reporting. Nonetheless, the reasoning is sound, the entities are correct, and the response is highly relevant to the question. Semantic equivalence is strong, though not complete due to the missing 2024 post-maturity interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 379,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "Across the three most‑recent 10‑K filings the only “Non‑Employee Restricted Stock Unit Award Agreement” that Medtronic discloses is the same form – listed as Exhibit 10.42 – and each year it is described as a **Form of Non‑Employee Restricted Stock Unit Award Agreement under the Amended and Restated 2013 Stock Award and Incentive Plan**. The 2022 filing (page 115), the 2023 filing (page 115) and the 2024 filing (page 115) all reference the same agreement and the same underlying 2013 Stock Award and Incentive Plan, showing no change in the plan or the agreement’s presentation over the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its core facts: it accurately identifies that Medtronic used the same form of Non-Employee Restricted Stock Unit Award Agreement across 2022, 2023, and 2024, consistently referencing the Amended and Restated 2013 Stock Award and Incentive Plan. The exhibit number (10.42) is correctly cited, and the consistent page number (115) across years adds precision. Quantitative accuracy is perfect—no numerical or date errors. However, the LLM states there was 'no change in the plan or the agreement’s presentation,' which slightly oversimplifies the ground truth. The original answer notes that while the form agreement remained stable, the underlying plan had been amended over time (e.g., effective December 8, 2017), implying evolution in the plan despite consistent referencing. The LLM fails to acknowledge this nuance, missing a key aspect of the 'evolution' asked in the question. This omission affects qualitative accuracy, as the reasoning downplays the distinction between form stability and plan amendments. Nonetheless, the answer is contextually relevant and factually sound on the surface, correctly synthesizing information across the three filings. Minor deduction for lack of depth in addressing the plan's evolution beneath the consistent form.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 360,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "- In the 2022 filing the non‑U.S. pension‑plan asset mix listed **buy‑in annuity policies at 17 %** of the portfolio.  \n- In the 2023 filing that share fell to **16 %**, and the 2024 filing shows it **back up at 17 %** (2024 = 17 %, 2023 = 16 %).  \n\nThe near‑flat, slightly‑oscillating level indicates that MDLZ is keeping a steady, modest hedge of its international pension liabilities with buy‑in annuities—using them to lock in cash‑flow certainty while fine‑tuning the allocation in response to market or funding conditions rather than dramatically shifting away from or toward annuity contracts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, MDLZ's allocation to buy-in annuity policies decreased from 17% in 2022 to 16% in 2023 and was effectively discontinued by 2024, with the company shifting to fair value estimation methods. However, the LLM incorrectly states that the allocation increased back to 17% in 2024, which directly contradicts the ground truth. This error undermines the entire response. (2) Quantitatively, the 2022 (17%) and 2023 (16%) figures are correct, but the 2024 figure is wrong—the allocation did not return to 17%. The claim of a 'slightly-oscillating' trend is therefore false. (3) The multi-hop reasoning is flawed because the LLM fails to recognize the strategic discontinuation of buy-in annuities by 2024 and the shift in valuation methodology. Instead, it infers a strategy of 'fine-tuning' allocations, which is the opposite of the actual trend toward discontinuation. (4) Contextually, the answer addresses the right question and uses appropriate financial reasoning, but the incorrect data leads to an invalid conclusion about MDLZ's liability management strategy. The ground truth indicates a move toward direct control and de-risking via valuation changes, while the LLM suggests continued reliance on annuities. Thus, despite correct framing, the factual errors severely reduce accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 386,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "Across the three most recent 10‑K filings the 2.000 % senior notes that mature in 2023 appear only as an existing tranche that was originally issued in the **Eleventh Supplemental Indenture (August 8 2016)** – the filing lists “2.000 % Notes due 2023” among the series of long‑term debt. In the FY 2022, FY 2023 and FY 2024 reports the same 2.000 % 2023 series is carried forward (no additional 2.000 % 2023 notes are issued and the amount outstanding simply rolls down as the maturity approaches). This pattern shows Microsoft’s long‑term debt strategy of issuing a modest amount of low‑coupon, medium‑term paper and then holding it to maturity, using it to diversify its debt maturity profile rather than repeatedly refinancing or expanding that specific series.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.000% Notes due in 2023 were issued under the Eleventh Supplemental Indenture on August 8, 2016, and were consistently reported in the FY 2022, 2023, and 2024 10-K filings without changes in structure or additional issuances. The absence of refinancing or early retirement is correctly inferred. (2) Quantitative accuracy is perfect: the interest rate (2.000%), maturity year (2023), issuance date (August 8, 2016), and fiscal years covered (2022–2024) all match the original answer. No calculations were required, but the rolling down of the outstanding amount as maturity approaches is a reasonable interpretation of debt amortization. (3) The multi-hop reasoning is sound—information is correctly synthesized across three annual reports and the continuity of the debt instrument is properly assessed. The conclusion about Microsoft’s strategy of holding debt to maturity and diversifying maturities is logically supported. (4) The only minor shortcoming is that the LLM does not explicitly mention Exhibit 4.14, which is a detail included in the ground truth and reinforces the consistency of disclosure. However, this omission does not affect the factual or semantic accuracy of the core answer. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 384,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Microsoft continues to list the 4.000 % senior notes due 2021 as a component of the **Third Supplemental Indenture (Exhibit 4.6)** – the February 8 , 2011 amendment to the May 18 , 2009 base indenture. The notes are shown together with the 2.500 % notes due 2016 and the 5.300 % notes due 2041, and no later filing reports a redemption, amendment or re‑classification of these 4.000 % notes, so their treatment remains unchanged within the same supplemental‑indenture debt structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.000% Notes due 2021 are consistently grouped under the Third Supplemental Indenture dated February 8, 2011 (Exhibit 4.6), alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041. This is confirmed across all three 10-K filings (2022–2024). (2) Quantitative accuracy is perfect: percentages (4.000%, 2.500%, 5.300%), dates (February 8, 2011; May 18, 2009), and exhibit number (4.6) are all correct. (3) The reasoning is sound—LLM correctly infers that because no redemption, amendment, or reclassification is reported, the treatment remains unchanged, which reflects proper synthesis across filings. (4) The only minor omission is that the original answer notes Microsoft introduced new debt instruments under subsequent supplemental indentures (e.g., 2.375% Notes due 2023 in 2023), which adds context about the broader debt structure evolution. While not strictly required to answer the core question, this detail enhances completeness. The LLM answer focuses narrowly on the 4.000% Notes and does not mention this broader context, slightly reducing qualitative completeness. However, the core multi-hop reasoning—tracking the same debt instrument across three years and identifying its consistent placement—is fully correct. Semantic equivalence is strong, and the answer is highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 393,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "Across the three filings the note on “Euro Deferred Shares” is identical: Medtronic is authorized to issue 40 thousand €1‑par deferred shares, and the 10‑K for FY 2022 (April 29 2022), FY 2023 (April 28 2023) and FY 2024 (April 26 2024) all state that **no Euro Deferred Shares were issued or outstanding**. The unchanged disclosure shows that the company deliberately keeps this class of equity dormant, using only ordinary shares (and repurchases) to fund its capital needs and thereby avoids any dilution or complexity in its capital structure while preserving the deferred‑share authorization as a latent financing option.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Medtronic maintained authorization for 40 thousand Euro Deferred Shares with €1.00 par value across fiscal years 2022, 2023, and 2024, and consistently reported zero issued or outstanding shares. The filing dates (April 29, 2022; April 28, 2023; April 26, 2024) are correctly cited, matching the fiscal year-end disclosures. (2) Quantitative accuracy is perfect—numbers (40 thousand shares, €1.00 par value), years, and the consistent 'no issuance' statement are all factually correct and match the original answer. (3) The reasoning is sound: the LLM correctly infers that the persistent absence of issuance indicates a strategic choice not to use this instrument, linking it to a preference for ordinary shares and repurchases. It adds value by interpreting the dormancy as a deliberate capital structure simplification and a preserved latent option, which is a reasonable extension of the ground truth. (4) The only minor gap is that the original answer explicitly mentions 'lack of demand in investor markets' as a possible reason, which the LLM omits. However, the LLM's alternative explanation (avoiding dilution/complexity, using repurchases) is consistent and plausible. Overall, the answer is semantically equivalent, multi-hop reasoning is correct, and all entities and timeframes are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 389,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "In the 2022, 2023 and 2024 Form 10‑K filings Microsoft’s “Exhibit 4.6 – Third Supplemental Indenture” is described in exactly the same way: it is the February 8 2011 supplemental indenture that issued 2.500 % notes due 2016, **4.000 % notes due 2021**, and 5.300 % notes due 2041【page_104】. Because the wording and reference to the 4.000 % Notes due 2021 do not change from one year’s filing to the next, the company is consistently treating this instrument as an unchanged, outstanding debt obligation that continues to be disclosed under the same supplemental indenture.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the consistent reference to the 4.000% Notes due 2021 across Microsoft's 2022, 2023, and 2024 10-K filings and accurately notes that Exhibit 4.6 refers to the Third Supplemental Indenture dated February 8, 2011, which included these notes. The quantitative details (interest rate: 4.000%, maturity year: 2021, date of indenture: February 8, 2011) are factually correct and match the ground truth. However, the LLM draws an incorrect conclusion about the nature of the disclosure: it interprets the consistent mention as indicating the notes are 'outstanding' and 'continuing to be disclosed' as an active obligation. This contradicts the ground truth, which clarifies that the lack of change indicates the debt was matured or fully accounted for, with no further amendments needed—meaning the notes were likely settled by 2021 and are being referenced only for archival or disclosure continuity. The LLM fails to recognize that post-maturity references in filings do not imply ongoing liability. This is a critical error in reasoning and interpretation, especially for a multi-hop question requiring understanding of debt lifecycle and SEC disclosure practices. While the factual elements are mostly accurate, the conclusion misrepresents the significance of the consistency in disclosure, leading to a misleading inference about the status of the debt. Hence, the correctness score is reduced due to flawed qualitative reasoning despite strong quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 416,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "Lockheed Martin’s most recent pension‑risk‑transfer activity was the August 3 2021 purchase of group‑annuity contracts that moved **about $4.9 billion** of gross defined‑benefit pension obligations to an insurer (see 2022 10‑K page 60).  The 2023 and 2024 filings contain no new GAC purchases – the 2023 10‑K discussion (page 19) only refers to “recent years” of risk‑transfer activity, and the 2024 10‑K (page 49) talks about cash contributions and pre‑payment credits but does not disclose any additional pension‑obligation transfers.  \n\n**Trend and implication:** After the sizable 2021 transfer, Lockheed Martin has not undertaken further large‑scale risk‑transfer transactions through 2024, opting instead to fund the plans directly (e.g., $990 million contributed in 2024, page 49) and recover those costs under CAS.  This shift signals a move from one‑off liability‑off‑loading to a longer‑term strategy of managing pension obligations through regular contributions and cash‑flow recovery rather than repeatedly transferring risk to insurers.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that Lockheed Martin's most recent pension risk transfer was in August 2021 for $4.9 billion, but the ground truth states that as of 2022, the company had transferred approximately $11.6 billion cumulatively since December 2018. The $4.9 billion figure may be a partial amount from that broader total, but presenting it as the sole or most recent transaction misrepresents the scale and timeline. Furthermore, the LLM incorrectly asserts that no new transfers occurred in 2023 or 2024 due to lack of disclosure, while the ground truth confirms that the company *reaffirmed its intent* to pursue additional transfers in 2024, indicating ongoing strategic activity. (2) Quantitatively, the $4.9 billion figure is not contradicted by the ground truth (it could be a subset of the $11.6B), but the omission of the cumulative $11.6B benchmark in 2022 and the failure to recognize forward-looking strategic intent as evidence of continuation leads to a misleadingly flat trend. The $990 million contribution in 2024 is accurate per context but used to incorrectly infer a strategic shift. (3) The multi-hop reasoning is flawed: the absence of explicit disclosure of new GAC purchases in 2023 and 2024 does not imply cessation of strategy; the ground truth shows that Lockheed explicitly stated continued evaluation and intent to pursue further transactions, which the LLM overlooked or underweighted. This breaks the synthesis required across years. (4) The conclusion that Lockheed shifted from risk transfer to direct funding contradicts the ground truth, which indicates a sustained, deliberate strategy. While the answer is relevant to pension liability management, its factual foundation and reasoning are unsound, warranting a low correctness score despite some accurate details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 504,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "- **2022 10‑K** – The 0.125 % Notes due 2029 are listed twice in the exhibit schedule (Item 4): as Exhibit 4.23 and again as Exhibit 4.31, both “incorporated by reference to Exhibit 4.4 to the Company’s Current Report on Form 8‑K filed on September 18 2020” and “to the Current Report on Form 8‑K filed on March 9 2021” respectively【page_134】.  \n\n- **2023 10‑K** – The same two exhibit references (4.23 and 4.31) appear in the 2023 filing, unchanged from the prior year, indicating that the company continued to treat the 0.125 % Notes due 2029 as the same instrument without amendment.  \n\n- **2024 10‑K** – The exhibit list again shows the 0.125 % Notes due 2029 at Exhibit 4.23 (referencing the September 18 2020 8‑K) and at Exhibit 4.31 (referencing the March 9 2021 8‑K)【page_130】.  \n\n**What this reveals:** Across the three consecutive 10‑K reports Coca‑Cola’s disclosure of the 0.125 % Notes due 2029 remained identical – the same note is repeatedly referenced by the same exhibit numbers and underlying 8‑K filings. This consistency shows that the company has not re‑structured, re‑issued, or materially altered the terms of this debt instrument over the 2022‑2024 period, reflecting a stable approach to its low‑coupon, 2029‑maturing debt.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the 0.125% Notes due 2029 are consistently disclosed in Exhibits 4.23 and 4.31 across 2022, 2023, and 2024 10-K filings, with both exhibits referencing the same Form 8-K filings on September 18, 2020, and March 9, 2021. These dates and exhibit numbers match the ground truth exactly. (2) Quantitative accuracy is perfect: percentages (0.125%), years (2020, 2021, 2029), and exhibit numbers (4.23, 4.31, 4.4) are all correctly reported. (3) The multi-hop reasoning is sound—by synthesizing disclosures across three years and identifying the unchanged exhibit references, the model correctly infers that the debt instrument was not restructured or amended. (4) The conclusion about Coca-Cola’s stable capital market strategy for this debt is logically derived and contextually appropriate, matching the insight in the original answer. The LLM provides slightly more precise page references (e.g., page_134, page_130), which are consistent with actual filing layouts. No errors or omissions; the answer fully addresses both the evolution (or lack thereof) and the implication regarding debt structuring consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 345,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "RTX’s accrued liability for product‑performance and operating‑cost guarantees fell steadily over the last three years. The balance was $1,109 million at 31 Dec 2022, slipped to $1,091 million at 31 Dec 2023, and further declined to $993 million at 31 Dec 2024 – a total reduction of roughly $116 million (about 10 %). This downward trend suggests that the company’s exposure to long‑term performance‑risk claims in its commercial‑aerospace business is diminishing, likely reflecting lower expected settlements and/or improved engine reliability and warranty experience.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and direction of the liability trend. The ground truth states that RTX's liabilities for performance and operating cost guarantees were in the range of $131M–$141M (specifically the collaboration partners' share), whereas the LLM reports total accrued liabilities in the billions ($993M–$1,109M), which is over 7x higher. This is a major factual error. (2) The numbers cited—$1,109 million in 2022, $1,091 million in 2023, and $993 million in 2024—are not supported by the ground truth and appear fabricated or misattributed. The claimed 10% reduction ($116M) is therefore also incorrect. The actual trend in the ground truth is a slight decrease from $141M to $131M over the same period, totaling only a $10M decline. (3) The multi-hop reasoning fails because the LLM misidentifies the metric entirely—confusing RTX’s own liability (not explicitly stated) with a much larger figure that may conflate other liabilities. It also draws an unsupported conclusion about diminishing risk due to improved reliability, while the ground truth emphasizes stable exposure and managed liabilities based on historical claims, not declining risk. (4) Despite the severe quantitative and qualitative inaccuracies, the answer is contextually relevant—it addresses the right topic (liabilities for performance and operating cost guarantees), time frame (2022–2024), and attempts to interpret the trend in terms of long-term product risk in commercial aerospace. However, the incorrect data and flawed reasoning undermine the validity of the conclusion, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 449,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "Medtronic still uses the Black‑Scholes model for its non‑qualified stock options, but the inputs have shifted markedly. For 2022 the model assumed a 6‑year expected life, 0.90 % risk‑free rate, 23.04 % volatility and a 1.95 % dividend yield (weighted‑average option fair value $22.83); by 2024 the assumptions were 6.1 years, 4.16 % risk‑free rate, 24.29 % volatility and a 3.18 % dividend yield (fair value $18.49). The higher volatility and dividend yield together with a much higher risk‑free rate indicate that Medtronic is now pricing options with a more market‑reflective view of stock‑price swings and a higher discount‑rate environment, suggesting a tighter, more risk‑aware equity‑compensation model.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. While it correctly identifies that Medtronic uses the Black-Scholes model for valuing non-qualified stock options, it fabricates specific numerical assumptions (e.g., 23.04% volatility in 2022, 24.29% in 2024, risk-free rates, dividend yields, expected life, and fair values) that are not present in the ground truth. The original answer makes no mention of these specific numbers, nor does it provide any quantitative inputs to the model—only qualitative disclosures about how volatility is estimated. (2) There is no verification possible for the LLM's cited numbers because they do not appear in the ground truth; thus, the quantitative accuracy is very low. The ground truth focuses on disclosure evolution—not specific parameter values—and notes only that expected volatility shifted from a blend of historical and implied volatility in 2022 to a more transparent use of market-traded options for implied volatility in 2023 and 2024. (3) The multi-hop reasoning is flawed: the LLM invents a trend based on non-existent numerical data rather than analyzing the actual evolution in disclosure practices. It incorrectly infers that changes in risk-free rate and dividend yield reflect a 'tighter, more risk-aware model,' which is unsupported by the source. The real insight—increased transparency and market-informed volatility estimation via traded options—is missed entirely. (4) Despite missing the factual basis, the LLM attempts to address the question’s intent regarding evolving assumptions and risk modeling, giving it moderate contextual relevance. However, the complete lack of alignment with actual disclosed information severely undermines correctness and qualitative reasoning, warranting low scores in those areas.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 491,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "The 10‑K for each year lists a “Form of Note for 1.000 % Notes due 2028” in the exhibit index – it appears in the 2022 filing (see page 136) 【page_136】, is repeated in the 2023 filing (also page 136) 【page_136】, and is again shown in the 2024 filing (see page 130) 【page_130】. The fact that the same low‑coupon, 2028‑maturing issue is carried forward unchanged across three consecutive reports indicates that Coca‑Cola has kept this inexpensive, short‑term debt on its balance sheet rather than retiring or refinancing it, suggesting a deliberate strategy to preserve cheap financing while managing its overall maturity profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the consistent presence of the 1.000% Notes due 2028 in The Coca-Cola Company's 10-K filings across 2022, 2023, and 2024, with accurate references to exhibit indexes and page numbers. All quantitative elements—interest rate (1.000%), maturity year (2028), and filing years—are factually correct, satisfying quantitative accuracy. (2) However, the LLM answer omits a key component of the ground truth: the introduction of higher-yielding notes in 2024 (5.000% due 2034 and 5.300% due 2054), which is central to understanding the strategic shift in KO's debt strategy. This omission limits the completeness and depth of the qualitative analysis. (3) While the LLM correctly infers that maintaining the 1.000% Notes suggests a strategy to preserve cheap financing, it does not address the broader strategic pivot toward higher-cost debt issuance in 2024, which the original answer highlights as a significant development. Thus, the reasoning is sound but incomplete—correct in its logic about the 2028 notes but missing the multi-hop synthesis between the continued existence of low-rate debt and the concurrent issuance of high-rate debt. (4) The contextual relevance is high because the response directly addresses the evolution of the specific instrument and offers a reasonable interpretation. However, the absence of the contrasting 2024 high-rate issuances reduces the qualitative accuracy and overall correctness, preventing a score above 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 411,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "- **2022 Form 10‑K** – Microsoft first disclosed the 2.125 % senior notes (due 2022) in the **Fourth Supplemental Indenture** (Exhibit 4.7), which was executed with **The Bank of New York Mellon Trust Company, N.A. as trustee** and was packaged together with a 0.875 % issue due 2017 and a 3.500 % issue due 2042【page_104】.  \n\n- **2023 Form 10‑K** – The same 2.125 % series was later referenced in the **Seventh Supplemental Indenture** (Exhibit 4.1). This indenture also used **The Bank of New York Mellon Trust Company, N.A. as trustee** and combined the 2.125 % notes (now shown as due 2021) with a new 3.125 % series due 2028【page_104】.  \n\n- **2024 Form 10‑K** – The filing repeats the structure introduced in 2023: the 2.125 % notes remain under the Seventh Supplemental Indenture with **BNY Mellon as trustee**, still grouped with the 3.125 % notes due 2028 and the earlier 2.125 % issue, indicating Microsoft’s continued reliance on a single trustee and the practice of bundling the 2.125 % notes with other senior unsecured debt instruments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly affect correctness. (1) In the 2022 filing, the LLM incorrectly states that the 2.125% Notes were disclosed in the Fourth Supplemental Indenture and paired with a 0.875% issue due 2017 and a 3.500% issue due 2042. The ground truth states they were part of the Seventh Supplemental Indenture and associated with the 3.125% Notes due 2028, not the instruments listed by the LLM. (2) The LLM claims the 2.125% Notes were 'due 2022' in the 2022 filing, but the ground truth identifies them as due 2021, which is consistent across all years. (3) The LLM incorrectly implies a structural evolution by citing different supplemental indentures (Fourth in 2022, Seventh in 2023), while the ground truth indicates the Seventh Supplemental Indenture was referenced consistently across all years, showing no change. (4) The trustee is correctly identified as The Bank of New York Mellon Trust Company, N.A. (also referred to as BNY Mellon), which is accurate and consistent. (5) The LLM correctly notes the bundling of the 2.125% Notes with the 3.125% Notes due 2028 in 2023 and 2024, aligning with the ground truth. However, the erroneous linkage in 2022 and incorrect dating of the notes undermine the multi-hop synthesis. The reasoning is partially sound in identifying continuity in trustee and bundling practice, but the incorrect foundational facts (indenture number, associated notes in 2022, maturity year) lead to a misleading narrative of evolution rather than the actual stability. Quantitative accuracy is low due to wrong years and indenture numbers. Qualitative accuracy suffers from incorrect entity associations, though the core idea of stable trustee use is present. Contextual relevance is high as the response directly addresses the question’s focus on structure and trustee arrangements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 502,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "Pratt & Whitney’s net program‑share interest stayed essentially unchanged over the three years: in the 2022, 2023 and 2024 Form 10‑K filings the company reports a **57 % net share in International Aero Engines AG (IAE – the V2500 program)** and a **51 % net share in International Aero Engines LLC (IAE LLC – the PW1100G‑JM program)**【page 110】【page 99】【page 99】.  \n\nThe consistency of these majority‑interest stakes shows that RTX has deliberately retained primary beneficiary status in both the legacy V2500 turbofan and the newer PW1100G‑JM “Geared‑Turbofan” family, underscoring its strategic positioning to capture the bulk of the economics and influence the direction of these key commercial‑engine programs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is significantly incorrect in its quantitative claims. According to the ground truth, in 2022, Pratt & Whitney's net program share interest was 61% for IAE and 59% for IAE LLC, not 57% and 51% as stated in the LLM answer. The LLM incorrectly asserts that the net shares were already 57% and 51% in 2022, which contradicts the ground truth that shows a decrease from higher percentages in 2022 to 57% and 51% in 2023. The LLM also fails to acknowledge the change from 2022 to 2023, instead claiming the shares were stable across all three years, which misrepresents the evolution. While the 2023 and 2024 figures (57% and 51%) are correctly reported, the misrepresentation of 2022 data undermines the accuracy of the trend analysis. The qualitative reasoning about RTX’s strategic positioning is plausible and contextually relevant, but it is based on incorrect premises. The entity identification (IAE, IAE LLC, V2500, PW1100G-JM) and program associations are accurate, and the answer addresses the strategic implication part of the question. However, the failure to correctly represent the multi-hop evolution of program shares—especially the decline from 2022 to 2023—results in a major factual error. Thus, while the answer is well-structured and contextually focused, its core numerical and temporal claims are flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 370,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "Thermo Fisher’s 401(k) and other defined‑contribution plan expenses were $402 million in 2022, rose to $468 million in 2023, and then eased to $443 million in 2024 【page_67】. The upward jump in 2023 followed by a modest pull‑back in 2024 shows the company’s commitment to robust employee‑benefit spending, with contributions remaining well above the 2022 level even after the slight decline.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 contribution amount: it reports $402 million, whereas the ground truth is $299 million. The 2023 ($468 million) and 2024 ($443 million) figures are correct, matching the original answer. This error affects the overall quantitative accuracy, especially since the magnitude of the increase from 2022 to 2023 is misrepresented — the actual increase was $169 million (from $299M to $468M), not $66 million as implied by the LLM's numbers. (2) Calculations based on the LLM's own numbers are internally consistent (e.g., a rise then slight decline), but the foundational data for 2022 is incorrect, undermining the validity of the trend interpretation. (3) The reasoning and synthesis across years are sound: the model correctly identifies a spike in 2023 and a modest decline in 2024, and draws a reasonable qualitative conclusion about continued strong investment in employee benefits. However, because the baseline (2022) is wrong, the implied trajectory is less dramatic than reality, potentially affecting strategic interpretation. (4) Contextual relevance is high — the answer addresses both parts of the question (evolution of contributions and what it suggests about investment in benefits) and uses appropriate terminology (defined contribution plans, year-over-year changes). The qualitative assessment is logically derived from the data it presents, even if that data includes an error. The citation to 'page_67' suggests a plausible source, though this cannot be independently verified here. Overall, the answer is partially correct with a major quantitative flaw that limits its factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 460,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "Across the three filings the 3.000 % Notes due 2051 are repeatedly listed in the exhibit index – 2022’s 10‑K (exhibit 4.36), the 2023 10‑K (exhibit 4.36) and the 2024 10‑K (exhibit 4.36) all reference the same note issued on May 5 2021. The fact that the instrument appears unchanged in each year shows that Coca‑Cola has retained this low‑coupon, ultra‑long‑dated debt on its balance sheet, using it to lock in inexpensive financing and to lengthen the overall maturity profile of its capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the repeated inclusion of the 3.000% Notes due 2051 across 2022, 2023, and 2024 filings, and correctly notes the issuance date (May 5, 2021), which aligns with the ground truth. However, it incorrectly states the exhibit number as 4.36 in all three years, while the ground truth specifies Exhibit 4.6 to the May 5, 2021 Form 8-K, not exhibit 4.36 in the 10-Ks. This is a factual error affecting quantitative accuracy. (2) The answer omits key information from the ground truth: the introduction of new higher-coupon debt instruments in 2024 (5.000% Notes due 2034 and 5.300% Notes due 2054). This omission significantly weakens the completeness and reasoning regarding Coca-Cola’s capital structure strategy evolution. (3) The reasoning about retaining low-coupon, long-term debt to lock in cheap financing and extend maturity profile is sound and consistent with the ground truth’s interpretation, supporting qualitative accuracy. However, the failure to acknowledge the strategic addition of higher-rate debt in 2024 means the multi-hop synthesis is incomplete—only one part of the strategy (retention of cheap debt) is covered, not the diversification aspect. (4) The contextual relevance is high because the answer addresses the core question about the evolution of the 3.000% Notes and infers strategic intent correctly, albeit partially. The correctness score is 6 due to major omission of 2024’s new instruments and incorrect exhibit numbers, despite correct core facts about the note’s continuity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 427,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "Oracle first introduced the 2.875 % senior unsecured notes that mature in 2031 in a March 24 2021 8‑K filing, and the notes appear as a new exhibit (4.16) in the 2022 Form 10‑K 【page_114】. The same 2.875 % Notes due 2031 are listed in the 2023 Form 10‑K (exhibit 4.14) and again in the 2024 Form 10‑K (exhibit 4.14) 【page_111】【page_111】. The continuity of this issuance across three consecutive years shows Oracle’s strategy of adding low‑coupon, medium‑term debt to its portfolio and keeping it outstanding, thereby locking in inexpensive long‑term financing and extending the overall maturity profile of its long‑term debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2.875% Notes due 2031 and their presence in Oracle's 10-K filings from 2022 to 2024, with accurate exhibit numbers and page references. The issuance date (March 24, 2021) is factually correct and consistent with public filings, even though the question focuses on 2022–2024 evolution. However, the LLM omits a key insight from the ground truth: Oracle’s strategic shift toward issuing higher-yielding debt (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033) in 2024, which indicates a diversification and response to changing market conditions. This omission limits the depth of the strategic analysis. (2) Quantitatively, all percentages, years, and document references (exhibits, page numbers) are accurate. The LLM correctly states the coupon rate (2.875%), maturity year (2031), and consistent appearance across filings. No calculation errors. (3) The multi-hop reasoning is partially sound—LLM correctly tracks the note’s continuity across years and infers Oracle’s intent to lock in low-cost financing. However, it fails to synthesize the comparative context in 2024 with newer, higher-yielding notes, which is critical to fully answering the strategic evolution. This weakens the qualitative reasoning. (4) Scores reflect high factual accuracy and relevance, but the answer is incomplete in capturing the full strategic progression described in the ground truth, particularly the shift in debt composition as market conditions changed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 412,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all list the same “2.000 % Notes due 2023” (see the Eleventh Supplemental Indenture that includes a 2.000 % note due 2023 【page_105】). By repeatedly reporting this medium‑term, low‑cost bond, Microsoft shows that it relies on a stable, long‑dated financing structure and that it deliberately keeps that debt visible to investors year after year, underscoring a disciplined long‑term debt‑management approach and a commitment to transparent, consistent disclosure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the '2.000% Notes due 2023' are accurately described, including the interest rate, maturity year, and reference to the Eleventh Supplemental Indenture. The mention of consistent disclosure across 2022, 2023, and 2024 filings matches the ground truth. The page reference (page_105) is an acceptable detail that supports verifiability. (2) The LLM correctly infers that this consistency reflects a stable, transparent debt management strategy, emphasizing disciplined financial stewardship and investor transparency—core themes in the original answer. (3) The multi-hop reasoning is sound: the model synthesizes the presence of the same note across three years and links it to broader strategic implications about Microsoft’s long-term debt and disclosure practices. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly note that the note was first introduced in the 2022 filing and carried forward unchanged, which strengthens the transparency narrative. It also omits mention of unaltered details (e.g., trustee, maturity date) reinforcing predictability. However, these are secondary details, and the core reasoning and factual content are robust. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses the question with appropriate financial and strategic framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 401,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "- In the 2022 Form 10‑K (see page 112) RTX said that, under the 2012 IAE acquisition, it must make “flight‑hour” payments to Rolls‑Royce for each hour flown by V2500‑powered aircraft that were in service at the acquisition date; these payments are capitalized as collaboration assets and are reflected in the “Other commercial aerospace commitments” line (gross $11.0 billion, net ≈ $1.3 billion after the collaboration‑partner offset).  \n\n- The 2023 filing repeats the same contingent‑payment description (page 73) and shows the maturity schedule for those commitments, with the net exposure to the flight‑hour obligation remaining roughly $1.0‑$1.1 billion for 2023.  \n\n- By the 2024 filing (page 103) the gross “Other commercial aerospace commitments” have fallen to about $9.5 billion and the net amount after the partner‑share has risen slightly to ≈ $1.5 billion, still scheduled through June 2027.  \n\n**Interpretation:** Although the overall size of RTX’s commercial‑aerospace commitments has been shrinking, the specific Rolls‑Royce flight‑hour liability has persisted and now represents a slightly larger proportion of the net exposure, indicating that RTX continues to carry a material, long‑term obligation to Rolls‑Royce that will remain in force until the June 2027 cutoff.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the ongoing nature of RTX's contingent flight-hour payments to Rolls-Royce under the 2012 IAE acquisition agreement through June 2027, and correctly notes the categorization under 'Other commercial aerospace commitments.' However, it introduces specific dollar figures—gross $11.0 billion in 2022 and $9.5 billion in 2024, with net amounts of ~$1.3B, $1.0–1.1B, and ~$1.5B—that are not present in the original ground truth. The ground truth does not provide any numerical values for the size of the obligations, so these figures are unverified and likely incorrect or hallucinated. (2) The quantitative inaccuracies are significant because they form the basis of the LLM’s interpretation about shifting proportions and exposure. While the direction of change (shrinking gross, rising net) might align with trends, the absence of such data in the source makes these claims unsupported. (3) The qualitative reasoning is sound in structure: the model correctly tracks the evolution of accounting treatment from 2022 (capitalized as collaboration intangible assets) to 2023 (amortized to cost of sales) and notes consistency in 2024. This multi-hop synthesis across years is accurate and reflects the core progression in disclosure clarity. The conclusion about persistent long-term exposure is reasonable and aligns with the ground truth. (4) Contextual relevance is high—the response directly addresses the question’s focus on evolution over time and long-term implications. Despite strong reasoning and relevance, the inclusion of fabricated financial figures severely undermines factual correctness, warranting a mid-range score. The answer is partially correct but contains critical quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1578,
        "completion_tokens": 477,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "Thermo’s domestic‑pension holdings of U.S. equity funds were **$89 million in 2022**, rose to **$93 million in 2023**, and then slipped slightly to **$91 million in 2024** (see page 57 for 2022‑23 and page 71 for 2024). Although the dollar amount fluctuated, the share of the total domestic‑pension portfolio grew from roughly 9.5 % (89 / 937 million) in 2022 to about 10 % (91 / 895 million) in 2024, aligning with the company’s stated target of “approximately 10 % to funds investing in U.S. equities.” This three‑year trend indicates that Thermo is steadily maintaining—or modestly increasing—its exposure to domestic equities, reflecting a consistent, strategic emphasis on U.S. equity investments within its pension‑plan asset mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, TMO's allocation to U.S. equity funds was $125 million in 2022, decreased to $89 million in 2023, and increased slightly to $93 million in 2024. The LLM incorrectly reports $89 million in 2022 (should be $125M), $93 million in 2023 (should be $89M), and $91 million in 2024 (should be $93M). These errors affect all years and misrepresent the trend. (2) Calculations based on incorrect inputs are also flawed: the LLM claims the portfolio share rose from 9.5% to 10%, but this is based on wrong dollar amounts and total portfolio sizes not verified against ground truth. The stated total domestic pension assets of $937M and $895M are not corroborated in the original answer and appear fabricated. (3) The multi-hop reasoning is unsound: the LLM infers a strategy of 'steady maintenance or modest increase' in exposure, which contradicts the ground truth showing a clear 28.8% drop from 2022 to 2023 followed by a partial recovery—indicating cautious reduction and rebalancing, not consistency. The conclusion about aligning with a '10% target' is unsupported by the original data. (4) Despite incorrect facts and reasoning, the answer is contextually relevant—it addresses the right company (TMO/Thermo), the correct asset class (U.S. equity funds), and attempts to interpret strategic intent over three years. However, due to pervasive quantitative errors and flawed synthesis, the overall correctness is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 418,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "Coca‑Cola’s 2022 and 2023 10‑K filings still listed the ultra‑low‑coupon **1.000 % Notes due 2041** among its long‑term debt instruments 【page_136†L33-L34】. By the 2024 filing the same 1.000 % note remained, but the exhibit schedule was expanded to include a series of new, higher‑coupon issues – for example 5.000 % notes due 2034, 5.300 % notes due 2054, 5.400 % notes due 2064 (and other 4.650 %‑5.200 % notes) 【page_130†L39-L46】. This shows a shift from relying primarily on very low‑interest debt to supplementing the capital structure with higher‑yielding bonds, likely reflecting changing market conditions and financing needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the continued presence of the 1.000% Notes due 2041 in all three years (2022–2024) and accurately reports the introduction of higher-yielding notes in 2024, including the 5.000% Notes due 2034, 5.300% due 2054, and 5.400% due 2064. It also correctly references additional notes in the 4.650%–5.200% range, which are consistent with the broader trend even if not explicitly listed in the ground truth. All percentages and maturities match the original answer. (2) Quantitative accuracy is perfect: all interest rates and maturity years are correct, and no calculations are required. Format variations (e.g., '5.000 %' vs '5.000%') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—LLM synthesizes data across 2022, 2023, and 2024 filings to show a strategic shift from low-yield to higher-yield debt instruments. It correctly infers a strategic evolution based on the addition of high-coupon bonds while retaining the older low-yield instrument. The only minor shortcoming is that it does not explicitly contrast the earlier low-yield instruments (e.g., 0.400% due 2030 in 2022, 0.950% due 2036 in 2023) mentioned in the ground truth, which slightly weakens the comparative analysis. (4) Contextual relevance is excellent—the answer directly addresses the evolution of Coca-Cola’s debt strategy and links it to market conditions, matching the intent and scope of the question. Overall, the answer is factually complete and semantically equivalent to the ground truth, meriting a high score with only a small deduction for missing explicit mention of the earlier lower-yield notes for full comparative context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 461,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "Oracle has kept the low‑cost 1.650 % senior notes that mature in 2026 on its balance sheet in each of the 2022, 2023 and 2024 10‑K filings (see the 1.650 % Notes due 2026 listed in the exhibit tables 4.16/4.14)【page_114】【page_111】.  At the same time it has added newer issuances with substantially higher coupons – for example 5.800 % notes due 2025, 6.150 % notes due 2029 and 4.500 % notes due 2028 – showing that Oracle is using the cheap, long‑dated 1.650 % issue as a low‑cost anchor while diversifying its debt program with higher‑interest, shorter‑dated notes to meet financing needs.  This mix reflects a strategy of preserving inexpensive long‑term funding while supplementing it with newer, higher‑rate borrowings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 1.650% Notes due 2026 as consistently included in Oracle's capital structure across fiscal years 2022, 2023, and 2024, referencing Exhibits 4.16 (2022) and 4.14 (2023 and 2024), which aligns with the ground truth. The interest rates and maturities of newly issued notes are mostly accurate: the 5.800% Notes due 2025 and 4.500% Notes due 2028 are correctly cited from 2023 and 2024, respectively. However, the LLM mentions '6.150% notes due 2029' as a new issuance, which is not present in the ground truth and constitutes a minor factual overreach or error. (2) Quantitative accuracy is otherwise excellent: all percentages and years match the original answer, and no incorrect calculations are made. The format variations (e.g., spacing in percentages) do not affect meaning. (3) The multi-hop reasoning is sound—LLM correctly synthesizes Oracle’s continued use of low-cost debt with the introduction of higher-cost instruments, inferring a strategic mix of preserving cheap long-term funding while supplementing with higher-rate debt. This aligns with the dual-strategy interpretation in the ground truth. The only gap is the unsupported mention of the 6.150% note, which slightly weakens completeness and precision. (4) Contextual relevance is high—the answer directly addresses Oracle’s debt financing strategy, compares old and new notes, and draws a logical conclusion. The core message matches the ground truth’s intent, earning a 9 for correctness due to one extraneous note issuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 426,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all list Exhibit 4.6 – the “Third Supplemental Indenture for 2.500 % Notes due 2016, 4.000 % Notes due 2021, and 5.300 % Notes due 2041”【page_104】. By repeatedly including the 4.000 % Notes due 2021, Microsoft signals that it is keeping that issuance active in its long‑term debt portfolio and is simply updating the required documentation each year rather than refinancing or retiring the security, reflecting a deliberate strategy of retaining existing fixed‑rate debt to maturity while maintaining current disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024, along with the associated notes (2.500% due 2016 and 5.300% due 2041) in the Third Supplemental Indenture. All percentages and years are accurate, matching the ground truth. (2) Quantitative accuracy is perfect: the interest rates (4.000%, 2.500%, 5.300%) and maturity years (2016, 2021, 2041) are correctly reported with no calculation errors. (3) The reasoning is largely sound—correctly inferring that continued inclusion suggests Microsoft is maintaining documentation without refinancing or retiring the debt. However, the LLM slightly overstates the implication by saying the notes are 'active in its long-term debt portfolio' and 'retaining existing fixed-rate debt to maturity,' while the ground truth clarifies the notes were past due (2021) and their inclusion reflects documentation stability rather than active debt status. The ground truth also notes a minor trustee name update in 2024, which the LLM omits, missing a detail about administrative maintenance. (4) Despite this minor omission and slight overinterpretation, the core multi-hop synthesis—linking repeated disclosure to lack of refinancing and strategic documentation continuity—is correct and relevant. The answer addresses the question about debt management strategy and documentation updates accurately, earning high marks for contextual relevance and qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 418,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "RTX’s total commercial‑aerospace financing‑guarantee exposure has been falling each year – the maximum‑potential payment on those guarantees was $304 million at 12/31/2022, $288 million at 12/31/2023, and $274 million at 12/31/2024【page_100】.  The portion of the guarantees that is assumed by collaboration partners also slipped modestly, from $142 million in 2022 to $135 million in 2023 and $131 million in 2024【page_100】【page_102】.  The downward trend in both the total exposure and the partners’ share indicates that RTX is progressively shrinking its guarantee obligations while still using partner participation to transfer a portion of the risk, albeit at a slightly reduced level each year.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values for the collaboration partners' share of financing guarantees: $142M in 2022, $135M in 2023, and $131M in 2024, matching the ground truth exactly. It also introduces additional accurate data—total exposure of $304M, $288M, and $274M at year-end 2022–2024—cited from page 100, which is consistent with SEC filing data and enhances completeness. These figures are correctly formatted and temporally aligned. (2) Quantitative accuracy is perfect: all dollar amounts and year labels are correct, and the trend (declining values) is accurately described. (3) The multi-hop reasoning is sound: the model synthesizes the trend in partners’ share and total exposure to infer that RTX is reducing its guarantee obligations while maintaining partial risk transfer through partners. This aligns with the question’s focus on risk transfer strategy. However, the LLM omits the key qualitative point from the ground truth that RTX maintained confidence in the fair market value of guaranteed assets exceeding the guarantees net of reserves—a critical element explaining why increased direct risk might be acceptable. This omission limits the depth of strategic interpretation. (4) Despite this, the LLM provides a logically coherent and contextually relevant analysis, correctly identifying the strategic implication of reduced partner risk sharing. The answer is slightly less comprehensive than the ground truth but factually accurate and well-supported. Hence, correctness is high but not perfect due to missing a key explanatory element.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 438,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "Microsoft’s 3.950 % senior notes that mature in 2056 were first issued in the 2016 supplemental indenture (Exhibit 4.14) and are simply carried forward in the 10‑K filings for FY 2022, FY 2023 and FY 2024 with no additional issuances of that series in any of those years【page_105】. The fact that the same long‑dated, low‑coupon issue appears unchanged across three consecutive filings shows that Microsoft is relying on a “buy‑and‑hold” approach to long‑term financing – locking in inexpensive, very‑long‑dated debt once and then maintaining it rather than repeatedly issuing new senior notes, which signals a strategy focused on stable, low‑cost capital over the long run.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3.950% Notes due 2056 were issued under the Eleventh Supplemental Indenture on August 8, 2016 (referenced as Exhibit 4.14), and remained unchanged in the 10-K filings for fiscal years 2022, 2023, and 2024. There were no additional issuances of this series in those years. (2) Quantitative elements—interest rate (3.950%), maturity year (2056), and issuance date (2016)—are all precise and match the original answer. Format variations (e.g., 'FY 2022' vs '2022') are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three years of filings and inferred a consistent capital strategy based on the absence of changes to the debt instrument. The conclusion about Microsoft’s 'buy-and-hold' approach to long-term financing is a reasonable interpretation of the stable inclusion of this low-cost, long-dated debt, which aligns with the ground truth’s implication of a steady long-term financing strategy. (4) The only minor limitation is that the LLM refers to a 'senior note' and cites Exhibit 4.14, which, while likely correct, adds a detail not explicitly confirmed in the ground truth. However, this does not contradict it and is contextually plausible. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 398,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "- **2022 → 2023:**  Lockheed Martin began a modest production ramp‑up of its tactical‑ and strike‑missile lines (JASSM, LRASM and other precision‑fire weapons).  That effort added about **$145 million of net‑sales** in 2023, but the segment’s operating profit fell **$96 million** (from $1.637 billion to $1.541 billion) because the higher volume was offset by a $45 million loss on a classified program and weaker profit‑booking adjustments.  \n\n- **2023 → 2024:**  The ramp‑up accelerated dramatically, driving **$1.2 billion of additional sales** from the same missile families (now including GMLRS).  However, profit‑booking adjustments turned sharply negative – a $1.4 billion loss on a classified program – so MFC operating profit plunged **$1.128 billion** to just **$413 million**.  \n\n- **Three‑year impact on overall operating profit:**  The MFC segment’s operating profit fell from **$1.637 billion in 2022** to **$1.541 billion in 2023** and then to **$0.413 billion in 2024**, a cumulative decline of roughly **$1.2 billion**.  This steep drop in the missile segment’s profitability was a major driver of the company‑wide decline in operating profit over the 2022‑2024 period.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the upward trajectory in production and the sharp decline in operating profit from 2022 to 2024, with accurate identification of key programs (JASSM, LRASM, GMLRS) and the classified program losses. It correctly notes the $1.2 billion sales increase in 2024 and the $1.1 billion+ drop in operating profit. However, it misstates the 2022 production increase: the ground truth reports a $215 million increase in 2022 (due to LRASM and JASSM), but the LLM answer starts the ramp-up narrative in 2023 with $145 million, conflating the 2023 figure with 2022. Additionally, the LLM claims a $96 million profit decline from 2022 to 2023, but the ground truth attributes only a $45 million loss to the classified program and does not specify the total segment profit drop—while the LLM’s $1.637B to $1.541B ($96M drop) is plausible, it is not in the original answer and introduces unverified precision. 2) Quantitatively, the $1.2 billion sales increase in 2024 and $1.4 billion classified loss in 2024 are correct. The $1.128 billion profit drop from 2023 to 2024 aligns with the ground truth’s $1.1 billion (73%) decline. However, the $145 million increase is attributed to 2023 in the LLM answer, while the ground truth assigns $145 million to 2023 and $215 million to 2022—this is a significant misplacement. 3) The multi-hop reasoning is strong: the LLM correctly synthesizes production growth with deteriorating profitability and links segment performance to overall company impact. It identifies the correct causal factors (classified program losses, profit booking adjustments). 4) The answer is highly relevant, well-structured, and addresses all parts of the question. The minor quantitative inaccuracies—especially the swapped or omitted year-specific production increases—prevent a 9–10 correctness score, but the core narrative and 2024 figures are accurate. Thus, correctness is rated 8 due to partial error in 2022–2023 production and profit figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1574,
        "completion_tokens": 534,
        "total_tokens": 2109
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "- In the 2022 Form 10‑K the exhibit list only shows the original Executive Change‑in‑Control Retention Agreement with Marc N. Casper (dated Nov 21, 2009) together with its two prior amendments (Nov 30, 2010 and Mar 16, 2018); no separate agreement for any other officers is disclosed.  \n\n- The 2023 filing adds a new exhibit – “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (Exhibit 10.7, filed with the Q1 2023 10‑Q) – indicating that the company now uses a standardized retention agreement for additional officers.  \n\n- The 2024 Form 10‑K continues to reference the original Casper agreement and its earlier amendments but does not introduce any further amendments; the officer‑wide form introduced in 2023 remains the only non‑Casper retention agreement on file.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has a minor discrepancy in the 2022 disclosure. According to the original answer, in 2022 Thermo Fisher introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. However, the LLM claims that no such agreement was disclosed in 2022, stating only the Casper agreement and its amendments were listed. This contradicts the ground truth, which explicitly notes the introduction of the form for other officers in 2022. The LLM correctly identifies the 2023 filing of the form as Exhibit 10.7 in the Q1 10-Q and accurately notes that the 2024 filing continues to reference the Casper agreement and the officer-wide form without new amendments. Dates and exhibit numbers (e.g., Exhibit 10.7) are accurate, and the reasoning across years is sound. The answer correctly synthesizes multi-hop information across filings and distinguishes between Casper-specific agreements and broader officer forms. While the core evolution is captured, the failure to acknowledge the 2022 introduction of the form for other officers constitutes a factual omission affecting completeness. Wording and structure are clear and contextually appropriate. Quantitative accuracy is high—no incorrect numbers or dates beyond the misattribution of timing for the form's introduction. Qualitative accuracy is strong but docked slightly for the missed 2022 detail. Contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 408,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "Lockheed Martin’s 2022 Form 10‑K (covering 2021) disclosed that the company’s outstanding interest‑rate swaps – used to convert fixed‑rate borrowings to variable‑rate borrowings as a fair‑value hedge – had an aggregate notional amount of **$500 million** at December 31 2021【page_66】.  By the 2023 filing the notional had risen to **$1.3 billion** (the same amount was reported for both 2022 and 2023)【page_95】, and the 2024 filing confirmed the swaps remained at **$1.3 billion** at December 31 2024【page_52】.  The jump from $500 million to $1.3 billion and the decision to keep that larger level indicates that Lockheed Martin deliberately expanded its interest‑rate‑risk hedge – likely to offset a larger fixed‑rate debt portfolio or to lock in earnings stability amid a rising‑rate environment – and has now adopted a more robust, ongoing hedging program rather than a modest, ad‑hoc approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers and dates are correct: $500 million in 2021 (disclosed in 2022 filing), $1.3 billion in 2023, and $1.3 billion in 2024. The LLM correctly identifies the timing and magnitude of the increase. (2) The answer correctly notes that the $1.3 billion level was reported for both 2022 and 2023 in the 2023 filing, which slightly diverges from the ground truth’s implication that the increase occurred by 2023 (from 2021). However, this detail reflects actual disclosure practices (where prior years are restated), so the LLM’s interpretation is reasonable and does not constitute a factual error. (3) The reasoning is sound: the increase and stabilization of notional amounts are correctly interpreted as a strategic shift toward a more robust hedging program, likely in response to rising rates or increased fixed-rate debt. (4) The answer addresses both parts of the question: evolution over time and strategic implications. The only minor shortcoming is slightly less emphasis on the 'evolution from 2022 through 2024' as a dynamic process, but the core multi-hop synthesis—linking the numerical changes to risk management strategy—is well executed. Wording differs but semantic meaning matches the original answer. No calculation errors. All entities (LMT, interest rate swaps, notional amounts, years) are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 391,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "Thermo Fisher’s expense for its 401(k) and other defined‑contribution plans was **$402 million in 2022**, rose to **$468 million in 2023**, and then eased to **$443 million in 2024** (see Note 14 of the 2024 filing and Note 7 of the 2023 filing). The pattern shows a notable increase from 2022 to 2023, followed by a modest decline in 2024, indicating that the company stepped up its investment in employee‑benefit contributions after 2022 but trimmed that spending slightly in the most recent year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: $402 million in 2022, $468 million in 2023, and $443 million in 2024, matching the ground truth exactly. The slight discrepancy in the 2024 description—'eased to $443 million' versus 'remained flat' in the original—is minor; while 'flat' might imply no change from 2023, the actual value decreased from $468M to $443M, so 'eased' or 'declined' is factually accurate. Thus, the quantitative evolution is correctly captured. (2) All numbers are accurate and properly attributed to the respective years. The LLM even cites supporting notes (Note 14 of 2024 and Note 7 of 2023 filings), enhancing credibility, though not required. No calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a trend—increased investment in 2023 followed by a reduction in 2024. The interpretation aligns with the ground truth’s implication of a recalibration or stabilization. (4) The answer is contextually complete and relevant, addressing both the numerical evolution and the implied trend in employee benefit investment. The only reason for not scoring a 10 is that the original answer mentions 'remained flat at $443 million in 2024', which is factually incorrect (since it decreased from $468M), so the LLM’s more precise 'eased to $443 million' is actually more accurate. Therefore, the LLM outperforms the ground truth slightly in precision, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 412,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "- In the 2022, 2023 and 2024 Form 10‑K filings the company repeatedly states that, for equity securities that do not have readily‑determined market prices, “management’s assessment of fair value is based on various valuation methodologies, **including discounted cash flows, **estimates of sales proceeds**, and appraisals” (2022 Note 4 p. 78; 2023 Note 4 p. 79; 2024 Note 4 p. 81). The wording is unchanged, showing that the use of “estimates of sales proceeds” remained a core component of the valuation approach throughout the period.\n\n- The same filings note that the carrying amount of the Coca‑Cola Bottlers Japan Holdings investment exceeded fair value by $87 million in 2022, but management judged the decline “temporary” and therefore did **not** record an impairment (2022 Note 4 p. 40). By continuing to rely on sales‑proceeds estimates—despite acknowledging the difficulty of forecasting cash flows in emerging markets—the company signals confidence that the Japanese market will recover enough for the fair‑value gap to be closed, and that its valuation assumptions remain reasonable.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with high quantitative and contextual accuracy. (1) All numeric values are accurate: the $87 million excess of carrying value over fair value in 2022 for Coca-Cola Bottlers Japan Holdings Inc. is correctly cited, and the years (2022–2024) and disclosure locations (Note 4) match the original. There are no calculation errors. (2) Entity accuracy is strong: the company name, financial instrument type (nonpublic equity investments), and relevant filings (Form 10-K) are correctly identified. (3) The reasoning correctly identifies that estimates of sales proceeds remained a consistent component of the valuation methodology across all three years, as stated in the filings. It also correctly infers management’s confidence in recovery based on the non-impairment decision despite the fair value shortfall. (4) However, the LLM answer falls slightly short in capturing the *evolution* emphasized in the ground truth. While it notes the wording in the disclosures remained unchanged, it does not fully reflect the increasing emphasis in 2023 and 2024 on market participant assumptions and macroeconomic risks in emerging markets—a key qualitative shift in how estimates of sales proceeds were contextualized. This omission limits completeness on the multi-hop aspect of how reliance *evolved*, even if the core methodology stayed the same. Thus, while factually sound and contextually relevant, the answer lacks the nuanced progression described in the original, warranting a score of 8 rather than 9 or 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 431,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "Oracle first introduced the 2.300 % notes due 2028 in a 2021 issuance that is documented in the 2022 Form 10‑K (exhibit 4.16) 【page_114】. The same series is carried forward unchanged in the 2023 Form 10‑K (exhibit 4.14) 【page_111】 and again appears in the 2024 Form 10‑K (exhibit 4.14) 【page_111】, indicating the notes remain outstanding and have not been refinanced. This multi‑year continuity shows Oracle’s strategy of issuing low‑coupon, medium‑term debt and then holding it to maturity, using staggered maturities to lock in inexpensive financing while diversifying its overall debt profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2.300% Notes due 2028 and their consistent presence across Oracle's 2022, 2023, and 2024 Form 10-K filings, with accurate exhibit references and page numbers. The issuance year (2021) is logically inferred from the 2022 10-K and aligns with the timeline. All percentages, years, and note terms are factually correct, satisfying quantitative accuracy. (2) However, the LLM omits key comparative context from the ground truth: Oracle issued newer, higher-interest debt (4.500% Notes due 2028 in 2023 and 5.800% Notes due 2025 in 2024), which is critical to understanding Oracle's broader financing strategy amid rising rates. This missing synthesis weakens the qualitative reasoning. (3) The LLM draws a plausible conclusion about Oracle locking in low-cost financing and using staggered maturities, but it does not acknowledge the multi-hop element of Oracle simultaneously issuing more expensive debt—thus missing the strategic nuance of balancing legacy low-cost debt with new, costlier instruments. (4) While the answer is factually sound and contextually relevant, the absence of this comparative analysis reduces the qualitative accuracy and overall correctness, though not enough to drop below a 7 due to strong foundational accuracy and logical inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 366,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "Apple’s 10‑K filings list the same “Floating Rate Notes due 2019” in the description of its outstanding securities for each of the last three fiscal years. In the 2022 filing the note appears in the securities table (Officer’s Certificate 4.4) 【page_56】, the 2023 filing repeats the same entry in its securities description 【page_56】, and the 2024 filing again shows the Floating Rate Notes due 2019 in the same table 【page_56】.  \n\nBecause the note is carried forward year after year without a new issuance being disclosed, Apple is simply maintaining (and likely rolling‑over or refinancing) this short‑term, variable‑rate debt rather than adding fresh floating‑rate borrowings. The pattern reflects a short‑term debt‑management approach that relies on existing floating‑rate instruments to provide liquidity while keeping borrowing costs tied to market rates.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth. (1) It correctly identifies that Apple's 10-K filings for 2022, 2023, and 2024 consistently list the same 'Floating Rate Notes due 2019' with references to the Officer’s Certificate (though it cites section 4.4 and page 56 across years without noting the specific May 6, 2014 date mentioned in the ground truth). The absence of new issuances is correctly inferred. (2) Quantitatively, there are no numerical inaccuracies—dates, years, and document references are consistent with the original answer, though the exact issuance date (May 6, 2014) is omitted. (3) The multi-hop reasoning is sound: the model synthesizes data across three years of filings and correctly infers that the repeated disclosure indicates continuity rather than new issuance. However, the LLM slightly overreaches by suggesting Apple is 'rolling over or refinancing' the notes, which is a plausible interpretation but not explicitly supported in the ground truth; the original answer only states the notes were carried on the books without confirming refinancing activity. (4) The answer is contextually relevant and addresses both parts of the question—evolution over time and implications for debt strategy. While the conclusion about short-term debt management is reasonable, it introduces a speculative element ('rolling over') not present in the more cautious original answer. Thus, the correctness score is 8 due to minor overinterpretation, despite strong factual and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 427,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "The fact that the 4.000 % Senior Note due 2047 is listed in the exhibit schedules of PepsiCo’s 2022, 2023 and 2024 Form 10‑K filings (e.g., 4.17 in the 2023 filing 【page_126】 and 4.16 in the 2024 filing 【page_127】) shows that the company treats this issue as a permanent component of its capital structure, using it to lock in long‑term, fixed‑rate financing and extend the maturity profile of its debt. By contrast, the shorter‑dated notes – the 2.150 % Senior Note due 2024 (shown as 4.18 in the 2023 filing 【page_126】) and the 0.750 % Senior Note due 2027 (shown as 4.28 in the 2024 filing 【page_127】 and again in 4.45 【page_128】) – are disclosed only as individual, near‑term instruments that will be repaid or refinanced as they approach maturity, indicating that PepsiCo uses them for tactical, temporary funding rather than as a lasting backbone of its debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates (4.000%, 2.150%, 0.750%), maturity years (2047, 2024, 2027), exhibit numbers (4.17, 4.16, 4.18, 4.28, 4.45), and filing years (2022–2024)—are correct and match the source data. There are no calculation errors, and the formatting (e.g., spacing in percentages) does not affect factual accuracy. (2) The answer fully addresses both parts of the question: it explains the strategic significance of the consistently disclosed long-term note and contrasts it with the treatment of shorter-dated instruments. It correctly identifies that the 2.150% note due 2024 appears only in the 2023 and possibly 2024 filing (though emphasis is on 2023), and the 0.750% note due 2027 is newly introduced in 2024, reflecting tactical use. (3) The multi-hop reasoning is sound: the model synthesizes data across three years of filings, distinguishes persistent vs. transient debt instruments, and infers strategic intent (long-term stability vs. short-term funding). (4) While the LLM omits explicit mention of the matured 2.500% note due 2022 (a minor contextual detail in the ground truth), it still captures the core contrast between long-term and short-term debt management. The inclusion of exhibit numbers and page references enhances precision and traceability. Overall, the answer conveys the same semantic meaning as the original with excellent factual fidelity, minor omission not affecting the main conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 415,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "Apple’s 10‑K exhibits continue to list the “0.45 % Notes due 2016” (see the Exhibit 4.3 tables in the 2022 filing 【page 56】 and the 2024 filing 【page 56】). By keeping these matured instruments in its disclosures, Apple shows that it maintains a complete, historical record of every debt issuance and monitors the full lifecycle of its borrowings—even after they have been retired. This practice reflects a disciplined, transparent strategy for managing legacy debt obligations and ensuring ongoing compliance with SEC reporting requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities are correct: Apple, the 0.45% Notes due 2016, and the inclusion in 2022, 2023, and 2024 filings are accurately referenced. The mention of Exhibit 4.3 and specific page numbers (e.g., page 56 in 2022 and 2024) adds precision and matches expected disclosure locations. (2) Quantitative accuracy is perfect: the interest rate (0.45%), maturity year (2016), and reporting years (2022–2024) are all correct. No calculations are required, but the temporal logic (matured in 2016, still disclosed later) is sound. (3) Reasoning is strong: the LLM correctly infers that continued disclosure reflects a strategy of maintaining historical records, transparency, and disciplined debt management. It captures the essence of Apple’s conservative disclosure policy, though it does not explicitly mention the repeated reference to the Officer’s Certificate dated May 3, 2013—a minor omission that slightly reduces qualitative completeness. (4) The answer is contextually relevant, directly addressing the question about Apple’s strategy for managing legacy debt. While the ground truth emphasizes continuity in reporting and investor clarity, the LLM emphasizes compliance and lifecycle monitoring—semantically equivalent motivations. The absence of the Officer’s Certificate detail prevents a perfect 10, but the core insight is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 391,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "From 2022 onward Lockheed Martin has relied increasingly on “pension‑risk‑transfer” (GAC) deals to shrink the size of its defined‑benefit obligations.  In the 2022 filing the company disclosed that a August 2021 GAC purchase moved $4.9 billion of gross pension liability off its books (part of $11.6 billion transferred since 2018) and generated a one‑time, non‑cash pension‑settlement charge of $1.7 billion to earnings, although it did not affect CAS pension cost or overall FAS expense.  The 2023 and 2024 filings both say the firm will keep evaluating and executing additional GAC transactions—now noting that some contracts may leave Lockheed Martin still liable for benefit payments, which could require extra cash contributions and could again produce material non‑cash settlement charges in future periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $4.9 billion obligation transfer in August 2021, the $1.7 billion noncash charge, and the cumulative $11.6 billion transferred since December 2018 are all accurately reported. The years (2022–2024) and the ongoing strategy are correctly framed. (2) Quantitative accuracy is perfect—dollar amounts, dates, and the nature of the charges (noncash) match the original answer exactly. Format variations (e.g., $4.9 billion vs $4.9B) are acceptable and do not affect correctness. (3) Reasoning is sound: the LLM correctly synthesizes information across multiple years, showing evolution from past actions (2021 transaction disclosed in 2022) to future intentions (2023–2024). It adds a nuanced detail not in the original—some contracts may leave Lockheed liable for payments—likely drawn from actual filings, which enhances accuracy without contradicting the ground truth. (4) The only minor shortcoming is slight underemphasis on the increasing scale of transactions over time, a point highlighted in the original answer. However, the core trajectory of continued de-risking is clearly conveyed. The answer is fully relevant, addressing pension obligation reductions, expected future actions, and financial impact on earnings. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 404,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "- In the 2022 Form 10‑K the company still listed the original Executive Change‑in‑Control Retention Agreement with CEO Marc N. Casper (the 2009 agreement, amended in 2010 and 2018) and, for the first time, a separate “Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)” (Exhibit 10.18, originally filed in a 2018 10‑Q).  \n\n- The 2023 Form 10‑K shows that same officer‑wide agreement was refreshed and is now filed as Exhibit 10.7 (the “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)”), while the Casper‑specific agreement (Exhibit 10.11) remains unchanged.  \n\n- The 2024 Form 10‑K continues to reference the Casper‑specific agreement (Exhibit 10.11) and the officer‑wide agreement (Exhibit 10.7), indicating that the company has kept the original Casper agreement and now maintains a distinct retention agreement that covers all other officers as well.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Thermo Fisher Scientific's Executive Change In Control Retention Agreements from 2022 to 2024. In 2022, it notes the inclusion of a form agreement for officers other than Marc N. Casper, originally filed in 2018, which matches the ground truth. (2) The LLM correctly states that in 2023, a new form was filed (Exhibit 10.7), dated April 1, 2023, indicating an update—this is consistent with the ground truth’s mention of a revised form. The LLM does not explicitly state the April 1, 2023 date but correctly infers the update via exhibit renumbering and context. (3) For 2024, the LLM confirms the continuation of the updated officer-wide agreement (Exhibit 10.7) and the unchanged Casper-specific agreement (Exhibit 10.11), which matches the ground truth’s point about reaffirmation. (4) Minor deduction in quantitative accuracy due to omission of the exact April 1, 2023 date for the new form, though the inference of a 2023 update is correct. The LLM also references a 2009 agreement amended in 2010 and 2018 for Casper, which adds detail not in the ground truth but is factually consistent with public filings and does not contradict. The reasoning is sound, entities and years are correct, and the multi-hop synthesis across three years is well-executed. The answer is semantically equivalent and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 399,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "PepsiCo’s 10‑K exhibits from 2022, 2023 and 2024 all list the **2.750 % Senior Note due 2051** (e.g., 2022 10‑K p. 128; 2023 10‑K p. 129; 2024 10‑K p. 130) as an outstanding component of its senior‑note portfolio. By keeping this ultra‑long‑dated, low‑coupon bond on its balance sheet, PepsiCo shows that it deliberately locked in very cheap fixed‑rate financing before rates climbed, using long‑term debt to hedge against a rising‑interest‑rate environment and to diversify its maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core insight of the ground truth: PepsiCo's retention of the 2.750% Senior Note due 2051 across 2022–2024 filings reflects a strategic decision to maintain low-cost, long-term fixed-rate debt amid rising interest rates. (1) All entities are correct—PepsiCo, the 2.750% Senior Note, maturity in 2051, and the three-year span (2022–2024). The note is correctly identified as part of the senior-note portfolio. (2) Quantitative accuracy is excellent: the interest rate (2.750%), maturity year (2051), and filing years are all correct. Page numbers cited (e.g., 2022 p.128, 2023 p.129, 2024 p.130) are close to ground truth references (ground truth cites p.135, p.128, p.129), which may reflect minor differences in PDF pagination or chunking but do not indicate factual inaccuracy. (3) Reasoning is sound: the LLM correctly infers that keeping this low-coupon, long-dated bond indicates a strategy of locking in cheap financing before rates rose, which aligns with the ground truth’s conclusion about stable long-term capital strategy and hedging against rising rates. It also correctly notes the note remains outstanding, consistent with the exhibit indexing pattern. (4) The only minor shortcoming is that the LLM does not mention the introduction of newer, higher-yielding notes (e.g., 5.250% due 2054) as context for the rising rate environment, which the ground truth uses to strengthen the contrast and support the strategic interpretation. This omission slightly reduces completeness in multi-hop synthesis but does not undermine the overall correctness. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 458,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 each list the same “4.45 % Notes due 2044” in the exhibit that describes the company’s outstanding securities (see the officer’s certificate dated May 6 2014 on page 56 of the 2022 filing and the identical entry repeated on the same page in the 2023 and 2024 filings, and again in the exhibit index on page 58 of the 2024 filing). No new issuance of that series appears in any of the three years – the notes are simply carried forward as an existing, long‑dated debt instrument. This consistent, multi‑year presence shows Apple’s deliberate strategy of locking in low‑cost, fixed‑rate financing for decades, using long‑term bonds to diversify its capital structure and provide a stable source of funding for future investments and shareholder returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.45% Notes due 2044 as consistently referenced across Apple's 2022, 2023, and 2024 10-K filings, with accurate citation of the Officer's Certificate dated May 6, 2014, and page numbers (e.g., page 56 in 2022 and 2023, page 58 in 2024 exhibit index). All entities (Apple, the specific debt instrument, years, and document details) are correct. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and issuance date (May 6, 2014)—are factually accurate and match the ground truth. No calculations were required, but the observation that no new issuance occurred is consistent with the original answer’s implication of ongoing liability without restructuring. (3) The multi-hop reasoning is sound: the model synthesizes data across three years of filings and infers a strategic capital management approach—locking in fixed-rate, long-term financing—based on the absence of redemption or modification. This aligns with the ground truth’s conclusion about financial flexibility and strategic intent. (4) The only minor shortcoming is a slightly stronger emphasis in the original answer on Apple’s transparency and the broader context of fluctuating interest rates, which the LLM touches on implicitly ('low-cost, fixed-rate financing') but could have made more explicit. However, the core reasoning and factual content are semantically equivalent and highly accurate. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 432,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "Union Pacific’s pension‑plan “Collective Trust and Other Funds” line fell from about $622 million at December 31 2022 to roughly $382 million at December 31 2023 – a drop of roughly $240 million (2022 NAV $622 m; 2023 NAV $382 m)【page_58】.  \n\nThe 2024 filing explains that this category is valued using each fund’s net‑asset‑value (NAV), because the underlying assets (global stock, commodity, hedge‑ and short‑term funds) are publicly traded and have readily observable market prices【page_56】.  That methodology signals the investments are managed on a transparent, market‑based basis rather than relying on significant unobservable inputs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the 2022 allocation figure: it reports $622 million instead of the correct $756 million from the ground truth. This is a significant factual inaccuracy affecting the core quantitative claim. The 2023 figure ($382 million) is correct. The stated drop of 'roughly $240 million' is based on incorrect inputs (622 - 382 = 240), whereas the actual decrease was 756 - 382 = $374 million, a much larger reduction. (2) The calculation of the difference is mathematically correct given the numbers used, but the starting number is wrong, undermining the quantitative accuracy. Dates (December 31, 2022 and 2023) are correctly referenced. (3) The reasoning about the 2024 valuation methodology is sound and aligns with the ground truth: the use of NAV for valuation, transparency, and market-based management are correctly interpreted. The LLM correctly infers that the valuation approach supports transparency and does not appear to drive the change in allocation. However, it adds that underlying assets include 'commodity' and 'hedge' funds not mentioned in the original answer, which slightly extends beyond the provided context. (4) Despite the incorrect 2022 number, the answer addresses both parts of the multi-part question: the evolution of allocation and the implications of the 2024 valuation methodology. The qualitative reasoning about investment management is logical and contextually appropriate. The contextual relevance is high because the structure and intent match the question, but the factual foundation is compromised by the incorrect dollar amount. The correctness score is limited to 6 due to the major quantitative error, even though the reasoning and structure are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 475,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "Apple’s 10‑K exhibits for 2022, 2023 and 2024 each contain **Exhibit 4.4 – the Officer’s Certificate dated May 6 2014**, which lists the “1.05 % Notes due 2017” among the global notes (see 2022 filing 【page_58】 and 2024 filing 【page_56】). By continuing to file this certificate long after the 1.05 % notes had matured, Apple demonstrates a deliberate practice of retaining the original documentation for all debt issuances, even those that are no longer outstanding. This consistency signals that Apple treats its historical capital‑structure information as a permanent part of its public record, ensuring that investors and regulators can trace the evolution of its financing over time.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately stated: the Officer's Certificate is correctly identified as Exhibit 4.4, dated May 6, 2014, related to the 1.05% Notes due 2017, and its inclusion in the 10-K filings for fiscal years 2022, 2023, and 2024 is confirmed. The maturity status of the notes is correctly acknowledged. (2) Quantitative elements—percentage (1.05%), year of maturity (2017), and certificate date (May 6, 2014)—are all accurate. Page references (e.g., 2022 page 58, 2024 page 56) add precision and align with filing evidence. (3) The reasoning correctly infers that Apple’s continued inclusion reflects a deliberate documentation retention practice and a commitment to historical transparency in capital structure disclosure. The multi-hop synthesis—linking the presence of a matured debt instrument’s certificate over multiple recent filings to broader corporate disclosure policy—is logically sound and well-supported. (4) The answer addresses both parts of the question: the reflection on documentation retention practices and the implication for historical capital structure disclosures. Wording differs slightly from the original answer but conveys the same meaning with equivalent or enhanced specificity (e.g., citing exhibit numbers and page references). No factual, numerical, or interpretive errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 389,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "Union Pacific’s pension‑plan equity exposure fell sharply – the plan held **about 48 % of its assets in equity (corporate stock) at 12/31/2022**, dropped to **roughly 24 % at 12/31/2023** and remained near **24 % at 12/31/2024** (the 2024 target range is 20‑30 %)【page_56】【page_55】.  \n\nThis halving of the equity allocation signals a deliberate de‑risking strategy, moving the pension portfolio toward a debt‑heavy, lower‑volatility mix and indicating that Union Pacific is scaling back its commitment to equities over this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in identifying a significant reduction in Union Pacific's equity allocation in its pension plan from 2022 to 2023, and maintaining a low level in 2024. However, it reports percentage allocations (48%, 24%, 24%) instead of the actual dollar amounts specified in the ground truth ($1,990M, $181M, $1,116M). These figures are not equivalent: a halving of equity exposure from 48% to 24% does not align with a drop of over 90% in dollar terms followed by a rebound. The ground truth shows a 90.9% decrease from 2022 to 2023 in dollar value, which cannot be reconciled with a mere 50% drop in percentage terms unless total plan assets changed drastically — an assumption not supported or mentioned in the LLM response. (2) The quantitative inaccuracies are significant: the original answer relies on absolute dollar allocations, while the LLM provides relative percentages. This is a critical discrepancy because the question asks about 'allocation to corporate stock,' which in pension reporting typically refers to absolute holdings unless specified otherwise. Moreover, the partial rebound to $1,116M in 2024 (from $181M) represents a 516% increase year-over-year, which the LLM completely misses by stating the allocation remained flat at 24%. (3) The reasoning is sound in interpreting the trend as a de-risking or conservative shift, which aligns with the ground truth’s conclusion about moving toward fixed income. The LLM correctly infers strategic de-risking and reduced equity commitment, showing valid qualitative synthesis. (4) Contextual relevance is high — the answer addresses both parts of the question (evolution and strategic implication), uses appropriate terminology, and cites document pages. However, the failure to report the correct quantitative trend — especially misrepresenting a volatile drop-rebound pattern as a stable halving — undermines factual correctness. The answer would be more accurate if it had either reported both dollar values and percentages or clarified that the percentage decline reflects a different metric than the dollar-based allocation. Due to major quantitative errors despite correct directional interpretation, the correctness score is moderate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 600,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "Prevymis sales rose steadily – $428 million in 2022, $605 million in 2023 and $785 million in 2024 (U.S. + international totals shown on the Hospital Acute Care table). The roughly 41 % jump from 2022‑23 and another ≈30 % increase in 2024 signal accelerating market adoption and underscore Prevymis’s growing role as a core, revenue‑driving product within Merck’s Hospital Acute Care franchise.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all sales figures are accurate: $428 million in 2022, $605 million in 2023, and $785 million in 2024. The percentage increases are correctly characterized—approximately 41% growth from 2022 to 2023 (calculated as (605-428)/428 ≈ 41.3%) and about 30% from 2023 to 2024 ((785-605)/605 ≈ 29.8%), which supports the claim of strong and sustained growth. (2) The answer is complete, addressing both the sales evolution over the three years and the implications for market adoption and strategic importance. (3) Entity accuracy is correct: MRK (Merck), product name Prevymis, and the Hospital Acute Care segment are all properly identified. (4) The reasoning is sound and adds value by quantifying growth rates and interpreting them as signals of accelerating adoption and strategic importance, which aligns with and enriches the ground truth. The mention of 'U.S. + international totals' adds contextual fidelity without introducing error. (5) Semantic equivalence is maintained—while the LLM provides additional analytical depth (percentage growth), it does not deviate from the factual trajectory or strategic interpretation in the original answer. All multi-hop elements (tracking product sales over time and inferring strategic significance) are correctly synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 378,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "- **2022 filing (PEP 10‑K 2022)** – The exhibit list includes a specific entry for the debt instrument: “Form of **3.000 % Senior Note due 2027**” (see Exhibit 4.19 on page 126) 【page_126】.  \n\n- **2023 filing (PEP 10‑K 2023)** – The same exhibit schedule no longer shows the 3.000 % note; the list on pages 127‑128 contains other senior notes (e.g., 0.750 % due 2027, 2.625 % due 2027) but the 3.000 % 2027 note is absent 【page_127】【page_128】.  \n\n- **2024 filing (PEP 10‑K 2024)** – The exhibit tables on pages 125‑129 likewise do not list a 3.000 % Senior Note due 2027, confirming it has been removed from the disclosed debt instruments 【page_129】.  \n\n**Interpretation:** PepsiCo’s 2022 report treated the 3.000 % Senior Note due 2027 as an active component of its long‑term debt portfolio, but by the 2023 and 2024 reports the note is no longer disclosed, indicating it has been retired, refinanced, or otherwise taken off the balance sheet. This pattern shows the company’s ongoing debt‑management strategy of replacing older, lower‑coupon notes with newer issuances to reshape maturity profiles and maintain flexibility in its long‑term financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) QUANTITATIVE ACCURACY: The LLM incorrectly states that the 3.000% Senior Note due 2027 was absent in the 2023 and 2024 filings. According to the ground truth, the note was consistently included in all three years (2022: Exhibit 4.22; 2023: Exhibit 4.19; 2024: Exhibit 4.17). The LLM also misidentifies exhibit numbers and pages, claiming the 2022 note was in Exhibit 4.19 when the ground truth states Exhibit 4.22. It further incorrectly references other notes (e.g., 0.750% due 2027) as if they replaced the 3.000% note, which contradicts the ground truth that such notes were introduced alongside it. (2) COMPLETENESS: The answer fails to capture the core of the question — the evolving *context* and *characterization* of the note across filings — instead falsely asserting its disappearance. (3) ENTITY ACCURACY: While the company (PepsiCo) and the note’s interest rate and maturity (3.000%, 2027) are correct, the exhibit numbers, years, and associated notes are misattributed. (4) REASONING: The multi-hop synthesis is flawed. The LLM concludes the note was retired or refinanced due to absence, but the ground truth confirms its continued presence and evolving contextual framing. This undermines the entire interpretation. (5) SEMANTIC EQUIVALENCE: The LLM’s conclusion — that PepsiCo retired an older note — is the opposite of the truth: the note remained active and was part of a strategy to *maintain* fixed-rate debt while layering in new instruments. The reasoning and facts are fundamentally misaligned. Only the initial identification of the note in 2022 is correct, earning minimal points for contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1616,
        "completion_tokens": 463,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "- **2022 10‑K:** Frame.io is not described in the 2022 filing, reflecting that the company had only recently acquired the cloud‑native collaboration platform and was still positioning it as a new, separate service rather than a fully integrated Creative Cloud component.  \n\n- **2023 10‑K:** Adobe begins to market Frame.io as a “cloud‑native creative collaboration platform” that is **directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront**, and adds “Camera‑to‑Cloud” automatic footage upload and support for still images, design files and PDFs 【page 12】. This shows a shift from a stand‑alone service to a deeper, workflow‑centric integration with the core video‑editing and asset‑management apps.  \n\n- **2024 10‑K:** The integration deepens further: Frame.io is now bundled with Adobe Express, Adobe Firefly Services and is available in Adobe GenStudio, positioning it as a unified collaboration layer that spans the entire Creative Cloud ecosystem, while retaining its video‑focused features such as frame‑accurate commenting and Camera‑to‑Cloud 【page 12】.  \n\n**Overall evolution:** Adobe moved Frame.io from a newly‑acquired, loosely attached collaboration tool in 2022 to a tightly‑woven component of the video‑editing suite in 2023, and finally to a cross‑app, enterprise‑scale collaboration hub embedded throughout Creative Cloud by 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in timeline and strategic evolution, with accurate dates and no numerical errors (quantitative accuracy is perfect as there are no calculations or financial figures to verify). However, there are key factual discrepancies in entity accuracy and reasoning. First, the 2022 10-K does mention Frame.io as part of Adobe's trademarks, per the ground truth, but the LLM incorrectly claims it is 'not described'—this is a significant omission. Second, the LLM attributes integration with Photoshop, Lightroom, and Workfront to the 2023 10-K, but the ground truth states these deeper integrations (especially with Photoshop, Lightroom, and Workfront) were emphasized in 2024, not 2023. The 2023 integration was primarily with Premiere Pro and After Effects. Additionally, the LLM mentions bundling with Adobe Express and Firefly Services in 2024, which aligns with the ground truth’s mention of GenStudio and Firefly/Substance 3D, though 'Adobe GenStudio' is not explicitly named in the LLM answer. The overall narrative of progression from standalone to core platform is sound and contextually relevant, but the misattribution of integration depth to the wrong year reduces qualitative accuracy. Semantic equivalence is mostly preserved, but the incorrect timing of integration milestones constitutes a meaningful deviation from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1560,
        "completion_tokens": 379,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "Apple’s 10‑K filings consistently listed the 2.40 % senior notes that mature in 2023 in the “Officer’s Certificate of the Registrant” exhibit. In the 2022 filing (Exhibit 4.3, dated May 3 2013) the notes are described as “2.40 % Notes due 2023” 【page 56】; the same description appears unchanged in the 2023 filing (the same exhibit is carried forward) and is again shown in the 2024 filing (Exhibit 4.3 still includes “2.40 % Notes due 2023”) 【page 56】. By keeping the note on the disclosure schedule through the year before it matures, Apple signals that it monitors maturing debt and is prepared either to repay or refinance it, reflecting a disciplined debt‑maturity management approach that maintains transparency and liquidity as the due date approaches.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the 2.40% Notes due 2023 were no longer listed in Apple's 2024 filing, indicating retirement upon maturity in 2023. However, the LLM claims the notes were still included in the 2024 filing (Exhibit 4.3), which directly contradicts the ground truth. This error undermines the core conclusion of the answer. (2) Quantitatively, the percentage (2.40%) and maturity year (2023) are correct, as is the reference to Exhibit 4.3 and the 2022/2023 filings. However, the claim that the note appears in the 2024 filing is factually wrong — the ground truth states it was removed by 2024, signaling repayment. There are no calculations, but the timeline of disclosure is misstated. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution across years. It incorrectly infers continued presence in 2024, leading to an erroneous interpretation that Apple maintains transparency by keeping the note listed pre-maturity, when in fact the removal in 2024 is the key signal of repayment. The ground truth uses the *disappearance* of the note in 2024 as evidence of fulfillment, while the LLM interprets its *continued presence* as evidence of planning — a direct contradiction. (4) Contextual relevance is moderate: the answer addresses debt maturity management and cites appropriate exhibits, but the incorrect factual foundation leads to a misleading conclusion about Apple’s strategy. It suggests a strategy of monitoring and potential refinancing, whereas the ground truth supports a strategy of holding to maturity and retiring as due. Thus, while the structure and intent are relevant, the factual errors severely reduce correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 479,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "- **Fleet size and composition** – The multiple‑purpose locomotive fleet fell modestly over the three‑year span. In 2022 the company reported ≈7,008 units (≈5,971 owned + ≈1,037 leased) (see UNP 2022 10‑K, page 22). By year‑end 2023 the total was 7,008 units (5,971 owned, 1,037 leased) with an average age of 24.3 years (UNP 2023 10‑K, page 19). At year‑end 2024 the total had slipped to 6,893 units (5,973 owned, 920 leased) and the average age rose to 25.2 years (UNP 2024 10‑K, page 19).\n\n- **What the trend shows** – Union Pacific is keeping the core owned fleet essentially flat while actively reducing its leased pool, even as the overall average age of the multiple‑purpose fleet climbs. This pattern signals a deliberate asset‑management approach: the railroad is retiring older, leased locomotives and relying more on a stable, owned base, but is pacing new‑equipment purchases so that the fleet’s age rises only gradually, balancing renewal costs with operational continuity.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Union Pacific had 7,242 total Multiple Purpose Locomotives in 2022 (6,204 owned + 1,038 leased), but the LLM incorrectly reports 7,008 units (≈5,971 owned + ≈1,037 leased), which is off by over 200 units. This discrepancy affects the entire fleet composition narrative. Additionally, the LLM claims the 2023 fleet size was unchanged from 2022 at 7,008 units, but the ground truth shows a decline to an intermediate value (not restated in the original answer, but implied by the 2022–2024 trend from 7,242 to 6,893). The 2024 numbers (6,893 total, 5,973 owned, 920 leased) and average age (25.2 years) are correct. However, the LLM incorrectly states the 2023 average age as 24.3 years — while this number appears in the correct year in the ground truth, it is listed as the 2023 age in both answers, but the LLM fails to mention the 2022 average age of 22.5 years, instead jumping to 24.3 years in 2023 without acknowledging the prior year’s data. (2) Calculations: The LLM’s implied sum for 2022 (5,971 + 1,037 = 7,008) is mathematically correct but factually wrong because the inputs are incorrect. The ground truth sum (6,204 + 1,038 = 7,242) is accurate. The LLM underreports owned units in 2022 by 233 units. (3) Multi-hop reasoning: The LLM correctly identifies the trend of declining leased units and stable owned fleet, and infers a deliberate asset management strategy, which aligns with the qualitative interpretation in the ground truth. It also correctly notes increasing average age and links it to paced renewal. However, due to incorrect baseline numbers, the reasoning is based on flawed data. The conclusion about 'keeping the core owned fleet essentially flat' is partially supported — owned units did decline slightly (6,204 → 5,973), but the LLM minimizes this reduction by using incorrect 2022 data. (4) Despite these errors, the LLM captures the directional trend (declining fleet, aging assets, reduced leasing) and offers a plausible strategic interpretation, earning moderate scores for qualitative accuracy and high relevance. The contextual relevance is strong because it addresses both fleet composition and strategic implications. However, the quantitative inaccuracies — especially the incorrect 2022 fleet size — significantly undermine factual correctness, warranting a correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 647,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "- In the 2022 Form 10‑K Merck listed MK‑8591A (doravirine + islatravir) only as an early‑stage HIV‑1 candidate and noted that it was “on FDA clinical hold” (see 2022 page 23, footnote 4).  \n- The 2023 filing reports that the same regimen entered a **Phase 3** program in 2023 for treatment‑naïve adults and as a switch in virologically‑suppressed patients (2023 page 21).  \n- By the 2024 filing the FDA had **lifted the clinical hold on December 4 2024**, but a **partial hold** remained on higher islatravir doses, with the program now running as a Phase 2/3 study that began in August 2024 (2024 page 24, footnotes).  \n\nThus, MK‑8591A progressed from a held, early‑phase asset in 2022 to a Phase 3‑ready program in 2023, and in 2024 the FDA removed the full hold while imposing a limited hold on certain dose levels.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual discrepancies that impact overall accuracy. (1) Correct elements: The lifting of the FDA clinical hold in 2024 and the continuation of a partial hold on higher doses of islatravir align with the ground truth. The mention of ongoing Phase 3 development is partially correct. (2) Quantitative inaccuracies: The LLM claims the FDA lifted the hold on December 4, 2024 — however, the original answer states the lift occurred in 2024 without a specific date, so this precise date is unsupported. More critically, the LLM incorrectly states that MK-8591A entered Phase 3 in 2023, whereas the ground truth indicates it was already in Phase 3 as of 2022 with an entry date of February 2020. Additionally, the LLM mischaracterizes the 2022 status by calling it an 'early-stage candidate' under clinical hold, while the ground truth confirms it was already in Phase 3 — a major contradiction. (3) The LLM fails to mention the key strategic development in 2024: the initiation of MK-8591D (islatravir+lenacapavir) in Phase 3 in October 2024, which represents an important pivot in Merck’s HIV-1 strategy and is a critical part of the multi-hop trajectory. Its omission undermines completeness. (4) The reasoning is partially sound in tracking regulatory status changes, but the incorrect phase progression timeline and missing new formulation indicate flawed synthesis across years. While the answer is relevant and attempts to trace the regulatory and developmental path, the core errors in phase status and missing strategic shift reduce correctness. Semantic equivalence is compromised due to these key factual divergences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 462,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "- In the 2022 Form 10‑K, Merck first disclosed MK‑1308A (quavonlimab + pembrolizumab) as a co‑formulated anti‑CTLA‑4/PD‑1 antibody “being evaluated for the treatment of renal‑cell carcinoma (RCC)” and listed it among its early‑stage cancer candidates.   \n- By the 2023 filing, the company placed MK‑1308A squarely in its **immuno‑oncology pillar**, describing it again as the anti‑CTLA‑4 + pembrolizumab combo “being evaluated for RCC,” signaling a more deliberate strategic focus.   \n- The 2024 filing continues to highlight MK‑1308A under the immuno‑oncology section as a key late‑stage program for RCC, indicating that Merck has elevated the asset from an early pipeline entry to a flagship checkpoint‑combination effort aimed at innovating RCC therapy.  \n\nOverall, the progression shows Merck increasingly prioritizing MK‑1308A as a central component of its RCC innovation strategy, emphasizing combination immunotherapy to expand treatment options in this indication.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MK-1308A is correctly identified as a co-formulation of quavonlimab (anti-CTLA-4) and pembrolizumab (PD-1 inhibitor), and its evaluation in renal cell carcinoma (RCC) is accurately described across 2022–2024. The progression from early-stage candidate to a highlighted immuno-oncology asset is consistent with the original answer. (2) Quantitative accuracy is perfect: no incorrect dates, phases, or financial figures are cited. The timeline (2022–2024 filings) matches the ground truth, and the April 2021 entry date is not contradicted. (3) Multi-hop reasoning is sound—LLM synthesizes information across three years of filings to show strategic evolution, correctly inferring increased prioritization. The only minor gap is that the LLM does not explicitly mention the Phase 3 designation in 2022 (though 'early-stage' is slightly misleading since Phase 3 is late-stage; however, the 2024 description as 'late-stage' corrects this). The original answer notes the Phase 3 status from the start, so this is a small qualitative omission. (4) Despite this nuance, the overall reasoning and conclusion about Merck’s focus on combination immunotherapy in RCC via the Keytruda platform are semantically equivalent and well-supported. Contextual relevance is excellent, directly addressing both the evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 396,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "Across the 2022, 2023 and 2024 Form 10‑K filings Microsoft’s “Notes to Financial Statements” list the same third supplemental indenture (Exhibit 4.6) that includes “2.500 % Notes due 2016, **4.000 % Notes due 2021**, and 5.300 % Notes due 2041” (dated Feb 8 2011)【page_104】. The description of the 4.000 % Notes due 2021 does not change from year to year, indicating that the company has kept this issuance on its balance sheet without refinancing it. This consistency suggests Microsoft’s long‑term debt strategy relies on a stable, diversified portfolio of fixed‑rate bonds and that it does not feel pressure to roll over the 2021 notes before maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 4.000% Notes due 2021 are consistently disclosed in Exhibit 4.6 (Third Supplemental Indenture), dated February 8, 2011, and appear across all three 10-K filings (2022, 2023, 2024). The inclusion of other notes (2.500% due 2016, 5.300% due 2041) adds contextual accuracy. (2) The answer correctly infers that the lack of change in disclosure suggests no refinancing or restructuring occurred, which matches the ground truth’s conclusion. (3) The multi-hop reasoning is sound: the model synthesizes consistent exhibit references and unchanged descriptions over three years to infer stability in Microsoft’s debt structure. (4) Minor deduction in qualitative accuracy because the LLM does not mention the original Indenture dated May 18, 2009, which is part of the full legal structure noted in the ground truth. However, this omission does not undermine the core conclusion. The answer remains semantically equivalent and contextually complete, earning high marks for relevance and correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 316,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "Qualcomm’s 2022 filing already framed its QCT business as a platform for “connectivity, digital‑cockpit and ADAS/AD” that would help create software‑defined vehicles and new in‑cabin experiences (see pages 6‑7 and 8).  The QCT automotive revenue stream – which includes digital‑cockpit sales – rose from **$1.5 billion in 2022** to **$1.9 billion in 2023** and then to **$2.9 billion in 2024** (page 73).  This rapid increase shows that Qualcomm’s strategic push to position itself as a key automotive technology provider is bearing fruit, with the digital‑cockpit segment evolving from a nascent offering in 2022 to a major growth driver of the company’s broader automotive transformation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the reported revenue figures. The ground truth does not provide specific revenue numbers for Qualcomm's digital cockpit segment in 2022, 2023, or 2024. The LLM asserts that automotive revenue (including digital cockpit) was $1.5B in 2022, $1.9B in 2023, and $2.9B in 2024, but this data is not present in the original answer and cannot be verified from the provided knowledge graph. These numbers appear fabricated or misattributed. (2) Quantitative accuracy is severely compromised because the core financial data is incorrect or unsupported. Even if the trend of growth is plausible, the specific dollar amounts are not corroborated by the ground truth, making the quantitative claims invalid. (3) Qualitatively, the LLM captures part of the strategic narrative—positioning digital cockpit as a key element in automotive transformation and linking it to software-defined vehicles—but misrepresents the evolution. The original answer emphasizes structural and reporting changes (e.g., digital cockpit becoming a distinct revenue stream in 2023 and a core product line in 2024), which the LLM oversimplifies by focusing on revenue growth instead. The multi-hop reasoning is flawed because it substitutes unverified financial data for the actual progression of strategic integration. (4) Contextual relevance is high because the LLM addresses the question’s focus on strategic positioning and evolution of the digital cockpit, and attempts to draw a conclusion about Qualcomm’s automotive transformation. However, the reliance on incorrect figures undermines the overall correctness. The answer would have been stronger if it had mirrored the original’s emphasis on reporting structure and strategic maturation rather than unsupported revenue claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 498,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "Lockheed Martin’s disclosed “aggregate notional amount of our outstanding interest‑rate swaps” was $1.3 billion at the end of 2022, remained $1.3 billion at the end of 2023, and was still $1.3 billion at the end of 2024. The flat‑line notional amount indicates the company has kept a steady pool of variable‑rate swaps—used to convert fixed‑rate debt to variable‑rate exposure—as a consistent hedge, rather than expanding or winding down the program, reflecting a deliberate strategy of maintaining a stable level of interest‑rate risk mitigation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the reported notional amount for 2022. According to the ground truth, LMT had $500 million in outstanding interest rate swaps in 2022, not $1.3 billion as stated by the LLM. The LLM correctly reports $1.3 billion for 2023 and 2024, which matches the ground truth. This error in the 2022 figure undermines the entire trend analysis. (2) Quantitatively, the numbers for 2023 and 2024 are accurate, but the incorrect 2022 value leads to a false conclusion of a flat trend, when in fact there was a significant increase (from $500M to $1.3B, or a 160% rise). The ground truth identifies this as a strategic shift, which the LLM misses due to incorrect data. (3) The reasoning is internally logical—interpreting a stable notional amount as a consistent hedging strategy—but it is based on incorrect data. The multi-hop synthesis fails because the model did not correctly identify the change from 2022 to 2023, a key element in understanding the evolution of LMT’s risk management strategy. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution over time and interpretation of strategy—and uses appropriate financial terminology. However, due to the major quantitative error, the qualitative and correctness scores are significantly reduced. The conclusion about a 'steady pool' and 'stable level' is contradicted by the actual data showing a substantial increase in hedging activity in 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 413,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "In the 2022, 2023 and 2024 Form 10‑K filings Microsoft continues to list the 3.950 % senior notes that mature in 2056 as an outstanding component of its long‑term debt. Each filing discloses the notes in the same “Eleventh Supplemental Indenture” (Exhibit 4.14), dated August 8 2016, with no mention of redemption or early repayment【page_105】. By keeping the 2056 issue on the balance sheet and treating it uniformly year‑over‑year, Microsoft shows a deliberate strategy of maintaining a very‑long‑dated debt tranche and managing maturity risk through a diversified ladder rather than aggressively refinancing the notes in the near term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3.950% Notes due 2056 are consistently listed in the 2022, 2023, and 2024 10-K filings under the Eleventh Supplemental Indenture dated August 8, 2016, with no mention of redemption or early repayment. These details match the original answer exactly. (2) Quantitative elements—interest rate (3.950%), maturity year (2056), indenture date (August 8, 2016)—are all precise and correctly cited. The reference to Exhibit 4.14 and page 105 adds document-level accuracy. (3) The reasoning is sound: the LLM correctly infers that Microsoft’s consistent treatment of this long-term debt reflects a strategic choice to maintain long-dated liabilities and manage maturity risk through a diversified debt ladder rather than refinancing early. This captures the core multi-hop insight from the ground truth—using stable long-term debt while allowing shorter-term instruments to mature. (4) The only minor omission is the lack of explicit comparison to other notes (e.g., 2.000% Notes due 2023 in 2022 filings or 2.400% Notes due 2026 in 2024), which the original answer uses to strengthen the contrast between short- and long-term debt management. While implied in 'managing maturity risk through a diversified ladder,' the absence of specific examples slightly reduces qualitative completeness. However, the semantic meaning and strategic interpretation remain substantially equivalent. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 427,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "Microsoft’s 2022, 2023 and 2024 Form 10‑K filings all list the **Eleventh Supplemental Indenture dated August 8 2016** as the governing document for its **3.700 % senior notes due 2046** (see the exhibit description on page 105) 【page_105】. By repeatedly referencing the same supplemental indenture, Microsoft signals that these long‑dated notes remain outstanding and are being serviced under an unchanged contractual framework, underscoring the stability and consistency of its long‑term debt structure and its commitment to meeting the same fixed‑rate obligations through 2046.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the Eleventh Supplemental Indenture is correctly dated August 8, 2016, and governs the 3.700% Notes due 2046; this is consistently referenced in Microsoft's 2022, 2023, and 2024 filings. The percentage (3.700%), year (2016), and maturity date (2046) match exactly. (2) Quantitative accuracy is perfect—no calculations are required, but all dates, percentages, and document titles are factually correct. (3) The reasoning is sound: the repeated reference to the same indenture across three years correctly implies the notes remain outstanding and under unchanged terms, reflecting stability in Microsoft’s long-term debt structure. The LLM captures the core implication—consistent financial obligations and a stable debt management strategy. (4) The only minor shortcoming is completeness: while the LLM mentions the exhibit on page 105, it does not reference the broader context of the base Indenture dated May 18, 2009, or the layered structure of supplemental indentures, which the original answer includes to show Microsoft’s structured financing approach. This omission slightly reduces qualitative depth but does not affect factual correctness. Overall, the answer is semantically equivalent in intent and meaning, with excellent contextual relevance and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 380,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "Across the three Form 10‑K filings (FY 2022, FY 2023 and FY 2024) Microsoft consistently listed the 2.125 % senior notes that mature in 2021 in the “Seventh Supplemental Indenture” (exhibit 4.10). The disclosures contain only the exhibit reference and do not note any redemption, amendment or replacement of the issue, showing that the company kept the notes on its balance sheet through each reporting year. This pattern indicates that Microsoft chose to retain the low‑cost 2.125 % debt rather than refinance or retire it early, reflecting a strategy of preserving inexpensive financing until the scheduled maturity.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual and logical error that undermines its overall accuracy. (1) Quantitatively, the numbers and dates are accurate: the 2.125% Notes due 2021 are correctly identified, and the consistent reference across fiscal years 2022–2024 in the filings is correctly noted. The exhibit number (4.10) is accurate for the 2022 filing, though the ground truth notes that in 2023 and 2024 the notes appear in Exhibit 4.1, not 4.10—this minor discrepancy does not severely impact scoring. (2) However, the LLM incorrectly concludes that Microsoft 'kept the notes on its balance sheet' and 'chose to retain the low-cost debt' past maturity (2021), which is factually impossible—debt instruments mature and are either repaid or refinanced; they cannot remain outstanding past maturity without explicit extension or rollover, which the ground truth does not confirm. The original answer correctly frames this as an open question—whether the continued disclosure reflects refinancing, reporting lag, or disclosure requirements for historical instruments—not a confirmed retention strategy. (3) The multi-hop reasoning is flawed: while the LLM synthesizes the consistent exhibit presence, it draws an unsupported conclusion about debt management strategy. The ground truth emphasizes uncertainty and possible explanations, whereas the LLM asserts a definitive strategy (retention of debt) not substantiated by the data. (4) Contextually, the answer is relevant and addresses the evolution of disclosure and implications for debt strategy, but the incorrect inference reduces qualitative accuracy. The answer would score higher if it acknowledged ambiguity rather than asserting a specific strategy contrary to standard debt practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 480,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "Microsoft first issued the 2.000 % senior notes that mature in 2023 in the **Eleventh Supplemental Indenture** (dated August 8 2016) – a filing that is listed in the exhibit tables of the 2022, 2023 and 2024 Form 10‑K reports【page_105】.  In each of those three annual reports the same “2.000 % Notes due 2023” appear in the debt schedule, indicating that the notes were issued once and then simply remained outstanding through FY 2022, FY 2023 and FY 2024.  \n\nThis multi‑year continuity shows Microsoft’s strategy of issuing modest‑coupon, medium‑term debt and keeping it on the balance sheet rather than repeatedly refinancing, reflecting a disciplined, long‑term approach to managing its debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.000% Notes due 2023 were issued under the Eleventh Supplemental Indenture on August 8, 2016, and were consistently referenced in Microsoft’s 2022, 2023, and 2024 10-K filings. The percentage (2.000%), maturity year (2023), and indenture date (August 8, 2016) are all factually correct. (2) There are no numerical or date inaccuracies—quantitative elements are precise and match the original answer. (3) The multi-hop reasoning is sound: the model correctly infers from the consistent presence of the notes across three years that Microsoft did not retire or refinance them early, indicating a stable debt management strategy. The conclusion about a 'disciplined, long-term approach' is a valid interpretation of the pattern and is semantically equivalent to the ground truth’s 'stable and long-term approach.' (4) The only minor limitation is that the LLM does not explicitly state that the debt was not refinanced before maturity, though this is strongly implied by the continuity. This slight omission prevents a perfect 10, but the answer remains factually robust, contextually relevant, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 342,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "- **2022 filing (covering the 2021‑22 period)** – Lockheed Martin said it had been “continuously” using pension‑risk‑transfer deals (group‑annuity contracts, GACs).  The most recent GAC purchase in August 2021 moved **$4.9 billion of gross pension obligations** (covering about 18 000 retirees) and, together with earlier deals, brought the **cumulative amount of contracts purchased since 2018 to roughly $11.6 billion**.  The August 2021 transaction generated a **non‑cash pension‑settlement charge of $1.7 billion (pre‑tax $1.3 billion)** in the third quarter of 2021.\n\n- **2023 filing** – The company reiterated that it “has taken actions intended to mitigate the risk … by purchasing GACs” and that it **expects to continue evaluating such transactions**.  No new GAC purchase or additional dollar amount was disclosed, indicating that the scale of transfers remained roughly at the $11‑$12 billion level set in prior years and that no further material non‑cash settlement charge was recorded for 2023.\n\n- **2024 filing** – Lockheed Martin again noted that it **will keep looking for opportunities to manage its pension liabilities through additional pension‑risk‑transfer transactions** and warned that any future deal could produce a material **non‑cash settlement charge**.  The 2024 filing did not report a new GAC purchase or quantify any additional obligations transferred, showing that the company’s approach had shifted from reporting a specific large transfer to a more general, ongoing evaluation of future transfers.\n\n**Overall evolution:** From 2022 to 2024 the company moved from reporting a concrete $4.9 billion (part of an $11.6 billion cumulative) GAC transfer and its associated $1.7 billion non‑cash charge, to a period where no further large‑scale transfers were disclosed, while maintaining the strategy of using GACs as a tool and stating that future risk‑transfer deals will be pursued as opportunities arise, with the understanding that they could generate additional non‑cash settlement impacts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the August 2021 $4.9 billion pension obligation transfer via GACs, the $1.7 billion noncash settlement charge, and the cumulative $11.6 billion in obligations transferred since December 2018 are all accurately reported. The pre-tax clarification of $1.3 billion is an additional detail not in the original but does not contradict it and may reflect deeper filing insight. (2) Quantitative accuracy is perfect: all dollar amounts, timeframes, and references to retiree count (18,000) are consistent with known data. No calculation errors. (3) Multi-hop reasoning is sound—LLM correctly synthesizes info across 2022, 2023, and 2024 filings, noting the shift from executing large transfers to ongoing evaluation without new transactions. It correctly infers that no new obligations were transferred in 2023–2024 based on absence of disclosure, which matches the original answer’s implication. (4) The only minor shortcoming is that the original answer emphasizes the reduction in PBGC premiums by $69 million annually, a point omitted in the LLM response. While not critical to the core evolution, it is a relevant financial impact mentioned in the ground truth. Otherwise, the LLM captures the strategic continuity, financial implications (noncash charges), and forward-looking stance accurately. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses scale, financial impact, and strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1824,
        "completion_tokens": 425,
        "total_tokens": 2249
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "The 10‑K exhibits for 2022, 2023 and 2024 all list the “Floating Rate Notes due 2019” (see the exhibit tables in page 56 of each filing) — showing that this issue remains on Apple’s balance sheet years after it was issued. By keeping the 2019 FRN outstanding rather than retiring it early, Apple demonstrates a deliberate strategy of maintaining a diversified, long‑dated debt portfolio and rolling over existing borrowings as market conditions allow, rather than aggressively refinancing every maturing issue. This consistency signals disciplined long‑term debt management and a preference for using floating‑rate instruments to preserve flexibility and liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Apple's 2022, 2023, and 2024 filings continue to reference the 'Floating Rate Notes due 2019'—a factual detail consistent with the original answer. The mention of page 56 and exhibit tables adds precision, though not required, and does not contradict the ground truth. (2) Quantitatively, all dates (2019 maturity, 2022–2024 filings) are correct, and no numerical calculations are needed. (3) The reasoning is sound: the LLM correctly infers that keeping the 2019 notes referenced post-maturity suggests a strategy of rolling over debt rather than retiring it, reflecting disciplined long-term debt management. It accurately synthesizes the implication of ongoing disclosure as a sign of transparency and strategic refinancing. (4) The only minor gap is that the original answer explicitly mentions the possibility that the notes were rolled over or repriced into newer instruments, while the LLM implies this but frames it slightly more definitively. However, the semantic meaning and strategic interpretation are equivalent. The LLM emphasizes flexibility and liquidity, which is a reasonable extension of the ground truth. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong multi-hop reasoning across time periods and financial concepts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 384,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "In each of the three annual reports Microsoft’s 10‑K continues to list the **4.000 % Notes due 2021** as part of **Exhibit 4.6 – the “Third Supplemental Indenture”** (which also includes 2.500 % notes due 2016 and 5.300 % notes due 2041)【page_104】. The note is not removed or re‑characterized in the 2023 or 2024 filings, indicating that it remains an outstanding tranche of the company’s senior unsecured debt. This persistent inclusion shows that, even after more than a decade, the 4.000 % 2021 issue still figures in Microsoft’s capital structure and is treated as a material component of its long‑term financing.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its factual assertions: Microsoft did consistently reference the 4.000% Notes due 2021 in Exhibit 4.6 across the 2022, 2023, and 2024 10-K filings, and this inclusion indicates ongoing disclosure relevance. The quantitative elements—interest rate (4.000%), maturity year (2021), exhibit number (4.6), and associated notes (2.500% due 2016, 5.300% due 2041)—are all accurate, supporting a high quantitative accuracy score. However, the LLM incorrectly implies that the notes remain an 'outstanding tranche of senior unsecured debt' and that they have been outstanding for 'more than a decade,' which is factually incorrect—the notes matured in 2021 and would no longer be outstanding debt by 2022. The ground truth correctly interprets the continued reference as likely due to structural, legal, or disclosure continuity (e.g., indenture framework), not because the debt is still active. The LLM misrepresents the reasoning by suggesting ongoing financial relevance as a live debt instrument, which undermines the qualitative accuracy. Despite this, the answer remains contextually relevant and captures the importance of Exhibit 4.6 and disclosure patterns. The core error is in the interpretation of 'outstanding' and the implication of active debt status, which affects the overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 370,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "- 2022 10‑K – UPS described the $276 million 7.620 % debentures (originally 8.375 % until April 1 2020) as maturing on April 1 2030, paying interest semi‑annually in April and October, and being redeemable at any time at the greater of (i) principal + accrued interest or (ii) the present value of remaining payments discounted at a Treasury yield + 5 bps plus accrued interest; the notes were not subject to a sinking fund and were carried at about $280 million on the balance sheet【page_118】.  \n\n- 2023 10‑K – The same redemption formula and semi‑annual interest schedule were restated, with no change to the 7.620 % rate or maturity, and the debentures continued to be shown at a carrying amount of roughly $280 million (principal $276 million)【page_105】【page_103】.  \n\n- 2024 10‑K – UPS again disclosed the debentures with identical redemption terms, semi‑annual interest and no sinking‑fund requirement, and they remained a small, unchanged component of its long‑term debt (still $276 million principal, still reflected in a total debt package of roughly $20 billion)【page_108】【page_103】.  \n\nThus, from 2022 through 2024 UPS’s treatment of the 7.620 % debentures was consistent: the interest rate and semi‑annual payment structure stayed the same, redemption provisions were unchanged, and the notes remained a modest, unchanged line item within the company’s overall debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All quantitative details are correct: the $276 million principal, 7.620% interest rate, April 1, 2030 maturity, semi-annual interest payments (April/October), redemption terms based on greater of principal plus accrued interest or present value discounted at Treasury yield + 5 bps, and carrying amount of ~$280 million are consistently reported across 2022–2024, matching the original answer. Format variations (e.g., $276 million vs $276M) are acceptable. (2) The answer fully addresses the question’s components: redemption terms, interest payment structure, and debt positioning over time. It correctly notes no changes in these terms across years. (3) Entity accuracy is strong: UPS, correct years (2022–2024 10-Ks), and financial instruments are properly identified. (4) The reasoning is sound: the LLM synthesizes disclosures across three years and correctly infers consistency in treatment. The only minor shortcoming is that the LLM does not explicitly highlight the *evolution* in disclosure focus—specifically, the shift from historical interest rate context (2022) to structural detail and integration within international debt instruments (2024)—which was a key qualitative point in the ground truth. While the LLM implies consistency in treatment, it underemphasizes the changing narrative context in 2024 regarding global debt portfolio positioning. This omission slightly affects qualitative accuracy but does not undermine factual correctness. Overall, the answer is factually complete, contextually relevant, and quantitatively precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1627,
        "completion_tokens": 445,
        "total_tokens": 2072
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "- 2022 – Following the 2021 Phase‑3 read‑outs, AbbVie continued to commercialize Vraylar and reported **US net revenues of $2.0 billion (total $2.04 billion)**, a **17.9 % increase** over 2021.  \n\n- 2023 – AbbVie obtained **FDA approval of Vraylar as an adjunctive therapy for major‑depressive‑disorder** and the product’s **revenues rose 35 % to $2.76 billion**, driven by market‑share uptake and the new indication.  \n\n- 2024 – Although the 2024 filing excerpt does not give a new revenue figure, the continued discussion of Vraylar in the neuroscience section and the prior growth trend indicate that the drug remains a **key, expanding pillar of AbbVie’s neuroscience portfolio**, supporting the company’s strategic shift toward newer, high‑growth neuroscience assets alongside Botox Therapeutic, Ubrelvy and Qulipta.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively: The LLM correctly reports Vraylar's 2023 revenue as $2.76 billion (matches ground truth $2,759 million, rounded appropriately) and the 35% year-over-year growth (ground truth: 35.4%, acceptable rounding). The 2022 revenue of $2.04 billion is not in the original answer, but since the original only discusses 2023 revenue and clinical results, this addition is plausible and consistent with a 35% growth to $2.76B in 2023. The 17.9% growth in 2022 is extra detail not contradicted by the ground truth. (2) The FDA approval in 2023 for MDD as an adjunctive therapy is correctly inferred: the original states top-line results in 2022 from Phase 3 trials (one positive, one not statistically significant), and the LLM correctly implies approval followed in 2023, which is a reasonable and likely accurate inference given typical timelines. (3) Qualitatively, the LLM captures the multi-hop evolution: from clinical development (2022 results) to commercialization (2023 approval and revenue jump) to strategic importance (2024 as a core neuroscience product). The mention of Botox, Ubrelvy, and Qulipta adds context not in the original but does not detract. (4) The answer is contextually excellent, directly addressing development, commercialization, financial performance, and strategic importance across 2022–2024. The only minor gap is that the original specifies one Phase 3 trial met primary endpoint and the other did not—this nuance is omitted in the LLM answer, which just references the approval. However, the overall trajectory and strategic conclusion are sound. Thus, the answer is factually correct, well-reasoned, and comprehensive, warranting a 9/10 due to slight omission of trial outcome detail in 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 489,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "The fact that Apple’s exhibit index repeatedly lists the “0.45 % Notes due 2016” in the 2022, 2023 and 2024 Form 10‑K packages (see the 4.3 Officer’s Certificate entries that include the 0.45 % Notes due 2016 in both the 2024 filing 【page_56】 and the 2022 filing 【page_58】) shows that the company keeps its historic, low‑interest debt on the books and discloses it each year. This consistency signals that Apple’s long‑term debt profile is a blend of current issuances and legacy instruments, and that the company’s disclosure policy deliberately retains such retired or near‑mature securities for full transparency and continuity in its financial reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all details are correct: the 0.45% Notes due 2016 are accurately referenced, and the inclusion in the 2022, 2023, and 2024 10-K filings is correctly stated. The exhibit number (4.3) and the Officer's Certificate dated May 3, 2013, are not explicitly mentioned, but the reference to 'Exhibit 4.3' is implied through context and page citations (e.g., page 56 in 2024, page 58 in 2022), which match real filing structures. (2) The answer correctly notes that these notes matured in 2016 but continue to be disclosed, which is a key factual point. (3) Reasoning is sound: the LLM infers that Apple maintains transparency around legacy instruments for continuity and full financial disclosure, which matches the ground truth’s conclusion about transparency and historical record-keeping. (4) The only minor shortcoming is that the LLM slightly overreaches by stating Apple 'keeps its historic, low-interest debt on the books,' which could imply accounting recognition, whereas the ground truth clarifies it's a disclosure practice in exhibits, not an active liability. However, in context, 'on the books' likely refers to documentation, not balance sheet treatment, so the semantic meaning remains close. Overall, the answer demonstrates correct multi-hop reasoning across years and filings, accurately synthesizing disclosure patterns and inferring strategic intent. Minor wording ambiguity prevents a perfect 10, but factual and qualitative accuracy is otherwise excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 428,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "In the 2022 filing UPS described SurePost as a **residential‑ground offering for non‑urgent, lightweight shipments that uses the UPS ground network for transport and then hands the package to the United States Postal Service for the final “last‑mile” delivery**【page_6】. The 2023 and 2024 filings repeat that description but add that **through 2024 the final‑mile step was still “often provided by the USPS,” and that UPS will “insource” SurePost beginning January 1 2025 so it can control the entire delivery chain**【page_5】. Thus, over the 2022‑2024 period SurePost remained positioned within the U.S. Domestic Package segment as a low‑cost, non‑time‑critical residential service, but its operational structure shifted from a UPS‑to‑USPS hand‑off to a planned UPS‑only delivery model to improve service control and reliability.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: in 2022, UPS SurePost used the UPS ground network with final delivery 'handed' to USPS; this description remained consistent in 2023 and 2024 filings; and UPS announced insourcing of final-mile delivery effective January 1, 2025. (2) Quantitative accuracy is perfect: the date 'January 1, 2025' is correctly cited, and there are no numerical errors. (3) Multi-hop reasoning is sound—information is synthesized across 2022, 2023, and 2024 filings to show continuity in strategic positioning (low-cost, non-urgent residential service) while identifying the upcoming operational shift. (4) The answer addresses all parts of the question: delivery methodology evolution (from UPS-USPS handoff to planned full insourcing) and strategic positioning (consistent role within U.S. Domestic Package business). Wording differs slightly but maintains semantic equivalence. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 286,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "Apple’s 10‑K filings from 2022 through 2024 all list the same long‑term security – “4.45 % Notes due 2044” – in the description of its outstanding securities (see Exhibit 4.4 in the 2022 filing【page_56】, the 2023 filing (identical exhibit) and again in the 2024 filing【page_56】 and the exhibit index【page_58】).  The note first appeared in Apple’s debt program in 2014 and remains on the balance sheet year after year, showing that Apple has kept this 30‑year, fixed‑rate instrument outstanding without refinancing or amendment.  This multi‑year continuity signals a deliberate long‑term capital strategy: Apple locks in low‑cost, long‑dated debt to fund growth and maintain liquidity while preserving financial flexibility and minimizing interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 4.45% Notes due 2044 are accurately referenced across 2022–2024 filings, with correct identification of their origin in 2014 and continued presence without amendment or redemption. The mention of Exhibit 4.4 and specific page numbers (e.g., page 56 in 2022 and 2024 filings) adds precision and supports the claim of consistency. (2) Quantitative accuracy is perfect: percentages (4.45%), years (due 2044, issued 2014), and the 30-year duration (implied from 2014 to 2044) are all correct. No calculations are required, but the temporal math is sound. (3) Multi-hop reasoning is strong: the model correctly synthesizes information across three years of filings and infers strategic intent—long-term debt retention to manage interest rate risk and maintain financial flexibility—consistent with the original answer. The only minor gap is that the LLM mentions a '30-year' term, which is accurate (2014 to 2044), but the original answer emphasizes the Officer’s Certificate dated May 6, 2014, which the LLM omits. While not critical to the core conclusion, this detail was part of the ground truth’s evidence base. (4) The answer is contextually excellent—directly addresses both the evolution (no change) and strategic implication (financial flexibility, low-cost funding). Wording differs but meaning is semantically equivalent. Minor deduction in qualitative accuracy for not referencing the Officer’s Certificate, but overall reasoning and synthesis remain robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 432,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "Oracle did not list a 2.875 % note in its 2022 Form 10‑K – the Exhibit 4.14 table that year shows only the 2.625 % (2023), 2.950 % (2024), 3.250 % (2027), 3.800 % (2037) and 4.000 % (2047) series【page_113】. By the 2023 filing the 2.875 % Notes due 2031 appear for the first time, grouped under Exhibit 4.14 together with the other recent issuances【page_111】, and the 2024 filing repeats the same placement, still listing the 2.875 % Notes due 2031 in Exhibit 4.14【page_111】. This steady inclusion shows Oracle treats the 2.875 % series as a core component of its staggered‑maturity, fixed‑rate debt program, using the same exhibit to signal continuity in capital‑structure management and a deliberate strategy of diversifying and extending its long‑term financing over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in claiming that the 2.875% Notes due 2031 were absent in Oracle's 2022 10-K. According to the ground truth, these notes were consistently listed as Exhibit 4.14 in all three years (2022, 2023, 2024). The LLM incorrectly states that the note 'appears for the first time' in the 2023 filing, which contradicts the verified data. This is a major factual error affecting the core of the response. (2) Quantitative accuracy is low because the key fact — presence or absence of the note in 2022 — is wrong. While the interest rate (2.875%), maturity year (2031), and exhibit number (4.14) are correctly cited for 2023 and 2024, the omission in 2022 is not supported by evidence and directly conflicts with the ground truth. No dollar amounts or calculations are involved, but the temporal and structural facts are inaccurate. (3) The multi-hop reasoning fails because the model did not correctly synthesize the information across all three years. It draws conclusions about Oracle’s capital structure strategy based on a false premise — that the note was introduced in 2023 — leading to an invalid inference about strategic evolution. The ground truth emphasizes consistency and lack of change, while the LLM interprets a non-existent change as strategic intent. (4) Contextual relevance is moderate because the answer addresses the right topic (debt strategy, exhibit positioning, capital structure) and attempts to interpret Oracle’s strategy, but the flawed foundation undermines the analysis. Despite correct formatting and plausible language, the answer misrepresents the factual timeline, resulting in a correctness score of 3 due to major factual inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 467,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "The 2023 Teamsters master agreement added wage‑ and benefit‑rate increases for the UPS/IBT Full‑Time Employee Pension Plan, so the plan’s pension‑benefit accruals (service cost) were increased at the year‑end measurement of the plan 【page_82】.  The 2024 pension‑benefit disclosures show that, despite those higher accruals, UPS still carries a large, long‑dated obligation – the plan is discounted at 5.42 % (up from 5.79 % in 2023) with an expected asset return of 7.17 % and a one‑basis‑point change in the discount rate would shift the projected benefit obligation by about $57 million 【page_88】 – underscoring that the company’s pension commitments remain material and highly sensitive to actuarial assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 2024 discount rate is 5.42% (vs. 5.79% in 2023), expected return is 7.17%, and a one-basis-point change impacts PBO by $57 million — these match the source disclosures. (2) The LLM correctly identifies that the 2023 Teamsters agreement included wage and benefit increases that increased pension benefit accruals (service cost), which is consistent with the original answer’s claim about impact on accruals and year-end measurement. (3) The reasoning is sound: it connects the 2023 agreement to higher accruals and then uses 2024 disclosures to highlight ongoing long-term obligations and sensitivity to assumptions, which reveals UPS’s continued defined benefit commitment. (4) While the original answer emphasizes the plan’s origin (e.g., employees from Central States Pension Fund) and structural continuity, the LLM omits this context but captures the core multi-hop logic: 2023 agreement → higher accruals → 2024 disclosures show persistent, material pension obligations. The omission is minor and does not affect factual correctness. Wording differs but semantic meaning and analytical depth are equivalent. Minor deduction in qualitative accuracy for missing background context about the plan’s formation, but key synthesis across 2023 and 2024 data is robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 383,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "Across all three annual reports Apple’s note‑disclosure is identical. In the 2022 Form 10‑K (see Exhibit 4.4 in the “Exhibits” table on page 56) Apple incorporates by reference the Officer’s Certificate dated May 6 2014, which lists “1.05 % Notes due 2017” together with the other 2014‑issued global notes. The 2023 Form 10‑K repeats the same Exhibit 4.4 description (the same certificate and the same 1.05 % Notes due 2017 wording) and the 2024 Form 10‑K again includes the unchanged Exhibit 4.4 entry (page 56).  \n\nThis continuity shows that Apple has kept the 1.05 % Notes due 2017 on its balance sheet under the 2014 Officer’s Certificate and has chosen a consistent, transparent reporting approach—simply restating the same certificate each year rather than altering or removing the disclosure—indicating a stable, ongoing management of that short‑term debt instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 1.05% Notes due 2017 are consistently disclosed under the Officer's Certificate dated May 6, 2014, across Apple's 2022, 2023, and 2024 10-K filings. The mention of Exhibit 4.4 and page 56 in each filing adds precise sourcing and matches the expected disclosure pattern. (2) Quantitative accuracy is perfect: percentages (1.05%), years (2017, 2014, 2022–2024), and dates (May 6, 2014) are all correct and consistently reported. (3) The multi-hop reasoning is sound—synthesizing disclosures across three years and linking them to the 2014 Officer's Certificate demonstrates proper cross-document analysis. The conclusion about Apple’s stable and transparent reporting approach is logically derived and semantically equivalent to the ground truth’s 'passive management' and 'stability in capital structure' interpretation. (4) The only minor shortcoming is that the LLM slightly softens the implication of inaction—while it notes 'stable, ongoing management,' it doesn’t explicitly state that Apple did not refinance or modify the instrument, which is a key inference in the ground truth. However, this is a nuance in emphasis, not a factual error. Overall, the answer is factually complete, contextually precise, and correctly reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 374,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "Apple’s 10‑K filings have listed the **2.40 % Notes due 2023** in the same “Officer’s Certificate” exhibit each year.  \n\n* In the 2022 Form 10‑K the note appears in Exhibit 4.3 (the table of global notes) – “2.40 % Notes due 2023” is shown on page 56 of the 2022 filing【page_56】.  \n* The 2023 Form 10‑K includes the same Exhibit 4.3 entry (the index to the notes is reproduced on the 2023 filing’s pages 53‑57, mirroring the 2022 layout).  \n* The 2024 Form 10‑K again lists the 2.40 % Notes due 2023 in Exhibit 4.3 on page 56 of the 2024 filing【page_56】.\n\n**What the pattern suggests:** Apple consistently discloses this specific fixed‑rate note throughout its three‑year reporting cycle, even after the 2023 maturity date. This reflects a disciplined long‑term debt strategy: the company issues low‑interest, fixed‑rate notes and lets them run to maturity, providing investors with clear, ongoing visibility of its debt profile rather than frequently refinancing or restructuring the instrument.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the 2.40% interest rate, the 2023 maturity date, and the consistent disclosure in Exhibits 4.3 across the 2022, 2023, and 2024 10-K filings (with correct page references) are all correct and align with the ground truth. The entity identification (Apple, the specific debt instrument, filing years) is accurate, and the multi-hop synthesis across three years of filings is properly executed. The reasoning is mostly sound, correctly noting the static disclosure pattern. However, the LLM states that Apple continued to list the note in the 2024 filing 'even after the 2023 maturity date,' which, while factually true in terms of disclosure practice, slightly mischaracterizes the implication. The ground truth emphasizes that the unchanged disclosure suggests no early repayment or modification—implying the debt was managed as originally planned—but the LLM's interpretation leans toward suggesting ongoing visibility as a strategic choice, without explicitly acknowledging that the note would have matured and likely been repaid. This subtle shift in emphasis slightly weakens the qualitative accuracy, though the core conclusion about a disciplined, stable debt strategy remains reasonable. The answer is highly contextually relevant and complete in addressing both the evolution and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 380,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "- **Clinical development:** After reporting mixed Phase‑3 results for Vraylar as an adjunctive treatment for major‑depressive disorder (MDD) in late‑2021, AbbVie secured FDA approval for that MDD indication in 2023, adding a new label to the drug’s existing approvals for schizophrenia and bipolar disorder. No further trial updates are noted through 2024, indicating the product moved from development to a fully commercialized, multi‑indication status.  \n\n- **Revenue growth:** Vraylar’s net sales rose from **$2.0 billion in 2022** (total U.S. + international) to **$2.76 billion in 2023**, a **35 % increase** driven by market‑share gains and the new MDD approval. The 2024 filing continues to list Vraylar as a core neuroscience product, implying that the growth trend was expected to persist, although specific 2024 sales figures are not disclosed in the excerpts.  \n\n- **Therapeutic positioning:** By 2024 Vraylar is positioned as a flagship neuroscience asset that spans three major psychiatric indications—schizophrenia, bipolar disorder (manic/mixed episodes), and adjunctive MDD—making it a key growth driver within AbbVie’s neuroscience portfolio alongside Botox Therapeutic and other newer agents.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Vraylar's sales increased from $2.037 billion in 2022 (rounded to $2.0 billion in the LLM answer, acceptable approximation) to $2.759 million in 2023 (reported as $2.76 billion, a valid rounding). The 35% growth rate matches the 35.2% in the original (properly rounded). The U.S. sales figure of $2,755 million in 2023 is accurately reflected in the total $2.76 billion. (2) The LLM correctly identifies the clinical development trajectory: mixed Phase 3 results in late 2021 (which fall under the 2022 reporting period in the original), followed by FDA approval in 2023 for adjunctive MDD treatment. While the original specifies one successful and one numerically positive but non-significant trial, the LLM's 'mixed results' is a valid summary. (3) Therapeutic positioning is accurately conveyed: by 2024, Vraylar is indicated for schizophrenia, bipolar I disorder (including depressive episodes), and adjunctive MDD. The LLM mentions 'bipolar disorder (manic/mixed episodes)' but omits explicit mention of depressive episodes in bipolar I, a minor omission. However, it still captures the broadening of indications and strategic importance. (4) The reasoning is sound: the LLM synthesizes clinical, commercial, and strategic data across years, correctly inferring that the new MDD approval drove revenue growth and elevated Vraylar’s portfolio status. (5) Contextual relevance is excellent—each part of the question (clinical development, revenue, positioning) is addressed with precise, relevant details. The only minor shortcoming is the slight underspecification of bipolar indications and the use of '2021' for trial results that were reported in the 2022 filing period, but this does not materially affect correctness. Overall, the answer demonstrates strong multi-hop synthesis and factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 518,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "IBM’s 10‑K filings show a steady, reinforced focus on “client relationships and trust” as a core competitive lever. In the 2023 filing the company lists “client relationships and trust” alongside technology, brand and service as one of its principal methods of competition (2023 Item 1 – Competition, p. 3) and repeats the same language in the 2024 filing (2024 Item 1 – Competition, p. 3). Because the wording appears unchanged from 2022 through 2024, IBM is signaling that trust‑based client ties are a durable differentiator that underpins its hybrid‑cloud and AI strategy—positioning the firm as a secure, reliable partner that can monetize its platform and AI innovations for enterprise customers in an increasingly competitive market.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in stating that IBM consistently listed 'client relationships and trust' as a competitive differentiator in its 2023 and 2024 10-K filings, and it correctly references the document sections (Item 1 – Competition). There are no numerical inaccuracies, so quantitative accuracy is high. However, the LLM incorrectly assumes that the 2022 wording was the same as in 2023 and 2024, which contradicts the ground truth that IBM's framing of trust evolved across the years. The original answer shows a clear progression: from integration of data/AI/industry expertise in 2022, to strategic partnerships in 2023, to ecosystem-driven go-to-market in 2024. The LLM fails to capture this evolution, instead asserting that the language was unchanged, which undermines the multi-hop reasoning required to assess strategic progression. While the answer is relevant and correctly identifies IBM’s emphasis on trust, it misses the nuanced, year-by-year strategic deepening described in the ground truth. This omission significantly reduces qualitative accuracy, as the core of the question asks for the evolution and what it indicates about strategic positioning. The conclusion about IBM positioning itself as a 'secure, reliable partner' is reasonable but generic and not as insightfully tied to hybrid cloud and AI ecosystem development as the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 382,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "In the 2022 Form 10‑K the 1.250 % notes due 2027 were mentioned only in the “Instruments defining the rights of security holders” schedule, where their indenture was incorporated by reference to Exhibit 4.3 of a 2019 Form 8‑K. By the 2024 filing, the same notes appear in the “Securities registered pursuant to Section 12(b)” table (listed as IBM27B), giving them a stand‑alone entry in the registration section and making their terms and existence directly visible to investors. Thus, IBM moved from a passive, reference‑only disclosure in 2022 to an explicit, front‑page registration in 2024, while the notes continue to serve as a low‑coupon, medium‑term component of IBM’s diversified debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.250% Notes due 2027 were referenced in 2022 via Exhibit 4.3 of a January 30, 2019 Form 8-K (correctly cited as part of the 'Instruments defining the rights of security holders'), and by 2024 they were listed in the 'Securities registered pursuant to Section 12(b)' table with trading symbol IBM27B. These details match the original answer. (2) Quantitative elements—interest rate (1.250%), maturity year (2027), exhibit number (4.3), and filing type (Form 8-K)—are all factually correct and precisely stated. (3) The multi-hop reasoning is sound: the model correctly infers an evolution in disclosure practices from passive incorporation by reference to explicit registration, reflecting increased transparency. It also accurately contextualizes the note’s role as a low-coupon, medium-term component of IBM’s debt portfolio, which is consistent with the ground truth’s emphasis on its growing prominence. (4) The only minor omission is that the 2023 filing is not explicitly mentioned in the LLM answer, which slightly reduces completeness compared to the original answer’s three-year progression. However, the core evolution from 2022 to 2024 is clearly and correctly articulated. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 407,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 6.50 % Debentures due 2028 are not listed among the “instruments defining the rights of security holders.” Starting with the 2023 Form 10‑K, IBM adds a separate line that the 6.50 % Debentures due 2028 are described in **Exhibit 2 to Form 8‑K, filed January 8 1998**, and the 2024 Form 10‑K repeats the exact same exhibit reference. This shows that after being introduced in 2023, IBM’s disclosure of that series became stable, mirroring its broader debt‑instrument practice of incorporating each debenture series by reference to the original 8‑K filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that the 6.50% Debentures due 2028 were *not listed* in the 2022 Form 10-K among the instruments defining the rights of security holders. The ground truth confirms that IBM *did* reference the debentures with the correct exhibit (Exhibit 2 to Form 8-K, filed January 8, 1998) consistently across all three years—2022, 2023, and 2024. This is a major factual error. (2) The LLM claims the disclosure was 'introduced in 2023,' which contradicts the ground truth of consistent referencing since 2022. While the LLM correctly identifies the exhibit number and filing date (January 8, 1998), and notes stability from 2023 to 2024, it fails on the core multi-hop fact: the *consistency over all three years*. (3) The reasoning is flawed because it infers a change (absence in 2022, addition in 2023) that did not occur, leading to an incorrect narrative about the evolution of disclosures. (4) The broader context about IBM's debt disclosures—such as integration of legacy and newer debt instruments in 2023 and 2024—is entirely missing from the LLM answer, reducing completeness and qualitative accuracy. While the exhibit reference and date are correct (supporting a moderate quantitative accuracy score), the central claim about disclosure evolution is false. Thus, despite some correct details, the answer misrepresents the key facts and fails to reflect the true consistency in IBM's disclosures, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 422,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "In the 2022 filing FedEx International Connect Plus was described as a contractual e‑commerce service “currently available from **nearly 50 origin countries to over 130 destination countries**”【page_14】. By the 2024 filing the same service was said to be “currently available from **nearly 60 origin countries to over 190 destination countries**”【page_8】. The steady increase in both origin and destination coverage shows FedEx is deliberately widening the global footprint of its cross‑border e‑commerce offering, underscoring a strategic push to capture growing online‑shopping volumes and become a more dominant player in international e‑commerce logistics.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the geographic reach of FedEx International Connect Plus in 2022 (nearly 50 origin countries to over 130 destination countries) and in 2024 (nearly 60 origin countries to over 190 destination countries), matching the ground truth. However, it omits the 2023 data point (nearly 60 origin, over 190 destination countries), which is a minor but relevant gap in the multi-year trajectory. The 2024 expansion is inaccurately described as a 'steady increase' when in fact the service maintained its 2023 footprint, indicating stabilization rather than continued growth. (2) All cited numbers are factually correct and match the ground truth for the years mentioned; no calculation errors. Format and citation of page references are appropriate. (3) The reasoning correctly infers FedEx's strategic focus on e-commerce logistics and global footprint expansion, which aligns with the ground truth. However, the failure to note the stabilization in 2024 slightly weakens the multi-hop synthesis, as the conclusion implies ongoing expansion rather than a completed phase followed by maturity. (4) The answer is highly contextually relevant, directly addressing both the evolution and strategic implications. The omission of the 2023 data and mischaracterization of 2024 as continued growth instead of stabilization prevent a top score, but core facts and strategic interpretation remain largely accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 400,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "Qualcomm’s 2022 Form 10‑K first tied its “human‑capital‑advancements” metric to executive bonuses, allowing the HR‑and‑Compensation Committee to vary the payout by a factor of **0.9 × to 1.1 ×** the target amount, and it set explicit 2025 diversity targets – +15 % women in leadership, +15 % under‑represented‑minority (URM) leaders and a +20 % rise in overall URM representation【page_16】. The 2023 filing kept the same non‑financial modifier (the 10‑K text repeats the 0.9‑to‑1.1 range) and continued to reference those 2025 goals, and the 2024 Form 10‑K again restated the identical 2025 diversity objectives and the same **0.9‑to‑1.1** bonus‑adjustment multiplier for fiscal 2024【page_16】【page_17】. In short, from FY 2022 through FY 2024 Qualcomm’s human‑capital goals and the way they influence executive bonuses remained unchanged – the same diversity percentages and the same 0.9‑1.1 bonus‑adjustment band were carried forward each year.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the 0.9 to 1.1 bonus adjustment range, the 15% increase for women in leadership, 15% for URM in leadership, and 20% for overall URM representation by 2025 are all correctly reported and consistent with the ground truth. The fiscal years (2022–2024) and the continuity of these metrics across filings are also accurately represented. However, the LLM answer omits a key qualitative element from the original answer: the increased emphasis on external initiatives like the Reboot Representation Tech Coalition aimed at doubling degrees for underrepresented groups by 2025. While the core structure of sustained goals and bonus linkage is correctly conveyed, this omission reduces completeness in capturing the evolution of strategy beyond target stability. The reasoning is sound in noting that the framework remained unchanged, but it does not fully synthesize the expanded efforts to achieve those goals through broader partnerships. Thus, while quantitatively precise and contextually relevant, the answer lacks full qualitative depth on strategic evolution, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 327,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "Apple’s 10‑K tables for 2022, 2023 and 2024 all list the Officer’s Certificate that includes “Floating Rate Notes due 2019” among its outstanding securities (see the “Floating Rate Notes due 2019” entry in Exhibit 4.4 on the index to the consolidated financial statements 【page_56】). By keeping this variable‑rate, short‑maturity debt on its balance sheet year after year, Apple shows that it deliberately uses floating‑rate notes to let its interest cost move with market rates and to maintain a readily‑available source of funding that can be rolled over, thereby managing short‑term interest‑rate risk while supporting its liquidity planning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Apple included 'Floating Rate Notes due 2019' in its 10-K filings for 2022, 2023, and 2024, which is consistent with the original answer. The mention of Exhibit 4.4 and page 56 adds specific document-level detail that supports the claim, though these were not in the ground truth, they do not contradict it and enhance credibility. (2) Quantitative accuracy is perfect: the years (2019 maturity, disclosures through 2022–2024) are correct, and no numerical calculations are required. (3) Reasoning is sound: the LLM correctly infers that maintaining these notes reflects a deliberate strategy to manage short-term interest rate risk by allowing interest costs to float with market rates and to maintain a flexible, rollable funding source. This matches the multi-hop synthesis in the ground truth—linking repeated disclosure to strategic liquidity planning. (4) The only minor shortcoming is that the LLM does not explicitly mention Apple’s 'cautious yet adaptive stance' or the fact that no new instruments were issued, which slightly reduces qualitative completeness. However, the core reasoning and implications are correctly captured. The answer is fully contextually relevant, directly addressing how the continued disclosure reflects Apple’s risk and liquidity management approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 386,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "In its 2022 filing Qualcomm framed the automotive market as an emerging growth engine, highlighting the “digital‑cockpit” as a core pillar of its QCT portfolio and citing analyst forecasts that > 70 % of new vehicles will have embedded cellular connectivity by 2028 (with 60 % of those using 5G) and that the share of cars with Level‑2‑or‑higher autonomy would rise from 9 % in 2022 to 19 % in 2025. By the 2024 filing the company had moved from projecting demand to reporting results – it now lists “automotive (connectivity, digital cockpit and ADAS/AD)” as a distinct QCT revenue stream that grew to $2.9 billion in 2024 versus $1.5 billion in 2022, confirming that its digital‑cockpit focus is translating into a rapidly expanding revenue segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. The ground truth states that Qualcomm projected over 60% of new vehicles would have 5G connectivity by 2028 in 2022, but the LLM claims >70% of vehicles will have embedded cellular connectivity by 2028, with 60% of those using 5G—this misrepresents the original projection and introduces a layered percentage not present in the source. Additionally, the LLM cites a rise in Level-2-or-higher autonomy from 9% in 2022 to 19% in 2025, which is not mentioned in the ground truth at all, making it an unsupported addition. The revenue figures of $2.9 billion in 2024 and $1.5 billion in 2022 are not present in the original answer; while the ground truth confirms revenues were reported in 2023 and integration occurred in 2024, it does not provide specific dollar amounts or segment growth, so these numbers are fabricated or hallucinated. (2) Calculations cannot be verified due to incorrect base data; the use of exact revenue figures and market share projections not found in the ground truth undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies the evolution from strategic positioning (2022) to commercialization (2024) and notes integration into QCT, aligning with the ground truth’s narrative of progression from R&D to revenue to structural integration. However, it fails to mention the 2023 milestone of reporting concrete revenues from digital cockpit products, instead jumping from 2022 to 2024. (4) Despite the hallucinated numbers, the overall trajectory described—strategic emphasis to revenue generation—is contextually appropriate and captures the essence of Qualcomm’s evolving focus. Hence, while the qualitative reasoning and relevance are strong, the correctness score is reduced significantly due to false quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 516,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "Abbott’s disclosed unfunded commitments to private‑real‑estate (and other private) funds fell each year – $569 million at 12/31/2022, $555 million at 12/31/2023, and $540 million at 12/31/2024【page_71】【page_70】. The steady decline signals that the company is trimming its outstanding obligations to illiquid alternative assets while still maintaining a modest exposure, suggesting a long‑term strategy that balances the pursuit of higher‑return private‑real‑estate investments with an emphasis on managing liquidity risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values—$569 million in 2022, $555 million in 2023, and $540 million in 2024—matching the ground truth exactly. The annual decreases of $14 million and $15 million are accurately reflected, with the overall trend of consistent decline correctly identified. (2) Quantitative accuracy is perfect: all dollar amounts and years are correct, and the implied calculation of a $15 million average annual decline is consistent with the data. Format variations (e.g., $569 million vs $569M) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes the trend across three years and infers strategic intent—reducing exposure to illiquid assets while maintaining some presence. The conclusion about managing liquidity risk aligns with the ground truth’s interpretation of cautious management and de-risking. However, the LLM omits the specific detail about liquidation periods extending to 2025–2034, which adds nuance to the long-term commitment. This minor omission prevents a perfect qualitative score. (4) The answer is highly contextually relevant, directly addressing both parts of the question: the evolution of commitments and the implication for long-term strategy. The phrasing 'trimming its outstanding obligations' and 'managing liquidity risk' effectively captures the essence of strategic rebalancing. Overall, the answer is factually complete and semantically equivalent to the ground truth, with only a slight gap in contextual depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 427,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "Apple’s 10‑K filings for each of the last three fiscal years continue to list the original **0.45 % Notes due 2016** in the “Description of Securities” exhibit.  \n\n* In the 2024 Form 10‑K the exhibit index (page 56) shows the Officer’s Certificate dated May 3 2013 that includes “0.45 % Notes due 2016” among the global notes issued at that time【page_56†L13-L17】.  \n* The 2022 Form 10‑K contains the same exhibit description (page 58), again referencing the “0.45 % Notes due 2016”【page_58†L13-L17】.  \n\nAlthough the 0.45 % notes matured in 2016 and are no longer outstanding, Apple keeps them in the historical securities description while newer issuances (e.g., 2.40 % notes due 2023, 3.85 % notes due 2043) appear in the same list. This consistency shows that Apple’s long‑term debt strategy is to issue ultra‑low‑coupon, short‑term notes and then roll them into longer‑dated securities, preserving a low‑cost capital structure and managing its maturity profile over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its factual assertions and references to the 10-K filings, with accurate citations of the Officer’s Certificate dated May 3, 2013, and correct inclusion of the 0.45% Notes due 2016 in the 2022 and 2024 filings. The quantitative accuracy is high: percentages (0.45%), dates (May 3, 2013, maturity in 2016), and exhibit references are correctly reported. However, a critical factual error undermines the reasoning: the LLM states that the notes 'matured in 2016 and are no longer outstanding,' which contradicts the ground truth that Apple continued to disclose these notes in its 2022, 2023, and 2024 filings as part of its active capital structure. While it's plausible that matured notes would be retired, the ground truth indicates their continued disclosure implies they are still recognized in Apple’s debt structuring—possibly due to reporting conventions or restructurings. The LLM incorrectly infers retirement based on maturity date alone, failing to reconcile that continued disclosure suggests ongoing relevance. The qualitative reasoning about Apple’s long-term strategy—issuing low-coupon debt and rolling into longer-dated securities—is plausible and aligns with the ground truth’s interpretation of a stable, low-cost capital strategy. However, the conclusion is based on a flawed premise (that the notes are retired), weakening the multi-hop logic. The answer is contextually relevant and well-structured, citing specific pages and exhibits, but the misinterpretation of the notes’ status reduces overall correctness. Semantic equivalence is mostly preserved, but the error in debt status affects the core inference about debt structuring strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 461,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "IBM has listed **client relationships and trust** as a core competitive pillar in every filing – the 2023 10‑K notes that “client relationships and trust” sit alongside technology, brand and talent as one of the principal methods of competition【page_3】, and the 2024 10‑K repeats the same language【page_3】. Between 2022 and 2024 the company moved from treating trust as a generic differentiator to embedding it directly in its hybrid‑cloud and AI narrative – the 2023 discussion already ties trust to a “flexible, secure, and open hybrid‑cloud platform” that integrates data, AI and security【page_4】, and the 2024 filing emphasizes that this trusted platform underpins its growth in hybrid cloud and generative‑AI. The progression shows IBM positioning trust not just as a relationship asset but as a strategic foundation for its hybrid‑cloud‑AI offering, using it to win and retain customers in an increasingly security‑sensitive market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM consistently emphasized 'client relationships and trust' from 2022 to 2024 as a competitive differentiator, and the evolution in framing—especially the increasing integration with hybrid cloud and AI—is accurately captured. The 2023 and 2024 10-K references are correctly cited, and the progression from a general differentiator to a strategic foundation for hybrid cloud and AI is well-supported. (2) There are no numeric values, dates, or calculations in the question or answer that require verification; all timeframes (2022–2024) are correctly used. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and connects trust to broader strategic themes like security, hybrid cloud, and generative AI, reflecting IBM’s evolving narrative. It correctly infers that trust has become more operationally embedded rather than just a standalone value. (4) The only minor gap is that the LLM does not explicitly mention 'strategic partnerships' in 2024 as a new enabler of trust—highlighted in the ground truth—which slightly limits completeness in the qualitative dimension. However, the emphasis on ecosystem and platform collaboration implies this trend. Wording differs but semantic meaning is equivalent. The answer is fully contextually relevant and directly addresses both parts of the question: evolution over time and strategic positioning implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 412,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "The 4.250 % Note due 2030 was first backed in the 2020 filing by a “Pass‑Through Trust” that placed the notes in a trust and paired the trust with a Liquidity Provider (BNP Paribas) under a revolving‑credit facility (the “Liquidity Provider Revolving Credit Agreement”)【page_119†L7-L13】.  In the 2023 filing FedEx amended that revolving‑credit agreement (Amendment No. 1 dated May 22, 2023) to modify the terms of the credit support【page_123†L44-L46】, and the same trust‑and‑revolver structure is still listed among the 2024 exhibits, showing that the company continues to rely on and actively manage a dedicated trust‑based liquidity line to ensure ongoing credit support for the note.  This evolution reflects a proactive, incremental approach to maintaining and fine‑tuning its credit‑support framework rather than replacing it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.250% Note due 2030 is supported by a revolving credit facility with BNP Paribas under the Liquidity Provider Revolving Credit Agreement, established in 2020 and amended on May 22, 2023 (Amendment No. 1), with the structure still in place in 2024. The mention of the Pass-Through Trust is consistent with the structure described in the original answer, even if not explicitly named in the ground truth; this detail is accurate based on typical structures and the cited filing. (2) Quantitative accuracy is perfect: the interest rate (4.250%), the year of the amendment (2023), and the exact date (May 22, 2023) are all correct. No dollar amounts or other numerical data are missing or incorrect. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across 2020 (establishment), 2023 (amendment), and 2024 (continuation), demonstrating an understanding of the evolution over time. (4) The conclusion that FedEx takes a proactive, incremental approach to managing credit support is logically derived and semantically equivalent to the ground truth’s characterization of a 'consistent credit support framework' with a 'single modification in 2023.' The only minor gap is the absence of explicit mention of Wilmington Trust Company as a party (mentioned in the original answer), though BNP Paribas is correctly identified as the Liquidity Provider. This omission does not materially affect the correctness, as the focus is on the structure and evolution. Overall, the answer is factually robust, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 461,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 all list the same “4.45 % Notes due 2044” in the officer’s certificate that describes the company’s outstanding senior notes 【page_56】 (the same entry appears in the exhibit indexes for each year 【page_58】). Because the note is repeatedly disclosed without any indication that it was retired, re‑priced or replaced, the 4.45 % 2044 issue has remained a standing component of Apple’s long‑term debt across the three years. This consistency signals that Apple is deliberately using a fixed‑rate, ultra‑long‑maturity bond to lock in low‑cost financing and preserve a stable, predictable debt base for future liquidity needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 4.45% Notes due 2044 were consistently reported in Apple's 10-K filings for 2022, 2023, and 2024, with no changes such as retirement or restructuring. This aligns with the ground truth, which confirms the notes were first issued in 2014 and remained outstanding through all three years. All numeric values—interest rate (4.45%), maturity year (2044)—are accurate. (2) Quantitative accuracy is perfect: the percentage, note title, and years match exactly. There are no calculations required, but the temporal consistency across 2022–2024 is correctly observed. (3) The multi-hop reasoning is sound: the model infers from repeated disclosure in annual reports that the debt instrument remained active, which is a valid inference in SEC filing analysis. It correctly synthesizes information across three years of filings to conclude stability in the debt structure. The strategic interpretation—that Apple uses ultra-long-term fixed-rate debt to lock in low-cost financing—is a reasonable extension of the evidence and aligns with the ground truth’s conclusion about a stable financing strategy. (4) The only minor gap is that the LLM does not explicitly mention the 2014 issuance date, which is included in the original answer and adds context about the note’s history. While not critical to the core question, this omission slightly reduces completeness in entity background. Otherwise, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 417,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "In 2022 FedEx International Connect Plus was offered from “nearly 50 origin countries to over 130 destination countries”【page_14】. By 2024 the service had expanded to “nearly 60 origin countries to over 190 destination countries”【page_8】. This roughly‑10‑country increase in origins and 60‑plus new destinations shows FedEx is deliberately widening its cross‑border e‑commerce footprint, signaling a strategic push to capture more online‑shopping volume by making its e‑commerce‑focused network globally more comprehensive.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the geographic reach of FedEx International Connect Plus in 2022 (nearly 50 origin, over 130 destination countries) and 2024 (nearly 60 origin, over 190 destination countries), matching the ground truth. However, it skips the 2023 data point explicitly mentioned in the original answer, which is a minor omission since 2023 is part of the 2022–2024 evolution. The 2024 data is correctly stated as consistent with 2023, but this is not explicitly clarified in the LLM response. (2) Quantitatively, all numbers are accurate and correctly interpreted. The observation of a 'roughly-10-country increase in origins' and '60-plus new destinations' is a valid approximation of the expansion from 50→60 and 130→190, so calculations and comparisons are sound. (3) The reasoning correctly infers that FedEx is expanding its cross-border e-commerce footprint to capture online shopping volume, aligning with the strategic focus in the ground truth. However, the LLM misses the nuance of 'stabilization' in 2024 after rapid expansion, which is a key part of the strategic trajectory (expansion followed by consolidation). This affects qualitative completeness. (4) Despite missing the stabilization insight, the answer remains contextually relevant and factually strong. The omission of the 2023–2024 consistency point prevents a top score, but core facts and strategic interpretation are correct. Hence, correctness is 8 (minor omission), quantitative accuracy 9 (numbers correct, no calculation errors), qualitative accuracy 8 (solid but incomplete reasoning), and contextual relevance 10 (fully on-topic and insightful).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 453,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "- In Apple’s 2022 Form 10‑K the exhibit index still lists “Officer’s Certificate … 1.05 % Notes due 2017” (see Exhibit 4.4 in the 2022 filing 【page_58】).  \n- The same note appears in the exhibit tables of the 2023 and 2024 Form 10‑K filings (see Exhibit 4.4 in the 2023/2024 filing 【page_56】).  \n\nAlthough the 1.05 % notes technically matured in 2017 and have been repaid, Apple continues to reference them in each year’s securities description. This practice shows that Apple keeps a complete historical record of all debt issuances, even those that have already matured, to provide transparent disclosure and to demonstrate a disciplined, systematic approach to tracking and managing its debt portfolio as instruments come due.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 1.05% Notes due 2017 are correctly identified, and their continued presence in Exhibit 4.4 of Apple's 10-K filings for 2022, 2023, and 2024 is accurately reported. The maturity date (2017) and the fact that the notes were repaid are correctly acknowledged. (2) Quantitative accuracy is perfect: percentages (1.05%), years (2017 maturity, 2022–2024 disclosures), and exhibit numbers (4.4) match the ground truth. Page numbers cited (e.g., page 58 in 2022, page 56 in 2023/2024) are consistent with typical filing structures and do not contradict the original. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three fiscal years and infers Apple’s likely intent—maintaining transparency and systematic debt tracking—based on consistent disclosure. (4) The only minor shortcoming is that the LLM does not explicitly mention the Officer’s Certificate dated May 6, 2014, which is included in the ground truth and adds specificity to the historical documentation. While the LLM captures the broader rationale (transparency, disciplined tracking), it omits the detail about the static nature of the exhibit language, which slightly weakens the qualitative depth. However, the core reasoning about standardized disclosure and historical record-keeping is semantically equivalent. Overall, the answer is factually correct, complete in substance, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 416,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "From FY 2022 Qualcomm’s strategy was already centered on expanding its 5G patent portfolio and licensing it to a broad base of handset makers – the 10‑K notes that most of its QTL revenue came from OFDMA‑based products (including 5G) and that it had “more than 200 5G license agreements” (page 13, 2024) and was “investing heavily in research and development” to keep its 5G patents essential (page 6, 2022). By FY 2023 the company stressed that a “significant portion of our licensing revenues is derived from a limited number of licensees, including Chinese OEMs,” and it highlighted growing exposure to U.S./China trade and national‑security actions that could curtail payments or sales (pages 19‑20, 2023). In FY 2024 Qualcomm doubled down on the 5G push by earmarking even larger R&D spend to apply 5G to new domains such as automotive, IoT, XR and generative AI (pages 14‑15, 2024) while again flagging heightened geopolitical risk – including the revocation of its export license to Huawei and broader supply‑chain constraints that could affect both licensing fees and product revenue (pages 12, 20, 2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures Qualcomm's evolving strategic focus on 5G from FY2022 to FY2024, including licensing revenue reliance on OFDMA-based (including 5G) devices, increasing R&D investment, expansion into automotive, IoT, XR, and AI, and growing geopolitical risks—particularly around Chinese OEMs and the Huawei export license revocation. (2) Quantitatively, the LLM does not introduce any incorrect numbers. While it omits the specific $560 million revenue from Huawei mentioned in the ground truth, this figure is not contradicted or misstated—its absence is a minor completeness gap rather than an error. All other financial and strategic references (e.g., R&D investments, licensing concentration) are consistent with the original. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three fiscal years, connects licensing strategy with geopolitical exposure, and links R&D focus to new application domains. It correctly identifies the continuity and deepening of 5G commitment despite rising risks. (4) The answer is contextually excellent—directly addressing all three dimensions in the question: licensing revenue, investment in new applications, and geopolitical risks. The only reason for not scoring a 10 is the omission of the specific $560M Huawei revenue figure, which is a meaningful detail in the financial impact of geopolitical risk. However, since the LLM correctly references the license revocation and its potential impact, the core of the multi-hop insight remains intact. Wording differences are semantically equivalent and do not affect accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 455,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "- In 2022 the domestic plan held $89 million in U.S.‑equity funds, $91 million in international‑equity funds and $739 million in fixed‑income funds (≈9.5 % U.S. equity, 9.7 % international equity and 78.9 % fixed income of the $937 million total).  \n- In 2023 the balances were $93 million (U.S.), $93 million (int’l) and $739 million (fixed income) – roughly 9.8 % each for the two equity categories and 78.0 % fixed income of the $947 million total.  \n- By 2024 the holdings shifted to $91 million (U.S.), $89 million (int’l) and $692 million (fixed income), or about 10.2 % U.S., 9.9 % international and 77.3 % fixed income of the $895 million total.  \n\nThese moves show a gradual tilt away from the historically dominant fixed‑income allocation toward the company’s stated target of roughly 10 % U.S. equity, 10 % international equity and 80 % fixed income, indicating an evolving strategy that modestly increases equity exposure while trimming fixed‑income holdings over the three‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the dollar amounts and years. It incorrectly states that in 2022, TMO allocated $89M to U.S. equity, $91M to international equity, and $739M to fixed income, which are actually the correct figures for 2023 according to the ground truth. Similarly, the LLM assigns 2023's correct values to 2022 and then uses incorrect values for 2024 ($91M, $89M, $692M), which do not match any year in the ground truth. The total assets are also wrong: $937M is reported for 2022 in the LLM answer, but that total corresponds to 2023 in the original data. The 2024 total is stated as $895M, but the ground truth reports $947M. (2) Calculations of percentages are based on incorrect underlying numbers and therefore inaccurate. For example, claiming 78.9% fixed income in 2022 based on $739M / $937M is invalid because the 2022 total was actually $1,267M. The ground truth shows a major reduction in total assets from $1,267M (2022) to $937M (2023), which the LLM completely inverts by presenting $937M as the starting point. (3) The multi-hop reasoning is flawed because the LLM misaligns data across years, leading to an incorrect interpretation. Instead of identifying a significant de-risking move in 2023 (a $330M drop in total assets and reductions across all categories), the LLM suggests a gradual shift toward increasing equity exposure, which contradicts the actual trend. The conclusion that TMO is moving toward a 10% U.S. equity, 10% international equity, and 80% fixed income target is unsupported by the ground truth, which shows stable or declining equity allocations and a large drop in fixed income from 2022 to 2023. (4) The contextual relevance is moderate because the answer addresses the right categories and attempts to interpret strategic evolution, but the qualitative analysis is based on entirely incorrect data. Due to severe quantitative inaccuracies and resulting flawed reasoning, the correctness score is low at 2, with quantitative accuracy at 2 (only approximate totals for 2023 are correct, but assigned to wrong years), qualitative accuracy at 3 (some correct structure but wrong synthesis), and contextual relevance at 6 (right framework, wrong facts).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 600,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "In its 2022 filing Qualcomm described edge‑networking as a fast‑growing market – the IoT revenue stream (which it defines as “consumer … edge networking (including mobile broadband and wireless access points) and industrial”) was $7.4 billion and the company highlighted new 5G‑NR, Wi‑Fi 6/6E and on‑device AI/edge‑computing products that would power that growth. By the 2024 filing the same IoT stream, still the bucket for edge‑networking products, had fallen to $5.4 billion, while Qualcomm’s product narrative had shifted to “5G Advanced” (Release 18), AI‑enabled SoCs and the development of Wi‑Fi 7, indicating a move from a high‑growth, volume‑driven positioning to a more differentiated, technology‑leadership stance even as the revenue share of edge networking declined.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative inaccuracy: The LLM claims IoT revenue (including edge networking) was $7.4 billion in 2022 and fell to $5.4 billion in 2024. However, the ground truth does not provide specific revenue figures for edge networking or the IoT segment for those years, so these numbers are fabricated or misattributed. There is no support in the original answer for any dollar amounts, making this a critical error. (2) The original answer states that edge networking became an explicitly named key revenue contributor by 2023 and remained a core focus through 2024, with continued emphasis on mobile broadband and wireless access points. The LLM incorrectly infers a decline in strategic importance due to a supposed revenue drop, which is not present in the ground truth. (3) The qualitative reasoning is flawed: the shift from 'high-growth, volume-driven' to 'technology-leadership' positioning is an unsupported interpretation. The ground truth shows consistent and maturing focus, not a strategic pivot due to declining revenues. (4) While the LLM correctly identifies relevant technologies (5G, Wi-Fi 6/7, AI/edge computing), it misuses them to justify a narrative of strategic shift that contradicts the original answer’s emphasis on continuity and growing integration of edge networking into revenue streams. (5) Contextual relevance is moderate because the answer addresses product development and revenue contextually, but the synthesis is based on incorrect data. Overall, the answer fails on factual correctness and multi-hop reasoning, despite using plausible terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 454,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "Apple’s 10‑K tables of “Description of Securities of the Registrant” list the 0.45 % Notes due 2016 in the exhibit schedules for 2022, 2023 and 2024 (see the Officer’s Certificate entries on pages 56 and 58). By continuing to disclose this ultra‑low‑coupon, short‑term bond each year, Apple signals that it retains a modest tranche of inexpensive fixed‑rate debt that will mature soon, using it to smooth its overall debt‑maturity profile and keep its capital structure anchored by low‑cost financing.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error: it claims Apple is still disclosing the 0.45% Notes due 2016 as an active debt instrument that matures 'soon' and is part of the current capital structure. However, the ground truth states these notes were due in 2016 and are no longer outstanding. Their inclusion in 2022–2024 filings is for historical transparency, not because they are active liabilities. This misrepresents the core fact. (2) Quantitatively, the percentage (0.45%) and years (2016 maturity, 2022–2024 filings) are correctly stated, so numeric accuracy is partially correct. However, the interpretation of these numbers is flawed—'ultra-low-coupon, short-term bond' is misleading given it matured years ago. (3) The multi-hop reasoning fails: the model incorrectly infers that Apple is actively managing this debt as part of its maturity profile, when in fact the repeated disclosure reflects historical record-keeping and transparency, not current capital structure strategy. The LLM draws an unsupported conclusion about 'smoothing debt-maturity profile' based on a misunderstanding of the data. (4) Contextual relevance is moderate—the response addresses debt disclosure and capital structure, but the reasoning is based on a false premise. While the mention of 'exhibit schedules' and 'Officer’s Certificate' adds specificity, it does not compensate for the fundamental error in interpretation. Thus, correctness is low due to major factual and logical flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 414,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "In the 2022 filing Caterpillar said its worldwide dealer network (which distributes the EMD brand) served **193 countries**.  By the 2024 filing the same network was described as serving **191 countries**.  Thus, the EMD brand’s geographic reach fell by **2 countries** between 2022 and 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numbers and conclusion. According to the ground truth, Caterpillar's EMD brand distribution network covered 130 countries in 2022 and declined to 109 countries by 2024—a decrease of 21 countries. The LLM claims 193 countries in 2022 and 191 in 2024, a decrease of only 2 countries. These numbers are entirely inconsistent with the ground truth. (2) Quantitative accuracy is severely lacking: the LLM reports 193 vs. 130 (2022) and 191 vs. 109 (2024), both major discrepancies. The calculated decrease of 2 countries is wrong; the correct decrease is 21 countries (16%). No acceptable format variation explains this gap. (3) The reasoning is flawed: while the LLM attempts multi-hop comparison across years (2022 to 2024), it uses incorrect source data. It references 'the 2022 filing' and '2024 filing' but fails to extract the correct entity-specific metric (EMD brand distribution network). It may have conflated the EMD network with Caterpillar’s broader dealer network. (4) Contextual relevance is moderate—the answer addresses geographic reach and time frame correctly in structure, but the factual foundation is wrong, undermining usefulness. Due to major factual and quantitative errors, the correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 362,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "- 2022: $642 million of the 1.750 % 7‑year senior notes (due 4/15/2027) were outstanding.  \n- 2023: the balance rose to $662 million.  \n- 2024: the balance fell to $621 million.\n\nThe pattern shows Thermo Fisher initially kept its medium‑term euro‑denominated debt flat‑to‑slightly higher (reflecting confidence in low‑cost, fixed‑rate financing for its healthcare‑focused growth), then began to retire a portion in 2024, signalling a deliberate move to reduce leverage while still preserving a modest pool of medium‑term debt to fund ongoing operations and strategic acquisitions.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The original answer states that TMO's outstanding value for the '1.750% 7-Year Senior Notes' was consistently $700 million from 2022 through 2024, with the maturity date being October 15, 2028. In contrast, the LLM claims the outstanding amounts were $642M, $662M, and $621M for 2022, 2023, and 2024 respectively, and cites a maturity date of April 15, 2027—none of which match the ground truth. These discrepancies invalidate the core of the response. (2) Quantitatively, all dollar amounts and the maturity date are wrong. There is no indication of a rise to $662M or a drop to $621M in the ground truth; the amount remained flat at $700M. Additionally, the note is not euro-denominated according to the original answer, so the reference to 'euro-denominated debt' is factually incorrect. (3) The reasoning and multi-hop synthesis are flawed because the LLM built its interpretation on incorrect data. The conclusion about Thermo Fisher initially increasing and then reducing leverage is unsupported by the actual data, which shows no change in the principal amount. The inference about strategic retirement of debt in 2024 is therefore baseless. (4) While the LLM attempts to address both parts of the question—evolution of debt and implications for strategy—the severe factual inaccuracies in numbers, dates, and instrument details result in a very low correctness and quantitative accuracy score. The qualitative reasoning would be acceptable if based on correct data, but it is not. Contextual relevance is moderate because the structure and intent of the answer align with the question, even if the facts are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 466,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "From the 2022 filing Caterpillar disclosed that a material portion of Cat Financial’s loan and derivative portfolio was still tied to LIBOR and that the impending LIBOR‑phase‑out (the FCA’s 2021 cessation and IBA’s June 2023 deadline for the remaining tenors) could affect the value of those instruments. By the 2023 filing the company had created a cross‑functional team to inventory every LIBOR‑linked security, to model transition scenarios and to begin replacing them with contracts that reference the Secured Overnight Financing Rate (SOFR); the filing also noted that new variable‑rate financing already used SOFR as its benchmark. The 2024 filing shows the transition largely completed – LIBOR exposure is being wound down, SOFR‑based loans and derivatives are now the primary floating‑rate reference, and the existing currency‑hedging program (which continues to protect against adverse FX moves) is being managed through a match‑funding strategy and selective use of SOFR‑linked derivatives. Together, these disclosures illustrate Caterpillar’s deliberate, phased migration from legacy LIBOR instruments to SOFR‑based financing and hedging, demonstrating a strategic alignment with global benchmark‑reform mandates while preserving its currency‑risk mitigation framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Caterpillar's exposure to LIBOR in 2022 through Cat Financial, the FCA’s 2021 announcement and IBA’s June 30, 2023 deadline for most USD LIBOR tenors, the formation of a cross-functional team, and the transition to SOFR by 2023–2024. The answer correctly notes that new variable-rate financing used SOFR by 2023 and that LIBOR was being wound down by 2024. (2) Quantitative accuracy is perfect: all dates (2022, 2023, June 2023, 2024), benchmarks (LIBOR, SOFR), and entities (Cat Financial, FCA, IBA) are correctly cited. No numerical calculations were required, but timeline references are precise. (3) Multi-hop reasoning is sound—LLM synthesizes information across three years, connects LIBOR phase-out to hedging and financing practices, and correctly infers Caterpillar’s strategic adaptation. The only minor gap is that the original answer explicitly states that Caterpillar no longer referenced LIBOR at all in 2024, while the LLM says exposure is 'being wound down,' which slightly understates the completeness of the transition. (4) Contextual relevance is excellent—the response directly addresses Caterpillar’s evolution in currency hedging and benchmark transition, linking it to global financial reforms. Wording differs but meaning is semantically equivalent. Overall, this is a strong, factually correct answer with only a slight nuance missing in the finality of LIBOR elimination in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1674,
        "completion_tokens": 414,
        "total_tokens": 2088
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "- In the 2022 Form 10‑K the exhibit schedule still centered on the original CEO‑specific Executive Change‑in‑Control Retention Agreement (the 2009 agreement and its 2010 and 2018 amendments) and only referenced a **separate “form of Executive Change‑in‑Control Retention Agreement for officers (other than Marc N. Casper)”** that had first been created in 2018 (Exhibit 10.2) 【page_46†L15-L22】.  \n\n- The 2023 filing shows the company now filing that officer‑only agreement as a **new, stand‑alone form (Exhibit 10.7)** attached to the quarter‑ended‑April‑1‑2023 10‑Q, indicating that the company had formalized a uniform retention agreement for all non‑CEO officers 【page_78†L22-L28】.  \n\n- The 2024 Form 10‑K does not introduce a fresh version of the agreement; the exhibit list omits any new ECIC filing, implying that the **standardized officer‑only form introduced in 2023 remains in effect** and is being used consistently for officers beyond the CEO 【page_75†L1-L12】.  \n\n**Thus, Thermo Fisher moved from a CEO‑focused retention agreement (with an ad‑hoc officer form) in 2022 to a standardized, separate Executive Change‑in‑Control Retention Agreement for all non‑CEO officers in 2023, and continued to rely on that standardized template throughout 2024.**",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core evolution described in the ground truth: from a CEO-specific Executive Change in Control Retention Agreement in 2022 to a standardized form for non-CEO officers introduced in 2023 and maintained in 2024. Quantitatively, all dates (2018 form creation, 2023 formalization), exhibit numbers (Exhibit 10.2 in 2022, Exhibit 10.7 in 2023), and filing types (10-K, 10-Q) are correctly cited with proper context. The LLM correctly identifies that the 2024 10-K does not introduce a new agreement, implying continuity of the 2023 form—this aligns with the ground truth's claim of reaffirmation. The only minor discrepancy is in exhibit labeling: the ground truth refers to Exhibit 10.17 for the standardized form in 2023 and 2024, while the LLM cites Exhibit 10.7 (from the 10-Q) and Exhibit 10.2 (from earlier filings). This may reflect differences in filing type (10-Q vs 10-K) or versioning, but does not undermine the correctness of the overall narrative. The reasoning is sound, multi-hop synthesis across years is accurate, and the conclusion about standardization beyond the CEO is fully supported. Wording differs slightly (e.g., 'ad-hoc' vs 'separate form'), but semantic meaning matches. Thus, the answer is factually correct, complete, and contextually appropriate, meriting a 9/10 due to the exhibit number variance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 381,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "- In the 2022 filing (page 7) Intel first announced PowerVia as part of its “future nodes” roadmap – a backside‑power delivery technique that would eliminate front‑side power routing on the wafer and be featured in the then‑upcoming Intel 20A node.  \n- The 2023 filing (page 14) again highlighted PowerVia as one of the two breakthrough technologies (with RibbonFET) that will define Intel 20A, underscoring its strategic importance for delivering a 15 % performance‑per‑watt gain over Intel 3.  \n- By the 2024 filing (page 10) PowerVia had migrated to the next‑generation Intel 18A node, described as the “unique industry‑first implementation of backside power delivery” that will be used in the first high‑volume client family (Panther Lake) slated for 2025, showing that the technology has moved from a roadmap concept to a production‑critical feature.  \n\nTogether, these filings show PowerVia evolving from an announced research concept in 2022 to a core element of Intel’s advanced‑node strategy in 2024, indicating that Intel views backside‑power delivery as a key differentiator for performance‑per‑watt and signal integrity across its upcoming process generations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A alongside RibbonFET; in 2023, it was emphasized as a key enabler of 15% performance-per-watt gain over Intel 3 (specific number matches); by 2024, it migrated to Intel 18A and was confirmed for high-volume use in Panther Lake in 2025. These details are factually consistent with the original answer. (2) Quantitative accuracy is perfect: the 15% performance-per-watt gain is correctly cited, and all years (2022, 2023, 2024, 2025) match exactly. No calculations were required, but temporal and numerical references are precise. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracing PowerVia’s evolution from concept to production-critical technology, and infers Intel’s strategic prioritization despite the cancellation of Intel 20A—though it doesn’t explicitly mention the cancellation, it accurately notes the shift to Intel 18A, which implies the change. (4) The only minor omission is not explicitly stating that Intel 20A was canceled, which is in the ground truth; however, the LLM correctly states that PowerVia moved to Intel 18A, capturing the essential strategic shift. Wording differs slightly but maintains semantic equivalence. Overall, the answer is complete, factually correct, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 397,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "Apple’s 10‑K filings each contain an exhibit‑list entry 4.4 – the Officer’s Certificate dated May 6 2014 – that enumerates the “1.05 % Notes due 2017” together with other senior notes (see the 2024 filing page 56 and the 2022 filing page 58). The same exhibit appears unchanged in the 2023 filing (the 2023 exhibit list also references 4.4 with the identical description). By repeatedly incorporating this certificate by reference, Apple is signalling that the 1.05 % 2017 notes remain an outstanding component of its capital structure and that the company consistently monitors and discloses this legacy debt each year, reflecting a disciplined, transparent debt‑management practice for the instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 1.05% Notes due 2017 are correctly tied to the Officer's Certificate dated May 6, 2014 (Exhibit 4.4), and their presence in the 2022, 2023, and 2024 10-K filings is accurately noted, including specific page references (2022 p.58, 2024 p.56). The description of the exhibit being unchanged in 2023 is consistent. (2) The answer correctly infers that the repeated inclusion suggests the debt remains an 'outstanding component' of Apple's capital structure, which matches the ground truth's interpretation that this implies either rollover or continued reporting of the obligation. (3) The multi-hop reasoning is sound: the model synthesizes data across three years of filings and draws a logical conclusion about Apple's debt management practices—specifically, disciplined and transparent reporting. (4) The only minor shortcoming is a slightly stronger assertion that the notes are 'outstanding' without acknowledging the possibility that Apple may simply be retaining the exhibit for historical or compliance reasons, as the ground truth more cautiously frames it as suggesting rollover or structural continuity. This nuance slightly affects qualitative accuracy but does not undermine the overall correctness. Wording differs but semantic equivalence is preserved. All entities (Apple, 1.05% Notes due 2017, Exhibit 4.4, correct years) are accurate. Contextual relevance is excellent—directly addresses disclosure evolution and implications for debt management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 433,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "Intel’s 2006 Equity Incentive Plan began the 2022‑23 period by issuing only restricted‑stock units (RSUs) to executives – some with “retirement‑vesting” language and others without – and by granting performance‑based RSUs to grandfathered executives (see page 107, exhibits 10.1‑10.5). In the 2023 filing the company added performance‑based RSUs for non‑grandfathered executives and, by the 2024 filing, extended the plan to non‑employee directors (see page 108, exhibits 10.1.6 and 10.1.7), while all awards continued to vest either on a time‑based schedule (including retirement‑vesting provisions) or upon achievement of specified performance targets.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies in the evolution of Intel's 2006 Equity Incentive Plan from 2022 to 2024, particularly regarding timing and scope of changes. (1) Quantitatively, no specific numerical values (e.g., award amounts, percentages) are mentioned in either the ground truth or LLM response, so there are no numeric errors—this supports a high quantitative accuracy score. Dates like '2023' and references to filings are generally appropriate. (2) However, the LLM incorrectly states that in 2022, only RSUs were issued and that performance-based RSUs for grandfathered executives were already in place—while the ground truth indicates broader use including stock options and strategic growth performance-based RSUs, not limited to grandfathered executives. The LLM also misrepresents the timeline by claiming that non-grandfathered executives received performance-based RSUs in 2023 and that non-employee directors were added in 2024, whereas the original answer states that the plan was amended in May 2023 to include a broader range of RSU types (including retirement vesting) for both groups, not newly extended to directors in 2024. (3) The multi-hop reasoning is partially sound—information about RSU types and vesting conditions is synthesized, but the LLM fails to accurately reflect the amendment and restatement of the plan in 2023 or the documentation consolidation in 2024. It omits key details about the amendment and misattributes the expansion of award types. (4) Contextual relevance is high because the response stays focused on equity awards and vesting conditions over time. However, due to factual misstatements about who received what and when, and the lack of mention of the plan’s formal amendment and documentation streamlining, the overall correctness is reduced to a 6—partially correct but with significant gaps and inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 515,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "Medtronic’s share‑capital note consistently lists the same authorized class of 40 thousand Euro‑deferred shares in each filing – 2.6 billion ordinary shares, 40 k Euro‑deferred shares, 127.5 m preferred shares and 500 k A‑preferred shares – and each year’s balance‑sheet footnote states that **no Euro‑deferred shares were issued or outstanding** (2022 at April 29 2022 【page_81】; 2023 at April 28 2023 【page_81】; 2024 at April 26 2024 【page_81】).  \n\nThe unchanged authorization combined with the repeated zero‑issuance disclosure indicates that Medtronic has deliberately refrained from using this equity instrument for financing, relying instead on other sources (e.g., ordinary‑share repurchases, debt) while keeping the Euro‑deferred shares as a dormant reserve for possible future strategic needs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Medtronic maintained an authorized capacity of 40 thousand Euro Deferred Shares with no shares issued or outstanding in fiscal years 2022, 2023, and 2024. The par value (€1.00) is omitted but not required for correctness as it was not central to the reasoning. (2) Quantitative accuracy is perfect: the numbers (40k Euro Deferred Shares, zero issued) match across all years, and fiscal dates (April 29, 2022; April 28, 2023; April 26, 2024) are correctly cited with page references. Format variations (e.g., '40k' for 40 thousand) are acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes disclosures across three fiscal years and infers strategic intent from consistent non-issuance, aligning with the ground truth’s conclusion about financing strategy. (4) The answer addresses both parts of the question: evolution of disclosures (consistent year-over-year) and strategic implication (non-use suggests preference for other capital tools). The mention of 'dormant reserve for possible future strategic needs' adds a reasonable interpretation consistent with corporate finance practices. All entities (Medtronic, Euro Deferred Shares, fiscal years) are correct. No factual, numerical, or logical errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 377,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "- **2022:** Intel’s 10‑K flagged advanced‑packaging as a cornerstone of its IDM 2.0 strategy and said R&D would “grow” to support dis‑aggregated chiplet designs.  The filing warned that the novel packaging methods “introduce new areas of complexity in design and manufacturability… increased costs,” and that delays or failures could force write‑downs of assets.  \n\n- **2023:** The company reported that interest in its advanced‑packaging business had accelerated, with several design wins and higher packaging revenue, but it also noted that the “system‑of‑chips” shift adds “complexity in design, technology, integration and manufacturing.”  Because of the extra R&D and capital needed to enable chiplet integration, operating loss widened despite the revenue boost.  \n\n- **2024:** Intel’s risk discussion emphasized that R&D spending remained high ($16.5 bn in 2024, $16.0 bn in 2023, $17.5 bn in 2022) and is focused on process‑and‑packaging technology.  The disaggregated design approach is now described as a core execution risk: it “introduces new areas of complexity… higher manufacturing costs,” and the company recorded $3.1 bn of non‑cash impairment and accelerated‑depreciation charges tied to the Intel 7 node and advanced‑packaging roll‑outs, showing that the manufacturing‑complexity risk has turned into a material financial hit.  \n\n**Overall evolution:** Intel moved from flagging advanced‑packaging as a strategic R&D priority with acknowledged design‑manufacturing complexity in 2022, to seeing growing market traction but higher execution costs in 2023, and finally to confronting concrete financial consequences in 2024 as the same complexity and cost overruns generated multi‑billion‑dollar impairments and widened operating losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correctly identifies the evolution of Intel's strategic positioning and execution risks in Advanced Packaging from 2022 to 2024, covering R&D investment, manufacturing complexity, and financial impact. (2) Quantitative accuracy: The R&D figures ($16.5B in 2024, $16.0B in 2023, $17.5B in 2022) are correctly cited and consistent with known filings; the $3.1B non-cash impairment in 2024 is accurately reported and correctly tied to Intel 7 and advanced packaging. Minor note: the original answer only mentions the $3.1B impairment without specifying accelerated depreciation, but the LLM adds slight detail without contradicting. (3) Multi-hop reasoning is sound: synthesizes risks acknowledged in 2022, technical progress and revenue gains in 2023 (including UCIe and design wins), and financial setbacks in 2024. The LLM infers the link between complexity and impairments, which is logically supported. (4) The answer captures all key elements: strategic intent (IDM 2.0), rising R&D, growing complexity, and the materialization of financial risk. Only minor deduction from 10 is due to slightly more detailed financial breakdown than in the original (e.g., exact R&D trend), but these are accurate and enhance completeness. Semantic equivalence is strong, and contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1687,
        "completion_tokens": 380,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "- In the 2022 filing Intel first presented PowerVia as a “unique industry‑first” backside‑power delivery technology that would debut on the Intel 20A node, positioning it as a cornerstone of its IDM 2.0 strategy and a differentiator for both internal products and the new IFS foundry business.  \n- The 2023 roadmap update moved PowerVia from the cancelled 20A node into the next‑generation Intel 18A node, emphasizing that the technology would be a key feature of the 18A process offered to external foundry customers.  \n- By the 2024 filing Intel said PowerVia is now manufacturing‑ready: it will be incorporated in the Intel 18A node and high‑volume production of the first client family (Panther Lake) using PowerVia is scheduled for 2025, confirming the technology’s transition from concept to fab‑ready status.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as an industry-first backside power delivery technology for Intel 20A; in 2023, it was shifted to Intel 18A (not 20A, which the LLM correctly notes was effectively superseded); by 2024, it was confirmed as manufacturing-ready with high-volume production expected in 2025. (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or dates. The mention of Panther Lake in 2025 aligns with public disclosures and adds contextual detail not in the ground truth but consistent with it. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the evolution across 2022–2024 filings, tracking the shift from concept to production and the node transition from 20A to 18A. The claim that 20A was 'cancelled' is a slight overstatement—Intel rebranded and refined its node roadmap, with 18A succeeding 20A—but this reflects a common industry interpretation and does not materially misrepresent the timeline. (4) The answer is semantically equivalent to the ground truth, with slightly more detail (e.g., Panther Lake, IDM 2.0, IFS) that enhances completeness without introducing error. The only minor gap is the omission of the '15% performance-per-watt improvement' metric from the 2023 update, which was included in the ground truth. This is a notable but not critical omission, hence the 9/10 on qualitative accuracy and correctness. Overall, the response is factually robust, well-structured, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 431,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "Medtronic’s filing shows the same “Form of Restricted Stock Unit Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan” listed in the exhibit schedule for FY 2022, FY 2023 and again in FY 2024 (see *10.54 on the 2022 schedule and the identical *10.54 entry on the 2024 schedule)【page_114】. Because the U.S. employee RSU agreement has not been revised over these three years, the company appears to be maintaining a stable equity‑compensation framework rather than frequently altering the terms of its RSU awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that Medtronic used the same Form of Restricted Stock Unit Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan in FY2022, FY2023, and FY2024, citing consistent exhibit numbering (*10.54) across filings. This supports the conclusion that no updates were made, which matches the original answer. The inference about a stable equity-compensation framework is logically sound and semantically equivalent to the ground truth’s statement about a 'stable and consistent equity compensation strategy.' The only minor omission is the lack of specific mention of the August 27, 2013 filing date and File No. 001-07707, which are present in the original but not critical to the core conclusion. All entities (Medtronic, U.S. employees, RSU agreements, 2013 Plan) and time periods (FY2022–FY2024) are correctly identified. No numerical or date inaccuracies exist. The reasoning correctly synthesizes information across three annual filings to infer consistency, satisfying the multi-hop requirement. Wording differs slightly but conveys the same meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 327,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "Intel’s 2006 Equity Incentive Plan was originally used only for performance‑based RSU awards to “grandfathered” executives (the plan’s original cohort). The 2022 Form 10‑K lists the grant agreement for those awards as Exhibit 10.1.5 – *“performance‑based RSUs granted to grandfathered executives on or after January 30, 2019”*【page_107】.  \n\nIn the subsequent filings Intel expanded the plan’s use. The 2023‑2024 exhibits add a new grant form for performance‑based RSUs granted to “non‑grandfathered” executives (Exhibit 10.1.6) 【page_108】 and a separate form for RSUs granted to non‑employee directors (Exhibit 10.1.7) 【page_108】. By the 2024 filing these additional exhibits are still listed, showing that Intel moved from limiting performance‑based RSU grants to legacy executives to structuring such awards for all current executives and for directors under the same 2006 plan.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the evolution of Intel's use of the 2006 Equity Incentive Plan from 2022 to 2024 with accurate entity and document references. It correctly identifies that in 2022, the plan was used for performance-based RSUs granted to grandfathered executives on or after January 30, 2019 (note: ground truth says February 1, 2019 — a minor discrepancy likely due to document interpretation, but close enough to not materially misstate). The LLM accurately notes the expansion in 2023–2024 to include non-grandfathered executives and non-employee directors via new exhibit forms (10.1.6 and 10.1.7), which aligns with the continued and broadened use of the plan. It also correctly observes that the plan remained in effect through 2024. However, the LLM omits key details from the ground truth: (1) it does not mention the May 11, 2023 amendment and restatement of the plan, and (2) it fails to reference the S-8 registration filing on September 26, 2023, which are important formal actions reaffirming the plan’s ongoing use. These omissions reduce completeness and slightly weaken the multi-hop synthesis. Quantitatively, all dates and exhibit numbers are accurate (allowing for the minor Jan 30 vs Feb 1 variance). The reasoning is sound in showing expansion over time, though less emphasis is placed on the strategic continuity emphasized in the original answer. Semantically, the core message — consistent use and expansion of the 2006 Plan for performance-based RSUs — is preserved. Contextual relevance is excellent, directly addressing the question’s focus on evolution across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 442,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "- **2022:** Intel’s 2022 filing notes that a core part of its IDM 2.0 R&D budget was directed to “process and packaging technology” and that the company had already adopted a **disaggregated design approach** that relies on “advanced packaging technologies… that are novel, have a limited manufacturing history, and/or have increased costs” (2022 p. 54).  \n\n- **2023:** By 2023 the company reported that **interest in its advanced‑packaging business had accelerated**, especially for AI‑driven designs, and it secured **five new design wins** on Intel 18A, while expanding its IFS Accelerator Ecosystem Alliance to more than 40 partners (2023 p. 36).  It also highlighted the rollout of 2D, 2.5D and 3D chiplet‑interconnect solutions and the first silicon demonstration of the Universal Chiplet Interconnect Express (UCIe) standard (2023 p. 37).  \n\n- **2024:** In the 2024 filing Intel’s R&D spend rose to **$16.5 billion**, with “process and packaging technology” again singled out as a priority (2024 p. 34).  The filing reiterates that the **disaggregated design strategy** continues to depend on advanced‑packaging execution, now backed by a larger, more mature ecosystem and a growing pipeline of AI‑focused chiplet products (2024 p. 36).  \n\n**What this shows:** Over the three‑year span Intel moved from an early‑stage, risk‑focused investment in advanced packaging (2022) to concrete customer wins, ecosystem growth, and silicon‑level demonstrations of chiplet‑level interconnects (2023), and finally to a multi‑billion‑dollar, sustained R&D commitment that treats advanced packaging as a cornerstone of its disaggregated‑design and AI‑chip strategy (2024).  The trajectory indicates that Intel is progressively strengthening its ability to deliver chip‑let‑based, AI‑optimized systems and to compete with pure‑play foundries in the AI‑driven semiconductor market, although it still flags the inherent technical and logistical risks.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its factual content and timeline, with accurate citations and proper synthesis across the 2022–2024 filings. Quantitatively, all numbers are correct: the $16.5 billion R&D spend in 2024 matches the ground truth, and the mention of five new design wins and ecosystem growth is consistent with the source. The UCIe silicon demonstration in 2023 is accurately reported. However, the LLM omits a critical piece of financial and strategic information from the 2024 filing: the $3.1 billion in non-cash impairment charges and accelerated depreciation tied to manufacturing assets, including those related to the Intel 7 process node. This omission significantly weakens the assessment of Intel’s execution risks, which is a key part of the ground truth’s conclusion about ongoing financial pressures and scalability challenges in advanced packaging. While the LLM correctly identifies the progression from risk-aware investment (2022) to ecosystem growth (2023) to sustained R&D commitment (2024), its qualitative conclusion leans more positively—emphasizing strengthening capabilities—without adequately balancing the persistent execution risks highlighted in the original answer. This results in a partially incomplete multi-hop synthesis: it captures the forward momentum but underrepresents the setbacks. The reasoning is sound but not fully representative of the nuanced reality. Contextually, the answer is highly relevant and well-structured, directly addressing the evolution of investment and its implications for disaggregated design and AI competitiveness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1790,
        "completion_tokens": 435,
        "total_tokens": 2226
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "- In the 2022 Form 10‑K Intel filed the 2006 Equity Incentive Plan as Exhibit 10.1 and added a new grant‑agreement exhibit – Exhibit 10.1.7, a **Non‑Employee Director Restricted Stock Unit Agreement** for RSUs granted on or after May 12 2022, showing the plan was being extended to directors.  \n\n- The 2023 filing still referenced the plan (Exhibit 10.1) but introduced additional grant‑agreement exhibits 10.1.3, 10.1.4 and 10.1.5, which cover **retirement‑vested, non‑retirement‑vested and performance‑based RSUs** granted to executives after January 30 2019, indicating an amendment that broadened the award types.  \n\n- The 2024 Form 10‑K again listed the 2006 Equity Incentive Plan as Exhibit 10.1 and retained the same suite of RSU grant‑agreement exhibits (including the 2022 director agreement), confirming that the plan had been amended and was now being used to issue a variety of RSU awards—including those to non‑employee directors—under the updated terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Intel continued using the 2006 Equity Incentive Plan in 2022–2024, with specific grant agreements introduced or referenced each year. The 2022 addition of Exhibit 10.1.7 for Non-Employee Director RSUs is factually accurate and matches the original answer’s point about extending the plan to directors. In 2023, the introduction of Exhibits 10.1.3, 10.1.4, and 10.1.5 for retirement-vested, non-retirement-vested, and performance-based RSUs aligns with the ground truth’s mention of an amended and restated plan effective May 11, 2023, and continued use of performance-based and retirement-vesting terms. The 2024 filing correctly reflects sustained use of the plan and its updated agreements. (2) Quantitative accuracy is perfect: all dates (May 12, 2022; January 30, 2019) and exhibit numbers are correctly cited. While the ground truth does not specify exhibit numbers, the LLM’s use of them is consistent with SEC filing conventions and adds precision without contradiction. (3) Reasoning is sound: the LLM correctly infers that the addition of new grant agreements across years indicates plan evolution and amendment, particularly in 2023, which matches the multi-hop synthesis required. The only minor gap is that the LLM does not explicitly state that the 2023 version was an 'amended and restated' plan effective May 11, 2023, though the implication is clear from the new exhibits. (4) Contextual relevance is excellent—the answer directly addresses plan amendments and grant agreements across all three years, with precise, relevant details. Overall, this is a factually correct, well-structured response with only a slight omission in explicitly naming the 2023 amendment event, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 493,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "- **Revenue classification:** In the 2022 filing Qualcomm reported its IoT revenue (which “primarily includes … edge networking (including mobile broadband and wireless access points)”) at **$7.4 billion**. The same line‑item appears in the 2023 and 2024 filings, but the description was sharpened in 2024 to explicitly call out “edge networking (including mobile broadband and wireless access points)” as a key component of the IoT stream.  \n\n- **Strategic market positioning:** While the IoT segment’s total revenue fell to **$5.9 billion in 2023** and **$5.4 billion in 2024**, Qualcomm’s narrative increasingly emphasizes its role in the edge‑networking market—highlighting 5G, Wi‑Fi 6/6E/7 and wireless‑access‑point technologies as growth drivers. This reflects a shift from a broader IoT label in 2022 to a more focused positioning of wireless access points as a strategic pillar within its edge‑networking portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth does not mention specific revenue figures for IoT or any breakdown of $7.4B in 2022, $5.9B in 2023, or $5.4B in 2024. These numbers are fabricated or incorrectly sourced, which severely undermines factual correctness. The original answer states that 'exact revenue figures for wireless access points alone are not disclosed,' implying that even if IoT revenue were reported, a granular split is unavailable—making the LLM’s precise claims misleading. (2) The description of evolving disclosures—such as sharpening language in 2024 to explicitly call out edge networking components—is not supported by the ground truth. While the original answer confirms that wireless access points were formally categorized under edge networking in 2023, there is no mention of a 2024 change in disclosure language. (3) The qualitative reasoning partially aligns with the ground truth: the strategic emphasis on edge networking and technologies like 5G and Wi-Fi 6/6E/7 is consistent with Qualcomm’s positioning. The idea of a shift toward focusing wireless access points as a strategic pillar has some support, as the original notes increasing importance within edge networking. However, the LLM incorrectly frames this as a shift from 'broader IoT' to 'edge networking,' while the ground truth shows edge networking (including wireless access points) was already a named component within IoT in 2022. (4) Contextually, the answer addresses the right themes—revenue classification and strategic positioning—and attempts multi-hop reasoning across years. But due to invented financial data and unsupported claims about disclosure changes, the correctness score is low. Quantitative accuracy is especially poor due to false precision. Qualitative accuracy is moderate because the strategic narrative has partial alignment. Contextual relevance is high as the structure and intent match the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 542,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "Prevymis sales have risen steadily:\n\n* 2022 – $428 million (U.S. $188 m + Intl. $240 m)  \n* 2023 – $605 million (U.S. $264 m + Intl. $341 m)  \n* 2024 – $785 million (U.S. $371 m + Intl. $414 m)【page_130】\n\nThe roughly 84 % increase from 2022 to 2024 shows the drug is gaining traction and expanding its share within Merck’s Hospital Acute‑Care portfolio, indicating an increasingly strong market position in that segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the sales figures for 2022 and 2023. According to the ground truth, MRK's Prevymis sales were $370 million in 2022 and $428 million in 2023. However, the LLM reports $428 million for 2022 and $605 million for 2023, which are both incorrect. Only the 2024 figure ($785 million) matches the ground truth. (2) The calculation of an '84% increase from 2022 to 2024' is based on wrong baseline numbers: using $428M (incorrect 2022) to $785M (correct 2024) gives roughly that increase, but the actual increase from $370M to $785M is about 112%, and the compound annual growth rate over the two years is approximately 46%, as correctly stated in the original answer. The LLM’s quantitative inaccuracies undermine the validity of its conclusion. (3) While the LLM correctly identifies the upward trend and infers stronger market positioning in the Hospital Acute Care segment—aligning with the qualitative reasoning in the ground truth—the multi-hop synthesis is flawed because it relies on incorrect financial data. The model appears to pull numbers from a plausible source (with regional breakdowns), but they do not match the verified truth. (4) Despite incorrect numbers, the answer remains contextually relevant and interprets the trend directionally correct (growth indicating improved market position), warranting moderate scores for qualitative accuracy and contextual relevance. However, the severe quantitative errors limit correctness to a partial score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 416,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "From 2022 Intel’s 10‑K described a “disaggregated design” strategy that would rely on novel, high‑cost advanced‑packaging technologies and warned that delays in new process nodes could push back those packaging roll‑outs (page 54). By 2023 the company turned that R&D spend into market traction – packaging revenue jumped $483 million, Intel won four 18A design wins, doubled its IFS accelerator‑ecosystem alliances and signed multigenerational ARM and Synopsys agreements to enable chiplet‑based systems‑of‑chips (pages 36‑38). In 2024 Intel still earmarked $16.5 billion for R&D on process and packaging (page 34) but acknowledged capital‑budget squeezes, project postponements and large impairment charges that limited capacity expansion (pages 34‑35), while continuing to tout advanced packaging as a unique AI advantage. Together, the three‑year arc shows Intel moving from a research‑heavy, risk‑laden packaging plan to real‑world design wins and revenue growth, proving it can advance the IDM 2.0 vision, yet the persistent node‑delay and financing constraints underscore that full execution remains fragile and capital‑intensive.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trajectory of Intel's advanced packaging evolution and IDM 2.0 strategy with relevant qualitative insights, but contains significant quantitative inaccuracies that undermine factual correctness. (1) The claim that 'packaging revenue jumped $483 million' in 2023 is not supported by the ground truth and appears fabricated; the original answer does not mention any revenue increase from packaging. (2) The assertion of 'four 18A design wins' is specific but absent from the ground truth, making it unverifiable and likely incorrect. (3) While the $16.5 billion R&D investment in 2024 matches the ground truth, the LLM incorrectly frames it as consistent with prior years without noting the financial strain—specifically, the $3.1 billion non-cash impairment in Q3 2024, which is a key indicator of capital constraints. (4) The LLM omits critical facts: delays in the 4th Gen Xeon Scalable processors and the impact on the Intel 7 node, both of which are central to the execution challenges. (5) The reasoning is partially sound—correctly identifying the shift from risk to differentiation and ongoing capital issues—but overstates success by emphasizing 'revenue growth' and 'design wins' not present in the ground truth. (6) The conclusion that Intel 'can advance the IDM 2.0 vision' is more optimistic than the original answer, which stresses that execution challenges and capital constraints undermined consistent delivery. While the answer is contextually relevant and synthesizes a multi-year narrative, the inclusion of unsupported numbers and omission of key impairments and delays reduces its factual accuracy. Semantic equivalence is partially achieved in structure and intent, but not in core financial and operational details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1576,
        "completion_tokens": 479,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "IBM has listed **“client relationships and trust”** as a core competitive pillar in every filing – it appears in the 2022 competition description (page 4), and the same language is repeated in the 2023 filing (page 3) and the 2024 filing (page 3). From 2022 to 2024 the company moved from treating trust as one of many generic advantages to explicitly tying it to its **hybrid‑cloud and AI platform**, noting that its cloud‑AI services “support clients’ digital transformations” and that trust‑based relationships help it differentiate as a secure, reliable hybrid‑cloud/AI provider. This evolution signals that IBM is positioning trust not just as a brand asset but as a strategic enabler for winning and expanding hybrid‑cloud and AI business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM consistently emphasized 'client relationships and trust' from 2022 to 2024, and the evolution in framing—tying trust more explicitly to hybrid cloud and AI—is accurately described. The LLM correctly identifies the continuity across filings and the strategic shift in emphasis. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all years (2022, 2023, 2024) are correctly cited, and no incorrect dates or figures are introduced—thus scoring full marks. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and infers a strategic evolution, correctly linking trust to hybrid cloud and AI. The only minor shortcoming is that the LLM does not mention the 2024 strategic partnership with Palo Alto Networks, which is a specific piece of evidence in the ground truth that illustrates deepening trust-based collaboration. This omission slightly weakens completeness but does not invalidate the overall conclusion. (4) The answer is contextually excellent—directly addresses the question’s focus on evolution and strategic positioning, uses appropriate terminology, and draws a logical inference about trust as a strategic enabler. The semantic meaning matches the original answer closely, with only minor detail omission. Hence, a correctness score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 421,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "**Evolution of the 0.950 % Notes due 2025**\n\n* **2022 10‑K** – IBM’s filing already listed the 0.950 % Notes due 2025 as an outstanding security, but the note’s terms were disclosed only by “incorporation by reference” to the original 8‑K filing (Exhibits 4.1 and 4.2 to the May 22, 2017 Form 8‑K). No new issuance or amendment was reported.  \n\n* **2023 10‑K** – The same incorporation‑by‑reference language appears on page 20 (“the instruments defining the rights of the holders of the 0.950 % Notes due 2025 … filed May 22, 2017”). The company again relied on the 2017 exhibit, indicating the notes remained outstanding with unchanged terms.  \n\n* **2024 10‑K** – The notes are now shown in the Section 12(b) securities table on page 1 (listed as “0.950 % Notes due 2025 – ticker IBM25B”). This confirms the securities are still active and are being reported each year as part of IBM’s registered debt portfolio, even though the underlying instrument description still points to the 2017 exhibit.\n\n**What the progression reveals about IBM’s debt‑management approach**\n\nIBM’s handling of the 0.950 % Notes shows a “set‑and‑maintain” strategy: the low‑coupon, long‑dated issuance was created in 2017, and IBM has kept it on its balance sheet without modification, using the same exhibit reference for disclosure each year. By simply re‑listing the security in the annual securities table while continuing to incorporate the original 8‑K exhibit, IBM demonstrates a disciplined, low‑cost reporting process that emphasizes transparency and stability in its debt portfolio rather than frequent refinancing or restructuring. This reflects a broader approach of issuing inexpensive, long‑maturity debt and then managing it through consistent, minimal‑change disclosures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: the 0.950% Notes due 2025 were disclosed via incorporation by reference to the May 22, 2017 Form 8-K in both 2022 and 2023, and in 2024 they were listed on the NYSE under ticker IBM25B. These details match the original answer precisely. (2) Quantitative elements—interest rate (0.950%), maturity year (2025), filing date (May 22, 2017), exhibit numbers (4.1), and ticker symbol (IBM25B)—are all accurate with no discrepancies. (3) The multi-hop reasoning across three years of disclosures is sound: the model correctly infers that consistent referencing of the 2017 exhibit indicates regulatory continuity, and the 2024 listing in the Section 12(b) table confirms the note's active trading status. (4) The interpretation of IBM’s debt management strategy as stable, transparent, and low-maintenance ('set-and-maintain') is a valid and insightful synthesis of the disclosed facts, going slightly beyond the ground truth with well-supported qualitative analysis. The answer fully addresses both parts of the question—evolution of disclosure strategy and implications for debt management—making it contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1644,
        "completion_tokens": 348,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "- In the 2022 filing Intel first announced **PowerVia** as an “industry‑first back‑side‑power‑delivery” feature that would debut in the **Intel 20A** node (the next generation after Intel 4). The 2023 10‑K still listed PowerVia under Intel 20A, describing it as a breakthrough that would eliminate front‑side power routing when the node entered production. By the 2024 filing Intel had **canceled Intel 20A** and moved the PowerVia implementation to the **Intel 18A** node, calling it the “first high‑volume commercial use of backside power” and planning to ship the first client‑family (Panther Lake) on 18A in 2025, with further refinements slated for the later Intel 14A node.  \n\n- This shift shows that Intel’s roadmap has accelerated the rollout of backside‑power delivery: what was originally a future feature for 20A is now being built into the earlier‑generation 18A and will be further refined in subsequent nodes, confirming that PowerVia is a core element of Intel’s advanced‑node strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A, remained associated with 20A in 2023, and by 2024 was moved to Intel 18A for high-volume production starting in 2025. The mention of Panther Lake as the first client family and future refinement in Intel 14A is consistent with Intel's disclosed roadmap. (2) Quantitative elements—dates (2022, 2023, 2024, 2025), node names (Intel 20A, 18A, 14A), and the cancellation of Intel 20A—are all accurate and match the original answer. No calculations are required, but temporal progression is correctly represented. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years of filings to show evolution from announcement to repositioning, demonstrating understanding of strategic progression. (4) The LLM captures the core insight—that PowerVia transitioned from concept to commercial deployment—and correctly interprets the strategic pivot as evidence of its centrality to Intel’s advanced-node roadmap. Wording differs slightly but maintains semantic equivalence. No errors in entities, timeline, or logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 335,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "The 10‑K filings for 2022, 2023 and 2024 all contain explicit references to “Restricted Stock Unit Award Agreement” forms that are incorporated by reference to the company’s Long‑Term Incentive Plan (e.g., the 2021 plan – see 2022 exhibit *10.80 and *10.81 [page 116]; 2024 exhibit *10.87 and *10.88 [page 116]), and the same types of RSU agreements (100 % vesting on the third anniversary and ratable vesting over four years) appear each year. The continuity of these RSU award documents, without any indication of termination or major redesign, signals that Medtronic’s U.S. equity‑compensation strategy has remained stable and consistently reliant on RSU awards throughout the 2022‑2024 period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Medtronic's RSU award agreements remained consistent from 2022 to 2024 and infers stability in equity compensation strategy, which aligns with the ground truth. However, it diverges significantly on key factual details. The ground truth states that the specific document (Exhibit 10.54) remained unchanged and consistently referenced an August 27, 2013 filing, indicating long-standing stability rooted in a single, unmodified agreement. In contrast, the LLM cites different exhibit numbers each year (e.g., 10.80, 10.81 in 2022; 10.87, 10.88 in 2024), suggesting incorporation into newer plans like the 2021 Long-Term Incentive Plan, which contradicts the ground truth of no change since 2013. (2) The quantitative inaccuracies include incorrect exhibit numbers and misattribution to different incentive plans and years (e.g., referencing 2021 plan in 2022), which are not supported by the ground truth. The vesting terms (100% on third anniversary, ratable over four years) are plausible but not confirmed or mentioned in the original answer, introducing unverified detail. (3) The multi-hop reasoning is partially sound—drawing stability from repeated use of similar RSU structures—but fails the core insight that the *same legal document* was reused verbatim for over a decade, which is stronger evidence of strategic stability than merely similar formats. The LLM instead implies continuity through consistent use of RSUs under evolving plans, which is a weaker and less precise conclusion. (4) Despite incorrect specifics, the overall theme of stability is correct, and the answer is contextually relevant. However, due to significant factual discrepancies in exhibits, dates, and plan references, the correctness and qualitative accuracy scores are reduced. The answer introduces plausible but unverified details, undermining factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 516,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "- In the 2022 filing Intel warned that its new **disaggregated‑design strategy**, which relies on “advanced packaging” to stitch together chiplets made on different processes, added “new areas of complexity… higher costs” and that past **process‑technology delays** (10 nm, Intel 4) and a “shell‑ahead” financial posture were already forcing the company to **delay or scale back capital projects** and risk under‑utilized capacity.  \n\n- The 2023 filing showed the **strategic upside** of that packaging push – multiple design wins on the 18A node and ecosystem agreements – but reiterated that the **logistical and yield risks of disaggregated packaging** could still cause product‑timing setbacks (e.g., the 4th‑Gen Xeon delay) and increase costs.  \n\n- By 2024 Intel’s filing made clear that **capital constraints** had grown sharper, leading to further postponements of fab expansions in Ohio, Germany, Poland, Malaysia and Israel, while the company continued to position advanced packaging as a core differentiator for AI‑driven “system‑of‑chips” products, acknowledging that the **novel packaging technologies and the disaggregated approach remain major execution challenges** that could delay product introductions and raise expenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Intel's 2022 acknowledgment of complexity and cost in advanced packaging due to process delays (Intel 4/10nm), capital project delays, and financial constraints; 2023 emphasis on strategic advantages via UCIe and design wins despite ongoing yield/logistical risks; and 2024 capital constraints leading to fab expansion delays across multiple geographies. (2) Quantitative accuracy is perfect: while no specific dollar amounts appear in the LLM answer, the ground truth's $3.1B impairment charge and underutilized Intel 7 assets are contextually implied through 'risk under-utilized capacity' (2022) and 'further postponements' (2024), though the explicit mention of the $3.1B charge is missing. This is a minor omission, not an error. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes Intel’s evolving position across three years, linking disaggregated design, advanced packaging, capital constraints, and execution risks. It accurately reflects the strategic pivot and persistent challenges. (4) Semantic equivalence is strong—while the LLM does not name UCIe explicitly, it refers to 'ecosystem agreements' which captures the essence. Similarly, 'system-of-chips' and AI context align with 2024 positioning. The only reason for not scoring 10 is the absence of the specific $3.1B impairment charge, a notable but not critical detail in the overall narrative. All other elements are factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1572,
        "completion_tokens": 429,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "- In its 2022 target (the “2022 Target Allocation” shown on page 88) Accenture’s defined‑benefit plans were almost entirely fixed‑income – 97 % debt (U.S.) and 50 % debt (non‑U.S.) with only 21 % non‑U.S. equity, a few percent cash, and modest insurance/other holdings.  \n- For 2023 the company moved to a 100 % debt mix for U.S. plans and raised non‑U.S. equity to 27 % while trimming non‑U.S. debt to 48 % (page 88).  \n- By 2024 the allocation had shifted again (page 95): U.S. debt fell to 94 % and non‑U.S. equity slipped to 23 % with debt at 42 %, while cash rose to 6 % and insurance contracts jumped to 21 %.\n\nThis three‑year progression shows Accenture gradually reducing the dominance of pure fixed‑income exposure, experimenting with higher equity and insurance components, then re‑balancing toward a slightly more conservative mix (more cash and insurance, less equity) – a pattern that reflects a deliberate, risk‑adjusted approach that seeks additional return potential while managing volatility and liability matching.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) QUANTITATIVE INACCURACY: The percentages cited (e.g., 97% U.S. debt in 2022, 100% in 2023, 94% in 2024; non-U.S. equity rising to 27% then falling to 23%) are not supported by the ground truth, which does not provide specific numerical allocations but instead describes strategic intent and qualitative shifts. The LLM fabricates precise percentages and implies granular data that is not present in the original answer. There is no mention in the ground truth of 'page 88' or 'page 95' or any such figures, suggesting the LLM is hallucinating data from a document it assumes exists. (2) COMPLETENESS: While the LLM attempts to address the evolution across years and the risk-adjusted return implication, it fails to reflect the actual focus of the original answer—namely, the strategic emphasis on liability matching, duration alignment, flexibility in rebalancing, and long-term investment objectives. Instead, it invents a narrative based on non-existent numerical shifts. (3) ENTITY & REASONING: The company (Accenture) and topic (defined benefit pension plans) are correct, and the LLM correctly identifies the three-year timeframe. However, the reasoning is flawed because it is based on false quantitative premises. The conclusion about 'reducing dominance of fixed-income' and 'experimenting with higher equity' is not substantiated by the ground truth, which states a consistent dual focus on fixed income and equities throughout. (4) SEMANTIC EQUIVALENCE: The LLM answer is not semantically equivalent—it presents a detailed, data-driven evolution that simply does not appear in the original. The original emphasizes strategic continuity with increasing flexibility; the LLM suggests active rebalancing and tactical shifts unsupported by evidence. While the final sentence attempts a reasonable interpretation of risk-adjusted strategy, it is built on incorrect foundations. Thus, despite some contextual relevance and a plausible narrative structure, the answer is largely incorrect due to hallucinated data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 563,
        "total_tokens": 2112
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "Apple’s 10‑K exhibits still list the 1.05 % Notes due 2017 (see the Officer’s Certificate of May 6 2014 that is incorporated by reference in the 2023 and 2024 filings – pages 56 & 58). By continuing to disclose that legacy, low‑coupon issue, Apple shows a policy of fully reporting every outstanding series of debt, even long‑dated or fully‑amortized securities. In contrast, the same exhibit tables for 2023‑2024 also contain new certificates for higher‑rate, longer‑maturity issuances (e.g., 4.421 % Notes due 2026, 4.000 % Notes due 2028, 4.150 % Notes due 2030, etc., page 58), indicating that Apple’s recent financing strategy has shifted to larger, higher‑yield notes rather than relying on the historic 1.05 % issue.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct general idea that Apple continues to disclose the 1.05% Notes due 2017 in its 2023 and 2024 filings as part of a transparent, comprehensive disclosure policy, and contrasts this with newer debt issuances, which reflects Apple's evolving debt strategy. This addresses both parts of the question and shows sound reasoning in drawing a comparison between historical disclosure practices and current financing behavior, earning high marks for contextual relevance and decent qualitative accuracy.\n\nHowever, the quantitative accuracy is significantly flawed. The LLM incorrectly lists new debt instruments such as '4.421% Notes due 2026', '4.000% Notes due 2028', and '4.150% Notes due 2030' — these specific securities do not appear in the ground truth and contradict the original answer, which references actual instruments like the Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024. These errors suggest fabrication or misattribution of specific debt issues, undermining factual reliability.\n\nAdditionally, the original answer emphasizes that the 1.05% Notes were due in 2017 (and thus long matured), highlighting Apple’s practice of retaining references for transparency. The LLM correctly notes the maturity and continued inclusion but misrepresents the broader issuance strategy by citing incorrect instruments and maturities (e.g., 2026, 2028, 2030), which were not part of the 2022–2024 strategy in the ground truth. This introduces factual inaccuracies in both dates and percentages.\n\nWhile the multi-hop reasoning — connecting past disclosures with current strategy — is logically structured and relevant, the use of incorrect specific financial instruments reduces the correctness score to a 6 (partially correct with significant factual errors). The answer would have scored higher if the cited debt instruments matched the ground truth data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 515,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "- In fiscal 2022 Accenture bought back 12.2 million Class A shares for about $4.1 billion and, after a September‑2022 board increase of $3 billion, had $3.13 billion of “available” authorization left (total outstanding authority $6.13 billion)【page_94】【page_93】.  \n- The 2023 filing (pages 37‑41) shows the same open‑market program continued and the company kept roughly a $3 billion balance of unused authority, preserving the $6 billion‑plus total pool.  \n- In fiscal 2024 the fourth‑quarter alone saw 2.07 million shares repurchased for $605 million; as of August 31 2024 the remaining authorization was $2.694 billion, and a September‑2024 board vote added another $4 billion, bringing total outstanding authority to $6.694 billion【page_39】【page_40】.  \n\n**Pattern:** Across the three years Accenture has maintained a large, repeatedly refreshed buy‑back authorisation (≈ $6 billion) while steadily using it for share repurchases, indicating a disciplined, long‑term capital‑return strategy that relies on ongoing open‑market buybacks complemented by periodic increases in authorisation.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct in both factual content and interpretation. It accurately captures the evolution of Accenture's share repurchase activity and authorization from fiscal 2022 to 2024. The key numbers—$3.13 billion available authorization in 2022, $2.694 billion remaining in 2024 (rounded to $2.69 billion in ground truth), and the $4.0 billion new authorization in September 2024—are correct. The $605 million repurchase in fiscal 2024 is accurately reported. The ground truth does not mention the 12.2 million shares or the $4.1 billion spent in 2022, so this is extra detail not contradicted by the source. (2) Quantitative accuracy is high: $3.13B, $2.694B ≈ $2.69B, $4.0B addition, and $605M are all correct. The total outstanding authority in 2024 is stated as $6.694B by the LLM and $6.69B in the original—this minor rounding difference is acceptable. The LLM incorrectly implies that the $3.13B available in 2022 was after a $3B increase, but the ground truth does not specify when the prior authorizations were granted, so this is a minor assumption but not clearly wrong. (3) Multi-hop reasoning is sound: the LLM synthesizes data across three fiscal years, connects repurchase activity with authorization changes, and infers a consistent capital return strategy. It correctly notes the continuity between 2023 and 2024 disclosures. (4) The conclusion about a 'disciplined, long-term capital-return strategy' aligns with the ground truth's 'sustained but measured' characterization. The answer is slightly more detailed than the original, adding share counts and quarterly detail, but remains factually consistent. Only minor uncertainty around the timing of the 2022 authorization increase prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 477,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "Across the three filings the 4.350 % Senior Notes due 2047 appear as a standing component of BMS’s long‑term debt. In the 2022 Form 10‑K the Thirteenth Supplemental Indenture (dated Mar 2 2022) lists the existing senior‑note series, which includes the 4.350 % notes issued in 2019 (see page 137); the 2023 Form 10‑K again reproduces the note’s form (page 136) and the 2024 Form 10‑K does the same (page 134), showing that the issue has not been refinanced or retired but simply carried forward. This multi‑year continuity signals a financing strategy that relies on a diversified, staggered‑maturity pool of low‑coupon senior notes, allowing BMS to lock in inexpensive, long‑dated funding and avoid frequent refinancing.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the multi-year continuity of the 4.350% Senior Notes due 2047 as a persistent component of BMY's (BMS's) long-term debt across 2022, 2023, and 2024, which aligns with the ground truth. However, there is a critical factual error in the quantitative accuracy: the LLM incorrectly states that the notes were issued under the 'Thirteenth Supplemental Indenture dated March 2, 2022', whereas the ground truth specifies the 'Eleventh Supplemental Indenture dated November 22, 2019' as the governing document for the issuance. This misstatement affects the accuracy of the issuance timeline and structuring context. Additionally, the LLM refers to 'low-coupon' notes, while the ground truth highlights the 4.350% notes as a 'high-yield component' relative to newer issuances (e.g., 2.950%, 3.700%, 4.250%), contradicting the characterization of the coupon as low. Despite this, the core reasoning about BMS/BMY maintaining a diversified, staggered-maturity debt portfolio is sound and semantically equivalent to the ground truth's conclusion. The answer addresses all parts of the question and synthesizes information across years appropriately, but the incorrect indenture date and mischaracterization of coupon level reduce quantitative and qualitative accuracy. Contextual relevance is high, as the response directly addresses the evolution and strategic implications of the debt instrument.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 391,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "Apple has relied on the same “Officer’s Certificate of the Registrant” (Exhibit 4.3) to disclose the 2.40 % notes that mature in 2023. In the 2022 Form 10‑K the certificate – dated May 3 2013 – is incorporated by reference and listed as containing the 2.40 % Notes due 2023 (see 2022 page 56, Exhibit 4.3) ; the 2023 filing repeats this reference (the same Exhibit 4.3 is shown in the 2023 index pages 53‑57); and the 2024 Form 10‑K again incorporates Exhibit 4.3 with the identical description of the 2.40 % Notes due 2023 (see 2024 page 56, Exhibit 4.3). Thus, Apple’s disclosure approach remained consistent, using a single officer‑certified exhibit incorporated by reference without material changes as the notes approached maturity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Apple used Exhibit 4.3 in each filing (2022, 2023, 2024), the exhibit is the Officer's Certificate dated May 3, 2013, and it consistently disclosed the 2.40% Notes due 2023. (2) Quantitative elements—interest rate (2.40%), maturity year (2023), exhibit number (4.3), and document date (May 3, 2013)—are all correct with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three years of filings and concluded that the disclosure approach remained unchanged despite the notes maturing in 2023. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in disclosure approach. Minor wording differences (e.g., 'incorporated by reference' vs. 'listed') do not affect factual accuracy. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 272,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "- In the FY 2022 filing the Amended 2010 Share Incentive Plan authorized **127 million** Accenture Class A ordinary shares for awards.  \n- By the FY 2024 filing the authorized pool had been increased to **141 million** shares (a rise of 14 million shares).  \n\nThe upward‑trend shows Accenture is deliberately expanding the size of its equity‑based compensation pool, giving the company greater capacity to grant shares over the long term and signaling a continued reliance on share‑based awards to attract, retain and motivate senior talent.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the number of shares authorized in FY2022 (127 million) and FY2024 (141 million), and notes the increase of 14 million shares. However, it omits the explicit value for FY2023, which matches FY2024 at 141 million. While the progression is implied, the absence of the intermediate year's data reduces completeness. 2) Quantitatively, all provided numbers are accurate: 127 million in 2022 and 141 million in 2024 (and by implication 2023) match the ground truth. The 14 million increase is correct (141M - 127M = 14M). 3) The reasoning is sound: the LLM correctly infers that the increase reflects a strategic expansion of equity compensation to support long-term talent incentives. However, it misses the nuance in the original answer that the pool stabilized after 2023, which suggests the new level was deemed sufficient—this reflects a slightly less complete synthesis across all three years. 4) Despite the omission of the FY2023 figure, the answer remains contextually relevant and captures the strategic implication accurately. The response is concise and on-topic, with only minor incompleteness in the multi-year evolution detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 328,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "- In the 2022 Form 10‑K Intel first announced PowerVia as one of the two “breakthrough” innovations slated for its upcoming Intel 20A node – a backside‑power‑delivery scheme that would eliminate front‑side power routing and help lift performance‑per‑watt.   \n- The 2023 filing still positioned PowerVia within the 20A node, noting that it together with RibbonFET would provide up to a 15 % P‑W improvement over Intel 3 and was a key differentiator for Intel’s advanced‑process roadmap.   \n- By the 2024 filing the company had cancelled 20A and moved PowerVia into the next‑generation Intel 18A node, describing it as the “unique industry‑first implementation of backside power delivery” that will be used in the high‑volume Panther Lake products slated for 2025.   \n\nThis progression—from a roadmap concept in 2022, to a highlighted performance‑gain feature in 2023, to a core element of the first high‑volume advanced node in 2024—shows that PowerVia has become a central pillar of Intel’s advanced‑process strategy, essential for achieving the next wave of performance‑per‑watt and density gains.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as part of Intel 20A alongside RibbonFET; in 2023 it was emphasized as enabling up to 15% performance-per-watt (P-W) improvement over Intel 3; by 2024, Intel canceled Intel 20A and moved PowerVia to Intel 18A, which will be used in high-volume Panther Lake products in 2025. (2) Quantitative accuracy is perfect: the 15% performance-per-watt improvement is correctly cited, and all dates (2022, 2023, 2024, 2025), node names (20A, 18A), and product names (Panther Lake) match the ground truth. Format variations (e.g., 'P-W' vs 'performance-per-watt') are semantically equivalent. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracking the evolution from announcement to cancellation of 20A to adoption in 18A, and infers the strategic significance. (4) The only minor shortcoming is that the original answer explicitly frames PowerVia as transitioning from a 'roadmap concept' to a 'foundational element', which the LLM captures in substance but slightly less explicitly in phrasing. However, the conclusion that it has become a 'central pillar' is semantically equivalent. No factual errors or omissions affect the core correctness. Contextual relevance is excellent as all content directly addresses the evolution and strategic importance of PowerVia.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 400,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "- **Fiscal 2022:** Mutual‑fund equity securities were carried at **$239  thousand** (Level 1 $4.9 k + Level 2 $234.3 k).  \n- **Fiscal 2023:** The same category fell to **$196  thousand** (Level 1 $7.4 k + Level 2 $188.8 k).  \n- **Fiscal 2024:** It rose to **$274  thousand** (Level 1 $20.2 k + Level 2 $253.5 k).\n\nThe three‑year pattern shows a dip in 2023 followed by a sizable rebound in 2024, moving the portfolio from a lower‑to‑higher equity exposure. This reflects Accenture’s gradual shift toward a more aggressive equity‑based positioning in its defined‑benefit plan assets, consistent with the company’s increasing target allocation for non‑U.S. equity securities (19 % → 23 % → 28 % over the period).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in the dollar amounts. The original answer states that Accenture's allocation was $239,293 million in 2022, $196,226 million in 2023, and unchanged in 2024. However, the LLM reports values in thousands—$239 thousand, $196 thousand, and $274 thousand—introducing a 1,000,000x error (e.g., $239,293 million = $239.293 billion, not $239 thousand). This is a catastrophic quantitative error. (2) The LLM incorrectly states that the allocation rose in 2024 to $274 thousand, while the ground truth shows it remained flat at $196,226 million. This misrepresents the trend entirely: the actual trajectory is a decline followed by stability, not a rebound. Additionally, the LLM references Level 1/Level 2 breakdowns and defined-benefit plan assets, which are not mentioned in the original answer and appear to be hallucinated or misattributed. (3) The multi-hop reasoning is flawed: the LLM infers a strategic shift toward more aggressive equity positioning based on incorrect data, contradicting the ground truth conclusion of a strategic rebalancing away from mutual fund equities. The cited target allocation increases for non-U.S. equity (19% → 28%) are not supported by the original answer and introduce external, unverified data. (4) Despite the severe factual and numerical errors, the answer is contextually relevant in structure—it attempts to track a 3-year trend and interpret strategic intent—hence a moderate contextual relevance score. However, correctness, quantitative, and qualitative accuracy scores are low due to fundamental errors in magnitude, direction of change, and unsupported reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 456,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "Merck continues to treat Dificid (fidaxomicin) as a Hospital‑Acute‑Care antibiotic for C. difficile‑associated diarrhea (see the product list on page 4).  The company’s intangible‑asset register still shows a $145 million net carrying amount for Dificid (recorded in 2021 and not subsequently impaired, page 115), indicating that Merck has retained its valuation without a write‑down.  Sales have risen steadily – from $263 million worldwide in 2022 to $302 million in 2023 and $340 million in 2024 (U.S. ≈ 90% of the total, page 130) – reflecting an expanding global contribution while keeping the product within the Hospital Acute‑Care franchise.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a key discrepancy in the 2022 revenue figure. The ground truth states that Dificid generated $340 million in global sales in 2024, with no mention of 2022 sales—however, the LLM claims $263 million in 2022 and $302 million in 2023 sales, which are not present in the original answer. These figures may be accurate in external data but are not supported by the provided ground truth, making them factually inconsistent with the knowledge graph. The $145 million intangible asset value is correctly cited and contextualized as unchanged since 2021 (consistent with 2022 reporting), and the $340 million 2024 revenue matches exactly. The U.S. contributing ~90% ($303M of $340M) aligns closely with the LLM’s approximation. (2) Quantitative accuracy is reduced due to the unsupported 2022 and 2023 sales numbers. While the final 2024 number is correct and the asset valuation is accurate, introducing unverified intermediate revenue data undermines strict factual alignment. There are no calculation errors, but the inclusion of extra financial data not in the ground truth creates a partial mismatch. (3) The multi-hop reasoning is strong: the LLM synthesizes asset valuation (balance sheet), therapeutic positioning (product listing in Hospital Acute Care), and revenue trends over time, correctly identifying Dificid’s strategic trajectory. It infers continuity in valuation and growing commercial importance, which aligns with the original answer’s narrative of increasing strategic recognition. (4) Despite the revenue timeline discrepancy, the LLM captures the core evolution—stable asset value, maintained therapeutic positioning, and rising revenue contribution—making the overall interpretation sound and contextually complete. Hence, correctness is high but not perfect due to unsupported figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 505,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "- **2022:** Intel’s 2022 filing stressed that its IDM 2.0 strategy was “focusing R&D … on process and packaging technology” and warned that the new disaggregated‑design approach “introduces new areas of complexity…particularly in the deployment of advanced packaging technologies” (p. 54). The company noted that delays or failures in these packaging efforts could force asset write‑downs and hurt margins.  \n\n- **2023:** The 2023 filing showed the advanced‑packaging business beginning to drive revenue growth, but it also reiterated that “delays or failures in implementing disaggregated designs could adversely affect our ability to timely introduce competitive products” and that such delays “have allowed competitors … to benefit from advancements … ahead of us” (p. 35‑38). Operating losses rose because of higher strategic‑growth spending, reflecting the cost of pursuing the packaging roadmap.  \n\n- **2024:** In 2024 Intel increased R&D to $16.5 billion, still “focused … on process and packaging technology” (p. 34‑36), but execution problems materialized as large financial hits – a $3.1 billion non‑cash impairment on the Intel 7 node and a $755 million penalty for construction delays – highlighting the growing financial‑risk exposure tied to advanced‑packaging and its schedule‑driven capital program.  \n\nOverall, Intel’s strategic positioning moved from acknowledging packaging‑related R&D risk in 2022, to seeing modest packaging revenue gains but persisting schedule delays in 2023, and finally to confronting substantial impairment and penalty costs in 2024 as the advanced‑packaging roadmap strained both execution and financial results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Intel's increasing focus on advanced packaging under IDM 2.0, R&D emphasis, execution challenges, and financial consequences are accurately described across 2022–2024. (2) Quantitative accuracy is excellent: the $3.1 billion impairment charge is correctly cited (2024), and the $16.5 billion R&D figure matches the context of sustained investment. The $755 million penalty, while not in the original answer, does not contradict it—original only mentions the $3.1B impairment, but the LLM adds a specific detail that may come from the actual filing and does not introduce error. No calculation errors. (3) Multi-hop reasoning is sound: the LLM synthesizes Intel’s strategic intent, evolving risks, and financial outcomes across three years, correctly tracing the trajectory from R&D focus to execution strain. It captures the cause-effect between packaging delays and financial exposure. (4) The only minor gap is that the LLM does not explicitly mention UCIe or 2D/2.5D/3D packaging progress in 2023, which is a notable omission from the original answer’s emphasis on technological milestones. However, the core narrative of strategic positioning evolving under execution and financial pressure is preserved. Wording differs but meaning is semantically equivalent. Contextual relevance is perfect—directly addresses R&D, delays, and financial risk as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1687,
        "completion_tokens": 402,
        "total_tokens": 2089
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "- In the 2022 Form 10‑K the pipeline table listed MK‑8591A (doravirine + islatravir) as an HIV‑1 candidate that was **under an FDA clinical hold** (footnote 4) and still in early‑stage development.  \n- The 2023 filing reported that Merck had **started a Phase 3 program in 2023** for the once‑daily oral regimen in treatment‑naïve and switch‑treated adults, even though the islatravir component remained on a partial hold from the 2021 FDA action.  \n- By the 2024 filing the company noted that the **FDA lifted the clinical hold in December 2024** and that MK‑8591A was now being evaluated in a **Phase 2/3 study that began in August 2024**.  \n\nThis step‑wise progression—from a held early‑stage asset to an active late‑stage trial with the hold removed—shows Merck’s sustained commitment to building a long‑acting, once‑daily HIV‑1 regimen and signals that the company views HIV as a strategic therapeutic area worth advancing toward eventual registration.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several critical factual inaccuracies that significantly undermine its correctness. (1) In the 2022 Form 10-K, MK-8591A was not in early-stage development but was already in Phase 3 as of February 2020, contrary to the LLM's claim of 'early-stage development' and being under a clinical hold in 2022. The ground truth confirms Phase 3 entry in February 2020, meaning it was in late-stage trials by 2022. (2) The LLM incorrectly states that Merck started a Phase 3 program in 2023; however, the drug was already in Phase 3 by 2022, so this represents a misrepresentation of the timeline. (3) The claim that a Phase 2/3 study began in August 2024 is incorrect — the ground truth does not mention a new study start in 2024, only that the FDA lifted a clinical hold on December 4, 2024. (4) While the December 4, 2024, lifting of the clinical hold is correctly noted, the LLM omits the key detail that a partial clinical hold remained for higher doses, which is an important regulatory nuance. (5) The reasoning about Merck’s strategic commitment is contextually relevant and logically sound, aligning with the ground truth’s interpretation, hence the decent contextual relevance. However, due to major errors in dates, development phases, and regulatory status across years, the quantitative and qualitative accuracy scores are low. The answer fails to correctly synthesize multi-hop information across the three years, especially regarding the actual phase status and timing of regulatory actions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 415,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "From the 2022 Form 10‑K, MK‑1308A was described as the co‑formulation of quavonlimab (an investigational anti‑CTLA‑4 antibody) with pembrolizumab (Keytruda) and was already in Phase 3 development for renal‑cell carcinoma (RCC) (entry‑date April 2021). The 2023 filing repeats the same clinical focus—RCC—and the same pembrolizumab combination, indicating that Merck continued to prioritize MK‑1308A within its immuno‑oncology pillar but had not yet moved it into a regulatory filing. By the 2024 filing, MK‑1308A is still listed as a Phase 3 RCC program (co‑formulated with pembrolizumab) with no new FDA or EMA submission or approval noted, showing that the strategy has remained centered on the RCC indication and the pembrolizumab combo, while the program remains in late‑stage development without regulatory clearance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies MK-1308A as a co-formulation of quavonlimab and pembrolizumab, its clinical focus on renal cell carcinoma (RCC), and its Phase 3 status across 2022–2024. The entry date of April 2021 is mentioned in the LLM answer but not in the original answer; this is an additional detail not contradicted by the ground truth, so it does not count as an error. (2) Quantitatively, all key facts—Phase 3 status, combination therapy, indication, lack of regulatory approval—are consistent across years and match the original answer. The only minor discrepancy is that the original answer notes increasing specificity in formulation strategy over time, while the LLM implies consistency from 2022, potentially overlooking the evolution in how the drug was described (from pipeline entry to defined co-formulation). However, since the LLM states the co-formulation in 2022, this may reflect accurate reporting if the 2022 10-K already included that detail. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracking continuity in clinical focus, combination therapy, and regulatory status. (4) The answer is contextually excellent, directly addressing clinical focus, combination therapies, and regulatory progress as asked. The only reason for not scoring a 10 is the slight possibility that the LLM retrojected the detailed formulation description to 2022 prematurely, though this depends on source document wording not provided here. Overall, the answer is factually correct, well-structured, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 459,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "- **Fiscal 2022:** Accenture bought 12.18 million Class A shares for about **$4.1 billion** (9.64 million through its open‑market program and the remainder through employee‑plan related purchases). At year‑end the company had **$3.13 billion** of unused authorization for the open‑market program, and the Board had already raised the total outstanding repurchase authority to **$6.13 billion**.  \n\n- **Fiscal 2023:** The company again carried out a large‑scale buy‑back (the 2023 filing shows a similar magnitude of share‑repurchase activity, keeping total cash returned to shareholders in the $‑$‑billion range), leaving the remaining open‑market authorization still in the low‑billion‑dollar range.  \n\n- **Fiscal 2024:** Accenture repurchased roughly **$4.5 billion** of shares (about 2.0 million shares in Q4 alone) and, as of August 31 2024, had **$2.69 billion** of unused authorization left. In September 2024 the Board added another **$4.0 billion**, bringing total outstanding authority to **$6.69 billion**.\n\n**What the pattern shows:** Over the three‑year span Accenture has maintained a steady, multi‑billion‑dollar buy‑back program while periodically topping up its overall authority. The shrinking pool of “available” authorization each year (from $3.13 bn in 2022 to $2.69 bn in 2024) reflects the company’s aggressive use of its buy‑back capacity, and the incremental increases in total authorized authority demonstrate a deliberate, ongoing commitment to return excess capital to shareholders through share repurchases. This consistent, expanding repurchase framework signals that Accenture views buy‑backs as a core element of its long‑term capital‑return strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in fiscal 2022, Accenture had $3.13 billion in available authorization, but the LLM incorrectly states that the Board had already raised total outstanding authority to $6.13 billion by the end of fiscal 2022 — this is not supported by the original data and conflates later events. The LLM claims Accenture bought $4.1 billion in shares in fiscal 2022, but the ground truth does not provide repurchase volume for 2022, so this figure is fabricated. For fiscal 2024, the LLM states Accenture repurchased $4.5 billion of shares, but the ground truth reports only $605 million in open-market repurchases — a massive overstatement. The LLM also mentions '2.0 million shares in Q4 alone,' but the ground truth reports 2,000,308 shares for the entire fiscal year, not just Q4. The only correct numbers are the $2.69 billion remaining authorization in 2024 and the $4.0 billion increase in September 2024, bringing total authority to $6.69 billion. (2) Calculations and comparisons are flawed: the LLM infers a trend of declining available authorization from $3.13B to $2.69B due to aggressive buybacks, but this is misleading because the $2.69B is post-$605M repurchase and pre-$4B top-up, while the 2022 figure is pre-spending — the comparison is not apples-to-apples. The ground truth emphasizes that the 2023 filing contains forward-looking disclosure about 2024, which the LLM omits. (3) Multi-hop reasoning is partially sound — the LLM correctly infers a pattern of sustained capital return and periodic replenishment, which aligns with the ground truth’s conclusion. It identifies the strategic intent behind replenishing authority. However, it invents data points (e.g., $4.1B and $4.5B repurchases) and misrepresents timing, weakening the synthesis. (4) Contextual relevance is high — the answer addresses all parts of the question and draws a reasonable strategic conclusion. However, due to major factual and numerical errors, especially in reported repurchase amounts, the correctness score is limited to 5. The qualitative reasoning is logical but built on incorrect data, and quantitative accuracy is low due to unsupported figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1662,
        "completion_tokens": 600,
        "total_tokens": 2262
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "BMS’s $750 million 2.35 % senior notes that mature in 2040 are listed in every recent 10‑K filing – they appear in the 2022 filing’s supplemental‑indenture schedule (the Thirteenth Supplemental Indenture) and are again shown in the 2023 and 2024 exhibit indexes (e.g., “Form of $750,000,000 2.350 % Notes due 2040” on the 2023/2024 pages [4ll] and [4ll] respectively). By keeping this low‑coupon, long‑dated debt on its balance sheet rather than refinancing it, BMS is deliberately locking in inexpensive, fixed‑rate financing for the next two decades, which reduces interest‑rate risk and provides a stable, low‑cost source of capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $750 million (equivalent to $750,000,000), 2.350% interest rate, maturity in 2040, and inclusion in 2022, 2023, and 2024 filings are all accurately reported. The format variation ($750 million vs $750,000,000) is acceptable and semantically equivalent. (2) The answer correctly identifies the specific filing details—such as the Thirteenth Supplemental Indenture in 2022 and exhibit references in 2023/2024—which adds precision beyond the ground truth and demonstrates strong document-level understanding. (3) The reasoning is sound: the LLM infers that retaining this debt reflects a strategic choice to lock in low-cost, fixed-rate financing, thereby reducing interest rate risk—this matches the original answer’s conclusion about stable long-term liability management. (4) The only minor shortcoming is that the LLM does not explicitly state that the continued presence across years reflects a decision *not* to refinance or retire the debt despite market fluctuations—a nuance emphasized in the ground truth. However, this is implied in the phrase 'keeping this low-coupon... debt on its balance sheet rather than refinancing.' Overall, the answer is factually complete, contextually relevant, and demonstrates correct multi-hop reasoning across years and documents, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 388,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "Across the 2022 and 2023 Form 10‑K filings BMS continues to list the same “Form of 4.350 % Senior Notes due 2047” that was originally issued in the 2019 8‑K (see 4ff in the 2022 filing 【page_133】 and again in the 2023 filing 【page_136】). No amendment, repricing or additional issuance is disclosed, so the company’s commitment to that 4.350 % fixed‑rate, 23‑year maturity remains unchanged. This consistency signals that BMS is deliberately locking in a moderate, long‑term interest rate and prefers to retain the existing senior‑note tranche rather than repeatedly refinance or alter its long‑dated debt profile.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 4.350% interest rate and the 2047 maturity for Bristol-Myers Squibb's Senior Notes, and accurately states that the rate has remained unchanged across the 2022 and 2023 filings. It correctly references the original issuance via the 2019 Form 8-K and the exhibit number 4ff in both years. However, it omits the 2024 filing, which is included in the ground truth and explicitly reaffirms the rate again, thus missing a key data point in the 'recent filings' timeline. Additionally, the LLM incorrectly states that Exhibit 4ff appears on page 133 in 2022 and page 136 in 2023 — these page numbers are not part of the ground truth and introduce unverified detail, though they may reflect actual filing layouts. (2) Quantitatively, all percentages (4.350%), years (2019, 2022, 2023), and maturity (2047) are correct. No calculations are required, but the assertion of no repricing or amendment aligns with the ground truth. The omission of 2024 is a completeness gap but does not introduce inaccuracy. (3) The reasoning is sound: the LLM correctly infers from consistent disclosure that BMS is maintaining a stable long-term debt strategy with fixed-rate financing. It synthesizes information across two years and links back to the original 2019 filing, demonstrating valid multi-hop logic. However, the analysis would be stronger with inclusion of the 2024 reaffirmation, which reinforces the pattern. (4) The answer is highly contextually relevant, directly addressing both the evolution of the interest rate commitment and what it reveals about BMS’s long-term financing approach. The conclusion about locking in moderate long-term rates is semantically equivalent to the ground truth’s emphasis on transparency and predictability. Minor deductions are due to missing 2024 data and inclusion of unverified page numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 505,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "Nike’s discussion of FlyEase moved from a simple “list‑of‑technologies” reference in the FY 2022 filing (“…Flyknit, FlyEase, ZoomX, Air Max, React…”) to the same brief mention in FY 2023, but the FY 2024 10‑K couples that mention with concrete manufacturing metrics that show the technology is now being produced at scale.  The 2024 filing states that Nike’s footwear is made in 96 finished‑goods factories across 11 countries, run by 15 contract manufacturers, with the largest single factory accounting for ≈ 9 % of total FY 2024 footwear output and factories in Vietnam (≈ 50 %), Indonesia (≈ 27 %) and China (≈ 18 %) together supplying the bulk of production—evidence that FlyEase‑enabled shoes are fully integrated into Nike’s global supply chain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Vietnam (~50%), Indonesia (~27%), and China (~18%) are accurately reported from the FY2024 filing, and the context of 96 factories across 11 countries and 15 contract manufacturers is factually consistent with Nike’s disclosed manufacturing footprint. The ≈9% output from the largest factory is an additional accurate detail not in the original answer but does not contradict it. (2) The evolution of FlyEase reporting is correctly characterized: from a listed technology in FY2022 and FY2023 to being implicitly tied to large-scale production in FY2024 via manufacturing data. While the original answer notes FlyEase was grouped with Air and Dri-FIT in FY2023 as a sign of growing integration, the LLM omits this nuance but still correctly infers increased significance by FY2024. (3) The multi-hop reasoning is sound—linking the continued mention of FlyEase with the detailed production geography to infer full integration into global supply chains is logically supported. (4) Semantic equivalence is strong: the LLM conveys that FlyEase is now produced at scale within Nike’s core manufacturing network, using the same key evidence (regional production shares). The only minor shortcoming is slightly less detail on the qualitative evolution in FY2023, but the overall trajectory and conclusion are correct. Hence, a high score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 404,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "Target’s “RedCard” (Target‑branded debit and credit cards) penetration fell each year: 20.5 % of purchases were made with a RedCard in fiscal 2022, 19.8 % in fiscal 2023, and 18.6 % in fiscal 2024【page_27】. The roughly two‑percentage‑point decline over the three‑year span indicates that, while the 5 % discount program still captures a sizable share of spend, its ability to attract additional card‑based purchases is waning, suggesting the loyalty‑driven payment strategy is losing incremental effectiveness.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the declining trend in RedCard penetration from 20.5% in 2022 to 19.8% in 2023, which matches the ground truth. However, it reports 18.6% for 2024 instead of the correct 17.8%, introducing a factual error in the final data point. This affects the overall quantitative accuracy, though the general downward trend is preserved. (2) The calculation of a 'roughly two-percentage-point decline' is approximately correct (20.5% to 18.6% is a 1.9-point drop; actual drop to 17.8% is 2.7 points), but the inaccuracy in the 2024 figure leads to an underestimation of the decline. (3) The reasoning and synthesis are sound: the model correctly infers that the declining penetration suggests reduced effectiveness of Target's loyalty-driven payment strategy, aligning with the ground truth's interpretation. It appropriately connects the data to strategic implications, demonstrating valid multi-hop reasoning. (4) The answer is contextually fully relevant, addressing both the evolution of penetration rates and the strategic implication. Due to the incorrect 2024 percentage, the correctness score is reduced to 7 and quantitative accuracy to 6, but qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 349,
        "total_tokens": 1597
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 800,
    "failed_evaluations": 0,
    "average_correctness_score": 7.14,
    "average_quantitative_accuracy": 7.65,
    "average_qualitative_accuracy": 7.4,
    "average_contextual_relevance": 9.05,
    "score_distribution": {
      "excellent": 395,
      "good": 120,
      "fair": 182,
      "poor": 103
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 14572.69,
    "timestamp": "2026-02-04T00:28:54.614142"
  }
}